Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.8957493600628579,2.153681826056418,0.0,0.0,0.0,57/125,3.45%,KIF11;CENPF;BUB1;KNL1;CENPE;NUSAP1;DLGAP5;NDC80;KIF4A;BUB1B;NUF2;ZWILCH;CENPA;TTK;CDCA8;SPC24;STIL;NSL1;SPC25;BIRC5;AURKB;CENPP;SKA1;TACC3;CENPK;MAD2L1;ERCC6L;KIF2C;KNTC1;PMF1;CENPN;CENPM;SPDL1;CCNB1;SKA2;KIF18A;CENPH;CDC20;CKAP5;INCENP;CENPL;PLK1;CENPI;STMN1;ESPL1;WDR62;GPSM2;RCC1;NUP43;XPO1;AURKA;NDE1;SGO1;MAD1L1;PCNT;SUN2;PTPA
prerank,mitotic spindle organization (GO:0007052),0.8774672460273721,2.115059551677904,0.0,0.0,0.0,60/153,3.45%,KIF11;CENPF;BUB1;KNL1;CENPE;KIF23;TPX2;DLGAP5;PRC1;NDC80;KIF4A;BUB1B;NUF2;ZWILCH;CENPA;TTK;CDCA8;KIFC1;SPC24;STIL;NSL1;SPC25;BIRC5;AURKB;CENPP;SKA1;CENPK;MAD2L1;ERCC6L;KIF2C;KNTC1;PMF1;CENPN;CENPM;SPDL1;CCNB1;SKA2;KIF18A;CENPH;CDC20;CKAP5;INCENP;CENPL;PLK1;CENPI;STMN1;WDR62;GPSM2;CHEK2;RCC1;NUP43;XPO1;AURKA;NDE1;SGO1;MAD1L1;PCNT;FLNA;SUN2;PTPA
prerank,chromosome condensation (GO:0030261),0.9250403840336379,2.1105796283302305,0.0,0.0,0.0,16/36,4.60%,TOP2A;NUSAP1;NCAPG;CDK1;SMC4;NCAPD2;NCAPH;CCNB1;INCENP;SMC2;PLK1;NCAPD3;RB1;MCPH1;NCAPH2;NCAPG2
prerank,mitotic sister chromatid segregation (GO:0000070),0.887822348020909,2.106215133630763,0.0,0.0,0.0,37/98,4.60%,CENPE;NUSAP1;KIF23;DLGAP5;PRC1;KIF18B;NDC80;NCAPG;KIF14;CDCA8;KIFC1;CDK1;NSL1;SMC4;KIF22;KNSTRN;NCAPD2;CEP55;CENPK;KIF2C;NCAPH;SPDL1;CCNB1;KIF18A;SMC2;SPAG5;PLK1;RAD21;ESPL1;NCAPD3;RB1;SGO1;MCPH1;HASPIN;CDC23;NCAPH2;NCAPG2
prerank,centromere complex assembly (GO:0034508),0.9143007717511158,2.0621925379070953,0.0,0.0,0.0,20/36,4.13%,CENPF;KNL1;MIS18BP1;CENPE;DLGAP5;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;HELLS;NASP
prerank,sister chromatid segregation (GO:0000819),0.9253456289075819,2.045755653238566,0.0,0.0,0.0,18/31,4.60%,TOP2A;NUSAP1;KIF18B;NDC80;CDCA8;KIFC1;NSL1;SMC4;KNSTRN;CENPK;KIF18A;SPAG5;PLK1;ESPL1;RB1;SGO1;CHAMP1;NCAPG2
prerank,mitotic chromosome condensation (GO:0007076),0.9252329237199175,2.043992708289288,0.0,0.0,0.0,14/26,4.60%,NUSAP1;NCAPG;CDK1;SMC4;NCAPD2;NCAPH;CCNB1;SMC2;PLK1;NCAPD3;RB1;MCPH1;NCAPH2;NCAPG2
prerank,mitotic nuclear division (GO:0140014),0.85679184285926,2.019402501071582,0.0,0.00011289432773135949,0.001,23/71,4.60%,KIF11;NUSAP1;TPX2;KIF18B;NDC80;CDCA8;KIFC1;NSL1;SMC4;UBE2C;KNSTRN;CENPK;KIF18A;SPAG5;PLK1;ESPL1;CHEK2;NDE1;SGO1;FLNA;CEP192;ABRAXAS1;NCAPG2
prerank,chromatin remodeling at centromere (GO:0031055),0.901966630060436,2.0042231722316517,0.0,0.00010035051353898621,0.001,17/31,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;HELLS;NASP
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.8673463899477069,2.003316040678615,0.0,9.031546218508758e-05,0.001,18/56,2.09%,NUSAP1;KIF23;KIF4A;CENPA;CKAP2;AURKB;CEP55;ECT2;CIT;RACGAP1;CECR2;KIF20A;INCENP;PLK1;STMN1;ESPL1;ANLN;ALKBH4
prerank,mitochondrial protein processing (GO:0034982),-0.7511500504255311,-1.986281157904605,0.0,0.5520714625267805,0.28,7/11,20.93%,IMMP1L;SPG7;STOML2;ATP23;PMPCA;OMA1;AFG3L2
prerank,histone exchange (GO:0043486),0.8695292005728691,1.9860966996646738,0.0,0.00032841986249122757,0.003,16/37,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,CENP-A containing chromatin organization (GO:0061641),0.9023586676067062,1.9841202877794086,0.0,0.00041684059470040424,0.005,16/29,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.9023586676067062,1.9841202877794086,0.0,0.00041684059470040424,0.005,16/29,4.13%,KNL1;MIS18BP1;CENPA;CENPP;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,positive regulation of cell cycle process (GO:0090068),0.83519901453204,1.9784612421121135,0.0,0.00045157731092543795,0.006,31/91,8.22%,NUSAP1;KIF23;KIF20B;NDC80;KIF14;E2F7;GEN1;AURKB;ECT2;E2F8;CIT;MAD2L1;RACGAP1;CCNB1;SPAG5;CXCR5;RAD21;GPSM2;DBF4;AURKA;DDX11;PRKCE;FEN1;CEP295;XRCC3;CSPP1;TGFA;CDC25B;PKN2;DYNC1H1;RHNO1
prerank,mitotic metaphase plate congression (GO:0007080),0.8637016784577127,1.9741064273190536,0.0,0.0004214721568637421,0.006,15/51,4.02%,CENPE;NDC80;KIF14;NUF2;CDCA8;KIFC1;KIF22;CEP55;KIF2C;SPDL1;CCNB1;KIF18A;MAD1L1;CHAMP1;CDC23
prerank,mitotic cytokinesis (GO:0000281),0.8672514337566729,1.973456322758812,0.0,0.0003951301470597582,0.006,15/47,1.89%,NUSAP1;KIF23;KIF4A;CENPA;CKAP2;CEP55;ECT2;CIT;RACGAP1;KIF20A;INCENP;PLK1;STMN1;ESPL1;ANLN
prerank,regulation of cell cycle process (GO:0010564),0.8190107402754055,1.9645952781683569,0.0,0.0005312674246181623,0.009,22/104,2.97%,KIF11;MKI67;BUB1;PRC1;KIF20B;CDC25C;KNSTRN;AURKB;ECT2;RACGAP1;NEK2;BORA;KIF20A;SPAG5;TIPIN;PLK1;RMI2;DBF4;RCC1;AURKA;FBXO5;MAD1L1
prerank,zinc ion homeostasis (GO:0055069),-0.567332246966403,-1.9642350277463947,0.0,0.371039898933988,0.349,17/28,23.06%,PRKN;SLC39A7;SLC39A14;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SLC39A8;SLC39A6;MT2A;SLC39A12;SLC30A1;MT3
prerank,carbohydrate catabolic process (GO:0016052),-0.5391622250796718,-1.951487713408568,0.0,0.29124637228151745,0.391,21/38,20.82%,HK2;HK3;MANBA;GPI;DERA;MAN2B1;PFKL;ENO1;ALDOA;LDHA;TPI1;PGM1;PKM;PGAM1;PGAM4;ALDOC;MAN2C1;MAN2B2;ENO2;PFKFB2;PFKM
prerank,positive regulation of lipid localization (GO:1905954),-0.7762661986733932,-1.9496194407743026,0.006578947368421052,0.2244192937100734,0.402,5/11,7.90%,LRP1;LPL;ZC3H12A;IKBKE;VSTM2A
prerank,apoptotic nuclear changes (GO:0030262),0.8848532195743191,1.9468561836062985,0.0,0.0011038556489288483,0.019,3/24,1.06%,TOP2A;HMGB2;CECR2
prerank,regulation of mitotic nuclear division (GO:0007088),0.834648930152887,1.9459588511026726,0.0,0.0010457579831957512,0.019,16/55,7.21%,MKI67;NUSAP1;KIF20B;CDC25C;NEK2;BORA;CCNB1;CDK5RAP2;RCC1;AURKA;FBXO5;AURKAIP1;CHEK1;LCMT1;TGFA;PIN1
prerank,positive regulation of cytokinesis (GO:0032467),0.8742417628669101,1.9384900103863703,0.0,0.0015353628571464892,0.03,12/32,7.43%,KIF23;KIF20B;KIF14;AURKB;ECT2;CIT;RACGAP1;CXCR5;PRKCE;CSPP1;CDC25B;PKN2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.8616604746987121,1.9383773307041454,0.0,0.0014622503401395136,0.03,17/38,4.13%,KNL1;MIS18BP1;CENPA;CENPP;ASF1B;CENPK;CENPN;CENPM;CENPW;HJURP;CENPH;CENPL;OIP5;CENPI;SMARCA5;RSF1;NASP
prerank,kinetochore organization (GO:0051383),0.972121327810815,1.9306080868671647,0.0,0.0021347291061929795,0.045,8/13,1.14%,CENPF;CENPE;DLGAP5;NDC80;NUF2;CENPA;CENPW;CENPH
prerank,cellular zinc ion homeostasis (GO:0006882),-0.5765317825988213,-1.9289816041819305,0.0,0.2295061310341684,0.481,16/26,23.06%,SLC39A7;SLC39A14;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;SLC39A8;SLC39A6;MT2A;SLC39A12;SLC30A1;MT3
prerank,mitotic spindle assembly (GO:0090307),0.8511043091835333,1.9278363937965426,0.0,0.0020419147972280676,0.045,12/42,4.55%,KIF11;KIF23;TPX2;PRC1;KIF4A;KIFC1;AURKB;RACGAP1;CHEK2;FLNA;CEP192;ABRAXAS1
prerank,positive regulation of cell division (GO:0051781),0.857207781440033,1.925974361493496,0.0,0.0020697293417415905,0.047,12/38,7.43%,KIF23;KIF20B;KIF14;AURKB;ECT2;CIT;RACGAP1;CXCR5;PRKCE;CSPP1;CDC25B;PKN2
prerank,establishment of mitotic spindle localization (GO:0040001),0.8630199583501721,1.9245106826067235,0.0,0.0020591925378199974,0.049,11/28,4.06%,NUSAP1;NDC80;CENPA;MAD2L1;SPDL1;PLK1;CDK5RAP2;ESPL1;GPSM2;NDE1;FBXW11
prerank,reverse cholesterol transport (GO:0043691),-0.7166473318958646,-1.9117642946735656,0.0,0.236138967937155,0.547,4/13,10.86%,APOE;ABCA1;ABCA5;SCARB1
prerank,regulation of nuclear division (GO:0051783),0.9014296880224414,1.9107667119049667,0.0,0.0033694614738282672,0.076,7/20,2.73%,MKI67;KIF20B;CDC25C;NEK2;BORA;RCC1;FBXO5
prerank,cyclooxygenase pathway (GO:0019371),-0.7855356144100429,-1.9081451885018625,0.0,0.21266399737287905,0.563,4/10,5.70%,HPGDS;TBXAS1;PTGS1;PTGDS
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.9076255831039927,1.9020811132545068,0.0,0.004214721568637421,0.094,11/21,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;FBXO5;MAD1L1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.8727824305618664,1.89862163175454,0.0,0.004612539675881259,0.106,13/26,6.91%,CENPE;DLGAP5;UBE2C;CCNB1;PLK1;CDK5RAP2;ESPL1;RB1;FBXO5;CDC23;CDC27;LCMT1;ANAPC7
prerank,establishment of mitotic spindle orientation (GO:0000132),0.8659947407950667,1.8904364688416235,0.0012165450121654502,0.005948363199086803,0.14,9/23,4.06%,NDC80;CENPA;MAD2L1;SPDL1;PLK1;CDK5RAP2;GPSM2;NDE1;FBXW11
prerank,establishment of spindle orientation (GO:0051294),0.84224144818518,1.8860626909160862,0.0011655011655011655,0.006954290588251745,0.164,11/28,5.95%,NDC80;CENPA;MAD2L1;SPDL1;PLK1;CDK5RAP2;GPSM2;NDE1;FBXW11;MAP4;CLASP1
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.9061295173589284,1.8832778462741682,0.0,0.0068147121466929726,0.178,10/20,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;MAD1L1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.9061295173589284,1.8832778462741682,0.0,0.0068147121466929726,0.178,10/20,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;MAD1L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.9061295173589284,1.8832778462741682,0.0,0.0068147121466929726,0.178,10/20,2.97%,CENPF;BUB1;BUB1B;TTK;MAD2L1;KNTC1;CDC20;PLK1;TRIP13;MAD1L1
prerank,lysosome organization (GO:0007040),-0.5210504366750934,-1.8831993245357237,0.0,0.2502275124867318,0.677,19/36,20.16%,CLVS1;TPCN2;ABCA1;MBTPS1;ACP2;GRN;MYO7A;HPS1;CLN5;TMEM165;HOOK2;ZKSCAN3;NAGPA;SNAPIN;TFEB;HOOK3;TMEM106B;CLN6;ATP10B
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.9137037860980243,1.8823936395924514,0.0,0.006747096292650661,0.181,12/17,4.94%,KNL1;ZWILCH;CENPA;TTK;CDK1;AURKB;SPDL1;RB1;CHAMP1;HASPIN;CTCF;IK
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.7781697605261257,1.8808085963229417,0.0,0.006915583961600993,0.188,37/82,11.97%,CENPF;TPX2;HMMR;KIF14;CDK1;GTSE1;NEK2;CKAP5;PLK1;CDK5RAP2;CEP152;AURKA;NDE1;PCNT;HAUS5;HAUS6;CEP192;TUBB4B;ATAD5;ODF2;CLASP1;CEP72;CEP76;ALMS1;DYNC1H1;CEP250;OFD1;PRKACA;NEDD1;CEP70;NINL;PCM1;PAFAH1B1;HAUS4;TUBB;ATF5;HAUS7
prerank,interstrand cross-link repair (GO:0036297),0.8100158753139117,1.8760085293351447,0.0,0.007952778197964657,0.222,20/53,7.68%,NEIL3;RAD51AP1;RAD51;UBE2T;EME1;FANCD2;RFWD3;ERCC4;RPA2;FANCA;USP1;SLX4;NUCKS1;MSH6;MCM9;XRCC3;POLN;DCLRE1C;DCLRE1B;FAAP24
prerank,manganese ion transport (GO:0006828),-0.6836417423806362,-1.866512259428774,0.004098360655737705,0.26414982052244934,0.726,8/14,17.04%,TRPC5;TRPC4;TRPC1;TMEM165;SLC11A2;SLC39A14;SLC39A8;TRPC3
prerank,positive regulation of lipid transport (GO:0032370),-0.7244698777570677,-1.861628425633795,0.0,0.24925502888065484,0.748,3/12,1.48%,LRP1;SPP1;APOE
prerank,regulation of cytokinesis (GO:0032465),0.7897931313734341,1.8594756996669406,0.0,0.01413314935274749,0.344,23/78,9.56%,KIF23;PRC1;KIF20B;KIF14;E2F7;AURKB;ECT2;E2F8;CIT;RACGAP1;KIF20A;PLK1;CXCR5;AURKA;PRKCE;CSPP1;CDC25B;PIN1;PKN2;BIRC6;KLHL9;AHCTF1;CUL3
prerank,negative regulation of cell cycle process (GO:0010948),0.7958480278345262,1.8517058629500696,0.0,0.017017334453821767,0.403,27/61,10.57%,E2F7;RAD51;AURKB;E2F8;RRM2;NEK2;EZH2;BRCA1;ESPL1;E2F1;UXT;FBXO5;AURKAIP1;CBX5;APAF1;SUZ12;EPC1;RBBP8;CHEK1;TERF2;E2F6;RBBP4;TFDP1;MAX;TERF1;TFDP2;EHMT1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.9564644754714319,1.8480141835142219,0.0,0.01824835492355103,0.433,6/10,1.30%,KNSTRN;ECT2;RACGAP1;NEK2;CCNB1;SPAG5
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.7953397473202666,1.8448512118982716,0.0,0.01955329756307146,0.458,11/50,2.55%,CCNF;CDC25C;CDKN3;CCNB2;CCNB1;CCNA2;CCNE1;CDKN2C;CDC25A;BLM;CCNE2
prerank,membrane fusion (GO:0061025),-0.5186599201642657,-1.8439274890354804,0.0,0.27501564356470815,0.811,14/33,9.94%,RIMS1;DNM2;NSF;USO1;VTI1B;NAPA;UBXN2A;DNM3;DNM1L;UBXN2B;RABIF;MYOF;HUWE1;VAMP2
prerank,microtubule depolymerization (GO:0007019),0.9058250876657492,1.8423039643645724,0.0,0.0207945844640787,0.483,8/17,1.62%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;CCSAP;STMN1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.7698451433936333,1.8415428718033822,0.0,0.020880074709933347,0.491,9/80,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8108207392111091,1.8364756740252903,0.0,0.02350302376397977,0.53,19/40,7.30%,GEN1;RAD51;EME1;MMS22L;RFWD3;TIPIN;BLM;POLE;DDX11;TONSL;TIMELESS;NUCKS1;POLD1;MCM9;PCNA;TRAIP;PRIMPOL;ZRANB3;RTEL1
prerank,regulation of chromosome segregation (GO:0051983),0.8924233905983783,1.8354087133601646,0.001326259946949602,0.02364623009936839,0.539,6/16,3.65%,MKI67;BUB1;AURKB;KIF2C;RMI2;SMC6
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.9375910738773148,1.8338393321886506,0.0013192612137203166,0.02432496448185026,0.552,6/12,3.70%,CENPE;NDC80;NUF2;KIF2C;MAD1L1;CHAMP1
prerank,response to hexose (GO:0009746),-0.5700787122529004,-1.8263546048367287,0.0,0.3062076585288557,0.867,13/25,21.71%,EIF2B3;LPL;SELENOT;PFKL;VAMP2;IRS2;SELENOS;EIF2B4;ZBED3;SLC2A5;GPLD1;THBS1;EIF2B2
prerank,recombinational repair (GO:0000725),0.778863274539887,1.8253655343326176,0.0,0.030118243259113994,0.637,30/77,9.40%,RAD51AP1;GEN1;RAD51;POLQ;MMS22L;RFWD3;RAD54B;ERCC4;BRCA1;RPA2;BLM;BRCA2;XRCC1;RAD51B;RAD51C;TONSL;SLX4;SMC6;NUCKS1;MCM9;RBBP8;FEN1;XRCC3;HELQ;POLN;PALB2;RHNO1;HUS1;NABP2;RPA1
prerank,protein localization to kinetochore (GO:0034501),0.9023152071317037,1.8142878490590688,0.0,0.038681920293315165,0.721,8/14,4.94%,KNL1;ZWILCH;TTK;CDK1;AURKB;SPDL1;CHAMP1;IK
prerank,regulation of exit from mitosis (GO:0007096),0.7950349654530973,1.813051062123079,0.0,0.03894854306731902,0.732,10/38,4.40%,BUB1B;UBE2C;MAD2L1;KNTC1;NEK2;CDC20;ANLN;PPP1R9B;CDC23;CDC27
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.8933403330585638,1.81232446700899,0.002631578947368421,0.038688194923775274,0.74,4/16,3.46%,TOP2A;EME1;ERCC4;SLX4
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.5651288945659872,-1.8108484788067831,0.0,0.3065995017400955,0.913,15/24,23.11%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;TPI1;FOXK1;PKM;PGAM1;ALDOC;ENO2;PFKP;PFKM;ENO3
prerank,canonical glycolysis (GO:0061621),-0.5651288945659872,-1.8108484788067831,0.0,0.3065995017400955,0.913,15/24,23.11%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;TPI1;FOXK1;PKM;PGAM1;ALDOC;ENO2;PFKP;PFKM;ENO3
prerank,regulation of G0 to G1 transition (GO:0070316),0.793589576494403,1.8083752104444586,0.0,0.04161736497488837,0.768,19/38,10.57%,RAD51;RRM2;EZH2;BRCA1;E2F1;UXT;CBX5;APAF1;SUZ12;EPC1;RBBP8;CHEK1;E2F6;RBBP4;TFDP1;MAX;RHNO1;TFDP2;EHMT1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.845078344652908,1.8054232929216247,0.0024271844660194173,0.04382956253099839,0.792,7/24,1.62%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.8497555190676489,1.8029774435498394,0.001199040767386091,0.045765623626481886,0.805,5/23,1.74%,BUB1;BUB1B;ZWILCH;AURKB;WEE1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.7732724570801606,1.8023414409116885,0.0,0.04554966611712059,0.807,16/54,6.86%,CDC25C;E2F7;CDK1;E2F8;GTSE1;CCNB1;CHEK2;E2F1;AURKA;PML;PIDD1;PCNA;CASP2;MDM4;ATM;TFDP1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.770608441669053,1.8022748986351413,0.0010515247108307045,0.04477305412397768,0.809,24/56,11.66%,DLGAP5;CDC25C;CDK1;UBE2C;CCNB1;ESPL1;CDC25A;RAD51B;RB1;FBXO5;DTL;RAD51C;CDC23;CDC27;TFDP1;ANAPC7;BRD4;CDC25B;EGFR;MECP2;CUL3;NSMCE2;RDX;PLCB1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.47861677923352414,-1.8022428251012264,0.0,0.31249139875273774,0.93,11/43,7.43%,SIRPA;PTPN6;HAVCR2;VSIR;CD274;CD34;IGF1;TNFAIP3;ZC3H12A;TLR4;TRIM27
prerank,DNA recombination (GO:0006310),0.7816557492298586,1.8018259895025108,0.0033444816053511705,0.044320260443191165,0.81,16/37,9.40%,GEN1;RAD51;RAD54B;RAD21;EXO1;BLM;RAD51B;RAD51C;LIG4;HMGB3;HDAC10;XRCC3;RTEL1;HMGB1;RHNO1;RPA1
prerank,cell cycle checkpoint signaling (GO:0000075),0.9249855015394886,1.79565260354131,0.0,0.05010895375161914,0.847,4/12,1.74%,BUB1;BUB1B;ZWILCH;WEE1
prerank,chromosome organization (GO:0051276),0.7456974097990337,1.794197016845253,0.0,0.051131227451101345,0.858,21/99,7.99%,TOP2A;NDC80;NUF2;CDCA8;HMGB2;EZH2;CENPW;CENPH;RFWD3;SUV39H1;LIG4;NUCKS1;HDAC10;MSH6;TCF7L1;HMGN2;LRWD1;PHF19;H3-3A;SMARCA4;PHF1
prerank,protein depolymerization (GO:0051261),0.8252902144286153,1.7939372873493276,0.0011574074074074073,0.05063894534929394,0.858,7/27,1.62%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.7912999681180505,1.7926140398089432,0.0011507479861910242,0.051143043925487734,0.863,18/36,10.57%,RAD51;RRM2;EZH2;BRCA1;E2F1;UXT;CBX5;APAF1;SUZ12;EPC1;RBBP8;CHEK1;E2F6;RBBP4;TFDP1;MAX;TFDP2;EHMT1
prerank,positive regulation of cell communication (GO:0010647),-0.5381398664607175,-1.7913775262171854,0.0,0.32409886333296434,0.95,13/28,20.51%,RIMS1;ANK3;RIMS2;WLS;SYT1;KCTD13;CLSTN3;GRIK2;CLSTN1;DLG4;SOX11;CLSTN2;PTPN23
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.8416155163351606,1.791174255000669,0.004889975550122249,0.05199160106454876,0.873,11/21,7.13%,CDC25C;CDK1;CCNB1;CDC25A;RAD51B;FBXO5;DTL;RAD51C;ATAD5;BRD4;CDC25B
prerank,DNA integrity checkpoint signaling (GO:0031570),0.8044468627944868,1.7895637463824283,0.0,0.05293078316585052,0.877,15/36,8.84%,BRIP1;CLSPN;TIPIN;RAD1;CDC45;CHEK2;E2F1;RAD9A;PRPF19;TIMELESS;CHEK1;ATM;RHNO1;DNA2;HUS1
prerank,regulation of potassium ion transport (GO:0043266),-0.5013906506945377,-1.7885842572135802,0.008,0.3132189279663338,0.956,8/31,9.84%,ANK3;DPP10;KCNIP3;KCNN2;KCNAB1;ANK2;CD63;FHL1
prerank,lytic vacuole organization (GO:0080171),-0.5174174131084535,-1.7877924643331666,0.0,0.29764647806510103,0.958,17/32,20.10%,CLVS1;TPCN2;ABCA1;MBTPS1;ACP2;GRN;MYO7A;HPS1;CLN5;HOOK2;ZKSCAN3;NAGPA;SNAPIN;TFEB;HOOK3;TMEM106B;CLN6
prerank,regulation of chromosome organization (GO:0033044),0.8474518028809352,1.7871935726086674,0.0024509803921568627,0.05510699894293328,0.888,8/22,6.05%,BUB1;PIF1;RMI2;SMG6;RB1;LIG4;SMG5;TERF2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.7995124709683862,1.7856548734095534,0.001122334455667789,0.0562106233694807,0.895,9/34,6.91%,NUSAP1;DLGAP5;ESPL1;RB1;AURKA;CDC23;CDC27;TGFA;ANAPC7
prerank,DNA replication checkpoint signaling (GO:0000076),0.8647414336958907,1.7849285625796498,0.0025806451612903226,0.05629193416504913,0.9,9/16,8.84%,TICRR;CLSPN;TIPIN;CDC45;TOPBP1;RAD9A;TIMELESS;DNA2;HUS1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.4898078547089705,-1.7849023745197614,0.008695652173913044,0.2887528245736277,0.958,10/33,24.50%,UBASH3B;TLR4;FBN1;CAMK4;TCTA;CSF1;CCL3;TMEM178A;MAFB;CCR1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.6571917355613727,-1.7840585061372207,0.016,0.2767089891445205,0.959,7/13,25.34%,SLC9A1;ATP1A1;ATP1B2;ATP1B1;ATP1A2;ATP1A3;ATP1B3
prerank,organonitrogen compound catabolic process (GO:1901565),-0.4536476130058008,-1.7838998606531287,0.0,0.26381734749473074,0.959,30/57,30.82%,CAPN3;PLA2G15;PLA2G7;ENPP2;PPT1;CPQ;NAGK;NPEPPS;ANPEP;CLN5;IDE;CLN8;TXN2;PLA2G6;SIAH1;RIDA;NPL;GNPDA1;CLN6;GNPDA2;TRIM24;AMDHD2;ADO;PLA2G4A;USE1;IL4I1;RENBP;SMPD2;TST;SGPL1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.5527032930010137,-1.7829899672001615,0.0,0.25413784866501343,0.96,15/25,23.11%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;TPI1;FOXK1;PKM;PGAM1;ALDOC;ENO2;PFKP;PFKM;ENO3
prerank,regulation of spindle organization (GO:0090224),0.8346534085158618,1.7808035833617937,0.007822685788787484,0.06031683405314849,0.913,7/18,8.24%,TPX2;TACC3;BORA;GPSM2;GNAI1;DYNC1H1;CLTC
prerank,double-strand break repair via homologous recombination (GO:0000724),0.7523671016796244,1.7797313111173418,0.0,0.06062083295150576,0.919,28/95,5.81%,RAD51AP1;GEN1;RAD51;POLQ;MMS22L;RFWD3;RAD54B;ERCC4;CDC45;BRCA1;RAD21;RPA2;BLM;BRCA2;XRCC1;RAD51B;RAD51C;TONSL;SLX4;SMC6;MCM6;NUCKS1;MCM9;RBBP8;FEN1;XRCC3;HELQ;POLN
prerank,protein localization to condensed chromosome (GO:1903083),0.9084836927328084,1.778520243711251,0.0,0.06127971508856839,0.925,8/12,4.94%,KNL1;ZWILCH;TTK;CDK1;AURKB;SPDL1;CHAMP1;IK
prerank,DNA replication (GO:0006260),0.7402916369399939,1.7768353226241982,0.0,0.0626762744193277,0.931,41/105,9.60%,CDK1;BRIP1;PIF1;TICRR;CLSPN;MCM10;BARD1;PCLAF;TIPIN;POLE2;RAD1;CDC45;BRCA1;RMI2;EXO1;RPA2;DBF4;POLA1;BLM;POLE;WDHD1;TOPBP1;MCM6;RFC5;RAD9A;ORC5;TIMELESS;POLD1;MCM9;RBBP8;FEN1;DUT;CHEK1;ORC3;ATM;POLD2;RHNO1;DNA2;HUS1;RPA1;RFC2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.7990032368868952,1.7762981137993745,0.004651162790697674,0.06247473927672798,0.934,13/32,7.25%,CDK1;TICRR;CLSPN;PLK1;BRCA1;BLM;DTL;BABAM1;TOPBP1;ABRAXAS1;CHEK1;ATM;MRNIP
prerank,acylglycerol catabolic process (GO:0046464),-0.5124325867445102,-1.7732241512642886,0.007246376811594203,0.26448952122468355,0.97,7/30,16.11%,MGLL;LPL;ABHD12;ABHD16A;ABHD6;DAGLA;LIPH
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.872212339839007,1.7726926922077315,0.0013089005235602095,0.0665237890037588,0.944,7/15,6.91%,CENPE;UBE2C;TACC3;PLK1;CDC23;CDC27;ANAPC7
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.8936628361303587,1.7717267730336306,0.0,0.06701152884380865,0.945,7/13,6.05%,NDC80;GEN1;MAD2L1;CCNB1;CDK5RAP2;XRCC3;LCMT1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.751797481338344,1.7710858311156148,0.0,0.06695888015888855,0.947,18/63,6.86%,CDC25C;E2F7;CDK1;E2F8;GTSE1;CCNB1;RFWD3;RPA2;CHEK2;E2F1;AURKA;PML;PIDD1;PCNA;CASP2;MDM4;ATM;TFDP1
prerank,cellular response to radiation (GO:0071478),0.7871373409084785,1.7670248815414606,0.001092896174863388,0.0715966547486441,0.957,13/40,8.84%,RAD51AP1;RAD51;ECT2;RAD1;BLM;NET1;LIG4;RAD9A;TANK;MAPK14;RHNO1;GRB2;HUS1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.8573064877677893,1.7651092900789687,0.003826530612244898,0.07319213874648246,0.961,7/17,8.97%,NEIL3;MUTYH;SMUG1;MBD4;TERF2;NEIL1;TERF1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.7728894899136748,1.7647155805791568,0.0032858707557502738,0.07272201015143252,0.961,14/42,7.30%,RAD51AP1;RAD51;POLQ;PARPBP;RMI2;RPA2;RADX;SMCHD1;TIMELESS;ARID2;CHEK1;CGAS;MRNIP;RTEL1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.7562789662754741,1.764552026779161,0.0010638297872340426,0.0721097663867252,0.961,20/57,7.25%,CDK1;TICRR;CLSPN;EME1;FANCD2;RFWD3;TIPIN;PLK1;BRCA1;RPA2;CHEK2;BLM;DTL;BABAM1;TOPBP1;RAD9A;ABRAXAS1;CHEK1;ATM;MRNIP
prerank,replication fork processing (GO:0031297),0.7767966977835709,1.7644076888267854,0.003367003367003367,0.071431320091842,0.962,18/38,11.24%,GEN1;RAD51;EME1;MMS22L;RFWD3;BLM;BRCA2;DDX11;TONSL;NUCKS1;PCNA;TRAIP;PRIMPOL;ZRANB3;RTEL1;DNA2;EME2;FAM111A
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.7487334815014448,1.7634924047075264,0.0,0.07175447681551125,0.963,9/79,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.7501587013103179,1.761611170244748,0.0,0.07230881691193576,0.966,9/78,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.7501587013103179,1.761611170244748,0.0,0.07230881691193576,0.966,9/78,1.12%,KIF11;CENPE;KIF23;KIF15;KIF4A;KIF22;KIF2C;RACGAP1;KIF18A
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.8481759022277426,1.7610152661305505,0.008871989860583017,0.07226351980512996,0.969,10/18,7.13%,CDC25C;CDK1;CCNB1;CDC25A;RAD51B;FBXO5;DTL;RAD51C;BRD4;CDC25B
prerank,DNA metabolic process (GO:0006259),0.7253073189041029,1.7604291080617658,0.0,0.07217527118279012,0.971,97/270,12.68%,TOP2A;NEIL3;RAD51AP1;CDK1;GEN1;RAD51;TICRR;DNTT;UBE2T;POLK;POLQ;MCM10;UHRF1;HMGB2;BARD1;MEN1;POLE2;RAD1;ERCC4;CDC45;BRCA1;RAD21;PRIM2;RMI2;PRIM1;EXO1;RPA2;DBF4;POLA1;BLM;FANCA;MUTYH;POLE;XRCC1;CHD1L;RAD51B;WDHD1;RAD51C;SLX4;TOPBP1;LIG4;MCM6;RFC5;RAD9A;HMGB3;HELLS;ORC5;TIMELESS;POLD1;POLH;MSH6;SMUG1;RBBP8;FEN1;PCNA;CHEK1;SP100;ORC3;LIG1;XRCC3;MBD4;ATM;TERF2;GMNN;LRWD1;PRIMPOL;XRCC6;ZRANB3;DCLRE1B;RTEL1;HMGB1;ASF1A;NEIL1;POLD2;RAD18;DNA2;DNASE1L1;HUS1;TERF1;NABP2;RPA1;ERCC3;LONP1;RFC2;DNMT1;PARK7;SUMO1;RFC1;TYMS;KMT5C;POLD3;CTC1;APEX1;TOP3A;PDS5B;RPAIN;TDP1
prerank,DNA modification (GO:0006304),0.8188623659769912,1.7600337096579555,0.004790419161676647,0.07199121660440234,0.972,7/22,8.97%,NEIL3;MUTYH;SMUG1;MBD4;TERF2;NEIL1;TERF1
prerank,base-excision repair (GO:0006284),0.7498250554451469,1.7545931092497515,0.0032119914346895075,0.07901527757121532,0.98,21/48,12.38%,NEIL3;POLQ;RPA2;MUTYH;POLE;XRCC1;RFC5;POLD1;SMUG1;FEN1;PCNA;LIG1;MBD4;NEIL1;POLD2;DNA2;RPA1;RFC2;RFC1;POLD3;APEX1
prerank,response to ionizing radiation (GO:0010212),0.7527860594172677,1.753806496369915,0.0,0.07912697022262909,0.98,27/70,9.00%,RAD51AP1;RAD51;ECT2;TICRR;FANCD2;RFWD3;MEN1;RAD1;BRCA1;BLM;NET1;BABAM1;TOPBP1;LIG4;RAD9A;TANK;BRAT1;ABRAXAS1;STK11;ATM;MRNIP;EYA3;MAPK14;RHNO1;GRB2;HUS1;NABP2
prerank,regulation of sister chromatid cohesion (GO:0007063),0.8982565976096593,1.752823245777336,0.004160887656033287,0.07958262470216206,0.981,7/12,4.84%,BUB1;RAD21;ESPL1;RB1;DDX11;CTCF;FEN1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.7934631358480112,1.7497722670538736,0.0022497187851518562,0.08304870085985067,0.984,16/32,11.96%,E2F7;GFI1;RRM2;CCNE1;CDC45;POLA1;E2F1;RB1;FBXO5;PCNA;TFDP1;BRD4;CDK17;TFDP2;TYMS;NPAT
prerank,placenta development (GO:0001890),0.8950960390901854,1.7481808466476327,0.0,0.08417811600478277,0.987,2/12,0.44%,E2F7;E2F8
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6252500635997025,-1.7438821262059956,0.017937219730941704,0.32877426528525755,0.992,5/15,18.56%,APOE;ABCA5;PLTP;SCARB1;APOC1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.5312240617764423,-1.7425889483679673,0.03225806451612903,0.3194533839531658,0.992,7/27,6.50%,PLA2G15;GPCPD1;ABHD12;PLA2G7;ENPP2;GDE1;ABHD16A
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.7181281199716703,1.7394012576691964,0.0,0.09702316111815983,0.996,60/184,12.14%,CENPF;CENPE;TPX2;HMMR;BUB1B;KIF14;CDK1;UBE2C;MAD2L1;KNTC1;NEK2;CCNB1;CDC20;CKAP5;PLK1;CDK5RAP2;ANLN;PPP1R9B;E2F1;CEP152;AURKA;FBXO5;NDE1;PCNT;PSMB7;HAUS5;PSMD11;HAUS6;CDC23;CEP192;CDC27;PSMF1;TUBB4B;ODF2;CLASP1;CEP72;ZFP36L1;CEP76;PSMC1;ANAPC7;ALMS1;DYNC1H1;CEP250;OFD1;PRKACA;ZW10;NEDD1;CEP70;ERCC3;CUL3;NINL;PCM1;PSMC3;PAFAH1B1;HAUS4;PSMA4;TUBB;HAUS7;FZR1;PSMC4
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.7198962884367158,1.7393684117646229,0.0,0.09599530125139422,0.996,49/145,11.30%,CENPF;TPX2;HMMR;KIF14;CDC25C;CDK1;NEK2;CCNB1;CKAP5;PLK1;CDK5RAP2;CDC25A;RAD51B;CEP152;AURKA;FBXO5;NDE1;DTL;RAD51C;PCNT;PSMB7;HAUS5;PSMD11;HAUS6;CEP192;PSMF1;TUBB4B;ODF2;CLASP1;CEP72;CEP76;PSMC1;BRD4;CDC25B;ALMS1;DYNC1H1;CEP250;OFD1;PRKACA;NEDD1;CEP70;MECP2;NINL;PCM1;PSMC3;PAFAH1B1;HAUS4;PSMA4;TUBB
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.563981945587761,-1.7381927613896642,0.004694835680751174,0.3217251977264155,0.993,9/19,22.76%,POLR3C;AR;ZC3H8;ZNF76;NAB2;TENM1;POLR3G;MAF1;ICE1
prerank,DNA replication initiation (GO:0006270),0.7657460176310976,1.7315799975542525,0.0011086474501108647,0.10835870506997651,0.997,15/37,6.79%,MCM10;POLE2;CDC45;PRIM2;PRIM1;RPA2;DBF4;POLA1;POLE;TOPBP1;MCM6;ORC5;ORC3;GMNN;LRWD1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.755530548341875,1.7304392317591881,0.00547645125958379,0.10909518818074765,0.997,10/45,9.00%,BUB1;BUB1B;ZWILCH;MAD2L1;WEE1;AURKAIP1;CHEK1;ZFP36L1;ZW10;NABP2
prerank,response to nutrient levels (GO:0031667),-0.5864532033545768,-1.7283776409187936,0.014084507042253521,0.33718306227797445,0.995,4/17,9.40%,PRKAA2;CD68;ATF4;ULK1
prerank,double-strand break repair (GO:0006302),0.727820266796293,1.7282233997239151,0.0,0.11171925558895135,0.998,63/158,12.23%,RAD51AP1;BRIP1;GEN1;RAD51;DNTT;EME1;POLQ;HMGB2;BARD1;MMS22L;RFWD3;RAD54B;ERCC4;BRCA1;RAD21;TRIP13;RPA2;CHEK2;POLA1;BLM;BRCA2;SMARCA5;XRCC1;NSD2;RAD51B;RAD51C;TONSL;BABAM1;SLX4;SMC6;LIG4;PRPF19;NUCKS1;ABRAXAS1;MCM9;RBBP8;FEN1;ACTR5;XRCC3;HELQ;POLN;ATM;DCLRE1C;SETX;XRCC6;DCLRE1B;HMGB1;EYA3;TDP2;BAZ1B;CIB1;PALB2;DNA2;HUS1;NABP2;RPA1;EME2;NSMCE2;SUMO1;RNF168;RNF8;BAP1;PAXIP1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.7960910493290312,1.7251359325968372,0.007317073170731708,0.11603615285205347,0.998,14/24,12.18%,POLK;RPA2;POLE;XRCC1;LIG4;RFC5;POLD1;PCNA;LIG1;POLD2;RPA1;RFC2;RFC1;POLD3
prerank,nucleosome assembly (GO:0006334),0.775265804308124,1.7244431205051443,0.002331002331002331,0.11614568437002264,0.998,17/31,12.12%,ASF1B;HMGB2;CHAF1A;ANP32B;SMARCA5;RSF1;NASP;NAP1L4;RBBP4;H3-3A;ASF1A;SART3;UBN1;SPTY2D1;HIRA;CHAF1B;HAT1
prerank,negative regulation of cell division (GO:0051782),0.9063301491381006,1.7227528869845943,0.0,0.11781463884831792,0.999,4/11,2.10%,E2F7;AURKB;E2F8;BLM
prerank,DNA conformation change (GO:0071103),0.8371589680076087,1.7224199813426215,0.006361323155216285,0.11714939641368784,0.999,8/17,12.48%,TOP2A;HMGB2;HMGB3;HMGB1;ERCC3;KAT6A;HAT1;TOP3A
prerank,regulation of mitotic spindle organization (GO:0060236),0.7604101678830117,1.722065343918406,0.00563063063063063,0.1165806731266692,0.999,9/35,8.24%,TPX2;TACC3;BORA;CCSAP;PLK1;GPSM2;GNAI1;DYNC1H1;CLTC
prerank,positive regulation of signaling (GO:0023056),-0.46743880536096105,-1.7217086876273764,0.011363636363636364,0.34341495254158133,0.996,15/37,21.96%,RIMS1;NSF;RIMS2;WLS;SYT1;KCTD13;ECE1;CLSTN3;GRIK2;CLSTN1;DLG4;SOX11;CLSTN2;PTPN23;ANXA2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.7287719374800556,1.7200877911205004,0.0,0.11909781402286045,0.999,19/72,6.86%,CDC25C;E2F7;CDK1;E2F8;GTSE1;FOXM1;CCNB1;CHEK2;E2F1;AURKA;BATF;PML;PIDD1;PCNA;SP100;CASP2;MDM4;ATM;TFDP1
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.7512317967729057,1.71852282955085,0.004347826086956522,0.12098659314314335,0.999,15/43,9.00%,CDK1;TICRR;CLSPN;PLK1;BRCA1;BLM;DTL;BABAM1;TOPBP1;ABRAXAS1;CHEK1;ATM;MRNIP;HUS1;NABP2
prerank,spindle assembly (GO:0051225),0.7282575883179028,1.7140953235397114,0.0010604453870625664,0.12789921342904037,0.999,25/67,13.81%,KIF11;TPX2;KIFC1;NEK2;TUBGCP6;CHEK2;RCC1;FLNA;HAUS5;HAUS6;CEP192;ABRAXAS1;TUBGCP4;CLASP1;STAG1;MAPRE3;OFD1;KIF2A;HAUS4;HAUS7;CCDC61;TUBGCP3;NUMA1;LSM14A;PIBF1
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.44450825847248443,-1.7120083205330043,0.0,0.360515407918619,0.998,9/47,14.30%,SPOCK1;SERPINE2;TIMP2;SPOCK2;BIN1;TIMP3;RECK;SERPINI1;SERPINE1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.7151902732498215,1.7078528988718622,0.0,0.13868736119657127,0.999,24/78,12.13%,CCNF;CDC25C;CDKN3;CCNB2;CCNB1;CCNA2;PLK1;MEN1;CCNE1;CDKN2C;CDC25A;BLM;CCNE2;CCNYL1;CDKN2A;MAPRE3;EGFR;CDKN2D;IPO7;NR2F2;CCNJ;CCNT1;PTEN;CDK5RAP3
prerank,DNA geometric change (GO:0032392),0.788467620485241,1.707411517569845,0.007281553398058253,0.13813004619433833,0.999,11/24,8.37%,PIF1;HMGB2;BLM;DDX11;HMGB3;MCM9;ZRANB3;RTEL1;HMGB1;HNRNPA2B1;DNA2
prerank,telomere maintenance (GO:0000723),0.7413690739991,1.7072448257248811,0.0010741138560687433,0.137140555656433,0.999,27/50,14.79%,RAD51;ERCC4;RPA2;BLM;SMC6;POLD1;PCNA;SP100;XRCC3;ATM;TERF2;XRCC6;DCLRE1B;RTEL1;POLD2;DNA2;HUS1;TERF1;RPA1;NSMCE2;TEP1;POLD3;CTC1;APEX1;PRKDC;RPA3;RAD50
prerank,mitotic cell cycle phase transition (GO:0044772),0.7004758829776717,1.7011536303569839,0.0,0.14858183750335266,0.999,73/203,11.97%,CCNF;CDC25C;CDK1;UBE2C;CDKN3;TACC3;FOXM1;CCNB2;NEK2;BORA;CCNB1;MASTL;CKAP5;CCNA2;PLK1;CCNE1;CDKN2C;CDK5RAP2;FBXL15;WEE1;DBF4;CHEK2;CDC25A;RCC1;POLE;E2F1;SKP2;CCNE2;RB1;CEP152;AURKA;NDE1;PCNT;HAUS5;HAUS6;CDC23;FBXW11;NASP;CEP192;CDC27;TUBB4B;CDK6;CDKN2A;PPP1CB;ODF2;CLASP1;LCMT1;CEP72;CEP76;ANAPC7;CDC25B;PIM2;ALMS1;MAX;DYNC1H1;CEP250;OFD1;PRKACA;PPP1R12B;NEDD1;CEP70;CDKN2D;CUL3;NINL;PCM1;PAFAH1B1;MELK;HAUS4;CCNJ;TUBB;PLCB1;CCDC57;HAUS7
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.46083373169612185,-1.7003773592386977,0.018867924528301886,0.3810140897655468,0.999,10/41,7.43%,SIRPA;PTPN6;HAVCR2;VSIR;CD34;IGF1;TNFAIP3;ZC3H12A;TLR4;TRIM27
prerank,B cell proliferation (GO:0042100),0.8186779649664457,1.6974260763905877,0.0038412291933418692,0.15527443234538077,0.999,4/17,5.38%,CD19;MS4A1;CD79A;RASGRP1
prerank,negative regulation of coagulation (GO:0050819),-0.6090857354768792,-1.6943896291343743,0.017094017094017096,0.38822124701157645,0.999,6/14,16.18%,SERPINE2;APOE;CD34;TFPI;SERPINE1;HS3ST5
prerank,cardiac muscle cell action potential (GO:0086001),-0.48678960790967407,-1.6937709281647495,0.006369426751592357,0.3783335259795654,0.999,13/30,18.55%,CACNA1C;SCN1A;ANK2;ATP1A1;DMD;SCN1B;HCN2;ATP1B1;FGF12;SLC8A1;KCND3;ATP1A2;CACNA1G
prerank,cell cycle G2/M phase transition (GO:0044839),0.7014225256079653,1.6936694331418654,0.0,0.1623483738007453,0.999,50/129,11.97%,CDC25C;CDK1;FOXM1;CCNB2;NEK2;BORA;CCNB1;MASTL;CKAP5;CCNA2;PLK1;CDK5RAP2;FBXL15;WEE1;CHEK2;CDC25A;SKP2;CEP152;AURKA;NDE1;PCNT;HAUS5;HAUS6;FBXW11;CEP192;TUBB4B;PPP1CB;ODF2;CLASP1;LCMT1;CEP72;CEP76;CDC25B;ALMS1;DYNC1H1;CEP250;OFD1;PRKACA;PPP1R12B;NEDD1;CEP70;NINL;PCM1;PAFAH1B1;MELK;HAUS4;TUBB;PLCB1;CCDC57;HAUS7
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.7002100124920602,1.6924255281142908,0.0,0.16350443672618822,0.999,50/128,11.97%,CDC25C;CDK1;FOXM1;CCNB2;NEK2;BORA;CCNB1;MASTL;CKAP5;CCNA2;PLK1;CDK5RAP2;FBXL15;WEE1;CHEK2;CDC25A;SKP2;CEP152;AURKA;NDE1;PCNT;HAUS5;HAUS6;FBXW11;CEP192;TUBB4B;PPP1CB;ODF2;CLASP1;LCMT1;CEP72;CEP76;CDC25B;ALMS1;DYNC1H1;CEP250;OFD1;PRKACA;PPP1R12B;NEDD1;CEP70;NINL;PCM1;PAFAH1B1;MELK;HAUS4;TUBB;PLCB1;CCDC57;HAUS7
prerank,DNA damage checkpoint signaling (GO:0000077),0.7887750773889535,1.6904010973838617,0.008149010477299184,0.16676045797587824,0.999,11/28,8.84%,BRIP1;CLSPN;RAD1;CHEK2;E2F1;RAD9A;PRPF19;CHEK1;ATM;RHNO1;HUS1
prerank,glycolytic process (GO:0006096),-0.5206090920518959,-1.689035284495385,0.0136986301369863,0.38187549715554503,0.999,17/28,23.11%,HK2;HK3;GPI;PFKL;ENO1;ALDOA;LDHA;TPI1;PGM1;PKM;PGAM1;PGAM4;ALDOC;ENO2;PFKFB2;PFKM;ENO3
prerank,positive regulation of viral genome replication (GO:0045070),0.7578935013831241,1.6883692044612588,0.009153318077803204,0.16996548933577255,0.999,1/29,0.01%,TOP2A
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.8484523133082439,1.6845992247335029,0.01335113484646195,0.17728681131088952,0.999,4/12,3.59%,TICRR;CLSPN;CHEK2;TOPBP1
prerank,signal transduction in response to DNA damage (GO:0042770),0.7355014671188965,1.682130210370591,0.007376185458377239,0.18162278167810067,0.999,16/49,8.84%,E2F7;BRIP1;CLSPN;RAD1;CHEK2;E2F1;BATF;RAD9A;PRPF19;CHEK1;MDM4;ATM;MAPK14;RHNO1;GRB2;HUS1
prerank,establishment of spindle localization (GO:0051293),0.8317335657597635,1.6813943525462376,0.010723860589812333,0.18194169744967556,0.999,5/14,7.70%,NUSAP1;ESPL1;MAP4;CLASP1;DYNC1H1
prerank,microtubule polymerization (GO:0046785),0.7575794769585309,1.679891961302052,0.01079136690647482,0.18398210336177975,0.999,11/28,13.11%,TPX2;CKAP5;TUBGCP6;NDE1;TUBGCP4;CLASP1;PIN1;SLAIN2;CCDC57;TUBGCP3;FGF13
prerank,DNA repair (GO:0006281),0.6930562535166307,1.675618940460281,0.0,0.19285885259819094,1.0,114/284,15.03%,NEIL3;RAD51AP1;CDK1;BRIP1;RAD51;TICRR;UBE2T;EME1;POLK;POLQ;BARD1;FANCD2;RFWD3;MEN1;POLE2;RAD1;ERCC4;BRCA1;RAD21;TRIP13;RMI2;EXO1;RPA2;CHEK2;POLA1;BLM;FANCA;MUTYH;BRCA2;POLE;SMARCA5;XRCC1;CHD1L;NSD2;RAD51B;WDHD1;USP1;RAD51C;BABAM1;SLX4;TOPBP1;LIG4;RFC5;RAD9A;TIMELESS;NUCKS1;POLD1;POLH;MSH6;SMUG1;ABRAXAS1;PMS2;RBBP8;FEN1;ACTR5;PCNA;CHEK1;LIG1;XRCC3;MBD4;POLN;ATM;DCLRE1C;SETX;TRAIP;FTO;PRIMPOL;ZRANB3;DCLRE1B;ASF1A;EYA3;NEIL1;TDP2;FAAP24;BAZ1B;CIB1;POLD2;UBE2V1;RHNO1;RAD18;DNA2;HUS1;NABP2;CDKN2D;RPA1;ERCC3;RFC2;EME2;PMS1;PARK7;SUMO1;RAD23A;RNF168;FAM111A;RNF8;KMT5C;POLD3;BAP1;APEX1;PDS5B;RPAIN;TDP1;PRKDC;REXO4;APTX;FANCM;FANCL;RAD52;RPA3;VCPIP1;RAD50;EYA1;TP53;RNASEH2A
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6920104408496505,-1.6732820704734004,0.016778523489932886,0.42168825325953596,0.999,5/10,15.97%,LAG3;IRF1;ZC3H8;GLI3;MDK
prerank,bicarbonate transport (GO:0015701),0.7688624374623252,1.6732494896274992,0.014510278113663845,0.19671641961796751,1.0,3/25,1.86%,SLC4A1;RHAG;AQP1
prerank,telomere organization (GO:0032200),0.7313797793778664,1.6730733805081834,0.0054466230936819175,0.19542104621176729,1.0,23/43,14.79%,ERCC4;RPA2;BLM;POLD1;PCNA;SP100;ATM;TERF2;XRCC6;DCLRE1B;RTEL1;H3-3A;POLD2;DNA2;HUS1;TERF1;RPA1;POLD3;CTC1;APEX1;PRKDC;RPA3;RAD50
prerank,protein localization to chromosome (GO:0034502),0.7526060340357288,1.6692008084365895,0.0068415051311288486,0.2037991365764684,1.0,11/34,9.40%,CENPA;PLK1;RAD21;RPA2;RB1;HASPIN;MCM9;CTCF;TERF2;MRNIP;RPA1
prerank,negative regulation of hemostasis (GO:1900047),-0.6379615944242323,-1.6683757692402732,0.024,0.4253279947457581,0.999,5/12,14.30%,SERPINE2;APOE;CD34;TFPI;SERPINE1
prerank,defense response to Gram-positive bacterium (GO:0050830),0.7329315871572062,1.66797017101505,0.006696428571428571,0.2051906584568091,1.0,8/40,6.84%,IL12A;HMGB2;RNASE6;PGLYRP1;GBP4;CAMP;PPP1R11;GBP2
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.5524299097298533,-1.6644042896498028,0.02577319587628866,0.4259395076360264,1.0,7/18,23.01%,TLR4;FBN1;TCTA;FBXW7;CCL3;TMEM178A;MAFB
prerank,regulation of centrosome duplication (GO:0010824),0.7665948791245872,1.6624437960475904,0.0035294117647058825,0.21698289789967296,1.0,7/29,7.60%,CCNF;STIL;GEN1;CEP295;XRCC3;CEP76;ALMS1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.7001816030845812,1.6579500932107425,0.002036659877800407,0.226818699576896,1.0,28/84,13.51%,BUB1B;CDK1;UBE2C;AURKB;MAD2L1;CCNB1;CDC20;PLK1;SKP2;RB1;AURKA;FBXO5;PSMB7;PSMD11;CDC23;CDC27;PSMF1;PSMC1;ANAPC7;CUL3;PTTG1;PSMC3;PSMA4;FZR1;PSMC4;BUB3;PSMD13;PSME1
prerank,regulation of mitotic cell cycle (GO:0007346),0.6829548661791213,1.6561523728374359,0.0,0.23010455009008832,1.0,48/171,14.47%,MKI67;DLGAP5;KIF20B;BUB1B;CDC25C;CDK1;UBE2C;MAD2L1;NEK2;BORA;CKS2;CCNB1;CDC20;PLK1;RCC1;DYNLT3;RB1;FBXO5;PSMB7;PSMD11;CDC23;CDC27;PSMF1;PSMC1;ANAPC7;CDC25B;PIN1;PIM2;PKN2;PIM3;PRKCA;SMOC2;CAV2;ERCC3;PSMC3;PSMA4;CCDC57;FZR1;CDK5RAP3;PSMC4;BUB3;CUL9;PSMD13;HNRNPU;PSME1;INTS13;RNF20;PSMB1
prerank,regulation of double-strand break repair (GO:2000779),0.7393581250599103,1.6542580899252908,0.009879253567508232,0.2333957139036743,1.0,13/39,9.14%,RAD51AP1;RAD51;FOXM1;RPA2;DDX11;TWIST1;DEK;PML;TIMELESS;CHEK1;MRNIP;RTEL1;RNF169
prerank,positive regulation of nuclear division (GO:0051785),0.7641681717947976,1.6535183308435504,0.011876484560570071,0.23356015531364543,1.0,3/25,6.87%,NUSAP1;AURKA;TGFA
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.7945326854916858,1.6533967456955827,0.01668806161745828,0.232002359261053,1.0,6/16,5.12%,POLQ;PARPBP;RMI2;RADX;SMCHD1;CGAS
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.8533729097704635,1.6529371177208734,0.012430939226519336,0.22790542410768197,1.0,8/12,10.70%,DLGAP5;ESPL1;RB1;CDC23;CDC27;ANAPC7;CUL3;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.8533729097704635,1.6529371177208734,0.012430939226519336,0.22790542410768197,1.0,8/12,10.70%,DLGAP5;ESPL1;RB1;CDC23;CDC27;ANAPC7;CUL3;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.8533729097704635,1.6529371177208734,0.012430939226519336,0.22790542410768197,1.0,8/12,10.70%,DLGAP5;ESPL1;RB1;CDC23;CDC27;ANAPC7;CUL3;NSMCE2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.7597085447588452,1.6529038871388702,0.0057670126874279125,0.2262017261812399,1.0,6/32,6.64%,RNASE6;PGLYRP1;CAMP;S100A9;RPS19;HMGN2
prerank,translesion synthesis (GO:0019985),0.7281838483064559,1.651524495326858,0.006764374295377677,0.2283452777768815,1.0,18/42,12.18%,POLK;PCLAF;POLE2;RPA2;DTL;USP43;RFC5;POLD1;POLH;PCNA;POLN;NPLOC4;PRIMPOL;POLD2;RPA1;RFC2;RFC1;POLD3
prerank,microtubule nucleation (GO:0007020),0.780239436714439,1.6468133645362018,0.02069857697283312,0.2396737959849149,1.0,8/19,12.70%,TPX2;TUBGCP6;NDE1;TUBGCP4;CLASP1;SLAIN2;CCDC57;TUBGCP3
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.7234296103672939,1.6459811139462364,0.011098779134295227,0.24020491900999014,1.0,19/42,12.18%,POLK;PCLAF;RPA2;POLA1;POLE;DTL;USP43;RFC5;POLD1;POLH;PCNA;POLN;PRIMPOL;POLD2;CDKN2D;RPA1;RFC2;RFC1;POLD3
prerank,microglial cell activation (GO:0001774),-0.5306136539571028,-1.6458651770386454,0.01020408163265306,0.4788015958235999,1.0,8/21,10.39%,APP;TREM2;ITGAM;AIF1;GRN;C1QA;CX3CR1;C5AR1
prerank,cellular response to ionizing radiation (GO:0071479),0.731066480470653,1.6456663396783435,0.0075107296137339056,0.2391390463391011,1.0,16/47,8.84%,RAD51AP1;RAD51;ECT2;RAD1;BLM;NET1;LIG4;RAD9A;TANK;NUCKS1;ATM;XRCC6;MAPK14;RHNO1;GRB2;HUS1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.6830338014346878,1.643968390200898,0.0020408163265306124,0.24228133725129428,1.0,14/104,2.67%,CCNF;CDC25C;CDKN3;CCNB2;EZH2;CCNB1;CCNA2;INCENP;CCNE1;CDKN2C;CDC25A;BLM;CCNE2;RB1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.7884532729809882,1.6431717899241651,0.01608910891089109,0.24271444207962797,1.0,6/21,5.26%,UBE2C;MAD2L1;CDC20;PLK1;FBXO5;RPS7
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5376016838149158,-1.6424780095320461,0.03286384976525822,0.47793435199062817,1.0,5/18,5.70%,HPGDS;TBXAS1;DAGLB;PTGS1;PTGDS
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.8092828991766107,1.640973741829767,0.024161073825503355,0.24719873267483095,1.0,9/16,8.97%,ERCC4;SMG6;SLX4;SMG5;ATM;TERF2;RTEL1;HNRNPA2B1;TERF1
prerank,regulation of DNA replication (GO:0006275),0.7215529651542844,1.6407522818945808,0.00972972972972973,0.24601404509657654,1.0,21/49,12.22%,ESCO2;CCNA2;BLM;DSCC1;FBXO5;CCDC88A;S100A11;ORC5;NUCKS1;PCNA;ORC3;ATAD5;FAF1;GMNN;DNA2;TERF1;EGFR;BRPF3;DHX9;CDAN1;CTC1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.8316361726436385,1.6404474878342334,0.019390581717451522,0.24508867705574966,1.0,4/12,4.26%,CD19;PAX5;BLK;PTPN22
prerank,negative regulation of cell aging (GO:0090344),0.8047765896961467,1.6402570346337948,0.024296675191815855,0.24396220565924345,1.0,7/16,7.50%,FOXM1;FBXO5;TWIST1;RBL1;CDK6;TERF2;AKT3
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.5103324340086022,-1.640232804447273,0.016304347826086956,0.4737357022266148,1.0,16/24,44.39%,PLA2G15;SLC27A1;CDS2;CRLS1;LPCAT1;SERAC1;PGS1;PLA2G12A;PLA2G4A;PLA2G3;ABCA3;PNPLA8;LPCAT4;PLA2G5;PLA2G4F;PLA2G2D
prerank,postreplication repair (GO:0006301),0.7120972970097662,1.6395339004461462,0.0088008800880088,0.24428397189733655,1.0,19/45,12.18%,POLK;PCLAF;BRCA1;RPA2;DTL;USP43;RFC5;POLD1;POLH;PCNA;POLN;PRIMPOL;POLD2;UBE2V1;RAD18;RPA1;RFC2;RFC1;POLD3
prerank,negative regulation of leukocyte activation (GO:0002695),-0.5966932044596099,-1.639368519071088,0.04680851063829787,0.4651089862141271,1.0,7/15,6.25%,CD84;LRFN5;HAVCR2;CD300LF;GRN;CD300A;ZC3H12A
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4608339440889955,-1.6393465416577424,0.015625,0.4538013555412151,1.0,17/36,20.04%,ARHGAP25;FCGR1A;ITGAM;AIF1;GULP1;RHOBTB1;XKR6;RHOBTB2;SH3BP1;RHOG;VAMP7;RHOH;CD36;THBS1;CDC42;ADGRB1;XKR4
prerank,acylglycerol metabolic process (GO:0006639),-0.45313686775318296,-1.6386414949545771,0.008928571428571428,0.4451695100785376,1.0,13/37,13.74%,DGKH;MGLL;APOE;LPL;ABHD12;DGKA;ABHD6;DGKI;DGKZ;DGKQ;LMF1;DGKB;DGAT1
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.8205602143632927,1.6346966641077054,0.015172413793103448,0.2560731593783994,1.0,8/12,12.39%,CDK1;CCNB2;CCNB1;PLK1;PRKCA;VRK1;PRKCB;CNEP1R1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.8354543201638541,1.6323070215834503,0.014745308310991957,0.26101804595871897,1.0,5/12,8.54%,TICRR;TIPIN;BLM;GMNN;METTL4
prerank,mitotic nuclear membrane organization (GO:0101024),0.7096860267433411,1.6321352339011728,0.00644468313641246,0.25782555691004033,1.0,21/51,10.98%,CDK1;CCNB2;CCNB1;LBR;RCC1;NUP43;POM121;NDC1;REEP4;ANKLE2;NUP107;UBE2I;RANGAP1;NUP160;NUP205;AHCTF1;SEC13;NUP188;EMD;SUMO1;VRK1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.7096860267433411,1.6321352339011728,0.00644468313641246,0.25782555691004033,1.0,21/51,10.98%,CDK1;CCNB2;CCNB1;LBR;RCC1;NUP43;POM121;NDC1;REEP4;ANKLE2;NUP107;UBE2I;RANGAP1;NUP160;NUP205;AHCTF1;SEC13;NUP188;EMD;SUMO1;VRK1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.8122055598628231,1.6295788554844308,0.01602136181575434,0.26322285737529666,1.0,7/15,9.87%,EME1;FANCD2;TIPIN;CHEK2;RAD9A;HUS1;EME2
prerank,regulation of DNA recombination (GO:0000018),0.7262639538910671,1.6284901372653473,0.017045454545454544,0.26432737665539674,1.0,9/32,7.30%,RAD51AP1;RAD51;RPA2;BLM;IL7R;MSH6;CHEK1;ZRANB3;RTEL1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.7237243106339499,1.6277569346718355,0.018161180476730987,0.2646673115652519,1.0,18/35,12.38%,RPA2;MUTYH;POLE;XRCC1;RFC5;POLD1;SMUG1;FEN1;PCNA;LIG1;MBD4;NEIL1;POLD2;RPA1;RFC2;RFC1;POLD3;APEX1
prerank,nucleosome organization (GO:0034728),0.6927090287111297,1.6273960911917622,0.004223864836325237,0.2638370951062339,1.0,24/55,13.98%,HMGB2;CHAF1A;ANP32B;SMARCC2;HMGA1;SMARCA5;SMARCD2;RSF1;NASP;ARID2;CTCF;LIN54;NAP1L4;H3-3A;ASF1A;SMARCA4;SART3;SPTY2D1;SMARCC1;NFE2;CHAF1B;RNF8;ANP32E;NAP1L1
prerank,mismatch repair (GO:0006298),0.7347629527657842,1.6265325787166127,0.020785219399538105,0.2645697512385707,1.0,17/27,17.83%,EXO1;RPA2;MUTYH;POLD1;MSH6;MCM9;PMS2;PCNA;LIG1;POLD2;RPA1;PMS1;POLD3;RPA3;RNASEH2A;MSH5;TDG
prerank,regulation of chromatin organization (GO:1902275),0.821981485169508,1.6257271443806567,0.014804845222072678,0.2651902810986665,1.0,4/14,8.54%,MKI67;ALKBH4;TLK1;METTL4
prerank,B cell receptor signaling pathway (GO:0050853),0.7229210696912569,1.6257195945808889,0.012850467289719626,0.26344601638439524,1.0,10/32,11.77%,CD19;BLK;MS4A1;CD79A;CD38;CD79B;NFAM1;PLCG2;BTK;PRKCB
prerank,mitotic DNA replication (GO:1902969),0.8540089903229524,1.623568551993457,0.019287833827893175,0.26758926575693553,1.0,5/10,5.36%,CDC45;GINS1;POLA1;MCM6;LIG1
prerank,regulation of telomere capping (GO:1904353),0.7736494908795138,1.6213043235524096,0.020432692307692308,0.27233948780203926,1.0,8/23,9.00%,AURKB;NEK2;MAPK1;SMG6;ATM;TERF2;RTEL1;NABP2
prerank,protein palmitoylation (GO:0018345),-0.4697340313831561,-1.6200286451025205,0.013071895424836602,0.499393817460571,1.0,20/30,35.93%,GLUL;ZDHHC17;ZDHHC13;ZDHHC5;GOLGA7;ZDHHC8;SELENOK;CLIP3;ZDHHC24;ZDHHC16;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;HHAT;ZDHHC4;ZDHHC23;ZDHHC22;GOLGA7B;ZDHHC1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.5862394203514085,-1.6176997112016276,0.025179856115107913,0.49613665371570925,1.0,8/15,26.59%,ACLY;ACACA;ACAT1;NUDT7;PMVK;MLYCD;PPCS;MVK
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.7967913307346756,1.6145746106359076,0.023968042609853527,0.29019413635340935,1.0,3/16,8.59%,IL12A;KLRD1;CYRIB
prerank,synaptic vesicle localization (GO:0097479),-0.6291847227311602,-1.6118430421570638,0.023076923076923078,0.5079855390512906,1.0,8/13,16.09%,DNM2;KIF5C;SYNJ1;SPG11;SYNDIG1;KIF5A;CDK5;SNAPIN
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.7786437935891286,1.6111899659533913,0.018494055482166448,0.29872858808419805,1.0,4/16,3.68%,RAD51;HMGA1;BLM;MCM6
prerank,regulation of telomerase activity (GO:0051972),0.7188996156710576,1.6093007000805903,0.01079913606911447,0.3028752182187729,1.0,12/45,9.00%,AURKB;PIF1;NEK2;MEN1;ERCC4;MAPK1;SMG6;ATM;CCT2;TCP1;TERF1;NABP2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.675067697868672,1.6091259021722901,0.005076142131979695,0.301544344731217,1.0,35/83,15.28%,CDKN3;GFI1;RRM2;CCNE1;CDKN2C;CDC45;DBF4;POLA1;CDC25A;RCC1;POLE;E2F1;CCNE2;RB1;FBXO5;NASP;PCNA;CDK6;CDKN2A;TFDP1;BRD4;PIM2;CDK17;MAX;CDKN2D;CUL3;TFDP2;TYMS;NPAT;LATS1;CDK16;MYC;CDC7;E2F3;PPP6C
prerank,cellular response to DNA damage stimulus (GO:0006974),0.6679674742312235,1.6088507616290502,0.0,0.300533274673618,1.0,116/336,14.93%,TOP2A;RAD51AP1;CDK1;RAD51;BLK;TICRR;UBE2T;POLK;POLQ;MCM10;BARD1;MASTL;PCLAF;RFWD3;MEN1;POLE2;RAD1;ERCC4;SUV39H1;BRCA1;RMI2;EXO1;CHEK2;POLA1;BLM;FANCA;MUTYH;E2F1;CHD1L;RAD51B;WDHD1;DDX11;DTL;RAD51C;BATF;CBX5;SLX4;TOPBP1;SMC6;RFC5;RAD9A;PML;MAP2K6;TIMELESS;PIDD1;TANK;POLD1;BRAT1;POLH;MSH6;MCM9;RBBP8;STK11;FEN1;FOXP1;CHEK1;CGAS;LIG1;XRCC3;MBD4;TAF1;IKBKG;FOXO1;CASP2;ATM;SETX;TRAIP;FBXO45;MRNIP;ZRANB3;RTEL1;ASF1A;BOK;BAZ1B;CIB1;PHF1;MAPK14;GRB2;RAD18;HUS1;NABP2;RNF169;RPA1;ERCC3;RFC2;ALKBH7;PPP1R15A;PARK7;SUMO1;RNF168;FAM111A;XIAP;RNF8;KMT5C;APEX1;PDS5B;RPAIN;TDP1;KIN;SIRT7;PRKDC;REXO4;NIPBL;DDIT3;BCL6;MYC;PSEN1;APTX;FANCL;CASP9;RAD52;RBBP5;VCPIP1;CCNK;RAD50;TP53
prerank,synaptic membrane adhesion (GO:0099560),-0.6053282441859251,-1.6088343202395639,0.020242914979757085,0.5069599320375238,1.0,6/14,10.66%,LRFN5;PTPRD;LRRC4;PTPRS;NTNG1;LRRC4B
prerank,negative regulation of DNA recombination (GO:0045910),0.7082958803188488,1.6084811141389095,0.0165016501650165,0.2999154970674606,1.0,14/43,8.97%,POLQ;PARPBP;RMI2;RADX;BLM;SMCHD1;POLR2I;POLR2A;MSH6;CGAS;TERF2;ZRANB3;RTEL1;TERF1
prerank,glycine transport (GO:0015816),0.8335371477853851,1.6083912189547147,0.024320457796852647,0.2982442350007055,1.0,2/10,3.20%,SLC38A5;SLC6A5
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7346227944644317,1.6073691066730649,0.01463963963963964,0.299471487500056,1.0,8/31,5.38%,E2F7;CDKN2C;JADE1;WEE1;RB1;RBL1;CDK6;CDKN2A
prerank,glycerolipid catabolic process (GO:0046503),-0.5269583873856389,-1.606369648983578,0.037209302325581395,0.5041635140113677,1.0,5/19,7.19%,MGLL;GPCPD1;ABHD12;GDE1;ABHD6
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.5159215179836308,-1.6052387995989836,0.016483516483516484,0.49789913857287665,1.0,8/20,17.34%,SLC27A1;HAGH;CNDP2;PTDSS2;GSS;PLOD2;CHAC2;OPLAH
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.8569843069414878,1.6027830016208608,0.023943661971830985,0.31177789550857027,1.0,3/10,1.92%,E2F7;E2F8;DBF4
prerank,nuclear membrane disassembly (GO:0051081),0.7919140307271599,1.6027699827885233,0.02452316076294278,0.3098983926387699,1.0,8/14,12.39%,CDK1;CCNB2;CCNB1;PLK1;PRKCA;VRK1;PRKCB;CNEP1R1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.6948687339697742,1.6024199532038672,0.0031678986272439284,0.3089890214805423,1.0,23/58,12.23%,DNTT;POLQ;HMGB2;BARD1;ERCC4;BRCA1;POLA1;NSD2;BABAM1;LIG4;PRPF19;ABRAXAS1;ATM;DCLRE1C;XRCC6;DCLRE1B;HMGB1;ZBTB7A;NSMCE2;SUMO1;RNF168;RNF8;PAXIP1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.49661654502749064,-1.6020759588123863,0.017543859649122806,0.49946269476318106,1.0,11/24,14.77%,ITGAM;CTNNB1;GRN;MCL1;ATF4;NF1;CDK5R1;CDK5;SRPK2;PRNP;FBXW7
prerank,error-prone translesion synthesis (GO:0042276),0.7636799497092976,1.6016795916596236,0.017743979721166033,0.3093988787886106,1.0,10/21,11.20%,POLK;POLE2;RPA2;RFC5;POLH;PCNA;PRIMPOL;RPA1;RFC2;RFC1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.44625811501763885,-1.6012719175681374,0.017699115044247787,0.49183732409499686,1.0,12/34,13.05%,UBASH3B;PTPN2;PTPRZ1;PTPN6;PTPRS;PTPRJ;DUSP3;DUSP10;PTPRO;PTPRT;DUSP7;PTPN9
prerank,positive regulation of telomere capping (GO:1904355),0.7953129743249341,1.5946423480507106,0.025906735751295335,0.3303315232872044,1.0,5/17,9.00%,AURKB;NEK2;MAPK1;RTEL1;NABP2
prerank,nuclear membrane reassembly (GO:0031468),0.6913135854578809,1.5926422902144368,0.007494646680942184,0.33530291350152275,1.0,21/54,10.98%,CDK1;CCNB2;CCNB1;LBR;RCC1;NUP43;POM121;NDC1;REEP4;ANKLE2;NUP107;UBE2I;RANGAP1;NUP160;NUP205;AHCTF1;SEC13;NUP188;EMD;SUMO1;VRK1
prerank,neurotransmitter secretion (GO:0007269),-0.4208425442392021,-1.5912399958119785,0.036585365853658534,0.5197433498903752,1.0,20/44,25.62%,RIMS1;PCLO;RIMS2;SYT1;VAMP2;GAD2;CDK5;UNC13A;STX1A;PIP5K1C;SNAPIN;RAB3A;STXBP1;PTPRN2;CPLX1;SLC32A1;PDZD11;CPLX2;DVL1;SNAP25
prerank,activin receptor signaling pathway (GO:0032924),-0.570231037476657,-1.5879958667789098,0.036885245901639344,0.521141880380841,1.0,3/15,4.40%,ACVR1;TGFBR1;SMAD3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7478325998196288,1.587744991568706,0.027603513174404015,0.34938644064708496,1.0,10/21,15.02%,CD19;PAX5;BLK;PTPN22;FOXP1;NFAM1;PRKCB;CBFB;ELF1;RUNX1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.561197538148798,-1.5868711797068094,0.0423728813559322,0.5149787641701722,1.0,9/15,39.69%,SMOX;PAOX;SAT1;DDC;ASMT;SAT2;MOXD1;SRM;AANAT
prerank,negative regulation of centrosome duplication (GO:0010826),0.8207900869271952,1.5863815050380603,0.03536067892503536,0.3519310323512874,1.0,3/11,1.57%,CCNF;BRCA1;CDK5RAP2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.7296164660234606,1.5850564653234231,0.017462165308498253,0.3541959919929288,1.0,7/28,6.93%,SKA3;SKA1;SKA2;STMN1;CLASP1;GBA2;MAPRE3
prerank,nitric oxide metabolic process (GO:0046209),0.789427781451719,1.584918283009625,0.02763157894736842,0.3525207908505071,1.0,2/14,2.63%,CYP1B1;DDAH2
prerank,nucleosome disassembly (GO:0006337),0.7929612101968808,1.5845633417318663,0.03758389261744966,0.3496356906891255,1.0,7/14,10.90%,SMARCC2;HMGA1;SMARCD2;ARID2;SMARCA4;SMARCC1;NFE2
prerank,chromatin disassembly (GO:0031498),0.7929612101968808,1.5845633417318663,0.03758389261744966,0.3496356906891255,1.0,7/14,10.90%,SMARCC2;HMGA1;SMARCD2;ARID2;SMARCA4;SMARCC1;NFE2
prerank,cholesterol efflux (GO:0033344),-0.5128278195575423,-1.5840462942084552,0.005405405405405406,0.5154440173064451,1.0,8/20,18.56%,APOE;ABCA1;ABCA5;STX12;SCARB1;NPC2;NPC1;APOC1
prerank,negative regulation of axon extension (GO:0030517),-0.4625846487514226,-1.5835640413740535,0.007751937984496124,0.5073780201551865,1.0,13/30,24.18%,RTN4;DIP2B;SEMA3D;PTPRS;SEMA3E;SEMA4C;MAG;SEMA4G;SEMA3A;CDKL3;SEMA7A;MT3;SEMA4D
prerank,negative regulation of hormone secretion (GO:0046888),-0.6519006340206703,-1.5833376460609343,0.02711864406779661,0.49922606217457516,1.0,6/10,31.73%,RAB11FIP3;GJA1;RAB11FIP5;RAB11FIP1;OSM;IL1B
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.6951043716885023,1.582889093543182,0.025386313465783666,0.3530088840924027,1.0,13/37,12.18%,POLK;ERCC4;RPA2;CHD1L;RFC5;POLD1;PCNA;POLD2;RPA1;ERCC3;RFC2;RFC1;POLD3
prerank,mitotic recombination (GO:0006312),0.7885195878385401,1.581254234260092,0.025673940949935817,0.3564880314534243,1.0,9/15,14.79%,GEN1;RAD51;RAD54B;SMC6;XRCC3;NSMCE2;TEP1;RAD52;RAD50
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.7167759274919183,1.5811320861466447,0.022321428571428572,0.35480121425790573,1.0,8/33,5.38%,E2F7;CDKN2C;JADE1;WEE1;RB1;RBL1;CDK6;CDKN2A
prerank,positive regulation of telomere maintenance (GO:0032206),0.723674754194159,1.580191044425843,0.03154205607476635,0.3558939466940954,1.0,9/31,9.00%,AURKB;NEK2;MAPK1;SLX4;PML;ATM;RTEL1;HNRNPA2B1;NABP2
prerank,positive regulation of integrin activation (GO:0033625),-0.6284976521738745,-1.5791762888277894,0.03180212014134275,0.5045890645944386,1.0,5/11,18.49%,RAP1B;P2RY12;FERMT2;SKAP1;PLEK
prerank,regulation of cell cycle phase transition (GO:1901987),0.6610790782719268,1.5776961847691613,0.004056795131845842,0.3622614075072303,1.0,31/91,16.37%,BUB1B;CDK1;UBE2C;GTSE1;MAD2L1;CCNB1;CDC20;PLK1;DBF4;FBXO5;PSMB7;PSMD11;CDC23;CDC27;PSMF1;TAF1;PSMC1;ANAPC7;ERCC3;PSMC3;PSMA4;FZR1;PSMC4;BUB3;PSMD13;PSME1;PSMB1;TP53;PSMD8;TFAP4;PSME4
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.819001848940915,1.5775817800894696,0.03443526170798898,0.3605706074934589,1.0,8/11,12.12%,ASF1B;NASP;RBBP4;H3-3A;ASF1A;UBN1;HIRA;HAT1
prerank,protein sumoylation (GO:0016925),0.6805409875786532,1.5766792540004906,0.024838012958963283,0.36159300543502904,1.0,28/49,17.13%,NUP43;POM121;NDC1;SAE1;NUP107;UBE2I;RANGAP1;NUP42;UBA2;BCL11A;NUP50;NUP214;NUP160;NUP205;PIAS3;NUP188;NSMCE2;SUMO1;NUP98;RANBP2;NUP210;SUMO2;EYA1;PIAS1;TRIM28;AAAS;TRPM4;NUP37
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.6547988007179658,1.5761149819812843,0.0010070493454179255,0.36156123701278714,1.0,54/148,14.93%,TPX2;CDK1;BRIP1;AURKB;BARD1;RAD1;BRCA1;RMI2;EXO1;RPA2;MBD3;CHEK2;BLM;AURKA;RPS20;TOPBP1;RFC5;RAD9A;PML;MAP2K6;RBBP8;STK11;CHEK1;BRPF1;TAF1;MDM4;ATM;RBBP4;TAF7;TAF15;PIN1;MAPK14;RHNO1;DNA2;HUS1;RPA1;RFC2;PDPK1;HIPK2;KAT6A;EHMT1;TAF6;MLST8;TTC5;MTA2;CDK5RAP3;TOP3A;ING2;ING5;PRKAG2;TAF2;RPA3;RAD50;TP53
prerank,chromatin assembly (GO:0031497),0.6802943267039316,1.5754843528081732,0.03128491620111732,0.36164891500685786,1.0,19/38,16.99%,HMGB2;CHAF1A;ANP32B;SMARCA5;RSF1;CTCF;LIN54;NAP1L4;RBBP4;H3-3A;ASF1A;SART3;SPTY2D1;CHAF1B;CDAN1;NAP1L1;TP53;ATRX;SIRT1
prerank,gas transport (GO:0015669),0.81913304445653,1.5750387967350752,0.026499302649930265,0.3612322371134044,1.0,3/10,6.62%,RHAG;AQP1;IPCEF1
prerank,synaptic vesicle exocytosis (GO:0016079),-0.44086415277794166,-1.574325796364326,0.021505376344086023,0.5130173463570046,1.0,15/40,16.09%,RIMS1;PCLO;RIMS2;SNAP47;STX4;STX3;SYT1;STX2;VAMP2;SYT7;CDK5;UNC13A;STX1A;PIP5K1C;SNAPIN
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.7845875530591799,1.5740478162254474,0.03306878306878307,0.36247423565120457,1.0,4/14,7.25%,RAD51AP1;TIMELESS;ARID2;MRNIP
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.659597028871748,1.5735823018988522,0.006224066390041493,0.3620868926922033,1.0,30/72,17.75%,ANKLE1;POLK;RNASE6;ERCC4;RPA2;CHD1L;RFC5;POLD1;FEN1;PCNA;PDE12;DCP1B;POLD2;DNA2;DNASE1L1;EDC3;RPA1;ERCC3;RFC2;RFC1;POLD3;DCP1A;DXO;REXO4;RPA3;RAD50;MEI4;RNASE1;UBA52;DDB2
prerank,response to acidic pH (GO:0010447),-0.5867234533522828,-1.5735322423915608,0.047058823529411764,0.5069593807742132,1.0,8/13,22.57%,CTSS;IMPACT;SLC9A1;LGMN;GPR65;RAB11FIP5;PKD2L1;CHP1
prerank,negative regulation of telomere maintenance (GO:0032205),0.7780113662621111,1.5697041359074255,0.03790849673202614,0.3731630959347401,1.0,7/15,8.97%,ERCC4;SMG6;SLX4;ATM;TERF2;RTEL1;TERF1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.6861702831070549,1.5689402713227831,0.025027203482045703,0.3736355500300934,1.0,13/39,12.18%,POLK;ERCC4;RPA2;CHD1L;RFC5;POLD1;PCNA;POLD2;RPA1;ERCC3;RFC2;RFC1;POLD3
prerank,regulation of cell division (GO:0051302),0.663760991735979,1.568632053889482,0.008273009307135471,0.3728106982665711,1.0,18/72,13.91%,PRC1;KIF18B;AURKB;KIF20A;PLK1;BLM;AURKA;CSPP1;PIN1;BIRC6;CIB1;KLHL9;AHCTF1;KIF13A;BECN1;RACK1;BBS4;MYC
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.6406819329090769,-1.5678607217643719,0.054313099041533544,0.5188574070576897,1.0,5/10,11.84%,LRP1;PTPN2;APOD;PTPRJ;NDRG4
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.6454215332049219,1.5676911648768739,0.008088978766430738,0.37402069974745,1.0,40/94,16.00%,CDK1;NEK2;KIF24;CKAP5;PLK1;CDK5RAP2;CEP152;NDE1;PCNT;HAUS5;HAUS6;CEP83;CEP192;TUBB4B;ODF2;CEP89;CLASP1;CEP72;CEP76;ALMS1;DYNC1H1;CEP250;OFD1;PRKACA;NEDD1;CEP70;NINL;PCM1;PAFAH1B1;HAUS4;TUBB;CEP162;HAUS7;SCLT1;MKS1;CNTRL;DYNLL1;CEP57;SDCCAG8;MARK4
prerank,retinol metabolic process (GO:0042572),0.7828184339353557,1.5673665403874135,0.03537414965986395,0.373097927731975,1.0,2/14,1.41%,LRAT;CYP1B1
prerank,regulation of cell cycle (GO:0051726),0.6464346981100924,1.5666215359725975,0.0,0.373731056791768,1.0,66/271,13.91%,CENPF;DLGAP5;KIF20B;PRR11;CDKN3;BIRC5;FOXM1;CCNB2;DDIAS;IL12A;CKS2;BARD1;CCNB1;MASTL;PCLAF;PLK1;MEN1;CDKN2C;BRCA1;CDC25A;PHACTR4;PPP1R9B;SKP2;DYNLT3;RB1;FBXO5;DTL;LIN9;FAP;PML;MAP2K6;STK11;CHEK1;CDK6;CDKN2A;LIN54;ATM;RBBP4;GMNN;RUNX3;BIRC2;NOTCH1;PIM2;PIM3;PRKACA;HPGD;CDKN2D;PPP1R15A;HIPK2;WHAMM;RAD23A;PUM1;TAF6;JUN;RPRD1B;XIAP;KAT2B;CDK5RAP3;BAP1;HCFC1;RPS15A;RACK1;HNRNPU;BEX2;INTS13;MYC
prerank,fibrinolysis (GO:0042730),-0.5915828198657023,-1.566383796067472,0.04247104247104247,0.5146437202096689,1.0,4/13,23.49%,PLAUR;PLAU;SERPINE1;PLAT
prerank,regulation of axon extension (GO:0030516),-0.4159871009249222,-1.5648600409742877,0.0,0.511217498628807,1.0,17/37,20.27%,RTN4;DNM2;RUFY3;MACF1;MAP3K13;DIP2B;APOE;PTPRS;LIMK1;MAG;GOLGA4;SEMA3A;L1CAM;TWF2;CTTN;CDKL3;SEMA7A
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.7077090056184453,1.564550049927487,0.02957906712172924,0.3786946145142011,1.0,17/30,19.60%,PIF1;MEN1;ERCC4;DACH1;HNRNPC;TERF2;EXOSC10;DCP2;TERF1;CTC1;HNRNPU;TP53;NAT10;HNRNPA1;GNL3L;CDKN1A;XRN1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.6212621099810508,-1.5641731235507583,0.050473186119873815,0.5053115059854965,1.0,5/10,13.86%,TREM2;APPL2;CD300A;RAB31;NCKAP1L
prerank,regulation of protein export from nucleus (GO:0046825),0.7250666693851702,1.56404816125041,0.035452322738386305,0.378421786555517,1.0,15/23,17.55%,GTSE1;BARD1;ANP32B;SP100;RANGAP1;PARK7;EMD;PTPN14;SIRT7;BAG3;GSK3B;TP53;TCF7L2;XPO4;YWHAE
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.7875437080036666,1.5638408981603107,0.038410596026490065,0.37726723837913034,1.0,6/15,9.56%,FAM83D;EZH2;ATAD5;DDRGK1;PLCG2;CUL3
prerank,DNA duplex unwinding (GO:0032508),0.6686119547714986,1.5636823638224704,0.012903225806451613,0.37589295361433456,1.0,11/50,9.43%,RAD51;PIF1;HMGA1;BLM;CHD1L;DDX11;MCM6;MCM9;RTEL1;RPA1;ERCC3
prerank,regulation of embryonic development (GO:0045995),0.6899568782393937,1.5613574700070576,0.033256880733944956,0.3820482288381529,1.0,13/34,14.46%,CDK1;RACGAP1;FOXA2;CCSAP;WDPCP;CLASP1;RBM19;NR2C2;EHMT1;PLCB1;RPS6KA6;NIPBL;DAG1
prerank,protein localization to microtubule organizing center (GO:1905508),0.762112793415116,1.5609728959900702,0.036585365853658534,0.3813834001885915,1.0,8/15,13.81%,STIL;SPAG5;CEP83;CEP192;NEDD1;PCM1;BBS4;PIBF1
prerank,outer dynein arm assembly (GO:0036158),0.7892144670549784,1.5569503650072456,0.024128686327077747,0.3931459437238737,1.0,2/14,0.95%,CCDC63;DNAH8
prerank,embryonic axis specification (GO:0000578),0.7820987613552944,1.5561421525397878,0.034666666666666665,0.3939614922098758,1.0,1/15,0.26%,STIL
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6509635013024635,-1.5549589296286757,0.04436860068259386,0.5278996344334247,1.0,4/10,12.98%,PLA2G15;PLA2G7;ENPP2;PLA2G6
prerank,cellular potassium ion homeostasis (GO:0030007),-0.5861103990872917,-1.5527546252684281,0.05303030303030303,0.5273738315369437,1.0,8/13,25.34%,KCNMA1;SLC12A2;ATP1A1;ATP1B2;ATP1B1;ATP1A2;ATP1A3;ATP1B3
prerank,actin nucleation (GO:0045010),-0.5130015907820105,-1.5526769069414772,0.026595744680851064,0.5197686854018456,1.0,7/21,13.21%,TRIM27;SPIRE1;JMY;ARPC5L;WASHC1;ARPC3;ARPC2
prerank,response to UV (GO:0009411),0.6498723132865585,1.5525782685842184,0.006128702757916241,0.4044416712110408,1.0,28/95,11.38%,AURKB;POLK;IL12A;PCLAF;MEN1;ERCC4;AQP1;CDC25A;USP1;DTL;EIF2S1;USF1;POLD1;POLH;MSH6;COPS9;FEN1;PCNA;TAF1;PRIMPOL;ZRANB3;UBE4B;RHNO1;EGFR;CDKN2D;ERCC3;RUVBL2;CCAR2
prerank,regulation of telomere maintenance (GO:0032204),0.7039785444500077,1.5525041599318279,0.037383177570093455,0.4027485483599978,1.0,7/26,7.30%,PIF1;ERCC4;SMG6;PML;SMG5;TERF2;RTEL1
prerank,ion homeostasis (GO:0050801),0.6917699166864351,1.55192245263441,0.03428571428571429,0.40282931665791266,1.0,2/30,0.51%,SLC4A1;RHAG
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.6632991512016586,1.5514557168857914,0.025477707006369428,0.40246883449198984,1.0,25/53,19.54%,ANKLE1;PLA2R1;BRCA1;PMAIP1;SMCHD1;BABAM1;ABRAXAS1;PCNA;ATM;EYA3;EGFR;RNF168;CCAR2;RNF8;DHX9;FXR1;SPRED2;MYC;CEBPG;EYA1;TRIM28;SIRT1;WRAP53;RPS3;NPAS2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.6978942015239745,1.5511010785607386,0.04805491990846682,0.40164702746840764,1.0,14/33,15.28%,RAD51;PIF1;NOP10;TERF2;ANKRD28;DCLRE1B;RTEL1;TERF1;RPA1;RFC1;CTC1;PPP6R3;RAD50;PPP6C
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.8037941624791056,1.5494298359048404,0.03536067892503536,0.4017510994204282,1.0,6/10,8.97%,EXO1;BLM;SLX4;XRCC3;DNA2;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.8037941624791056,1.5494298359048404,0.03536067892503536,0.4017510994204282,1.0,6/10,8.97%,EXO1;BLM;SLX4;XRCC3;DNA2;TERF1
prerank,t-circle formation (GO:0090656),0.8037941624791056,1.5494298359048404,0.03536067892503536,0.4017510994204282,1.0,6/10,8.97%,EXO1;BLM;SLX4;XRCC3;DNA2;TERF1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.8045830000544038,1.5485696537294926,0.027818448023426062,0.4027418300025687,1.0,1/10,0.41%,BLK
prerank,cellular response to zinc ion (GO:0071294),-0.5722193272596663,-1.5484439628732798,0.025,0.5268159181301544,1.0,12/15,23.06%,GLRA2;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MT2A;P2RX4;MT3
prerank,T-helper cell differentiation (GO:0042093),0.7773467981825524,1.5479935464633503,0.03626220362622036,0.4028285679153914,1.0,6/14,10.54%,LEF1;BATF;ZFPM1;FOXP1;HMGB1;ATP7A
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.7220430400765939,1.5477084527930378,0.03195266272189349,0.40202852807618106,1.0,14/24,19.60%,PIF1;ERCC4;SLX4;HNRNPC;TERF2;EXOSC10;DCP2;TERF1;CTC1;HNRNPU;NAT10;HNRNPA1;GNL3L;XRN1
prerank,nitric oxide biosynthetic process (GO:0006809),0.789429428955889,1.5468910053675717,0.03504043126684636,0.4029653344308389,1.0,2/13,2.63%,CYP1B1;DDAH2
prerank,glycerolipid metabolic process (GO:0046486),-0.6139873845648806,-1.5464296729208002,0.058823529411764705,0.525713196461617,1.0,5/11,13.66%,PLA2G15;DGKA;DGKZ;DGKQ;DGKB
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.7651089707549646,1.5457751238275723,0.03937007874015748,0.4048007177748596,1.0,4/17,5.44%,IL12A;KLRD1;RASGRP1;RAET1E
prerank,cellular response to cAMP (GO:0071320),0.6937117299476466,1.5446013539796273,0.031578947368421054,0.40673759202368676,1.0,8/30,7.54%,SLC5A5;AQP1;EZR;HCN3;CRHBP;ZFP36L1;PDE2A;AHR
prerank,positive regulation of DNA repair (GO:0045739),0.6751053351136854,1.5441312653222503,0.03036876355748373,0.40623388449008363,1.0,27/46,21.23%,FOXM1;BRCA1;SMCHD1;XRCC1;DDX11;BABAM1;TIMELESS;HDAC10;ABRAXAS1;PCNA;HMGB1;EYA3;EGFR;RNF168;RNF8;DHX9;CEBPG;EYA1;TRIM28;SIRT1;WRAP53;SLF1;RPS3;NPAS2;ZCWPW1;UBE2N;FAM168A
prerank,histone H4 acetylation (GO:0043967),0.6676623953295213,1.5431708387895575,0.02798708288482239,0.4075495732900006,1.0,19/47,14.85%,KANSL1;JADE1;NAA40;BRCA2;LEF1;EPC1;BRD8;KANSL3;MSL2;YEATS4;RUVBL2;RUVBL1;HAT1;HCFC1;KMT2A;ING3;ING5;KANSL2;TADA3
prerank,regulation of centriole replication (GO:0046599),0.7554255356267566,1.542759347665434,0.03761348897535668,0.40713039597046197,1.0,8/17,12.94%,STIL;BRCA1;CDK5RAP2;CEP295;CEP76;ALMS1;KAT2B;MDM1
prerank,lipid droplet formation (GO:0140042),-0.6332898997434727,-1.5417536149556377,0.060790273556231005,0.5341829681006153,1.0,5/10,20.40%,CDS1;AUP1;CDS2;ZFYVE1;SQLE
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.6782105487367718,1.5404366148524757,0.030687830687830688,0.4129580863348652,1.0,18/51,13.39%,AURKB;PIF1;NEK2;MAPK1;SMG6;SMG5;CCT7;HNRNPC;ATM;TERF2;CCT2;TCP1;EXOSC10;DCP2;TERF1;CCT5;CTC1;HNRNPU
prerank,regulation of DNA repair (GO:0006282),0.6728868759634494,1.5391919670653385,0.033659066232356136,0.4154966980736064,1.0,25/44,19.54%,BRCA1;RADX;SMCHD1;USP1;BABAM1;DEK;PML;POLH;ABRAXAS1;PCNA;EYA3;UBE2V1;EGFR;RNF168;RNF8;DHX9;SIRT7;CEBPG;RAD52;EYA1;TRIM28;SIRT1;WRAP53;RPS3;NPAS2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.8160859032175055,1.5384986115103456,0.03506311360448808,0.4161522049816068,1.0,6/11,7.26%,TIPIN;BLM;FBXO5;TIMELESS;GMNN;ZRANB3
prerank,dendritic cell differentiation (GO:0097028),0.7221038095737009,1.5383492837560355,0.03629536921151439,0.4148312335609507,1.0,3/22,3.17%,BLK;PRTN3;BATF
prerank,replicative senescence (GO:0090399),0.7925923325515378,1.5372963493339444,0.04194857916102842,0.41644827414068625,1.0,5/12,6.00%,PLA2R1;CHEK2;CHEK1;CDKN2A;ATM
prerank,piRNA metabolic process (GO:0034587),0.7228713096154704,1.533781295226783,0.048327137546468404,0.42733859364171045,1.0,1/19,1.37%,MYBL1
prerank,cell cycle G1/S phase transition (GO:0044843),0.6487633712101607,1.533427554527714,0.017708333333333333,0.42664538333748275,1.0,24/61,15.28%,CDKN3;CCNA2;CCNE1;CDKN2C;DBF4;CDC25A;RCC1;POLE;E2F1;CCNE2;RB1;NASP;CDK6;CDKN2A;PIM2;MAX;CDKN2D;CUL3;MAP3K11;LATS1;MYC;CDC7;E2F3;PPP6C
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.7698518346926273,1.5320966810812586,0.0427807486631016,0.42932906448180785,1.0,4/16,5.44%,IL12A;KLRD1;RASGRP1;RAET1E
prerank,regulation of lymphocyte differentiation (GO:0045619),0.7343573081669182,1.531281095013089,0.05583756345177665,0.4302267356648833,1.0,8/18,16.03%,CD2;IKZF3;CCR2;ZFP36L1;XRCC6;PRKDC;SLAMF8;ZFP36L2
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.782893264580571,1.5287515427389824,0.046089385474860335,0.4374025788736456,1.0,2/13,8.59%,IL12A;CYRIB
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8046869770083489,1.5282309466309407,0.04857142857142857,0.4372581325816437,1.0,3/12,1.35%,UBE2C;CDC20;PLK1
prerank,protein-DNA complex disassembly (GO:0032986),0.7430644073237324,1.5281991203264644,0.047435897435897434,0.4354670922979489,1.0,8/16,13.91%,SMARCC2;HMGA1;SMARCD2;ARID2;SMARCA4;SMARCC1;NFE2;MYC
prerank,regulation of catabolic process (GO:0009894),0.7332423534631282,1.5271957607862825,0.05363984674329502,0.43743051778753794,1.0,8/18,15.55%,FAM83D;CHEK2;FAP;FAF1;NEDD4L;HPGD;ZDHHC7;HGS
prerank,lymphocyte proliferation (GO:0046651),0.7146115866391469,1.5265541529922886,0.04141291108404385,0.43797501696851865,1.0,6/22,11.69%,MS4A1;CD79A;HELLS;RASGRP1;MSN;FLT3
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.6595131067486466,1.5264689252378216,0.02583423035522067,0.4345419461615611,1.0,29/50,22.44%,NUP43;POM121;NDC1;POLR2I;NUP107;POLR2A;NUP42;NUP50;PUM2;H3-3A;NUP214;NUP160;NUP205;SEC13;NUP188;PUM1;NUP98;RANBP2;NUP210;POLR2K;AAAS;NUP37;POLR2J;NUP85;AGO2;TPR;NUP93;AGO1;POLR2B
prerank,regulation of gene silencing by RNA (GO:0060966),0.6595131067486466,1.5264689252378216,0.02583423035522067,0.4345419461615611,1.0,29/50,22.44%,NUP43;POM121;NDC1;POLR2I;NUP107;POLR2A;NUP42;NUP50;PUM2;H3-3A;NUP214;NUP160;NUP205;SEC13;NUP188;PUM1;NUP98;RANBP2;NUP210;POLR2K;AAAS;NUP37;POLR2J;NUP85;AGO2;TPR;NUP93;AGO1;POLR2B
prerank,regulation of multicellular organismal development (GO:2000026),0.715774598287895,1.5262619925304048,0.03760282021151586,0.43339405628551325,1.0,3/25,1.31%,CDK1;RACGAP1;CCSAP
prerank,V(D)J recombination (GO:0033151),0.7932257892169675,1.5252381811627804,0.0524822695035461,0.43510438816449976,1.0,5/11,7.33%,HMGB2;LIG4;LIG1;TCF3;HMGB1
prerank,DNA-dependent DNA replication (GO:0006261),0.6327371755880066,1.52468737079262,0.0020100502512562816,0.43506687579577263,1.0,49/128,16.98%,RAD51;MCM10;POLE2;CDC45;PRIM2;GINS1;PRIM1;RPA2;DBF4;HMGA1;POLA1;BLM;POLE;WDHD1;PSMB7;TOPBP1;PSMD11;MCM6;RFC5;ORC5;POLD1;PSMF1;ORC3;GMNN;LRWD1;PSMC1;PRIMPOL;POLD2;DNA2;RPA1;RFC2;PSMC3;PSMA4;RFC1;PSMC4;POLD3;TEFM;RPAIN;SIRT7;PSMD13;PSME1;CDC7;PSMB1;RPA3;PSMD8;PSME4;MCM3;BAZ1A;PSMD4
prerank,synaptic vesicle transport (GO:0048489),-0.6258967540258835,-1.5237287460562414,0.0539568345323741,0.5899021434664786,1.0,7/11,16.09%,DNM2;KIF5C;SYNJ1;SPG11;KIF5A;CDK5;SNAPIN
prerank,cellular response to alkaloid (GO:0071312),0.7415483095349072,1.5234737531277533,0.06102117061021171,0.4375210103912927,1.0,3/17,4.05%,RAD51;BLM;CRHBP
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.737544173592396,1.5231573311678988,0.05217391304347826,0.43686008244616337,1.0,12/19,19.60%,PIF1;HNRNPC;TERF2;EXOSC10;DCP2;TERF1;CTC1;HNRNPU;NAT10;HNRNPA1;GNL3L;XRN1
prerank,apoptotic DNA fragmentation (GO:0006309),0.7263308178441048,1.5215352591892322,0.05570291777188329,0.4408684775520633,1.0,3/16,7.33%,HMGB2;CECR2;HMGB1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.4478283209647128,-1.5208879504352033,0.026845637583892617,0.5916240460285465,1.0,8/29,16.08%,DPP10;KCNIP3;KCNN2;KCNAB1;CD63;SNTA1;FGF12;DLG1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.6431285708694329,1.5205608970081315,0.027253668763102725,0.4425873324928721,1.0,31/61,20.76%,RAD51;BRCA1;SMCHD1;BABAM1;PML;ABRAXAS1;PCNA;RTEL1;HMGB1;EYA3;SMOC2;EGFR;MECP2;RNF168;RNF8;DHX9;MYC;CEBPG;RAD50;EYA1;ATRX;TRIM28;SIRT1;USP7;WRAP53;RPS3;NPAS2;PRKD2;ZCWPW1;UBE2N;WRN
prerank,heterochromatin assembly (GO:0031507),0.7120091199019404,1.5200630472219756,0.05590851334180432,0.44245921238900177,1.0,7/20,7.38%,SUV39H1;HMGA1;SMCHD1;HELLS;CDKN2A;MBD2;H3-3A
prerank,regulation of spindle assembly (GO:0090169),0.6980638003981897,1.5199678007605426,0.04716981132075472,0.4409343269998924,1.0,13/25,18.28%,SPAG5;CCSAP;PLK1;GPSM2;DYNC1H1;CHMP1B;HNRNPU;NUMA1;CHMP3;CHMP2B;RNF4;DRG1;SENP6
prerank,positive regulation of cellular protein localization (GO:1903829),0.6445250043466718,1.5194108158482318,0.024793388429752067,0.4410006985356636,1.0,22/69,16.15%,NDC80;CDK1;GTSE1;PLK1;CARD10;CCDC88A;FYN;SNX33;TFRC;GPD1L;DDRGK1;CEP250;ABCA7;PARK7;ORMDL3;CDK5RAP3;NUMA1;TYROBP;CENPQ;GSK3B;MARK4;LIMK2
prerank,regulation of B cell apoptotic process (GO:0002902),0.7800634612208284,1.5192387814328476,0.051209103840682786,0.4397136502137178,1.0,6/12,13.77%,AURKB;BLK;FOXP1;BTK;ORMDL3;BCL6
prerank,somite development (GO:0061053),-0.6018293096925316,-1.518921164699295,0.0657439446366782,0.5907837906917682,1.0,4/11,19.20%,SMO;PPP2R3A;LOXL3;SOX11
prerank,hyaluronan catabolic process (GO:0030214),0.7339567843929028,1.5185786848987801,0.05377720870678617,0.4402286548984101,1.0,2/18,3.88%,HMMR;CD44
prerank,cell-cell junction maintenance (GO:0045217),0.7791971284246836,1.5184468152982995,0.05510752688172043,0.4388999691109679,1.0,2/11,1.29%,PRTN3;CD177
prerank,negative regulation of double-strand break repair (GO:2000780),0.6863591233054496,1.51649013146565,0.03128491620111732,0.4440032947267454,1.0,7/30,5.12%,POLQ;PARPBP;RMI2;RADX;SMCHD1;TWIST1;CGAS
prerank,regulation of interferon-alpha production (GO:0032647),-0.48423421836450264,-1.516328778205321,0.05917159763313609,0.5923849557439235,1.0,6/23,7.28%,HAVCR2;HSPD1;PTPRS;TLR7;MAVS;TLR4
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5752237068224828,-1.5160224946655736,0.06620209059233449,0.5855321770394086,1.0,6/12,22.12%,DPYD;ALDH6A1;UMPS;CRMP1;DPYSL2;DPYSL3
prerank,regulation of protein localization to nucleus (GO:1900180),0.6553647969655969,1.5150335647448487,0.04108108108108108,0.4473284620566496,1.0,14/43,16.15%,CDK1;GTSE1;PLK1;CARD10;CTNNA1;TFRC;PIN1;PARK7;ORMDL3;CDK5RAP3;LATS1;GSK3B;SIN3A;LIMK2
prerank,granulocyte differentiation (GO:0030851),0.7294527990179411,1.5146305049760416,0.04568527918781726,0.44690130070585515,1.0,5/18,3.87%,LBR;LEF1;E2F1;DEK;PML
prerank,intracellular pH reduction (GO:0051452),-0.43571165561159286,-1.509821262003939,0.024193548387096774,0.6006657202581351,1.0,15/33,21.99%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;DMXL2;RAB20;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1H;ATP6V1F;ATP6V1G2;ATP6V0C;TMEM9;RAB38
prerank,vasodilation (GO:0042311),-0.5786296507566613,-1.5089080821875591,0.051470588235294115,0.595971026120944,1.0,6/13,33.38%,KCNMA1;ADRB1;ADRB2;KLF2;SOD2;NOS1
prerank,Golgi ribbon formation (GO:0090161),-0.5771159849767985,-1.5086647974943916,0.055350553505535055,0.5893386664519685,1.0,8/13,20.41%,STX6;STX16;TRIP11;OPTN;GOLGA2;PRMT5;FHDC1;MYO18A
prerank,DNA double-strand break processing (GO:0000729),0.7266268799609723,1.5070158564247447,0.05981794538361508,0.4720705784493634,1.0,7/18,8.37%,BARD1;BRCA1;BLM;SLX4;RBBP8;ATM;DNA2
prerank,positive regulation of neuron migration (GO:2001224),0.7949796990420439,1.5066587708612063,0.0496551724137931,0.4713058204851485,1.0,1/11,0.11%,KIF20B
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.6651222101031211,1.5064205372879356,0.03650442477876106,0.47037084315622335,1.0,14/40,14.32%,ANKLE1;RFWD3;RPA2;RADX;USP1;FBXO5;POLH;ARMT1;UBE2V1;FXR1;SIRT7;ING2;MYC;CASP9
prerank,cellular response to amyloid-beta (GO:1904646),-0.4320233311413276,-1.5063895864613486,0.016260162601626018,0.5896089460986279,1.0,17/35,18.28%,IGF1R;APP;TREM2;LRP1;CASP4;IGF1;ABCC1;GRM5;TLR4;LGMN;CDK5;PRNP;GJA1;EPHA4;CD36;SNX6;ADRB2
prerank,natural killer cell mediated immunity (GO:0002228),0.7480577948171473,1.5057563314646392,0.07171853856562922,0.47086611320639593,1.0,7/15,13.98%,ULBP1;TUBB4B;KLRD1;RAET1E;SLAMF7;TUBB;CEBPG
prerank,neuron fate commitment (GO:0048663),-0.5498955775259937,-1.5048967321003603,0.04918032786885246,0.587353584398668,1.0,3/14,14.40%,TGFBR1;MYT1L;ID2
prerank,muscle cell development (GO:0055001),-0.42473933637721817,-1.5047303111330377,0.034722222222222224,0.580591414435769,1.0,13/30,16.65%,KDM1A;NEBL;ANK2;IGF1;SGCZ;BIN1;MYOF;DMD;ENG;NRAP;VEGFA;SLC8A1;CXADR
prerank,chromatin assembly or disassembly (GO:0006333),0.7585510168676166,1.5046214659767991,0.053824362606232294,0.473053114107473,1.0,7/11,14.93%,CHAF1A;HIRIP3;RBBP4;CHAF1B;MTA2;CDAN1;TP53
prerank,androgen metabolic process (GO:0008209),0.7229066860364102,1.5044153772974187,0.0605296343001261,0.4718805112827943,1.0,2/18,1.35%,HSD17B3;SRD5A2
prerank,telomere maintenance via recombination (GO:0000722),0.7867374197465158,1.5039447557020609,0.05898491083676269,0.47173005523262024,1.0,7/11,14.79%,RAD51;ERCC4;SMC6;XRCC3;NSMCE2;TEP1;RAD50
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.7246238605099298,1.5034743818010852,0.06997455470737914,0.47167250126161997,1.0,2/18,0.41%,CD19;BLK
prerank,nucleotide-excision repair (GO:0006289),0.6265132548015256,1.5008655124378314,0.009127789046653144,0.4795364477793118,1.0,36/101,17.75%,BRIP1;POLK;ERCC4;RPA2;POLA1;BRCA2;POLE;XRCC1;CHD1L;SLX4;LIG4;RFC5;POLR2I;PRPF19;POLR2A;POLD1;PCNA;LIG1;POLD2;HUS1;RPA1;ERCC3;RFC2;RAD23A;RFC1;POLD3;RPA3;RNF111;TP53;FANCC;POLR2K;SIRT1;POLR2J;UBA52;USP7;DDB2
prerank,negative regulation of platelet activation (GO:0010544),-0.5335894839655063,-1.4994765306863755,0.05116279069767442,0.5926885840797395,1.0,7/16,32.29%,SERPINE2;APOE;SH2B3;PRKG1;CEACAM1;PDGFRA;THBD
prerank,prostaglandin metabolic process (GO:0006693),-0.457266571764401,-1.499261977586337,0.05228758169934641,0.5863547025984251,1.0,7/26,8.49%,HPGDS;TBXAS1;DAGLB;PTGS1;PTGDS;PLAA;PTGR2
prerank,protein localization to chromatin (GO:0071168),0.7176755618148088,1.498705015576563,0.06491885143570537,0.48575716258339124,1.0,9/18,16.10%,PLK1;RAD21;MCM9;LRWD1;MRNIP;RUVBL2;NIPBL;WAPL;TASOR
prerank,protein localization to centrosome (GO:0071539),0.7174899852605919,1.4980377392455477,0.06606217616580311,0.48636794282584794,1.0,8/17,13.81%,STIL;SPAG5;CEP83;CEP192;NEDD1;PCM1;BBS4;PIBF1
prerank,synaptic vesicle cycle (GO:0099504),-0.4403298349585342,-1.4954119581330207,0.02054794520547945,0.5927373200858107,1.0,15/30,25.62%,RIMS1;PCLO;SYNDIG1;SLC17A6;VAMP2;SYT7;CDK5;STX1A;PIP5K1C;SNAPIN;RAB3A;CPLX1;SLC32A1;CPLX2;SNAP25
prerank,regulation of DNA metabolic process (GO:0051052),0.6526387443481269,1.4949481497856496,0.03982777179763186,0.4965544110936116,1.0,11/44,8.07%,PIF1;TICRR;RADX;SMG6;USP1;IL7R;SMG5;NUCKS1;POLH;TERF2;UBE2V1
prerank,regulation of nervous system development (GO:0051960),0.6656235610436929,1.4938712118658983,0.036954087346024636,0.49901888129162764,1.0,3/37,2.11%,KIF14;HMGB2;HEY2
prerank,liver development (GO:0001889),0.6751986220457622,1.4930649095942343,0.039908779931584946,0.5002063271485307,1.0,15/32,21.31%,E2F7;E2F8;AURKA;PHF2;ARID5B;CDK5RAP3;CEBPG;PRKCSH;XBP1;NKX2-8;PROX1;PKD2;MET;CITED2;PCK2
prerank,regulation of centrosome cycle (GO:0046605),0.7066547362629102,1.493043175705995,0.07451923076923077,0.49840055529401855,1.0,10/21,17.26%,GEN1;AURKA;XRCC3;ATF5;CHMP1B;MARK4;SIRT1;NAT10;CHMP3;CHMP2B
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5160989189814307,-1.4927361874893683,0.055776892430278883,0.5953701373687796,1.0,7/16,17.48%,KLK2;KLK3;BMPR2;GSK3A;DDAH1;GPR37L1;SLC2A5
prerank,protein K11-linked ubiquitination (GO:0070979),0.6824735050671763,1.4918260743530587,0.05931198102016608,0.5011858153627847,1.0,6/27,6.91%,UBE2C;UBE2T;RNF26;CDC23;CDC27;ANAPC7
prerank,dopaminergic neuron differentiation (GO:0071542),0.7142991392545512,1.4915474958044825,0.0625,0.5002522328472274,1.0,2/19,1.81%,FOXA2;NR4A2
prerank,histone H4-K16 acetylation (GO:0043984),0.7078750758881305,1.4909471960840777,0.0599250936329588,0.5009010973601284,1.0,7/19,13.94%,KANSL1;JADE1;KANSL3;MSL2;HCFC1;KMT2A;KANSL2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.6717343495290709,1.490063621845366,0.05630630630630631,0.5023298650312452,1.0,7/33,8.42%,KIF14;FAM83D;EZH2;E2F1;TAF1;DDRGK1;PLCG2
prerank,signal release from synapse (GO:0099643),-0.3973053364250279,-1.4899504012438507,0.04878048780487805,0.5978705999568676,1.0,19/43,25.62%,RIMS1;PCLO;SYT1;VAMP2;GAD2;CDK5;UNC13A;STX1A;PIP5K1C;SNAPIN;RAB3A;STXBP1;PTPRN2;CPLX1;SLC32A1;PDZD11;CPLX2;DVL1;SNAP25
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.45367513083169725,-1.4895421571813425,0.032467532467532464,0.592501729083541,1.0,9/27,13.86%,SIRPA;PTPN6;ARRB1;TNFAIP3;ZC3H12A;TLR4;SELENOS;CD200;NCKAP1L
prerank,positive regulation of chromosome organization (GO:2001252),0.7288557649963052,1.4888658840741742,0.07470511140235911,0.5049577930527435,1.0,6/15,7.30%,RAD21;DDX11;LIG4;PML;FEN1;RTEL1
prerank,hyaluronan metabolic process (GO:0030212),0.6949789206179324,1.4888206063625504,0.06551297898640297,0.5032552140463624,1.0,3/23,3.93%,HMMR;CD44;HAS1
prerank,response to ethanol (GO:0045471),-0.5501459126603528,-1.488659117014897,0.058823529411764705,0.5888211966768515,1.0,4/14,9.82%,ADCY7;GRIN3A;GOT2;GLRA2
prerank,negative regulation of cellular senescence (GO:2000773),0.7522795770776356,1.4865346093749714,0.07094133697135062,0.5099311345483584,1.0,6/13,7.50%,FBXO5;TWIST1;RBL1;CDK6;TERF2;AKT3
prerank,RNA biosynthetic process (GO:0032774),0.678914276400155,1.4859998649365653,0.06566820276497695,0.5101357236949646,1.0,9/31,7.14%,PRIM2;PRIM1;POLA1;SMARCA5;RSF1;POLR2A;SETX;BRF1;TAF7
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.7754322439849546,1.4855562491241268,0.08157524613220815,0.5099303966769353,1.0,7/10,16.90%,DCLRE1C;TERF2;DCLRE1B;RTEL1;APEX1;TFIP11;RIF1
prerank,anion transport (GO:0006820),0.6723814062672124,1.485286408891167,0.05549263873159683,0.509144320357039,1.0,6/33,11.20%,SLC4A1;VDAC2;TSPO;LRRC8B;LRRC8C;SLC19A1
prerank,response to cAMP (GO:0051591),0.6538031731193019,1.485014049071993,0.044571428571428574,0.5082914657559714,1.0,8/37,7.54%,SLC5A5;AQP1;EZR;HCN3;CRHBP;ZFP36L1;PDE2A;AHR
prerank,tRNA export from nucleus (GO:0006409),0.6637169079676126,1.4845934207637437,0.053738317757009345,0.5061952594519342,1.0,18/32,20.29%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NUP85;TPR
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6637169079676126,1.4845934207637437,0.053738317757009345,0.5061952594519342,1.0,18/32,20.29%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NUP85;TPR
prerank,mitotic sister chromatid cohesion (GO:0007064),0.7309907531270321,1.4837640711763755,0.06377551020408163,0.5075207297042008,1.0,5/16,3.81%,RAD21;DSCC1;RB1;SGO1;HASPIN
prerank,regulation of coagulation (GO:0050818),0.7775372071797915,1.482749698107056,0.06451612903225806,0.509349967905201,1.0,2/11,5.32%,FOXA2;CAV1
prerank,positive regulation of protein kinase activity (GO:0045860),0.6151217422581694,1.4814271819084541,0.006024096385542169,0.5125094953236424,1.0,23/148,8.51%,CENPE;TPX2;KIF14;ECT2;CLSPN;BORA;EZH2;INCENP;CCDC88A;ERBB3;CCN1;AXIN1;NEDD9;STK11;GPRC5B;MMD2;MMD;MAPRE3;XRCC6;MRNIP;CIB1;SNX9;MARK2
prerank,B cell activation involved in immune response (GO:0002312),0.7550727518230027,1.4813108257488143,0.06802721088435375,0.5111210049231778,1.0,6/13,11.42%,CD19;BATF;LIG4;MSH6;RNF168;RNF8
prerank,regulation of T cell differentiation (GO:0045580),0.6632617513991363,1.4805431537267848,0.05701254275940707,0.5120886705894466,1.0,5/33,5.33%,TNFRSF18;CD2;FANCA;IL2RA;CCR2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.6534232549942139,1.4805205678284095,0.04021739130434782,0.5103656309208092,1.0,17/42,13.19%,CECR2;SMARCC2;MBD3;SMARCA5;ARID1B;SMARCD2;NASP;ACTR5;HNRNPC;MBD2;RBBP4;SMARCA4;SPTY2D1;SMARCC1;RNF8;MTA2;ANP32E
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.6129177669614386,1.4790775878455849,0.0,0.5142141157419295,1.0,96/306,15.03%,CDK1;BRIP1;MRPL36;PIF1;TICRR;CLSPN;MCM10;BARD1;PCLAF;TIPIN;POLE2;RAD1;CDC45;BRCA1;RMI2;NR4A2;EXO1;RPA2;DBF4;POLA1;BLM;RPL7;POLE;E2F1;RPL18A;RPS20;MRPL18;ALAS2;TOPBP1;MCM6;RFC5;RAD9A;POLR2I;ORC5;POLR2A;RPL36;RPL14;TIMELESS;POLD1;EPC1;MCM9;RBBP8;RPS19;FEN1;DUT;CHEK1;RPS7;EXT1;ORC3;RPS4X;RPS18;MRPL10;ATM;PTMA;RPL23A;EEF1B2;RPL28;MRPL37;POLD2;ST3GAL2;RHNO1;RPL41;RPS14;DNA2;RPLP2;HUS1;RNPS1;RPA1;RPS27;RFC2;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;RPLP0;RPS11;FAM111A;MRPS17;TYMS;IGF2BP3;RPL27A;POLD3;TOP3A;KIN;RPS15A;RPS9;ING5;MRPL24;NAP1L1;CDC7;RPL12;RPA3;RAD50;RNASEH2A
prerank,inorganic ion transmembrane transport (GO:0098660),0.7497290903512508,1.4788001297328512,0.07554945054945054,0.5134370422784071,1.0,1/12,0.51%,RHAG
prerank,photoreceptor cell development (GO:0042461),-0.5442226847836114,-1.4782776963916189,0.064,0.6176461000903982,1.0,4/14,14.06%,AHI1;MYO7A;DCX;VEGFA
prerank,embryonic heart tube development (GO:0035050),-0.550676378582122,-1.4779435979407811,0.0639269406392694,0.6117989344782331,1.0,3/14,11.84%,ACVR1;RYR2;NDRG4
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.522074796972787,-1.4777578694679891,0.05394190871369295,0.6055497490353217,1.0,7/16,16.10%,RASGRF1;SH3BP1;STMN3;ARHGAP44;ALS2;PIK3CB;ARHGAP24
prerank,inorganic anion transport (GO:0015698),0.6438791341369385,1.4767404316775252,0.04371002132196162,0.5194089764718169,1.0,5/53,4.27%,SLC4A1;RACGAP1;SLC5A5;ANO10;CLIC5
prerank,indolalkylamine catabolic process (GO:0046218),0.7676961876966485,1.476298524167389,0.08784773060029283,0.5194149598296355,1.0,2/10,3.74%,HAAO;KMO
prerank,DNA biosynthetic process (GO:0071897),0.7292332166337147,1.4749602767788577,0.0712401055408971,0.5224954034621325,1.0,10/16,16.99%,POLA1;POLE;POLD1;POLH;POLD2;CDKN2D;TYMS;POLD3;PPIA;SIRT1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.609234891674145,1.473463757425304,0.019348268839103868,0.5263792109081079,1.0,50/96,21.02%,NUP43;POM121;SMG6;NDC1;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;EIF4A3;SRSF3;NUP214;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;RNPS1;CASC3;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;THOC7;SRSF7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.6295877523652249,1.4730899223456995,0.031545741324921134,0.5258953734245233,1.0,33/62,22.44%,NUP43;POM121;NDC1;POLR2I;NUP107;POLR2A;NUP42;NUP50;PUM2;H3-3A;NUP214;NUP160;NUP205;SEC13;NUP188;PUM1;DHX9;NUP98;RANBP2;FXR1;NUP210;LIMD1;POLR2K;AAAS;NUP37;POLR2J;ELAVL1;NUP85;AGO2;TPR;NUP93;AGO1;POLR2B
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6921268002741583,1.4727320608378702,0.07393483709273183,0.5253557005518077,1.0,10/20,17.80%,PLK1;MEN1;CDKN2A;IPO7;NR2F2;PTEN;LATS1;IPO5;TFAP4;HEXIM1
prerank,response to light stimulus (GO:0009416),0.6385803998349706,1.4721348866761594,0.0362087326943557,0.5258687617269652,1.0,15/55,11.38%,PCLAF;MEN1;ERCC4;USP1;DTL;USF1;POLD1;MSH6;CPT1B;PRIMPOL;ZRANB3;UBE4B;CDKN2D;ERCC3;CCAR2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.6699216074776914,1.4721178207036711,0.05561735261401557,0.5241389802015392,1.0,9/35,7.81%,AURKB;NEK2;MAPK1;CCT7;ATM;CCT2;TCP1;RTEL1;HNRNPA2B1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.5677318727075251,-1.4720790324329442,0.06181818181818182,0.6183121463625231,1.0,9/12,23.37%,PPT1;GRN;CLN5;TMEM165;ATP6AP2;TMEM199;CLN6;TMEM9;CCDC115
prerank,natural killer cell activation (GO:0030101),0.6823353452880027,1.4699163873415997,0.07080745341614907,0.5308422293585277,1.0,5/23,7.78%,CD2;ULBP1;RASGRP1;IL21R;SLAMF7
prerank,cellular response to inorganic substance (GO:0071241),0.6919342190059771,1.4695140662693316,0.07343941248470012,0.530581836655917,1.0,9/21,16.27%,AQP1;BLM;DDX11;TIMELESS;FOXO1;DPEP1;KCNC2;MTR;ATRX
prerank,regulation of lymphocyte activation (GO:0051249),0.7440255340079662,1.4688421868520898,0.06944444444444445,0.5313733179217811,1.0,2/12,2.80%,CD19;IKZF3
prerank,sympathetic nervous system development (GO:0048485),-0.5151844412056581,-1.46801994844418,0.08490566037735849,0.6255769123506596,1.0,7/15,19.20%,NRP2;CTNNB1;NF1;FZD3;SEMA3A;SOX4;SOX11
prerank,regulation of cellular senescence (GO:2000772),0.6657398687531018,1.4680037983329686,0.06367924528301887,0.5327208717818642,1.0,11/28,13.34%,HMGA1;FBXO5;TWIST1;RBL1;CDK6;CGAS;CDKN2A;TERF2;AKT3;B2M;ING2
prerank,cellular protein-containing complex assembly (GO:0034622),0.6135890766569572,1.4675024266022043,0.001001001001001001,0.5327973674743102,1.0,24/159,9.58%,CENPF;CENPE;DLGAP5;CENPA;CENPW;ANLN;FMOD;NDC1;STXBP6;TIAM1;EIF4B;PSMD11;AXIN1;NUP107;CHCHD4;CCT2;TCP1;SNX9;CLTC;VBP1;NUP205;AHCTF1;NDUFAF1;LONP1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5012272920927812,-1.467449484021832,0.07142857142857142,0.6205233689594948,1.0,10/17,44.39%,CRLS1;LPCAT1;SERAC1;PLA2G12A;PLA2G4A;PLA2G3;LPCAT4;PLA2G5;PLA2G4F;PLA2G2D
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.7582838784211156,1.4674320209018934,0.09941520467836257,0.5312579759022211,1.0,6/10,15.83%,FOXM1;SP100;HIPK2;RPS6KA6;TP53;TFAP4
prerank,antibacterial humoral response (GO:0019731),0.7326645183621264,1.4671203776446327,0.07850707850707851,0.5307286945742016,1.0,3/16,5.05%,RNASE6;CAMP;SLPI
prerank,vasoconstriction (GO:0042310),0.7476685933009973,1.4659522601819568,0.06990014265335236,0.5333760250264717,1.0,1/11,0.98%,KEL
prerank,positive regulation of myelination (GO:0031643),-0.578600567841252,-1.4649942540458212,0.10472972972972973,0.6228033307003669,1.0,6/11,30.43%,TNFRSF1B;CST7;PARD3;TENM4;EGR2;NCMAP
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.7436808828667829,1.4648811214014965,0.10296191819464035,0.5357837272298333,1.0,6/11,15.83%,FOXM1;SP100;HIPK2;RPS6KA6;TP53;TFAP4
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.6285002151683369,1.4646686776402038,0.04668838219326819,0.5347542629040419,1.0,25/48,20.89%,NUP43;POM121;NDC1;NOA1;NUP107;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;RUBCNL;AAAS;NUP37;NUP85;EIF6;PNPT1;TPR;PRKAG1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5396131256526296,-1.4645941380554894,0.0954356846473029,0.6179326194597999,1.0,8/15,27.13%,BCL2L1;GHITM;HGF;IGF1;PRKN;GPX1;PRELID1;PSMD10
prerank,RNA export from nucleus (GO:0006405),0.6045992394110702,1.463573872437664,0.021341463414634148,0.537287578751583,1.0,51/100,21.02%,NUP43;POM121;SMG6;NDC1;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;EIF4A3;SRSF3;NUP214;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;RNPS1;CASC3;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;THOC7;SRSF7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;HNRNPA1;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.561937016649072,-1.4619208913794002,0.07335907335907337,0.62047259308883,1.0,5/12,17.34%,HAGH;CNDP2;GSS;CHAC2;OPLAH
prerank,tRNA transport (GO:0051031),0.6442598359603262,1.4619109169595526,0.060090702947845805,0.5418630640769121,1.0,18/35,20.29%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NUP85;TPR
prerank,regulation of macrophage migration (GO:1905521),-0.6067356620287714,-1.4615491961662639,0.08579881656804733,0.61571091310051,1.0,8/10,34.16%,P2RY12;CX3CR1;CD200;CSF1;CD81;PTK2B;MTUS1;EMILIN1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.7351549084632321,1.4604225647805111,0.07755102040816327,0.5460650513472071,1.0,3/13,6.00%,PLA2R1;PMAIP1;ATM
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.5546937657477877,-1.4595908596522729,0.06692913385826772,0.6158248618827851,1.0,9/12,33.38%,ANK3;DMD;ATP1B2;ATP1B1;GLRX;ATP1B3;WNK2;FXYD1;NOS1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5428533541376153,-1.4584987776741347,0.08363636363636363,0.6133976237305164,1.0,4/13,4.87%,CACNB2;CACNA1C;KCNN2;ANK2
prerank,protein acetylation (GO:0006473),0.6631516472340353,1.4583453361487668,0.055299539170506916,0.5524768008031963,1.0,12/30,17.02%,ESCO2;NAA40;DSCC1;FOXO1;KAT6A;KAT2B;NAA16;HAT1;ING5;CREBBP;SIRT1;NAT10
prerank,cellular response to light stimulus (GO:0071482),0.6215318614687838,1.4579667959969569,0.031578947368421054,0.5521481379697183,1.0,16/66,14.93%,AURKB;POLK;ERCC4;AQP1;CDC25A;EIF2S1;POLD1;COPS9;PCNA;TAF1;RHNO1;RUVBL2;CREBBP;MYC;CASP9;TP53
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.6613522420521417,1.4567385359951002,0.06279069767441861,0.555135131137404,1.0,7/29,15.39%,FANCD2;RAD21;TRIP13;TEX11;SIRT7;P3H4;MEI4
prerank,regulation of lymphocyte proliferation (GO:0050670),0.7088953145022893,1.456691898326834,0.08192457737321196,0.5534876416700155,1.0,4/16,7.54%,IL12A;IKZF3;PTPN22;AHR
prerank,histone H4-K5 acetylation (GO:0043981),0.7159772995967899,1.456086083245657,0.07246376811594203,0.5522398468007336,1.0,5/15,13.94%,KANSL1;JADE1;KANSL3;HCFC1;KANSL2
prerank,histone H4-K8 acetylation (GO:0043982),0.7159772995967899,1.456086083245657,0.07246376811594203,0.5522398468007336,1.0,5/15,13.94%,KANSL1;JADE1;KANSL3;HCFC1;KANSL2
prerank,protein-DNA complex assembly (GO:0065004),0.5963190295298609,1.4552093762131435,0.024193548387096774,0.5537264144378536,1.0,40/116,17.75%,RAD51;HMGB2;CHAF1A;ANP32B;RPA2;SMARCA5;CHD1L;PSMB7;RSF1;PSMD11;MCM6;ORC5;PSMF1;ORC3;NAP1L4;GMNN;PSMC1;H3-3A;ASF1A;SART3;RPA1;ERCC3;SPTY2D1;PSMC3;PSMA4;CHAF1B;PSMC4;PSMD13;PSME1;NAP1L1;PSMB1;RPA3;PSMD8;TCF4;ATRX;PSME4;MCM3;PSMD4;UBA52;DDB2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5248800007218365,-1.4551714581187198,0.037815126050420166,0.6189035281936404,1.0,8/15,30.99%,LPL;CSF1;IL18;CD36;AGT;PF4;MAPK9;PLA2G3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6239650502141312,1.454611194114637,0.030303030303030304,0.5543147560085064,1.0,16/66,11.97%,KIF14;E2F7;CDKN2C;JADE1;WEE1;E2F1;RB1;RBL1;CDK6;CDKN2A;TFDP1;EGFR;CDKN2D;RDX;PLCB1;PTEN
prerank,cell junction maintenance (GO:0034331),0.7344925471046078,1.454463188778958,0.07835325365205843,0.553110298668546,1.0,2/14,1.29%,PRTN3;CD177
prerank,DNA packaging (GO:0006323),0.6963389780438728,1.4539284368323817,0.07951482479784366,0.5533241301813808,1.0,7/16,14.93%,CHAF1A;RBBP4;KAT6A;CHAF1B;CDAN1;HAT1;TP53
prerank,positive regulation of intracellular transport (GO:0032388),0.6397900850860329,1.4536651104730458,0.06153846153846154,0.5525991566974033,1.0,14/38,14.97%,KIF20B;SPAG5;PCNT;STK11;MLC1;DYNC1H1;PCM1;ACTN2;EIPR1;OAZ1;NUMA1;PGAP1;RIPOR1;PDCD10
prerank,oligodendrocyte development (GO:0014003),-0.5190439813280783,-1.4529849060731574,0.07346938775510205,0.620345292540624,1.0,7/15,23.55%,PLP1;EIF2B3;B4GALT5;EIF2B4;EIF2B2;SOX10;CNTNAP1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.7058361078401928,1.451685189854024,0.09102402022756005,0.5581865941905418,1.0,7/18,12.18%,GINS1;POLA1;POLE;PCNA;LIG1;POLD2;POLD3
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.676451378034803,1.4516364781513171,0.0856453558504222,0.5565960167499029,1.0,7/22,13.06%,PLA2R1;PMAIP1;RPS20;RPS7;ATM;CDK5RAP3;SPRED2
prerank,regulation of cell projection organization (GO:0031344),-0.550159399424968,-1.4513594509987187,0.09465020576131687,0.6200133036029283,1.0,4/13,6.13%,TREM2;MACF1;MYO9A;NTNG1
prerank,regulation of dendritic spine development (GO:0060998),-0.48873269050423707,-1.4512149957047056,0.08256880733944955,0.6144149970642326,1.0,6/19,4.61%,TANC2;CAMK1;APOE;PPFIA2;GRIN3A;PTPRS
prerank,nerve growth factor signaling pathway (GO:0038180),0.7689027921786523,1.450975453553541,0.09029649595687332,0.5574275988475028,1.0,2/10,6.08%,NTF4;KIDINS220
prerank,midbody abscission (GO:0061952),0.7083734648495136,1.4508669861543362,0.08448928121059268,0.5560892348227441,1.0,2/17,1.19%,CEP55;KIF20A
prerank,negative regulation of developmental growth (GO:0048640),-0.41278644062447717,-1.4507017805201659,0.01680672268907563,0.6101759194046643,1.0,14/30,27.03%,RTN4;DIP2B;WWC2;PTPRS;MAG;ULK1;DUSP10;CDKL3;ULK2;WWC1;MT3;DCC;NKD1;FGFR3
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.5277891445249814,-1.4497681403902059,0.07924528301886792,0.607242986669346,1.0,7/14,35.91%,DAGLB;SLC5A7;DAGLA;CHAT;NOS1;MOXD1;ACHE
prerank,error-free translesion synthesis (GO:0070987),0.6738920211643968,1.4493732748710995,0.08571428571428572,0.5602653577855604,1.0,10/22,14.58%,RPA2;RFC5;POLD1;POLH;PCNA;NPLOC4;RPA1;RFC2;RFC1;RPA3
prerank,tryptophan catabolic process (GO:0006569),0.7382613671423537,1.4472550004852553,0.10260115606936417,0.567049275605496,1.0,2/11,3.74%,HAAO;KMO
prerank,covalent chromatin modification (GO:0016569),0.7185157036847195,1.4471353671972578,0.09428950863213811,0.56571871903248,1.0,11/14,23.45%,AURKB;HELLS;MBD2;PARK7;SIRT7;SIRT1;HDAC1;CHD1;HLCS;SETD5;UFL1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.6910829311669906,1.4448029372019207,0.08789808917197452,0.5732355835058689,1.0,4/17,7.04%,DHDDS;ALG8;ALG14;NUS1
prerank,endocrine system development (GO:0035270),-0.4665673290997201,-1.4436573809972701,0.04081632653061224,0.6224177367312462,1.0,10/21,35.63%,TGFBR1;SALL1;NF1;MDK;TG;HOXD3;WNT4;PAX8;GLI2;DKK3
prerank,synaptonemal complex organization (GO:0070193),0.7120021544053315,1.4429242718435225,0.0868421052631579,0.577135196253363,1.0,3/15,6.10%,RAD21;TRIP13;TEX11
prerank,synaptonemal complex assembly (GO:0007130),0.7120021544053315,1.4429242718435225,0.0868421052631579,0.577135196253363,1.0,3/15,6.10%,RAD21;TRIP13;TEX11
prerank,B cell mediated immunity (GO:0019724),0.7477689133402211,1.4426722565991468,0.09295774647887324,0.5763756032444954,1.0,3/10,10.76%,CD19;CD74;CARD9
prerank,positive regulation by host of viral transcription (GO:0043923),0.7166803407779982,1.4416675583388703,0.07611548556430446,0.5784760423358631,1.0,8/15,21.66%,LEF1;NUCKS1;SMARCA4;JUN;CCNT1;TFAP4;CHD1;TAF11
prerank,regulation of DNA binding (GO:0051101),0.6252641089608106,1.4394999833579099,0.0546448087431694,0.5858042057279317,1.0,17/44,15.83%,HMGB2;HJURP;LEF1;E2F1;RSF1;SP100;EDF1;HMGB1;JAK2;ZBTB7A;TXN;SUMO1;JUN;SKI;CEBPG;EGF;TFAP4
prerank,Rap protein signal transduction (GO:0032486),-0.6083970508024066,-1.4381418336120246,0.09731543624161074,0.6348199597340213,1.0,8/10,27.14%,RAP1B;RAP2A;RAP2B;RAP1A;RAP2C;RAPGEF1;RAPGEF3;PLK2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6712134640276097,1.4378869399760985,0.0940279542566709,0.5905591230673506,1.0,3/21,7.79%,TPX2;CLASP1;CIB1
prerank,mRNA transport (GO:0051028),0.5940822653350665,1.4377886703146128,0.025380710659898477,0.5891678697213661,1.0,51/101,21.02%,NUP43;POM121;SMG6;NDC1;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;ZFP36L1;EIF4A3;SRSF3;NUP214;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;RNPS1;CASC3;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;THOC7;SRSF7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,glutathione biosynthetic process (GO:0006750),-0.561947888234605,-1.4377147806710915,0.07885304659498207,0.6305489501111982,1.0,5/11,17.34%,HAGH;CNDP2;GSS;CHAC2;OPLAH
prerank,negative regulation of blood coagulation (GO:0030195),-0.4047605445564215,-1.4377049103920467,0.041237113402061855,0.6248327271113127,1.0,8/38,16.92%,SERPINE2;APOE;CD34;PLAUR;TFPI;PLAU;SERPINE1;F8
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.6270274409584671,1.4375819072315414,0.0761478163493841,0.5882392950758067,1.0,23/41,21.96%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;AAAS;NUP37;NUP85;EIF6;TPR;PRKAG1;NUP93
prerank,macromolecule catabolic process (GO:0009057),-0.421997055692826,-1.4372164073404103,0.0449438202247191,0.6207981710793261,1.0,12/26,21.50%,CAPN3;PPT1;SH3GLB1;CLN5;IDE;LGMN;CLN8;SIAH1;UVRAG;PIK3R4;CLN6;TRIM24
prerank,zinc ion transmembrane transport (GO:0071577),-0.46033531463621424,-1.436169192415139,0.075,0.618561575191753,1.0,10/22,22.56%,SLC39A11;SLC30A4;SLC39A7;SLC39A14;SLC39A8;SLC39A6;SLC39A12;SLC39A3;SLC39A1;SLC30A1
prerank,cGMP metabolic process (GO:0046068),0.7307808055980485,1.4344619935482197,0.09103641456582633,0.5991603702287877,1.0,3/12,6.74%,NPPC;GUCY1A1;PDE2A
prerank,isotype switching (GO:0045190),0.7631579823742181,1.4342491289179782,0.09025787965616046,0.5982588153035839,1.0,6/10,11.42%,BATF;LIG4;MSH6;CCR6;RNF168;RNF8
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.45473023748549196,-1.434224608380741,0.05084745762711865,0.6196376998830634,1.0,13/20,31.02%,CACNA1C;ANK2;SLC9A1;DMD;RYR2;ATP1B1;CALM1;SLC8A1;ATP1A2;GSTO1;FKBP1B;CAMK2D;CALM2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.6531047535215512,1.4336585260007635,0.0912280701754386,0.599044936778038,1.0,14/29,19.01%,PIF1;NOP10;TERF2;ANKRD28;RTEL1;TERF1;RPA1;RFC1;PPP6R3;PPIA;RAD50;PPP6C;DKC1;WRAP53
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.6617625697858015,1.4333330263017705,0.07536557930258718,0.5986006691140611,1.0,7/32,7.09%,AURKB;NEK2;MAPK1;CCT7;ATM;CCT2;TCP1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.40812719243160545,-1.4322655485977456,0.039603960396039604,0.621012539951462,1.0,11/34,16.35%,ANK2;SLC9A1;ZC3H12A;SRI;RYR2;ADRA1A;ATP1B1;SMAD7;ASB3;CALM1;SLC8A1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.5239016031476489,-1.4315351974580728,0.0703125,0.6175467757618422,1.0,7/15,14.06%,TAFA1;KDM1A;CTNNB1;CX3CR1;NF1;FZD3;VEGFA
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.7312823014749352,1.431005272484978,0.08819345661450925,0.6059631515811157,1.0,7/12,16.89%,BRCA1;RBM15;SMCHD1;PCGF5;HNRNPU;PCGF3;LRIF1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.48973309385419805,-1.4306509826743257,0.09090909090909091,0.6148308058808324,1.0,9/17,21.85%,CACNB2;CACNA1C;ANK2;SCN1B;HCN2;SLC8A1;ATP1A2;CACNA1G;SCN3B
prerank,spermatid development (GO:0007286),0.6374015740596829,1.4289965997458154,0.06179775280898876,0.6123949467718727,1.0,8/32,15.39%,CCDC63;CIB1;JAM2;RFX2;RNF8;BBS4;ING2;CEP57
prerank,lipid phosphorylation (GO:0046834),-0.5859707684174198,-1.428913586655824,0.07931034482758621,0.6150507390317397,1.0,6/10,13.66%,DGKH;DGKA;DGKI;DGKZ;DGKQ;DGKB
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6775358729637326,1.4288980809866696,0.07448107448107448,0.6109854337685805,1.0,11/21,19.46%,CDK1;MAPK1;ZFP36L1;ITGAV;MYC;EGF;MAP2K1;ZFP36L2;PTGER4;LGALS9;SOX9
prerank,secretion (GO:0046903),-0.5389083241174233,-1.428660546806889,0.0916030534351145,0.6107145896466891,1.0,2/14,3.47%,RIMS1;PRKCI
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.5912714173166322,-1.4281457368906811,0.07232704402515723,0.6073014310805138,1.0,4/10,14.75%,IQSEC1;EPB41L4B;ADAM9;MAP4K4
prerank,endochondral bone morphogenesis (GO:0060350),-0.5607909297542255,-1.4279374929338964,0.10144927536231885,0.6029272632582788,1.0,10/11,38.55%,BMPR2;BMPR1B;INPPL1;TRPV4;FGFR3;MEF2C;FOXC1;COL13A1;SCX;BMP4
prerank,ncRNA export from nucleus (GO:0097064),0.628136368335095,1.4270550456087079,0.08333333333333333,0.6167961673074402,1.0,19/36,20.29%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;AAAS;NUP37;NCBP2;NUP85;TPR
prerank,phagosome acidification (GO:0090383),-0.45675517826431894,-1.4269398431535814,0.0440251572327044,0.6010322717711948,1.0,13/26,21.99%,ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;RAB20;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1H;ATP6V1F;ATP6V1G2;ATP6V0C;RAB38
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.6976174077100419,1.4262507084560785,0.08651399491094147,0.6182901193489083,1.0,1/17,0.10%,DLGAP5
prerank,negative regulation of peptidase activity (GO:0010466),-0.37742025433957244,-1.425484050444483,0.06060606060606061,0.6004298017940034,1.0,9/47,17.02%,SPOCK1;LRP1;SERPINE2;TIMP2;SPOCK2;TIMP3;SERPINI1;SERPINE1;CST7
prerank,mRNA export from nucleus (GO:0006406),0.5889057800862665,1.4249896825852855,0.029441624365482234,0.6216159745112744,1.0,51/102,21.02%,NUP43;POM121;SMG6;NDC1;DHX38;SMG5;NUP107;SLBP;NUP42;NUP50;UPF2;CPSF2;U2AF1;EIF4A3;SRSF3;NUP214;IWS1;HNRNPA2B1;NUP160;SRSF4;NCBP1;NUP205;RNPS1;CASC3;U2AF1L4;SEC13;NUP188;THOC3;NUP98;RANBP2;UPF3B;NUP210;THOC5;THOC2;AAAS;THOC7;SRSF7;CDC40;NUP37;DDX39B;POLDIP3;CPSF1;ALKBH5;NCBP2;NUP85;SRSF2;TPR;FYTTD1;SMG7;WDR33;GLE1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5022613659830176,-1.424310940432834,0.075,0.5992363042540452,1.0,9/16,24.99%,UPP2;NT5M;DPYD;CRMP1;TET2;NT5C;DPYSL2;DPYSL3;NT5E
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6528180252915295,1.4243083671643306,0.08187134502923976,0.6225921400215624,1.0,12/26,19.46%,KNSTRN;ZFP36L1;EGFR;PDPK1;STAT5B;ZFP36L2;DUSP22;PLCG1;PDE8A;IQGAP1;MED1;SOX9
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.7125169347296153,1.423626486211605,0.0891891891891892,0.6235573792520125,1.0,3/14,5.66%,ADAMTS7;RFLNB;PTHLH
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5905795940324995,1.4234339312149886,0.025252525252525252,0.6226426498224447,1.0,62/110,23.66%,RPL7;RPL18A;SMG6;RPS20;SMG5;RPL36;RPL14;RPS19;EIF3E;RPS7;RPS4X;RPS18;UPF2;SMG8;RPL23A;EIF4A3;RPL28;RPL41;RPS14;RPLP2;NCBP1;RNPS1;CASC3;RPS27;RPS5;RPS29;RPLP0;RPS11;RPL27A;DCP1A;UPF3B;SMG9;RPS15A;RPS9;HELZ2;RPL12;PYM1;RPL3;RPL18;GSPT1;UBA52;RPS17;RPS6;RPL5;NCBP2;RPS3;RPL21;PPP2CA;RPL23;RPL17;SMG7;RPL8;RPL24;RPL27;DHX34;RPL13A;RPS12;RPS8;RPL15;RPL10;RPS21;SMG1
prerank,regulation of B cell activation (GO:0050864),0.6587769711818505,1.423182387051399,0.08029197080291971,0.6218271776912752,1.0,5/25,7.54%,CD19;IKZF3;BANK1;ZFP36L1;AHR
prerank,peptidyl-lysine modification (GO:0018205),0.5911159530819431,1.4218090264194168,0.03350253807106599,0.6255790283162063,1.0,44/99,19.24%,NUP43;POM121;NDC1;SENP1;SAE1;PLOD3;NUP107;HDAC10;UBE2I;RANGAP1;NUP42;UBA2;BCL11A;NUP50;HDAC6;NUP214;NUP160;NUP205;PIAS3;NUP188;ATP7A;NSMCE2;PARK7;SUMO1;KAT2B;NUP98;RANBP2;NUP210;SIRT7;VPS33B;SUMO2;P3H4;EYA1;PIAS1;NDUFAB1;TRIM28;AAAS;SIRT1;TRPM4;NUP37;HDAC4;SENP6;GCSH;NUP85
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.42715442244633683,-1.4215107262905797,0.0763888888888889,0.6029155084730194,1.0,12/30,11.17%,NSF;ANK3;MACF1;SEC16A;GGA3;OPTN;GOLGA7;PREPL;VAMP5;VAMP2;GOLGA4;RAB31
prerank,tryptophan metabolic process (GO:0006568),0.7287605108902542,1.4214341357851101,0.11522048364153627,0.6252840498614232,1.0,3/11,10.54%,HAAO;KMO;ATP7A
prerank,telomere maintenance via telomerase (GO:0007004),0.6483034399738977,1.4212622142675044,0.10211267605633803,0.6242998097243343,1.0,13/28,19.01%,PIF1;NOP10;TERF2;ANKRD28;RTEL1;TERF1;RPA1;RFC1;PPP6R3;RAD50;PPP6C;DKC1;WRAP53
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.6040089406579513,1.42083341420255,0.04742268041237113,0.6243327269930734,1.0,20/66,16.30%,CDK1;ECT2;GTSE1;PLK1;CARD10;FLNA;TFRC;CCT7;CCT2;TCP1;EFCAB7;PARK7;ORMDL3;CCT5;CDK5RAP3;BAG3;PSEN1;IPO5;LIMK2;TRIM28
prerank,vacuolar acidification (GO:0007035),-0.47296161337499565,-1.420726259124004,0.06091370558375635,0.6005508561895265,1.0,13/21,23.37%,ATP6V0D2;PPT1;GRN;ATP6V0A1;DMXL2;CLN5;TCIRG1;ATP6V1H;ATP6AP2;TMEM199;CLN6;TMEM9;CCDC115
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6660609418337161,1.420279774554309,0.07590361445783132,0.6247642856630929,1.0,7/24,7.30%,ERCC4;BLM;MSH6;DACH1;TERF2;ZRANB3;RTEL1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.442156288408326,-1.4201168557436716,0.06951871657754011,0.5975178656316952,1.0,12/21,31.02%,CACNA1C;ANK2;SRI;DMD;RYR2;CALM1;SLC8A1;ATP1A2;GSTO1;FKBP1B;CAMK2D;CALM2
prerank,protein polymerization (GO:0051258),0.6027547261043646,1.418981830167419,0.059009483667017915,0.6282569338250156,1.0,7/55,8.57%,DIAPH3;UBE2C;CKAP5;GSN;PIN1;UBE2K;JAK2
prerank,zinc ion transport (GO:0006829),-0.4515655834901107,-1.4189006635110817,0.08383233532934131,0.5966584703511894,1.0,10/21,23.06%,SLC39A11;SLC30A4;SLC39A7;SLC39A14;SLC39A8;SLC39A6;SLC39A3;SLC39A1;SLC30A1;MT3
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.6436441978604828,1.4188559117814028,0.08840413318025259,0.626996547010315,1.0,9/27,13.06%,PLA2R1;PMAIP1;TWIST1;CD74;CD44;ATM;DYRK1A;YJU2;SPRED2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5008285753979143,-1.4181142885166085,0.09053497942386832,0.5943989440123603,1.0,3/17,9.09%,ANK2;SNTA1;SCN1B
prerank,acylglycerol homeostasis (GO:0055090),-0.4818333499738734,-1.4180218565577838,0.054945054945054944,0.5900240378745205,1.0,7/20,29.80%,APOE;LPL;SCARB1;IL18;MTLN;MLXIPL;ANGPTL3
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4499333127005645,-1.417153724099461,0.08045977011494253,0.5879553537277608,1.0,8/22,15.08%,RAP2A;PDGFD;RAP2C;PDGFC;TOM1L1;VEGFA;MRE11;CALM1
prerank,positive regulation of protein export from nucleus (GO:0046827),0.6922571164197994,1.4171272655130969,0.12433862433862433,0.6321674147477329,1.0,9/15,17.55%,GTSE1;ANP32B;EMD;BAG3;GSK3B;TP53;TCF7L2;XPO4;YWHAE
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6705999507088063,1.4164299738978916,0.08877928483353884,0.6333123736220448,1.0,4/23,5.44%,IL12A;KLRD1;RASGRP1;RAET1E
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.6152400080795593,1.416318355806277,0.0859375,0.6320078161520002,1.0,23/41,21.96%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;AAAS;NUP37;NUP85;EIF6;TPR;PRKAG1;NUP93
prerank,steroid hormone biosynthetic process (GO:0120178),0.6548179800260575,1.415898222854463,0.08862275449101796,0.6319603104974579,1.0,9/29,18.66%,HSD17B3;SRD5A2;TSPO;SRD5A3;DHCR7;STARD3NL;MED1;TSPOAP1;FDXR
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.6315278331045043,1.4148310657472263,0.09750566893424037,0.6346427163293731,1.0,8/37,9.25%,SKA3;SKA1;SKA2;STMN1;CLASP1;MAPRE3;MARK2;EPHA3
prerank,cell proliferation in forebrain (GO:0021846),0.7491288937915844,1.4138841250158323,0.09742120343839542,0.6368447644545857,1.0,1/10,0.17%,KIF14
prerank,positive regulation of DNA replication (GO:0045740),0.6898986069988953,1.4136051051587444,0.12073490813648294,0.6361595367662106,1.0,9/16,15.40%,PCNA;ATAD5;FAF1;DNA2;EGFR;BRPF3;DHX9;CTC1;EGF
prerank,positive regulation of dephosphorylation (GO:0035306),0.6470279900092533,1.4129647640042884,0.08992805755395683,0.6369591788604186,1.0,15/27,24.25%,CDCA2;PTPA;ANKLE2;PPP2R5A;PIN1;CNEP1R1;PPIA;CAMTA1;SPPL3;CALM3;PPP1R16B;PRKCD;SRC;SMPD1;PTBP1
prerank,nuclear migration (GO:0007097),0.722777312105806,1.4126671691432016,0.09078014184397164,0.6363023699211858,1.0,7/13,10.91%,SYNE2;SUN2;FBXW11;DYNC1H1;PCM1;PAFAH1B1;SYNE3
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.5500159413612964,-1.4114773960489928,0.11231884057971014,0.6005345212864277,1.0,4/11,5.59%,PJA2;TREM2;MFHAS1;TNFAIP3
prerank,cardiac muscle cell differentiation (GO:0055007),-0.4469693220393947,-1.4113085718949738,0.07386363636363637,0.5964413839549553,1.0,5/21,18.79%,ACVR1;VEGFA;SLC8A1;CXADR;KDM6B
prerank,phagosome maturation (GO:0090382),-0.4180017634628504,-1.4105969228469173,0.06666666666666667,0.5939403954038012,1.0,16/35,21.99%,RAB14;ATP6V1B2;ATP6V1C1;ATP6V0D2;ATP6V0A1;MCOLN1;RAB20;ATP6V0B;TCIRG1;RAB31;ATP6V1A;ATP6V1H;ATP6V1F;ATP6V1G2;ATP6V0C;RAB38
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6990942388812009,1.4103519217419733,0.12698412698412698,0.6438372840629162,1.0,3/15,5.41%,IL12A;CCR2;NKAP
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6282880212853417,1.4101786984388924,0.08797327394209355,0.6428277456844091,1.0,14/30,17.16%,DDIAS;FBXO5;TWIST1;CD74;CD44;RTEL1;CDKN2D;DYRK1A;CCAR2;YJU2;THOC5;TPT1;SIRT1;DDX39B
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.531312879780357,-1.409012244751031,0.08208955223880597,0.5940755548933677,1.0,8/12,18.02%,ACLY;ACO2;GLUD1;ACO1;IDH1;IDH3B;IDH3G;IDH3A
prerank,intestinal absorption (GO:0050892),-0.5433873124061595,-1.4081617627841283,0.11231884057971014,0.5923106234487261,1.0,7/13,32.20%,F11R;TJP2;CD36;SLC2A5;SLC26A6;SLC46A1;ADRA2A
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5838346338580136,-1.4081082302005359,0.08615384615384615,0.5880561265601933,1.0,5/10,17.48%,APP;SYNGR1;CAMK2B;SHANK3;DLG4
prerank,response to X-ray (GO:0010165),0.7116954354736296,1.4073172031159245,0.11390728476821192,0.6529659452208377,1.0,6/14,13.56%,BLM;LIG4;NUCKS1;ATM;XRCC6;NIPBL
prerank,diol metabolic process (GO:0034311),-0.47700446729853474,-1.4071278031799623,0.11312217194570136,0.5864934218414285,1.0,8/19,23.87%,HSP90AA1;PTS;SGPP1;CALM1;PRKG2;SPHK2;PLPP3;DEGS2
prerank,regulation of lipase activity (GO:0060191),-0.5218218128391843,-1.4059072082626636,0.12014134275618374,0.5859145472570734,1.0,4/13,11.91%,LPL;PCSK5;PCSK6;LMF1
prerank,muscle tissue morphogenesis (GO:0060415),0.6914881088962823,1.4056116469303503,0.11154345006485085,0.658449072040865,1.0,4/16,12.54%,HEY2;ZFPM1;NOTCH1;EFEMP2
prerank,positive regulation of nervous system process (GO:0031646),-0.4790044312976059,-1.4045170222579277,0.10194174757281553,0.5861029679835883,1.0,8/18,30.43%,RIMS1;RIMS2;TNFRSF1B;CST7;PARD3;TENM4;EGR2;NCMAP
prerank,renal system development (GO:0072001),0.6026598767482616,1.4037908516772915,0.0816542948038176,0.6643009857685213,1.0,3/52,3.98%,CENPF;LRP4;SULF2
prerank,regulation of ATP metabolic process (GO:1903578),0.5963730212536024,1.4032692752670222,0.06581740976645435,0.6647831572951421,1.0,25/54,20.89%,NUP43;POM121;NDC1;NUP107;ABCD1;NUP42;NUP50;NUP214;NUP160;ZBTB7A;NUP205;SEC13;NUP188;ATP7A;FIS1;NUP98;RANBP2;NUP210;PRKAG2;AAAS;NUP37;NUP85;EIF6;TPR;PRKAG1
prerank,neuron remodeling (GO:0016322),-0.5797198428383878,-1.4030291798639296,0.10850439882697947,0.5858366099785072,1.0,3/10,4.59%,APP;FARP2;C1QA
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.6407135465499516,1.4027108755031519,0.11501210653753027,0.6653312474839814,1.0,4/23,8.74%,HMGB2;CECR2;HMGB1;DNASE1L1
prerank,meiosis I (GO:0007127),0.6577828729195954,1.4012728192544304,0.10361445783132531,0.6696134823908639,1.0,5/23,13.34%,MYBL1;SGO1;FOXJ3;PTTG1;ING2
prerank,immunoglobulin mediated immune response (GO:0016064),0.733550977236343,1.4006937851404082,0.11772853185595568,0.6702113264053544,1.0,2/10,3.69%,CD19;CD74
prerank,response to amyloid-beta (GO:1904645),-0.37744121213312776,-1.4006051202774052,0.047619047619047616,0.5885342544381506,1.0,17/44,18.28%,IGF1R;APP;TREM2;LRP1;CASP4;IGF1;ABCC1;GRM5;TLR4;LGMN;CDK5;PRNP;GJA1;EPHA4;CD36;SNX6;ADRB2
prerank,axonemal dynein complex assembly (GO:0070286),0.6418551286090525,1.4002440013995623,0.10904872389791183,0.6702863995136484,1.0,2/27,0.95%,CCDC63;DNAH8
prerank,regulation of plasminogen activation (GO:0010755),-0.542494071659927,-1.399992589217772,0.08934707903780069,0.586206539021594,1.0,5/12,18.44%,PLGRKT;SERPINE2;ENO1;SERPINE1;THBS1
prerank,cellular response to nitrogen compound (GO:1901699),0.6706998479855097,1.3997785328292114,0.11475409836065574,0.6704530804755986,1.0,10/20,22.45%,BLM;DDX11;TIMELESS;PDE12;RIOK3;ROCK2;ATRX;EPG5;ATP2B4;SPIDR
prerank,positive regulation of double-strand break repair (GO:2000781),0.6218578699196511,1.3997756982856775,0.0739514348785872,0.6686700845879296,1.0,7/39,7.25%,RAD51AP1;FOXM1;SMCHD1;DDX11;TIMELESS;ARID2;MRNIP
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.6995760105956246,1.3994513967946896,0.11388888888888889,0.6681634228945778,1.0,3/14,3.27%,CD177;PHACTR4;FLNA
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.6346682647822383,1.3981359485598845,0.09490740740740741,0.6720311089011068,1.0,17/32,24.25%,CDCA2;ITGA1;PTPA;ANKLE2;PPP2R5A;PIN1;PPP1R15A;CNEP1R1;PPIA;CAMTA1;SPPL3;CALM3;PPP1R15B;PPP1R16B;PRKCD;SMPD1;PTBP1
prerank,negative regulation of B cell proliferation (GO:0030889),0.725232878620273,1.3970652154028005,0.12195121951219512,0.6746397330733922,1.0,6/11,17.65%,BLK;ATM;TNFRSF13B;TYROBP;RC3H1;FCGR2B
prerank,cellular response to UV (GO:0034644),0.585745315586265,1.3968979873798297,0.052795031055900624,0.6735932649386793,1.0,13/76,5.65%,AURKB;POLK;ERCC4;AQP1;CDC25A;EIF2S1;POLD1;COPS9;STK11;ACTR5;PCNA;CHEK1;TAF1
prerank,cGMP biosynthetic process (GO:0006182),0.7308958459894626,1.3968051157556007,0.12011577424023155,0.6721805720421212,1.0,2/10,6.32%,NPPC;GUCY1A1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5664689625607997,-1.3966673447594395,0.11447811447811448,0.5924880076287449,1.0,2/10,2.53%,WHRN;IFT88
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6532302196794677,1.3955867452619204,0.11467324290998766,0.6756523493293294,1.0,11/22,19.06%,PLK1;MEN1;CDKN2A;IPO7;NR2F2;PTEN;LATS1;IPO5;TFAP4;HEXIM1;CDKN1A
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.525062877895223,-1.39541597164374,0.11224489795918367,0.5922786115117602,1.0,7/12,28.35%,UBASH3B;ANK2;RYR2;ANXA6;FKBP1B;MTLN;PTK2B
prerank,nitrogen compound transport (GO:0071705),0.5801310562790317,1.3953230703173491,0.017085427135678392,0.675016816177516,1.0,33/141,19.13%,CENPF;RHAG;SLC6A12;SLC38A5;AQP1;SLC1A5;NDC1;RAMP1;SLC7A1;SLC6A2;RCN3;PICK1;ABCC2;SLC25A47;SLC16A10;SLC43A2;SLC3A1;CALCRL;SLC52A1;SLC44A1;CHMP1B;VPS33B;ATP11B;SCAMP1;CHMP3;CHMP2B;TMEM30A;ARL6IP5;HSP90B1;SLC22A4;RUFY1;SLC7A14;SEC14L1
prerank,intracellular sterol transport (GO:0032366),-0.5402429453854588,-1.3949737655413368,0.13257575757575757,0.5895370168378233,1.0,6/13,15.74%,OSBPL2;ABCA1;OSBP;NPC2;NPC1;SERAC1
prerank,neural tube development (GO:0021915),0.6976598638095155,1.3942776855254835,0.11360634081902246,0.6777347939300646,1.0,1/15,0.26%,STIL
prerank,positive regulation of DNA binding (GO:0043388),0.627969198620386,1.3932464569888565,0.09331797235023041,0.6804055651024279,1.0,10/31,15.40%,HMGB2;RB1;TWIST1;EDF1;HMGB1;TXN;PARK7;SKI;CEBPG;EGF
prerank,neuron projection extension (GO:1990138),-0.40011321488949636,-1.3930623081126203,0.07142857142857142,0.591228759981021,1.0,14/32,22.74%,IMPACT;NRP2;HSP90AA1;SPG11;CTNNB1;USP9X;ULK1;CDK5;SH3GL2;SEMA3A;CDKL3;ULK2;FLRT3;CYFIP1
prerank,response to hydroxyurea (GO:0072710),0.7073419067804905,1.3925537048625172,0.13426573426573427,0.6816065595735661,1.0,3/11,4.14%,BLM;DDX11;TIMELESS
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6414232921606985,1.3921729080438883,0.10173410404624278,0.681351576005104,1.0,7/31,11.99%,UBE2C;CDC20;PLK1;AXIN1;PIN1;PTEN;FZR1
prerank,regulation of microtubule depolymerization (GO:0031114),0.6297209073083196,1.391978347433551,0.11016949152542373,0.6803515241536536,1.0,3/25,7.79%,TPX2;CLASP1;CIB1
prerank,cellular response to hydroxyurea (GO:0072711),0.7223226347099796,1.3917184602867854,0.14511494252873564,0.6796506908708236,1.0,3/10,4.14%,BLM;DDX11;TIMELESS
prerank,signal transduction by p53 class mediator (GO:0072331),0.6342874742624438,1.3908262643769884,0.09666283084004602,0.6816350013790706,1.0,6/30,7.61%,E2F7;PMAIP1;BATF;STK11;MDM4;BOK
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5906246941847567,1.3889710016372632,0.05997931747673216,0.6873981800668654,1.0,21/60,16.36%,CDK1;CCNB1;HEY2;LEF1;PPM1D;CDKN2A;MED30;TNRC6C;TNRC6B;MED31;MECP2;MED8;PTEN;CBFB;PAXIP1;MED14;ATF7IP;TP53;TCF7L2;TRIM28;CDK8
prerank,regulation of establishment of cell polarity (GO:2000114),0.6893790153625191,1.3884875532256968,0.110397946084724,0.6876943500124003,1.0,6/16,13.14%,KIF20B;RIPOR2;GSN;CYRIB;ROCK2;RACK1
prerank,positive regulation of histone methylation (GO:0031062),0.6528599685278278,1.3878456060763484,0.10287081339712918,0.6887327794166177,1.0,11/24,16.99%,MYB;BRCA1;PHF19;PHF1;DNMT1;SMAD4;PAXIP1;KMT2A;JARID2;RIF1;SIRT1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.6293555845898839,1.3850907920620352,0.1027479091995221,0.6985463246500833,1.0,10/27,16.94%,RRM2;AK9;RRM1;DUT;RRM2B;NUDT13;NME4;TYMS;AK5;AK6
prerank,regulation of protein dephosphorylation (GO:0035304),0.611887684675043,1.3842944490770615,0.09717514124293786,0.7001378726169619,1.0,20/37,24.25%,CDCA2;PTPA;ANKLE2;PPP1R8;PPP2R5A;PIN1;PPP1R15A;CNEP1R1;PPP6R3;PPP1R2;PPIA;CAMTA1;HSP90B1;SPPL3;PPP1R16A;CALM3;PPP1R16B;PRKCD;SMPD1;PTBP1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.6148613545209335,1.3837879481782003,0.09540229885057472,0.7005178995878876,1.0,4/31,5.04%,HSD17B3;SRD5A2;PYCR3;LSS
prerank,epithelial structure maintenance (GO:0010669),-0.5586035575581845,-1.3837563466823708,0.1407942238267148,0.6152367833682825,1.0,4/11,25.87%,STRAP;CXADR;NOD2;RBP4
prerank,defense response to Gram-negative bacterium (GO:0050829),0.618167451717603,1.383298138946441,0.09460946094609461,0.7008136895453233,1.0,5/42,4.80%,HMGB2;RNASE6;AQP1;CAMP;RPS19
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5060961255399774,-1.3829267943265247,0.11553784860557768,0.6137078907675154,1.0,6/15,13.21%,TRIM27;JMY;ARPC5L;WASHC1;ARPC3;ARPC2
prerank,positive regulation of macrophage migration (GO:1905523),-0.45500986736187,-1.3821321170342042,0.05555555555555555,0.6120278062652691,1.0,11/19,20.00%,TREM2;CSF1R;CMKLR1;AKIRIN1;P2RY12;PTK2;CSF1;MDK;THBS1;CCL3;P2RX4
prerank,microtubule-based transport (GO:0099111),0.7063021992019137,1.3820694521631391,0.11475409836065574,0.7043260441278013,1.0,2/12,7.06%,SPA17;SPEF2
prerank,triglyceride catabolic process (GO:0019433),-0.4764417847976189,-1.381421852633786,0.0975609756097561,0.609848134383951,1.0,7/19,41.15%,LPL;LIPH;FABP4;FABP7;PNPLA3;LIPC;FABP3
prerank,sodium ion homeostasis (GO:0055078),0.6525756194978235,1.3813153522787955,0.11916461916461916,0.7058096496047854,1.0,4/21,7.98%,TMPRSS3;SLC12A3;SLC12A1;NEDD4L
prerank,defense response to bacterium (GO:0042742),0.5820756474020078,1.3807237108384225,0.039473684210526314,0.7065573760753169,1.0,14/105,6.84%,IL12A;HMGB2;RNASE6;PGLYRP1;AQP1;SPN;GBP4;CAMP;PPP1R11;S100A9;RPS19;SLPI;S100A8;GBP2
prerank,positive regulation of lipid storage (GO:0010884),-0.46032960057947486,-1.3801559285803542,0.10526315789473684,0.6096225436248749,1.0,5/21,10.86%,LPL;ZC3H12A;IKBKE;VSTM2A;SCARB1
prerank,homologous chromosome segregation (GO:0045143),0.6656823370595087,1.3793241634040874,0.12317073170731707,0.7104657910380952,1.0,7/20,20.16%,FANCD2;SGO1;PTTG1;SIRT7;MEI4;CENPC;ZCWPW1
prerank,maintenance of protein location in nucleus (GO:0051457),0.6480002522886793,1.3785559853398013,0.12285012285012285,0.7119590462916002,1.0,12/20,19.92%,BARD1;SUN2;PML;SP100;RANGAP1;PARK7;CHCHD10;BBS4;HNRNPU;SYNE1;MORC3;TAF3
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.549175246729458,-1.378492331641334,0.11258278145695365,0.6100736941108322,1.0,6/11,31.37%,HSP90AA1;PTS;CALM1;PRKG2;DHFR;SPR
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.7132998885008737,1.3774478426627614,0.13957055214723926,0.7149516130950084,1.0,5/10,14.93%,HMGB1;PSMC3;PSMC4;ATF7IP;TP53
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.6536113903661023,1.37684766285211,0.13350125944584382,0.7158286706819056,1.0,9/18,17.04%,MAPK1;EZR;SNX3;MTMR2;MSN;RDX;DNAJC13;MAP2K1;CHMP3
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.6041654263503714,1.3764083968074219,0.07263157894736842,0.7160111234581235,1.0,18/49,15.87%,HMGB2;RBM15;ZFPM1;DPY30;TNRC6C;TNRC6B;H3-3A;KMT2C;CIB1;NFE2;KAT2B;CNOT4;CBFB;KMT2A;RBBP5;KMT2B;RUNX1;SIN3A
prerank,positive regulation of immune effector process (GO:0002699),0.635515052334928,1.375840419574073,0.10939357907253269,0.7165995396888571,1.0,4/27,5.33%,MYB;DHX58;RPS19;CCR2
prerank,actin filament-based transport (GO:0099515),0.661004372926032,1.3757289299288356,0.11125,0.7152672403461261,1.0,4/21,3.39%,MYO5C;MYO15A;SYNE2;SUN2
prerank,positive regulation of response to stimulus (GO:0048584),0.5959975391534564,1.375500405639548,0.09856035437430787,0.7145065318226945,1.0,12/40,17.65%,ANKLE1;HMGA1;CGAS;CDKN2A;B2M;DHX9;FXR1;MYC;TGFB2;TAF9;SIRT1;FCGR2B
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4905943460598951,-1.3741127588686541,0.12446351931330472,0.6188854171629199,1.0,2/15,2.74%,TREM2;LPL
prerank,activation of protein kinase activity (GO:0032147),0.5698113406741533,1.3735169090847035,0.05835010060362173,0.7212832467838589,1.0,31/106,19.45%,TPX2;KIF14;ECT2;CLSPN;BORA;CARD10;CCDC88A;AXIN1;STK11;PRKACA;MARK2;JAK2;PDPK1;TXN;PARK7;MLST8;PIBF1;PPIA;TLR6;STK4;PAK5;PAK2;TGFB2;ADCY8;MAP3K7;TAOK1;MALT1;STK3;MAPKAP1;PRKAR2A;TRAF6
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.48875615635685166,-1.372377653679392,0.07860262008733625,0.6200133036029282,1.0,8/16,6.25%,ABCD2;SIRPA;TREM2;APPL2;ADCY7;APOD;PYCARD;ZC3H12A
prerank,negative regulation of protein depolymerization (GO:1901880),0.6291763478615632,1.371597678560503,0.11728395061728394,0.7276747778852276,1.0,4/24,10.14%,TPX2;CLASP1;CIB1;LIMA1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.4162704818467221,-1.3710185600286044,0.0625,0.62011616958935,1.0,11/24,17.85%,IQSEC1;PIK3R1;PTPRJ;DUSP3;TSC1;FERMT2;PPM1F;VEGFA;MAP4K4;COL16A1;THY1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5465034451593519,-1.370973098810636,0.12408759124087591,0.6162409018637512,1.0,5/11,33.38%,CACNB2;BIN1;CACNB1;CAMK2D;NOS1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7183290997690585,1.3708733116195146,0.14,0.7290710164386172,1.0,6/11,17.48%,CYP1B1;MAP3K5;PRODH;STK24;PDCD10;ARL6IP5
prerank,regulation of DNA damage checkpoint (GO:2000001),0.7172765477739669,1.3700987020378583,0.15064562410329985,0.7306564947096603,1.0,5/10,17.16%,RFWD3;RPA2;CCAR2;THOC5;DDX39B
prerank,response to nitric oxide (GO:0071731),0.6790837913997297,1.3685982284249985,0.12483574244415244,0.7351854418386198,1.0,6/13,14.34%,AQP1;FOXO1;DPEP1;TXN;KCNC2;MTR
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.39062719344648156,-1.3675051300964534,0.06086956521739131,0.6229937136800281,1.0,15/32,20.27%,ARHGAP6;ADAM15;NEXMIF;APOD;SEMA3E;CLASP2;CORO1C;RCC2;SERPINE1;MAP4K4;ACVRL1;JAG1;THBS1;RASA1;PHLDB2
prerank,C-terminal protein amino acid modification (GO:0018410),0.714341734125884,1.3673653925574392,0.14484679665738162,0.7386379926875595,1.0,3/11,6.07%,AGBL1;LCMT1;AGTPBP1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.3543963022404826,-1.3667069665221512,0.041666666666666664,0.6212745585319844,1.0,13/50,10.55%,IGF1R;ADAP2;CSF1R;PLCB2;PIK3CD;PIK3R1;IGF1;KCNH1;PI4KA;PIK3C2B;PLCL2;PLCB4;IRS2
prerank,regulation of cell aging (GO:0090342),0.7091608149921974,1.3661704571354172,0.1458625525946704,0.7418595162855566,1.0,1/11,0.50%,FOXM1
prerank,regulation of viral entry into host cell (GO:0046596),0.6143033971395179,1.3656206343190562,0.10804597701149425,0.7424803604775408,1.0,9/30,14.44%,TMPRSS4;CD74;SNX3;GSN;LY6E;TRIM11;TRIM68;IFITM3;TRIM5
prerank,fluid transport (GO:0042044),0.7004924313542001,1.3652496525553697,0.13472222222222222,0.7422864616277557,1.0,1/12,1.86%,AQP1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.585146387369767,1.365093831404075,0.07030430220356768,0.7411751430487797,1.0,21/59,16.36%,CDK1;CCNB1;LEF1;PPM1D;TWIST1;CDKN2A;MED30;SETX;TNRC6C;TNRC6B;MED31;MECP2;MED8;JUN;PTEN;CBFB;MED14;TP53;TCF7L2;TRIM28;CDK8
prerank,positive regulation of telomerase activity (GO:0051973),0.6258954459774524,1.3647883183702822,0.12906846240179573,0.7406647601008995,1.0,5/33,7.09%,AURKB;NEK2;MAPK1;CCT2;TCP1
prerank,negative regulation of transferase activity (GO:0051348),0.6174005983766008,1.3642218858477977,0.11652794292508918,0.7412609148986213,1.0,9/28,14.93%,PIF1;MEN1;ERCC4;FBXO5;TERF1;PARK7;HNRNPU;GSK3B;TP53
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6762469896820872,1.3637317963920408,0.13151041666666666,0.7397825522306414,1.0,8/15,20.79%,ZFP36L1;TNRC6C;TNRC6B;CPEB3;CNOT1;ZFP36L2;AGO2;CNOT7
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6762469896820872,1.3637317963920408,0.13151041666666666,0.7397825522306414,1.0,8/15,20.79%,ZFP36L1;TNRC6C;TNRC6B;CPEB3;CNOT1;ZFP36L2;AGO2;CNOT7
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5925273669457437,1.3636824128087839,0.08524590163934426,0.7382184224532922,1.0,10/48,14.15%,IL12A;CD2;ZFPM1;PTPN22;CCR2;RASGRP1;CYRIB;IL1R1;CEBPG;IL27
prerank,myofibril assembly (GO:0030239),0.5911495997601315,1.3634318433528896,0.11328976034858387,0.7376526074851174,1.0,6/42,13.96%,TMOD4;CSRP3;CSRP1;FLII;ACTN2;CFLAR
prerank,water transport (GO:0006833),0.7017513582108607,1.3633756639986518,0.13674033149171272,0.7361756375566215,1.0,1/12,1.86%,AQP1
prerank,negative regulation of transposition (GO:0010529),0.6587288295186926,1.3633136763509843,0.14303638644918445,0.7346630328343049,1.0,4/16,12.98%,MYBL1;TUT4;UBR2;SIRT7
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5751720866429355,-1.363300529330992,0.14590747330960854,0.6273134755149764,1.0,2/10,6.54%,CTNNB1;RYK
prerank,response to hydrogen peroxide (GO:0042542),0.5870605684588364,1.362396900626038,0.10772578890097932,0.7366872870210209,1.0,14/45,14.97%,ECT2;CYP1B1;STK26;AQP1;FYN;NET1;SETX;HDAC6;MAP3K5;STK24;PARK7;NFE2L2;APTX;PDCD10
prerank,retinoic acid metabolic process (GO:0042573),-0.4736155686645842,-1.3622024377132531,0.12589928057553956,0.6266897014836309,1.0,10/14,49.65%,BCO2;ALDH1A2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1
prerank,mitotic cytokinetic process (GO:1902410),0.6535000112722822,1.3621545162262634,0.1312883435582822,0.7360137746141212,1.0,2/20,1.19%,CEP55;KIF20A
prerank,regulation of phosphate metabolic process (GO:0019220),0.6768552869419209,1.3615764358664333,0.14666666666666667,0.7367943865524287,1.0,8/16,20.99%,BARD1;SMG6;SMG5;PSEN1;CD24;SMG7;MCM7;IKBKB
prerank,chromatin organization (GO:0006325),0.5672307188454843,1.360377002012117,0.029175050301810865,0.7400170428431861,1.0,61/132,23.97%,MYB;HMGB2;EZH2;SUV39H1;HIRIP3;SMARCC2;SMARCA5;CHD1L;RB1;DDX11;SMARCD2;RSF1;NPM3;NUCKS1;HDAC10;BAZ2B;RBBP4;TCF7L1;HMGN2;LRWD1;PHF19;BAZ1B;SMARCA4;PHF1;ZBTB7A;SMARCC1;EHMT1;RUVBL2;RUVBL1;KAT2B;MTA2;CDAN1;HCFC1;SETDB2;SATB2;MYC;TADA2A;KDM4C;JARID2;ATRX;BAZ1A;SIRT1;HDAC4;SETDB1;HDAC1;SAFB;SOX9;HDAC8;ACTL6A;SETD7;CHD1;PADI4;PBRM1;SMARCAD1;SETD5;ZBTB1;GATAD1;KDM6A;NPM1;MTF2;HMGA2
prerank,melanocyte differentiation (GO:0030318),-0.539092392194296,-1.3599976120317099,0.14566929133858267,0.6296270301114201,1.0,2/11,4.09%,MITF;LRMDA
prerank,regulation of B cell proliferation (GO:0030888),0.6018520056776274,1.3597369968807511,0.09350935093509351,0.7411615246770779,1.0,8/44,7.54%,BLK;IKZF3;TNFSF13B;CD38;CD74;TFRC;ATM;AHR
prerank,histone mRNA metabolic process (GO:0008334),0.6343937878453285,1.3596889724099177,0.1166077738515901,0.7396038216316108,1.0,15/27,20.19%,SLBP;SNRPF;ATM;CPSF2;EXOSC10;DCP2;NCBP1;TUT4;ERI1;TUT1;SNRPG;TENT2;NCBP2;XRN1;SNRPB
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.6382841037028566,1.3595635348244006,0.12422360248447205,0.738382338265312,1.0,6/22,15.41%,CYP1B1;IL7R;OCIAD2;NOTCH1;IL10RA;F2R
prerank,cellular senescence (GO:0090398),0.6309069218156038,1.3595220624718423,0.11538461538461539,0.7368675490096795,1.0,12/27,19.38%,HMGA1;SMC6;PML;CDKN2A;TERF2;MAPK14;KAT6A;NSMCE2;MAP2K1;SIRT1;CDKN1A;SMC5
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5794747573632572,1.3584121392572543,0.06619144602851323,0.7398734437729768,1.0,30/87,19.06%,E2F7;CDKN2C;JADE1;WEE1;RB1;AURKA;FBXO5;PSMB7;PSMD11;PSMF1;RBL1;CDK6;CDKN2A;ZFP36L1;PSMC1;CDKN2D;PSMC3;PSMA4;PTEN;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;ZFP36L2;PSME4;PSMD4;AVEN;BRD7;CDKN1A
prerank,outflow tract septum morphogenesis (GO:0003148),-0.4288128016549675,-1.358259945271605,0.09146341463414634,0.6309388143163206,1.0,7/24,9.21%,ACVR1;NRP2;ZFPM2;BMPR2;ROBO1;SMAD6;ENG
prerank,regulation of cellular response to heat (GO:1900034),0.5768545737669102,1.3577805614398224,0.07372793354101766,0.7408573201039869,1.0,32/77,17.55%,RPA2;NUP43;MAPK1;POM121;NDC1;NUP107;NUP42;ATM;NUP50;NUP214;NUP160;NUP205;RPA1;SEC13;NUP188;CCAR2;MLST8;NUP98;RANBP2;NUP210;CREBBP;BAG3;DNAJC7;BAG1;RPA3;GSK3B;DNAJC2;DNAJB1;AAAS;SIRT1;NUP37;YWHAE
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6084290557455491,1.3574540826159613,0.12228571428571429,0.7405328082621593,1.0,8/33,11.66%,FAM83D;EZH2;TFDP1;DDRGK1;PLCG2;EGFR;RDX;PLCB1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.46520876267468525,-1.3571515390962936,0.1324200913242009,0.6301841533168957,1.0,4/17,6.67%,NLRP3;HAVCR2;CD86;FCER1G
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.4818436533498215,-1.3561066892840816,0.10743801652892562,0.629576432509924,1.0,3/16,1.48%,TREM2;LRP1;APOE
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6657329866190095,1.3551872577145607,0.14037433155080214,0.7486551093032897,1.0,6/16,13.98%,ULBP1;TUBB4B;RAET1E;SLAMF7;TUBB;CEBPG
prerank,response to gamma radiation (GO:0010332),0.6444931204533427,1.3551667267319905,0.13214285714285715,0.7470349419089648,1.0,9/24,16.22%,FANCD2;MEN1;LIG4;ATM;XRCC6;MYC;TP53;MAP3K20;TMEM109
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5701513628878976,1.3550529566606804,0.08350515463917525,0.7458118899445907,1.0,23/72,18.46%,POLK;ERCC4;RPA2;XRCC1;RFC5;POLR2I;PRPF19;POLR2A;POLD1;PCNA;LIG1;POLD2;RPA1;ERCC3;RFC2;RFC1;POLD3;RPA3;POLR2K;POLR2J;UBA52;USP7;PPIE
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5094107749968082,-1.354962809528953,0.14074074074074075,0.6293410323529726,1.0,3/13,10.58%,CLPTM1;ZC3H8;CAMK4
prerank,protein export from nucleus (GO:0006611),0.6209912629860492,1.3540077462515885,0.11966824644549763,0.7484127584405444,1.0,6/27,7.45%,ANKLE1;XPO1;CCHCR1;NUP42;DESI1;NUP214
prerank,positive regulation of locomotion (GO:0040017),-0.417875452009403,-1.354002342484171,0.052980132450331126,0.6284737642965211,1.0,10/27,12.67%,TREM2;CSF1R;AIF1;STX4;STX3;P2RY12;SPOCK2;AKT2;CFAP20;PPM1F
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5055859246045248,-1.3532954829004877,0.1145374449339207,0.6268778937634717,1.0,9/15,25.01%,BMP2K;SNAP91;WASL;TNK2;PIK3CB;SMAP1;HIP1R;AAK1;SCYL2
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.44666380398015754,-1.35262376471215,0.14102564102564102,0.6251488349336894,1.0,9/18,17.14%,HAVCR2;NAV3;CD34;TNFAIP3;TRIM27;HDAC7;PRNP;ZFP36;KAT5
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5162160591199578,-1.3515130895987104,0.13584905660377358,0.6248118113769344,1.0,5/12,13.48%,SNAP47;STX4;STX3;STX2;STX1A
prerank,regulation of mRNA metabolic process (GO:1903311),0.698457019426832,1.3514881220023558,0.13636363636363635,0.7576009914189044,1.0,8/11,20.14%,PTCD2;IWS1;NCBP1;DHX9;SRPK1;SAFB;CDK11B;SLTM
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4900727392645061,-1.3508838473547895,0.128099173553719,0.6231597042818846,1.0,7/14,22.33%,LRP1;AIF1;NDRG4;SERPINE1;PRKG1;CORO1B;TRIB1
prerank,cation transmembrane transport (GO:0098655),0.5901173352375881,1.350683674617562,0.10318331503841932,0.7594219669180866,1.0,4/44,3.20%,RHAG;SLC38A5;SLC7A1;SLC6A5
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6112438076302337,1.3504187480489624,0.12705882352941175,0.7589236894120389,1.0,4/32,7.79%,TPX2;STMN1;CLASP1;CIB1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5583103188551343,-1.3493078975269608,0.12962962962962962,0.6244048811543528,1.0,9/10,44.20%,TXN2;MTRR;ADO;TST;MPST;CBS;GADL1;CTH;BLMH
prerank,RNA catabolic process (GO:0006401),0.5967391484186145,1.3483429215670997,0.09385113268608414,0.7660341397821485,1.0,14/46,16.03%,SLFN14;RNASE6;LSM6;FEN1;PPP1R8;DCP2;DNA2;NCBP1;LSM2;LSM5;METTL16;DXO;RNASEH2A;ZFP36L2
prerank,glycine metabolic process (GO:0006544),0.6696685982038536,1.3471768335653302,0.14285714285714285,0.7695507959099134,1.0,1/12,1.10%,GCAT
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7087857461412357,1.3466989753564413,0.14831130690161526,0.7698632065923225,1.0,7/10,21.03%,STK26;TXN;PARK7;NFE2L2;PDE8A;LRRK2;RIPK1
prerank,amino acid transport (GO:0006865),0.5858056186312628,1.3465304650614045,0.11889596602972399,0.768803284314288,1.0,8/49,10.13%,SLC6A12;SLC38A5;SLC1A5;SLC7A1;SLC25A47;SLC16A10;SLC43A2;SLC3A1
prerank,cellular response to alcohol (GO:0097306),0.58354568692296,1.3463410975364243,0.116331096196868,0.7679400500309557,1.0,8/42,7.56%,RAD51;BRCA1;BLM;CTNNA1;MAP4K1;MLC1;AHR;GNAI1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.6950896444442752,1.3462605806349643,0.15437158469945356,0.766558533206345,1.0,4/11,10.78%,STK26;FYN;UBQLN1;PARK7
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5121314348364236,-1.3458288583413842,0.13541666666666666,0.6310075587393451,1.0,3/13,10.44%,GLUL;GOT2;GLUD1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.7244711172834298,1.3453557209965217,0.13728323699421965,0.7688340067432234,1.0,8/10,19.63%,MYB;BRCA1;DNMT1;JARID2;ATRX;RIF1;SIRT1;DNMT3B
prerank,nucleic acid metabolic process (GO:0090304),0.5756407834810052,1.3449985531203394,0.09090909090909091,0.7686568355648434,1.0,33/69,22.44%,ANKLE1;DNTT;TOPBP1;POLR2I;POLR2A;FEN1;HNRNPC;HNRNPM;HNRNPL;HNRNPA3;PDE12;HNRNPA2B1;DNA2;DNASE1L1;NCBP1;PCBP2;HNRNPA0;HNRNPR;WDR74;DXO;HNRNPU;RAD50;METTL14;POLR2K;POLR2J;HNRNPA1;NCBP2;DDX54;WRN;MMS19;RBFOX2;WTAP;POLR2B
prerank,negative regulation of wound healing (GO:0061045),-0.3866939789782636,-1.3448574520303838,0.07801418439716312,0.630331167391491,1.0,9/28,14.30%,SERPINE2;APOE;SLC12A2;CD34;CLASP2;TFPI;ALOX5;FGF2;SERPINE1
prerank,nuclear transport (GO:0051169),0.6638068150727892,1.3442838352289688,0.1447721179624665,0.7700284290539745,1.0,7/16,17.78%,HMGA1;XPO1;NUP205;NUP98;PSIP1;AAAS;RSRC1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3958828560859107,-1.3439545715836299,0.07272727272727272,0.6294290957536247,1.0,16/32,30.03%,APP;TREM2;ARNT;PRKAA2;IGF1;ENO1;PINK1;PFKFB4;PFKFB2;PPARGC1A;HIF1A;BEND3;INSR;MLXIPL;PFKFB1;GAPDHS
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6021740200562795,1.3439126127553267,0.13833528722157093,0.7697994460492664,1.0,4/27,3.20%,SLC38A5;SLC25A12;SLC7A1;SLC6A5
prerank,neuron maturation (GO:0042551),-0.46214950411947986,-1.343723419789461,0.13392857142857142,0.6264049795430098,1.0,6/18,8.91%,APP;FARP2;C1QA;CLN5;B4GALT5;SRRM4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.6547895363897641,1.3432761684790944,0.14375,0.7707876424823916,1.0,9/18,11.89%,NOP10;CCT7;CCT2;TCP1;EXOSC10;DCP2;RUVBL2;RUVBL1;CCT5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.5440868653168605,-1.342810936938145,0.1267123287671233,0.6222024918111785,1.0,3/10,25.23%,MBP;MAPK7;KLF4
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.5440868653168605,-1.342810936938145,0.1267123287671233,0.6222024918111785,1.0,3/10,25.23%,MBP;MAPK7;KLF4
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.6926415060165652,1.342768547394646,0.1595900439238653,0.7712025380020464,1.0,3/11,12.51%,IL12A;JAK2;CANX
prerank,negative regulation of phagocytosis (GO:0050765),0.645686196581198,1.3424986537951096,0.14138817480719795,0.7707561241979631,1.0,8/17,17.65%,PRTN3;CD47;SNX3;HMGB1;PIP4P2;RACK1;APPL1;FCGR2B
prerank,positive regulation of macrophage activation (GO:0043032),-0.47773412999468323,-1.3419753864872703,0.11894273127753303,0.6211385076832782,1.0,7/17,19.61%,TREM2;HSPD1;TLR4;TNIP2;TTBK1;THBS1;CCL3
prerank,primary neural tube formation (GO:0014020),0.6176610767061359,1.3419131582053914,0.1358313817330211,0.7715535059542061,1.0,5/30,7.73%,STIL;PHACTR4;DEAF1;LMO4;FUZ
prerank,myelination (GO:0042552),-0.34701864219248796,-1.3414792963253341,0.0759493670886076,0.6191366889130231,1.0,21/46,23.55%,ABCD2;PLP1;MBP;SCN8A;SLC8A3;PLLP;CMTM8;B4GALT5;NF1;EPB41L3;NFASC;MAL;DEGS1;EIF2B4;ADGRG6;ARHGEF10;TNFRSF21;EIF2B2;PARD3;SOX10;CNTNAP1
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5779412449104521,1.3410530805733598,0.09820485744456177,0.7735094438464136,1.0,9/55,10.96%,HMMR;FMOD;HSPG2;CD44;GALNS;HPSE2;DCN;CEMIP2;OGN
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.6344086507231239,1.3409056207737629,0.15012106537530268,0.770800165121466,1.0,5/21,9.43%,ERCC4;RPA2;CHD1L;RPA1;ERCC3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.6344086507231239,1.3409056207737629,0.15012106537530268,0.770800165121466,1.0,5/21,9.43%,ERCC4;RPA2;CHD1L;RPA1;ERCC3
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6998542487650358,1.3379065267053538,0.17765042979942694,0.7820690743752514,1.0,2/10,7.92%,IL12A;DCN
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.5558849909150407,1.3378913528247232,0.020060180541624874,0.7804529361217171,1.0,85/168,22.90%,RPL7;RPL18A;SMG6;RPS20;SMG5;RPL36;RPL14;RPS19;DCPS;EIF3E;RPS7;RPS4X;RPS18;EXOSC8;ATM;UPF2;SMG8;PDE12;ZFP36L1;RPL23A;CSDE1;EIF4A3;DCP1B;RPL28;EXOSC10;DCP2;RPL41;RPS14;RPLP2;NCBP1;RNPS1;CASC3;RPS27;RPS5;PNLDC1;RPS29;RPLP0;TUT4;RPS11;CNOT4;RPL27A;ERI1;DCP1A;UPF3B;SMG9;RPS15A;RPS9;DXO;HELZ2;RPL12;CNOT1;RC3H1;PYM1;CNOT6;SAMD4A;TUT1;RPL3;RPL18;GSPT1;UBA52;TENT2;RPS17;RPS6;RPL5;NCBP2;RPS3;RPL21;THRAP3;XRN1;PPP2CA;RPL23;RPL17;CNOT8;SMG7;CNOT7;RPL8;RPL24;RPL27;DHX34;RPL13A;RPS12;AGO1;RPS8;RPL15;RPL10
prerank,protein kinase A signaling (GO:0010737),0.6789510602565196,1.3374739655530765,0.16736401673640167,0.7805875472170961,1.0,4/12,11.57%,EZR;MYOM1;PRKACA;RDX
prerank,nucleoside catabolic process (GO:0009164),-0.5436992565174252,-1.3373422522458518,0.1342281879194631,0.6274629719966078,1.0,4/11,6.31%,UPP2;DERA;NT5M;DPYD
prerank,regulation of integrin activation (GO:0033623),0.6672818413538063,1.3371585053198773,0.15046604527296936,0.7802612215674481,1.0,1/15,0.17%,KIF14
prerank,tube closure (GO:0060606),0.6151331416116574,1.3371198018242714,0.14153132250580047,0.7787548049605497,1.0,5/31,7.73%,STIL;PHACTR4;DEAF1;LMO4;FUZ
prerank,regulation of neuron projection arborization (GO:0150011),-0.4788950223775282,-1.3369934777776566,0.14347826086956522,0.6249163028999318,1.0,5/15,9.26%,MACF1;MAP3K13;MYO9A;NTNG1;DVL3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6620192136012069,1.3368511889741204,0.17150395778364116,0.7782726159989495,1.0,4/15,10.78%,MAD2L1;FBXO5;RPS7;PARK7
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.5791977224425812,1.3362120654925596,0.11400651465798045,0.7793604194558054,1.0,2/45,0.90%,TTK;INHBC
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.648674651769791,1.335722408834566,0.1437578814627995,0.7797724835963958,1.0,5/18,13.14%,KIF20B;RIPOR2;CYRIB;ROCK2;RACK1
prerank,regulation of chemokine production (GO:0032642),-0.3812685821794071,-1.3357014647958063,0.09473684210526316,0.6250841925945919,1.0,8/36,7.28%,APP;TREM2;CSF1R;LPL;AIF1;PYCARD;TLR7;TLR4
prerank,male meiosis I (GO:0007141),0.6540207330742356,1.3356942134180478,0.16363636363636364,0.7782356008529506,1.0,3/16,13.34%,MYBL1;FOXJ3;ING2
prerank,prostanoid biosynthetic process (GO:0046457),-0.4733330004110149,-1.3353698090766795,0.09663865546218488,0.6226690044455392,1.0,4/15,5.70%,TBXAS1;DAGLB;PTGS1;PTGDS
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.6866869911532529,1.3351984496039029,0.16805555555555557,0.7786848944778413,1.0,2/11,5.38%,BLK;CDKN2A
prerank,striated muscle cell development (GO:0055002),0.6600614257150027,1.3351845930527908,0.1649214659685864,0.7770761582460721,1.0,2/14,9.26%,TMOD4;FLII
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.6298097799770557,1.3351465208128392,0.14320388349514562,0.7755720469785871,1.0,1/22,0.93%,LRAT
prerank,regulation of chemotaxis (GO:0050920),-0.38818564510053216,-1.3348917219261123,0.11864406779661017,0.6205990588793427,1.0,13/30,21.10%,TREM2;PTPN2;AIF1;STX4;STX3;P2RY12;ZSWIM6;DUSP3;PPM1F;ZSWIM8;THBS1;P2RX4;EFNB2
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5935258324369818,1.3347380873076915,0.13356562137049943,0.7756739642839884,1.0,7/32,17.96%,CD19;CAV1;NPSR1;PDPK1;F2R;PLCG1;SNCA
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6938577075365039,1.3345901849506896,0.16180371352785147,0.7746202528772743,1.0,2/12,2.25%,IL12A;MAPK1
prerank,positive regulation of DNA recombination (GO:0045911),0.612846251205934,1.334320389979749,0.14906103286384975,0.7741197396855528,1.0,7/27,12.23%,RAD51AP1;TIMELESS;ARID2;TFRC;MRNIP;KMT5C;PAXIP1
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.4630072880629108,-1.3341068831924154,0.14622641509433962,0.619559873316404,1.0,6/17,18.56%,LPL;PCSK5;PCSK6;LMF1;SORT1;APOC1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.6625397365360285,1.3330008966110702,0.16733067729083664,0.7781237973799919,1.0,6/13,17.60%,PRPF19;SART3;LSM2;PRPF31;SRSF10;PRPF8
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5927620424419285,1.3322852086548518,0.1377726750861079,0.7794926418527018,1.0,10/33,13.03%,ECT2;CYP1B1;AQP1;NET1;SETX;HDAC6;MAP3K5;PARK7;SIGMAR1;NFE2L2
prerank,regulation of myelination (GO:0031641),0.6164740411846508,1.3312739593194414,0.14645858343337334,0.7821621970175118,1.0,1/25,0.17%,KIF14
prerank,regulation of cellular component size (GO:0032535),0.5981460678559635,1.3310650454463997,0.140534262485482,0.7814403657203535,1.0,15/30,18.10%,EZR;RIN3;RAB22A;RAP1GAP2;PEX11B;MTPN;LARS1;PPP1R15A;MSN;RDX;PTEN;LAMTOR4;RAC1;PPP1CA;RARG
prerank,exit from mitosis (GO:0010458),0.6707055354775523,1.330622829589556,0.18875502008032127,0.7816831534623147,1.0,2/12,5.95%,UBE2C;CLASP1
prerank,negative regulation of chemotaxis (GO:0050922),-0.3893676654935223,-1.3306150151968634,0.09420289855072464,0.6263117910405994,1.0,12/31,20.61%,PTPN2;AIF1;SEMA3D;SEMA3E;SEMA4C;ROBO1;DUSP3;SEMA4G;SEMA3A;THBS1;SEMA7A;CORO1B
prerank,arachidonic acid secretion (GO:0050482),-0.5354632186793874,-1.3302922647502098,0.16181229773462782,0.6205093462485619,1.0,8/10,46.48%,ANXA1;DRD2;PNPLA8;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,arachidonate transport (GO:1903963),-0.5354632186793874,-1.3302922647502098,0.16181229773462782,0.6205093462485619,1.0,8/10,46.48%,ANXA1;DRD2;PNPLA8;NMUR2;BDKRB2;PLA2G5;DRD3;ACE
prerank,regulation of intracellular protein transport (GO:0033157),0.5889104665030591,1.3302058838845485,0.133032694475761,0.781864719280561,1.0,8/32,14.97%,KIF20B;PCNT;PCM1;PTPN14;OAZ1;SIRT7;RIPOR1;PDCD10
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.6048930304992892,1.3299888100482289,0.1532349602724177,0.7811667851099037,1.0,7/31,15.14%,BLK;SPN;GLMN;ATM;TNFRSF13B;TYROBP;RC3H1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.6129161291048176,1.3298968254878154,0.16105769230769232,0.7799639566774614,1.0,5/29,8.59%,IL12A;KLRD1;RASGRP1;RAET1E;CYRIB
prerank,organic anion transport (GO:0015711),0.5602670002053834,1.329679652574067,0.09165808444902163,0.7792840671417429,1.0,14/76,12.43%,SLC4A1;RHAG;AQP1;SLC2A8;SLCO4C1;SLC35A2;CYB5RL;SLC35A1;SLCO4A1;LRRC8C;SLC52A1;SLC19A1;ABCC4;SLCO2A1
prerank,telomere capping (GO:0016233),0.6628138063368604,1.3293550411496997,0.15344603381014305,0.7790809566411928,1.0,8/16,14.79%,DCLRE1C;TERF2;DCLRE1B;TERF1;CTC1;PRKDC;TFIP11;RAD50
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6173491522134513,1.3289416571261032,0.1682808716707022,0.7791971155454626,1.0,10/22,22.57%,CDKN2C;ANKLE2;CDKN2A;CDKN2D;TP53;DYNLL1;SIRT1;CDKN1A;ROCK1;CDKN1B
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.5808787267505959,1.3278277232516593,0.11496746203904555,0.7821802194367846,1.0,17/46,17.55%,ECT2;GTSE1;ANP32B;FLNA;EFCAB7;EMD;DHX9;BAG3;PSEN1;GSK3B;TP53;IPO5;TCF7L2;TRIM28;XPO4;HCLS1;YWHAE
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.613447673340034,1.3278218018670498,0.15587529976019185,0.7805982087399618,1.0,9/24,10.24%,EZH2;PPM1D;SUZ12;EPC1;RBBP4;PHF19;H3-3A;PHF1;DNMT1
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.6529839853643672,1.3272776138496014,0.15572715572715573,0.7813342393220025,1.0,8/18,19.13%,DHX58;NPLOC4;BIRC2;PUM2;PUM1;USP15;GPATCH3;SEC14L1
prerank,histone lysine methylation (GO:0034968),0.5848740160802345,1.3263005762526814,0.15664018161180476,0.7838329360744427,1.0,10/33,14.99%,EZH2;MEN1;SUV39H1;WDR5B;DPY30;PAXIP1;SETDB2;KMT2A;RBBP5;KMT2B
prerank,protein localization to mitochondrion (GO:0070585),-0.5174248428679812,-1.3262884549731875,0.15867158671586715,0.6281989435065877,1.0,5/11,19.54%,HK2;RALA;PINK1;MAIP1;COX18
prerank,negative regulation of DNA binding (GO:0043392),0.6064800585641884,1.3256608744730398,0.16372202591283863,0.7848247778341323,1.0,10/28,15.87%,HEY2;LEF1;E2F1;RSF1;SP100;JAK2;SUMO1;JUN;TFAP4;SIN3A
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.5461236323504166,1.3255340974202656,0.0,0.7837708246574188,1.0,86/417,12.31%,CENPF;DEPDC1;BIRC5;FOXM1;GFI1;MYB;HMGB2;EZH2;RCOR2;MEN1;SUV39H1;BRCA1;SMARCC2;HMGA1;DAP;HEY2;RBM15;DEAF1;LEF1;E2F1;RB1;RIOX1;NIF3L1;RSF1;CD38;CBX5;TWIST1;PML;BCL7A;FBXW11;TIMELESS;PA2G4;HDAC10;UBE2I;RPS6KA5;MTA3;EPC1;CTCF;SCMH1;FOXP1;DACH1;CDKN2A;NR1D1;NKAP;MBD2;FOXO1;PBXIP1;MBD1;ARID4A;GMNN;HDAC6;KLF10;TAF7;NOTCH1;XRCC6;AHR;SFMBT1;SAP18;SPEN;SMARCA4;PSPC1;CIPC;CIR1;ZBTB16;ZBTB7A;NONO;ZNF148;MECP2;PFDN5;TFDP2;NR2F2;ID4;KAT6A;ZEB1;TRIM33;EHMT1;ARID5B;SUMO1;SMAD4;JUN;CCAR2;ATF5;PLCB1;FOXP2;BAP1;SETDB2
prerank,negative regulation of bone remodeling (GO:0046851),-0.5212981215505685,-1.3249789365943911,0.14545454545454545,0.6284690146818394,1.0,2/11,5.59%,UBASH3B;TNFAIP3
prerank,histone H2A acetylation (GO:0043968),0.6584144884452807,1.324837142084163,0.1651376146788991,0.7853076291403422,1.0,7/16,13.33%,NAA40;EPC1;BRD8;YEATS4;RUVBL2;RUVBL1;ING3
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6131182401568603,1.324623220320507,0.16443361753958588,0.7846123718088345,1.0,7/23,15.41%,CYP1B1;OCIAD2;NOTCH1;JAK2;IL10RA;PIBF1;F2R
prerank,regulation of hormone secretion (GO:0046883),-0.47174217011054886,-1.3240830430213473,0.155893536121673,0.6278700632725056,1.0,5/15,29.75%,VAMP2;SNX6;SOX11;ANXA1;OSM
prerank,negative regulation of proteolysis (GO:0045861),-0.37047003484322455,-1.3239345461136651,0.07801418439716312,0.6249822752965314,1.0,11/34,17.02%,SERPINE2;TIMP2;CAMK2N1;TIMP3;BAG6;CLN8;CDK5;PRNP;DNAJC1;EPHA4;CST7
prerank,negative regulation of viral entry into host cell (GO:0046597),0.6710034979244237,1.3235046996950879,0.18059299191374664,0.7876020212041901,1.0,6/12,14.44%,SNX3;GSN;LY6E;TRIM11;IFITM3;TRIM5
prerank,lipoprotein biosynthetic process (GO:0042158),-0.5379778835539528,-1.3233168886513924,0.15625,0.6234025116456003,1.0,3/11,8.39%,ATG10;APOE;WIPI1
prerank,positive regulation of vacuole organization (GO:0044090),-0.5411387868497456,-1.3229389217580585,0.16151202749140894,0.621249969506701,1.0,4/10,7.94%,PIP4K2B;GRN;SH3GLB1;RAB3GAP2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.6586412134294078,1.3222148815700652,0.18933333333333333,0.7914024654190693,1.0,6/14,12.75%,MYB;BRCA1;DNMT1;SMAD4;PAXIP1;KMT2A
prerank,regulation of cellular component organization (GO:0051128),0.5539066680993714,1.3217364148951785,0.041289023162134945,0.791727920380024,1.0,25/135,13.62%,MKI67;KIF14;HJURP;RAB33B;CD177;ALKBH4;AURKA;NET1;STK11;TFRC;STON1;STK38L;ARFGAP1;METTL4;RIT2;SOCS2;PARK7;ATF5;BAP1;HCFC1;PACSIN2;ROCK2;STON2;HNRNPU;LATS1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6840240019859457,1.3216075936249643,0.18057455540355677,0.7906691669362497,1.0,5/13,15.87%,HEY2;TAF1;DDIT3;PSEN1;SIN3A
prerank,determination of bilateral symmetry (GO:0009855),0.6099591121598577,1.3211678165206446,0.15466351829988192,0.7910111094075611,1.0,2/24,7.16%,STIL;NOTCH1
prerank,positive regulation of embryonic development (GO:0040019),0.6355098516967049,1.3210243855282044,0.14698492462311558,0.7900829210675298,1.0,5/19,13.14%,FOXA2;RBM19;NR2C2;PLCB1;RACK1
prerank,sulfate transport (GO:0008272),0.6685399098492376,1.3207103021870683,0.15746971736204576,0.7898141357363221,1.0,1/14,0.69%,RACGAP1
prerank,mRNA stabilization (GO:0048255),0.5927025927467185,1.3203252389360922,0.13986784140969163,0.7899574398750635,1.0,21/40,23.73%,E2F1;HNRNPC;BOLL;TAF15;ELAVL4;MAPK14;DHX9;HNRNPA0;MYD88;HNRNPU;PAIP1;ANGEL2;EIF4ENIF1;ELAVL1;THRAP3;SYNCRIP;TENT5D;TARDBP;YBX1;GDNF;CIRBP
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.383074056427992,-1.3200861028734332,0.06993006993006994,0.6259601653802587,1.0,9/27,20.67%,ABCA1;ABCA5;LPL;ITGB3;CSF1;IL18;CD36;NFKBIA;AGT
prerank,negative regulation of nuclear division (GO:0051784),0.6916296712992206,1.3197776935954966,0.17397260273972603,0.7907334607839523,1.0,3/11,5.09%,FBXO5;AURKAIP1;CHEK1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6880166908155131,1.3191246798852887,0.17705382436260622,0.791962462273621,1.0,4/11,12.49%,BARD1;ZFP36L1;NCBP1;ZC3H3
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.6998303563274372,1.3188749184762334,0.18041958041958042,0.7915075076449295,1.0,2/10,7.16%,PHACTR4;NOTCH1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.6537227013399195,1.3188036773892968,0.1564102564102564,0.7902620825445101,1.0,6/16,15.19%,NAA40;KAT2B;NAA16;NAA25;CREBBP;NAA20
prerank,rRNA catabolic process (GO:0016075),0.6519592270326654,1.3164074810896422,0.17374005305039789,0.7987974256537312,1.0,3/16,7.57%,SLFN14;EXOSC8;EXOSC10
prerank,regulation of transposition (GO:0010528),0.6562259164417068,1.3162617055633086,0.1877496671105193,0.7978364609966995,1.0,3/13,12.98%,MYBL1;UBR2;SIRT7
prerank,positive regulation of cellular senescence (GO:2000774),0.6885038984673388,1.3158660432274472,0.17691154422788605,0.7979068847269587,1.0,5/10,16.99%,HMGA1;CGAS;CDKN2A;B2M;SIRT1
prerank,Golgi inheritance (GO:0048313),0.6876199243417085,1.3149642791760612,0.1768617021276596,0.7999448087090293,1.0,5/11,14.97%,CDK1;STX5;VRK1;VCPIP1;PDCD10
prerank,macrophage activation (GO:0042116),-0.35880258902215084,-1.313836419168432,0.09900990099009901,0.6402049472053313,1.0,9/34,10.39%,APP;TREM2;ITGAM;SBNO2;AIF1;C1QA;TLR4;NMI;C5AR1
prerank,chordate embryonic development (GO:0043009),0.5650377412179144,1.3133465787297391,0.13789473684210526,0.8050082778269165,1.0,5/55,3.98%,STIL;BRCA1;DEAF1;LIG4;SULF2
prerank,neural tube closure (GO:0001843),0.5926498593850928,1.3131508842965667,0.15748031496062992,0.8041858425844147,1.0,11/34,19.42%,STIL;PHACTR4;DEAF1;LMO4;FUZ;BBS4;SKI;TGFB2;KDM2B;MTHFD1L;PAX2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5672581730495285,1.3129791716405843,0.14500537056928034,0.8033013529463592,1.0,21/48,18.50%,ATAD2;POLR1B;HMGA1;SMARCA5;ARID1B;DEK;CDCA4;CHEK1;ASF1A;BAZ1B;PHF2;POLR1A;KAT2B;POLR1F;SERTAD2;POLR1C;ELOF1;POLR2K;TAF1C;TAF1D;POLR1G
prerank,prostanoid metabolic process (GO:0006692),-0.4965874406607829,-1.3128532758974947,0.1348314606741573,0.6396865867854277,1.0,4/13,8.49%,HPGDS;PTGS1;PLAA;PTGR2
prerank,positive regulation of cilium assembly (GO:0045724),0.6474637798602411,1.3128304852490176,0.18055555555555555,0.8023305243093988,1.0,10/18,22.63%,CCDC88A;ARHGAP35;FUZ;TAPT1;HAP1;BBS4;MARK4;SEPTIN9;CROCC;CEP135
prerank,chromatin remodeling (GO:0006338),0.5530257840602273,1.3121565383843097,0.06861755802219979,0.8036055457789667,1.0,37/100,19.46%,MYB;CECR2;SMARCC2;MBD3;SMARCA5;CHD1L;RB1;ARID1B;SMARCD2;RSF1;NPM3;ACTR5;HNRNPC;MBD2;BAZ2B;RBBP4;BAZ1B;SMARCA4;ZBTB7A;SMARCC1;RUVBL2;RUVBL1;KAT2B;MTA2;HCFC1;SATB2;MYC;TADA2A;KDM4C;JARID2;ATRX;BAZ1A;SIRT1;HDAC4;GATAD2B;HDAC1;SOX9
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.44967451718267026,-1.3119667725989241,0.17117117117117117,0.6357942158704712,1.0,8/16,20.27%,ARHGAP6;APOD;CLASP2;CORO1C;RCC2;ACVRL1;THBS1;PHLDB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.44967451718267026,-1.3119667725989241,0.17117117117117117,0.6357942158704712,1.0,8/16,20.27%,ARHGAP6;APOD;CLASP2;CORO1C;RCC2;ACVRL1;THBS1;PHLDB2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6129659442644848,1.311719758572419,0.1486810551558753,0.8038584706978302,1.0,5/24,8.34%,ADAMTS7;SOX6;PTHLH;MBOAT2;ZBTB16
prerank,defense response to protozoan (GO:0042832),0.6734835808628024,1.3116182280527007,0.20448179271708683,0.8027066749644418,1.0,4/12,11.93%,GBP4;BATF;GBP2;MYD88
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5339938849861897,-1.3107286928320963,0.16845878136200718,0.6359975119634824,1.0,5/11,17.60%,ACVR1;TGFBR1;SMAD7;TGFBR3;TGFBR2
prerank,establishment of vesicle localization (GO:0051650),-0.46121465411240903,-1.3095900077883451,0.1527777777777778,0.6357499365081432,1.0,9/18,16.09%,DNM2;KIF5C;SYNJ1;SPG11;CCDC186;KIF5A;CDK5;RAB11A;SNAPIN
prerank,nuclear export (GO:0051168),0.5471567560837002,1.3093147199707282,0.10082304526748971,0.8107847886110559,1.0,33/80,20.29%,ANKLE1;XPO1;POM121;DHX38;CCHCR1;NUP42;WASHC4;U2AF1;EIF4A3;DESI1;SRSF3;NUP214;SRSF4;NCBP1;RNPS1;CASC3;U2AF1L4;NUP188;THOC3;UPF3B;THOC5;THOC2;XPO4;THOC7;SRSF7;CDC40;DDX39B;POLDIP3;MALT1;HNRNPA1;NCBP2;SRSF2;TPR
prerank,response to UV-B (GO:0010224),0.6542930122084268,1.3048805191316943,0.20027816411682892,0.8281369949015405,1.0,2/12,4.80%,IL12A;STK11
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6730773439624129,1.3043652301417825,0.1925287356321839,0.8287653082191202,1.0,5/10,23.16%,OXSR1;CCR2;STK39;ADAM10;ADAM17
prerank,endothelial cell proliferation (GO:0001935),-0.44832811766152436,-1.3040572433325295,0.15086206896551724,0.64805444071555,1.0,7/17,19.55%,BMPR2;CD34;ERN1;HMOX1;ACVRL1;DLG1;BMPER
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.5759749498366602,1.3036827957185575,0.1716937354988399,0.8301345706742326,1.0,9/32,21.88%,CD19;NPSR1;PDPK1;HAP1;F2R;PLCG1;SNCA;PKD2;CALM3
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6240876344164699,1.3036422960738678,0.17375,0.8287457754241446,1.0,1/19,0.81%,CHRNB4
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.39338249502112466,-1.3029085989247018,0.12738853503184713,0.6479125734379472,1.0,8/27,12.42%,RIMS1;RIMS2;SYT1;SYT4;VAMP2;SYT7;SYT9;VAMP7
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.6094084697712665,1.3025523088218633,0.1632896305125149,0.8317656125554945,1.0,9/24,16.99%,DDIAS;CD74;CD44;CDKN2D;CCAR2;ING2;TPT1;TAF9;SIRT1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),-0.37055720786635205,-1.3024160336907546,0.10638297872340426,0.6461654238665673,1.0,14/39,19.08%,SPOCK1;EFNA5;GCNT2;ADAM15;NEXMIF;SEMA3E;CORO1C;CORO2B;PTPRO;RCC2;MAP4K4;JAG1;THBS1;RASA1
prerank,homeostasis of number of cells (GO:0048872),0.6564369094947871,1.3020847406932645,0.19568151147098514,0.8321663231987807,1.0,6/12,16.27%,OCIAD2;NOTCH1;NAPEPLD;CARD9;F2R;UBAP2L
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3725976223401314,-1.3015974642516797,0.08333333333333333,0.645425488331863,1.0,12/36,11.17%,NSF;ANK3;MACF1;GGA3;OPTN;GOLGA7;PREPL;AFDN;VAMP5;VAMP2;GOLGA4;RAB31
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6364580737955272,1.301546111212062,0.20053475935828877,0.8329309028469251,1.0,3/15,11.99%,HAAO;KMO;FAH
prerank,regulation of neuron migration (GO:2001222),0.5992480867990558,1.3012845901128178,0.16826923076923078,0.8324401954017291,1.0,2/26,3.78%,KIF20B;ULK4
prerank,establishment of skin barrier (GO:0061436),0.6420070082740899,1.3012139259987825,0.19256308100929614,0.8296032175613203,1.0,1/15,1.62%,STMN1
prerank,regulation of water loss via skin (GO:0033561),0.6420070082740899,1.3012139259987825,0.19256308100929614,0.8296032175613203,1.0,1/15,1.62%,STMN1
prerank,potassium ion export across plasma membrane (GO:0097623),-0.4772713351663642,-1.3007399499114602,0.1276595744680851,0.6446708771151841,1.0,9/13,51.74%,KCND3;KCNK5;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNA5;KCNE2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5414349770835297,1.300672496324436,0.052104208416833664,0.8303035700618062,1.0,42/153,14.90%,TTK;CDK1;CLSPN;MASTL;PLK1;MAPK1;AURKA;PRKCE;RPS6KA5;MAP4K1;MAPKAPK3;TLK1;TAF1;ATM;CSNK1A1;STK38L;PKN2;AKT3;CSNK1G2;PRKX;PRKCA;PRKACA;MAPK14;STK38;MARK2;MAST2;PDPK1;HIPK2;DYRK1A;VRK1;PRKCB;RPS6KA6;LMTK2;ROCK2;GRK2;PRKDC;LATS1;STK39;CDC7;SGK3;GSK3B;STK4
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.645675160883609,1.30051149290657,0.16840731070496084,0.8293878888710823,1.0,6/16,12.75%,MYB;BRCA1;DNMT1;SMAD4;PAXIP1;KMT2A
prerank,histone methylation (GO:0016571),0.5890855503236406,1.3003652043842937,0.17724550898203592,0.828480775277051,1.0,7/26,13.78%,EZH2;SUV39H1;EHMT1;FBL;NSD3;SIRT7;CREBBP
prerank,diacylglycerol metabolic process (GO:0046339),-0.4128485587784837,-1.299717350007196,0.10303030303030303,0.6443375695589091,1.0,9/23,14.61%,DGKH;PLA2G15;DGKA;DGKI;DGKZ;DGKQ;DGKB;DGAT1;DAGLA
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.6062996749611904,1.2990701923998487,0.18159509202453988,0.8323819969634655,1.0,7/22,19.45%,IL12A;CYRIB;B2M;MAP3K7;MALT1;CD55;TRAF6
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.6628277899252234,1.2982886158748224,0.1837270341207349,0.8342449427990922,1.0,4/14,16.27%,BRCA2;TERF2;NABP2;ATRX
prerank,cotranslational protein targeting to membrane (GO:0006613),0.5413504554085417,1.2981967967479076,0.10376398779247202,0.8330593174566824,1.0,48/91,23.49%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;ARL6IP1;RPL28;RPL41;RPS14;RPLP2;RPS27;RPS5;RPS29;RPLP0;RPS11;RPL27A;RPS15A;RPS9;RPL12;SSR1;RPL3;RPL18;SEC63;UBA52;RPS17;RPS6;RPL5;RPS3;RPL21;RPL23;RPL17;RPL8;RPL24;RPL27;SEC62;RPL13A;RPS12;SSR2;RPS8;RPL15;RPL10;SRP68;RPS21
prerank,UV-damage excision repair (GO:0070914),0.6614789993788444,1.2981837329990702,0.18019257221458046,0.8315601681101091,1.0,5/12,17.75%,POLA1;ACTR5;POLD3;SIRT1;DDB2
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5290698406718205,-1.297868473284907,0.18553459119496854,0.6467756817049799,1.0,6/10,25.66%,GALNT3;POGLUT1;GALNT1;POGLUT3;GALNT2;MGAT5B
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5580061467775707,1.2978670362066442,0.16379310344827586,0.8313833718546328,1.0,16/48,16.99%,BRCA1;CHEK2;E2F1;PML;MSH6;PHLDA3;CASP2;ATM;BOK;HIPK2;PRKDC;CASP9;TP53;TMEM109;CRIP1;SIRT1
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5413618912242555,1.297858279771834,0.0998980632008155,0.8298575583237991,1.0,45/87,23.49%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;RPL28;RPL41;RPS14;RPLP2;RPS27;RPS5;RPS29;RPLP0;RPS11;RPL27A;RPS15A;RPS9;ZFAND2B;RPL12;RPL3;RPL18;SEC63;UBA52;RPS17;RPS6;RPL5;RPS3;RPL21;RPL23;RPL17;RPL8;RPL24;RPL27;RPL13A;RPS12;RPS8;RPL15;RPL10;SRP68;RPS21
prerank,regulation of intracellular signal transduction (GO:1902531),0.535879838723975,1.297435684395053,0.004,0.830054598602968,1.0,111/420,15.29%,TPX2;CDK1;BRIP1;AURKB;ECT2;FAM83D;RACGAP1;BARD1;RAD1;BRCA1;DEPDC1B;ARHGEF5;RMI2;EXO1;RPA2;ARHGAP15;MBD3;CHEK2;BLM;ARHGAP11A;MAPK1;ARHGAP33;AURKA;DAPK2;TIAM1;NET1;AKAP12;EZR;RCN3;TOPBP1;RFC5;RAD9A;ULK4;PML;MAP2K6;PIDD1;AKAP7;PTPN22;ARHGEF18;RBBP8;STK11;ARHGDIB;CHEK1;BRPF1;TAF1;IKBKG;ARHGEF3;MDM4;ATM;TTI1;GPAT3;RBBP4;FAM13A;PDE2A;TRAF3;MOB3B;PIP5K1B;BIRC2;TAF7;TAF15;PIN1;ARHGAP35;GNAI1;MAPK14;RHNO1;ENTPD5;DNA2;PLCG2;HUS1;SOS1;ITGAV;ARHGAP19;EGFR;RPA1;GMIP;RFC2;PEX5L;PDPK1;HIPK2;RIT2;KAT6A;RHOU;EHMT1;STARD8;ARHGAP39;ARHGAP30;TAF6;XIAP;MLST8;TTC5;CRK;MTA2;PTEN;FGD3;TOP3A;ARHGAP9;RAC2;ARHGAP45;ING2;ING5;PRKAG2;TAF2;SGMS1;RPA3;RAD50;STK4;TP53;ARHGAP26;ARHGAP31;BCR;FAM13B
prerank,carboxylic acid transport (GO:0046942),0.5581246171207809,1.2974236538187962,0.13756613756613756,0.8285654654232214,1.0,6/55,7.50%,SLC6A12;SLC38A5;SLC1A5;SLC7A1;SLC16A12;SLC16A1
prerank,positive regulation of programmed cell death (GO:0043068),0.5392091273489646,1.297346920061214,0.015,0.8273533068540486,1.0,69/272,18.29%,TOP2A;ECT2;USP27X;BARD1;CYP1B1;ARHGEF5;PMAIP1;IAPP;E2F1;PDCD2;DAPK2;TIAM1;NET1;PTPA;APAF1;PIDD1;TFPT;TNFSF10;ARHGEF18;PHLDA3;FOXO1;FAF1;CASP2;ARHGEF3;ATM;TRADD;HDAC6;MAP3K5;UBE2Z;HMGB1;BOK;SAP18;TNFAIP8;SOS1;RNPS1;ERCC3;PRR7;MAP3K11;PAWR;MELK;ATF6;JUN;CCAR2;FAS;FGD3;RACK1;ING3;ING5;LATS1;BCL6;PSEN1;HTATIP2;CASP9;STK4;TP53;MAP3K20;TFAP4;MARK4;NLRP2B;SIRT1;ARL6IP5;ANO6;PNMA2;UBA52;LRRK2;SNCA;STK17B;RARG;ARHGEF7
prerank,engulfment of apoptotic cell (GO:0043652),-0.47698848517025705,-1.2973446284229035,0.15789473684210525,0.6451910835643001,1.0,9/15,22.86%,RHOBTB1;XKR6;RHOBTB2;RHOG;RHOH;THBS1;ADGRB1;XKR4;MEGF10
prerank,estrogen metabolic process (GO:0008210),0.644847477475805,1.2972729090005328,0.18758256274768825,0.8261004800299652,1.0,1/15,1.41%,CYP1B1
prerank,positive regulation of viral life cycle (GO:1903902),0.6080485671386956,1.296786248790546,0.16791044776119404,0.826755420160703,1.0,7/22,21.16%,TMPRSS4;CD74;TRIM11;CHMP3;CHMP2B;LGALS9;VPS4A
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6239888172088424,1.2966879188137437,0.19950433705080545,0.8256449590549468,1.0,10/19,23.89%,CCSAP;PLK1;CHMP1B;HNRNPU;CHMP3;CHMP2B;DRG1;TPR;CHMP5;EML3
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.40730905467635664,-1.2957257036679724,0.14788732394366197,0.6464349435375043,1.0,14/25,33.11%,HPRT1;PRPS2;GMPR2;PPAT;AMPD2;DCK;APRT;GART;PRPSAP2;SHMT2;AMPD3;SHMT1;PRPS1L1;PRPS1
prerank,regulation of biomineral tissue development (GO:0070167),0.5985999472961568,1.2950813039758333,0.17354368932038836,0.8310536095072044,1.0,10/26,21.87%,HEY2;FBXO5;SGMS2;TWIST1;NOTCH1;ROCK2;SOX9;ROCK1;NBR1;DDR2
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.5665703093409794,1.2942637783048712,0.14393939393939395,0.8328015331458157,1.0,16/46,17.47%,KIF14;ITGB7;ATRNL1;ATRN;LAMA5;LAMC1;LAMB2;LAMB3;ITGAV;NTNG2;NRP1;ITGA8;PARVB;PARVA;RAC1;FN1
prerank,wound healing (GO:0042060),-0.32230438549586055,-1.2939601120322457,0.06,0.648464892491774,1.0,18/62,15.90%,DST;TGFBR1;MACF1;SMAD3;AHNAK2;IGF1;FUT10;MYOF;MIA3;NF1;ITGB3;SYT7;SCARB1;EPB41L4B;HMOX1;FGF2;HPSE;DCBLD2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5665394769742103,1.2934773740015173,0.14315569487983282,0.8347419021190049,1.0,15/60,14.23%,AURKB;NEK2;MAPK1;DSCC1;RFC5;PCNA;CCT7;ATM;CCT2;TCP1;SMOC2;RFC2;CCT5;MYC;CHTF18
prerank,negative regulation of viral life cycle (GO:1903901),0.6351866090376075,1.2926662215254123,0.18628719275549807,0.8366172689864959,1.0,7/15,14.44%,SNX3;GSN;LY6E;TRIM11;IFITM3;PPIA;TRIM5
prerank,neuromuscular process (GO:0050905),0.6265619223921309,1.2924670976548522,0.18626155878467635,0.8359183101305625,1.0,7/16,21.89%,AGTPBP1;KCNA1;PAFAH1B1;TIFAB;CLN3;NRXN1;DCTN1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.6921610013654699,1.2921957152020944,0.19943422913719944,0.8355251512164769,1.0,6/10,17.28%,RUNX3;HMGB1;CBFB;ZBTB7B;RUNX1;SH3RF1
prerank,primary alcohol metabolic process (GO:0034308),0.5890644763054251,1.290685207412686,0.18224852071005918,0.8404108745332213,1.0,5/25,14.56%,LRAT;CYP1B1;NAPEPLD;RDH10;GPD2
prerank,rRNA 3'-end processing (GO:0031125),0.6752541019828576,1.2905316841040275,0.1915204678362573,0.8395232734932006,1.0,4/10,11.89%,ERI2;EXOSC8;EXOSC10;ERI1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.5456703457326934,1.290432328806886,0.12296747967479675,0.8384094175621107,1.0,21/88,16.98%,CCNF;KIF14;FBXL15;SKP2;PSMB7;PSMD11;FBXW11;PSMF1;FBXO44;PSMC1;FBXO17;PSMC3;PSMA4;FBXL4;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4
prerank,regulation of T cell chemotaxis (GO:0010819),0.6555887502363499,1.289882001648458,0.2036775106082037,0.8391484464762269,1.0,5/11,23.16%,OXSR1;CCR2;STK39;ADAM10;ADAM17
prerank,regulation of neuroinflammatory response (GO:0150077),-0.43866707138710254,-1.289737652853713,0.1641025641025641,0.6576442544398701,1.0,6/19,14.61%,TREM2;IGF1;TNFRSF1B;CD200;IL18;DAGLA
prerank,regulation of microtubule nucleation (GO:0010968),0.6809674591351172,1.2881560907398193,0.19236641221374046,0.8450113891338541,1.0,5/10,21.89%,CKAP5;MECP2;ARHGEF7;EML2;DCTN1
prerank,organelle assembly (GO:0070925),0.5289182241537149,1.2879211178742598,0.004,0.8444691343465657,1.0,102/384,18.37%,CENPF;CENPE;DLGAP5;CENPA;TMOD4;NEK2;KIF24;CENPW;EMC6;ANLN;TUBGCP6;RCC1;IFT80;EXOC2;ATG13;POC1B;PCNT;FLNA;EIF2S1;EIF2A;HAUS5;WDPCP;HAUS6;CEP83;EXOC4;TUBGCP4;BBIP1;CEP89;RAB1B;GSN;WDR90;DISC1;SSX2IP;ARF4;CSDE1;HDAC6;MAPRE3;NOTCH1;MRPL22;DYNC1H1;FUZ;RP2;CEP250;OFD1;PTPDC1;RAB8A;CFAP44;DBNL;UBQLN1;TMEM237;CYS1;FLII;EDC3;ABLIM3;PCM1;PDE6D;RFX2;TMEM41B;HAUS4;CCDC28B;BECN1;CEP162;AMBRA1;RAB8B;ABCC4;CCDC57;HAUS7;DHX29;SCLT1;RAB43;CCDC61;TUBGCP3;ARL13B;BBS4;CHMP1B;LSM14A;PIBF1;PRRC2C;EXOC5;TP53INP2;MKS1;DYNLL1;RC3H1;LIMD1;HGS;ATG101;DYNLT2B;UBAP2L;PARVA;IFT172;ATG2B;CHMP3;ATP6V0D1;IFT140;CHMP2B;BBS9;VTA1;HAUS3;TXNDC15;ATAT1;STAM;FAM161A
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4529275418737312,-1.2873687037791917,0.1689497716894977,0.6610559641860466,1.0,9/16,31.90%,TREM2;ENO1;FLCN;PINK1;SPHK2;PPARGC1A;ANTKMT;DNAJC30;AK4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.6712170801686245,1.286804623829392,0.20741758241758243,0.8475739982304854,1.0,8/11,19.50%,CCT7;CCT2;TCP1;TERF1;CCT5;DKC1;WRAP53;CCT6A
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.48905906695220996,-1.28617699120797,0.15444015444015444,0.6610711057127874,1.0,3/13,12.95%,TREM2;ENO1;PINK1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6419332049813737,1.2859933461781896,0.19635890767230169,0.8494445362906256,1.0,9/15,19.50%,NOP10;CCT7;CCT2;TCP1;RUVBL2;RUVBL1;CCT5;DKC1;CCT6A
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5353960495494221,-1.2859069889310861,0.18354430379746836,0.6587020876877163,1.0,3/10,4.82%,HK2;HK3;PFKL
prerank,monoacylglycerol metabolic process (GO:0046462),-0.49052009689339493,-1.2858152645371244,0.1647940074906367,0.6558540779187816,1.0,6/13,13.74%,MGLL;ABHD12;ABHD16A;ABHD6;MOGAT3;DGAT1
prerank,histone mRNA catabolic process (GO:0071044),0.6365972486295334,1.285614088373866,0.2069408740359897,0.8494485403698262,1.0,8/15,19.60%,ATM;EXOSC10;DCP2;TUT4;ERI1;TUT1;TENT2;XRN1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4454681642965104,-1.285386138958455,0.14814814814814814,0.654036784215237,1.0,11/16,31.02%,CACNA1C;ANK2;DMD;RYR2;CALM1;SLC8A1;ATP1A2;GSTO1;FKBP1B;CAMK2D;CALM2
prerank,regulation of dephosphorylation (GO:0035303),0.6390762691548693,1.2853551567841621,0.19613259668508287,0.8490171383532628,1.0,8/15,23.23%,SMG6;SMG5;MTMR2;CDK5RAP3;PPP1R16A;SMG7;PPP1R16B;SRC
prerank,negative regulation of B cell activation (GO:0050869),0.6015919824054354,1.284838930172634,0.18988902589395806,0.8497489402314112,1.0,7/21,17.65%,BLK;BANK1;ATM;TNFRSF13B;TYROBP;RC3H1;FCGR2B
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.43941947756705835,-1.28481060896164,0.15813953488372093,0.652525813044623,1.0,5/18,9.35%,RIMS1;RAP1B;RIMS2;PREPL;RAP1A
prerank,actin filament polymerization (GO:0030041),0.5828722809361707,1.2841336009340354,0.1772300469483568,0.8511893627961311,1.0,3/29,8.57%,DIAPH3;GSN;JAK2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5399833704464901,1.2834620311754397,0.13422131147540983,0.8525344956924853,1.0,21/73,15.41%,ANP32B;DAP;PDCD2;SENP1;APAF1;PIDD1;S100A9;TNFSF10;S100A8;CASP2;TRADD;BOK;JAK2;IFT57;BCL2L13;FAS;F3;RACK1;CFLAR;CASP9;F2R
prerank,RNA transport (GO:0050658),0.5363124749792305,1.2832386597725807,0.1344364012409514,0.8519255061295908,1.0,31/71,20.29%,CKAP5;POM121;DHX38;SLBP;U2AF1;ZFP36L1;EIF4A3;SRSF3;NUP214;HNRNPA2B1;SRSF4;NCBP1;RNPS1;CASC3;U2AF1L4;NUP188;THOC3;UPF3B;THOC5;FLOT1;THOC2;THOC7;SRSF7;CDC40;DDX39B;POLDIP3;HNRNPA1;NCBP2;SRSF2;PNPT1;TPR
prerank,regulation of macrophage cytokine production (GO:0010935),0.6400929921234865,1.2828053774037633,0.20741758241758243,0.8521688965466373,1.0,5/13,16.99%,CD74;GPRC5B;PLCG2;TGFB2;SIRT1
prerank,purine-containing compound salvage (GO:0043101),-0.5019680711667565,-1.2823532485289537,0.19133574007220217,0.6565945769978636,1.0,5/12,17.18%,HPRT1;GMPR2;AMPD2;DCK;APRT
prerank,regulation of fibrinolysis (GO:0051917),0.6431273194564091,1.282338048395619,0.22251655629139072,0.8525555442954789,1.0,2/13,3.71%,FAP;USF1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6455686081655881,1.2811945765106583,0.22116689280868385,0.8559220328837083,1.0,2/12,7.92%,IL12A;DCN
prerank,regulation of cholesterol storage (GO:0010885),-0.4563770555388228,-1.2805360544736812,0.15918367346938775,0.6586108502104516,1.0,4/15,10.86%,TREM2;ABCA1;LPL;SCARB1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.6387993201711473,1.2800957961809507,0.20671140939597316,0.8591553541072079,1.0,5/14,14.33%,DHX58;PUM2;PUM1;TLR5;USP15
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.2730780268789007,-1.279996725055885,0.09090909090909091,0.6570452873058319,1.0,44/118,22.44%,TANC2;PAK3;RUFY3;EFNA5;TNIK;LARP4;EGLN1;PPFIA2;CTNNB1;HECW1;RAP2A;KNDC1;TNFAIP3;CLASP2;CDH2;FMNL2;INF2;NF1;CDK5R1;STRIP1;POGLUT1;ARHGAP44;SPARC;FERMT2;CDK5;HMOX1;WTIP;FGF2;ZMYM6;VASH1;EPHA4;ABI2;SHANK3;MYO19;BMPER;CFL1;KIF1A;ZDHHC15;PHLDB2;SH3D19;CAPZB;TSPAN12;CEACAM1;LZTS1
prerank,synaptic vesicle membrane organization (GO:0048499),-0.45343300820504984,-1.2797590513296522,0.15,0.6546950544830703,1.0,8/17,20.34%,SYNGR1;SNAP47;STX4;STX3;STX2;STX1A;SYNGR2;AP3D1
prerank,vesicle transport along microtubule (GO:0047496),0.595809791790268,1.2796615034467427,0.18382352941176472,0.8594957770002398,1.0,10/23,19.33%,NDE1;FBXW11;DYNC1H1;PAFAH1B1;KIF13A;HAP1;KIFAP3;FYCO1;CLN3;TRAK2
prerank,DNA strand elongation (GO:0022616),0.6367348613498385,1.2796605140009827,0.20535714285714285,0.8579857603316543,1.0,7/18,16.38%,GINS1;POLA1;DCLRE1B;POLD2;POLD3;RAD50;MCM3
prerank,hematopoietic stem cell differentiation (GO:0060218),0.6837878354095288,1.2788914997092948,0.2076271186440678,0.8596254261573111,1.0,6/10,24.73%,BATF;TP53;HOXB4;LMBR1L;UFL1;MLLT3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6538383607405274,1.2760298167332005,0.20320855614973263,0.8700833178732067,1.0,2/13,3.04%,PMAIP1;VDAC2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4428108457916457,-1.2760059962526638,0.15859030837004406,0.6622862712155055,1.0,12/17,32.44%,CACNA1C;ATP1A1;ATP1B2;RYR2;ATP1B1;GJA1;SLC8A1;ATP1A2;ATP1A3;FKBP1B;GJC1;GJD3
prerank,regulation of multicellular organism growth (GO:0040014),-0.4585041348629766,-1.2751573696168683,0.16740088105726872,0.6617584889203826,1.0,3/15,7.49%,APP;IGF1;PPIB
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6371680220720243,1.2749485721125517,0.2079589216944801,0.8731100998858017,1.0,1/16,2.11%,CLDN18
prerank,eosinophil migration (GO:0072677),-0.46917063293731476,-1.274581343588101,0.1803921568627451,0.6573124747208348,1.0,5/14,32.99%,CCL4;CCL3;CCL13;CCL2;CCL5
prerank,eosinophil chemotaxis (GO:0048245),-0.46917063293731476,-1.274581343588101,0.1803921568627451,0.6573124747208348,1.0,5/14,32.99%,CCL4;CCL3;CCL13;CCL2;CCL5
prerank,positive regulation of synapse assembly (GO:0051965),-0.38936583241436473,-1.2735987094022185,0.13815789473684212,0.6569924473648617,1.0,9/27,19.27%,PTPRD;SYNDIG1;IL1RAP;CLSTN3;LRRC4B;CLSTN1;CUX2;AGRN;CLSTN2
prerank,in utero embryonic development (GO:0001701),0.585924193545917,1.2735184944084785,0.1981242672919109,0.8775820829426647,1.0,2/25,3.67%,STIL;LIG4
prerank,response to unfolded protein (GO:0006986),-0.33092806762264815,-1.2730832460812478,0.1095890410958904,0.6553966098833978,1.0,14/48,19.85%,HSP90AA1;STT3B;HSPD1;OPTN;ERN1;TM7SF3;TOR1B;HSPH1;ERP44;PRKN;HSPA5;DAB2IP;DNAJC4;HSPA13
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.4247867329717536,-1.272216984473525,0.14285714285714285,0.6549434294125356,1.0,8/19,16.18%,HS6ST3;NDST3;B3GAT3;EXT2;HS6ST2;XYLT2;EXTL3;HS3ST5
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6491369768250372,1.2713228000098618,0.19667590027700832,0.8854461712810772,1.0,5/11,11.61%,EZR;MTMR2;MSN;RDX;EIPR1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.5407982984231955,1.271317938295072,0.13697219361483007,0.8839224634137971,1.0,30/73,18.50%,EZH2;POLR1B;SMARCA5;GLMN;PPM1D;DEK;SUZ12;EPC1;CTCF;RBBP4;HDAC6;PHF19;H3-3A;BAZ1B;PHF1;PHF2;POLR1A;MECP2;DNMT1;KAT2B;POLR1F;POLR1C;JARID2;TASOR;POLR2K;TAF1C;TDG;HDAC4;TAF1D;POLR1G
prerank,termination of RNA polymerase II transcription (GO:0006369),0.5766887911362846,1.2709806463663238,0.17198177676537585,0.8839072188314661,1.0,17/33,21.85%,SLBP;SNRPF;SETX;CPSF2;NCBP1;CSTF3;SCAF8;SNRPG;PCF11;CPSF1;CLP1;TTF2;NCBP2;CPSF7;SNRPB;WDR33;PAPOLA
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5678426754673792,1.2696685340692446,0.16933638443935928,0.887768065767156,1.0,13/35,16.76%,CYP1B1;OCIAD2;CAV1;NOTCH1;JAK2;IL10RA;ADIPOR1;PIGU;EGF;F2R;HGS;JAK3;VHL
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.5782565622762629,1.2696503254456466,0.19421965317919074,0.8863171274535625,1.0,15/29,23.15%,LSM6;DCPS;EXOSC8;DCP1B;DCP2;LSM2;EDC3;LSM5;DCP1A;LSM7;CNOT6;CNOT8;CNOT7;DIS3;LSM3
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.6505824217276661,1.2690808430520475,0.23119015047879618,0.8871228460373983,1.0,8/12,19.50%,CCT7;CCT2;TCP1;CCT5;DKC1;GNL3L;WRAP53;CCT6A
prerank,negative regulation of DNA replication (GO:0008156),0.643235216446305,1.2689887817671592,0.22029372496662217,0.8860071628560456,1.0,5/13,15.74%,S100A11;GMNN;TERF1;CDAN1;WAPL
prerank,microtubule bundle formation (GO:0001578),0.5501053355268638,1.2689733702608827,0.18660812294182216,0.8845496366407478,1.0,5/42,5.95%,KIF20A;PLK1;CDK5RAP2;CFAP206;CLASP1
prerank,peptide catabolic process (GO:0043171),-0.39918246215134723,-1.2689384984843584,0.14285714285714285,0.6613019187578931,1.0,7/23,10.28%,XPNPEP1;CPQ;NPEPPS;ANPEP;IDE;ECE1;GGT5
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6000128090655028,1.268613146596333,0.19879518072289157,0.8845754410585149,1.0,6/22,14.67%,MASTL;PTPA;PPP1R11;PPP1R15A;ROCK2;GSK3B
prerank,cilium-dependent cell motility (GO:0060285),0.5988571941703467,1.2685396467202679,0.1890909090909091,0.8833519480889532,1.0,2/22,8.19%,DNAH8;CFAP44
prerank,positive regulation of chromatin organization (GO:1905269),0.6490044245926587,1.2676371976567378,0.22540983606557377,0.8855717660052371,1.0,8/12,24.85%,TERF2;H3-3A;TERF1;SIN3A;ATRX;UBE2N;MIER1;TINF2
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.5068112433348687,-1.2671754902097108,0.17689530685920576,0.6635720745118346,1.0,4/12,19.61%,TREM2;IL18;TTBK1;CCL3
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5921630024793068,1.2665077484929095,0.1949685534591195,0.8873486440414582,1.0,9/23,19.45%,PMAIP1;E2F1;YWHAH;TFDP1;TFDP2;PPP3CC;TP53;YWHAE;CASP8
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5921630024793068,1.2665077484929095,0.1949685534591195,0.8873486440414582,1.0,9/23,19.45%,PMAIP1;E2F1;YWHAH;TFDP1;TFDP2;PPP3CC;TP53;YWHAE;CASP8
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.4767490546292473,-1.2663125780880296,0.172,0.6630764343852783,1.0,6/13,18.81%,ABCA1;LPL;CDH13;FCER1G;CD36;CD81
prerank,peptidyl-serine modification (GO:0018209),0.5253561636215623,1.2661793737964335,0.07314629258517034,0.8872307420676622,1.0,42/166,14.90%,TTK;CDK1;CLSPN;MASTL;PLK1;MAPK1;AURKA;PRKCE;RPS6KA5;MAP4K1;MAPKAPK3;TLK1;TAF1;ATM;CSNK1A1;STK38L;PKN2;AKT3;CSNK1G2;PRKX;PRKCA;PRKACA;MAPK14;STK38;MARK2;MAST2;PDPK1;HIPK2;DYRK1A;VRK1;PRKCB;RPS6KA6;LMTK2;ROCK2;GRK2;PRKDC;LATS1;STK39;CDC7;SGK3;GSK3B;STK4
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.5357085047825645,1.266078169751404,0.13519091847265222,0.8860962312333961,1.0,18/86,16.23%,TTK;INHBC;MEN1;FBXL15;CCN1;UBE2O;STK11;NOTCH1;JAK2;HIPK2;SMAD4;BMPR1A;ING2;NUMA1;CREBBP;RNF111;BMP3;TGFB2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6205648256327218,1.264512759513927,0.21185372005044137,0.88967630414957,1.0,7/19,17.21%,POLR2I;POLR2A;TERF2;TERF1;ATRX;POLR2K;POLR2J
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6205648256327218,1.264512759513927,0.21185372005044137,0.88967630414957,1.0,7/19,17.21%,POLR2I;POLR2A;TERF2;TERF1;ATRX;POLR2K;POLR2J
prerank,double-strand break repair via break-induced replication (GO:0000727),0.655248521001188,1.2641234745773424,0.21991701244813278,0.8898950873856687,1.0,5/12,20.93%,CDC45;MCM6;CDC7;MCM3;MCM7
prerank,histone acetylation (GO:0016573),0.5384505884225192,1.264116609768979,0.16405433646812956,0.8884168499843279,1.0,26/69,18.52%,JADE1;NAA40;BRCA2;LEF1;EPC1;BRD8;BRD1;BRPF1;YEATS4;KAT6A;RUVBL2;RUVBL1;TAF6;BRPF3;KAT2B;HAT1;ING3;ING5;CREBBP;TADA2A;YEATS2;TADA3;TAF9;MAP3K7;PHF20;PHF20L1
prerank,regulation of phosphorylation (GO:0042325),0.5235278671838971,1.2630134091918952,0.11491935483870967,0.8916729636007918,1.0,47/120,21.01%,BARD1;CDKN2C;NUP43;POM121;NDC1;CCDC88A;GLMN;ANKLE2;PML;NUP107;CDKN2A;NUP42;CCDC88C;NUP50;PIN1;NUP214;NUP160;ZBTB7A;NUP205;EGFR;CDKN2D;SEC13;NUP188;NUP98;RANBP2;NUP210;NRP1;PRKAG2;PSEN1;DYNLL1;EGF;SLAMF8;CD24;AAAS;SIRT1;NUP37;FN1;CDKN1A;NUP85;PPP2CA;EIF6;TPR;ILK;PRKAG1;MCM7;IKBKB;ROCK1
prerank,negative regulation of cell cycle (GO:0045786),0.5260504969504659,1.2628388261092753,0.15082644628099173,0.8909003518889667,1.0,20/73,17.80%,MAD2L1;PLK1;MEN1;RB1;NPPC;CDK6;CDKN2A;GMNN;RUNX3;HPGD;IPO7;NR2F2;TAF6;PTEN;LATS1;IPO5;TFAP4;ANGEL2;NLRP2B;HEXIM1
prerank,neutrophil migration (GO:1990266),0.5367312713793948,1.2626579990394446,0.1624203821656051,0.890140984799661,1.0,5/58,5.79%,PRTN3;CD177;PECAM1;S100A9;S100A8
prerank,negative regulation of catabolic process (GO:0009895),0.5522289609413197,1.2625930309528655,0.17967914438502675,0.8889546025442961,1.0,7/47,9.21%,MAD2L1;FLNA;SNX3;AZIN1;MDM4;PIN1;EGFR
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.6300436410625979,1.262502573792459,0.1981981981981982,0.8878025086395148,1.0,8/14,18.80%,HNRNPC;BOLL;ELAVL4;MAPK14;HNRNPA0;MYD88;ANGEL2;ELAVL1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5693880843842324,1.2623223118189153,0.19362186788154898,0.8870581977696476,1.0,12/31,21.42%,MEN1;RIOX1;TWIST1;CDK6;NOTCH1;SKI;LIMD1;TRPM4;CRIM1;SUFU;SOX9;NBR1
prerank,oligosaccharide metabolic process (GO:0009311),-0.33707909743015785,-1.2618931521041579,0.0945945945945946,0.6725743051206435,1.0,18/46,23.51%,MANBA;ST8SIA1;MAN2B1;ST3GAL6;ST6GALNAC4;ST6GAL2;ST6GALNAC6;ST3GAL4;MAN2C1;MAN2B2;ST8SIA5;GLA;ST6GALNAC3;ST8SIA3;GAL3ST4;MAN1B1;B3GALT5;B3GALT2
prerank,positive regulation of cell aging (GO:0090343),0.6500875575727701,1.2602206749350426,0.21335268505079827,0.8945957970314296,1.0,5/11,16.99%,HMGA1;CGAS;CDKN2A;B2M;SIRT1
prerank,positive regulation of organelle assembly (GO:1902117),0.5599247170879273,1.2599928998744832,0.1836283185840708,0.894165293210684,1.0,16/44,20.54%,SPAG5;GPSM2;CCDC88A;ARHGAP35;DYNC1H1;FUZ;TAPT1;BBS4;NUMA1;CNOT1;CNOT6;MARK4;PIP4K2A;G3BP1;PLK4;CROCC
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.5130365073967579,-1.2599366322523509,0.2088607594936709,0.6751135943171219,1.0,3/11,12.73%,MERTK;SELENOS;AXL
prerank,thyroid hormone generation (GO:0006590),0.6511925726499546,1.259816767038193,0.23760932944606414,0.8933915203886679,1.0,3/10,18.23%,SLC5A5;CTSK;FOXE1
prerank,negative regulation of cell migration (GO:0030336),-0.26459900461067565,-1.2596145015193652,0.0,0.6731875502974335,1.0,48/137,17.85%,LDLRAD4;MITF;LRP1;TMEFF2;ADARB1;LIMCH1;PTPRG;EVL;SCAI;ADAM15;NAV3;NEXMIF;PTPRK;ARHGAP4;RAP2A;PTPRJ;RAP2B;CLASP2;CORO1C;ROBO1;BST2;AFDN;DUSP3;MIA3;NF1;ENG;ATP1B2;RAP2C;SULF1;DUSP10;FLCN;SINHCAF;RECK;PTPRT;NDRG4;SMAD7;HMOX1;FGF2;SERPINE1;GJA1;ADORA3;ACVRL1;PFN2;EPHA4;JAG1;DAB2IP;MCC;THY1
prerank,histone modification (GO:0016570),0.5213161218631251,1.2587255474805192,0.1191919191919192,0.896513955837633,1.0,33/109,19.37%,AURKB;UHRF1;EZH2;RCOR2;CCNA2;INCENP;HDAC10;RPS6KA5;MTA3;BRD8;HDAC6;EYA3;BAZ1B;SIN3B;KAT6A;EHMT1;RUVBL2;PARK7;RUVBL1;TAF6;NSD3;MTA2;SIRT7;CREBBP;EYA1;SIN3A;USP21;SIRT1;HDAC4;PHF20;PHF20L1;HDAC1;TBL1XR1
prerank,negative regulation of binding (GO:0051100),0.5300540152417242,1.258680787160966,0.15534979423868311,0.8952347659559411,1.0,27/81,19.06%,AURKB;LEF1;E2F1;AURKA;DDX11;RSF1;ZFPM1;SLPI;SP100;CAV1;DISC1;PIN1;JAK2;PARK7;SUMO1;JUN;RACK1;TFIP11;GSK3B;WAPL;TFAP4;STYX;PEX14;LRRK2;PPP1CA;GNL3L;CDKN1A
prerank,negative regulation of histone modification (GO:0031057),0.6273207114711224,1.2582128150501681,0.20526315789473684,0.8956897418586625,1.0,5/14,17.96%,BRCA1;TWIST1;TAF7;JARID2;SNCA
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.5178028098876057,1.2580767146959233,0.005,0.8947122195413227,1.0,114/497,15.93%,CENPF;DEPDC1;BIRC5;FOXM1;GFI1;MYB;HMGB2;EZH2;RCOR2;MEN1;SUV39H1;BRCA1;SMARCC2;HMGA1;DAP;HEY2;RBM15;DEAF1;LEF1;E2F1;RB1;RIOX1;RSF1;CD38;CBX5;S100A11;TWIST1;PML;BCL7A;FBXW11;TIMELESS;PA2G4;HDAC10;UBE2I;RPS6KA5;MTA3;EPC1;CTCF;SCMH1;FOXP1;DACH1;CDKN2A;NR1D1;NKAP;MBD2;FOXO1;PBXIP1;MBD1;ARID4A;GMNN;HDAC6;EIF4A3;KLF10;TAF7;NOTCH1;XRCC6;AHR;SFMBT1;SAP18;SPEN;SMARCA4;PSPC1;CIPC;CIR1;ZBTB16;TERF1;ZBTB7A;NONO;ZNF148;MECP2;PFDN5;TFDP2;CPEB3;NR2F2;ID4;KAT6A;ZEB1;TRIM33;EHMT1;ARID5B;SUMO1;SMAD4;JUN;CCAR2;TYMS;ATF5;PLCB1;IGF2BP3;CDAN1;FOXP2;BAP1;SETDB2;ZBTB33;FXR1;SP3;RACK1;NIPBL;DDIT3;LSM14A;BCL6;GSK3B;LIMS1;YEATS2;CNOT1;ATF7IP;TP53;LIMD1;POU2F1;JARID2;WAPL;TFAP4;SIN3A;TCF7L2;SAMD4A
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6189239060084138,1.2580081869334436,0.19974059662775617,0.8920648965353769,1.0,7/17,16.74%,IL2RG;IL7R;SMARCA4;SOCS2;STAT5B;IRS1;JAK3
prerank,cellular response to interleukin-7 (GO:0098761),0.6189239060084138,1.2580081869334436,0.19974059662775617,0.8920648965353769,1.0,7/17,16.74%,IL2RG;IL7R;SMARCA4;SOCS2;STAT5B;IRS1;JAK3
prerank,mRNA metabolic process (GO:0016071),0.524018893676691,1.2576364698884899,0.1510204081632653,0.8921263153316689,1.0,38/90,20.25%,SLFN14;LSM6;AURKAIP1;SCAF11;SLBP;SNRPF;U2AF1;HNRNPA2B1;DCP2;PRKACA;SRSF4;NCBP1;LSM2;NONO;CSTF3;PCBP2;HNRNPA0;LSM5;METTL16;KIN;PRMT9;HNRNPR;DXO;PCBP3;TP53;ZFP36L2;SRSF7;TCERG1;SNRPG;PCF11;PRPF8;ALKBH5;HIPK3;NCBP2;SRSF2;SF3A2;SNRPB;PNPT1
prerank,cilium movement (GO:0003341),0.548136082478176,1.2567944098346744,0.17768147345612134,0.8942136881848884,1.0,5/47,10.61%,CCDC63;SPA17;CFAP206;SPEF2;CFAP73
prerank,ribosomal small subunit assembly (GO:0000028),0.6298665302318475,1.2566823486747154,0.22236340533672172,0.8932243700480624,1.0,6/16,13.38%,RPS19;RPS14;RPS27;MRPS7;RPS5;PRKDC
prerank,pyruvate metabolic process (GO:0006090),-0.33590017061438665,-1.2554541082072155,0.11267605633802817,0.6818017305531683,1.0,19/52,14.43%,HK2;HK3;GPI;PDHX;HAGH;PFKL;ENO1;ALDOA;LDHA;TPI1;PGM1;PKM;PDHB;SLC16A3;PGAM1;PGAM4;ME1;ALDOC;HOGA1
prerank,regulation of cellular localization (GO:0060341),0.5486581976764344,1.255408550982047,0.17297297297297298,0.8971493839062411,1.0,7/46,7.70%,BLK;FOXA2;SPAG5;MAD1L1;NR1D1;GSN;DYNC1H1
prerank,protein localization to vacuole (GO:0072665),-0.4581296926790698,-1.2552101257121941,0.1724137931034483,0.6794959767519917,1.0,7/13,18.81%,RTN4;RNF128;MFSD1;SH3GLB1;GLMP;LAMTOR5;CD81
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5094132098051406,-1.2548117411632442,0.19601328903654486,0.6777715181204509,1.0,7/11,23.62%,KMT2D;CTR9;SETD1B;PRDM9;TET2;OGT;BEND3
prerank,kidney development (GO:0001822),0.5331458842338869,1.2547344155591933,0.15047021943573669,0.8984954674023097,1.0,5/65,8.34%,CENPF;LRP4;SULF2;PRKX;ZBTB16
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5831598373953112,1.254600378891801,0.215311004784689,0.8976043530064622,1.0,3/24,3.98%,CYP1B1;BRCA1;SULF2
prerank,positive regulation of microtubule polymerization (GO:0031116),0.5671295585168573,1.2540717843144489,0.20902612826603326,0.898263148205615,1.0,12/28,21.89%,CKAP5;CDK5RAP2;CLASP1;MECP2;SLAIN2;NUMA1;RAC1;DRG1;RPS3;MET;MAPT;DCTN1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.593150531800276,1.2538142695676313,0.21428571428571427,0.8978827877063913,1.0,12/20,22.17%,TNRC6C;TNRC6B;CNOT1;LIMD1;CNOT6;AGO2;HELZ;EIF6;CNOT8;CNOT7;CELF1;AGO1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5709869441000252,1.2536264176327312,0.19518072289156627,0.897180584449755,1.0,12/31,19.45%,PMAIP1;E2F1;YWHAH;TFDP1;BOK;TFDP2;CHCHD10;PPP3CC;GSK3B;TP53;YWHAE;CASP8
prerank,cellular response to dsRNA (GO:0071359),0.6059432921443806,1.2535336300095592,0.23809523809523808,0.8960935948073144,1.0,7/15,17.80%,CGAS;CAV1;PDE12;RIOK3;DHX9;FLOT1;COLEC12
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.6346175944193714,1.2533515176757068,0.2154696132596685,0.8954053502656595,1.0,5/12,23.20%,POU2AF1;MFNG;FCGR2B;GPR183;DOCK10
prerank,negative regulation of axonogenesis (GO:0050771),-0.3694969673414735,-1.2526912162400754,0.12949640287769784,0.6806316579235512,1.0,15/27,25.46%,RTN4;RUFY3;DIP2B;GDI1;PTPRS;MAG;ULK1;EFNB3;THY1;CDKL3;ULK2;MT3;MCF2;DCC;OMG
prerank,transition metal ion homeostasis (GO:0055076),0.566726601588212,1.252289811787051,0.2107728337236534,0.8984722474036102,1.0,6/28,11.37%,TFR2;CUTC;HEPH;CYBRD1;B2M;XIAP
prerank,methylguanosine-cap decapping (GO:0110156),0.6590905514227214,1.2513270075301255,0.23430962343096234,0.901091519047488,1.0,5/10,12.21%,DCPS;DCP1B;DCP2;EDC3;DCP1A
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6372620914848469,1.2512263967192474,0.23324022346368714,0.9000256280964635,1.0,3/12,10.76%,RASGRP1;PAEP;CARD9
prerank,regulation of gastrulation (GO:0010470),0.6145700078465339,1.2511364589455563,0.23128342245989306,0.8989791678744928,1.0,4/14,14.46%,FOXA2;CLASP1;RACK1;DAG1
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5764599549028273,1.2510298221000138,0.20971563981042654,0.8979534966813103,1.0,4/26,5.33%,CYP1B1;BRCA1;SULF2;CCR2
prerank,zymogen activation (GO:0031638),-0.349852552081747,-1.2504146491952133,0.11494252873563218,0.6841439383620701,1.0,8/39,11.49%,ASPH;KLK2;KLK3;VSIR;TBC1D10A;MMP14;PLAU;LGMN
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6181461929308897,1.2500673176314474,0.22306717363751585,0.9005973750564217,1.0,4/15,12.39%,NTF4;GRB2;SOS1;HAP1
prerank,negative regulation of cartilage development (GO:0061037),0.6311723596101964,1.2495140315355373,0.23140495867768596,0.9014264702186804,1.0,2/13,5.66%,ADAMTS7;PTHLH
prerank,epithelial cell differentiation (GO:0030855),0.5257344578460189,1.249509700127641,0.14852492370295015,0.90000441852986,1.0,5/88,5.61%,E2F7;CDK1;E2F8;PCNA;EDF1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3864604431451104,-1.249182355321187,0.185,0.6851334020890448,1.0,8/23,16.93%,HAVCR2;VSIR;CD274;ZC3H12A;TLR4;AXL;PRNP;RARA
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5135708909109402,-1.24847203633477,0.22151898734177214,0.6842274217107375,1.0,2/10,2.30%,SALL1;BASP1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.5035042905922653,-1.2483779179414702,0.2206896551724138,0.6816658767072367,1.0,5/10,27.58%,CD34;RAP1A;TMEM100;CEACAM1;KDR
prerank,T cell homeostasis (GO:0043029),0.6497542935467341,1.2482555812662228,0.23395149786019973,0.9037432593679928,1.0,4/10,16.74%,PMAIP1;PPP2R3C;FAS;JAK3
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6504767697342606,1.248189995014072,0.2532005689900427,0.9011412198276415,1.0,5/11,21.42%,IL2RG;IL2RA;STAT5B;JAK3;SYK
prerank,cellular response to interleukin-2 (GO:0071352),0.6504767697342606,1.248189995014072,0.2532005689900427,0.9011412198276415,1.0,5/11,21.42%,IL2RG;IL2RA;STAT5B;JAK3;SYK
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.38406174829619727,-1.2481806859384152,0.14935064935064934,0.6794517304984599,1.0,7/25,11.98%,CTSS;ANK3;ANK2;DMD;ATP1B2;COX17;ATP1B1
prerank,negative regulation of protein metabolic process (GO:0051248),0.5450750980686763,1.247429165279693,0.1961206896551724,0.9028487841172442,1.0,11/48,9.92%,MAD2L1;IAPP;FLNA;SNX3;AZIN1;MDM4;PIN1;ITGAV;VBP1;EGFR;PFDN5
prerank,cytosolic transport (GO:0016482),-0.27650132953610207,-1.2471858454571239,0.125,0.6794876626168168,1.0,41/108,22.59%,RAB14;GAK;STX6;STX16;GBF1;WDR91;SNX5;VTI1B;RAB6B;EEA1;LAMP1;VPS13C;TBC1D23;VPS50;ANKRD27;TBC1D10A;PREPL;TRIM27;TBC1D5;SNX16;CLN5;ARL1;GOSR2;WASHC1;YKT6;HOOK2;TBC1D17;GOSR1;SNX6;HOOK3;EPS15;VPS51;SORT1;MYO1D;TBC1D10B;PLEKHJ1;PTPN23;VPS26A;TMEM87B;RGP1;DOP1B
prerank,regulation of cellular response to stress (GO:0080135),0.517518905682767,1.24647327884084,0.13366834170854272,0.9053838368302062,1.0,46/115,20.29%,RPA2;NUP43;MAPK1;POM121;NDC1;NUP107;CRHBP;ABCD1;NUP42;MBTPS2;ARMT1;ATM;NUP50;NUP214;NUP160;NUP205;RPA1;SEC13;AMFR;NUP188;CCAR2;MLST8;NUP98;RANBP2;NUP210;ROCK2;ING2;CREBBP;BAG3;DNAJC7;BAG1;CASP9;RPA3;GSK3B;DNAJC2;DNAJB1;AAAS;SIRT1;NUP37;ADCY8;YWHAE;CLN3;NUP85;NPAS2;PNPT1;TPR
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5456362742165224,1.2458579503717286,0.19453551912568307,0.906594052209525,1.0,12/40,13.62%,XPO1;GLMN;PML;AXIN1;RPS7;TAF1;DESI1;HIPK2;RAD23A;PTEN;CDK5RAP3;LATS1
prerank,cilium assembly (GO:0060271),0.5129871078299578,1.2457780549623363,0.04,0.9054896766801549,1.0,92/296,18.74%,CDK1;NEK2;KIF24;CKAP5;PLK1;CDK5RAP2;IFT80;EXOC2;CEP152;NDE1;POC1B;PCNT;CFAP206;FLNA;HAUS5;WDPCP;HAUS6;CEP83;CEP192;TUBB4B;EXOC4;TNPO1;BBIP1;ODF2;CEP89;GSN;CLASP1;WDR90;DISC1;CEP72;SSX2IP;ARF4;HDAC6;CEP76;NOTCH1;ALMS1;DYNC1H1;FUZ;RP2;CEP250;OFD1;PTPDC1;RAB8A;PRKACA;CFAP44;NEDD1;GORAB;CEP70;TMEM237;CYS1;TBC1D32;ABLIM3;NINL;PCM1;PDE6D;RFX2;PAFAH1B1;HAUS4;CCDC28B;TUBB;CEP162;IFT57;RAB8B;ABCC4;CCDC57;HAUS7;SCLT1;ARL13B;BBS4;PIBF1;EXOC5;MKS1;CNTRL;DYNLL1;CEP57;KIFAP3;DYNLT2B;SDCCAG8;MARK4;PARVA;IFT172;ATP6V0D1;IFT140;BBS9;YWHAE;C2CD3;HAUS3;TXNDC15;ATAT1;FAM161A;BBOF1;CEP63
prerank,hepaticobiliary system development (GO:0061008),0.5980399850066286,1.245363692782858,0.22236024844720498,0.9058783535619553,1.0,12/20,20.81%,PHF2;ARID5B;CDK5RAP3;NIPBL;CEBPG;PRKCSH;XBP1;NKX2-8;PROX1;PKD2;MET;CITED2
prerank,microtubule anchoring at centrosome (GO:0034454),0.6453809092153895,1.2450777776885507,0.24383164005805516,0.9056304621233946,1.0,4/10,13.22%,NIN;NINL;PCM1;BBS4
prerank,tRNA modification (GO:0006400),-0.29986125224908694,-1.2447761938304231,0.13953488372093023,0.6838223812150753,1.0,31/62,27.72%,PUS10;PUS7;ANKRD16;TRMT1;DTWD2;NSUN2;DUS2;WDR4;QTRT1;ELP5;TYW5;TRMT61B;TRIT1;MTO1;TPRKB;METTL2A;METTL2B;METTL1;FTSJ1;THUMPD1;THADA;ALKBH1;TRMT10A;TRMT12;LCMT2;THUMPD2;GTPBP3;TRMT9B;TRMT13;BCDIN3D;DTWD1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5998443816045014,1.2447472543507627,0.23536895674300254,0.9055995396382169,1.0,6/18,9.72%,STMN1;RIPOR2;ARHGAP35;TNFAIP1;CUL3;HEG1
prerank,cellular response to interleukin-4 (GO:0071353),0.6550926203945877,1.2445566127397418,0.2609308885754584,0.9050049527821207,1.0,3/10,17.11%,LEF1;JAK3;XBP1
prerank,regulation of protein catabolic process (GO:0042176),0.517239165153539,1.244537571532612,0.15423901940755874,0.9036522784792427,1.0,16/99,9.21%,MAD2L1;FAM83D;BARD1;CHEK2;DTL;FLNA;AXIN1;SNX3;AZIN1;FOXO1;FAF1;MDM4;STX5;PIN1;NEDD4L;EGFR
prerank,macrophage chemotaxis (GO:0048246),-0.4986161454274738,-1.2439661521473995,0.21725239616613418,0.6832928901985568,1.0,5/10,32.99%,EDNRB;CCL3;CXCL17;CCL2;CCL5
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6430858047681444,1.2437745522862325,0.24034334763948498,0.9054464828740367,1.0,3/10,11.62%,FAP;NOTCH1;DPP4
prerank,positive regulation of phagocytosis (GO:0050766),-0.32191155642873154,-1.2434253308268266,0.1323529411764706,0.6821801380704344,1.0,9/47,6.67%,MERTK;SIRPA;TREM2;APPL2;CD300LF;IL15RA;PTPRJ;PYCARD;FCER1G
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.5168970397970868,1.2433639185988998,0.13333333333333333,0.9057354674525969,1.0,42/108,21.42%,PMAIP1;ANP32B;DAP;PDCD2;SENP1;APAF1;PIDD1;S100A9;TNFSF10;S100A8;CASP2;GSN;TRADD;MAP3K5;HMGB1;BOK;JAK2;PRR7;CARD9;IFT57;BCL2L13;FAS;FIS1;F3;RACK1;UACA;MYC;CFLAR;CASP9;F2R;SIRT1;ARL6IP5;SNCA;MALT1;RPS3;LGALS9;GRAMD4;CASP8;DAPK1;RIPK1;MAPT;SYK
prerank,carbohydrate transport (GO:0008643),0.6334841968190977,1.2429601299935455,0.240981240981241,0.9059868582978364,1.0,1/11,1.86%,AQP1
prerank,macrophage activation involved in immune response (GO:0002281),-0.4681928981313768,-1.2426708602623822,0.2178988326848249,0.6814684902361183,1.0,5/13,7.83%,TREM2;SBNO2;GRN;CX3CR1;NMI
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.583931756084945,1.2412517082766128,0.21933085501858737,0.911618350109001,1.0,7/23,15.40%,PLK1;MAPK1;AXIN1;UBE2K;S1PR2;PRKAG2;EGF
prerank,positive regulation of intracellular protein transport (GO:0090316),0.5153807330920167,1.2407006317130025,0.09729187562688064,0.9126082029394084,1.0,41/144,17.55%,KIF20B;ECT2;GTSE1;PMAIP1;ANP32B;E2F1;C2CD5;ATG13;FYN;PCNT;FLNA;SAE1;YWHAH;TFDP1;UBL5;CIB1;EFCAB7;ABLIM3;TFDP2;PCM1;RHOU;EMD;FIS1;OAZ1;BAP1;RAC2;BAG3;PSEN1;ARIH2;PPP3CC;GSK3B;RIPOR1;TP53;PDCD10;IPO5;TCF7L2;TRIM28;XPO4;TMEM30A;HCLS1;YWHAE
prerank,protein import into peroxisome membrane (GO:0045046),0.5818620066100533,1.240498189792226,0.24,0.9120414947784816,1.0,9/22,12.06%,PEX26;ABCD1;ACBD5;PEX11B;PXMP4;GDAP1;PEX2;RAB8B;FIS1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5920647563141213,1.2403390752680865,0.22303921568627452,0.911302647243661,1.0,5/21,9.89%,MASTL;PTPA;PPP1R11;PPP1R8;PPP1R15A
prerank,apical junction assembly (GO:0043297),0.5409156366008324,1.2394695477860103,0.20126448893572182,0.9134435833413569,1.0,6/53,8.99%,ECT2;CLDN18;PECAM1;CTNNA1;PKN2;STRN
prerank,cytoplasmic translation (GO:0002181),0.5183443097371326,1.2393084137842372,0.14169215086646278,0.9127118432053227,1.0,45/91,22.90%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;RPL28;RPL41;RPS14;RPS27;RPS5;RPS29;RPLP0;RPS11;TMA7;RPL27A;RPS15A;RPS9;RPL12;RPL22L1;ZC3H15;RPL3;RPL18;GSPT1;UBA52;DRG1;RPS17;RPS6;RPL5;RPS3;RPL21;RPL23;RPL17;RPL8;RPL24;RPL27;RPL13A;RPS12;RPS8;RPL15;RPL10
prerank,response to molecule of bacterial origin (GO:0002237),0.519366363205483,1.2392369831121783,0.1792452830188679,0.9115649875334904,1.0,17/69,17.96%,IL12A;HMGB2;PTPN22;S100A9;MAPKAPK3;SLPI;FOXP1;S100A8;JAK2;CYRIB;HNRNPA0;OTUD5;F2R;TNFRSF11A;CD24;FCGR2B;SNCA
prerank,base conversion or substitution editing (GO:0016553),0.6319312622381338,1.2392287196590186,0.24397163120567375,0.9102014579127246,1.0,1/11,0.80%,ADAD1
prerank,positive regulation of secretion (GO:0051047),0.6435133922055581,1.239201733074247,0.25666199158485276,0.9089061442732328,1.0,1/11,1.86%,AQP1
prerank,heme biosynthetic process (GO:0006783),0.5880562106814609,1.2391203730376394,0.23067632850241546,0.9078496364158514,1.0,13/22,28.59%,ALAS2;ABCB10;TSPO;NFE2L1;COX10;PPOX;UROS;FXN;CPOX;COX15;PGRMC1;ALAS1;ATP5IF1
prerank,regulation of membrane repolarization (GO:0060306),0.6263169352769852,1.2389935047534413,0.24022346368715083,0.9070030871673341,1.0,4/13,17.55%,CAV1;NEDD4L;KCNJ2;YWHAE
prerank,sensory organ development (GO:0007423),0.534199445473582,1.2389338683621716,0.2051009564293305,0.9058419224128249,1.0,11/51,16.23%,NTF4;SMCHD1;PBX4;PBX3;SHROOM2;SALL2;HIPK2;ATF6;SMG9;PBX2;TGFB2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6408132714128773,1.238287546995743,0.2563739376770538,0.9069816185410159,1.0,3/11,11.57%,BLK;PRKCA;RDX
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6225639385075163,1.2381681384211676,0.23829201101928374,0.9060601835089405,1.0,4/13,10.78%,BARD1;SP100;RANGAP1;PARK7
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5635377657500531,1.237459489357428,0.23176470588235293,0.9075793900669361,1.0,5/26,8.13%,RRM2;RRM1;ALG8;RRM2B;ST3GAL2
prerank,hexose biosynthetic process (GO:0019319),-0.32092155808406464,-1.2373829001979435,0.13846153846153847,0.6933084081211308,1.0,18/42,23.11%,GPI;GOT2;ENO1;ALDOA;AKR1B1;ATF4;TPI1;PGM1;PGAM1;G6PC3;SLC25A11;ALDOC;SLC39A14;PER2;ENO2;CRY1;PPARGC1A;ENO3
prerank,regulation of glucose import (GO:0046324),-0.362772805123335,-1.2373308222407382,0.17985611510791366,0.6907206944381133,1.0,10/30,14.99%,APPL2;PRKCI;PIK3R1;IGF1;AKT2;IRS2;GSK3A;SELENOS;RHOQ;GRB10
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.5606402966181063,1.237158023577455,0.21288837744533948,0.9073757682999533,1.0,15/31,23.15%,LSM6;DCPS;EXOSC8;DCP1B;DCP2;LSM2;EDC3;LSM5;DCP1A;LSM7;CNOT6;CNOT8;CNOT7;DIS3;LSM3
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.45508701188530226,-1.2368604048905192,0.19245283018867926,0.6893755377090258,1.0,7/14,24.99%,UPP2;NT5M;DPYD;UMPS;NT5C;DHODH;NT5E
prerank,histone H2B ubiquitination (GO:0033523),-0.5207274836475839,-1.236041449250653,0.2636986301369863,0.6888663023779393,1.0,4/10,5.75%,WAC;UBE2E1;CTR9;DTX3L
prerank,regulation of lipid kinase activity (GO:0043550),0.6391807402864763,1.2357285725048979,0.24358974358974358,0.9118796178704917,1.0,3/11,5.73%,RB1;RBL1;PPP2R5A
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.5265812678143273,1.2354987352119815,0.18305439330543932,0.9114175258380222,1.0,17/59,15.76%,CDK1;CIT;MAPK1;OXSR1;CHEK1;TAF1;PRKCA;MARK2;PDPK1;HIPK2;DYRK1A;LMTK2;ROCK2;PRKDC;STK39;GSK3B;MAP2K1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.45879023958017096,-1.2352913692968193,0.21804511278195488,0.688171858962547,1.0,6/14,17.02%,TREM2;GRN;IGF1;TNFRSF1B;CD200;CST7
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.5010718081318999,-1.2352879150585458,0.1879432624113475,0.6854801917456638,1.0,9/11,41.60%,ITPKB;IP6K1;FGF2;IPPK;IPMK;ITPKC;ITPKA;IP6K2;IP6K3
prerank,regulation of epithelial cell migration (GO:0010632),-0.31557302116663216,-1.2349057574249211,0.19402985074626866,0.6837542501876666,1.0,24/51,22.77%,RTN4;GLUL;MACF1;PTPRG;EVL;RREB1;BMPR2;ENPP2;PFN1;CLASP2;CORO1C;DUSP10;PPM1F;RAB11A;PTK2;PFN2;DAB2IP;MCC;BMPER;PTPN23;CEACAM1;HYAL1;CAPN7;HIF1A
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5441134462500319,1.23435631223619,0.22184300341296928,0.9148079204086877,1.0,9/35,14.67%,MASTL;ITGA1;PTPA;PPP1R11;PPP1R15A;PPP6R3;PPP1R2;PPP1R12A;GSK3B
prerank,positive regulation of protein sumoylation (GO:0033235),0.6544148839544481,1.2341976097214473,0.23487031700288186,0.9140978453523023,1.0,5/10,18.01%,SAE1;UBA2;PIAS3;PIAS1;HDAC4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5888417743724758,1.2334613085404704,0.2313167259786477,0.9158589057751866,1.0,4/21,10.16%,CHST3;CSGALNACT2;DCN;CHST12
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.42749906611184507,-1.2334563525400715,0.185,0.6853028854098154,1.0,5/19,14.35%,HSPD1;TLR7;MAVS;TLR4;CHUK
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6519266942954716,1.2332207777823851,0.24720670391061453,0.9155013731012541,1.0,7/10,19.50%,CCT7;CCT2;TCP1;CCT5;DKC1;WRAP53;CCT6A
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.4574334505273732,-1.2327811192047928,0.2178988326848249,0.6844468274988521,1.0,13/14,54.30%,ECE1;CORIN;ENPEP;RASL10B;AVPR2;ACE;OXTR;EDN3;EDN2;AVPR1A;ACE2;AGTR1;EDN1
prerank,axon development (GO:0061564),-0.3011047439805115,-1.2323953834375379,0.047619047619047616,0.6828609392796744,1.0,31/78,24.09%,RTN4;PAK3;APP;ANK3;PLP1;ZDHHC17;CAMSAP2;DSCAML1;NTNG1;RYK;S100B;BAIAP2;MAP1A;CDK5R1;CTNNA2;ACTB;CDK5;GAP43;L1CAM;MAP1S;LLGL1;ADGRB1;SVBP;MAPK8IP3;AFG3L2;RAB3A;PARD3;SLITRK4;BRSK2;DCC;ATL1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6320499280358669,1.2323894085864884,0.26676176890156916,0.9175764890930105,1.0,3/11,16.84%,STMN1;NRP1;RAC1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.49619411633702293,-1.2314962110811345,0.20216606498194944,0.6826043526160092,1.0,5/11,9.28%,OGFOD1;EGLN1;P4HA1;P3H2;EGLN3
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.39391423976019047,-1.2313140895548982,0.1893491124260355,0.6804220355063494,1.0,6/21,10.30%,TREM2;LRP1;APOE;PLTP;ZDHHC8;GPS2
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.45656752829756264,-1.2311021449627908,0.19838056680161945,0.6783366932433013,1.0,5/13,17.40%,LTBP1;FSTL1;FBN1;GREM2;CD46
prerank,positive regulation of apoptotic process (GO:0043065),0.5103662494755437,1.2310402403763478,0.045,0.9216366474558604,1.0,68/293,18.29%,TOP2A;ECT2;USP27X;BARD1;CYP1B1;ARHGEF5;PMAIP1;IAPP;E2F1;PDCD2;DAPK2;FAP;TIAM1;NET1;PTPA;APAF1;PIDD1;TFPT;TNFSF10;ARHGEF18;PHLDA3;FOXO1;FAF1;CASP2;ARHGEF3;ATM;TRADD;MAP3K5;UBE2Z;HMGB1;BOK;SAP18;TNFAIP8;SOS1;RNPS1;ERCC3;PRR7;MAP3K11;PAWR;MELK;ATF6;JUN;CCAR2;FAS;FGD3;RACK1;ING3;ING5;DDIT3;LATS1;BCL6;PSEN1;CASP9;STK4;TP53;MAP3K20;TFAP4;TGFB2;NLRP2B;SIRT1;ARL6IP5;ANO6;PNMA2;UBA52;SNCA;STK17B;RARG;ARHGEF7
prerank,regulation of erythrocyte differentiation (GO:0045646),0.5441287286558185,1.2310165292695714,0.2122587968217934,0.9203566616108205,1.0,9/35,13.38%,HMGB2;ZFPM1;ABCB10;CDK6;BRD1;ZFP36L1;MAPK14;STAT5B;PRKDC
prerank,innate immune response in mucosa (GO:0002227),0.6570488688528919,1.2306242878465319,0.2556497175141243,0.9204894950207253,1.0,1/10,3.71%,CAMP
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5101864601804755,1.2304028846055928,0.036,0.9200870784419481,1.0,83/314,18.14%,CCNF;BUB1B;KIF14;CDK1;UBE2C;AURKB;MAD2L1;CCNB1;CDC20;PLK1;FBXL15;SKP2;RB1;AURKA;FBXO5;PSMB7;PSMD11;PML;CDC23;FBXW11;CDC27;PSMF1;TAF1;FAF1;NPLOC4;FBXO44;PSMC1;ANAPC7;FBXO45;BIRC2;SPSB3;UBE2K;UBE4B;NEDD4L;DNAJC18;FBXO17;FAF2;UBQLN1;TNFAIP1;CUL3;PTTG1;PSMC3;DERL2;PCBP2;AMFR;RAD23A;UBR2;PSMA4;SPSB4;TRIM3;FZR1;FBXL4;ARRB2;PSMC4;PCNP;BUB3;NFE2L2;PSMD13;SPOP;PSME1;DDIT3;RHBDD2;DCAF11;ZFAND2B;PSMB1;RBCK1;ARMC8;PSMD8;YOD1;PSME4;DNAJB9;KLHL22;PSMD4;SIRT1;RNF103-CHMP3;UBXN1;RNF4;HSP90B1;UBA52;FAM8A1;SYVN1;FEM1C;UBE2G1
prerank,regulation of macrophage activation (GO:0043030),-0.3549124525760625,-1.2295907938292878,0.15,0.6798419891619686,1.0,11/30,20.41%,PJA2;LRFN5;MFHAS1;HSPD1;ZC3H12A;TLR4;TNIP2;CD200;IL31RA;THBS1;MYO18A
prerank,mononuclear cell differentiation (GO:1903131),0.568351376555874,1.229545855098695,0.2460220318237454,0.9222303831677832,1.0,2/24,1.16%,BLK;LY6D
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.40625008741235646,-1.2294197234588211,0.1875,0.6776723138784843,1.0,6/19,16.08%,PATJ;PRKCI;ERBIN;DLG2;LRRC7;DLG1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5362292710365887,1.2282474278042825,0.21766561514195584,0.9261155393522805,1.0,17/55,21.03%,FOXM1;CYP1B1;BRCA1;DCXR;ARF4;MAPK14;GRB2;DHRS4;RAC2;MPV17;TP53;RAC1;SNCA;CDKN1A;PAX2;EIF6;RIPK1
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5862824271088876,1.2280548874607187,0.23572296476306198,0.9255339845851569,1.0,6/22,15.02%,TNFRSF18;FANCA;IL2RA;CBFB;BCL6;RUNX1
prerank,histone H3-K9 demethylation (GO:0033169),-0.5010108675018292,-1.2279948332412416,0.2188679245283019,0.679038378089419,1.0,5/11,6.91%,KDM1A;KDM7A;KDM4A;PHF8;KDM4B
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6112805974769366,1.227608231003784,0.2588075880758808,0.9258936593792645,1.0,1/13,0.73%,IL12A
prerank,filopodium assembly (GO:0046847),0.5997586358877791,1.227469447333817,0.24199743918053776,0.9250762811321402,1.0,5/16,12.56%,PPP1R9B;EZR;FGD6;FGD3;S1PR2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.5575707790397678,1.2271000066866085,0.2290909090909091,0.9251577766500838,1.0,6/25,17.96%,CD19;NPSR1;PDPK1;F2R;PLCG1;SNCA
prerank,transepithelial transport (GO:0070633),-0.4430464535734143,-1.22656101583677,0.2170212765957447,0.6804618816025234,1.0,11/15,36.81%,SLC12A2;SLC1A2;ABCC1;SLC1A3;CXADR;GPLD1;SLC1A1;SLC26A6;SLC23A1;SLC23A2;BEST1
prerank,regulation of monocyte differentiation (GO:0045655),0.6041450171365632,1.2265583411368113,0.2655440414507772,0.92603096562571,1.0,5/14,13.91%,CD74;FOXP1;CDK6;ZFP36L1;MYC
prerank,neurotrophin signaling pathway (GO:0038179),0.5864081624796976,1.2264223021232807,0.25,0.9252063126993563,1.0,5/21,12.39%,NTF4;KIDINS220;GRB2;SOS1;HAP1
prerank,response to interleukin-4 (GO:0070670),0.6495057085441989,1.2260119378485643,0.2622478386167147,0.9255584677884755,1.0,3/10,17.11%,LEF1;JAK3;XBP1
prerank,steroid metabolic process (GO:0008202),0.517436826138077,1.2260039899169857,0.1845672575599583,0.9242260062705725,1.0,10/72,13.00%,HSD17B3;SRD5A2;CYP1B1;LSS;CYP2A6;GBA2;TSPO;CYP27A1;CYP46A1;DHRS4
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5317095623894054,1.2259680348402608,0.23034330011074197,0.9229853930241709,1.0,11/37,14.93%,PMAIP1;S100A9;RPS7;CAV1;S100A8;BOK;BECN1;FIS1;RACK1;DDIT3;TP53
prerank,amide transport (GO:0042886),0.5716834264888552,1.2258305046848905,0.22894424673784106,0.9222459006246986,1.0,5/26,11.20%,SLC38A5;ABCA13;SLC14A2;TAP1;SLC19A1
prerank,cellular response to interleukin-6 (GO:0071354),-0.3737104928477614,-1.225090485834585,0.18354430379746836,0.6819196784313108,1.0,8/26,12.34%,SBNO2;CTR9;ST3GAL6;RELA;SELPLG;SPI1;PTPRT;STAT3
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.603869189556651,1.2249269700075929,0.25,0.9245049314777183,1.0,1/16,0.73%,IL12A
prerank,plasma membrane invagination (GO:0099024),0.5544674378255066,1.2248501483611705,0.2491186839012926,0.923439129840904,1.0,5/29,8.00%,AURKB;ALKBH4;SNX33;GSN;SNX9
prerank,regulation of store-operated calcium entry (GO:2001256),-0.5017029777195684,-1.224479523602135,0.2569444444444444,0.6810691294556095,1.0,4/10,19.94%,CD84;SLC8B1;SARAF;STIM1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.6449817677230432,1.2240459592444881,0.24895104895104894,0.9240356096014575,1.0,1/10,7.90%,CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.6449817677230432,1.2240459592444881,0.24895104895104894,0.9240356096014575,1.0,1/10,7.90%,CEP250
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5256541350199634,1.223972535274259,0.19042769857433808,0.9230134603196437,1.0,19/72,19.16%,SHCBP1;MAPK1;POLR2I;POLR2A;FLRT2;HNRNPM;SETX;GRB2;NCBP1;FGF9;SPRED2;CEP57;FGFR1;FIBP;POLR2K;POLR2J;KIF16B;HNRNPA1;NCBP2
prerank,cardiac ventricle development (GO:0003231),0.5841812162243567,1.223349754490154,0.24968789013732834,0.9242712998414798,1.0,4/20,7.16%,HEY2;MDM4;PDE2A;NOTCH1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.6439906062118163,1.222557325405611,0.2525399129172714,0.9260402439961146,1.0,5/10,19.13%,DHX58;NPLOC4;RIOK3;GPATCH3;SEC14L1
prerank,actin-myosin filament sliding (GO:0033275),0.535562934862383,1.2221259169617793,0.22812846068660023,0.9251493248873751,1.0,6/38,16.48%,DES;MYL1;MYBPC1;ACTN2;TPM4;VIM
prerank,muscle filament sliding (GO:0030049),0.535562934862383,1.2221259169617793,0.22812846068660023,0.9251493248873751,1.0,6/38,16.48%,DES;MYL1;MYBPC1;ACTN2;TPM4;VIM
prerank,positive regulation of cell junction assembly (GO:1901890),-0.306379303374567,-1.2221176864286099,0.10869565217391304,0.6849924422092892,1.0,19/56,20.67%,CNTNAP2;PTPRD;SYNDIG1;PTPRJ;IL1RAP;CLSTN3;LRRC4B;CLSTN1;TSC1;CUX2;FERMT2;PPM1F;NPHP1;VEGFA;MAP4K4;COL16A1;THY1;CLSTN2;AGT
prerank,organelle fusion (GO:0048284),-0.3731943292479325,-1.2217398946613887,0.17346938775510204,0.683441567048018,1.0,12/22,29.33%,EEA1;STX4;MFN2;MIEF1;MIGA2;MFF;SPG7;VPS11;AFG3L2;USP30;MFN1;MIEF2
prerank,negative regulation of interleukin-17 production (GO:0032700),0.634272669848226,1.2215681754567997,0.2600297176820208,0.9260677463645962,1.0,1/10,0.73%,IL12A
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.4861642409681553,-1.2213879198904587,0.22058823529411764,0.6819354271536764,1.0,5/12,13.39%,RIMS1;RIMS2;SYT1;SYT7;UNC13A
prerank,lymphocyte chemotaxis (GO:0048247),-0.3465989428470131,-1.220542302519382,0.14393939393939395,0.6818978859188122,1.0,11/34,32.99%,SLC12A2;PIK3CD;CCL15;CH25H;CCL4;CCL3;CCL14;CYP7B1;CCL13;CCL2;CCL5
prerank,pancreas development (GO:0031016),0.613578662921378,1.2203199406838068,0.27041499330655955,0.9299154859722399,1.0,1/12,0.89%,NKX6-1
prerank,epithelial cell migration (GO:0010631),0.5352542317412567,1.2198729166488154,0.2348993288590604,0.9304753759182404,1.0,7/37,12.89%,CYP1B1;ANLN;FAP;PKN2;PRKX;DPP4;NRP1
prerank,positive regulation of developmental growth (GO:0048639),-0.31357778536593806,-1.219248503195136,0.17647058823529413,0.6827461968569328,1.0,14/49,15.98%,RIMS1;RUFY3;RIMS2;MACF1;MAP3K13;SYT1;PPIB;LIMK1;PLAA;SYT4;GOLGA4;UNC13A;L1CAM;AGRN
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6112568783932253,1.2179961237427672,0.2614980289093298,0.9367501465922969,1.0,7/13,20.79%,TNRC6C;TNRC6B;CPEB3;CNOT1;EIF4ENIF1;AGO2;CNOT7
prerank,modulation by host of symbiont process (GO:0051851),0.5568912506620654,1.2179183935992097,0.22441860465116278,0.9357138021072978,1.0,14/31,23.97%,AQP1;LEF1;NUCKS1;SMARCA4;NAPEPLD;CARD9;JUN;CCNT1;TFAP4;HDAC1;CHD1;TAF11;TARDBP;HMGA2
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.48480255017364615,-1.2177562222279519,0.24561403508771928,0.6844103417578148,1.0,4/10,9.37%,APOE;ABCA1;PRKACB;ZDHHC8
prerank,epiboly involved in wound healing (GO:0090505),0.6063509019146862,1.217502052128833,0.2516297262059974,0.9360325733875338,1.0,6/16,14.97%,FLNA;CCN1;CD44;ARHGAP35;TOR1A;PDCD10
prerank,epithelial to mesenchymal transition (GO:0001837),0.5235368571630928,1.216991451524782,0.2198505869797225,0.9367454762684634,1.0,16/47,21.74%,FAM83D;HEY2;LEF1;NOTCH1;ROCK2;HNRNPAB;GSK3B;LIMS1;FGFR1;TASOR;TGFB2;TRIM28;SOX9;RBPJ;ROCK1;AKNA
prerank,regulation of protein kinase activity (GO:0045859),0.5106402589777669,1.2169488356787648,0.16902834008097167,0.9355747584490401,1.0,26/106,17.96%,CENPE;ECT2;RB1;CCN1;MMD2;SMG8;MMD;MAPRE3;TAF7;XRCC6;MRNIP;CEP85;TAB1;SNX9;PDPK1;PARK7;RELN;PRKAG2;ADCYAP1;PPIA;DTNBP1;TARBP2;PAK2;SIRT1;IQGAP1;SNCA
prerank,positive regulation of binding (GO:0051099),0.5149027271052818,1.2169291595379308,0.18800813008130082,0.9343361323533429,1.0,27/84,15.91%,HMGB2;MEN1;STMN1;DDX11;TIAM1;EPB41;CAV1;EDF1;TAF1;GMNN;PIN1;HMGB1;NCBP1;TXN;HIPK2;AMFR;B2M;DHX9;FLOT1;ADD2;SKI;CEBPG;PSEN1;GSK3B;STK4;EGF;TCF7L2
prerank,cellular response to interleukin-12 (GO:0071349),0.5267518591741794,1.2167832076639196,0.21336206896551724,0.9336056832701287,1.0,13/48,16.20%,IL12A;LMNB1;CD47;CNN2;TCP1;HNRNPA2B1;JAK2;MSN;RPLP0;PLCB1;PPIA;PAK2;MTAP
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6039845126612507,1.2163126104726159,0.266839378238342,0.9341228764667868,1.0,8/15,22.23%,TNRC6C;TNRC6B;CPEB3;CNOT1;EIF4ENIF1;AGO2;CNOT7;TENT4A
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.5829895562081624,1.2162412880962157,0.25728155339805825,0.9317257443817818,1.0,7/23,14.60%,MEN1;STK11;HIPK2;SMAD4;ING2;CREBBP;RNF111
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.5829895562081624,1.2162412880962157,0.25728155339805825,0.9317257443817818,1.0,7/23,14.60%,MEN1;STK11;HIPK2;SMAD4;ING2;CREBBP;RNF111
prerank,response to thyroid hormone (GO:0097066),-0.4519703776444808,-1.215683865107964,0.22393822393822393,0.6875093253293271,1.0,3/13,0.68%,CTSS;LMO2;CTSB
prerank,histone H3 acetylation (GO:0043966),0.5375003445715325,1.215531532383632,0.24172185430463577,0.9332803606332978,1.0,15/40,17.74%,JADE1;BRCA2;LEF1;BRD1;BRPF1;KAT6A;BRPF3;KAT2B;ING5;PHF14;TADA2A;YEATS2;TADA3;TAF9;MAP3K7
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.44500251718309863,-1.2153025787423037,0.2209737827715356,0.6860538612224891,1.0,8/15,13.76%,SRPRA;SPCS2;ZFAND2A;RAB3GAP2;RYR2;SEC61G;SEC61A1;SRPRB
prerank,mesenchyme development (GO:0060485),-0.4340315247753218,-1.2152929412742268,0.22897196261682243,0.6835898418503024,1.0,2/15,3.12%,TGFBR1;BMPR2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6358756472728513,1.2147888094540555,0.24963503649635035,0.9350155530342353,1.0,4/11,13.71%,CAV1;NEDD4L;ACTN2;STK39
prerank,plasma membrane repair (GO:0001778),-0.4619325300032856,-1.2141864940770624,0.24125874125874125,0.6843249120041538,1.0,7/13,29.09%,AHNAK2;MYOF;SYT7;RAB3A;ANXA6;DYSF;SYT11
prerank,atrial septum development (GO:0003283),0.6098579497184987,1.2141036273280483,0.2833562585969739,0.9364366394001334,1.0,3/13,5.93%,HEY2;ZFPM1;MDM4
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.5748551262171884,1.2140790016217493,0.24231678486997635,0.9352108461098467,1.0,1/22,0.14%,SHCBP1
prerank,gene expression (GO:0010467),0.5000301994247832,1.2139842443235638,0.044,0.9342878711879647,1.0,131/348,21.45%,MRPL36;ADAD1;NR4A2;NUP43;RPL7;POM121;E2F1;RPL18A;SMG6;NDC1;RPS20;DHX38;MRPL18;RBM3;POLR2I;SMG5;NUP107;POLR2A;RPL36;RPL14;SLBP;EPC1;RPS19;RPS7;NUP42;RPS4X;HNRNPL;RPS18;MRPL10;NUP50;UPF2;PTMA;SETX;CPSF2;U2AF1;RPL23A;DNAJB11;EIF4A3;ELAVL4;SRSF3;NUP214;RPL28;HNRNPA2B1;MRPL37;RPL41;RPS14;TSPAN33;NUP160;RPLP2;SRSF4;NCBP1;NUP205;RNPS1;CASC3;RPS27;U2AF1L4;MRPL51;MRPS7;MRPL43;SEC13;RPS5;DHPS;RBMS2;NUP188;RPS29;RPLP0;RPS11;MRPS17;IGF2BP3;RPL27A;THOC3;NUP98;RANBP2;UPF3B;NUP210;RPS15A;THOC5;RPS9;HNRNPU;PRPF4;TFIP11;MRPL24;RPL12;THOC2;DARS1;SNRNP40;POLR2K;AAAS;THOC7;SRSF7;CDC40;NUP37;DDX39B;RPL3;POLR2J;POLDIP3;RPL18;CPSF1;GSPT1;CLP1;DRG1;TSPAN5;DKC1;ALKBH5;YARS2;RPS17;NKX2-8;RPS6;RPL5;NCBP2;NUP85;RPS3;DDX54;RPL21;AGO2;GOLPH3;SRSF2;SRBD1;RPL23;RPL17;TPR;FYTTD1;SYNCRIP;SMG7;MMS19;WDR33;GLE1;RPL8;RSL24D1;RPL24;RPL27
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5271633322037959,1.2138683417718124,0.2305229455709712,0.9334288246560299,1.0,14/49,16.77%,KIF14;IAPP;MEFV;LCMT1;PMEPA1;HDAC6;HMGB1;RIOK3;PARK7;TFIP11;GSK3B;AIDA;NLRC3;NLRP2B
prerank,organic substance transport (GO:0071702),0.5048546384591336,1.2131535111990097,0.1743951612903226,0.9350443992402122,1.0,25/121,18.55%,CENPF;ABCA13;NDC1;RAMP1;SLC6A2;RCN3;ABCD1;TAP1;PICK1;ABCA2;NME4;ABCA7;CALCRL;SLC19A1;ATP8A1;SLCO2A1;CHMP1B;VPS33B;SCAMP1;CHMP3;CHMP2B;ARL6IP5;HSP90B1;SLC22A4;RUFY1
prerank,regulation of myoblast fusion (GO:1901739),0.6355967996663596,1.21221041693165,0.2917251051893408,0.9375229035117174,1.0,4/11,13.96%,RIPOR2;MAPK14;FLOT1;CFLAR
prerank,positive regulation of neuron differentiation (GO:0045666),0.5408591747764849,1.2121473702771548,0.2290748898678414,0.9364403218367517,1.0,10/40,16.06%,ECT2;GPRC5B;MMD2;TCF3;MMD;ZEB1;NRCAM;SIN3A;TCF4;FGFR1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5641001345027223,1.2121307771397523,0.25058823529411767,0.9351867598244532,1.0,11/27,22.74%,AQP1;E2F1;LIG4;CD74;CDK6;DHX9;MYC;FN1;CDKN1A;DDR2;S100A6
prerank,axonal transport (GO:0098930),0.5368302952704399,1.2119776892521905,0.241917502787068,0.934482163558532,1.0,8/36,14.41%,KIF4A;BLOC1S4;FBXW11;DYNC1H1;PAFAH1B1;AP3M2;HAP1;DTNBP1
prerank,neurogenesis (GO:0022008),0.528853095341963,1.2117167328430092,0.24395604395604395,0.9342925558120796,1.0,14/43,21.52%,CIT;CDK5RAP2;WDR62;CDK6;HAP1;METTL14;THOC2;LPAR1;TGFB2;CXCR4;TRAK2;BTBD1;MAPT;BTBD2
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5571707392870416,1.2116630115063292,0.24334140435835352,0.9331990596354724,1.0,6/25,13.38%,HMGB2;ABCB10;BRD1;MAPK14;STAT5B;PRKDC
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.5162898389951915,1.2115677573732562,0.23101604278074866,0.9323082004135587,1.0,19/52,19.82%,PMAIP1;E2F1;ATG13;SAE1;YWHAH;TFDP1;UBL5;ABLIM3;TFDP2;RHOU;BAP1;RAC2;ARIH2;PPP3CC;TP53;YWHAE;CASP8;SREBF2;HPS4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.4674327907547755,-1.211419187734456,0.27058823529411763,0.6897960223669362,1.0,5/12,27.52%,ZC3H12A;STAT3;LIN28B;BCDIN3D;ZC3H10
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4923888166981386,-1.2109119746097243,0.23208191126279865,0.6886374398963012,1.0,3/10,25.23%,SH2B3;MAPK7;KLF4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5886350464378386,1.21082941076747,0.2635561160151324,0.9341040657080449,1.0,4/16,14.59%,DDIAS;CDKN2D;CCAR2;TPT1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5279236072601694,1.2105346757864066,0.22017353579175705,0.934060900514381,1.0,12/46,16.20%,IL12A;LMNB1;CNN2;TCP1;HNRNPA2B1;JAK2;MSN;RPLP0;PLCB1;PPIA;PAK2;MTAP
prerank,negative regulation of phosphatase activity (GO:0010923),0.5617850184617348,1.21041761359081,0.2564705882352941,0.9332216203551954,1.0,7/25,16.23%,MASTL;PTPA;PPP1R11;PPP1R15A;PPP1R35;GSK3B;TGFB2
prerank,calcium ion transmembrane transport (GO:0070588),-0.2890158901202875,-1.2099654672267603,0.1,0.6887695289787997,1.0,27/86,20.93%,SLC24A3;TRPM3;CACNA1C;TRPC5;MCOLN1;NALCN;SLC8A3;MCUR1;TRPC4;TRPC1;SLC8B1;TMEM165;PKD1;LETM1;MCOLN3;ATP2B3;SPG7;TRPV4;SLC8A1;TRPC3;STOML2;MAIP1;CACNA1G;PMPCA;ORAI1;P2RX4;AFG3L2
prerank,modification-dependent protein catabolic process (GO:0019941),0.5051848851516464,1.2093893641867,0.103,0.9359495604701842,1.0,55/193,18.66%,BUB1B;UBE2C;AURKB;MAD2L1;UHRF1;CDC20;PLK1;AURKA;DTL;PSMD11;PPP1R11;CDC23;UBE2I;CDC27;PSMF1;TAF1;NPLOC4;ANAPC7;FBXO45;BIRC6;UBE2K;UBE4B;UBE3B;NEDD4L;UBQLN1;CUL3;LONP1;KCTD21;PTTG1;UBE3C;AMFR;RNF168;MIB1;RNF8;SPSB4;CNOT4;FZR1;FBXL4;BUB3;FBXO11;PSMD13;ARIH2;RNF20;RNF111;RC3H1;MYLIP;UBE2R2;XBP1;RNF19A;UBA52;SYVN1;FEM1C;UBE2G1;RBBP6;RNF43
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4993762726024118,-1.209275644489093,0.23125,0.6880967084509788,1.0,3/10,5.03%,SIRPA;PTPRS;PYCARD
prerank,mucosal immune response (GO:0002385),0.604359853963365,1.2087615677282635,0.25673940949935814,0.9371270338280805,1.0,1/15,3.71%,CAMP
prerank,apical protein localization (GO:0045176),-0.48767845582750774,-1.2086626890624554,0.23,0.6872854133422635,1.0,6/10,15.49%,ATP8B1;SHROOM3;INSC;ACTB;GOPC;MAL
prerank,regulation of actin filament-based movement (GO:1903115),-0.49881183276876817,-1.2081119295862464,0.2507936507936508,0.6863688316225872,1.0,2/10,7.62%,ANK2;SRI
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.42613246732587406,-1.2075447508785961,0.22083333333333333,0.6831953249429259,1.0,5/14,20.63%,ABCC1;HMOX2;SLCO2B1;HMOX1;BLVRA
prerank,heme catabolic process (GO:0042167),-0.42613246732587406,-1.2075447508785961,0.22083333333333333,0.6831953249429259,1.0,5/14,20.63%,ABCC1;HMOX2;SLCO2B1;HMOX1;BLVRA
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.4577876728770662,-1.2075100818635922,0.20503597122302158,0.6808797671660146,1.0,7/13,32.70%,SYNGR1;SHISA6;GRIK2;RAB3A;SHISA7;SLC8A2;PPFIA3
prerank,ganglion development (GO:0061548),-0.4785419705647405,-1.2070455107770286,0.2765957446808511,0.6798053987353271,1.0,4/11,14.87%,NRP2;CTNNB1;FZD3;SEMA3A
prerank,nucleus organization (GO:0006997),0.5288537589554737,1.2070370779619206,0.21753246753246752,0.9426115808434982,1.0,14/47,17.26%,CEP55;NDC1;REEP4;SUN2;RPS19;NUP205;IRAG2;TOR1A;NUP98;CHMP1B;NUMA1;SYNE1;CHMP3;CHMP2B
prerank,regulation of presynapse assembly (GO:1905606),-0.4186853609962806,-1.206870921599542,0.18840579710144928,0.675623731585249,1.0,3/18,2.35%,APP;LRFN5;PTPRD
prerank,regulation of presynapse organization (GO:0099174),-0.4186853609962806,-1.206870921599542,0.18840579710144928,0.675623731585249,1.0,3/18,2.35%,APP;LRFN5;PTPRD
prerank,regulation of cell development (GO:0060284),0.5369552024379012,1.2055314592417712,0.25112107623318386,0.9473303912008256,1.0,4/36,5.80%,HMGB2;HEY2;RPS19;FOXO1
prerank,phospholipid biosynthetic process (GO:0008654),0.5421677071826241,1.2045321150069803,0.22058823529411764,0.9500187280657547,1.0,12/36,18.76%,DHDDS;SGMS2;AGPAT4;PCYT2;NUS1;IDI1;AGPAT3;SGMS1;FDPS;SRD5A3;FAR1;CLN3
prerank,inhibitory synapse assembly (GO:1904862),-0.47791887395013277,-1.2036606819834093,0.238562091503268,0.6818889955756674,1.0,5/11,14.65%,GABRB3;GABRG2;GABRA2;LGI2;GABRA1
prerank,RNA 3'-end processing (GO:0031123),0.5113611499629281,1.2034636742293499,0.21294363256784968,0.9530464300013259,1.0,35/69,22.23%,DHX38;CPSF2;U2AF1;EIF4A3;SRSF3;SRSF4;NCBP1;RNPS1;CASC3;U2AF1L4;CSTF3;TUT4;RPRD1B;THOC3;UPF3B;THOC5;THOC2;THOC7;SRSF7;CDC40;TUT1;DDX39B;POLDIP3;PCF11;CPSF1;CLP1;TENT2;NCBP2;SRSF2;CPSF7;PNPT1;RPRD2;WDR33;PAPOLA;TENT4A
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.6176080459729834,1.2030739705116025,0.2719298245614035,0.953365035903733,1.0,8/11,24.44%,DNMT1;SETDB2;ATF7IP;TASOR;TRIM28;SETDB1;TPR;RESF1
prerank,sprouting angiogenesis (GO:0002040),0.5216632283689628,1.2024932509233937,0.2329059829059829,0.9543868763848768,1.0,3/51,4.68%,E2F7;E2F8;PGF
prerank,negative regulation of bone mineralization (GO:0030502),0.6009275986929793,1.201877245363869,0.2750677506775068,0.9555574667737282,1.0,1/13,1.49%,RFLNB
prerank,protein modification by small protein conjugation (GO:0032446),0.49407846051295556,1.2015916128069515,0.051,0.9554284173815194,1.0,102/361,17.81%,CCNF;UBE2C;UBE2T;UHRF1;TRIM58;BARD1;RFWD3;PLK1;RNF26;BRCA1;FBXL15;MEFV;NUP43;POM121;NDC1;SAE1;NUP107;CDC23;FBXW11;MKRN1;UBE2I;CDC27;PCNA;RANGAP1;NUP42;UBA2;BCL11A;NUP50;TRAIP;MSL2;ANAPC7;FBXO45;UBE2Z;DDRGK1;NUP214;BIRC6;UBE2K;NEDD4L;TRIM11;RAD18;RNF157;NUP160;KLHL9;NUP205;TNFAIP1;ASB1;CUL3;PIAS3;CBLL1;TRIM47;AMFR;TRIM33;NUP188;TRIM44;NSMCE2;SUMO1;UBR2;RTF1;RNF168;MIB1;RNF8;SPSB4;PEX2;EIPR1;CNOT4;TRIM68;CDK5RAP3;ARRB2;NUP98;PCNP;RANBP2;RNF152;FBXO11;CUL9;NUP210;NFE2L2;RACK1;PRKDC;NFX1;SUMO2;ARIH2;RNF20;TRIM5;RNF111;VCPIP1;EYA1;PIAS1;MYLIP;TRIM28;UBE2R2;AAAS;VHL;SIRT1;TRPM4;RNF103-CHMP3;NUP37;PEX14;CAND2;UBA52;USP7;UBE2M;SYVN1
prerank,negative regulation of mRNA processing (GO:0050686),0.593161759612271,1.2009972635111545,0.2799479166666667,0.9565943675484583,1.0,6/15,16.68%,BARD1;SAP18;SRSF4;RNPS1;SRSF10;SRSF7
prerank,regulation of synapse maturation (GO:0090128),0.6222241900768714,1.2003572043569595,0.2867756315007429,0.9578412528030024,1.0,2/10,11.01%,CDC20;RELN
prerank,cellular response to reactive oxygen species (GO:0034614),0.5112384793842587,1.199635210329601,0.25341745531019977,0.9594294326799645,1.0,24/59,23.18%,ECT2;CYP1B1;AQP1;MAPK1;NET1;SETX;HDAC6;MAP3K5;EGFR;PARK7;JUN;NFE2L2;MPV17;ERCC6L2;SIRT1;RPS3;PAX2;PKD2;RIPK1;MAPT;PLEKHA1;PXN;OSER1;PRKCD
prerank,aortic valve morphogenesis (GO:0003180),0.5385975626859384,1.1994193083846618,0.27842227378190254,0.9589811753684805,1.0,10/30,22.30%,HEY2;RB1;TWIST1;NOTCH1;SLIT3;ROCK2;ELN;SOX9;ROCK1;EFNA1
prerank,regulation of peptidase activity (GO:0052547),0.5723742002886577,1.1993598197793944,0.25475285171102663,0.9579094489183124,1.0,3/19,5.32%,NRDC;RCN3;CAV1
prerank,positive regulation of macroautophagy (GO:0016239),-0.3193657619868012,-1.1990574890475119,0.1791044776119403,0.69215743035538,1.0,16/48,19.17%,WAC;SCOC;SPTLC1;PIP4K2B;PRKAA2;OPTN;GNAI3;SH3GLB1;RAB3GAP2;IRGM;PINK1;SESN3;UVRAG;TSC2;ADRB2;VPS13D
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5066527049188658,1.1985225472504242,0.20649895178197064,0.9599561570123227,1.0,11/72,11.11%,TPX2;STMN1;IAPP;CLASP1;CIB1;CYRIB;VBP1;PFDN5;LIMA1;DYRK1A;SMAD4
prerank,regulation of striated muscle contraction (GO:0006942),-0.3582172710294752,-1.1981434971734979,0.20567375886524822,0.6919492414830591,1.0,10/27,20.00%,ANK2;SLC8A3;SRI;DMD;RYR2;SMAD7;ASB3;CALM1;ATP1A2;P2RX4
prerank,protein targeting to ER (GO:0045047),0.5023642838468851,1.1978903247274142,0.17922606924643583,0.9611211744103223,1.0,48/99,22.95%,RPL7;RPL18A;RPS20;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;RPL23A;RPL28;SPCS1;RPL41;RPS14;RPLP2;RPS27;GET3;RPS5;RPS29;RPLP0;RPS11;RPL27A;RPS15A;RPS9;ZFAND2B;RPL12;RPL3;RPL18;SEC63;UBA52;RPS17;RPS6;RPL5;RPS3;RPL21;RPL23;RPL17;SPCS3;RPL8;RPL24;RPL27;SEC62;RPL13A;RPS12;RPS8;RPL15;RPL10;SRP68
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5538158446955325,1.1968659554927668,0.27304550758459745,0.9638475941290611,1.0,3/26,9.30%,CYP1B1;DDAH2;ABCA2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.4745238724837706,-1.1965267355153815,0.26353790613718414,0.6940504946452922,1.0,5/11,25.09%,CSNK1E;CSNK1D;RSPO3;WNT5B;NKD1
prerank,mRNA catabolic process (GO:0006402),0.5241935842431913,1.1964584076860918,0.25161290322580643,0.9642284618017631,1.0,17/44,22.17%,SLFN14;LSM6;PDE12;EXOSC10;DCP2;LSM2;TUT4;LSM5;METTL16;DXO;RC3H1;ZFP36L2;THRAP3;XRN1;PNPT1;DHX34;AGO1
prerank,determination of left/right symmetry (GO:0007368),0.5296917168103163,1.1964328016500594,0.24745762711864408,0.9630283886178869,1.0,3/36,7.95%,STIL;NOTCH1;OFD1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6311268129059913,1.195851414305996,0.28924418604651164,0.9640876166225145,1.0,4/10,17.96%,BRCA1;TAF7;SIRT1;SNCA
prerank,regulation of nervous system process (GO:0031644),-0.40722742816295787,-1.1956984408152185,0.21524663677130046,0.6938220164110004,1.0,5/18,9.45%,APP;DLGAP4;HTR2C;SLC8A3;DLGAP2
prerank,actomyosin structure organization (GO:0031032),0.5060287112507973,1.1943807716672032,0.2268041237113402,0.9686784896661568,1.0,14/75,13.07%,CIT;TMOD4;ALKBH4;CSRP3;EPB41;SORBS1;MYH10;CSRP1;FLII;TNFAIP1;CUL3;ACTN2;FAM171A1;ROCK2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5197181035047881,1.194239851894963,0.24312431243124313,0.9679696778303439,1.0,8/42,16.69%,RBM15;OXSR1;CCR2;GPR75;CIB1;STK39;GPR35;CCL25
prerank,negative regulation of secretion (GO:0051048),0.6396787301536927,1.1935014793706973,0.2943786982248521,0.9696107351174718,1.0,4/10,15.40%,ERBB3;CD74;TIFAB;EGF
prerank,actin filament bundle organization (GO:0061572),0.542658217558051,1.1934850373435224,0.2460136674259681,0.9683774583847284,1.0,7/33,13.46%,RFLNB;EZR;NEDD9;SHROOM2;LIMA1;PAWR;ADD2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.4432692759624928,-1.193254775552646,0.2708333333333333,0.6983826987808349,1.0,4/13,18.53%,HSP90AA1;PTS;CALM1;PRKG2
prerank,negative regulation of histone acetylation (GO:0035067),0.6146458933020177,1.192971393722667,0.3045897079276773,0.9691613860486465,1.0,5/11,17.96%,BRCA1;TAF7;SIN3A;SIRT1;SNCA
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.45744329304890713,-1.1928335242589398,0.24723247232472326,0.6972161570803497,1.0,3/12,0.68%,CTSS;LMO2;CTSB
prerank,regulation of glycolytic process (GO:0006110),0.506335536487098,1.1924142891949963,0.24765868886576484,0.9701553596232977,1.0,28/68,21.96%,NUP43;POM121;NDC1;NUP107;NUP42;NUP50;NUP214;ENTPD5;NUP160;ZBTB7A;NUP205;SEC13;NUP188;NUP98;RANBP2;NUP210;PRKAG2;PSEN1;AAAS;NUP37;HDAC4;ZBTB20;NUP85;EIF6;TPR;PRKAG1;CBFA2T3;NUP93
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.4591831857406323,-1.1921381098843988,0.2556390977443609,0.6967022670545004,1.0,9/12,22.61%,SEC61A2;SGTA;SEC61G;SEC61A1;SGTB;HSPA5;CHMP4B;CHMP4A;SEC61B
prerank,peptide cross-linking (GO:0018149),0.55338524005421,1.1919818837018128,0.2781065088757396,0.9706430325681373,1.0,4/25,17.63%,EPB42;ABCA7;FN1;F13A1
prerank,positive regulation of protein import (GO:1904591),0.5409039552781987,1.1917090852641379,0.2735632183908046,0.97040518347231,1.0,9/30,17.50%,ECT2;ARHGEF5;FLNA;EFCAB7;BAG3;PSEN1;IPO5;TRIM28;HCLS1
prerank,regulation of ERAD pathway (GO:1904292),-0.4763856368231646,-1.1909907951515701,0.24758842443729903,0.6975523993016529,1.0,5/11,16.96%,RNF185;USP19;BAG6;ATXN3;TMEM259
prerank,peptide biosynthetic process (GO:0043043),0.4954805365974886,1.1908608365299997,0.15515515515515516,0.972567125729169,1.0,60/153,22.90%,MRPL36;RPL7;RHD;RPL18A;RPS20;MRPL18;RPL36;RPL14;RPS19;RPS7;RPS4X;RPS18;MRPL10;RPL23A;RPL28;MRPL37;RPL41;RPS14;RPLP2;RPS27;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;RPLP0;RPS11;MRPS17;IGF2BP3;RPL27A;RPS15A;RPS9;MRPL24;RPL12;PCSK1;DARS1;RPL3;RPL18;GSPT1;YARS2;RPS17;RPS6;RPL5;RPS3;RPL21;AGO2;SRBD1;RPL23;RPL17;RPL8;RSL24D1;RPL24;RPL27;RPL13A;MRPS12;RPS12;RPS8;RPL15;RPL10
prerank,regulation of platelet aggregation (GO:0090330),0.5720955998965013,1.189771511790436,0.2816166883963494,0.975785617168053,1.0,2/17,8.08%,BLK;PRKCA
prerank,glycosphingolipid metabolic process (GO:0006687),-0.30826906093924494,-1.189755104575294,0.1686746987951807,0.6983468072988335,1.0,15/42,21.63%,HEXB;CTSA;PSAP;ST8SIA1;LARGE1;ST6GALNAC6;B4GALNT1;GALC;ST8SIA5;CERK;GLA;ST6GALNAC3;CLN6;ST8SIA3;GLB1
prerank,apoptotic cell clearance (GO:0043277),-0.35700245913740986,-1.1895702678132873,0.18604651162790697,0.6965675651035731,1.0,14/30,20.04%,TREM2;LRP1;RHOBTB1;XKR6;RHOBTB2;ITGB3;SCARB1;RHOG;TGM2;RHOH;RARA;THBS1;ADGRB1;XKR4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.545124719219143,1.1895476414279962,0.2718786464410735,0.9754009705681338,1.0,12/29,23.73%,E2F1;TAF15;HNRNPU;PAIP1;EIF4ENIF1;ELAVL1;THRAP3;TENT5D;DHX34;YBX1;GDNF;CIRBP
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.5811825062725082,1.1890141291156073,0.27939317319848295,0.9761790625273457,1.0,12/16,26.11%,DCPS;SNRPC;SNRNP200;CWC15;PSIP1;SART1;NCBP2;WBP11;DDX23;RBM22;SFSWAP;PRPF39
prerank,lipoprotein transport (GO:0042953),-0.4851988837598204,-1.1890126934836323,0.2415902140672783,0.6958091620950619,1.0,5/10,20.30%,LRP1;ZDHHC17;MIA3;CD36;UNC119B
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.619958353360482,1.1886813389889137,0.30272596843615496,0.976256101063904,1.0,1/10,1.41%,CYP1B1
prerank,negative regulation of developmental process (GO:0051093),0.5077028746371596,1.1885668403428868,0.24293193717277486,0.9754153874586445,1.0,10/69,7.73%,FOXM1;ANP32B;HEY2;SUZ12;TFRC;CDK6;BCL11A;NOTCH1;SFMBT1;FUZ
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5447345300286489,1.1885272482734688,0.27986348122866894,0.9742810428661345,1.0,13/29,19.03%,MEN1;LEF1;TCF7L1;SMARCA4;TLE4;RUVBL1;BCL9L;CREBBP;MYC;RBBP5;TCF7L2;TLE3;HDAC1
prerank,gluconeogenesis (GO:0006094),-0.31061393950640553,-1.1881779349855088,0.208955223880597,0.6956106372719387,1.0,17/39,23.11%,GPI;GOT2;ENO1;ALDOA;ATF4;TPI1;PGM1;PGAM1;G6PC3;SLC25A11;ALDOC;SLC39A14;PER2;ENO2;CRY1;PPARGC1A;ENO3
prerank,synaptic vesicle endocytosis (GO:0048488),-0.342078328949336,-1.1880297353643912,0.16666666666666666,0.6937395363625498,1.0,13/33,15.39%,DNM2;OPHN1;GAK;SYNJ1;SYNJ2;SNAP91;DNM3;SYT1;VAMP2;CDK5;STX1A;PIP5K1C;PACSIN1
prerank,vasculogenesis (GO:0001570),0.5391847541751343,1.1879758958373963,0.26674500587544064,0.9752191832868526,1.0,5/32,7.16%,HEY2;GLMN;CAV1;CCM2;NOTCH1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2752158485563452,-1.187616000015803,0.1111111111111111,0.6925057727464503,1.0,25/78,16.08%,NUMB;TREM2;LRP1;SQSTM1;DPP10;BCL2L1;VTI1B;STX4;PRKCI;PIK3R1;STX3;ZDHHC5;MMP14;AR;ZDHHC8;VAMP8;RHOG;ACTB;CLIP3;CDK5;PTPN9;AP2M1;RHOQ;PPFIA1;DLG1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3524239713099588,-1.187537950147049,0.20270270270270271,0.6904363809460163,1.0,7/29,17.48%,APP;SYNGR1;APOE;SHISA6;GRIK2;CAMK2B;DLG4
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5207350817161762,1.1872780804941157,0.24532453245324531,0.9766482318795056,1.0,22/44,23.82%,FTO;ZFP36L1;TNRC6C;TNRC6B;CPEB3;PUM1;METTL16;ROCK2;CNOT1;RC3H1;METTL14;ZFP36L2;EIF4ENIF1;AGO2;CNOT8;PNPT1;PRR5L;CNOT7;ROCK1;CELF1;ZC3HAV1;MEX3D
prerank,embryonic organ development (GO:0048568),0.5075964241270114,1.1865640143545462,0.24973544973544973,0.9782894507355269,1.0,6/61,3.80%,STIL;HEY2;TEAD4;PBX4;ZFPM1;PBX3
prerank,regulation of protein binding (GO:0043393),0.4973700699394269,1.186164470166332,0.20080726538849647,0.9785763732534621,1.0,43/114,21.01%,AURKB;PLK1;MEN1;AURKA;DDX11;TIAM1;ZFPM1;EPB41;SLPI;CAV1;TAF1;DISC1;PIN1;PRKACA;MARK2;HIPK2;AMFR;PARK7;B2M;CRK;RACK1;FLOT1;ADD2;TFIP11;PSEN1;GSK3B;STK4;TCF7L2;STYX;LDLRAP1;PEX14;SPPL3;LRRK2;PPP1CA;HDAC4;GNL3L;CDKN1A;AKTIP;STK3;PPP2CA;PRMT7;BTBD1;ROCK1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.5097099322842241,1.1857851342398067,0.2368692070030896,0.9787471167946447,1.0,20/65,17.79%,AURKB;AURKA;PSMB7;PSMD11;PSMF1;CHEK1;PSMC1;NABP2;PSMC3;PSMA4;CDK5RAP3;PSMC4;PSMD13;PSME1;PABIR1;PSMB1;PSMD8;PSME4;PSMD4;AVEN
prerank,regulation of synapse assembly (GO:0051963),-0.3191392894748597,-1.1857773239940104,0.16666666666666666,0.6931133659179458,1.0,9/46,11.74%,APP;LRFN5;PTPRD;SYNDIG1;IL1RAP;CLSTN3;LRRC4B;CLSTN1;CUX2
prerank,peroxisomal membrane transport (GO:0015919),0.5448640456784581,1.1855634410685048,0.2826855123674912,0.9783493742880285,1.0,12/27,18.82%,PEX26;ABCD1;ACBD5;PEX11B;PXMP4;GDAP1;PEX2;RAB8B;FIS1;PEX14;ATAD1;ABCD4
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.48643924395441995,-1.1854401715976972,0.3010033444816054,0.6917767370715509,1.0,3/10,15.08%,CACNB2;SRI;CALM1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.27206631985095076,-1.185110671753826,0.08571428571428572,0.6903516364238511,1.0,19/75,12.98%,CSF1R;DGKH;SYNJ1;PLA2G15;GPCPD1;ABHD12;PLCB2;PLA2G7;GDE1;PIGB;PIGN;HDHD5;ABHD6;CRLS1;AGK;PIGX;PIGP;ABHD3;PLA2G6
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.45108431634347,-1.18493830282332,0.25448028673835127,0.6885774635530609,1.0,6/12,25.15%,PARP6;PARP16;PARP2;TNKS2;PARP3;TNKS
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.38734805627150737,-1.184936201565278,0.23036649214659685,0.6863610721500665,1.0,11/21,16.18%,HS6ST3;NDST3;HS3ST4;B3GAT3;EXT2;SULF1;HS6ST2;XYLT2;EXTL3;HPSE;HS3ST5
prerank,anion transmembrane transport (GO:0098656),0.4960819075498768,1.1848638838767604,0.2365702479338843,0.9799595555009432,1.0,17/67,18.09%,SLC38A5;SLC25A21;SLC25A12;SLC7A1;SLC6A5;SLC16A12;SLC35A2;SLC35A1;LRRC8B;LRRC8C;SLC19A1;SLC25A22;SLC35C2;SLC25A13;SFXN1;ARL6IP5;SLC35B1
prerank,bicellular tight junction assembly (GO:0070830),0.5235275302700853,1.1844207653085055,0.2521459227467811,0.9804466417985653,1.0,3/46,2.62%,ECT2;CLDN18;PECAM1
prerank,regulation of interleukin-12 production (GO:0032655),0.5134911243650166,1.1841138630004457,0.2647702407002188,0.9803500763969135,1.0,10/47,13.81%,MEFV;CD47;IL16;FOXP1;HMGB1;MAPK14;PLCG2;MAST2;PLCB1;PIBF1
prerank,mesenchymal cell development (GO:0014031),0.5711629906029269,1.1836645625661848,0.31056701030927836,0.9808259193300513,1.0,5/18,11.60%,HEY2;PEF1;NOTCH1;TCOF1;TAPT1
prerank,retinal metabolic process (GO:0042574),0.6092061090340353,1.1827921422560275,0.2887139107611549,0.9830737708333245,1.0,2/12,13.10%,CYP1B1;RDH10
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.505223121606919,1.1816619364213243,0.2236842105263158,0.9862212660005337,1.0,22/87,19.16%,SHCBP1;MAPK1;POLR2I;CD44;POLR2A;FLRT2;HNRNPM;SETX;ZFP36L1;GRB2;NCBP1;FGF9;SPRED2;CEP57;ZFP36L2;FGFR1;FIBP;POLR2K;POLR2J;KIF16B;HNRNPA1;NCBP2
prerank,regulation of cell size (GO:0008361),0.548515086052084,1.1813948277098587,0.27884615384615385,0.9859928586790494,1.0,10/23,18.10%,EZR;RAP1GAP2;MTPN;LARS1;MSN;RDX;PTEN;LAMTOR4;RAC1;RARG
prerank,regulation of cellular metabolic process (GO:0031323),0.517886919444586,1.1812980228578684,0.2600216684723727,0.9850594566199772,1.0,9/45,14.72%,FOXM1;CYP1B1;PANK2;AGPAT1;ARF4;ABCA2;FASN;FLOT1;MPV17
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.617091479169657,1.1807709224107839,0.2875,0.9858960344178669,1.0,4/11,12.98%,DDX11;SMARCA4;NOL11;SIRT7
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.49846985608465466,1.1805543312677134,0.2435500515995872,0.9854847896651054,1.0,6/63,5.06%,IL12A;SLC7A1;TNFSF13B;CD38;CD74;TFRC
prerank,second-messenger-mediated signaling (GO:0019932),0.49635847680091283,1.1805213391962854,0.2310838445807771,0.9843249113604902,1.0,21/82,17.85%,CXCR5;PPP1R9B;SAMD14;DDAH2;RCAN3;CCR2;INPP5A;GUCY1A1;PLCG2;NUDT4;PDPK1;CCR6;BTK;DGKD;CHRM3;MCU;PLCG1;TRPM4;MCTP1;CXCR4;LRRK2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.5359625397801349,1.1803207066203973,0.2952941176470588,0.9838313652154592,1.0,13/27,21.87%,TNRC6B;PUM2;EGFR;PUM1;DHX9;FXR1;TP53;LIMD1;MAP2K1;EIF4ENIF1;AGO2;RIPK1;EIF4E2
prerank,regulation of cell morphogenesis (GO:0022604),-0.3466719623590796,-1.1799294186325395,0.2184873949579832,0.6970708608486523,1.0,11/30,14.51%,EFNA5;MACF1;MYO9A;LARP4;NTNG1;FMNL2;STRIP1;SPARC;FERMT2;WTIP;ZMYM6
prerank,positive regulation of vascular permeability (GO:0043117),0.5974724066073415,1.1798417826405436,0.28843537414965986,0.984488777984,1.0,3/12,6.74%,FGFBP3;TJP3;PDE2A
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.6043635252145727,1.1780387458832773,0.3056338028169014,0.9904163945716434,1.0,3/12,14.80%,EZH2;ASXL1;CNOT1
prerank,regulation of cytokine production (GO:0001817),0.4921539028759149,1.1773538043437934,0.18875502008032127,0.9919341384984158,1.0,23/126,13.77%,ERMAP;RNF26;PLA2R1;POLA1;CD47;GLMN;BATF;PPP1R11;CCN4;RPS6KA5;FOXP1;AGPAT1;CCR2;TRAF3;NFAM1;MAPK14;MAST2;ASB1;BTN3A3;CARD9;IGF2BP3;FLOT1;BCL6
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.34301713187223537,-1.1771953277247058,0.19642857142857142,0.7023125072111889,1.0,9/30,14.44%,CACNA1C;SCN1A;ANK2;ATP1A1;SNTA1;SCN1B;RYR2;FGF12;GJA1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5011053510268938,1.176778517460221,0.24145077720207253,0.9929533306183066,1.0,26/70,22.51%,KIF14;ITGB7;RB1;ATRNL1;ATRN;LAMA5;LAMC1;LAMB2;LAMB3;ITGAV;NTNG2;RELN;ARL13B;NRP1;ITGA8;PARVB;PARVA;RAC1;FN1;TBCD;PROX1;ILK;ITGA4;EFNA1;PXN;ACTN1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.3445132067295281,-1.1766651070254077,0.17699115044247787,0.7015743858360449,1.0,15/35,28.26%,BMP2K;MKLN1;SNAP91;PPT1;TNK2;PIK3CB;SMAP1;SERPINE1;APOC1;HIP1R;ARF1;AAK1;VTN;PICALM;ARF6
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.6019317773955465,1.1766372543969656,0.3141711229946524,0.9921717266194803,1.0,1/13,0.72%,GFI1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5234540366786608,1.1762920675802706,0.29194630872483224,0.9922500126894785,1.0,5/36,5.80%,FOXM1;MEN1;EZR;PTPN22;FOXO1
prerank,cellular response to pH (GO:0071467),-0.425309934473495,-1.1760430790221719,0.271889400921659,0.7010029670595993,1.0,8/17,22.57%,IMPACT;MCOLN1;SLC9A1;RAB11FIP5;GPLD1;HYAL1;PKD2L1;CHP1
prerank,positive regulation of stem cell proliferation (GO:2000648),0.5686983693981373,1.1759038051975585,0.2746566791510612,0.9925947544602288,1.0,2/17,2.65%,CCNE1;PDCD2
prerank,positive regulation of protein maturation (GO:1903319),0.609821651685966,1.17521471642817,0.28904109589041094,0.9940362925104314,1.0,2/11,14.84%,TFR2;CCBE1
prerank,erythrocyte development (GO:0048821),0.614858051700142,1.1751658346248242,0.31759656652360513,0.9929739850183271,1.0,3/10,9.03%,ALAS2;ABCB10;ZBTB7A
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.49080388772324723,-1.174805920892679,0.2724458204334365,0.7017508196057065,1.0,5/10,14.06%,KDM1A;CTNNB1;CX3CR1;FZD3;VEGFA
prerank,positive regulation of lymphocyte activation (GO:0051251),0.5322696144952612,1.1740875830868842,0.2705202312138728,0.9959300831977823,1.0,7/28,14.50%,IL12A;CD47;CCR2;XRCC6;CYRIB;PRKDC;TYROBP
prerank,regulation of interferon-gamma production (GO:0032649),0.49261531061659913,1.1736787902260684,0.2346193952033368,0.9962510620605901,1.0,13/71,14.15%,IL12A;CD2;CD47;ZFPM1;PTPN22;CCR2;RASGRP1;HMGB1;CYRIB;IL1R1;DDIT3;CEBPG;IL27
prerank,vesicle transport along actin filament (GO:0030050),0.5725564403214713,1.1731824295804554,0.30614805520702637,0.996946768536915,1.0,2/19,2.62%,MYO5C;MYO15A
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.37900333768196315,-1.1731581022734567,0.23204419889502761,0.7040421479593952,1.0,8/19,18.44%,CSF1R;CMKLR1;AKIRIN1;MPP1;PTK2;CSF1;MDK;THBS1
prerank,regulation of histone modification (GO:0031056),-0.4333057675980357,-1.1731425321543536,0.2648221343873518,0.7018400734058923,1.0,4/13,10.06%,PARG;AKAP8L;MTHFR;FLCN
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.34012672207870986,-1.1726270931105307,0.1484375,0.7009691943367681,1.0,15/31,20.24%,TANC2;PPFIA2;CDK5R1;ARHGAP44;CUX2;CDK5;CAMK2B;EPHA4;ABI2;LRP8;SHANK3;CAPRIN1;CFL1;KIF1A;ZDHHC15
prerank,neuron apoptotic process (GO:0051402),0.5682210520050192,1.172303618865914,0.2742927429274293,0.9991536303186939,1.0,3/19,3.67%,CIT;ERBB3;LIG4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.5476490350383693,1.1718410773990624,0.284325637910085,0.9997427571666048,1.0,5/25,10.78%,HEY2;RB1;TWIST1;ZBTB7A;PARK7
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5353083390487289,1.1717502958549193,0.2869047619047619,0.9988235990435038,1.0,6/27,7.08%,MAPK1;FBXW11;IKBKG;CCDC88C;CCM2;MAP3K5
prerank,regulation of dendrite extension (GO:1903859),-0.3920720598311669,-1.1716272010149031,0.2608695652173913,0.7014263717890018,1.0,6/18,13.39%,RIMS1;RIMS2;SYT1;PLAA;SYT4;UNC13A
prerank,regulation of mononuclear cell migration (GO:0071675),-0.36516918206758775,-1.171299529179568,0.24358974358974358,0.7001835209734766,1.0,5/23,2.97%,CSF1R;CMKLR1;STK10;AKIRIN1;AIF1
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5940680390550015,1.171268250233827,0.32083333333333336,0.9994368644437753,1.0,2/11,7.54%,KLRD1;AHR
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.556182650329434,1.1712202504395046,0.3079710144927536,0.9983544449630074,1.0,7/21,20.63%,MEFV;FYN;BIRC2;DELE1;USP50;EPHA7;AIM2
prerank,L-amino acid transport (GO:0015807),0.52808930147914,1.1711643184164215,0.2927669345579793,0.99732392483376,1.0,3/28,2.84%,SLC38A5;SLC25A12;SLC7A1
prerank,connective tissue development (GO:0061448),0.5249907921649907,1.1710862197956249,0.2839506172839506,0.996380502659349,1.0,8/35,10.78%,SOX6;CD44;SULF2;DDRGK1;ZBTB16;PGRMC2;ATP7A;ARID5B
prerank,regulation of hippo signaling (GO:0035330),0.5724455608019805,1.169953297347661,0.2974683544303797,0.9995812022411388,1.0,3/17,8.09%,CIT;MOB3B;MAPK14
prerank,nucleoside salvage (GO:0043174),0.6223662248196062,1.1697875616894198,0.3220588235294118,0.9989869579177361,1.0,2/10,3.25%,TK1;UCK2
prerank,regulation of organelle assembly (GO:1902115),0.4948240626831625,1.1697571758146323,0.2502596053997923,0.9978391229560253,1.0,24/72,19.58%,STIL;CDKL1;TBC1D1;EZR;TBC1D22B;CEP295;EVI5;RAB1B;GSN;CEP76;ALMS1;MSN;RDX;NPRL3;DYNLT2B;SDCCAG8;RAB5A;IFT140;ADPRH;RNF4;SENP6;STAM;RABEP2;SGSM3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5433816672344188,1.1696803163073168,0.30145278450363194,0.9969077518167445,1.0,5/24,10.49%,CD177;PECAM1;EZR;GFUS;MSN
prerank,positive regulation of B cell proliferation (GO:0030890),0.5372060940249102,1.1696395852468218,0.3023255813953488,0.9958073937357284,1.0,4/29,5.06%,TNFSF13B;CD38;CD74;TFRC
prerank,regulation of interferon-beta production (GO:0032648),-0.29940421785803156,-1.1695694675312218,0.15463917525773196,0.7027376741253649,1.0,11/46,8.16%,SIRPA;HSP90AA1;POLR3C;PTPRS;PYCARD;TLR7;RNF135;POLR3A;MAVS;TLR4;IRF1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.5852425576106921,1.1694841611879931,0.3159340659340659,0.9951868710524052,1.0,2/12,10.63%,CCR2;IL1R1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5366629796366876,1.169329311584323,0.29540229885057473,0.9945894072452498,1.0,7/27,9.10%,SMG6;SMG5;DACH1;ATM;TERF2;NABP2;SMOC2
prerank,negative regulation of transport (GO:0051051),0.5005285151297914,1.1690237393605423,0.2641711229946524,0.9945167938980833,1.0,16/51,17.96%,PRTN3;ERBB3;SNX33;SNX3;MTMR2;ITGAV;EPHA3;ABCA7;PIP4P2;PTEN;RACK1;EGF;ARL6IP5;MCTP1;FCGR2B;SNCA
prerank,nucleotide biosynthetic process (GO:0009165),0.5615297862974531,1.168923860709022,0.3075,0.9936473281305017,1.0,3/18,5.90%,RRM2;RRM1;RRM2B
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.46621287830009134,-1.168333022779269,0.2597864768683274,0.7037937734337937,1.0,1/11,0.60%,TREM2
prerank,cardiac atrium morphogenesis (GO:0003209),0.579010128899398,1.1682598856130433,0.32845744680851063,0.9950644169139874,1.0,3/16,7.16%,HEY2;ZFPM1;NOTCH1
prerank,digestive tract development (GO:0048565),-0.34201247089570974,-1.1678986451512015,0.23333333333333334,0.7028145274287543,1.0,9/32,20.54%,SALL1;SMO;PCSK5;CLMP;PKD1;GLI3;EDNRB;PKDCC;CCDC39
prerank,regulation of fatty acid metabolic process (GO:0019217),0.5642654555353258,1.1678039522839656,0.3231162196679438,0.9956502677615287,1.0,7/17,24.19%,PANK2;CAV1;ADIPOR1;PRKAG2;EIF6;PPARD;PRKAB2
prerank,motile cilium assembly (GO:0044458),-0.4443143346152192,-1.167193539509579,0.27205882352941174,0.7025755374216863,1.0,7/12,35.05%,E2F4;SPATA6;BBS5;CCDC39;DNAAF3;CCDC40;RSPH9
prerank,intestinal lipid absorption (GO:0098856),0.6085820143817213,1.166982309787655,0.3179271708683473,0.9976394416738229,1.0,2/11,10.14%,CEL;LIMA1
prerank,regulation of apoptotic process (GO:0042981),0.4819672250107698,1.166945509269864,0.026,0.9965435057342023,1.0,150/676,18.29%,TOP2A;KIF14;CDK1;STIL;BIRC5;ECT2;MAD2L1;USP27X;BARD1;PLK1;CYP1B1;ARHGEF5;STK26;PMAIP1;ANP32B;AQP1;IAPP;LEF1;E2F1;SKP2;DDAH2;PDCD2;IKZF3;DAPK2;TIAM1;NET1;FLNA;SLK;CD38;PTPA;CD74;ANKLE2;CD44;GLS2;APAF1;PIDD1;TFPT;PA2G4;TNFSF10;ARHGEF18;UBE2O;PHLDA3;TFRC;FOXO1;FAF1;CASP2;ARHGEF3;ATM;TRADD;LCMT1;DPEP1;PTMA;SETX;ARF4;ARL6IP1;BIRC2;MAP3K5;UBE2Z;DDRGK1;HMGB1;PIM2;BIRC6;BOK;SAP18;PIM3;CIB1;TNFAIP8;RNF157;ERC1;JAK2;SOS1;ZBTB7A;EGFR;RNPS1;ERCC3;PIM1;PRR7;ACTN2;MAP3K11;PAWR;SOCS2;MELK;PARK7;SIGMAR1;ATF6;JUN;XIAP;CCAR2;ATF5;IFT57;FLT3;FAS;MYD88;NAA16;FGD3;TOMM70;APEX1;FBXO11;RACK1;ANP32E;ING3;ING5;PRKDC;ACTN4;BEX2;LATS1;GLO1;BCL6;CREBBP;BAG3;MYC;CFLAR;PSEN1;BAG1;MYDGF;PPIA;HTATIP2;CASP9;TPT1;GSK3B;STK4;TP53;PDCD10;MAP3K20;TFAP4;PAK2;STEAP3;TAF9;ARHGDIA;JAK3;VHL;NLRP2B;SIRT1;XBP1;SH3RF1;ARL6IP5;HSP90B1;ANO6;PNMA2;UBA52;AVEN;NDRG1;SNCA;STK17B;RARG;MED1;RBM25;MALT1;ARHGEF7;ADAM10
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5742973743356576,1.1668538686109213,0.2925531914893617,0.9956567279589292,1.0,5/13,23.18%,CD177;TYROBP;MAPT;SYK;PRKCD
prerank,cellular response to organic cyclic compound (GO:0071407),0.4827452222638116,1.1662663469703354,0.2046138415245737,0.9966972370271924,1.0,22/141,10.64%,RAD51;SLC5A5;CYP1B1;BRCA1;AQP1;BLM;CTNNA1;EZR;HCN3;CRHBP;TAF1;PDE12;ZFP36L1;PDE2A;AHR;GNAI1;EGFR;P2RY1;EGR1;RIOK3;MSN;RUVBL2
prerank,regulation of microtubule polymerization (GO:0031113),0.508599291120257,1.1662335941618702,0.28114663726571115,0.9955785639709909,1.0,18/40,22.95%,CDK5RAP2;STMN1;CLASP1;GBA2;MAPRE3;DYRK1A;SLAIN2;NUMA1;RAC1;DRG1;SNCA;TBCD;EML2;RPS3;MET;MAPT;DCTN1;CAMSAP1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.3995226386320063,-1.1659396590569726,0.27906976744186046,0.7038525606378541,1.0,13/17,41.00%,ROBO1;MIA3;VEGFA;FGF2;GPLD1;EFNB2;KDR;SRF;NR4A1;EGR3;GREM1;EPHB4;SLIT2
prerank,response to axon injury (GO:0048678),-0.4003216839780517,-1.16580509229855,0.25,0.7020698305353702,1.0,10/18,28.85%,TREM2;APOD;P2RY12;GAP43;P2RX4;MAPK8IP3;DPYSL3;FLRT3;DHFR;MORN4
prerank,negative regulation of protein catabolic process (GO:0042177),0.5105540493475424,1.165706268870724,0.2625272331154684,0.9964567537755495,1.0,9/40,12.88%,MAD2L1;FLNA;SNX3;AZIN1;MDM4;PIN1;EGFR;CDK5RAP3;NELL1
prerank,Golgi to lysosome transport (GO:0090160),-0.4596739928408027,-1.1652414265888125,0.2711864406779661,0.7015196135919353,1.0,2/11,3.60%,GAK;LAMP1
prerank,regulation of programmed cell death (GO:0043067),0.4823178919237303,1.1651242311976577,0.17635270541082165,0.9974600403010994,1.0,51/161,21.03%,BIRC5;STK26;PMAIP1;ANP32B;SKP2;IKZF3;DAPK2;SLK;GLS2;APAF1;PIDD1;DCPS;CASP2;ATM;LCMT1;BIRC2;JAK2;ZBTB7A;ACTN2;IFT57;FLT3;FAS;TOMM70;APEX1;FBXO11;ANP32E;ACTN4;BEX2;BCL6;CREBBP;HTATIP2;TPT1;TP53;MARK4;STEAP3;ACER3;JAK3;SIRT1;LRRK2;NDRG1;RARG;RBM25;MALT1;RPS3;PAX2;SOX9;DAPK1;ALK;WRN;BNIP3;RIPK1
prerank,regulation of cellular pH (GO:0030641),0.5222247587125297,1.1650085256798088,0.2906574394463668,0.996685760492035,1.0,8/29,19.15%,SLC4A1;SLC9A8;SLC9A9;ATP6AP1;ATP5F1B;CLN3;SLC9A6;SLC9A7
prerank,B cell differentiation (GO:0030183),0.5086139024841092,1.1646612871741424,0.2717271727172717,0.9968544081984848,1.0,17/46,23.16%,MS4A1;CD79A;TCF3;CD79B;NFAM1;PLCG2;ZBTB7A;FLT3;CEBPG;DNAJB9;JAK3;SYVN1;HDAC4;NHEJ1;ITGA4;HDAC9;ADAM17
prerank,positive regulation of neutrophil migration (GO:1902624),0.5601875859293881,1.164343016390299,0.29396984924623115,0.9968613629054504,1.0,6/18,16.84%,DAPK2;CD74;RIPOR2;RAC2;MCU;RAC1
prerank,neutral amino acid transport (GO:0015804),0.5324935745324959,1.1638496225914197,0.29452852153667053,0.99752039369312,1.0,2/28,2.20%,SLC38A5;SLC1A5
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.510139971870482,1.1638336695430491,0.288135593220339,0.996353743571824,1.0,12/34,20.54%,FLNA;NEDD9;CRKL;CIB1;CRK;NRP1;LIMS1;TRIOBP;RAC1;ARHGEF7;S100A10;ILK
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.43713658022324076,-1.163625432231228,0.26171875,0.7038555360531302,1.0,8/12,33.11%,HPRT1;PRPS2;PPAT;AMPD2;GART;PRPSAP2;PRPS1L1;PRPS1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.42919303950208626,-1.1635851044464443,0.2687224669603524,0.7018025600890475,1.0,7/14,26.75%,ANK3;SLC9A1;DMD;ATP1B1;GLRX;CHP1;WNK2
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5473797550169324,1.1627954592644845,0.30434782608695654,0.9991206182897275,1.0,4/20,10.78%,RB1;TWIST1;DDRGK1;PARK7
prerank,ion transport (GO:0006811),0.4836777541784578,1.162546284166529,0.24596774193548387,0.9988834777313956,1.0,11/111,7.26%,SLC4A1;CHRNB4;SLC12A3;SLC5A5;P2RX1;VDAC2;ANO10;KCNN4;SLC12A7;SLC12A1;TSPO
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5632829407474543,1.1617460393518073,0.30283505154639173,1.0,1.0,3/17,4.26%,UBASH3A;EZR;PTPN22
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5618564585956408,1.1616822307676087,0.311787072243346,0.9998893272773339,1.0,6/19,16.84%,DAPK2;CD74;RIPOR2;RAC2;MCU;RAC1
prerank,peptidyl-threonine modification (GO:0018210),0.49086390226951293,1.1615673441046614,0.2706611570247934,0.9990952265586269,1.0,17/66,15.76%,CDK1;CIT;MAPK1;OXSR1;CHEK1;TAF1;PRKCA;MARK2;PDPK1;HIPK2;DYRK1A;LMTK2;ROCK2;PRKDC;STK39;GSK3B;MAP2K1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3702945470688774,-1.1615296791983094,0.22485207100591717,0.7054110453926817,1.0,6/23,8.37%,NLRP3;PPM1A;RELA;ZC3H12A;NMI;SPI1
prerank,protein modification by small protein removal (GO:0070646),0.4803875306406034,1.1611200963739634,0.129,0.9995928115272671,1.0,86/252,21.41%,CDK1;CLSPN;USP27X;BARD1;CDC20;CCNA2;BRCA1;CDC25A;SKP2;USP1;SENP1;PSMB7;BABAM1;PSMD11;TFPT;ABRAXAS1;PSMF1;SNX3;ACTR5;INO80D;IKBKG;MDM4;USP38;TRAF3;PSMC1;BIRC2;DESI2;DESI1;TAB1;USP48;USP31;ASXL1;PSMC3;RAD23A;TOR1A;PSMA4;SMAD4;RUVBL1;KAT2B;BECN1;PTEN;ARRB2;PSMC4;BAP1;HCFC1;UCHL5;USP14;PSMD13;PSME1;MYC;USP24;USP15;PSMB1;VCPIP1;TADA3;TP53;OTUD5;HGS;PSMD8;USP50;YOD1;FOXK2;PSME4;USP25;USP21;PSMD4;USP40;UBA52;USP7;MAP3K7;DDB2;SENP6;STAM;TRAF6;USP34;COPS3;ACTL6A;KEAP1;SMAD2;INO80E;RIPK1;OTUD7A;MDM2;USP46;USP47;COPS2
prerank,lipoprotein localization (GO:0044872),-0.4620886911132004,-1.1609803118446735,0.24695121951219512,0.7047308225623096,1.0,6/11,24.41%,LRP1;ZDHHC17;MIA3;CD36;UNC119B;ZDHHC3
prerank,detection of calcium ion (GO:0005513),-0.43262692709476236,-1.1603787008797486,0.28085106382978725,0.7043250821510484,1.0,7/13,33.88%,SYT1;RYR2;CALM1;STIM1;KCNMB2;CALM2;KCNMB4
prerank,tight junction assembly (GO:0120192),0.5094156006870247,1.160294272400403,0.2763018065887354,1.0,1.0,3/49,2.62%,ECT2;CLDN18;PECAM1
prerank,positive regulation of protein transport (GO:0051222),0.49146914273001446,1.1599994523850348,0.2715920915712799,1.0,1.0,14/67,16.23%,KIF20B;ARHGEF5;PCNT;EZR;MYOM1;MYH10;PCM1;CNST;OAZ1;RACK1;PPIA;RIPOR1;PDCD10;TGFB2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5780428374867087,1.1596815246804768,0.30474934036939316,1.0,1.0,6/13,16.99%,TWIST1;CD74;CD44;DYRK1A;YJU2;SIRT1
prerank,intracellular cholesterol transport (GO:0032367),-0.43621335026436564,-1.1595839058251982,0.25333333333333335,0.704411502403206,1.0,6/15,15.74%,OSBPL2;ABCA1;OSBP;NPC2;NPC1;SERAC1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.477966583959948,1.1593623125293169,0.024,1.0,1.0,181/807,18.39%,CENPF;DEPDC1;E2F7;BIRC5;AURKB;E2F8;FOXM1;UHRF1;GFI1;NKX6-1;MYB;HMGB2;EZH2;RCOR2;PLK1;MEN1;SUV39H1;BRCA1;SMARCC2;NR4A2;HMGA1;DAP;HEY2;RBM15;DEAF1;LEF1;E2F1;UXT;RB1;RIOX1;RSF1;FLNA;ELK4;CD38;EZR;CBX5;TWIST1;ZFPM1;MCPH1;PML;BCL7A;FBXW11;TIMELESS;PA2G4;HDAC10;UBE2I;RPS6KA5;MTA3;EPC1;CTCF;SCMH1;FOXP1;ETS2;DACH1;SP100;CAV1;CDKN2A;NR1D1;NKAP;TAF1;MBD2;FOXO1;MDM4;E2F6;BCL11A;PBXIP1;MBD1;TCF3;ARID4A;GMNN;RUNX3;HDAC6;PDE2A;KLF10;TAF7;NOTCH1;XRCC6;HMGB1;AHR;SFMBT1;SAP18;SPEN;MAX;SMARCA4;PSPC1;NEDD4L;CIPC;CIR1;RPS14;ZBTB16;ETV6;NCOA5;ZBTB7A;SIN3B;NONO;ZNF148;MECP2;PFDN5;TFDP2;CPEB3;ZBTB32;NR2C2;IRF2BPL;NR2F2;ID4;KAT6A;ZEB1;TRIM33;CUX1;EHMT1;MXI1;ARID5B;SUMO1;RTF1;SMAD4;JUN;CCAR2;PEX2;ATF5;PLCB1;MTA2;ZNF25;FOXP2;CBFB;RNF2;BAP1;PRDM6;HCFC1;SETDB2;ZBTB33;SP3;SIRT7;ZBTB7B;HNRNPU;NIPBL;DDIT3;BCL6;CREBBP;SKI;MYC;NFX1;PSEN1;POU6F1;LIMS1;YEATS2;CNOT1;ATF7IP;TP53;MOSPD1;RUNX1;LRRFIP1;LIMD1;IRF8;POU2F1;JARID2;TFAP4;SIN3A;TCF7L2;HIVEP1;DUSP22;FOXK2;TRIM28;DNAJB1;VHL;RIF1;TCERG1;SIRT1;GCFC2;PEX14;TRIM37;UBA52;HEXIM1;MBTD1;SNCA;HDAC4;RARG;MED1;KDM2B;FOXE1;DPF2;CREB1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.567884185170946,1.1593448399890092,0.32073011734028684,1.0,1.0,1/17,0.89%,NKX6-1
prerank,cellular copper ion homeostasis (GO:0006878),-0.42729341983509517,-1.1593445210915168,0.26587301587301587,0.7029027291496467,1.0,7/14,22.15%,APP;SLC31A2;PRNP;COX19;CCDC22;MT2A;ARF1
prerank,cell chemotaxis (GO:0060326),0.4929932274490205,1.1592841173297777,0.2926315789473684,0.9995658310296907,1.0,12/60,17.70%,HMGB2;CXCR5;LEF1;CCR2;CCR6;ARRB2;NRP1;LPAR1;ELMO2;CCL25;PARVA;CXCR4
prerank,ncRNA transcription (GO:0098781),0.5826223495751743,1.1592195904381906,0.3328804347826087,0.998603977478915,1.0,7/13,20.65%,BRF1;SNAPC3;NIFK;SIRT7;POLR1G;RPAP2;SPIN1
prerank,sensory perception of taste (GO:0050909),-0.4659983230757557,-1.1592076435057979,0.2931596091205212,0.7011216019950389,1.0,4/10,34.34%,CD36;PKD2L1;ASIC1;PKD1L3
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.44462190900312903,-1.1591674518528954,0.28113879003558717,0.6991373441271042,1.0,5/11,18.44%,CD34;CD200;ATP6AP2;CD46;THBS1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5028555124681278,1.1583302984432042,0.2704741379310345,1.0,1.0,2/51,0.92%,KIF20B;NTF4
prerank,ncRNA catabolic process (GO:0034661),0.5311000768534971,1.158147872921412,0.2894736842105263,1.0,1.0,8/28,19.63%,SLFN14;EXOSC8;EXOSC10;TUT4;RBM7;DIS3L;XRN1;ZCCHC8
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4983541771202815,1.1576549897750816,0.2753623188405797,1.0,1.0,20/62,15.87%,RBM15;ZFPM1;CDK6;DPY30;TNRC6C;TNRC6B;H3-3A;KMT2C;ZBTB16;NFE2;KAT2B;PRKCB;CNOT4;CBFB;KMT2A;CREBBP;RBBP5;KMT2B;RUNX1;SIN3A
prerank,leukocyte tethering or rolling (GO:0050901),0.566550938435266,1.1576331396733648,0.32175032175032175,0.999801947846918,1.0,8/17,22.20%,SPN;ITGB7;JAM2;ADD2;GOLPH3;ROCK1;GCNT1;ITGA4
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.5787900567490515,1.156747586887354,0.31835686777920413,1.0,1.0,3/14,5.36%,PISD;CHKB;PCYT2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.527849566549611,1.156709784472028,0.3008225616921269,1.0,1.0,6/29,13.06%,FOXA2;VASN;FUZ;ADIPOR1;PTEN;SPRED2
prerank,regulation of establishment of protein localization (GO:0070201),-0.44093405916894557,-1.1564972451241173,0.28512396694214875,0.7040328473814215,1.0,4/13,8.32%,CTSD;TREM2;CORO2B;PTP4A3
prerank,extracellular transport (GO:0006858),0.6006289743911667,1.156469676198196,0.3342503438789546,1.0,1.0,2/12,7.06%,SPA17;SPEF2
prerank,apoptotic process (GO:0006915),0.4780900881980912,1.1561977651736297,0.19238476953907815,1.0,1.0,51/203,15.76%,CIT;CD2;JADE1;ESPL1;PMAIP1;DAP;IAPP;IL2RA;TCHP;DAPK2;ERBB3;FAP;PRKCE;LIG4;APAF1;PIDD1;BRAT1;STK11;CHEK1;CYFIP2;IKBKG;FOXO1;CASP2;TRADD;TRAIP;PAEP;AHR;BOK;CIB1;ZBTB16;JAK2;RFK;ERCC3;TNFAIP1;PPP1R15A;PAWR;MELK;IFT57;BCL2L13;FAS;MYD88;RNF152;FXR1;MAGI3;MYC;CFLAR;PPIA;CASP9;STK4;PLAGL1;PAK5
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.3713242841855129,-1.1561819517206462,0.23711340206185566,0.7027865025964904,1.0,7/20,14.15%,TGFBR1;HSP90AA1;PRKN;WASHC1;PINK1;ZMIZ1;EPAS1
prerank,positive regulation of immune system process (GO:0002684),0.560282153470856,1.1559719837589872,0.3249001331557923,1.0,1.0,1/16,0.75%,TNFRSF18
prerank,regulation of mast cell degranulation (GO:0043304),0.5753001202640927,1.1558302790317423,0.32132963988919666,0.9995375134728421,1.0,1/14,0.41%,BLK
prerank,regulation of keratinocyte migration (GO:0051547),-0.44842056923890883,-1.1554869471964124,0.2857142857142857,0.7024787295796676,1.0,4/12,14.75%,IQSEC1;EPB41L4B;ADAM9;MAP4K4
prerank,regulation of cell population proliferation (GO:0042127),0.47705056006322244,1.1551989423708962,0.049,1.0,1.0,119/691,16.26%,PRC1;KIF20B;SHCBP1;KIF14;TTK;E2F7;CDKN3;BIRC5;PRTN3;FOXM1;UHRF1;HMGB2;EZH2;RAB33B;TIPIN;MEN1;CYP1B1;CDKN2C;HMGA1;ITGA1;PPP1R9B;LEF1;CD47;FBXO5;IL7R;CCDC88A;ERBB3;GLMN;TIAM1;S100A11;PPM1D;PML;TIMELESS;ARID2;COPS9;CTCF;PGF;STK11;TFRC;CDK6;CDKN2A;CRKL;PTHLH;RPS4X;MDM4;RBBP4;ZFP36L1;TGFA;BIRC2;KLF10;CDC25B;NOTCH1;XRCC6;TSPO;DDRGK1;PIM2;BIRC6;BOK;FUZ;CIB1;JAK2;ITGAV;STRN;EGFR;CDKN2D;CAPN1;MECP2;CUL3;DHPS;DERL2;PTPN14;JUN;RPRD1B;XIAP;FGF9;KAT2B;ATF5;DPP4;FLT3;PTEN;BAP1;BMPR1A;S1PR2;PDS5B;STAT5B;RPS15A;RPS9;ING5;PRKDC;SLURP1;BCL6;SKI;TMEM115;MYC;NAP1L1;CDC7;IRS1;SGK3;KDM4C;LIMS1;ADAMTS1;TP53;PDCD10;RUNX1;JUNB;EGF;F2R;TNFRSF11A;PIAS1;PTPRU;HGS;ELN;MAP2K1;TFAP4;CNOT6;TCF7L2;FGFR1;TGFB2;DUSP22
prerank,protein deubiquitination (GO:0016579),0.4781964617205858,1.1550010885513615,0.147,1.0,1.0,69/242,17.75%,CDK1;CLSPN;USP27X;BARD1;CDC20;CCNA2;BRCA1;CDC25A;SKP2;USP1;PSMB7;BABAM1;PSMD11;TFPT;ABRAXAS1;PSMF1;SNX3;ACTR5;INO80D;IKBKG;MDM4;USP38;TRAF3;PSMC1;BIRC2;DESI2;TAB1;USP48;USP31;ASXL1;PSMC3;RAD23A;PSMA4;SMAD4;RUVBL1;KAT2B;BECN1;PTEN;ARRB2;PSMC4;BAP1;HCFC1;UCHL5;USP14;SPATA2;PSMD13;PSME1;MYC;USP24;USP15;PSMB1;VCPIP1;TADA3;TP53;OTUD5;HGS;PSMD8;USP50;YOD1;FOXK2;PSME4;USP25;USP21;PSMD4;USP40;UBA52;USP7;MAP3K7;DDB2
prerank,regulation of neuron differentiation (GO:0045664),0.4918801137437244,1.1548744218770475,0.2665289256198347,0.9996921742700716,1.0,17/76,18.12%,ECT2;NTF4;CDK5RAP2;TIAM1;GPRC5B;MMD2;YWHAH;TCF3;MMD;ZEB1;CDK5RAP3;NRCAM;SIN3A;TCF4;FGFR1;LRRK2;MED1
prerank,lysine metabolic process (GO:0006553),0.5867416266503886,1.1547910826053078,0.32472826086956524,0.9976372523327457,1.0,1/12,1.71%,SLC25A21
prerank,lysine catabolic process (GO:0006554),0.5867416266503886,1.1547910826053078,0.32472826086956524,0.9976372523327457,1.0,1/12,1.71%,SLC25A21
prerank,positive regulation of stem cell differentiation (GO:2000738),0.5649864267996583,1.1546717070612103,0.3193717277486911,0.9969016430558785,1.0,4/16,19.46%,SOX6;HOXB4;TGFB2;SOX9
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3970566089603915,-1.1545833588145809,0.2581967213114754,0.7026920116327041,1.0,4/16,15.97%,RELA;ALOX5;ST3GAL4;MDK
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5618775806537086,1.154398677659725,0.30217669654289375,0.9967937786514478,1.0,6/17,16.84%,DAPK2;CD74;RIPOR2;RAC2;MCU;RAC1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5978982298039541,1.1541507114382599,0.33617021276595743,0.9965824938097266,1.0,2/12,3.25%,TK1;UCK2
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.45784947586466634,-1.1540932266649204,0.3017543859649123,0.7019344110166139,1.0,9/11,54.24%,PLA2G7;AGT;PLA2G3;LIPC;PLA2G5;ABCG1;PLA2G10;APOA2;AGTR1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4735967631759755,1.1539910191875762,0.2032032032032032,0.9960418328350636,1.0,38/175,16.99%,TNFRSF18;ADAMTS7;BRCA1;EDARADD;TNFSF13B;PSMB7;PSMD11;CRHBP;TANK;PSMF1;NR1D1;TRADD;ZFP36L1;TRAF3;PSMC1;GBP2;BIRC2;CIB1;JAK2;PSMC3;TNFRSF13B;PSMA4;DHX9;PSMC4;NFE2L2;PSMD13;ACTN4;PSME1;PSMB1;LIMS1;TP53;TNFRSF11A;PSMD8;ZFP36L2;PSME4;CCL25;PSMD4;SIRT1
prerank,calcium ion import into cytosol (GO:1902656),0.5615941357245484,1.153124509086426,0.32729624838292365,0.9981873875153829,1.0,1/15,1.23%,MS4A1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.37585687414725616,-1.1530603629348162,0.27011494252873564,0.7025155075694594,1.0,16/22,41.00%,ROBO1;MIA3;VEGFA;FGF2;GPLD1;EFNB2;KDR;SRF;NR4A1;EGR3;ID1;EMP2;GREM1;EPHB4;CDH5;SLIT2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.49418124765396365,1.1529804787065734,0.2751322751322751,0.9976013774064347,1.0,7/56,12.44%,TTK;INHBC;PMEPA1;PIN1;SMAD4;SNX25;BMPR1A
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5466813651176465,1.1528772208272597,0.31605562579013907,0.9967944164191013,1.0,8/20,15.44%,ERBB3;CASP2;BOK;ITGAV;FAS;CASP9;GSK3B;APPL1
prerank,histone H3-K4 methylation (GO:0051568),0.5249652939336557,1.1527415790208717,0.3183431952662722,0.9961221710196574,1.0,8/26,14.99%,MEN1;WDR5B;DPY30;KMT2C;PAXIP1;KMT2A;RBBP5;KMT2B
prerank,plasma membrane organization (GO:0007009),-0.2977421767292756,-1.1524121335611959,0.20454545454545456,0.7022121138153022,1.0,18/61,15.74%,ABCD2;NSF;ANK3;OSBPL2;STX4;AHNAK2;ANK2;BIN1;STX2;MYOF;BIN3;SYT7;EPB41L3;TLCD2;SERP1;PLSCR4;PACSIN1;DEGS1
prerank,insulin receptor signaling pathway (GO:0008286),-0.2815212354712481,-1.1522155808495267,0.18604651162790697,0.7006796572318096,1.0,22/69,14.99%,IGF1R;BCAR3;PTPN2;ATP6V1B2;ATP6V1C1;ATP6V0D2;PIK3R1;ATP6V0A1;ATP6V0B;AKT2;BAIAP2;IDE;SH2B2;TCIRG1;GAB1;IRS2;GSK3A;ATP6V1A;ATP6V1H;RHOQ;SLC39A14;GRB10
prerank,phagolysosome assembly (GO:0001845),-0.44109311575817006,-1.1520965273771164,0.275,0.6990216497086075,1.0,3/12,10.76%,RAB14;RAB20;SYT7
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5011870085236371,1.1520727747164374,0.3104575163398693,0.9974690107282479,1.0,16/47,19.34%,FOXM1;MAPK1;ULK4;RASGRP1;FOXO1;EGFR;CARD9;FAS;MYC;PPIA;PDCD10;MAP2K1;TGFB2;ARL6IP5;TAOK1;LGALS9
prerank,positive regulation of histone acetylation (GO:0035066),0.5372372260658977,1.152059249675263,0.3145933014354067,0.9963544546064521,1.0,8/23,18.94%,BRCA1;RPS6KA5;RUVBL2;SMAD4;PAXIP1;TADA2A;GLYR1;BRD7
prerank,positive regulation of heart rate (GO:0010460),-0.3953488154226178,-1.1519024666350928,0.25217391304347825,0.6974034945421094,1.0,5/17,21.85%,RYR2;ADRA1A;ADRA1B;ADRB1;SCN3B
prerank,protein monoubiquitination (GO:0006513),0.5192114677884399,1.1518642619004946,0.3090079817559863,0.995905319241423,1.0,10/36,16.80%,UBE2T;UHRF1;DTL;UBE2O;RAD18;CUL3;RNF20;FANCL;UBE2R2;KLHL22
prerank,RNA destabilization (GO:0050779),0.5568875755192836,1.1517150839771066,0.3388746803069054,0.9952869688607172,1.0,11/18,25.36%,ZC3H18;FTO;PUM1;METTL16;ROCK2;DXO;METTL14;ROCK1;CELF1;MEX3D;GIGYF2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4890301904366786,1.1515828259155638,0.2579001019367992,0.9946478821685527,1.0,20/85,16.45%,KIF14;FOXM1;ARHGEF18;ARHGDIB;MMD2;RASGRP1;CRKL;DENND4C;NOTCH1;ARFGAP1;GRB2;JAK2;STARD8;RDX;ARHGEF28;DENND1A;PDCD10;BCR;TGFB2;ARHGDIA
prerank,rRNA methylation (GO:0031167),0.5380121348740038,1.1515707478559234,0.3284313725490196,0.9935397197895174,1.0,9/22,15.25%,ZCCHC4;TFB1M;TFB2M;EMG1;METTL15;FBL;METTL16;NSUN3;DIMT1
prerank,negative regulation of vascular permeability (GO:0043116),-0.4345582319274064,-1.1515140751479227,0.2644927536231884,0.6963249939323123,1.0,6/12,14.06%,PTPRJ;ANGPT1;FERMT2;SH3GL2;DDAH1;VEGFA
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.3798185163998969,-1.1514012113696814,0.2608695652173913,0.6946336038950953,1.0,10/20,22.12%,FHOD1;FMNL2;STRIP1;NCKAP1L;RHOQ;FHOD3;DLG1;LLGL1;PLEK;FMNL3
prerank,B cell activation (GO:0042113),0.4815422116798437,1.151323333085588,0.2772585669781931,0.9933193826229826,1.0,25/68,23.16%,MS4A1;CD79A;BANK1;RASGRP1;TCF3;CD79B;NFAM1;PLCG2;ZBTB7A;FCRL1;BTK;FLT3;PRKCB;CEBPG;DNAJB9;JAK3;HDAC4;MALT1;CASP8;NHEJ1;ITGA4;GPR183;HDAC9;PHB2;ADAM17
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5366097475542918,1.151199065991515,0.30612244897959184,0.9926164029190392,1.0,7/24,17.72%,SDHAF4;COQ10B;COX10;GFPT2;MYC;SLC25A13;NDUFS1
prerank,transport along microtubule (GO:0010970),-0.4463872149929999,-1.1511352060103681,0.28214285714285714,0.6933720229848078,1.0,4/13,12.08%,APP;SPG11;COPG2;CLIP3
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.4951919426260649,1.1508210677117587,0.2804621848739496,0.9928644762802171,1.0,19/61,16.99%,PSMB7;PSMD11;PSMF1;PANK2;AZIN1;CAV1;PSMC1;PSMC3;PSMA4;PSMC4;OAZ1;PSMD13;PSME1;PRKAG2;PSMB1;PSMD8;PSME4;PSMD4;SIRT1
prerank,regulation of extracellular matrix organization (GO:1903053),0.5754662068654305,1.1506558544987218,0.30930537352555704,0.9923989006472566,1.0,5/15,15.02%,RB1;FAP;NOTCH1;EFEMP2;RUNX1
prerank,regulation of cartilage development (GO:0061035),0.5577470528762644,1.1504560137638902,0.32954545454545453,0.9920288128972606,1.0,5/18,11.60%,SOX6;PTHLH;MBOAT2;ZBTB16;TAPT1
prerank,import into nucleus (GO:0051170),0.48322223781628365,1.150393012732165,0.2867494824016563,0.9911378077154994,1.0,32/73,22.66%,POM121;GEMIN8;NUP107;BACH2;TNPO1;SNRPF;IPO13;NUP50;NUP214;SEC13;IPO7;NUP188;RANBP6;RPAIN;HTATIP2;E2F3;APPL1;IPO5;GEMIN7;KPNB1;SNRPG;HNRNPA1;EIF4ENIF1;NUP85;MMP12;SNRPB;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5739511296695595,1.1501237805229598,0.34506089309878213,0.9909814378126014,1.0,8/13,23.16%,HMGB1;AKT3;PDPK1;FGFR1;PLCG1;APLN;ITGA4;ADAM17
prerank,protein phosphorylation (GO:0006468),0.47425840608834097,1.1490003540511837,0.092,0.9940836856135405,1.0,112/478,16.36%,TTK;CDK1;BIRC5;AURKB;BLK;CLSPN;CIT;NEK2;MASTL;CCNA2;INCENP;PLK1;CCNE1;STK26;CHEK2;MAPK1;CDKL1;AURKA;OXSR1;DAPK2;FYN;SLK;PRKCE;HASPIN;MAP2K6;RSKR;ERG;RPS6KA5;MAP4K1;STK11;MAPKAPK3;CHEK1;CDK6;GRK6;TLK1;GMFG;TAF1;SIK2;ATM;RUNX3;CSNK1A1;STK38L;MAP3K5;CDC25B;PIM2;PKN2;CDK17;AKT3;BIRC6;CSNK1G2;PIM3;BAZ1B;MAP3K1;MAP4K2;PRKX;PRKCA;PRKACA;MAPK14;HCST;ERC1;STK38;MARK2;PICK1;JAK2;LMTK3;MAST2;STK24;EGFR;EPHA3;PIM1;PDPK1;MAP4K5;CDK19;HIPK2;MAP3K11;TESK2;MELK;DYRK1A;BTK;VRK1;RELN;FLT3;PRKCB;RPS6KA6;CCNT1;BMPR1A;LMTK2;ROCK2;GRK2;PRKDC;PRKAG2;LATS1;CDK16;STK39;NRBP1;FAM20A;HTATIP2;CDC7;USP15;SGK3;GSK3B;STK4;MAP3K20;BCR;PAK5;MAP2K1;MARK4;FGFR1;PAK2;LIMK2;TGFB2;CDK8
prerank,response to sterol (GO:0036314),-0.45828511711337905,-1.1489588185959727,0.3053435114503817,0.696785572417463,1.0,6/11,19.78%,TGFBR1;CCR5;TGFBR2;INSIG1;CCL3;PMVK
prerank,negative regulation of potassium ion transport (GO:0043267),0.5784370562550394,1.1488983443226821,0.3178717598908595,0.9933312174871702,1.0,4/13,13.71%,CAV1;NEDD4L;ACTN2;STK39
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.5734707541523357,1.1483750400603088,0.33514246947082765,0.9941364995132876,1.0,7/13,20.36%,TXN;PARK7;NFE2L2;RACK1;PDE8A;LRRK2;MET
prerank,spliceosomal snRNP assembly (GO:0000387),0.5091437752239699,1.1483485284342887,0.29592959295929594,0.9930846547279073,1.0,15/38,20.56%,GEMIN8;PRPF19;SNRPF;SNRPC;SART3;LSM2;PRPF31;CLNS1A;SART1;SRSF10;GEMIN7;SNRPG;PRPF8;SNRPB;PRMT7
prerank,non-motile cilium assembly (GO:1905515),0.5233424695071588,1.1477344309786355,0.30824372759856633,0.994200515538889,1.0,11/30,13.81%,CEP89;DISC1;FUZ;CEP250;GORAB;TBC1D32;PCM1;IFT57;ARL13B;BBS4;PIBF1
prerank,modulation by symbiont of entry into host (GO:0052372),0.5557089550805048,1.147574463882997,0.3215686274509804,0.9936207830234991,1.0,4/16,14.44%,EXOC2;CAV1;TRIM68;TRIM5
prerank,nuclear pore complex assembly (GO:0051292),0.6098298961637278,1.14752158746604,0.3357245337159254,0.9926759308339912,1.0,5/10,12.23%,NDC1;NUP107;NUP205;AHCTF1;NUP98
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.5570431049789503,1.1473898248585694,0.31679389312977096,0.9920391387108726,1.0,3/18,7.95%,SPA17;SPEF2;OFD1
prerank,protein autoubiquitination (GO:0051865),0.48668438568225725,1.1473553130885306,0.2778355879292404,0.9910133377480846,1.0,25/61,24.39%,UBE2T;UHRF1;BRCA1;RAD18;RNF157;RNF141;CUL3;AMFR;RNF8;CNOT4;TRIM68;NFX1;RNF115;SH3RF1;RNF4;TRIM37;DDB2;TRAF6;RNF213;MDM2;LRSAM1;UHRF2;OBI1;ITCH;RNF41
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.26713622450677355,-1.146819141947739,0.2857142857142857,0.7001199967799995,1.0,44/107,27.85%,SLC24A3;TPCN2;HTR2C;ANK2;SLC8A3;ATP2B2;ATP13A1;SLC8B1;TMEM165;CCL15;RYR2;ATP1B1;SLC39A7;SLC41A1;SLC39A14;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;ATP2B3;TRPV4;SLC8A1;SLC39A8;STOML2;SLC39A6;MT2A;SLC39A12;CCL3;STIM1;SLC30A1;CHERP;MT3;CD40;CCR1;RMDN3;CCL14;ATP13A4;CHRNA7;STIM2;ATP2C1
prerank,amino acid import across plasma membrane (GO:0089718),0.5336133873708808,1.14668286630886,0.3240963855421687,0.9924996842246276,1.0,3/24,3.20%,SLC1A5;SLC7A1;SLC6A5
prerank,peptidyl-arginine modification (GO:0018195),0.5640460979531812,1.1464046687580631,0.32317880794701986,0.9923788583143679,1.0,6/15,21.45%,ART3;KRTCAP2;PARK7;NDUFAF5;PRMT7;PADI4
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.28645092629868596,-1.1458772288616543,0.21052631578947367,0.7008342519179277,1.0,28/90,18.79%,IGF1R;KDM1A;EBF2;CMKLR1;APPL2;LPIN1;ESRRG;IL4R;ACADL;GNAS;PPARGC1B;MFN2;PRLR;HDAC3;PDGFC;ELOVL6;VEGFA;EPAS1;GJA1;IL18;GRB10;HADH;CD36;ADRB1;KDM3A;PER2;ADRB2;KDM6B
prerank,global genome nucleotide-excision repair (GO:0070911),0.5187224577064615,1.1458510907709256,0.32167832167832167,0.9932729382842221,1.0,6/26,17.75%,ERCC4;CHD1L;ERCC3;RNF111;UBA52;DDB2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5570242530058953,1.1453398007333278,0.32627646326276466,0.9940649701282102,1.0,8/18,26.38%,AQP1;ZFP36L1;HNRNPU;ZFP36L2;PCK2;KLF9;BCL2L11;UBE2L3
prerank,skeletal system morphogenesis (GO:0048705),0.4982907655688362,1.1451898923542199,0.29535398230088494,0.9934536068706845,1.0,9/42,16.06%,RAB33B;RFLNB;SPEF2;FUZ;HHIP;SKI;ANKRD11;HOXB4;FGFR1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4857767107148762,1.1451674526338462,0.28868120456905505,0.9924260043763067,1.0,4/69,3.67%,KIF14;NTF4;ERBB3;LIG4
prerank,negative regulation of histone methylation (GO:0031061),0.6036860905890695,1.144344350288986,0.3319559228650138,0.9944205027222116,1.0,5/10,19.63%,BRCA1;PHF1;DNMT1;JARID2;DNMT3B
prerank,positive regulation of calcium ion import (GO:0090280),-0.4603523125082833,-1.1438621935449707,0.3146067415730337,0.7040705018152481,1.0,8/12,49.00%,CCL3;SPHK2;CCL2;PDGFRB;STC1;RAMP3;CXCL12;ATP2A1
prerank,response to lipid (GO:0033993),0.474978603875737,1.1436337850803435,0.2682926829268293,0.9959393908770693,1.0,28/105,21.48%,IL12A;HMGB2;ALPL;PTPN22;S100A9;MAPKAPK3;SLPI;FOXP1;S100A8;FOXO1;JAK2;CDKN2D;ABCA2;ASXL1;SOCS2;HNRNPA0;STAT5B;OTUD5;F2R;TNFRSF11A;RXRB;SNCA;RARG;LGALS9;SOX9;PPARD;PCK2;RPS6KA3
prerank,T cell differentiation in thymus (GO:0033077),0.5755862157196381,1.1435186258590493,0.34972677595628415,0.9952548651899276,1.0,4/14,16.03%,LIG4;ZFP36L1;CCR6;ZFP36L2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.5774865705809913,1.1434069005771506,0.3423180592991914,0.994526836382619,1.0,2/12,1.91%,RFWD3;RPA2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.5992477266866543,1.1427106827762596,0.3309557774607703,0.996079311035218,1.0,4/10,12.75%,BRCA1;CHEK1;SMAD4;KMT2A
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.5014747328911306,1.1415970577529129,0.32131147540983607,0.9990218286232232,1.0,18/46,21.77%,RB1;NRDC;MAP2K6;STK11;ACOT11;NR1D1;NOTCH1;LAMA4;NOVA2;ACOT13;DDIT3;LGR4;ADAMTS5;TLE3;ACVR2B;RBPJ;PLCL1;NR1H3
prerank,regulation of platelet activation (GO:0010543),0.5311370742098008,1.1415390421641327,0.33291925465838507,0.9981052572477676,1.0,2/21,8.08%,BLK;PRKCA
prerank,serine family amino acid biosynthetic process (GO:0009070),0.5840391831454188,1.1411671671824437,0.3231197771587744,0.9983253046498186,1.0,4/12,17.57%,SERINC5;SERINC3;SEPHS1;PHGDH
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2651705202328865,-1.1409132597680889,0.18518518518518517,0.7099552959566715,1.0,22/80,13.78%,STX6;TBC1D14;STX16;GBF1;SNX5;VTI1B;RAB6B;TBC1D23;VPS50;TMED9;TBC1D10A;PREPL;TRIM27;SGSM2;TBC1D5;CLN5;ARL1;GOSR2;WASHC1;YKT6;TBC1D17;GOSR1
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4877291987358334,1.1407788704174542,0.28950050968399593,0.9986527864319285,1.0,20/85,16.53%,UHRF1;RAB33B;DEAF1;CDK6;NR1D1;ZFP36L1;RUNX3;TGFA;LAMC1;EGFR;B2M;MTSS1;PEX2;FGF9;PRKDC;MYC;LIMS1;TCF7L2;TGFB2;NLRC3
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.47886820204990876,1.1406268046897172,0.27125506072874495,0.9980468811061538,1.0,25/94,16.47%,CYP1B1;BRCA1;PMAIP1;CHEK2;E2F1;ITPR1;PML;APAF1;MSH6;STK11;CASP2;ATM;MAP3K5;PRODH;BOK;STK24;CUL3;PPP1R15A;HIPK2;PRKDC;DDIT3;CASP9;TP53;CD24;CRIP1
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5209100348489204,1.1404451560314255,0.332541567695962,0.9975896475810762,1.0,5/29,10.59%,IL12A;CCR2;HMGB1;JAM2;CCR6
prerank,T cell proliferation (GO:0042098),0.5763153526408803,1.1400044500266135,0.33738191632928477,0.9980599361198191,1.0,3/13,17.01%,RASGRP1;MSN;LMBR1L
prerank,protein K63-linked ubiquitination (GO:0070534),0.4931075936890134,1.1397715107404172,0.3076086956521739,0.997815565364667,1.0,20/41,24.65%,UBE2T;PRPF19;UBE2O;TRAF3;UBE2V1;RNF168;RNF8;RNF152;ARIH2;TRIM5;RNF115;TRAF3IP2;RNF4;UBE2G1;TRAF6;UBE2N;HECTD1;NEDD4;ITCH;UBE2S
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5316423820013536,1.139462917708518,0.34225844004656575,0.9978228438110047,1.0,10/25,20.82%,FBXL15;CCN1;UBE2O;NOTCH1;SMAD4;BMPR1A;NUMA1;ACVR2B;RBPJ;SMAD2
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5743333579152474,1.139394316336582,0.3386034255599473,0.9969734744168051,1.0,3/13,11.11%,HEY2;NOTCH1;SMAD4
prerank,actin filament network formation (GO:0051639),-0.45032837376099194,-1.139351512179202,0.3288135593220339,0.7120434353088831,1.0,3/11,15.26%,FHOD1;SPIRE1;FHOD3
prerank,organic acid transport (GO:0015849),0.4799361325049149,1.139306838571042,0.2884811416921509,0.9961603533402016,1.0,13/94,11.74%,SLC6A12;SLC38A5;SLC1A5;SLC7A1;SLC16A1;ABCC2;SLC25A47;SLC16A10;SLC43A2;SLC3A1;SLC19A1;STARD5;ABCC4
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.47166555763455786,1.1392715245408735,0.2729103726082578,0.9951764912600416,1.0,43/122,20.02%,ZCCHC4;RBM3;ABCB10;PCNA;EIF3E;ATAD5;SLC25A37;RPS4X;FAF1;SORBS1;EIF4A3;NIBAN1;DNA2;JAK2;MTPN;SMOC2;EGFR;CPEB3;BRPF3;DHX9;CTC1;UPF3B;FXR1;PRKDC;MYC;IRS1;PLD1;METTL14;EGF;PYM1;SAMD4A;EEF2;TGFB2;VIM;LARP4B;SIRT1;NAT10;XBP1;POLDIP3;ELAVL1;RPL5;PRKD2;EIF6
prerank,actin polymerization or depolymerization (GO:0008154),0.4935094617549247,1.1390557036689424,0.31309904153354634,0.9948742072371223,1.0,5/50,9.26%,DIAPH3;GSN;JAK2;CFL2;FLII
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.4243440214187898,-1.1389285243296108,0.2928870292887029,0.7111023706406923,1.0,7/13,29.21%,SEC16A;EDEM2;BCAP31;CD81;EDEM1;SAR1A;SORL1
prerank,nuclear envelope organization (GO:0006998),0.5415545763130905,1.1388000726949183,0.3105590062111801,0.9947085234839863,1.0,5/20,10.95%,NEMP1;REEP4;SUN2;EMD;TOR1A
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.42335289049129554,-1.1383715821295173,0.29699248120300753,0.7104725091067926,1.0,5/14,9.28%,OPHN1;MYO9A;PATJ;RAP2A;SH3BP1
prerank,negative regulation of reproductive process (GO:2000242),0.5480626342345272,1.1381478954041246,0.3337628865979381,0.9959773941387188,1.0,3/17,6.96%,NPPC;ARHGDIB;PAEP
prerank,epithelial cell-cell adhesion (GO:0090136),-0.4566927952323335,-1.1380550303292094,0.2751677852348993,0.7092652672495123,1.0,2/11,9.20%,ITGB5;JUP
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.36489264395112003,-1.1378528005037816,0.2602040816326531,0.7077896966860543,1.0,12/20,36.83%,SEMA3D;SEMA3E;SEMA4C;SEMA4G;SEMA3A;SEMA7A;SEMA4D;SEMA4F;SEMA6C;SEMA6B;SEMA3B;SEMA3F
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.5974914787694623,1.1370882390694268,0.34540389972144847,0.9988156744062288,1.0,1/11,1.81%,NR4A2
prerank,defense response to fungus (GO:0050832),0.5447290972574635,1.1370762690027512,0.3312020460358056,0.9977460194178597,1.0,4/17,10.76%,S100A9;S100A8;PLCG2;CARD9
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.559996580470687,1.1367193606248238,0.3350582147477361,0.9980149264948668,1.0,6/17,22.11%,ITGA1;PTPA;PPP1R15A;PPP1R12A;CALM3;PPP1R15B
prerank,positive regulation of cell adhesion (GO:0045785),0.47981619278487997,1.1365389776357078,0.2955715756951596,0.9975893502380639,1.0,10/74,8.88%,IL12A;TNFRSF18;ECM2;CD47;PPP3CA;ATM;CIB1;PRKCA;JAK2;ITGAV
prerank,regulation of macromolecule metabolic process (GO:0060255),0.47317842374586266,1.136442675270248,0.2316950852557673,0.9968556636538651,1.0,37/170,14.49%,TCF19;TRIM58;TMPRSS4;AFF3;MEFV;AFF1;CTCF;FOXP1;CDK6;NKAP;PTHLH;ZFP36L1;ZUP1;PIN1;MTMR2;AHR;NOVA2;TRIM11;SART3;PCBP2;TRIM44;PRDM10;ZNF462;ATXN7L3B;UBAP2;IGF2BP3;NPAT;TRIM68;PRDM6;NELL1;ROCK2;FLOT1;MYC;PSEN1;HNRNPAB;TRIM5;PCBP3
prerank,intraciliary retrograde transport (GO:0035721),-0.4434900344770041,-1.136315428251151,0.30268199233716475,0.7097426400094929,1.0,6/12,19.87%,DYNC2H1;IFT43;DYNC2I1;WDR35;DYNC2I2;WDR19
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.47099505897400423,1.136261571435709,0.2780586450960566,0.996434309437547,1.0,30/105,18.22%,MUC19;FYN;PSMB7;PSMD11;FBXW11;RPS6KA5;PSMF1;KLRD1;IKBKG;PSMC1;TAB1;PRKACA;PLCG2;TAB3;PDPK1;PSMC3;CARD9;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;PSMB1;TYROBP;PSMD8;PAK2;PSME4;PSMD4;MAP3K7;MALT1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.467456380600612,1.1357108463411665,0.24248496993987975,0.9973930683657931,1.0,41/163,17.74%,CD19;BLK;ERMAP;MS4A1;CD79A;GRAP2;FYN;PSMB7;CD38;PSMD11;FBXW11;PTPN22;PSMF1;IKBKG;CD79B;PSMC1;NFAM1;PLCG2;BTN3A3;PDPK1;PSMC3;BTK;PSMA4;PRKCB;PSMC4;PRAM1;DENND1B;PSMD13;PSME1;THEMIS;PSMB1;RBCK1;RC3H1;PSMD8;PAK2;PSME4;PLCG1;PIK3CA;PSMD4;SPPL3;MAP3K7
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5703688735622612,1.1353042858835067,0.34573002754820936,0.997760566919458,1.0,4/13,12.63%,STK11;ATM;SZT2;RNF152
prerank,regulation of Golgi organization (GO:1903358),0.5632067958642814,1.1351752670054847,0.33,0.9971454354243335,1.0,6/17,15.76%,RAB33B;MAPK1;STX5;ARMH3;PDCD10;MAP2K1
prerank,regulation of protein metabolic process (GO:0051246),0.4984466947250733,1.1350102421647097,0.3057671381936888,0.9966311252124415,1.0,10/44,15.55%,FAM83D;CHEK2;FAF1;TRAF3;NEDD4L;MTPN;ABCA7;ROCK2;SPOP;HGS
prerank,negative regulation of metabolic process (GO:0009892),0.4916076791308215,1.1346698473656092,0.33084311632870866,0.9968194066215074,1.0,20/54,21.77%,RB1;NRDC;MAP2K6;STK11;ACOT11;NR1D1;NOTCH1;LAMA4;NOVA2;ACOT13;FIS1;ZDHHC7;DDIT3;LGR4;ADAMTS5;TLE3;ACVR2B;RBPJ;PLCL1;NR1H3
prerank,negative regulation of lipid storage (GO:0010888),-0.3859615673500107,-1.134530811076737,0.28415300546448086,0.7125177882274597,1.0,3/19,1.79%,TREM2;PTPN2;ABCA1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4747742612893184,1.1344543450971996,0.22945891783567135,0.9964991256907864,1.0,33/140,15.29%,ECT2;FOXM1;RACGAP1;DEPDC1B;ARHGEF5;ARHGAP15;ARHGAP11A;ARHGAP33;TIAM1;NET1;ARHGEF18;ARHGDIB;ARHGEF3;FAM13A;ARHGAP35;CYRIB;SOS1;ITGAV;ARHGAP19;GMIP;RHOU;STARD8;ARHGAP39;RELN;ARHGAP30;FGD3;ARHGAP9;RAC2;ARHGAP45;ARHGAP26;ARHGAP31;BCR;FAM13B
prerank,mitochondrial fission (GO:0000266),-0.41570840594599495,-1.1343780458823634,0.2908366533864542,0.7109214727246935,1.0,7/16,16.69%,DNM2;DNM3;DNM1L;MIEF1;PRKN;MFF;MTFR1L
prerank,atrioventricular valve morphogenesis (GO:0003181),0.5426828219695156,1.134171427837589,0.3398294762484775,0.9964779557403493,1.0,8/19,16.23%,HEY2;ZFPM1;MDM4;NOTCH1;SMAD4;SLIT3;BMPR1A;TGFB2
prerank,cellular response to lectin (GO:1990858),0.4710065210845765,1.1341501633095796,0.2823886639676113,0.9943732386578144,1.0,30/104,18.22%,MUC19;FYN;PSMB7;PSMD11;FBXW11;RPS6KA5;PSMF1;KLRD1;IKBKG;PSMC1;TAB1;PRKACA;PLCG2;TAB3;PDPK1;PSMC3;CARD9;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;PSMB1;TYROBP;PSMD8;PAK2;PSME4;PSMD4;MAP3K7;MALT1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.4710065210845765,1.1341501633095796,0.2823886639676113,0.9943732386578144,1.0,30/104,18.22%,MUC19;FYN;PSMB7;PSMD11;FBXW11;RPS6KA5;PSMF1;KLRD1;IKBKG;PSMC1;TAB1;PRKACA;PLCG2;TAB3;PDPK1;PSMC3;CARD9;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;PSMB1;TYROBP;PSMD8;PAK2;PSME4;PSMD4;MAP3K7;MALT1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.3876300883104326,-1.1338194945378373,0.28846153846153844,0.7103272498653608,1.0,5/17,5.80%,RTN4;APOE;GGA3;IGF1;BIN1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.42323312993289286,-1.1336800100422106,0.29044117647058826,0.7086964003677338,1.0,7/13,46.09%,NAXD;PARP16;NAXE;NAPRT;NUDT12;NAMPT;PARP10
prerank,nucleocytoplasmic transport (GO:0006913),0.4982506210367903,1.1332555834998908,0.3203991130820399,0.996637054017399,1.0,16/40,20.19%,XPO1;GEMIN8;BACH2;SNRPF;NCBP1;NUP205;NUP98;HTATIP2;GEMIN7;AAAS;SNRPG;RSRC1;MALT1;HNRNPA1;NCBP2;SNRPB
prerank,positive regulation of dendrite extension (GO:1903861),-0.39208044739580367,-1.13317910869669,0.3076923076923077,0.7081156285952515,1.0,6/17,13.39%,RIMS1;RIMS2;SYT1;PLAA;SYT4;UNC13A
prerank,sarcomere organization (GO:0045214),0.518439033516538,1.132936432079255,0.33884297520661155,0.9967688192777401,1.0,3/27,10.23%,CSRP3;CSRP1;ACTN2
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.34685317795105597,-1.1329318111023945,0.28313253012048195,0.7068635462229435,1.0,7/24,15.12%,NUMB;BCL2L1;GDI1;LZTFL1;AP2M1;RHOQ;PPFIA1
prerank,phospholipid catabolic process (GO:0009395),-0.36277941259915586,-1.1327901780881375,0.25146198830409355,0.7052758490284747,1.0,6/24,15.23%,GPCPD1;ABHD12;ENPP2;GDE1;PLBD2;SMPDL3A
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.4845671325886569,1.1313986614146172,0.32048458149779735,1.0,1.0,6/49,13.81%,IL12A;TNFRSF18;JAK2;PARP14;FLT3;PIBF1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5999391206101861,1.1313763630276346,0.35311143270622286,1.0,1.0,2/10,3.56%,PMAIP1;PRKCE
prerank,regulation of mast cell activation (GO:0033003),-0.45916594277564576,-1.1309840578112562,0.3322475570032573,0.7080875928913469,1.0,2/10,2.48%,CD84;CD300LF
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3257699128899806,-1.1302196185167925,0.20967741935483872,0.7079364397409205,1.0,18/34,27.37%,TREM2;CD300LF;MFHAS1;PTPRS;TNFAIP3;CD300A;TLR4;GPS2;GPR108;LY96;DAB2IP;TICAM1;CACTIN;TICAM2;SMPDL3B;LYN;TYRO3;CD14
prerank,positive regulation of cellular process (GO:0048522),0.4672461804090006,1.1301536255500693,0.109,1.0,1.0,105/565,17.80%,PRC1;KIF20B;KIF14;TTK;BIRC5;PRTN3;FOXM1;ANKLE1;IL12A;TNFRSF18;EZH2;SPAG5;TIPIN;IL2RG;LEF1;CD47;FBXO5;IL7R;ERBB3;TIAM1;PPP3CA;SMC6;PA2G4;S100A9;BRAT1;COPS9;PGF;RPS19;DDX49;CHEK1;MLC1;AGPAT1;CAV1;CRKL;PTHLH;RPS4X;S100A8;FAF1;ATM;CSPP1;ZFP36L1;TGFA;CDC25B;NOTCH1;PRODH;DDRGK1;H3-3A;DYNC1H1;CIB1;PRKCA;RAD18;ITGAV;MTPN;NCBP1;EGFR;CAPN1;MECP2;CUL3;PRR7;DHPS;DERL2;ABCA7;RAD23A;RPRD1B;FGF9;DPP4;FLT3;FASN;PTEN;HCFC1;S1PR2;FXR1;RPS15A;RPS9;FLOT1;NUMA1;ACTN4;MYC;NAP1L1;PABIR1;CDC7;IRS1;KDM4C;PDCD10;EGF;F2R;TNFRSF11A;CNOT6;FGFR1;TGFB2;ACER3;VHL;CAPN10;KLHL22;RAC1;SIRT1;TRPM4;CYBA;SSR1;XBP1;FN1;HCLS1;KITLG;FCGR2B;COLEC12
prerank,brain morphogenesis (GO:0048854),0.5866210030331602,1.129713196198869,0.34615384615384615,1.0,1.0,5/12,13.22%,FBXW11;SPEF2;PAFAH1B1;PTEN;BBS4
prerank,positive regulation of nervous system development (GO:0051962),-0.3006011322408305,-1.1294448802692447,0.21359223300970873,0.708121721677396,1.0,10/42,11.74%,NUMB;PTPRD;SYNDIG1;CX3CR1;IL1RAP;CLSTN3;LRRC4B;TGM2;CLSTN1;CUX2
prerank,sodium ion transport (GO:0006814),0.47121739402808976,1.1292080750051126,0.29533678756476683,1.0,1.0,8/85,7.98%,SLC6A12;SLC12A3;SLC5A5;SLC6A2;SLC6A5;HCN3;SLC12A1;NEDD4L
prerank,regulation of interleukin-17 production (GO:0032660),0.5023946998681782,1.1291140268588928,0.3325499412455934,1.0,1.0,5/31,13.59%,IL12A;CARD9;MYD88;ZBTB7B;DDIT3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5852425514230984,1.1290819075799288,0.3581890812250333,1.0,1.0,6/13,19.55%,NKAP;RUNX3;CBFB;ZBTB7B;RUNX1;PNP
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5244761255141647,1.1289542265932273,0.3227771010962241,1.0,1.0,6/21,21.01%,HEY2;NOTCH1;ROCK2;TRPM4;SOX9;ROCK1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5914396552883922,1.1288267944244539,0.36213991769547327,1.0,1.0,6/12,18.96%,STMN1;DYRK1A;SNCA;ARHGEF7;TBCD;EML2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4769232859759337,1.1286861275862201,0.3169968717413973,1.0,1.0,20/67,19.18%,ECM2;FLNA;NEDD9;PLEKHA2;CDK6;CRKL;CIB1;JAK2;CRK;NRP1;RSU1;GSK3B;LIMS1;TRIOBP;CCL25;RAC1;UTRN;FN1;ARHGEF7;S100A10
prerank,macrophage differentiation (GO:0030225),-0.42938304969123153,-1.1284148786644963,0.31226765799256506,0.7089068758543361,1.0,5/13,19.06%,CSF1R;VEGFA;CSF1;IL31RA;CDC42
prerank,smoothened signaling pathway (GO:0007224),0.5077671934104036,1.1283583273726425,0.3333333333333333,1.0,1.0,1/32,0.26%,STIL
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.3856912955195851,-1.1281505059439996,0.2943722943722944,0.7077171017127992,1.0,3/17,9.94%,ANK3;KCNAB1;VAMP2
prerank,cellular response to virus (GO:0098586),0.5012101346565214,1.1280151170866886,0.32950631458094143,1.0,1.0,5/30,12.11%,IL12A;POU2AF1;MAPK14;RIOK3;TOMM70
prerank,regulation of histone acetylation (GO:0035065),0.5054300020805091,1.1278660776425138,0.3236929922135706,1.0,1.0,13/33,18.94%,BRCA1;RPS6KA5;CHEK1;TAF7;IWS1;RUVBL2;PARK7;PAXIP1;KMT2A;TADA2A;GLYR1;SNCA;BRD7
prerank,regulation of mRNA stability (GO:0043488),0.46708745310041566,1.1278507299278802,0.2637913741223671,0.99993799329234,1.0,65/145,26.38%,XPO1;E2F1;PSMB7;PSMD11;PSMF1;TNPO1;EXOSC8;FTO;PDE12;ZFP36L1;PSMC1;PUM2;TAF15;NUP214;DCP2;PRKCA;PSMC3;PUM1;PSMA4;IGF2BP3;PSMC4;DCP1A;APEX1;METTL16;FXR1;ROCK2;PSMD13;HNRNPU;PSME1;PAIP1;PSMB1;RC3H1;METTL14;PSMD8;SAMD4A;ZFP36L2;PSME4;VIM;PSMD4;UBA52;EIF4ENIF1;ELAVL1;THRAP3;XRN1;ROCK1;TENT5D;CELF1;PSME2;DIS3;PRKCD;YBX1;GDNF;NPM1;CIRBP;MEX3D;PSME3;PSMD6;GIGYF2;FASTKD1;SET;YWHAZ;KHSRP;CARHSP1;PSMD9;PSMA1
prerank,regulation of focal adhesion assembly (GO:0051893),-0.2867566005156633,-1.1277313405814786,0.1694915254237288,0.7067984375914111,1.0,22/54,18.44%,ARHGAP6;EFNA5;LIMCH1;MACF1;APOD;PTPRJ;SLC9A1;CLASP2;CORO1C;LDB1;DUSP3;TSC1;FERMT2;RCC2;PPM1F;PTK2;VEGFA;MAP4K4;ACVRL1;COL16A1;THY1;THBS1
prerank,cellular response to interleukin-15 (GO:0071350),0.581965165204648,1.1275346415576497,0.3450134770889488,0.9989559480387205,1.0,5/13,16.74%,IL2RG;GRB2;PLCB1;STAT5B;JAK3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.581965165204648,1.1275346415576497,0.3450134770889488,0.9989559480387205,1.0,5/13,16.74%,IL2RG;GRB2;PLCB1;STAT5B;JAK3
prerank,regulation of protein autophosphorylation (GO:0031952),-0.31850631331058776,-1.1270784908514233,0.19801980198019803,0.7064447342606796,1.0,12/36,15.08%,IMPACT;PPP2R5C;RAP2A;PDGFD;ENG;RAP2C;PDGFC;MVP;TOM1L1;VEGFA;MRE11;CALM1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5036240299621464,1.1268959852724874,0.36818181818181817,1.0,1.0,9/32,16.99%,PMAIP1;PML;STK11;PHLDA3;BOK;HIPK2;TP53;TMEM109;SIRT1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5665562214924091,1.1267806328923116,0.3466299862448418,0.9996111482599956,1.0,4/12,13.22%,NIN;NINL;PCM1;BBS4
prerank,rRNA modification (GO:0000154),0.5334697448318414,1.1265209467350756,0.34529702970297027,0.9995252812972377,1.0,9/21,18.03%,ZCCHC4;NOP10;TFB1M;TFB2M;FBL;NSUN3;DIMT1;NAT10;DKC1
prerank,positive regulation of cell population proliferation (GO:0008284),0.46822783776207044,1.1261479777646133,0.156,0.9999438190901287,1.0,74/423,17.58%,PRC1;KIF20B;KIF14;TTK;BIRC5;PRTN3;FOXM1;EZH2;TIPIN;AQP1;LEF1;E2F1;CD47;FBXO5;IL7R;ERBB3;TIAM1;CCN1;LIG4;CD74;CCN4;COPS9;PGF;FOXP1;CDK6;CRKL;PTHLH;RPS4X;TGFA;CDC25B;NOTCH1;DDRGK1;CIB1;LAMC1;ITGAV;EGFR;CAPN1;MECP2;CUL3;PIM1;DHPS;DERL2;RPRD1B;FGF9;DHX9;DPP4;FLT3;PTEN;BMPR1A;S1PR2;RPS15A;RPS9;HNRNPU;MYC;NAP1L1;CDC7;IRS1;KDM4C;PDCD10;EGF;F2R;TNFRSF11A;CNOT6;TCF7L2;FGFR1;TGFB2;ACER3;SIRT1;TRPM4;SSR1;XBP1;FN1;HCLS1;KITLG
prerank,response to interleukin-6 (GO:0070741),0.602554194179255,1.1257847638177358,0.371994342291372,1.0,1.0,1/10,0.77%,FOXA2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.46733374513852177,1.1256855212965846,0.3101010101010101,0.9995598715502151,1.0,32/101,20.02%,UHRF1;PLK1;ZCCHC4;AURKAIP1;EZR;RBM3;FBXW11;CYFIP2;EIF3E;RPS4X;FAF1;EIF4A3;NIBAN1;CPEB3;MSN;RDX;UPF3B;FXR1;PRKDC;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;LARP4B;NAT10;POLDIP3;ELAVL1;RPL5;CASP8;EIF6
prerank,small GTPase mediated signal transduction (GO:0007264),0.4723108851829819,1.1256223424739082,0.2778904665314402,0.9986974043366335,1.0,35/103,19.82%,CCNA2;RRAD;ARHGAP33;RB1;CCDC88A;GRAP2;TIAM1;NTN1;ARHGEF18;RASGRP1;CDKN2A;CRKL;CCDC88C;MAPK14;GRB2;SOS1;DNMT1;RIT2;PARK7;ARHGAP30;JUN;PLD2;PLD1;TP53;ARHGAP31;BCR;USP50;TRIM28;RAC1;RASSF1;SETDB1;CDKN1A;KSR1;ARHGAP1;G3BP1
prerank,action potential (GO:0001508),-0.30718123576103556,-1.1255618445364126,0.24175824175824176,0.7086582792295887,1.0,11/44,11.03%,ANK3;SCN8A;GNA15;SCN1A;KCND2;GNA14;SRI;SCN9A;DMD;SCN3A;KCNA2
prerank,negative regulation of neuron projection development (GO:0010977),-0.27865711262424725,-1.125509531680303,0.1875,0.7068889426628007,1.0,22/56,17.91%,RTN4;SPOCK1;RUFY3;GAK;APOE;PRAG1;STMN2;GDI1;PTPRS;HDAC2;MAG;EFNB3;PTPRO;FKBP4;PTPN9;PAQR3;CBFA2T2;SEMA3A;TRPV4;EPHA4;THY1;CRMP1
prerank,"transcription, DNA-templated (GO:0006351)",0.4649268818625873,1.1253483602657304,0.239,0.9985889220524601,1.0,62/207,19.97%,PAX5;PMF1;TRIP13;NR4A2;GTF3C5;DEAF1;E2F1;SMARCA5;RSF1;GTF2E1;DEK;POLR2I;POLR2A;EPC1;TAF1;MBD1;PTMA;SETX;IRF9;BRF1;TFDP1;TAF7;TAF15;IWS1;TFB2M;GTF2A1;NCBP1;SNAPC3;RNPS1;ERCC3;KLF13;BTF3;RTF1;TAF6;NELFA;CCNT1;ARRB2;CBFB;TEFM;ZBTB7B;TAF2;POLR1C;NFX1;GMEB2;CCNK;TP53;NELFB;MLLT1;TAF9;POLR2K;PIR;XBP1;POLR2J;TAF1C;DRG1;TTF2;NKX2-8;HIPK3;NCBP2;NCOA6;TAF3;GTF2A2
prerank,regulation of T cell cytokine production (GO:0002724),0.5510141834266458,1.1253116324391466,0.34554973821989526,0.997668792224781,1.0,7/15,19.45%,CCR2;B2M;TRPM4;MAP3K7;MALT1;CD55;TRAF6
prerank,regulation of intracellular pH (GO:0051453),0.49812360272532635,1.1252542571213646,0.33518312985571586,0.9968043658173769,1.0,8/34,19.15%,SLC4A1;SLC9A8;SLC9A9;LRRK2;ATP5F1B;CLN3;SLC9A6;SLC9A7
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3304830470709378,-1.1250390921847968,0.26506024096385544,0.7062877976916515,1.0,8/28,18.03%,PTPN2;APPL2;PTPRE;PIP4K2B;GSK3A;GRB10;TSC2;SLC27A4
prerank,regulation of superoxide anion generation (GO:0032928),0.5459818126870303,1.1248633139148785,0.34776902887139105,0.9971210530380953,1.0,1/14,1.29%,CD177
prerank,regulation of organelle organization (GO:0033043),0.482741440481263,1.1248562579698504,0.3010204081632653,0.996084731032414,1.0,27/80,19.67%,RAB33B;ARHGEF5;PISD;MAPK1;EZR;S100A9;S100A8;STX5;PDE2A;ARL6IP1;MARK2;MSN;RDX;FIS1;ARMH3;SIRT7;DIAPH1;TBC1D25;PDCD10;MTM1;PAK2;LMAN1;TAOK1;CLN3;PDE4DIP;SAR1B;GOLPH3
prerank,protein destabilization (GO:0031648),0.5070424750271957,1.1247847162958517,0.33370786516853934,0.9952620423058011,1.0,11/32,17.96%,PLK1;FBXW11;NR1D1;GSN;CCDC88C;CUL3;RAD23A;PEX2;CREBBP;SIRT1;SNCA
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.29948994976347154,-1.1246961287586188,0.25252525252525254,0.7052861161337812,1.0,8/41,8.57%,CTSS;ANK3;KCNMA1;KCNN2;ANK2;KCNJ6;GABBR1;GABBR2
prerank,protein localization to nucleus (GO:0034504),0.46616022874743596,1.1246196362057894,0.31097560975609756,0.9947803750270298,1.0,40/102,21.96%,PLK1;POM121;PML;NUP107;TNPO1;IPO13;NUP50;GBP2;NUP214;ZBTB7A;SEC13;IPO7;NUP188;ABCA7;TOR1A;RANBP6;CNEP1R1;RPAIN;CHCHD10;BBS4;HNRNPU;INTS13;NOL8;E2F3;APPL1;IPO5;KPNB1;YWHAE;MORC3;EIF4ENIF1;NUP85;TAF3;MMP12;TPR;TNPO2;WRN;MDM2;TNPO3;SYK;NUP93
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2670956537092494,-1.124522076997641,0.22580645161290322,0.7039304917217288,1.0,33/75,25.93%,PAK3;APP;OPHN1;ANK3;ZDHHC17;DSCAML1;NTNG1;MINK1;RYK;S100B;BAIAP2;MAP1A;MAP6;CTNNA2;ACTB;MEF2A;CDK5;FARP1;MAP1S;LLGL1;TMEM106B;ADGRB1;AFG3L2;RAB3A;CELSR2;PARD3;SLITRK4;BRSK2;DCC;ATL1;KLF7;DVL1;SLITRK3
prerank,peripheral nervous system development (GO:0007422),0.5284998478839271,1.1243638097977038,0.336144578313253,0.9946319647704164,1.0,3/23,9.66%,NTF4;ERBB3;PMP22
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5176469188002567,1.124250638474377,0.34782608695652173,0.9939507492201376,1.0,10/24,20.59%,MAP2K6;IKBKG;TAB1;UBE2V1;TAB3;UBA52;MAP3K7;TRAF6;CASP8;UBE2N
prerank,cellular response to exogenous dsRNA (GO:0071360),0.5677384233462363,1.1239432935416502,0.3581267217630854,0.9939254721258841,1.0,5/12,17.80%,CGAS;CAV1;DHX9;FLOT1;COLEC12
prerank,regulation of stem cell proliferation (GO:0072091),0.5436579001655314,1.1239129584109335,0.3354673495518566,0.9929942386082232,1.0,2/17,6.60%,HMGB2;ZFP36L1
prerank,negative regulation of defense response to virus (GO:0050687),0.5934941057667913,1.1235874684734242,0.3624260355029586,0.9930660411788197,1.0,4/10,18.88%,RNF26;PCBP2;TARBP2;PPM1B
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.4582888707551314,-1.1233846494364939,0.3333333333333333,0.7052632221577498,1.0,6/11,54.18%,RTP4;PKD2L1;PKD1L3;LPO;RTP2;TAS1R3
prerank,supramolecular fiber organization (GO:0097435),0.46301801961078237,1.1231141125802448,0.179,0.9936552734694659,1.0,45/333,11.44%,KIF18B;KIF14;KIF2C;MYO5C;TMOD4;SPTA1;KIF24;KIF18A;CKAP5;CYP1B1;STMN1;DES;TUBGCP6;IAPP;PPP1R9B;SAMD14;MYO15A;CCDC88A;SLK;HSPG2;PLOD3;CRTAP;TUBGCP4;GSN;CCDC88C;COL1A2;RND3;PIN1;SHROOM2;H3-3A;DYNC1H1;CIB1;COL4A4;TSPAN33;LAMB3;FLII;PCM1;WHAMM;KIF2A;ATP7A;SHROOM4;B2M;SLAIN2;GGA1;TLL2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.2907837662046465,-1.1228344066414682,0.2111111111111111,0.7048179487338573,1.0,9/48,12.88%,TREM2;PTPN2;RFFL;PADI2;YTHDF2;ROBO1;SH2B3;GPS2;CARD16
prerank,regulation of response to stress (GO:0080134),0.5849865605085038,1.1226290717377954,0.3469675599435825,0.9942783694748469,1.0,2/10,5.17%,CRHBP;MLC1
prerank,protein localization to lysosome (GO:0061462),-0.3377106156752527,-1.1224858736383,0.25165562913907286,0.7039089351018613,1.0,9/28,14.07%,RTN4;GGA3;RNF128;MFSD1;SNX16;SCARB2;GLMP;LAMTOR5;NAGPA
prerank,response to purine-containing compound (GO:0014074),-0.38089595026443474,-1.1222159004918355,0.3317307692307692,0.7026921609928033,1.0,8/17,29.71%,RYR2;DGKQ;TRPC3;P2RX4;VGF;NDUFS4;ABCC9;TRPM2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.26472480232348883,-1.1221497191087195,0.2,0.7010531457366033,1.0,23/87,15.54%,ACVR1;ITGB5;TGFBR1;GCNT2;APPL2;F11R;NLK;PTPRK;SMAD1;SMAD3;ZFYVE9;USP9X;SMAD6;ZMIZ2;ENG;LPXN;FERMT2;SMAD7;ZMIZ1;ADAM9;PTK2;TGFBR3;ACVRL1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.5676942554536254,1.121962833950232,0.3603851444291609,0.9956829550139507,1.0,4/12,23.99%,CCR2;CARD9;ZBTB1;PRKCQ
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.5725673682548084,1.1218675826893068,0.36947791164658633,0.9949876488775011,1.0,5/13,16.43%,CD74;AGPAT1;TRIM44;DHX9;TAF9
prerank,positive regulation of ion transport (GO:0043270),-0.2888188622582676,-1.1216317621566796,0.24210526315789474,0.7005534849227667,1.0,17/48,22.09%,ANK3;CACNB2;CNKSR3;ANK2;SCN1B;FHL1;VAMP8;VAMP7;CCL4;DLG1;WFS1;CCL3;ORAI1;P2RX4;RAB3B;SCN3B;AHCYL1
prerank,regulation of autophagosome assembly (GO:2000785),-0.3229659154426249,-1.1214003248140598,0.26356589147286824,0.6992695889037659,1.0,8/33,7.94%,TBC1D14;IFT88;TBC1D12;PIP4K2B;FEZ2;FEZ1;SH3GLB1;RAB3GAP2
prerank,protein targeting to peroxisome (GO:0006625),0.5140579340389713,1.1212108762608064,0.3596698113207547,0.9963800387704506,1.0,9/29,12.06%,PEX26;ABCD1;ACBD5;PEX11B;PXMP4;GDAP1;PEX2;RAB8B;FIS1
prerank,xenobiotic transport (GO:0042908),-0.38547569307963336,-1.1211996746066375,0.2766990291262136,0.6979304725592933,1.0,3/17,6.32%,ABCC5;ABCC3;ABCC1
prerank,positive regulation of leukocyte migration (GO:0002687),0.5145879391152219,1.1211307560609438,0.34441805225653205,0.9956287747377723,1.0,1/27,0.75%,TNFRSF18
prerank,cellular response to glucagon stimulus (GO:0071377),-0.38856824955067715,-1.1211279484754904,0.33739837398373984,0.6963206267604598,1.0,4/17,4.80%,PRKACB;PRKAR1A;ADCY7;ADCY2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5796054087814132,1.1208781864546524,0.3278008298755187,0.9955104396184521,1.0,5/11,15.31%,PUM2;PUM1;DHX9;FXR1;LIMD1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.47768703407128926,1.1208366216240313,0.30340557275541796,0.9946221246913933,1.0,27/68,21.85%,POLR1B;POLR2A;SLBP;SNRPF;SETX;CPSF2;NCBP1;POLR1A;ERCC3;CSTF3;POLR1F;POLR1C;POLR2K;SCAF8;SNRPG;PCF11;CPSF1;TAF1C;CLP1;TTF2;TAF1D;POLR1G;NCBP2;CPSF7;SNRPB;WDR33;PAPOLA
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.5500613777477437,1.120787174078623,0.36595174262734587,0.9937695659647943,1.0,1/14,0.97%,MYB
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5230871735065865,1.1207545342902971,0.35396039603960394,0.9928585730940853,1.0,7/22,18.70%,BARD1;SP100;RANGAP1;PARK7;LMAN1;LRRK2;SUFU
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5790796916458685,1.1206940998477952,0.3343065693430657,0.9920359384033469,1.0,5/11,14.81%,ARID1B;CDCA4;CHEK1;SERTAD2;ELOF1
prerank,steroid biosynthetic process (GO:0006694),0.48370678987583077,1.1206558633876182,0.337953091684435,0.9911361522377086,1.0,9/56,13.57%,HSD17B3;LBR;SRD5A2;LSS;OSBPL3;CYP27A1;SLC27A2;CYP46A1;PRKAG2
prerank,extracellular matrix assembly (GO:0085029),0.5223213308800146,1.1205050892403905,0.36069651741293535,0.990663083222672,1.0,6/23,12.54%,HAS1;LAMB2;LAMB3;NTNG2;ATP7A;EFEMP2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.4691665490914872,1.120465728616036,0.225,0.9897815780751472,1.0,93/241,20.41%,RBM15;LSM6;DHX38;POLR2I;SNRNP25;PRPF19;POLR2A;IK;SNRPF;HNRNPC;SNRPC;HNRNPM;HNRNPL;HNRNPA3;CPSF2;CRNKL1;PPIL3;U2AF1;SNRNP200;EIF4A3;UBL5;SRSF3;SPEN;TXNL4A;HNRNPA2B1;RNPC3;PSPC1;NOVA2;SART3;PRPF38A;SRSF4;NCBP1;LSM2;SNRNP35;RNPS1;RALY;NONO;CASC3;U2AF1L4;PPWD1;CSTF3;SRRT;RBM19;PCBP2;PRPF31;DHX9;HNRNPA0;LSM5;U2SURP;UPF3B;ZMAT2;HNRNPR;CWC15;HNRNPU;SF3B5;PRPF4;TFIP11;LSM7;SRRM2;PDCD7;METTL14;SART1;SRSF10;GEMIN7;DNAJC8;SNRNP40;ESS2;POLR2K;SRSF7;CDC40;DDX39B;POLR2J;SNRPG;GCFC2;PCF11;CPSF1;PRPF8;RSRC1;CLP1;PPIE;HNRNPA1;PPIH;ELAVL1;NCBP2;ZCCHC8;SRSF2;SF3A2;SNRNP48;CPSF7;SNRPB;PPIL1;RBM4B;SYNCRIP
prerank,rRNA transcription (GO:0009303),0.5385245125388445,1.1202551514437538,0.37290322580645163,0.9894690622655878,1.0,7/17,20.65%,GTF3C5;BRF1;NIFK;TCOF1;SIRT7;POLR1G;SPIN1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.49637321516656147,1.1195178231549798,0.33221099887766553,0.9910280137748099,1.0,2/39,1.86%,BLK;TFR2
prerank,negative regulation of protein binding (GO:0032091),0.4778503369377943,1.119362673990303,0.31386861313868614,0.990555145489121,1.0,20/71,19.06%,AURKB;AURKA;DDX11;ZFPM1;SLPI;CAV1;DISC1;PIN1;PARK7;B2M;ARRB2;RACK1;TFIP11;GSK3B;STYX;PEX14;LRRK2;PPP1CA;GNL3L;CDKN1A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.47357908767790274,1.118981037956874,0.3274793388429752,0.9908996388053858,1.0,22/73,17.58%,MYB;PDCD2;PSMB7;PSMD11;PSMF1;TCF3;PSMC1;PSMC3;PSMA4;PSMC4;CBFB;KMT2A;PSMD13;PRKDC;PSME1;PSMB1;RUNX1;METTL14;PSMD8;PSME4;PSMD4;KITLG
prerank,regulation of protein localization to centrosome (GO:1904779),0.5834376681277891,1.1189161543648072,0.3489736070381232,0.9901352158863428,1.0,4/10,16.00%,CEP72;CEP250;GSK3B;MARK4
prerank,activation of phospholipase C activity (GO:0007202),0.5102017408958005,1.118690980806962,0.34651162790697676,0.9898937779508818,1.0,3/29,3.43%,NTF4;S1PR4;HTR2A
prerank,lymphocyte differentiation (GO:0030098),0.4752283138863173,1.1186703347394702,0.32356020942408376,0.9889571013117406,1.0,15/68,18.01%,LY6D;MS4A1;CD79A;PTPN22;TCF3;CD79B;NFAM1;PLCG2;ZBTB7A;FLT3;CEBPG;DNAJB9;JAK3;LMBR1L;HDAC4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5250701240620059,1.118537324723055,0.34478527607361964,0.9884070289593528,1.0,6/22,11.89%,ERI2;KRI1;EXOSC8;EXOSC10;URB1;ERI1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5020942831933051,1.1171905908723707,0.34843205574912894,0.9920833286350947,1.0,4/29,5.32%,PMAIP1;PML;TNFSF10;CAV1
prerank,negative regulation of hippo signaling (GO:0035331),0.576925065371997,1.1171117831934747,0.364010989010989,0.9913262508884079,1.0,2/12,8.09%,CIT;MAPK14
prerank,positive regulation of kinase activity (GO:0033674),0.4655281878146686,1.1168414139773573,0.31281533804238143,0.9912747235705412,1.0,18/107,13.68%,CENPE;ERBB3;CCN1;LMO4;CD74;MMD2;MMD;MAPRE3;XRCC6;MRNIP;SNX9;EGFR;EPHA3;RELN;FLT3;LMTK2;PRKAG2;ADCYAP1
prerank,protein K48-linked ubiquitination (GO:0070936),0.4829644034151372,1.1167555635442228,0.3273305084745763,0.9905514880551053,1.0,15/54,18.14%,UBE2C;UBE2T;SKP2;UBE2K;NEDD4L;CUL3;AMFR;RNF8;RNF152;ARIH2;RNF115;UBE2R2;RNF4;SYVN1;UBE2G1
prerank,glutathione metabolic process (GO:0006749),-0.30952775570180013,-1.1164840714916748,0.26,0.7062419404765371,1.0,9/38,17.34%,HPGDS;CTNS;HAGH;CNDP2;GGT5;GSS;CHAC2;GPX1;OPLAH
prerank,positive regulation of synaptic transmission (GO:0050806),-0.28004778567293376,-1.1164543935361864,0.12,0.7045384780688857,1.0,17/72,11.68%,RIMS1;APP;RIMS2;SQSTM1;STX4;SLC8A3;SYT1;KCTD13;CACNG2;CACNG7;SHANK2;VAMP2;CLSTN3;GRIK2;LGMN;ADRA1A;CLSTN1
prerank,activation of protein kinase A activity (GO:0034199),-0.39216362010763606,-1.116282369850072,0.30980392156862746,0.7031307102179362,1.0,4/16,4.80%,PRKACB;PRKAR1A;ADCY7;ADCY2
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.5163245412608803,1.1162636334799212,0.35961768219832735,0.9912182061865993,1.0,7/26,11.75%,CCNB1;CDC25B;PKN2;PRKCA;SMOC2;CUL3;CCDC57
prerank,pre-replicative complex assembly (GO:0036388),0.4743219134164308,1.1161843015748338,0.33611691022964507,0.9904835788753648,1.0,19/64,17.62%,PSMB7;PSMD11;MCM6;ORC5;PSMF1;ORC3;GMNN;PSMC1;PSMC3;PSMA4;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;MCM3;PSMD4;UBA52
prerank,alcohol catabolic process (GO:0046164),0.5887154805809508,1.115853318717413,0.3855072463768116,0.9906388465135321,1.0,4/10,15.36%,CEL;CYP27A1;CYP46A1;SRD5A3
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5676154912295092,1.1153720853711417,0.3772290809327846,0.9912591983851264,1.0,7/12,17.80%,RNF168;NELFA;RNF8;HNRNPU;NELFB;TCERG1;HEXIM1
prerank,regulation of cell adhesion (GO:0030155),0.46560915096168276,1.1149914253305593,0.2686116700201207,0.9916094566243828,1.0,16/129,9.84%,KIF14;IL12A;TNFRSF18;SPN;ERBB3;PPP3CA;RIPOR2;CYTIP;ARHGDIB;PPP1CB;ATM;PRKX;PRKCA;PLXNA2;ITGAV;CBLL1
prerank,regulation of actin nucleation (GO:0051125),0.5675454898329949,1.1145817214298448,0.355463347164592,0.9920408556425253,1.0,3/12,10.21%,GSN;PICK1;WHAMM
prerank,mitochondrial translational termination (GO:0070126),0.47251335128784855,1.1143726503084572,0.32073544433094997,0.9918089410488766,1.0,21/88,17.25%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MTRF1L;MRPS34;MRPL38
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5220549835033623,1.1143597741125342,0.36666666666666664,0.9908395544158164,1.0,5/24,9.90%,ALAS2;ABCB10;TSPO;NFE2L1;COX10
prerank,positive regulation of proteolysis (GO:0045862),0.4762816208793266,1.113961292335295,0.3198724760892667,0.9911878994128297,1.0,9/55,8.00%,PLK1;NRDC;AURKAIP1;RCN3;FBXW11;SNX33;TANK;CYFIP2;SNX9
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5596709003402801,1.1137268469983914,0.3656207366984993,0.9909832029017595,1.0,4/13,7.58%,SMUG1;DUT;MBD4;NEIL1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3621341303250184,-1.113345463009024,0.3069306930693069,0.7066523857006147,1.0,8/20,20.01%,ECHS1;ACADSB;HIBCH;ACAD8;ALDH6A1;ACAT1;BCKDHA;SLC25A44
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3621341303250184,-1.113345463009024,0.3069306930693069,0.7066523857006147,1.0,8/20,20.01%,ECHS1;ACADSB;HIBCH;ACAD8;ALDH6A1;ACAT1;BCKDHA;SLC25A44
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),-0.35746440498836163,-1.1131629556931812,0.266304347826087,0.7035743710349531,1.0,13/22,35.93%,GOLGA7;ZDHHC8;CLIP3;ZDHHC24;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;ZDHHC4;ZDHHC23;ZDHHC22;GOLGA7B;ZDHHC1
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),-0.35746440498836163,-1.1131629556931812,0.266304347826087,0.7035743710349531,1.0,13/22,35.93%,GOLGA7;ZDHHC8;CLIP3;ZDHHC24;ZDHHC20;ZDHHC15;ZDHHC3;ZDHHC12;ZDHHC4;ZDHHC23;ZDHHC22;GOLGA7B;ZDHHC1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.5009804343238908,1.1128302604407054,0.358974358974359,0.9930317749540317,1.0,7/37,10.90%,RNASE6;PPP1R8;ENTPD3;ENTPD5;DNASE1L1;NCBP1;NUDT9
prerank,RNA modification (GO:0009451),-0.28054972657246474,-1.1125647744145795,0.23333333333333334,0.7033429120361682,1.0,22/54,18.51%,ADARB1;ADAR;PUS7;ANKRD16;TRMT1;DTWD2;NSUN2;NSUN4;JMJD6;WDR4;QTRT1;ELP5;TYW5;TRIT1;NOP2;METTL1;FTSJ1;MEPCE;THUMPD1;FTSJ3;ALKBH1;PARN
prerank,cellular response to increased oxygen levels (GO:0036295),0.5760166371319411,1.11237338560658,0.38108882521489973,0.9936072026526412,1.0,5/11,17.14%,CAV1;FOXO1;FAS;ATP6AP1;ATP6V0D1
prerank,regulation of cholesterol efflux (GO:0010874),-0.32548099178846956,-1.1123085003563642,0.2682926829268293,0.702219464205987,1.0,7/30,10.30%,TREM2;LRP1;APOE;ABCA5;PLTP;ZDHHC8;GPS2
prerank,necroptotic process (GO:0070266),-0.3902668570227973,-1.111979632243004,0.33195020746887965,0.701330967988291,1.0,9/16,27.37%,ITPK1;DNM1L;TLR4;LY96;TICAM1;IPMK;TICAM2;MLKL;CD14
prerank,adherens junction organization (GO:0034332),-0.2847741977345202,-1.1118784349283637,0.273972602739726,0.6997944783162884,1.0,18/48,19.35%,CDH11;CDH8;CTNNB1;CTNND1;CDH13;CDH2;CDH12;AFDN;JUP;FERMT2;ACTB;SMAD7;NECTIN4;CADM2;PIP5K1C;CADM1;ANG;CSK
prerank,regulation of glucose transmembrane transport (GO:0010827),0.5264088967148793,1.1116464785013713,0.3620253164556962,0.9951841600978584,1.0,5/18,18.63%,C2CD5;PRKCB;PRKAG2;APPL1;SLC2A1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.4666733711438523,-1.1109134251665402,0.35331230283911674,0.7004649801710047,1.0,3/10,6.31%,UPP2;NT5M;DPYD
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.48217088688393783,1.110193532872632,0.34796573875803,0.9992457122288301,1.0,18/52,15.93%,LSM6;DCPS;EXOSC8;PDE12;DCP1B;DCP2;LSM2;EDC3;PNLDC1;TUT4;CNOT4;LSM5;DCP1A;CNOT1;LSM7;RC3H1;CNOT6;SAMD4A
prerank,response to cholesterol (GO:0070723),-0.38388843263122757,-1.1100971823532095,0.3225806451612903,0.7008709682914546,1.0,9/17,19.78%,TGFBR1;SMO;OSBPL7;CCR5;GRAMD1B;TGFBR2;GPLD1;CCL3;PMVK
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.37990043834513854,-1.1100859321921404,0.3192488262910798,0.6991461167363109,1.0,8/16,20.58%,ST8SIA1;ST6GALNAC4;LARGE1;ST6GALNAC6;B4GALNT1;ST8SIA5;ST6GALNAC3;ST8SIA3
prerank,male gonad development (GO:0008584),0.4945091863508228,1.1096833209728205,0.3478747203579418,1.0,1.0,7/34,19.46%,SRD5A2;CSDE1;FGF9;ING2;TGFB2;KITLG;SOX9
prerank,plasma membrane tubulation (GO:0097320),0.5629652834682741,1.1092950771606063,0.3629139072847682,1.0,1.0,4/13,12.34%,SNX33;SNX9;WHAMM;PACSIN2
prerank,protein import (GO:0017038),0.4644919006882694,1.1086324672259475,0.3378099173553719,1.0,1.0,38/84,23.75%,PEX26;POM121;NUP107;SNX33;ABCD1;TNPO1;IPO13;ACBD5;NUP50;NUP214;PEX11B;PXMP4;SEC13;IPO7;NUP188;GDAP1;RANBP6;PEX2;RAB8B;FIS1;RPAIN;E2F3;APPL1;IPO5;KPNB1;PEX14;ATAD1;EIF4ENIF1;NUP85;MMP12;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2;PEX3;IPO8
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5531950396506468,1.1084560985098295,0.3767313019390582,1.0,1.0,4/13,7.07%,SAE1;UBA2;DESI2;DESI1
prerank,protein localization to phagophore assembly site (GO:0034497),0.5727237938926519,1.1080882027694468,0.3710144927536232,1.0,1.0,2/11,3.96%,ATG13;STX17
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.3871478414086012,-1.1080682778421231,0.3108108108108108,0.7022411966967139,1.0,5/16,17.82%,DAGLB;SLC27A1;SCARB1;CTDNEP1;GPLD1
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.3252249728494011,-1.1079939146907907,0.3008849557522124,0.7007140633672909,1.0,11/32,22.74%,RREB1;AKIRIN1;ENPP2;PIK3R1;CORO1C;ARPC2;ABI2;TWF2;CDC42;CORO1B;CYFIP1
prerank,nuclear pore organization (GO:0006999),0.5506845348381665,1.1078593313631222,0.38501971090670173,1.0,1.0,5/14,12.23%,NDC1;NUP107;NUP205;AHCTF1;NUP98
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.48193400299371403,1.1078206344879096,0.33015873015873015,1.0,1.0,11/52,13.39%,MBNL3;RBM15;HNRNPL;SAP18;NOVA2;ZBTB7A;RNPS1;RBFOX3;RBM7;FXR1;HNRNPU
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5655407658777369,1.1077295043666946,0.37329700272479566,0.9997442032677191,1.0,5/13,16.74%,IL7R;JAK2;PIGU;EGF;JAK3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5098836089416635,1.1076032195113787,0.3635280095351609,0.9992036241878935,1.0,11/26,20.59%,MAP2K6;IKBKG;TAB1;UBE2V1;TAB3;TIFA;UBA52;MAP3K7;TRAF6;CASP8;UBE2N
prerank,glucan biosynthetic process (GO:0009250),0.5690980087243799,1.1075656495291661,0.3851540616246499,0.9973254084107575,1.0,2/12,5.39%,PGM2;NR1D1
prerank,glycogen biosynthetic process (GO:0005978),0.5690980087243799,1.1075656495291661,0.3851540616246499,0.9973254084107575,1.0,2/12,5.39%,PGM2;NR1D1
prerank,nucleic acid-templated transcription (GO:0097659),0.4887371583599104,1.1074105023680951,0.36108108108108106,0.9968807996937318,1.0,7/42,9.28%,NR4A2;E2F1;POLR2I;POLR2A;EPC1;PTMA;RNPS1
prerank,protein-containing complex subunit organization (GO:0043933),0.46189530552179714,1.1074002616213432,0.3249243188698285,0.9959220182685655,1.0,33/109,18.63%,KNTC1;CARD10;FANCA;NDC1;CD74;PML;NAPG;TUBGCP4;IKBKG;MDM4;KPNA3;SNX9;LAMC1;ZW10;NUP205;NDUFAF1;NIFK;FAS;MAGI1;NUP98;KMT2A;CHCHD10;ADD2;CREBBP;TP53;KIFAP3;TFAP4;FANCC;DARS1;PEX14;EPRS1;PPIH;SLC2A1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5196737112880436,1.1071892221815587,0.3561320754716981,0.9956883901091551,1.0,6/26,10.96%,FMOD;ST3GAL1;SLC35D2;ST3GAL2;B3GNT2;OGN
prerank,mitochondrial translational elongation (GO:0070125),0.47037063669551543,1.1069276877174148,0.3391393442622951,0.9956313644991988,1.0,20/88,17.25%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MRPS34;MRPL38
prerank,pore complex assembly (GO:0046931),0.5328519721658386,1.1066655367530427,0.38089330024813894,0.995533154931603,1.0,10/19,21.96%,NDC1;NUP107;TSPAN33;NUP205;AHCTF1;NUP98;ANO6;ADAM10;TPR;NUP93
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.4486904949092961,-1.1065887558285514,0.33220338983050846,0.7025376724379739,1.0,5/10,12.77%,PADI2;APOD;WASL;MIA3;CD200
prerank,alpha-amino acid metabolic process (GO:1901605),0.4770144011529736,1.1062464778629417,0.3538961038961039,0.9960602633288189,1.0,12/45,17.23%,SLC25A12;PYCR3;DDAH2;KMO;GLS2;DPEP1;RIMKLB;ATP7A;SLC25A13;KYAT3;ASS1;NAALAD2
prerank,vascular transport (GO:0010232),0.4616239710140882,1.1061028042521905,0.3607399794450154,0.9955649010060897,1.0,15/81,12.42%,SLC38A5;SLC5A5;SLC1A5;SLC7A1;SLC2A4;SLC16A12;TFRC;LRP3;SLC16A1;ABCC2;ABCA2;SLC19A1;ATP8A1;ABCC4;SLC44A1
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.4733913670373351,1.1057910911891842,0.3504273504273504,0.9956603906362302,1.0,13/49,14.93%,PMAIP1;DAPK2;S100A9;CAV1;S100A8;BOK;UBQLN1;BECN1;FIS1;RACK1;DDIT3;SGMS1;TP53
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5867673903636816,1.1055173180818882,0.3782608695652174,0.9955696949786426,1.0,5/10,28.56%,TYROBP;CD24;FN1;LAPTM4B;HSP90AB1
prerank,cilium organization (GO:0044782),0.4574558085922278,1.104778689793345,0.2652652652652653,0.9972050884612438,1.0,58/209,18.37%,KIF24;TSGA10IP;IFT80;EXOC2;RTTN;POC1B;PCNT;FLNA;WDPCP;CEP83;MNS1;EXOC4;BBIP1;ODF2;CEP89;GSN;WDR90;DISC1;SSX2IP;ARF4;HDAC6;NOTCH1;FUZ;RP2;CEP250;OFD1;PTPDC1;RAB8A;CFAP44;TMEM237;CYS1;ABLIM3;PCM1;PDE6D;RFX2;CCDC28B;CEP162;RAB8B;ABCC4;CCDC57;SCLT1;ARL13B;BBS4;PIBF1;EXOC5;MKS1;DYNLL1;KIFAP3;DYNLT2B;MARK4;PARVA;IFT172;ATP6V0D1;IFT140;BBS9;TXNDC15;ATAT1;FAM161A
prerank,regulation of immunoglobulin production (GO:0002637),-0.34581799763078713,-1.1046379588904982,0.3005464480874317,0.7058115763787388,1.0,3/23,3.44%,GPI;CD86;STX4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5391650819836901,1.1044729420263335,0.38058748403575987,0.9973531134427551,1.0,8/18,22.20%,SPN;ITGB7;JAM2;ADD2;GOLPH3;ROCK1;GCNT1;ITGA4
prerank,negative regulation of programmed cell death (GO:0043069),0.45705575918159397,1.1042782109188538,0.194,0.9970737868805057,1.0,88/355,21.04%,KIF14;CDK1;STIL;BIRC5;MAD2L1;BARD1;PLK1;AQP1;LEF1;DDAH2;FLNA;CD38;CD74;ANKLE2;CD44;PIDD1;PA2G4;UBE2O;DCPS;TFRC;FOXO1;CASP2;DPEP1;PTMA;SETX;ARF4;ARL6IP1;BIRC2;UBE2Z;DDRGK1;PIM2;BIRC6;PIM3;CIB1;TNFAIP8;RNF157;ERC1;EGFR;PIM1;SOCS2;PARK7;XIAP;ATF5;FAS;MYD88;NAA16;PRKDC;GLO1;BAG3;MYC;CFLAR;PSEN1;BAG1;MYDGF;HTATIP2;TPT1;GSK3B;TP53;PDCD10;PAK2;TAF9;ARHGDIA;VHL;SIRT1;XBP1;SH3RF1;HSP90B1;UBA52;AVEN;SNCA;MED1;MALT1;ADAM10;CLN3;HDAC1;HIPK3;PAX2;TRAF6;SOX9;GOLPH3;DSTYK;ARAF;MET;CITED2;BNIP3;IKBKB;RIPK1;DNAJC3
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.3438330011169674,-1.1040847881661062,0.30526315789473685,0.7053750206739534,1.0,9/23,24.52%,SMO;PIK3CD;VEGFA;FGF2;GJA1;MDK;SOX8;AGT;WNT5B
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.5584257756898638,1.1035826093247494,0.37841530054644806,0.998465045692117,1.0,5/12,16.99%,CD74;CD44;ING2;TAF9;SIRT1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3825349287647884,-1.1035151686527267,0.3395348837209302,0.7051716248092851,1.0,9/16,27.14%,TMEM50B;VPS36;LEPROTL1;TMEM50A;CHMP7;LEPROT;CHMP4B;CHMP4A;VPS28
prerank,mitochondrial RNA metabolic process (GO:0000959),0.5527157905346314,1.1033339357761967,0.37989556135770236,0.9982981795809516,1.0,8/14,26.28%,FASTKD5;TFB1M;TFB2M;TEFM;PNPT1;TFAM;FASTKD1;FOXO3
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3750766618942458,-1.1030062309113298,0.2947976878612717,0.7047131624116044,1.0,5/21,9.28%,ARHGAP25;RASAL3;LZTR1;MFN2;SH3BP1
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.38424605551037233,-1.102975676337345,0.3248730964467005,0.7030855771755232,1.0,6/17,15.97%,SERPINE2;PTPRZ1;BIN1;TNFRSF1B;ID2;MDK
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.46113187819582757,1.1027259211993412,0.247,0.9993761463465711,1.0,99/264,20.56%,RBM15;LSM6;DHX38;POLR2I;SNRNP25;GEMIN8;PRPF19;POLR2A;SCAF11;IK;DCPS;SNRPF;HNRNPC;SNRPC;HNRNPM;HNRNPL;HNRNPA3;CPSF2;CRNKL1;PPIL3;U2AF1;SNRNP200;EIF4A3;UBL5;SRSF3;SPEN;TXNL4A;HNRNPA2B1;RNPC3;PSPC1;NOVA2;SART3;PRPF38A;SRSF4;NCBP1;LSM2;SNRNP35;RNPS1;RALY;NONO;CASC3;U2AF1L4;PPWD1;CSTF3;SRRT;RBM19;PCBP2;PRPF31;DHX9;HNRNPA0;LSM5;U2SURP;UPF3B;ZMAT2;HNRNPR;CWC15;HNRNPU;SF3B5;PRPF4;TFIP11;CLNS1A;LSM7;SRRM2;PDCD7;METTL14;SART1;SRSF10;GEMIN7;DNAJC8;SNRNP40;ESS2;POLR2K;SRSF7;CDC40;SRPK1;DDX39B;POLR2J;SNRPG;GCFC2;PCF11;CPSF1;PRPF8;RSRC1;CLP1;PPIE;HNRNPA1;PPIH;ELAVL1;NCBP2;ZCCHC8;SRSF2;SF3A2;SNRNP48;CPSF7;SNRPB;PPIL1;RBM4B;SYNCRIP;PRMT7
prerank,protein localization to cilium (GO:0061512),-0.31647899144550784,-1.1026299598786964,0.2624113475177305,0.7021866747573727,1.0,15/32,27.15%,TULP3;ZNF423;ARL6;WDR35;INVS;TCTN1;CSNK1D;RABEP1;WDR19;TULP2;ARL3;SNX10;TCTN2;BBS1;TUB
prerank,regulation of immune response (GO:0050776),0.45592899834208506,1.1025471490820637,0.3135678391959799,0.9990017950875949,1.0,20/135,11.37%,CD19;ICAM4;ULBP1;SPN;ITGB7;DHX58;PTPN22;KLRD1;FOXP1;RAET1E;COL1A2;TRAF3;BIRC2;AHR;SLAMF7;HCST;TREML1;PILRA;B2M;XIAP
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4657857673124299,1.1018104612585589,0.34049079754601225,1.0,1.0,14/74,14.46%,FOXA2;EZH2;LEF1;TIAM1;VASN;TWIST1;CLASP1;EPHA3;SMAD4;ADIPOR1;PTEN;BCL9L;SPRED2;DAG1
prerank,Notch signaling involved in heart development (GO:0061314),0.5636226728655463,1.1017691072690543,0.36944444444444446,0.9996299708091367,1.0,2/11,7.16%,HEY2;NOTCH1
prerank,regulation of blood coagulation (GO:0030193),0.5128192912914283,1.1017316593134558,0.37735849056603776,0.9987792164993143,1.0,3/27,5.32%,FOXA2;FAP;CAV1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.4357130774792645,-1.1014237334374282,0.34035087719298246,0.7035072778390375,1.0,3/11,5.23%,IGF1R;PIK3R1;IGF1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5027558677009094,1.1010278356588177,0.37217598097502974,1.0,1.0,9/26,17.92%,GFI1;BIRC2;LRRC14;TLR5;FLOT1;APPL1;LGR4;NLRP2B;FLOT2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.4697755575359397,-1.1003735831028574,0.34967320261437906,0.7043976430145106,1.0,6/10,20.96%,TREM2;CD68;TLR4;MIA3;CD36;TICAM1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.38202164610403894,-1.0996037037073993,0.29583333333333334,0.7048428187634898,1.0,5/17,12.28%,ZDHHC17;PCSK6;FSTL1;SULF1;DOK5
prerank,anterograde axonal transport (GO:0008089),0.4869405315747807,1.0995220140568214,0.3635346756152125,1.0,1.0,2/37,3.52%,KIF4A;BLOC1S4
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.4602750057048021,1.0991710430724304,0.36134453781512604,1.0,1.0,16/70,16.23%,IL12A;ERBB3;CASP2;TRADD;BOK;CIB1;JAK2;ITGAV;PDPK1;FAS;DELE1;BAG3;CASP9;GSK3B;APPL1;TGFB2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.44720704032236686,-1.0990762111756243,0.3586206896551724,0.7044927206596029,1.0,5/11,20.00%,TREM2;CDH13;CCL4;CCL3;P2RX4
prerank,transport across blood-brain barrier (GO:0150104),0.45700570029052895,1.0990614599921862,0.36858316221765913,1.0,1.0,15/83,12.42%,SLC38A5;SLC5A5;SLC1A5;SLC7A1;SLC2A4;SLC16A12;TFRC;LRP3;SLC16A1;ABCC2;ABCA2;SLC19A1;ATP8A1;ABCC4;SLC44A1
prerank,positive regulation of translation (GO:0045727),0.4612286814106858,1.0988783011155745,0.3208502024291498,1.0,1.0,31/94,20.91%,ZCCHC4;RBM3;JMJD4;EIF3E;RPS4X;BOLL;EIF4A3;MPV17L2;NIBAN1;CPEB3;DHX9;UPF3B;FXR1;RPS9;PRKDC;EIF5A2;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;TRUB2;LARP4B;NAT10;POLDIP3;ELAVL1;RPL5;AGO2;EIF6;EIF2B5
prerank,heart development (GO:0007507),-0.20758260627426994,-1.098647476517531,0.25,0.7038062381938959,1.0,39/150,18.99%,ACVR1;ADAP2;TGFBR1;ERBB4;CACNA1C;SGCD;SALL1;ZFPM2;BMPR2;NDUFV2;PCSK5;SGCZ;ECE1;NF1;PKD1;FBN1;GPC3;TCF25;NDRG4;MEF2A;FGF12;PTK2;MICAL2;KAT2A;VEGFA;ID2;TGFBR3;PDLIM2;SOX4;ACVRL1;TSC2;LDB3;CXADR;PDLIM4;TGFBR2;PDLIM1;ZDHHC16;KDM6B;CHD7
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4659558203446205,1.098591498044257,0.34306569343065696,1.0,1.0,22/72,16.84%,STMN1;NET1;RIPOR2;ARHGEF18;LPAR4;ARHGDIB;ARHGEF3;ARHGAP35;TNFAIP1;CUL3;HEG1;RIT2;STARD8;ARHGEF28;NRP1;PDCD10;BCR;F2R;LPAR1;GPR35;ARHGDIA;RAC1
prerank,regulation of B cell differentiation (GO:0045577),0.5331295427847271,1.0983381752375,0.38082901554404147,1.0,1.0,7/17,17.11%,IKZF3;ZFP36L1;PPP2R3C;BTK;SLAMF8;ZFP36L2;XBP1
prerank,response to tumor necrosis factor (GO:0034612),0.45101358043012235,1.09822421492449,0.34384537131230924,1.0,1.0,22/91,21.03%,ADAMTS7;BRCA1;AFF3;CRHBP;TANK;NR1D1;TRADD;ZFP36L1;GBP2;CIB1;JAK2;DHX9;NFE2L2;TNFRSF11A;ZFP36L2;CCL25;SIRT1;ADAM10;RPS3;CASP8;IKBKB;RIPK1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.49865457865570534,1.098025790112138,0.3672514619883041,1.0,1.0,8/29,11.01%,MMD2;RASGRP1;CRKL;NOTCH1;GRB2;JAK2;ITGAV;RELN
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.57452577384019,1.0977849719625292,0.3969359331476323,1.0,1.0,2/10,10.23%,CFL2;ACTN2
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.3905033213406796,-1.097716440454787,0.33624454148471616,0.7043931430137697,1.0,11/16,40.69%,PTPRJ;PDGFD;PDGFC;PLAT;FER;PDGFRA;PTPN1;PDGFRB;BCAR1;PDGFA;RGS14
prerank,regulation of urine volume (GO:0035809),-0.4462056175418244,-1.0975729142496033,0.3449367088607595,0.7031410818189826,1.0,7/10,45.35%,NPR3;HAS2;NPR1;TFAP2B;HYAL2;ADCY6;ADM
prerank,pentose-phosphate shunt (GO:0006098),0.5602994588971048,1.0975628131546131,0.38285714285714284,1.0,1.0,2/11,4.03%,PGM2;H6PD
prerank,positive regulation of protein import into nucleus (GO:0042307),0.5030154315312465,1.0974681213018211,0.36608187134502923,1.0,1.0,8/28,17.50%,ECT2;FLNA;EFCAB7;BAG3;PSEN1;IPO5;TRIM28;HCLS1
prerank,protein insertion into membrane (GO:0051205),-0.3179960608111107,-1.097033518659408,0.296,0.7028019580778279,1.0,16/32,24.56%,APP;SGTA;VAMP2;SEC61G;HMOX1;STX1A;TRAM1;SERP1;PRNP;RTP4;MAIP1;GET4;COX18;SEC61B;REEP1;GET1
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.40559418995119134,-1.0967079009511083,0.3319327731092437,0.7019728640920758,1.0,9/15,29.04%,SMAD1;ITGA5;PKM;VEGFA;FGF2;BMPER;KLF4;JMJD8;TJP1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4813321792278692,1.0966975902416112,0.36283185840707965,1.0,1.0,8/38,14.67%,BRCA1;PMAIP1;TNFSF10;SP100;TRADD;FAS;CFLAR;GSK3B
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4918129858220432,1.096530053956325,0.3825581395348837,1.0,1.0,7/29,15.02%,BRCA1;AXIN1;DDRGK1;CBFB;LATS1;CNOT1;RUNX1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.48957674986061633,1.096287866842278,0.3675115207373272,1.0,1.0,7/29,17.75%,RPA2;CHD1L;RPA1;ERCC3;RPA3;UBA52;DDB2
prerank,regulation of cell differentiation (GO:0045595),0.4607618857326756,1.0959516059330774,0.3135678391959799,1.0,1.0,31/148,16.76%,HEMGN;NTF4;CDK5RAP2;ANP32B;HEY2;PDCD2;TIAM1;PA2G4;SUZ12;CDK6;NR1D1;PTHLH;CLASP1;YWHAH;ZFP36L1;MBOAT2;RUNX3;BIRC2;PRKACA;EPHA3;PRKCB;CDK5RAP3;CBFB;BCL6;CREBBP;DAG1;RUNX1;FGFR1;ST7;CD24;VHL
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.30732956820305235,-1.0959311886618501,0.32989690721649484,0.7022387099537458,1.0,13/39,18.42%,BMP2K;EPN2;MAML1;PRKCI;ROBO1;MAML3;POGLUT1;STAT3;ZMIZ1;TSPAN14;TM2D3;JAG1;NEPRO
prerank,protein import into nucleus (GO:0006606),0.4611333165789305,1.0959099333324465,0.367816091954023,1.0,1.0,28/66,22.69%,POM121;NUP107;TNPO1;IPO13;NUP50;KPNA3;NUP214;SEC13;IPO7;NUP188;RANBP6;RANBP2;RPAIN;E2F3;APPL1;IPO5;KPNB1;EIF4ENIF1;NUP85;MMP12;RPL23;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2;KPNA4
prerank,dendritic cell chemotaxis (GO:0002407),0.5474569735916242,1.095596493768656,0.38035961272475793,1.0,1.0,6/14,22.28%,CCR2;HMGB1;CCR6;TRPM4;CXCR4;GPR183
prerank,positive regulation of chemotaxis (GO:0050921),-0.30525807279697215,-1.0951194059367666,0.2988505747126437,0.7026167463942505,1.0,14/43,20.00%,TREM2;AIF1;STX4;PRKD1;STX3;P2RY12;CDH13;LGMN;PPM1F;VEGFA;FGF2;MDK;THBS1;P2RX4
prerank,negative regulation of autophagy (GO:0010507),-0.2665612778401321,-1.0948962763628938,0.23076923076923078,0.7014933298565798,1.0,15/54,13.00%,CTSA;TREM2;TBC1D14;KDM4A;SNRNP70;HGF;MCL1;FOXK1;EIF4G3;TSC1;GOLGA2;WASHC1;STAT3;PINK1;ZKSCAN3
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.23641349327280195,-1.0947820221953148,0.16666666666666666,0.7001105670599946,1.0,39/91,23.37%,APP;NDFIP1;FTH1;CUL1;HMOX2;SLC11A2;SLC31A2;ACO1;HMOX1;SLC39A7;ISCU;ATP6V1A;FTL;PRNP;SLC39A14;TMEM199;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;COX19;SLC39A8;CCDC22;BMP6;SLC39A6;MT2A;SLC39A12;SLC22A17;GLRX3;ARF1;NUBP1;SLC30A1;FRRS1;MT3;CCDC115
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.5639494892017921,1.0947182659215582,0.3941908713692946,1.0,1.0,5/11,16.99%,CD74;CD44;ING2;TAF9;SIRT1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3217023800851897,-1.093731508433698,0.2912621359223301,0.7010401096158657,1.0,15/33,20.51%,PTPRG;APOE;EVL;CORO1C;KRIT1;DUSP10;VASH1;ACVRL1;PFN2;DAB2IP;MCC;THBS1;ADGRB1;SVBP;PTPN23
prerank,glycerol metabolic process (GO:0006071),-0.45400022940611806,-1.093461061212936,0.36363636363636365,0.7001636121022526,1.0,7/10,36.92%,COQ2;TPI1;COQ3;ANGPTL3;TKFC;PDXP;GK5
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5061931436308446,1.0933730908481956,0.3695121951219512,1.0,1.0,4/23,12.57%,SLC12A3;SLC12A7;SLC12A1;SLC12A6
prerank,myeloid leukocyte differentiation (GO:0002573),0.4567904374278775,1.0933579421470907,0.3670490093847758,1.0,1.0,18/65,19.45%,PRTN3;LEF1;E2F1;BATF;DEK;PML;FOXP1;MAPK14;THOC5;GLO1;TYROBP;RUNX1;TNFRSF11A;PIR;SIRT1;CDKN1A;LGALS9;CASP8
prerank,positive regulation of transmembrane transport (GO:0034764),0.5495986550262044,1.0928119904819036,0.39402173913043476,1.0,1.0,4/13,17.56%,C2CD5;AZIN1;ACSL5;ANO6
prerank,regulation of protein kinase C signaling (GO:0090036),0.5499900955045585,1.0923825224946406,0.3622589531680441,1.0,1.0,4/14,14.82%,ULK4;GPD1L;DGKD;ADGRV1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5082335276488645,1.0922029080481455,0.36904761904761907,1.0,1.0,7/21,17.85%,PMAIP1;BOK;PARK7;DDIT3;XBP1;SYVN1;LRRK2
prerank,endocytic recycling (GO:0032456),-0.2828367806539407,-1.0921683683221786,0.2898550724637681,0.7019050652890579,1.0,18/50,20.72%,RAB14;STX6;VPS39;EHD4;ACAP2;RAB11FIP3;VPS50;ANKRD27;SNX27;CMTM6;WASHC1;CCDC22;EPS15;VPS51;VPS26C;ENTR1;PTPN23;VPS26A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.569160565523183,1.0917756642517302,0.39436619718309857,1.0,1.0,5/11,11.82%,GSN;PRR7;PARK7;CAAP1;FAS
prerank,N-terminal protein amino acid modification (GO:0031365),0.5427299891772126,1.0913624921175031,0.3691275167785235,1.0,1.0,3/14,12.01%,NAA40;METAP2;NAA16
prerank,actin crosslink formation (GO:0051764),0.5519519756597064,1.0910345370598027,0.3674033149171271,1.0,1.0,2/12,3.41%,FLNA;GAS2L3
prerank,serine family amino acid metabolic process (GO:0009069),-0.3955299662138404,-1.0908847639581412,0.36752136752136755,0.7033797043996859,1.0,11/16,42.90%,SARS1;CDO1;PSPH;SHMT2;SHMT1;SEPHS2;SRR;CBS;THNSL2;CTH;DAO
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.4495205313275579,1.0907455416727954,0.068,1.0,1.0,317/1646,16.32%,CENPF;DEPDC1;E2F7;BRIP1;BIRC5;PAX5;E2F8;FOXM1;E2F2;GFI1;FOXA2;RRM2;NKX6-1;VAX2;MYB;HMGB2;EZH2;RCOR2;SPIB;MYBL1;MEN1;CCNE1;ATAD2;SUV39H1;CDC45;BRCA1;RAD21;CDK5RAP2;DMRTA1;SPIN4;SMARCC2;NR4A2;HMGA1;SOX6;CHEK2;POLA1;DAP;BLM;HEY2;RBM15;BRCA2;MYRFL;DEAF1;LEF1;E2F1;SMARCA5;UXT;NSD2;RB1;FBXO5;TEAD4;ARID1B;RIOX1;IKZF3;PBX4;NIF3L1;LIN9;SMARCD2;BATF;RSF1;ELK4;CD38;CBX5;TWIST1;DEK;CD74;USF1;PBX3;HMGB3;PML;AXIN1;NUP107;BCL7A;POLR2A;FBXW11;TIMELESS;PA2G4;NUCKS1;HDAC10;ERG;UBE2I;BACH2;RPS6KA5;MTA3;LCORL;EPC1;CTCF;RBBP8;SCMH1;BRD9;ACTR5;PCNA;FOXP1;ETS2;DACH1;BRPF1;SP100;CDKN2A;NR1D1;NKAP;MED30;HOMEZ;EDF1;MBD2;NFXL1;FOXO1;LIN54;MDM4;FOXJ3;BAZ2B;ATF7;KDM3B;E2F6;BCL11A;YWHAH;ZBTB26;PBXIP1;MBD1;EBF1;TCF7L1;TCF3;ARID4A;GMNN;ZFP41;IRF9;RUNX3;HDAC6;TFDP1;TGFA;MAPRE3;EBF3;PHF19;KLF10;MAP3K5;BRD4;TAF7;NOTCH1;TAF15;MED31;XRCC6;HMGB1;PIM2;PCBD2;CDK17;MLF2;CAMTA2;AHR;SFMBT1;SAP18;SPEN;MAX;ZNF326;BAZ1B;ILF2;SMARCA4;PSPC1;DMTF1;PHF1;PHF2;CIPC;YEATS4;UBE2V1;CIR1;MAPK14;SEC14L2;PCGF5;ZBTB16;ERC1;RLF;E2F5;METTL4;NCOA7;PLAG1;ETV6;NFE2L1;NRF1;ZBTB7A;EGFR;FLI1;ABCA2;NONO;ZNF148;MECP2;PIAS3;SP110;SRRT;KLF13;EGR1;PFDN5;TFDP2;IFRD1;SPTY2D1;SMARCC1;HIRA;SALL2;ZBTB32;MYNN;NR2C2;IRF2BPL;RFX2;HIPK2;NR2F2;ID4;KAT6A;ZEB1;TRIM33;CUX1;TSHZ1;DBX2;EHMT1;TRIM44;NFYC;MXI1;RUVBL2;DYRK1A;ARID5B;NFE2;SUMO1;SMAD4;RUVBL1;ATF6;MED8;JUN;CCAR2;TYMS;DHX9;ATF5;PLCB1;CRK;PRKCB;NSD3;CCNT1;NPAT;NAA16;ZNF25;FOXP2;CBFB;BAP1;HCFC1;SETDB2;RAI1;SATB2;ZBTB33;KMT2A;STAT5B;SP3;NFE2L2;ZBTB7B;HIVEP2;ING2;ING5;CC2D1A;PSIP1;SP140;REXO4;NIPBL;DDIT3;CDK16;BCL6;CREBBP;MYC;PHF14;CEBPG;NFX1;GABPA;PSEN1;TADA2A;MED14;ZNF112;POU6F1;HNRNPAB;HTATIP2;RNF20;TP53INP2;CAMTA1;RNF111;PBX2;GMEB2;KDM4C;E2F3;LIMS1;CCNK;YEATS2;ELF1;TADA3;ATF7IP;TP53;DNAJC2;KMT2B;RUNX1;JUNB;LRRFIP1;GPATCH3;GON4L;LIMD1;EGF;F2R;IRF8;HOXB4;PIAS1;POU2F1;SRSF10;PLAGL1;JARID2;MAP2K1;TFAP4;SIN3A;TCF7L2;TCF4;HIVEP1;ZNF23;PURG;ATRX;FOXK2;TRIM28;RFX7;RFX4
prerank,regulation of cardiac conduction (GO:1903779),-0.269292295703404,-1.0906995091420912,0.20689655172413793,0.7022388342107285,1.0,32/54,38.22%,ITPR2;ASPH;ANK2;SLC8A3;ATP2B2;ATP1A1;TRPC1;ATP1B2;RYR2;ATP1B1;ATP2B3;SLC8A1;ITPR3;ATP1A2;STIM1;AGT;AHCYL1;ATP1A3;ATP1B3;FKBP1B;ABCC9;SLC8A2;FXYD1;NPR2;NOS1;ATP2A3;CORIN;ATP2B1;DMPK;FXYD2;FXYD6;NPR1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4951324174096339,1.090262628138858,0.38495575221238937,1.0,1.0,9/33,21.03%,LEF1;CD74;ZFP36L1;PRKCA;RUNX1;HCLS1;TRAF6;CASP8;RIPK1
prerank,regulation of stem cell differentiation (GO:2000736),0.4558127726769965,1.0901996692796518,0.35728744939271256,1.0,1.0,25/89,16.98%,MYB;PSMB7;PSMD11;PSMF1;TCF3;PSMC1;NOTCH1;PSMC3;PSMA4;PSMC4;CBFB;BMPR1A;KMT2A;PSMD13;PRKDC;HNRNPU;PSME1;PSMB1;RUNX1;NELFB;HOXB4;PSMD8;ZFP36L2;PSME4;PSMD4
prerank,organophosphate catabolic process (GO:0046434),-0.4472818489498125,-1.0900076951774458,0.3795379537953795,0.7022201478099512,1.0,3/11,10.31%,ABHD12;ENPP2;PLBD2
prerank,negative regulation of secretion by cell (GO:1903531),0.4767175672476763,1.089967735043126,0.35906040268456374,1.0,1.0,3/38,7.16%,IL12A;STXBP6;NOTCH1
prerank,regulation of cytoplasmic transport (GO:1903649),0.5687586575348087,1.0896507570660767,0.4047287899860918,1.0,1.0,6/11,17.85%,MAPK1;DNAJC13;MAP2K1;CHMP3;USP7;LRRK2
prerank,negative regulation of cell differentiation (GO:0045596),0.4520012792071532,1.089551372715324,0.3049147442326981,1.0,1.0,34/181,17.00%,FOXA2;ADAMTS7;MYB;MEN1;ANP32B;E2F1;RB1;RIOX1;VASN;TWIST1;ZFPM1;SUZ12;CDK6;CAV1;PTHLH;FOXO1;LRP3;NOTCH1;ZBTB16;ITGAV;EGFR;ASXL1;ADIPOR1;PTEN;SPRED2;HNRNPU;SKI;ADGRV1;METTL14;LIMD1;NELFB;ZFP36L2;SIRT1;TRPM4
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.41963763927294995,-1.08948956307238,0.37735849056603776,0.7016808537040498,1.0,6/12,16.08%,CACNA1C;BIN1;CTNNA3;JUP;RYR2;DLG1
prerank,histone H2A monoubiquitination (GO:0035518),0.5335092525176144,1.089210210757736,0.38235294117647056,1.0,1.0,7/17,18.15%,PCGF5;RNF168;RNF2;PCGF3;TRIM37;DDB2;KDM2B
prerank,mRNA methylation (GO:0080009),0.5332691389639296,1.089193622209359,0.3898963730569948,1.0,1.0,7/15,22.26%,CBLL1;METTL8;METTL16;VIRMA;METTL14;WTAP;TRMT10C
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.35326596202052607,-1.089193374241239,0.3465909090909091,0.7007146120026501,1.0,7/22,14.06%,PJA2;MFHAS1;ZC3H12A;MINK1;SPI1;NCF1;VEGFA
prerank,response to metal ion (GO:0010038),0.45848641790274,1.088933231014056,0.3586278586278586,1.0,1.0,19/67,17.96%,TFR2;SLC25A12;HAAO;PPP3CA;CAV1;PEF1;NEDD4L;PPP2CB;SEC31A;SLC25A13;ANXA11;ATP5F1D;GPHN;HVCN1;CRIP1;SLC30A5;NDRG1;PPP1CA;SNCA
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.5800061909065835,1.0887316864112684,0.3850658857979502,1.0,1.0,3/10,9.00%,EMC6;EMC10;EMC3
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.2486857708438885,-1.0886976927676155,0.11764705882352941,0.7002089279499056,1.0,26/92,14.75%,RTN4;IQSEC1;ANXA3;NRP2;RREB1;GPI;BMPR2;ENPP2;PFN1;PRKD1;PIK3CD;GRN;CLASP2;ZC3H12A;ANGPT1;ITGB3;SCARB1;EPB41L4B;SPARC;PPM1F;PIK3CB;RAB11A;ADAM9;VEGFA;FGF2;MAP4K4
prerank,response to organic cyclic compound (GO:0014070),0.46839223206944275,1.088411229751374,0.3638297872340426,1.0,1.0,7/52,12.75%,CYP1B1;ALPL;PMAIP1;CDKN2D;ABCA2;SOCS2;STAT5B
prerank,angiogenesis involved in wound healing (GO:0060055),-0.43779387739594305,-1.0884047131796593,0.3448275862068966,0.6993022400239162,1.0,7/11,29.85%,CD34;ITGB3;VEGFA;HPSE;NDNF;KDR;SRF
prerank,regulation of neuron projection development (GO:0010975),-0.2242734210077986,-1.088209980236097,0.0,0.6981727219522244,1.0,57/163,20.24%,TANC2;PAK3;SPOCK1;RUFY3;GAK;CAMSAP2;CAMK1;APOE;PRAG1;STMN2;PPFIA2;PRKCI;PRKD1;KNDC1;PTPRS;HDAC2;MBOAT1;NTNG1;CDH2;MAG;SCN1B;CDK5R1;RAP1A;ATP1B2;ARHGAP44;PTPRO;FES;GSK3A;NDRG4;CTNNA2;SCARB2;CDK5;FKBP4;SERPINI1;PTPN9;PAQR3;CAMK2G;CBFA2T2;LRRC7;SEMA3A;CAMK2B;TRPV4;MDK;EPHA4;ABI2;SHANK3;DAB2IP;NCS1;RTN4IP1;CRMP1;TWF2;RAPGEF1;PLXNB3;CFL1;ABL2;KIF1A;ZDHHC15
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5056089567933624,1.0876873766933295,0.38562874251497004,1.0,1.0,3/25,8.88%,CD2;ITGB7;ITGAV
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3621185954117989,-1.0876246872044781,0.31413612565445026,0.6980160646794278,1.0,10/20,22.11%,SLC8A3;MCUR1;SLC8B1;LETM1;SPG7;STOML2;MAIP1;PMPCA;AFG3L2;SMDT1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.5002734287087534,1.087556239348637,0.38739789964994165,1.0,1.0,5/29,10.78%,PLK1;FBXO5;AXIN1;PIN1;PARK7
prerank,protein import into peroxisome matrix (GO:0016558),0.5556919951263677,1.0874337240577965,0.39290586630286495,1.0,1.0,4/12,17.46%,PEX26;PEX5L;PEX2;PEX14
prerank,synapse organization (GO:0050808),-0.23234250346046986,-1.0866549339220217,0.25,0.6987434222801482,1.0,32/125,15.98%,PAK3;APP;ANK3;LRFN5;CACNB2;PTPRD;PPFIA2;LRRC4;DNM3;APBB2;C1QA;PTPRS;SLC8A3;SEMA3E;SPOCK2;NTNG1;CX3CR1;RYK;CDH2;C1QC;GRM5;PDZRN3;SHANK2;C5AR1;LRRC4B;CDK5;CACNB4;UNC13A;PPFIA1;FARP1;L1CAM;AGRN
prerank,epithelium development (GO:0060429),0.4508119858838042,1.0864531385350333,0.3468149646107179,1.0,1.0,5/107,5.00%,CDK1;STIL;RCN3;TIMELESS;PCNA
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.2906155806374121,-1.086239936736315,0.2980769230769231,0.6981899423903394,1.0,11/39,15.77%,PIK3CD;PIP4K2B;ITPKB;PIK3R1;IP6K1;PI4KA;PIK3C2B;SOCS7;PIK3CB;TMEM150A;TTC7B
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.38773759798751367,-1.085910126582362,0.3386454183266932,0.6974174615874823,1.0,8/15,35.05%,ATF3;ZC3H12A;ZFAND1;MKNK2;GSTO1;GSTO2;PPIF;DHX36
prerank,aggrephagy (GO:0035973),0.4969234601446474,1.0858869793055077,0.3872901678657074,1.0,1.0,11/27,17.62%,PCNT;ACBD5;HDAC6;DYNC1H1;UBE2V1;UBQLN1;PARK7;ARL13B;DYNLL1;VIM;UBA52
prerank,membrane repolarization (GO:0086009),-0.3826632370200339,-1.0858567658457183,0.35294117647058826,0.6959548324258981,1.0,5/15,18.50%,ATP1A1;ATP1B2;ATP1B1;KCND3;ATP1A2
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.27729603642557765,-1.0857459492296075,0.24444444444444444,0.6946684655989166,1.0,13/51,12.54%,VWC2L;SMAD1;BMPR2;SPART;SMAD6;FSTL1;BMPR1B;UBE2D1;SKIL;FBN1;LEMD2;SMAD7;GREM2
prerank,translation (GO:0006412),0.45014734955744107,1.0853121385512936,0.305,1.0,1.0,80/208,23.52%,MRPL36;RPL7;VARS1;RPL18A;RPS20;MRPL18;NOA1;RPL36;RPL14;GATC;MRPL47;RPS19;RPS7;RPS4X;MRPL16;RPS18;MRPL10;RPL23A;EEF1B2;RPL28;MRPL37;PPA2;RPL41;RPS14;RPLP2;LARS1;RPS27;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;RPLP0;RPS11;MRPS17;IGF2BP3;TMA7;RPL27A;GFM2;RPS15A;RPS9;MRPL24;RPL12;RPL22L1;EEF2;ZC3H15;DARS1;MRPS34;RPL3;RPL18;GSPT1;UBA52;EPRS1;DRG1;YARS2;RPS17;RPS6;RPL5;RPS3;RPL21;AGO2;PTCD3;SRBD1;RPL23;RPL17;RPL8;RSL24D1;RPL24;RPL27;RPL13A;TRMT112;MRPS12;RPS12;RPS8;RPL15;RPL10;ABCE1;RPS21;KARS1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.40351853293651796,-1.0852155111059159,0.3659574468085106,0.6943729271960337,1.0,2/15,0.97%,IGF1R;TEC
prerank,protein K63-linked deubiquitination (GO:0070536),0.494200559800847,1.085071532872435,0.38941176470588235,1.0,1.0,9/31,17.67%,USP27X;BABAM1;ABRAXAS1;SPATA2;OTUD5;USP50;YOD1;USP25;USP7
prerank,amino acid transmembrane transport (GO:0003333),0.4776354832750912,1.0846355045793443,0.368763557483731,1.0,1.0,3/45,2.84%,SLC38A5;SLC25A12;SLC7A1
prerank,cellular response to osmotic stress (GO:0071470),0.5075943118757517,1.084604364949809,0.3940520446096654,1.0,1.0,3/21,6.60%,AQP1;OXSR1;ZFP36L1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5155161180730624,1.0845022475711104,0.37559808612440193,1.0,1.0,3/22,7.79%,NTF4;KIDINS220;CIB1
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3265432765883426,-1.084027311773337,0.36363636363636365,0.695818014794378,1.0,8/27,10.30%,TREM2;LRP1;APOE;ABCA5;PLTP;SCP2;ZDHHC8;GPS2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.5274440734093979,1.0836906032994884,0.3904881101376721,1.0,1.0,9/16,28.03%,RBM3;NCBP1;NUP98;DAZAP1;THRAP3;NCL;CIRBP;PRDX6;TRA2A
prerank,heart looping (GO:0001947),0.47679166225185904,1.082661690714852,0.3947078280044101,1.0,1.0,4/39,13.22%,STIL;NOTCH1;SETDB2;BBS4
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5142671900909824,1.0819268720820598,0.371007371007371,1.0,1.0,11/20,23.77%,PPIL3;PIN1;PPWD1;PPIG;PPIA;PPIE;PPIH;PPIL1;FKBP1A;CWC27;NKTR
prerank,mRNA processing (GO:0006397),0.4512189642632059,1.0817445950491607,0.288,1.0,1.0,111/287,20.91%,RBM15;LSM6;AURKAIP1;DHX38;POLR2I;SNRNP25;PRPF19;POLR2A;SCAF11;IK;SNRPF;HNRNPC;SNRPC;HNRNPM;HNRNPL;HNRNPA3;CPSF2;CMTR2;CRNKL1;PPIL3;U2AF1;SNRNP200;EIF4A3;UBL5;SRSF3;SPEN;TXNL4A;HNRNPA2B1;RNPC3;PSPC1;NOVA2;PRKACA;SART3;PRPF38A;SRSF4;NCBP1;LSM2;SNRNP35;RNPS1;RALY;NONO;CASC3;ERCC3;U2AF1L4;PPWD1;CSTF3;SRRT;RBM19;PCBP2;PRPF31;RPRD1B;DHX9;HNRNPA0;THOC3;LSM5;U2SURP;UPF3B;KIN;ZMAT2;PRMT9;HNRNPR;THOC5;CWC15;HNRNPU;SF3B5;PRPF4;TFIP11;LSM7;SRRM2;PDCD7;METTL14;SART1;THOC2;SRSF10;GEMIN7;DNAJC8;SNRNP40;ESS2;POLR2K;THOC7;SRSF7;CDC40;TCERG1;DDX39B;POLR2J;POLDIP3;SNRPG;GCFC2;PCF11;CPSF1;PRPF8;RSRC1;CLP1;PPIE;ALKBH5;HNRNPA1;PPIH;ELAVL1;NCBP2;ZCCHC8;SRSF2;SF3A2;SNRNP48;CPSF7;SNRPB;PPIL1;RNMT;RBM4B;SYNCRIP;RPRD2;WDR33
prerank,regulation of protein sumoylation (GO:0033233),0.52594991247571,1.081499416651563,0.3772609819121447,1.0,1.0,8/17,18.77%,SAE1;UBA2;PIAS3;EGR1;PARK7;PIAS1;HDAC4;GNL3L
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.4502883532543135,-1.0811340141312964,0.3654970760233918,0.7011755064813907,1.0,4/10,14.99%,APPL2;GSK3A;SELENOS;GRB10
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5783863101303803,1.0810084878266344,0.40615835777126097,1.0,1.0,2/10,8.34%,SOX6;ZBTB16
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.44892466416790505,1.0806713189517265,0.271,1.0,1.0,86/341,18.14%,BUB1B;KIF14;UBE2C;AURKB;MAD2L1;UHRF1;CDC20;PLK1;SKP2;AURKA;DTL;PSMB7;PSMD11;PML;PPP1R11;CDC23;FBXW11;UBE2I;CDC27;PSMF1;TAF1;FAF1;NPLOC4;PSMC1;ANAPC7;FBXO45;BIRC2;SPSB3;BIRC6;UBE2K;UBE4B;UBE3B;NEDD4L;UBQLN1;TNFAIP1;CUL3;KCTD21;PTTG1;PSMC3;UBE3C;PCBP2;AMFR;RAD23A;PSMA4;RNF168;MIB1;RNF8;SPSB4;TRIM3;CNOT4;FZR1;FBXL4;ARRB2;PSMC4;PCNP;BUB3;FBXO11;NFE2L2;PSMD13;SPOP;PSME1;DDIT3;DCAF11;ARIH2;RNF20;ZFAND2B;PSMB1;RNF111;RBCK1;RC3H1;ARMC8;MYLIP;PSMD8;RNF115;PSME4;UBE2R2;KLHL22;PSMD4;SIRT1;UBXN1;XBP1;RNF4;RNF19A;SYVN1;FEM1C;UBE2G1
prerank,negative regulation of cell development (GO:0010721),0.4987188762887282,1.0803392182789122,0.39156626506024095,1.0,1.0,6/25,14.67%,RFLNB;PTHLH;NOTCH1;PCM1;B2M;GSK3B
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.3959003057967093,-1.0802180727840713,0.3611111111111111,0.7017011354341486,1.0,6/13,31.60%,ZFYVE28;ZGPAT;SNX6;SOCS5;ERRFI1;CHMP6
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5385833611272416,1.0801839315883046,0.3985611510791367,1.0,1.0,3/11,10.78%,FYN;ABCD1;PARK7
prerank,neuromuscular synaptic transmission (GO:0007274),0.5130924373211947,1.080135326075651,0.40414507772020725,1.0,1.0,2/18,8.40%,CHRNB4;ERC1
prerank,regulation of lymphocyte migration (GO:2000401),0.5699556542186219,1.079706598419468,0.41021897810218977,1.0,1.0,4/10,10.59%,SPN;JAM2;MSN;CCR6
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.48448357961138355,1.0795033143955215,0.39359267734553777,1.0,1.0,6/33,13.38%,HMGB2;ABCB10;BRD1;MAPK14;STAT5B;PRKDC
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5318248608302392,1.0794529983861052,0.39602649006622515,1.0,1.0,5/14,12.46%,RPL7;DDX18;URB1;NIFK;ZNHIT6
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.4662948449894413,1.079059873720325,0.3798767967145791,1.0,1.0,31/69,22.93%,GTF2E1;POLR2I;POLR2A;INTS4;INTS9;GTF2A1;NCBP1;NABP2;SNAPC3;SRRT;INTS1;TAF6;INTS14;RPRD1B;CCNT1;INTS13;CCNK;POU2F1;TAF9;POLR2K;POLR2J;POU2F2;NCBP2;SNAPC5;GTF2A2;RPAP2;INTS12;RPRD2;TAF11;POLR2B;INTS11
prerank,brain development (GO:0007420),0.4496912597558238,1.078899627363743,0.3631790744466801,1.0,1.0,23/136,14.66%,CENPF;CDK5RAP2;SOX6;PBX4;HSPG2;UTP3;PBX3;FBXW11;SPEF2;SHROOM2;PAFAH1B1;SHROOM4;RELN;PTEN;CDK5RAP3;HAP1;SMG9;MDGA1;BBS4;NIPBL;POU6F1;ADGRL3;PBX2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3612501916066313,-1.0787372159003823,0.35714285714285715,0.70220311680516,1.0,11/20,30.03%,APP;ARNT;PRKAA2;IGF1;PFKFB4;PFKFB2;HIF1A;INSR;MLXIPL;PFKFB1;GAPDHS
prerank,positive regulation of glycolytic process (GO:0045821),-0.3612501916066313,-1.0787372159003823,0.35714285714285715,0.70220311680516,1.0,11/20,30.03%,APP;ARNT;PRKAA2;IGF1;PFKFB4;PFKFB2;HIF1A;INSR;MLXIPL;PFKFB1;GAPDHS
prerank,negative regulation of response to stimulus (GO:0048585),0.462268312708383,1.078588411105395,0.3797071129707113,1.0,1.0,9/60,7.67%,FOXA2;FBXO5;ERBB3;TWIST1;RBL1;CDK6;TERF2;AKT3;PIM3
prerank,negative regulation of protein transport (GO:0051224),0.4906417381722786,1.0784462491061828,0.40389294403892945,1.0,1.0,2/25,4.60%,IL12A;SNX3
prerank,response to alcohol (GO:0097305),-0.32088071816717334,-1.078073808036192,0.32167832167832167,0.7023288625550146,1.0,8/27,19.78%,TGFBR1;GRIN3A;GOT2;CCR5;TGFBR3;TGFBR2;CCL3;PMVK
prerank,generation of neurons (GO:0048699),0.4498358371776092,1.0776909857703774,0.33133133133133136,1.0,1.0,32/190,17.28%,CIT;RACGAP1;VAX2;HMGB2;NR4A2;HEY2;NIF3L1;CDK6;DISC1;RUNX3;PIN1;IER2;MYEF2;MARK2;MTPN;PAFAH1B1;DNER;RELN;NRP1;MDGA1;FGF13;NRCAM;ADGRL3;RUNX1;THOC2;MAP2K1;SDCCAG8;FGFR1;LRP12;TGFB2;RAC1;SH3RF1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.4793389315307097,1.077677077266401,0.39776536312849164,1.0,1.0,6/36,10.58%,GFI1;CD74;AGPAT1;UBE2K;PARP14;TRIM44
prerank,regulation of fibroblast proliferation (GO:0048145),0.472178769981229,1.0775685842613427,0.384446878422782,1.0,1.0,15/45,19.06%,AQP1;E2F1;LIG4;CD74;CDK6;EMD;PEX2;DHX9;SKI;MYC;TP53;NLRC3;FN1;MORC3;CDKN1A
prerank,regulation of cellular amine metabolic process (GO:0033238),0.46865501430049394,1.0775289060324138,0.3827956989247312,1.0,1.0,15/50,16.98%,PSMB7;PSMD11;PSMF1;AZIN1;PSMC1;PSMC3;PSMA4;PSMC4;OAZ1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.5051908317917717,1.0775038120903846,0.39520958083832336,1.0,1.0,7/23,16.84%,DAPK2;CD74;RIPOR2;DPP4;RAC2;MCU;RAC1
prerank,mRNA 3'-end processing (GO:0031124),0.45706375681181544,1.0774412279572154,0.36934156378600824,1.0,1.0,33/78,20.91%,DHX38;SLBP;CPSF2;U2AF1;EIF4A3;SRSF3;SRSF4;NCBP1;RNPS1;CASC3;U2AF1L4;CSTF3;RPRD1B;THOC3;UPF3B;THOC5;THOC2;THOC7;SRSF7;CDC40;TUT1;SCAF8;DDX39B;POLDIP3;PCF11;CPSF1;CLP1;TENT2;NCBP2;SRSF2;CPSF7;RPRD2;WDR33
prerank,regulation of JUN kinase activity (GO:0043506),0.48302873431684007,1.0773047544174503,0.4034285714285714,1.0,1.0,12/33,21.16%,ARHGEF5;PTPN22;MAP3K5;MAP3K11;TLR6;TNFRSF11A;AIDA;MAP3K7;HIPK3;RPS3;TRAF6;SASH1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3781093046363857,-1.0772299328618948,0.34558823529411764,0.7026972940467532,1.0,4/14,12.88%,PTPN2;RFFL;GPS2;CARD16
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.44454254556656086,1.0769088257403727,0.216,1.0,1.0,146/572,20.88%,E2F7;AURKB;E2F8;FOXM1;UHRF1;GFI1;NKX6-1;MYB;EZH2;PLK1;MEN1;SUV39H1;NR4A2;HEY2;DEAF1;E2F1;UXT;RB1;ELK4;EZR;CBX5;TWIST1;ZFPM1;MCPH1;HDAC10;UBE2I;MTA3;EPC1;CTCF;FOXP1;ETS2;DACH1;SP100;CAV1;NR1D1;NKAP;TAF1;MBD2;MDM4;E2F6;BCL11A;TCF3;RUNX3;PDE2A;KLF10;TAF7;NOTCH1;HMGB1;SPEN;MAX;SMARCA4;NEDD4L;CIR1;RPS14;ZBTB16;ETV6;NCOA5;ZBTB7A;SIN3B;ZNF148;MECP2;CPEB3;ZBTB32;NR2C2;IRF2BPL;NR2F2;ID4;ZEB1;TRIM33;CUX1;MXI1;ARID5B;SUMO1;RTF1;SMAD4;JUN;PEX2;MTA2;ZNF25;FOXP2;CBFB;RNF2;PRDM6;HCFC1;SIRT7;ZBTB7B;HNRNPU;CC2D1A;NIPBL;DDIT3;BCL6;CREBBP;SKI;BAG3;MYC;NFX1;PSEN1;POU6F1;YEATS2;CNOT1;TP53;MOSPD1;RUNX1;LRRFIP1;IRF8;SIN3A;TCF7L2;HIVEP1;DUSP22;ATRX;DNAJB1;NFATC3;VHL;RIF1;TCERG1;SIRT1;TRIM37;UBA52;HEXIM1;SNCA;HDAC4;RARG;MED1;KDM2B;FOXE1;DPF2;SUFU;PROX1;GATAD2B;HDAC1;TBL1XR1;TRAF6;SOX9;SREBF2;DNMT3B;ZBTB18;HDAC8;TAF3;RPL23;TPR;ACVR2B;RBPJ;PPARD;CITED2;SMAD2;GATAD2A
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.444998526231768,1.0765222718577445,0.227,1.0,1.0,103/476,16.30%,FOXM1;FOXA2;MYB;HMGB2;MYBL1;ATAD2;BRCA1;CDK5RAP2;SMARCC2;HMGA1;CHEK2;BLM;HEY2;BRCA2;MYRFL;DEAF1;LEF1;E2F1;ARID1B;PBX4;NIF3L1;RSF1;CD38;CD74;PML;AXIN1;FBXW11;EPC1;CTCF;ETS2;BRPF1;SP100;NR1D1;MED30;EDF1;FOXO1;YWHAH;TCF3;RUNX3;MAPRE3;EBF3;MAP3K5;BRD4;NOTCH1;TAF15;XRCC6;PIM2;PCBD2;AHR;ILF2;SMARCA4;YEATS4;UBE2V1;SEC14L2;ZBTB16;RLF;EGFR;FLI1;EGR1;SMARCC1;HIPK2;NR2F2;KAT6A;TRIM44;DYRK1A;NFE2;SMAD4;JUN;ATF5;PLCB1;NSD3;NPAT;NAA16;HCFC1;RAI1;KMT2A;SP3;ING2;ING5;DDIT3;CREBBP;MYC;PSEN1;MED14;HNRNPAB;RNF20;TP53INP2;RNF111;ELF1;TADA3;ATF7IP;TP53;DNAJC2;KMT2B;RUNX1;GPATCH3;EGF;F2R;MAP2K1;TFAP4;TCF4;FOXK2;TRIM28
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5349522909126462,1.0764747007977244,0.42091503267973857,1.0,1.0,5/14,19.45%,CARD10;TLR6;MAP3K7;MALT1;TRAF6
prerank,positive regulation of chemokine production (GO:0032722),-0.2961430231398897,-1.076217321968294,0.27586206896551724,0.7035893954489906,1.0,9/44,7.28%,APP;CSF1R;MBP;LPL;AIF1;PYCARD;TLR7;MAVS;TLR4
prerank,copper ion transport (GO:0006825),0.5576701884302513,1.0761489691061714,0.42053445850914206,1.0,1.0,5/11,17.18%,CUTC;ATP7A;STEAP2;STEAP3;ATOX1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5268883920143854,1.0758919960296531,0.40878828229027964,1.0,1.0,4/14,18.29%,OXSR1;CCR2;STK39;ADAM10
prerank,negative regulation of catalytic activity (GO:0043086),0.49805680057487134,1.0756760395017684,0.3926829268292683,1.0,1.0,8/24,18.76%,HDAC6;NOTCH1;CCAR2;PPP1R12A;TP53;NOSIP;SIRT1;CLN3
prerank,aspartate family amino acid metabolic process (GO:0009066),0.5135887173837862,1.0755880013504344,0.409261576971214,1.0,1.0,6/18,17.23%,SLC25A12;MSRA;SMS;SLC25A13;ASS1;NAALAD2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5651821345776713,1.0755156874108691,0.40465793304221254,1.0,1.0,4/10,19.34%,KLRD1;ARRB2;FCGR2B;LGALS9
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.34597786069876646,-1.0748528727331488,0.33,0.7054097184493338,1.0,7/19,14.77%,CAMKK2;DNM1L;HTRA2;GSK3A;PRKN;PINK1;FBXW7
prerank,protein-containing complex assembly (GO:0065003),0.4476934620967681,1.0745111239120972,0.315,1.0,1.0,85/259,19.46%,KNTC1;F5;MEN1;CARD10;MEFV;BLM;FANCA;LEF1;TIAM1;CD74;PML;AXIN1;NAPG;TUBGCP4;IKBKG;RAB1B;MDM4;TRADD;STX5;TCF7L1;PEF1;ANKRD28;CSNK1A1;TGFA;KPNA3;TRAPPC9;BOK;SMARCA4;SNX9;SEC24B;DBNL;LAMC1;TSPAN33;SEC24A;ZW10;TLE4;NDUFAF1;CUL3;SEC13;NIFK;TRAPPC4;BET1;RUVBL1;DHX9;FAS;MAGI1;SEC31A;BCL9L;ZNHIT6;KMT2A;PPP6R3;CHCHD10;ADD2;CREBBP;MYC;MCU;RBBP5;GSK3B;TP53;PPP6C;CNIH1;KIFAP3;TFAP4;FANCC;TCF7L2;DARS1;LMAN1;GORASP1;ADCY8;PEX14;FN1;ANO6;CAND2;EPRS1;LRRK2;ADAM10;TLE3;PPIH;SLC2A1;HDAC1;PDE4DIP;SAR1B;TRAPPC3;CASP8;SOX9
prerank,mRNA destabilization (GO:0061157),0.4806471218835218,1.0742924854553353,0.39373601789709173,1.0,1.0,13/38,16.03%,DCPS;FTO;PDE12;ZFP36L1;CPEB3;TUT4;PUM1;METTL16;ROCK2;CNOT1;RC3H1;METTL14;ZFP36L2
prerank,regulation of interleukin-1 production (GO:0032652),0.5265397152882811,1.0736898432056015,0.4102902374670185,1.0,1.0,3/15,7.33%,MEFV;FOXP1;HMGB1
prerank,regulation of endothelial cell migration (GO:0010594),-0.24323476062646363,-1.0731091600405709,0.2,0.7080031514263063,1.0,30/85,20.67%,ANXA3;GLUL;NRP2;APOE;GPI;BMPR2;PRKD1;PIK3CD;GRN;ZC3H12A;KRIT1;ANGPT1;NF1;SH3BP1;ITGB3;SCARB1;SPARC;PIK3CB;PTK2;VEGFA;FGF2;VASH1;ACVRL1;DAB2IP;GPLD1;THBS1;BMPER;ADGRB1;SVBP;AGT
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.47301357973333913,1.0731000669325803,0.3955056179775281,1.0,1.0,8/37,15.40%,PLK1;MAPK1;AXIN1;UBE2K;S1PR2;SPRED2;PRKAG2;EGF
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5576834068434052,1.0730990000007792,0.4123287671232877,1.0,1.0,6/13,20.17%,CPSF2;NCBP1;TUT1;CPSF1;NCBP2;CPSF7
prerank,regulation of defense response to virus (GO:0050688),0.5318899897473932,1.0730643599688068,0.40217391304347827,1.0,1.0,4/14,11.50%,RNF26;TRAF3;PCBP2;DHX9
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.48980770884130886,1.073062268966504,0.3961352657004831,1.0,1.0,4/25,9.85%,CSGALNACT2;HAS1;EXT1;B3GNT2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.5592836737911296,1.072782830381222,0.40483383685800606,1.0,1.0,6/10,23.09%,PRKCE;NEDD4L;STK39;HECW2;NEDD4;OSR1
prerank,positive regulation of cell development (GO:0010720),0.48771865444812695,1.0725445891107217,0.37757437070938216,1.0,1.0,9/31,22.63%,NKX6-1;LIG4;SPEN;NAP1L1;TYROBP;ATP6AP1;MME;NUMBL;NIBAN2
prerank,mesoderm development (GO:0007498),0.5120749835623688,1.0722370592466086,0.39711664482306686,1.0,1.0,3/18,10.94%,IKZF3;JAK2;BTK
prerank,snRNA transcription (GO:0009301),0.46221613348332,1.0720812029458797,0.39201637666325484,1.0,1.0,31/70,22.93%,GTF2E1;POLR2I;POLR2A;INTS4;INTS9;GTF2A1;NCBP1;NABP2;SNAPC3;SRRT;INTS1;TAF6;INTS14;RPRD1B;CCNT1;INTS13;CCNK;POU2F1;TAF9;POLR2K;POLR2J;POU2F2;NCBP2;SNAPC5;GTF2A2;RPAP2;INTS12;RPRD2;TAF11;POLR2B;INTS11
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5512480558792151,1.0717141404869726,0.4260752688172043,1.0,1.0,3/14,14.97%,CARD10;NOTCH1;PDCD10
prerank,phosphorylation (GO:0016310),0.44149049362614023,1.0712514466391438,0.299,1.0,1.0,126/384,21.48%,CDK1;BIRC5;AURKB;NEK2;PLK1;CCNE1;STK26;CHEK2;MAPK1;CDKL1;AURKA;OXSR1;DAPK2;FYN;PRKCE;HASPIN;RSKR;ERG;RPS6KA5;MAP4K1;PANK2;STK11;CHEK1;CDK6;GRK6;TLK1;GMFG;TAF1;SIK2;ATM;RUNX3;CSNK1A1;STK38L;MAP3K5;CDC25B;PIM2;PKN2;CDK17;AKT3;BIRC6;CSNK1G2;PIM3;MAP3K1;MAP4K2;PRKCA;PRKACA;HCST;STK38;MARK2;PICK1;JAK2;LMTK3;MAST2;STK24;PIM1;PDPK1;MAP4K5;CDK19;HIPK2;MAP3K11;TESK2;MELK;DYRK1A;BTK;VRK1;FGGY;PRKCB;CCNT1;BMPR1A;LMTK2;ROCK2;GRK2;DGKD;PRKDC;PRKAG2;LATS1;CDK16;STK39;NRBP1;FAM20A;SGK3;GSK3B;STK4;MAP3K20;BCR;LIMD1;PAK5;MAP2K1;MARK4;FGFR1;PAK2;LIMK2;TGFB2;CDK8;JAK3;PIK3CA;SRPK1;PGK1;LRRK2;FAM20B;TAOK1;MORC3;STK17B;ADAM10;CREB1;NIM1K;HIPK3;STK3;NADK;CDK11B;PRKD2;DAPK1;ALK;PLK4;EPHA7;MARK1;ACVR2B;ILK;PRKAG1;IKBKB;ROCK1;TYK2;DGKE;COPS2;SYK;GRK3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3362704355585424,-1.071148092242677,0.3401360544217687,0.7113117310511542,1.0,4/26,5.29%,RIMS1;APP;RIMS2;SLC8A3
prerank,negative regulation of calcium ion transport (GO:0051926),-0.39755039849282714,-1.0710014432624129,0.3601694915254237,0.710114054123663,1.0,10/15,44.85%,TRIM27;ATP1A2;CBARP;SLC30A1;PACSIN3;ADRA2A;NOS1;PLN;EPO;STC1
prerank,positive regulation of transferase activity (GO:0051347),0.4489815004864854,1.0707929366745448,0.36810431293881646,1.0,1.0,20/142,9.60%,AURKB;NEK2;PLK1;MAPK1;DSCC1;ERBB3;LMO4;CD74;RFC5;AXIN1;UBE2I;PCNA;SERINC5;CCT2;TCP1;PIN1;HNRNPA2B1;EGFR;EPHA3;RFC2
prerank,cellular response to organonitrogen compound (GO:0071417),0.4429857993187745,1.0704143627259959,0.39899497487437185,1.0,1.0,26/99,19.93%,SLC5A5;BRCA1;AQP1;CTNNA1;EZR;HCN3;CRHBP;TAF1;ZFP36L1;PDE2A;AHR;LARS1;P2RY1;EGR1;CPEB3;LAMTOR4;DIAPH1;LAMTOR3;IPO5;XBP1;HSP90B1;GLRA1;SOX9;GOLPH3;GABRB2;PKD2
prerank,glutathione derivative metabolic process (GO:1901685),-0.3537838251650582,-1.0703688214067022,0.3764705882352941,0.708397217908508,1.0,8/20,33.56%,HPGDS;GSTO1;GSTA3;MGST1;AKR1A1;GSTA4;GSTO2;GSTZ1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.3537838251650582,-1.0703688214067022,0.3764705882352941,0.708397217908508,1.0,8/20,33.56%,HPGDS;GSTO1;GSTA3;MGST1;AKR1A1;GSTA4;GSTO2;GSTZ1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5241306072235233,1.070259391380846,0.41624365482233505,1.0,1.0,5/19,15.54%,FOXA2;NOTCH1;FLOT1;DENND6A;PTPRU
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4967886356418713,1.0700286674292678,0.4245742092457421,1.0,1.0,9/23,21.16%,ARHGEF5;MAP3K5;MAP3K11;TLR6;TNFRSF11A;MAP3K7;RPS3;TRAF6;SASH1
prerank,nuclear membrane organization (GO:0071763),0.5182287065678788,1.0700238859861397,0.4064102564102564,1.0,1.0,4/19,10.95%,PLK1;NEMP1;EMD;TOR1A
prerank,positive regulation of protein metabolic process (GO:0051247),0.44173266032572683,1.0697886707125126,0.3922369765066394,1.0,1.0,21/110,14.67%,UHRF1;BARD1;TFR2;DTL;AXIN1;ABCB10;RASGRP1;SLC25A37;FOXO1;RAB1B;STX5;PAEP;NEDD4L;MTPN;ABCA2;CARD9;FZR1;OAZ1;ROCK2;PSEN1;GSK3B
prerank,regulation of acute inflammatory response (GO:0002673),-0.36563544607959253,-1.0696326378571368,0.31336405529953915,0.7086313380016621,1.0,10/18,51.54%,NLRP3;PTGES;OSM;OSMR;IL6;PLA2G2D;GSTP1;KLKB1;F12;DNASE1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.532306213801699,1.0696228441805629,0.3997233748271093,1.0,1.0,5/13,14.81%,ARID1B;CDCA4;CHEK1;SERTAD2;ELOF1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.4840480461223943,1.0695961207387852,0.4078014184397163,1.0,1.0,10/25,19.93%,GLMN;CCR2;PLCG2;RUNX1;MAP3K7;MALT1;RPS3;TRAF6;PNP;PRKD2
prerank,regulation of cation channel activity (GO:2001257),-0.25235088328620614,-1.0683620327697376,0.22727272727272727,0.7102298981056294,1.0,22/89,16.08%,CTSS;APP;ANK3;CACNB2;GRIA1;KCNAB1;GRIA4;ANK2;DLG2;SHISA6;MINK1;CACNG2;DMD;CACNG7;VAMP2;FGF12;CACNB4;LRRC7;CALM1;JPH4;CAMK2B;DLG1
prerank,nuclear body organization (GO:0030575),0.5496206847896066,1.0679885762348142,0.42657342657342656,1.0,1.0,6/12,23.11%,PML;HIPK2;USP50;WRAP53;AFF2;ZPR1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4630639857869101,1.0676251200782292,0.3969957081545064,1.0,1.0,18/47,24.39%,CD177;DCXR;MAPK14;GRB2;PLCG2;DHRS4;TLR6;TYROBP;TP53;CYBA;CDKN1A;RAB27A;RIPK1;MAPT;SYK;PRKCD;SLC5A3;RNF41
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.45103723487683517,1.0673015905235006,0.4055727554179567,1.0,1.0,19/70,16.98%,MYB;PSMB7;PSMD11;PSMF1;TCF3;PSMC1;PSMC3;PSMA4;PSMC4;CBFB;KMT2A;PSMD13;PRKDC;PSME1;PSMB1;RUNX1;PSMD8;PSME4;PSMD4
prerank,regulation of tube diameter (GO:0035296),0.545434644535188,1.0670643958142825,0.3972222222222222,1.0,1.0,5/13,23.72%,ROCK2;ROCK1;GCLM;GCLC;ITGB1BP1
prerank,vascular process in circulatory system (GO:0003018),0.545434644535188,1.0670643958142825,0.3972222222222222,1.0,1.0,5/13,23.72%,ROCK2;ROCK1;GCLM;GCLC;ITGB1BP1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.5085285202973941,1.0668684223367833,0.40965346534653463,1.0,1.0,6/20,20.20%,FGFBP3;SULF2;SMOC2;APLN;PRKD2;DSTYK
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.44323842324053214,1.0666111969911416,0.37424547283702214,1.0,1.0,25/114,16.98%,TNFRSF18;EDARADD;TNFSF13B;PSMB7;PSMD11;PSMF1;TRADD;TRAF3;PSMC1;BIRC2;JAK2;PSMC3;TNFRSF13B;PSMA4;PSMC4;PSMD13;ACTN4;PSME1;PSMB1;LIMS1;TP53;TNFRSF11A;PSMD8;PSME4;PSMD4
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3540881612682286,-1.0665082120199871,0.33497536945812806,0.7131872398513298,1.0,2/18,0.69%,RIMS1;RIMS2
prerank,positive regulation of protein binding (GO:0032092),0.4638616819735046,1.066458613138824,0.40252897787144365,1.0,1.0,21/56,19.73%,MEN1;TIAM1;EPB41;CAV1;TAF1;PIN1;PPP2CB;HIPK2;AMFR;B2M;FLOT1;ADD2;PSEN1;GSK3B;STK4;TCF7L2;SPPL3;LRRK2;AKTIP;STK3;PPP2CA
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.3545600775563619,-1.06620120706456,0.34210526315789475,0.7124109167487979,1.0,5/19,5.80%,RTN4;APOE;GGA3;IGF1;BIN1
prerank,skeletal muscle tissue development (GO:0007519),0.48000350749045695,1.0660977542735026,0.4172494172494173,1.0,1.0,7/32,20.78%,CSRP3;CAV1;CAV2;SKI;CFLAR;ZBTB18;SVIL
prerank,translational termination (GO:0006415),0.45029698833185344,1.0650583615991005,0.3930399181166837,1.0,1.0,22/95,17.53%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MTRF1L;MRPS34;MRPL38;GSPT1
prerank,monocyte differentiation (GO:0030224),-0.43597111389467136,-1.0647045672324156,0.37800687285223367,0.7145653109254743,1.0,5/10,17.87%,CSF1R;PDE1B;VEGFA;MT1G;IL31RA
prerank,mRNA modification (GO:0016556),0.5019533555997413,1.0645169607037333,0.4194341943419434,1.0,1.0,11/22,23.90%,CBLL1;PUS3;METTL8;METTL16;VIRMA;METTL14;TRUB2;DKC1;WTAP;TRMT10C;TRUB1
prerank,artery development (GO:0060840),-0.3452141068092138,-1.064236535890402,0.32558139534883723,0.7141779705287842,1.0,8/23,15.54%,TGFBR1;BMPR2;ROBO1;NF1;ENG;SMAD7;VEGFA;ACVRL1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.49140905886856145,1.0641916136988163,0.419838523644752,1.0,1.0,7/26,17.26%,FOXA2;NR1D1;PIM3;BAIAP3;CDK16;TRPM4;ADCY8
prerank,protein autophosphorylation (GO:0046777),0.4439974982665738,1.0635769746631256,0.3863863863863864,1.0,1.0,35/157,16.06%,AURKB;NEK2;STK26;CHEK2;AURKA;OXSR1;DAPK2;SLK;MAP4K1;STK11;MAPKAPK3;TAF1;SIK2;ATM;PIM2;PIM3;PRKX;MARK2;JAK2;STK24;EGFR;PIM1;PDPK1;MAP3K11;MELK;DYRK1A;VRK1;FLT3;LMTK2;STK39;HTATIP2;GSK3B;STK4;FGFR1;PAK2
prerank,keratan sulfate catabolic process (GO:0042340),0.5560334822473091,1.0633577116590136,0.4200848656294201,1.0,1.0,3/11,10.96%,FMOD;GALNS;OGN
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.4964097233865113,1.0630285504623764,0.41585365853658535,1.0,1.0,4/21,10.78%,BRCA1;ABCD1;HDAC6;PARK7
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4725487769323163,1.0626958872319536,0.3895538628944505,1.0,1.0,9/40,16.23%,EZH2;LEF1;TIAM1;TWIST1;NOTCH1;SMAD4;BCL9L;TCF7L2;TGFB2
prerank,respiratory electron transport chain (GO:0022904),0.5391257099129511,1.0625748052056074,0.4509043927648579,1.0,1.0,9/14,24.60%,SLC25A12;SLC25A22;SLC25A13;GPD2;NDUFA5;ETFRF1;ETFDH;ETFB;ETFA
prerank,protein autoprocessing (GO:0016540),0.5157716124364027,1.0625142598106552,0.4172099087353325,1.0,1.0,3/17,11.24%,MYRFL;PIDD1;FAM111A
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.45458569695843387,1.0621352427449453,0.41412012644889357,1.0,1.0,8/57,9.35%,MRPL36;XPO1;RPL7;RPL14;RPS19;RPS7;URB2;EMG1
prerank,regulation of receptor recycling (GO:0001919),-0.37542799886122225,-1.0618806297017762,0.35909090909090907,0.7185488936664389,1.0,3/16,8.73%,NSF;OPTN;ECE1
prerank,positive regulation of leukocyte activation (GO:0002696),0.5167710291059384,1.061709990317323,0.4198966408268734,1.0,1.0,1/18,0.99%,CD2
prerank,Notch signaling pathway (GO:0007219),0.45192607114283306,1.0612085547720516,0.40209424083769635,1.0,1.0,8/59,14.04%,DLGAP5;HEY2;NOTCH1;MIB1;KAT2B;CREBBP;MYC;PSEN1
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5533458752830108,1.061043043484243,0.41379310344827586,1.0,1.0,6/11,19.50%,CCT7;CCT2;TCP1;CCT5;DKC1;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5533458752830108,1.061043043484243,0.41379310344827586,1.0,1.0,6/11,19.50%,CCT7;CCT2;TCP1;CCT5;DKC1;CCT6A
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.49701779401781365,1.0608079084848459,0.42788461538461536,1.0,1.0,5/24,9.78%,CGAS;PDE2A;GNAI1;RNF157;PEX5L
prerank,regulation of Notch signaling pathway (GO:0008593),-0.24804188015519676,-1.060557118833303,0.36363636363636365,0.7202859759400108,1.0,22/76,18.42%,BMP2K;EPN2;PRAG1;MAML1;GALNT11;PRKCI;ARRDC1;ARRB1;YTHDF2;MMP14;MAML3;POGLUT1;STAT3;ZMIZ1;TSPAN15;FBXW7;TSPAN14;TM2D3;JAG1;CD46;LLGL1;NEPRO
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.4964061484327238,1.0600580602412641,0.423500611995104,1.0,1.0,9/20,25.58%,PRKCE;NEDD4L;ACTN2;STK39;YWHAE;HECW2;NEDD4;OSR1;CAB39
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.5589128977240851,1.059910515691194,0.43323863636363635,1.0,1.0,1/11,0.60%,E2F2
prerank,protein complex oligomerization (GO:0051259),0.44810477672672333,1.0597991388315045,0.41513292433537835,1.0,1.0,15/85,14.08%,ECT2;POLQ;MS4A1;BLM;CUTC;ATL2;BOK;MPP2;LRRC8C;TIFA;CARD9;KCNC2;ZNHIT6;MICU1;MCU
prerank,RNA stabilization (GO:0043489),0.475274317535327,1.0595934128654885,0.42272727272727273,1.0,1.0,15/33,24.83%,E2F1;TRDMT1;TAF15;HNRNPU;PAIP1;DKC1;TENT2;EIF4ENIF1;ELAVL1;THRAP3;TENT5D;YBX1;GDNF;CIRBP;ZCCHC17
prerank,neurotransmitter transport (GO:0006836),-0.26302464744029946,-1.0591469914301779,0.358974358974359,0.721993064525582,1.0,27/73,27.27%,RIMS1;GLUL;SYNJ1;PPFIA2;SLC1A2;GABRA2;SYT1;SLC17A6;VAMP2;SLC1A3;GAD2;UNC13A;STX1A;SLC5A7;PPFIA1;SNAPIN;ATP1A2;RAB3A;STXBP1;PTPRN2;CPLX1;SLC32A1;PDZD11;DVL1;SNAP25;SLC38A1;SLC1A1
prerank,determination of heart left/right asymmetry (GO:0061371),0.46302745888890495,1.0589808605278694,0.4184008762322015,1.0,1.0,4/42,13.22%,STIL;NOTCH1;SETDB2;BBS4
prerank,chloride transport (GO:0006821),0.4484783435464834,1.0589636490822414,0.4010204081632653,1.0,1.0,11/74,12.57%,SLC4A1;SLC12A3;ANO10;CLIC5;SLC12A7;SLC12A1;GABRA4;CLIC1;GABRA5;ANO3;SLC12A6
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3222034480975666,-1.0585971240962053,0.358974358974359,0.7218274816344548,1.0,6/27,9.62%,CACNA1C;ANK2;SRI;CTNNA3;JUP;RYR2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.46814743001773984,1.0584864936617495,0.40337078651685393,1.0,1.0,9/36,15.40%,CCR2;TAF1;HDAC6;TGFA;JAK2;PARK7;RELN;NRP1;EGF
prerank,cell junction organization (GO:0034330),-0.25772289364071516,-1.0584301632782798,0.3448275862068966,0.7206758677997818,1.0,17/71,9.28%,PAK3;APP;OPHN1;FBLIM1;MYO9A;CAPZA1;PPFIA2;PRKCI;VASP;SMAD3;APBB2;C1QA;SLC8A3;SEMA3E;GRM5;TJP2;SH3BP1
prerank,protein secretion (GO:0009306),-0.2613211706701495,-1.0583652188192942,0.2833333333333333,0.719279820620964,1.0,17/56,14.81%,RIMS2;TMEM167A;ABCA1;WLS;PCSK5;MON1A;TANGO2;COPG2;MIA3;MTTP;CYB5R4;PDIA4;RAB12;CAMK2G;OLFM2;NAGPA;PTPRN
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.44591718586601536,1.058337014898628,0.40425531914893614,1.0,1.0,15/55,16.06%,PMAIP1;PML;S100A9;TNFSF10;CAV1;S100A8;BOK;BECN1;FAS;FIS1;RACK1;ING5;DDIT3;TP53;PAK2
prerank,stem cell differentiation (GO:0048863),0.4710427078664059,1.0576268906701773,0.42400881057268724,1.0,1.0,17/39,25.94%,BATF;PSMD11;PUM1;TP53;NELFB;HOXB4;JARID2;TGFB2;LMBR1L;PAX2;FGFR2;OSR1;UFL1;MTF2;HMGA2;MLLT3;SETD2
prerank,calcium-mediated signaling (GO:0019722),0.44415359369764085,1.0574962210681278,0.39271255060728744,1.0,1.0,23/93,17.85%,CXCR5;PPP1R9B;SAMD14;PPP3CA;RCAN3;CCR2;PRKACA;PLCG2;NUDT4;EGFR;PDPK1;CCR6;BTK;FIS1;CHRM3;MCU;PPP3CC;STIMATE;PLCG1;TRPM4;MCTP1;CXCR4;LRRK2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.5192623978739416,1.0571956479349356,0.4177718832891247,1.0,1.0,3/15,8.00%,NRDC;SNX33;SNX9
prerank,aortic valve development (GO:0003176),0.4711252251814465,1.0567609543333163,0.42369020501138954,1.0,1.0,10/34,22.30%,HEY2;RB1;TWIST1;NOTCH1;SLIT3;ROCK2;ELN;SOX9;ROCK1;EFNA1
prerank,ribosome assembly (GO:0042255),0.4661815420699321,1.056749549479791,0.41442411194833156,1.0,1.0,20/47,23.79%,EIF2A;RPS19;RPL23A;MPV17L2;MRPL22;RPS14;RPS27;MRPS7;RPS5;RPLP0;DHX29;RPL3;RPL5;EIF6;RSL24D1;RPL24;EFL1;RPL10;NPM1;MRPL20
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.34694480802341376,-1.0567342339751924,0.3383838383838384,0.7217720050640197,1.0,11/21,24.04%,RAP1GDS1;SLC8A3;MCUR1;SLC8B1;LETM1;TGM2;BCAP31;MAIP1;AFG3L2;SMDT1;ANXA6
prerank,regulation of protein acetylation (GO:1901983),0.5420726296136317,1.056667337983805,0.4206128133704735,1.0,1.0,6/12,18.37%,CEP295;PARK7;GSK3B;SIRT1;TAOK1;FAM161A
prerank,cellular response to ketone (GO:1901655),0.47026739173236254,1.0564984444682595,0.4114285714285714,1.0,1.0,14/35,23.23%,AQP1;MAP4K1;DCPS;AHR;GNAI1;MSN;ROCK2;ADCY8;PTGER4;GOLPH3;PCK2;GNB1;KLF9;SRC
prerank,hexose transmembrane transport (GO:0008645),0.5077493668186297,1.056417765170761,0.40613496932515336,1.0,1.0,6/21,20.70%,SLC2A4;SLC2A8;SLC2A12;SLC2A3;SLC2A1;PPARD
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.23604393363041495,-1.0563654680567556,0.3333333333333333,0.7211371803740957,1.0,28/128,17.71%,ACVR1;ITGB5;TGFBR1;GCNT2;APPL2;F11R;NLK;PTPRK;SMAD1;BMPR2;SMAD3;ZFYVE9;USP9X;SMAD6;ZMIZ2;BMPR1B;ENG;LPXN;FERMT2;SMAD7;ZMIZ1;ADAM9;PTK2;TGFBR3;ACVRL1;SMURF2;TGFBR2;BMP6
prerank,mitochondrial gene expression (GO:0140053),0.4655461615039337,1.056021475298294,0.4160427807486631,1.0,1.0,11/42,12.36%,FASTKD5;NOA1;GATC;MRPL47;MRPL16;TFB2M;MRPL51;MRPS7;MRPS17;GFM2;TEFM
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5464792549278341,1.0559283442771776,0.43137254901960786,1.0,1.0,5/11,16.52%,NOVA2;PCBP2;IGF2BP3;PCBP3;ZNF445
prerank,response to progesterone (GO:0032570),0.5132798463631066,1.0556053656975044,0.44430538172715894,1.0,1.0,2/18,5.32%,CATSPERB;CAV1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.46749569882513176,1.0555540393664036,0.41565600882028664,1.0,1.0,8/36,14.16%,NR4A2;RB1;DAPK2;BCL2L12;FAS;ING5;SGMS1;PPIA
prerank,organophosphate ester transport (GO:0015748),-0.32956785468092553,-1.055180223040879,0.38235294117647056,0.7224840070272479,1.0,8/24,13.35%,OSBPL2;PLTP;PRELID2;SCP2;MTTP;SCARB1;PITPNB;NPC2
prerank,negative regulation of organelle assembly (GO:1902116),0.4818824431259407,1.055065755565004,0.42775229357798167,1.0,1.0,10/35,17.85%,BRCA1;CDK5RAP2;TCHP;SMAD4;KAT2B;MDM1;MTM1;LIMK2;TRIM37;LRRK2
prerank,tRNA processing (GO:0008033),-0.2645687552999538,-1.0548891937792348,0.28888888888888886,0.7217679499287931,1.0,35/61,37.07%,ANKRD16;SARS1;TRMT1;DTWD2;NSUN2;WDR4;QTRT1;ELP5;TYW5;TRIT1;TSEN15;METTL1;FTSJ1;THUMPD1;TRMT10B;RPP21;RTRAF;FAM98B;TRMT10A;LCMT2;ELAC2;TRMT9B;DDX1;DTWD1;RPP40;NSUN6;POP5;CTU2;AARS2;TSEN54;POP7;THG1L;QTRT2;TRMT61A;CTU1
prerank,cardiac muscle cell development (GO:0055013),0.5008424135251477,1.054656751526535,0.4254278728606357,1.0,1.0,2/20,3.66%,HEY2;CSRP3
prerank,positive regulation of mRNA processing (GO:0050685),0.4980457848648711,1.054142809816995,0.41706161137440756,1.0,1.0,9/21,23.73%,RBM3;NCBP1;NUP98;DAZAP1;NCBP2;THRAP3;LEO1;NCL;CIRBP
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5442825826675249,1.0539348870875116,0.4250343878954608,1.0,1.0,3/11,10.23%,SNX33;NEDD4L;ACTN2
prerank,keratan sulfate metabolic process (GO:0042339),0.48148743478476497,1.053342925551211,0.42093287827076226,1.0,1.0,7/31,10.96%,FMOD;GALNS;ST3GAL1;SLC35D2;ST3GAL2;B3GNT2;OGN
prerank,cytoskeleton organization (GO:0007010),0.4358619966561072,1.052864902171852,0.4068825910931174,1.0,1.0,22/114,15.76%,DIAPH3;CECR2;DES;WDPCP;NEDD9;CNN2;ANK1;RND3;PPP2R3C;MAST2;FGD6;RHOU;SYNE3;PDZD8;FGD3;PACSIN2;PLD2;RAC2;PALLD;DIAPH1;LIMD1;PAK5
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3143977807277841,-1.0526665778321147,0.35947712418300654,0.7255306541795884,1.0,8/25,16.65%,CACNA1C;ANK2;CTNNA3;JUP;RYR2;CALM1;DLG1;CXADR
prerank,ribosomal small subunit biogenesis (GO:0042274),0.4643248123467179,1.052362901483324,0.4324618736383442,1.0,1.0,14/39,18.98%,LSM6;RPS19;RPS7;RPS14;NOL11;EMG1;RPS27;MRPS7;RPS5;RIOK3;SRFBP1;RIOK1;RPS17;RPS6
prerank,DNA methylation (GO:0006306),0.49025593717455795,1.051848389740349,0.4196319018404908,1.0,1.0,10/23,20.88%,PPM1D;HELLS;PICK1;METTL4;DNMT1;EHMT1;ATF7IP;ATRX;DNMT3B;GATAD2A
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5516383542744488,1.0517429902648872,0.4246987951807229,1.0,1.0,6/10,23.09%,PRKCE;NEDD4L;STK39;HECW2;NEDD4;OSR1
prerank,mitochondrial translation (GO:0032543),0.444250572279813,1.0515313049597967,0.4109311740890688,1.0,1.0,23/104,17.25%,MRPL36;AURKAIP1;MRPL18;NOA1;GATC;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;MRPL24;MRPL48;MRPS10;MTRF1L;MRPS34;MRPL38
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5422411206129968,1.0513980755791175,0.4153846153846154,1.0,1.0,3/13,11.66%,RAMP1;ABCA2;PLCB1
prerank,cellular sodium ion homeostasis (GO:0006883),0.5232087019636933,1.0512506468446812,0.42929936305732486,1.0,1.0,2/15,7.98%,TMPRSS3;NEDD4L
prerank,magnesium ion transport (GO:0015693),0.5334238567903491,1.0512466048353992,0.44428969359331477,1.0,1.0,7/12,23.52%,MAGT1;TUSC3;NIPAL4;NIPA2;NIPAL3;MMGT1;CNNM4
prerank,glycoprotein metabolic process (GO:0009100),-0.2703818848856774,-1.0512210361922383,0.3283582089552239,0.7275004347505805,1.0,23/53,22.77%,MANBA;ST8SIA1;MAN1C1;NGLY1;MAN2A2;GANAB;STT3B;MAN2B1;LARGE1;PCSK6;B4GALT5;ERP44;ST6GALNAC6;ST3GAL4;B4GALT7;HPSE;ST8SIA5;ST6GALNAC3;AGA;ST8SIA3;GAL3ST4;MAN1B1;HIF1A
prerank,establishment of endothelial barrier (GO:0061028),0.48437233068321955,1.0509550974844646,0.42823529411764705,1.0,1.0,7/29,11.57%,PECAM1;EZR;TJP3;RAB1B;PDE2A;MSN;RDX
prerank,negative regulation of phosphorylation (GO:0042326),0.44343439197222073,1.050391239077527,0.42901234567901236,1.0,1.0,31/85,22.84%,MEN1;CDKN2C;ANKLE2;CDKN2A;CRKL;NIBAN1;CIB1;IBTK;CDKN2D;PARK7;PTEN;CDK5RAP3;PRKDC;HNRNPU;PPIA;DYNLL1;FKBP8;SIRT1;PTPN13;LRRK2;HDAC4;CDKN1A;PRR5L;ROCK1;MAPT;CBFA2T3;CADM4;PPP1R15B;NTRK3;CDKN1B;TARDBP
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4325680870455187,1.0500980697728053,0.274,1.0,1.0,203/834,20.82%,DLGAP5;CKAP2;E2F7;E2F8;FOXM1;E2F2;UHRF1;FOXA2;NKX6-1;MYB;HMGB2;SPIB;POU2AF1;MYBL1;MEN1;ATAD2;BRCA1;NR4A2;TFR2;HMGA1;HEY2;LEF1;E2F1;SMARCA5;SENP1;SMARCD2;RSF1;ELK4;PPP3CA;CCN1;TWIST1;ZFPM1;BCLAF3;CSRP3;USF1;ERG;RPS6KA5;EPC1;RBL1;BRD8;NR1D1;MED30;IKBKG;FOXO1;FOXJ3;ATM;KANSL3;TCF3;SETX;BCL2L12;ARF4;TFDP1;KLF10;BRD4;TAF7;NOTCH1;PIN1;XRCC6;DDRGK1;HMGB1;CAMTA2;AHR;MAX;KMT2C;SMARCA4;IER2;DCN;YEATS4;SSBP3;GABPB1;GABPB2;PCGF5;RLF;EFCAB7;E2F5;NCOA7;PLAG1;NRF1;EGFR;ASXL1;EGR1;TFDP2;SALL2;NR2C2;IRF2BPL;HIPK2;PSMC3;NR2F2;KAT6A;RUVBL2;PRDM10;PARK7;ZNF462;SMAD4;ATF6;MLLT10;TAF6;JUN;RPRD1B;DHX9;KAT2B;ATF5;PELP1;CCNT1;NPAT;NFATC2IP;PAXIP1;HCFC1;BCL9L;APEX1;BMPR1A;SATB2;KMT2A;STAT5B;SP3;SIRT7;NFE2L2;PRKDC;HNRNPU;BEX1;HELZ2;DDIT3;CEBPZ;ADCYAP1;CREBBP;SKI;MYC;CEBPG;GABPA;MED14;MYDGF;HTATIP2;RNF111;PPP1R12A;PBX2;E2F3;CCNK;ELF1;SS18;TP53;MOSPD1;RUNX1;JUNB;IRF8;HOXB4;POU2F1;PLAGL1;SIN3A;TCF7L2;TCF4;HIVEP1;TGFB2;ATRX;FOXK2;RFX4;CDK8;TAF9;NFATC3;TCERG1;SIRT1;XBP1;TMF1;APLN;RNF4;RXRB;MLXIP;HCLS1;GLYR1;UBA52;ZBED4;POU2F2;HDAC4;RARG;MED1;DPF2;CREB1;NKX2-8;PROX1;HDAC1;TBL1XR1;PAX2;TRAF6;SOX9;THRAP3;NPAS2;SREBF2;AGO2;NCOA6;ZBTB18;HDAC8;PKD2;PRKD2;MMP12;NCOA2;MET;PRDM4;RBPJ;PHF10;FIZ1;MED13;PPARD;CITED2;SMAD2
prerank,modulation by symbiont of host process (GO:0044003),0.5443391655133113,1.0500028981723344,0.44903988183161003,1.0,1.0,4/10,17.63%,B2M;HGS;UBA52;PGK1
prerank,mesenchymal cell differentiation (GO:0048762),0.4519921184841986,1.049715842140657,0.4160506863780359,1.0,1.0,16/51,22.80%,FAM83D;HEY2;LEF1;NOTCH1;ROCK2;HNRNPAB;GSK3B;LIMS1;FGFR1;TGFB2;TRIM28;SOX9;RBPJ;ROCK1;AKNA;FGFR2
prerank,axon extension (GO:0048675),-0.32263140213835884,-1.0496484130518162,0.37790697674418605,0.7299595811353954,1.0,7/23,14.87%,NRP2;HSP90AA1;SPG11;USP9X;ULK1;CDK5;SEMA3A
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.28779694705198544,-1.049429225360101,0.3474576271186441,0.7290012449110066,1.0,18/39,33.36%,PRKCI;TNFAIP3;KRIT1;ANGPT1;TNIP2;SERPINE1;ECSCR;THBS1;MAPK7;PDCD4;CD40;NDNF;RGCC;KDR;ICAM1;CCL2;PAK4;TEK
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5584669554902829,1.0493365901429073,0.43812233285917496,1.0,1.0,1/11,1.98%,SOX6
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.5040387175561866,1.0492008391346341,0.4401972872996301,1.0,1.0,7/19,21.77%,IL12A;DCN;SMOC2;CCBE1;CADM4;SEMA6A;ADAMTS3
prerank,positive regulation of metabolic process (GO:0009893),-0.25083160431450674,-1.0488727566520417,0.25,0.7288843825131434,1.0,30/103,18.79%,IGF1R;KDM1A;EBF2;CMKLR1;APPL2;LPIN1;ESRRG;ACLY;IL4R;ACACA;ACADL;GNAS;PPARGC1B;MFN2;PRLR;HDAC3;PDGFC;ELOVL6;VEGFA;EPAS1;GJA1;IL18;GRB10;HADH;CD36;ADRB1;KDM3A;PER2;ADRB2;KDM6B
prerank,negative regulation of apoptotic process (GO:0043066),0.4340358664661076,1.0487618276872004,0.343,1.0,1.0,87/444,18.29%,KIF14;CDK1;STIL;BIRC5;MAD2L1;NTF4;BARD1;PLK1;NR4A2;AQP1;MAPK1;LEF1;DDAH2;RB1;ERBB3;FLNA;CD38;LIG4;CD74;ANKLE2;CD44;PIDD1;PA2G4;UBE2O;TFRC;CAV1;FOXO1;CASP2;DPEP1;PTMA;SETX;ARF4;ARL6IP1;BIRC2;NOTCH1;UBE2Z;DDRGK1;PIM2;BIRC6;PIM3;CIB1;PRKCA;TNFAIP8;RNF157;ERC1;EGFR;CDKN2D;PIM1;SOCS2;PARK7;XIAP;ATF5;FAS;MYD88;NAA16;PRKDC;GLO1;BAG3;MYC;CFLAR;PSEN1;BAG1;MYDGF;HTATIP2;TPT1;GSK3B;TP53;PDCD10;F2R;PAK2;TAF9;ARHGDIA;VHL;PIK3CA;SIRT1;XBP1;SH3RF1;HSP90B1;HCLS1;YWHAE;UBA52;AVEN;SNCA;MED1;KDM2B;MALT1;ADAM10
prerank,protein deacylation (GO:0035601),0.49734416014659233,1.0486693500281774,0.4290909090909091,1.0,1.0,10/23,19.03%,ABHD17A;HDAC10;HDAC6;LYPLA1;ABHD17B;SIRT7;SIN3A;SIRT1;HDAC4;HDAC1
prerank,mammary gland epithelium development (GO:0061180),-0.3827435181276027,-1.0479203030057314,0.3905579399141631,0.7299010604645465,1.0,4/14,14.40%,CSF1R;ERBB4;AKT2;ID2
prerank,gliogenesis (GO:0042063),0.5092804879237681,1.0474728746381294,0.41580310880829013,1.0,1.0,5/15,19.42%,CDK6;RELN;METTL14;TGFB2;PAX2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.4464089790840314,1.0474480467619578,0.4270941054808687,1.0,1.0,29/80,21.48%,PMAIP1;AQP1;CD44;TNFSF10;DPEP1;ARL6IP1;MAP3K5;HMGB1;CDKN2D;CARD9;XIAP;DELE1;FIS1;UACA;MYC;F2R;SIRT1;SH3RF1;ARL6IP5;YWHAE;SNCA;MALT1;GRAMD4;PAX2;DAPK1;EPHA7;USP47;SYK;RPS6KA3
prerank,positive regulation of ruffle assembly (GO:1900029),-0.38310798426653975,-1.0473378007612284,0.39436619718309857,0.729717215202639,1.0,3/13,15.43%,PFN1;P2RY12;EPS8
prerank,transcription by RNA polymerase I (GO:0006360),0.47404960403383356,1.0471520951921751,0.41743119266055045,1.0,1.0,11/34,18.50%,POLR1B;TAF1;POLR1A;ERCC3;TCOF1;POLR1F;POLR1C;POLR2K;TAF1C;TAF1D;POLR1G
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.4341434525929191,1.04710425165704,0.381,1.0,1.0,72/259,18.37%,KIF24;STK26;IFT80;EXOC2;PPP1R9B;CCDC88A;POC1B;PCNT;NTN1;FLNA;EZR;WDPCP;CEP83;EXOC4;BBIP1;CEP89;GSN;WDR90;DISC1;SSX2IP;ARF4;HDAC6;NOTCH1;FXYD5;FUZ;RP2;CEP250;OFD1;PTPDC1;RAB8A;CFAP44;FGD6;TMEM237;CYS1;ABLIM3;PMP22;PCM1;PDE6D;RFX2;WHAMM;ACTN2;CCDC28B;MTSS1;CEP162;RAB8B;ABCC4;CCDC57;FGD3;SCLT1;S1PR2;ARL13B;NRP1;EMP1;BBS4;PIBF1;EXOC5;MKS1;PARVB;DYNLL1;DYNLT2B;PARVA;RAC1;IFT172;ATP6V0D1;IFT140;BBS9;ANO6;TXNDC15;ARHGEF7;ATAT1;ABLIM2;FAM161A
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.47633140052135076,1.0464326776760908,0.4348864994026284,1.0,1.0,10/27,18.52%,BRD8;KAT6A;RUVBL2;RUVBL1;TAF6;KAT2B;CREBBP;PHF20;ATAT1;PHF20L1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.40033278636089575,-1.0463845002474665,0.36742424242424243,0.730503502634098,1.0,5/12,27.17%,MTTP;DGAT1;APOC1;SOAT2;ACSL3
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.3420548696212561,-1.0460780232116857,0.4018264840182648,0.729644200691914,1.0,4/18,3.69%,MANBA;NGLY1;DERA;STT3B
prerank,positive regulation of phosphatase activity (GO:0010922),0.4963085224428321,1.0456880624360063,0.41514041514041516,1.0,1.0,3/21,9.89%,ITGA1;PTPA;PPP1R15A
prerank,negative regulation of signaling (GO:0023057),-0.32001106544222063,-1.0455083893087858,0.38181818181818183,0.7295241126251372,1.0,3/25,5.28%,ACVR1;UBASH3B;OPTN
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.44851969649387374,1.0454089627016034,0.43524416135881105,1.0,1.0,21/57,21.42%,PMAIP1;MEFV;FYN;TNFSF10;CYFIP2;MAP3K5;HMGB1;CARD9;FIS1;UACA;MYC;F2R;USP50;SIRT1;ARL6IP5;MALT1;GRAMD4;CASP8;DAPK1;AIM2;SYK
prerank,regulation of osteoblast differentiation (GO:0045667),0.44558076013191356,1.0452200576731534,0.43075356415478616,1.0,1.0,24/82,21.87%,HEMGN;MEN1;FBXO5;RIOX1;CCN1;TWIST1;CCN4;CDK6;LRP3;NOTCH1;PRKACA;BMPR1A;NELL1;SKI;LIMD1;ATP6AP1;TRPM4;CRIM1;SUFU;SOX9;ZHX3;ACVR2B;NBR1;DDR2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.47864649112555335,1.045134201862786,0.43462897526501765,1.0,1.0,4/27,14.41%,CD19;AMBRA1;FLT3;IRS1
prerank,regulation of cell growth (GO:0001558),0.43482663182944553,1.044933264724845,0.4028056112224449,1.0,1.0,40/204,16.99%,KIF14;RAB33B;CDKN2C;JADE1;PPP1R9B;RB1;TCHP;NET1;PML;S100A9;BRAT1;STK11;DDX49;TFRC;CDKN2A;S100A8;H3-3A;CIB1;SMARCA4;MTPN;NCBP1;EGFR;CDKN2D;DERL2;SOCS2;SMAD4;CCAR2;SLIT3;BAP1;RACK1;SERTAD2;BCL6;PABIR1;SGK3;TP53;PAK5;TGFB2;NDRG3;KLHL22;SIRT1
prerank,regulation of transport (GO:0051049),-0.2886177827225318,-1.0447683039651505,0.3063063063063063,0.729835084713581,1.0,15/36,22.31%,MBTPS1;REEP5;MYO6;VAMP2;FES;ACTB;PRKN;CDK5;PINK1;RAB11A;ICA1L;YRDC;POFUT2;LEPR;WWC1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.35707447712839324,-1.0444356123406626,0.3622448979591837,0.7290504958984447,1.0,6/18,18.35%,CDH8;NAPA;SLC17A6;GRIK2;UNC13A;GRIK4
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4425376081480263,1.0442922443207714,0.4215885947046843,1.0,1.0,35/84,25.66%,MBNL3;RBM15;RBM3;HNRNPL;SRSF3;SAP18;NOVA2;SRSF4;NCBP1;ZBTB7A;RNPS1;RBFOX3;NUP98;METTL16;RBM7;FXR1;HNRNPU;DAZAP1;SRSF10;SRSF7;SRPK1;RBM25;HNRNPA1;THRAP3;CELF1;RBFOX2;WTAP;NCL;HNRNPK;CIRBP;PTBP1;NSRP1;SFSWAP;YTHDC1;KHDRBS3
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4160419458963161,-1.044078520719817,0.39603960396039606,0.7284912481938471,1.0,4/10,22.21%,SERPINE2;SH2B3;PRKG1;CEACAM1
prerank,regulation of protein kinase A signaling (GO:0010738),0.49476658481347646,1.0436640986902952,0.43125,1.0,1.0,3/20,4.22%,IAPP;AKAP12;AKAP7
prerank,RNA processing (GO:0006396),0.4311158434489666,1.0435892832832465,0.4044044044044044,1.0,1.0,59/176,20.41%,ADAD1;PPP1R9B;FASTKD5;LSM6;AURKAIP1;RBM3;SNRNP25;SCAF11;SNRPF;HNRNPC;HNRNPL;SETX;U2AF1;ELAVL4;HNRNPA2B1;RNPC3;PRKACA;SRSF4;NCBP1;SNRNP35;RNPS1;NONO;CSTF3;RBMS2;TUT4;CCAR2;HNRNPA0;LSM5;YJU2;KIN;PRMT9;HNRNPR;PPIG;HNRNPU;PRPF4;TFIP11;PDCD7;SNRNP40;SRSF7;TUT1;SRPK1;TCERG1;DDX39B;SNRPG;PRPF8;RSRC1;CLP1;DKC1;TENT2;ALKBH5;NCBP2;DDX54;ZCCHC8;PPP2CA;SRSF2;SF3A2;SNRNP48;SNRPB;SYNCRIP
prerank,transcription by RNA polymerase II (GO:0006366),0.4333027412736262,1.0435634450851863,0.37,1.0,1.0,105/305,22.93%,PAX5;E2F2;PMF1;TRIP13;NR4A2;DEAF1;TEAD4;GTF2E1;DEK;POLR2I;POLR2A;HDAC10;SLBP;INTS4;SNRPF;NR1D1;INTS9;TAF1;MBD1;SETX;CPSF2;IRF9;TFDP1;TAF7;NOTCH1;TAF15;IWS1;GTF2A1;NCBP1;NABP2;SNAPC3;ERCC3;CSTF3;SRRT;KLF13;BTF3;NR2C2;INTS1;RTF1;TAF6;NELFA;INTS14;RPRD1B;KAT2B;CCNT1;ARRB2;CBFB;ZBTB7B;TAF2;CREBBP;INTS13;NRBP1;NFX1;GMEB2;E2F3;CCNK;ELOF1;NELFB;POU2F1;MLLT1;TAF9;POLR2K;PIR;SCAF8;XBP1;POLR2J;SNRPG;RXRB;PCF11;CPSF1;TAF1C;CLP1;POU2F2;RARG;MED1;TTF2;NKX2-8;HDAC1;NCBP2;TBL1XR1;SNAPC5;PRRX1;TAF3;GTF2A2;RPAP2;CPSF7;SNRPB;NRBF2;RNMT;INTS12;RBPJ;PPARD;RPRD2;WDR33;COPS2;TAF11;NR1H3;PAPOLA;MED23;HDAC9;POLR2B;ELP4;ZBTB1;RXRG;INTS11
prerank,translational elongation (GO:0006414),0.4401763670136429,1.0434137876173248,0.4252288911495422,1.0,1.0,23/101,17.25%,MRPL36;AURKAIP1;MRPL18;MRPL47;MRPL19;MRPL40;MRPL16;MRPL10;MRPL22;EEF1B2;MRPL37;MRPL51;MRPS7;MRPL43;MRPS17;GFM2;RACK1;MRPL24;MRPL48;MRPS10;EEF2;MRPS34;MRPL38
prerank,RNA methylation (GO:0001510),0.4479247831437272,1.0432532831736925,0.4450317124735729,1.0,1.0,16/60,15.25%,RBM15;ZCCHC4;TRMO;TRDMT1;TFB1M;TFB2M;TRMT5;CBLL1;METTL8;TYW3;FBL;METTL16;VIRMA;NSUN3;METTL14;DIMT1
prerank,long-term memory (GO:0007616),0.4988088609120142,1.0431898702089464,0.44171779141104295,1.0,1.0,2/19,3.16%,NTF4;SLC2A4
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.5185172004432244,1.0431178878285283,0.4423076923076923,1.0,1.0,3/15,10.16%,CSGALNACT2;DCN;CHST12
prerank,regulation of cell motility (GO:2000145),0.4344195068507288,1.0420905769771527,0.4334677419354839,1.0,1.0,22/121,15.40%,KIF14;ERBB3;NTN1;FLNA;SLK;TWIST1;LMO4;CDK6;AMOTL2;PIN1;PKN2;PRKX;PLXNA2;CYRIB;EGFR;KIF2A;FGF9;CRK;ROCK2;DIAPH1;SGK3;EGF
prerank,regulation of acrosome reaction (GO:0060046),0.5488613886463696,1.041699811394039,0.4407027818448023,1.0,1.0,2/10,19.29%,PLCB1;GLRA1
prerank,regulation of leukocyte migration (GO:0002685),0.5097035900475984,1.0414350026832326,0.4609271523178808,1.0,1.0,1/16,0.75%,TNFRSF18
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.407600391286448,-1.041406487422683,0.4119718309859155,0.7320277796746926,1.0,3/12,12.49%,EFNA5;CORO1C;RCC2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.407600391286448,-1.041406487422683,0.4119718309859155,0.7320277796746926,1.0,3/12,12.49%,EFNA5;CORO1C;RCC2
prerank,negative regulation of dephosphorylation (GO:0035305),0.5043504021598046,1.0413500692896918,0.45173267326732675,1.0,1.0,4/18,10.27%,PTPA;PPP1R8;PPP1R15A;PPP1R35
prerank,positive regulation of actin nucleation (GO:0051127),0.5459128717752493,1.0413158196433832,0.4407252440725244,1.0,1.0,3/11,14.61%,GSN;WHAMM;BRK1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5121678080313892,1.0408385901724138,0.44754316069057104,1.0,1.0,2/15,3.56%,PMAIP1;PRKCE
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.484117231508237,1.0395782196015546,0.43857634902411025,1.0,1.0,4/27,10.16%,CHST3;CSGALNACT2;DCN;CHST12
prerank,positive regulation of viral transcription (GO:0050434),0.4872857075650844,1.0392607530701117,0.4318975552968568,1.0,1.0,9/25,17.21%,RSF1;POLR2I;POLR2A;NELFA;DHX9;CCNT1;NELFB;POLR2K;POLR2J
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.5278862072006522,1.0387316905197514,0.4379172229639519,1.0,1.0,6/12,19.59%,H6PD;MBTPS2;SEC14L2;ABCA2;KPNB1;SREBF2
prerank,ceramide catabolic process (GO:0046514),-0.376178032015382,-1.0381609908683918,0.3852140077821012,0.7381831186015074,1.0,1/14,0.15%,HEXB
prerank,regulation of mRNA catabolic process (GO:0061013),0.432600643881998,1.0377860795033438,0.4127144298688194,1.0,1.0,38/121,20.79%,XPO1;PSMB7;PSMD11;PSMF1;TNPO1;EXOSC8;ZFP36L1;PSMC1;PUM2;NUP214;DCP2;PRKCA;PSMC3;PUM1;PSMA4;IGF2BP3;PSMC4;DCP1A;APEX1;FXR1;PSMD13;PSME1;PSMB1;CNOT1;RC3H1;PSMD8;SAMD4A;ZFP36L2;PSME4;VIM;PSMD4;UBA52;ELAVL1;XRN1;CNOT8;PNPT1;PRR5L;CNOT7
prerank,skeletal system development (GO:0001501),0.4314856058755011,1.0373866102356148,0.4166666666666667,1.0,1.0,23/148,12.80%,RAB33B;RFLNB;ALPL;SOX6;DEAF1;TEAD4;CD44;SULF2;HAPLN2;ETS2;EXT1;PTHLH;COL1A2;SPEF2;DDRGK1;SLC10A7;ZBTB16;ATP7A;DYM;TCOF1;BPNT2;PAPSS2;HHIP
prerank,membrane lipid catabolic process (GO:0046466),0.5479019732707148,1.0364383978069798,0.45272206303724927,1.0,1.0,1/10,1.41%,CYP1B1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4288816315060657,1.0364302042738154,0.407,1.0,1.0,65/366,14.26%,ESCO2;MYB;EZH2;CCNA2;MYBL1;SPIN4;HMGA1;SOX6;CHEK2;BRCA2;E2F1;DSCC1;NSD2;RB1;FBXO5;CCDC88A;EIF2A;RBM3;PML;NUP107;ORC5;POLR2A;NUCKS1;HDAC10;RPS6KA5;ACTR5;ORC3;EDF1;NFXL1;LIN54;ATF7;TCF7L1;TCF3;GMNN;RUNX3;PHF19;NOTCH1;MLF2;AHR;PSPC1;DMTF1;PHF1;UBE2V1;ERC1;PLAG1;MTPN;NONO;SRRT;PFDN5;SPTY2D1;NR2C2;PUM3;NFYC;TCOF1;CCAR2;ATF5;NSD3;HCFC1;SP3;ING2;REXO4;DDIT3;CREBBP;NFX1;RNF20
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.42485284399407947,-1.036136385303616,0.412751677852349,0.741960474726126,1.0,6/10,14.65%,GABRG2;GABRG3;GABRA2;GABRA3;GABRG1;GABRA1
prerank,protein polyubiquitination (GO:0000209),0.42851604088315615,1.0353063133998992,0.397,1.0,1.0,72/297,18.57%,CCNF;UBE2C;UBE2T;BARD1;RNF26;BRCA1;FBXL15;SKP2;DTL;PSMB7;PSMD11;PRPF19;CDC23;FBXW11;MKRN1;CDC27;UBE2O;PSMF1;TAF1;FBXO44;TRAF3;PSMC1;ANAPC7;BIRC2;UBE2K;UBE4B;UBE3B;NEDD4L;UBE2V1;FBXO17;CUL3;PSMC3;UBE3C;AMFR;UBR2;PSMA4;RNF168;RNF8;TRIM3;FZR1;TRIM68;FBXL4;PSMC4;CBFB;RNF152;FBXO11;PSMD13;SPOP;PSME1;ARIH2;RNF20;TRIM5;PSMB1;RBCK1;HECTD2;RC3H1;MYLIP;PSMD8;RNF115;PSME4;TRAF3IP2;UBE2R2;PSMD4;HERC6;RNF4;RNF19A;UBA52;DDB2;SYVN1;UBE2G1;FBXW8;RBBP6
prerank,nitric oxide mediated signal transduction (GO:0007263),0.49577945637681203,1.0352701134681908,0.4304291287386216,1.0,1.0,3/16,11.09%,DDAH2;GUCY1A1;KCNC2
prerank,RNA metabolic process (GO:0016070),0.4321581740591391,1.0350189573166009,0.4442211055276382,1.0,1.0,47/127,22.44%,ADAD1;RNASE6;RBM3;POLR2I;POLR2A;PPP1R8;HNRNPC;HNRNPM;HNRNPL;HNRNPA3;SETX;FTO;ELAVL4;HNRNPA2B1;NCBP1;RBMS2;PCBP2;DHX9;HNRNPA0;HNRNPR;WDR74;HNRNPU;PRPF4;TFIP11;PCBP3;RNASEH2A;METTL14;SNRNP40;POLR2K;RNASE1;DDX39B;POLR2J;CLP1;DKC1;TENT2;HNRNPA1;NCBP2;DDX54;AGO2;PNPT1;SYNCRIP;PAPOLA;RBFOX2;RNASEH2B;WTAP;AGO1;POLR2B
prerank,cochlea morphogenesis (GO:0090103),0.5474536216116337,1.0349048293713043,0.46618705035971225,1.0,1.0,3/10,19.46%,TIFAB;PAX2;SOX9
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4317598309002411,1.034451840828745,0.43743743743743746,1.0,1.0,52/166,22.44%,E2F2;NR4A2;POLR1B;SMARCA5;TEAD4;RSF1;GTF2E1;POLR2I;POLR2A;HDAC10;NR1D1;TAF1;BRF1;TAF7;NOTCH1;TAF15;TFB1M;TFB2M;GTF2A1;POLR1A;ERCC3;NR2C2;TAF6;KAT2B;POLR1F;TAF2;POLR1C;CREBBP;NRBP1;E2F3;TAF9;POLR2K;POLR2J;RXRB;TAF1C;RARG;MED1;TAF1D;POLR1G;HDAC1;TBL1XR1;NCOA6;TAF3;GTF2A2;NRBF2;RBPJ;PPARD;TAF11;NR1H3;MED23;HDAC9;POLR2B
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4984629878400243,1.0343300846461154,0.4404907975460123,1.0,1.0,6/20,21.48%,STMN1;RNF157;GRK2;SNCA;MET;GRK3
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4462797395194062,1.0341736125219319,0.4531914893617021,1.0,1.0,11/52,9.86%,CNPY4;GPSM2;PRKCE;EPB41;SORBS1;GNAI1;CIB1;EFCAB7;EGFR;EPHA3;PDPK1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.4471629335083866,1.0341034638358686,0.4396551724137931,1.0,1.0,15/53,16.98%,PSMB7;PSMD11;PSMF1;AZIN1;PSMC1;PSMC3;PSMA4;PSMC4;OAZ1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5181431774103836,1.0340900964846296,0.45614035087719296,1.0,1.0,7/13,17.80%,RNF168;NELFA;RNF8;HNRNPU;NELFB;TCERG1;HEXIM1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.30090458855780855,-1.0339344076160821,0.35,0.7460430120616587,1.0,10/31,16.08%,OPHN1;MYO9A;PRKCI;RAP2A;ERBIN;DLG2;SH3BP1;PDCD6IP;LRRC7;DLG1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.5242874951878987,1.0338870708118053,0.45417789757412397,1.0,1.0,5/12,19.03%,FOXP1;SMARCA4;ZBTB7A;SIRT1;HDAC1
prerank,protein deacetylation (GO:0006476),0.45643410726143757,1.0332615812482913,0.45076586433260396,1.0,1.0,13/41,19.37%,RCOR2;FLNA;HDAC10;MTA3;HDAC6;SIN3B;MTA2;SIRT7;SIN3A;SIRT1;HDAC4;HDAC1;TBL1XR1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.43142496107039885,-1.0331659891985858,0.4258064516129032,0.7463366037513837,1.0,7/10,24.51%,ARNT;ITGA5;ITGB3;GRB10;HIF1A;MT3;VTN
prerank,protein ubiquitination (GO:0016567),0.4255126692256342,1.03282947186874,0.369,1.0,1.0,113/471,17.81%,CCNF;UBE2C;UBE2T;UHRF1;TRIM58;BARD1;RFWD3;PLK1;RNF26;BRCA1;FBXL15;MEFV;SKP2;DTL;PSMB7;PSMD11;PRPF19;CDC23;FBXW11;MKRN1;CDC27;UBE2O;PSMF1;PCNA;TAF1;TRAIP;FBXO44;MSL2;PSMC1;ANAPC7;FBXO45;BIRC2;UBE2Z;BIRC6;UBE2K;UBE4B;UBE3B;NEDD4L;UBE2V1;TRIM11;FBXO17;RAD18;RNF157;KLHL9;RNF141;TNFAIP1;ASB1;CUL3;CBLL1;TRIM47;PSMC3;UBE3C;AMFR;TRIM33;TRIM44;UBR2;PSMA4;RTF1;RNF168;MIB1;RNF8;SPSB4;PEX2;TRIM3;EIPR1;CNOT4;TRIM68;FBXL4;ARRB2;PSMC4;CBFB;PCNP;RNF152;FBXO11;CUL9;NFE2L2;RACK1;PSMD13;PRKDC;SPOP;PSME1;NFX1;ARIH2;RNF20;FANCL;TRIM5;PSMB1;RNF111;RBCK1;VCPIP1;HECTD2;RC3H1;MYLIP;PSMD8;RNF115;PSME4;UBE2R2;VHL;KLHL22;PSMD4;SIRT1;RNF103-CHMP3;SH3RF1;HERC6;RNF4;PEX14;RNF19A;TRIM37;CAND2;UBA52;USP7;DDB2;SYVN1
prerank,positive regulation of T cell migration (GO:2000406),0.4925764195472847,1.0324801540425848,0.4628712871287129,1.0,1.0,3/20,5.33%,SPN;OXSR1;CCR2
prerank,histone deacetylation (GO:0016575),0.4532076636891425,1.0323019158655298,0.45806451612903226,1.0,1.0,16/43,22.40%,RCOR2;ELK4;HDAC10;MTA3;HDAC6;SIN3B;MTA2;SIRT7;SIN3A;SIRT1;HDAC4;HDAC1;TBL1XR1;HDAC8;SMARCAD1;HDAC9
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.4675438104671282,1.0321320340001785,0.4548611111111111,1.0,1.0,7/26,19.03%,BRCA1;FOXP1;SMARCA4;ZBTB7A;CNOT1;SIRT1;HDAC1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.29650207793857225,-1.0319139439486171,0.359375,0.7478909803920947,1.0,8/33,8.16%,HSP90AA1;POLR3C;TLR7;RNF135;POLR3A;MAVS;TLR4;IRF1
prerank,regulation of hemopoiesis (GO:1903706),0.5539557413129564,1.0319035833357382,0.4395448079658606,1.0,1.0,6/10,25.76%,PRKCB;CBFB;CREBBP;RUNX1;PURB;PTN
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4285763740861679,1.0316115487596556,0.4419778002018164,1.0,1.0,34/109,18.22%,MAPK1;GRAP2;PSMB7;PPP3CA;PSMD11;FBXW11;PSMF1;IKBKG;PSMC1;MAP3K1;TAB1;GRB2;PLCG2;SOS1;TAB3;PDPK1;PSMC3;BTK;PSMA4;JUN;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PAK2;PSME4;PLCG1;NFATC3;PIK3CA;RAC1;PSMD4;MAP3K7;MALT1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.4264543114103793,1.0308624573316756,0.414,1.0,1.0,71/348,17.96%,CENPE;TTK;INHBC;NTF4;PLK1;MAPK1;PECAM1;CCN1;CD74;CD44;AXIN1;RPS6KA5;BRAT1;PGF;TFRC;BANK1;CAV1;MMD2;RASGRP1;CRKL;HDAC6;MMD;MAPRE3;PIN1;XRCC6;MRNIP;DDRGK1;NIBAN1;UBE2K;CIB1;SNX9;PLCG2;JAK2;EGFR;P2RY1;TXN;PARK7;RELN;SMAD4;WDFY2;FGF9;FAS;BMPR1A;S1PR2;FXR1;NRP1;ROCK2;RACK1;FLOT1;PRKAG2;LATS1;ADCYAP1;FAM20A;MYDGF;PPIA;RAD50;STK4;TP53;PDCD10;EGF;BMP3;PAK2;LIMK2;TGFB2;RAC1;PDE8A;SIRT1;HCLS1;LRRK2;IQGAP1;SNCA
prerank,thymus development (GO:0048538),-0.3841718540467821,-1.0306599928986717,0.3870967741935484,0.749572579966288,1.0,1/13,0.53%,TGFBR1
prerank,positive regulation of lyase activity (GO:0051349),-0.39178872080821736,-1.030637292740767,0.4075471698113208,0.7480855125700957,1.0,6/14,24.33%,CACNA1C;NF1;ISCU;ORAI1;STIM1;AKAP5
prerank,Fc receptor signaling pathway (GO:0038093),0.42810467520904694,1.0305784231735695,0.4448938321536906,1.0,1.0,34/110,18.22%,MAPK1;GRAP2;PSMB7;PPP3CA;PSMD11;FBXW11;PSMF1;IKBKG;PSMC1;MAP3K1;TAB1;GRB2;PLCG2;SOS1;TAB3;PDPK1;PSMC3;BTK;PSMA4;JUN;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PAK2;PSME4;PLCG1;NFATC3;PIK3CA;RAC1;PSMD4;MAP3K7;MALT1
prerank,sulfur compound transport (GO:0072348),0.47307579696663615,1.0304463983118768,0.45336481700118064,1.0,1.0,1/27,0.69%,RACGAP1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4242566971478018,1.0303066216784764,0.328,1.0,1.0,234/1082,17.62%,CKAP2;E2F7;E2F8;FOXM1;E2F2;UHRF1;FOXA2;NKX6-1;MYB;HMGB2;SPIB;POU2AF1;MYBL1;MEN1;ATAD2;BRCA1;CDK5RAP2;SMARCC2;NR4A2;TFR2;HMGA1;CHEK2;BLM;HEY2;BRCA2;MYRFL;DEAF1;LEF1;E2F1;SMARCA5;SENP1;ARID1B;PBX4;NIF3L1;SMARCD2;RSF1;ELK4;CD38;PPP3CA;CCN1;TWIST1;ZFPM1;BCLAF3;CSRP3;CD74;USF1;PML;AXIN1;FBXW11;ERG;RPS6KA5;EPC1;CTCF;RBL1;BRD8;CDCA4;ETS2;CHEK1;BRPF1;SP100;NR1D1;MED30;EDF1;IKBKG;FOXO1;FOXJ3;ATM;YWHAH;KANSL3;TCF3;SETX;BCL2L12;ARF4;RUNX3;TFDP1;MAPRE3;EBF3;KLF10;MAP3K5;BRD4;TAF7;NOTCH1;TAF15;PIN1;XRCC6;DDRGK1;HMGB1;PIM2;PCBD2;ASF1A;CAMTA2;AHR;MAX;KMT2C;ILF2;SMARCA4;IER2;DCN;YEATS4;UBE2V1;SSBP3;SEC14L2;GABPB1;GABPB2;PCGF5;ZBTB16;RLF;EFCAB7;E2F5;NCOA7;PLAG1;NRF1;EGFR;FLI1;ASXL1;EGR1;TFDP2;SMARCC1;SALL2;NR2C2;IRF2BPL;HIPK2;PSMC3;NR2F2;KAT6A;TRIM44;RUVBL2;DYRK1A;PRDM10;PARK7;ZNF462;NFE2;SMAD4;ATF6;MLLT10;TAF6;JUN;RPRD1B;DHX9;KAT2B;ATF5;PLCB1;PELP1;NSD3;CCNT1;NPAT;NAA16;NFATC2IP;HCFC1;BCL9L;APEX1;BMPR1A;RAI1;SATB2;KMT2A;STAT5B;SP3;SIRT7;NFE2L2;CHCHD10;THOC5;ING2;ING5;PRKDC;HNRNPU;BEX1;HELZ2;DDIT3;CEBPZ;ADCYAP1;SERTAD2;CREBBP;SKI;MYC;CEBPG;GABPA;PSEN1;MED14;MYDGF;HNRNPAB;HTATIP2;RNF20;TP53INP2;RNF111;PPP1R12A;PBX2;E2F3;CCNK;ELOF1;ELF1;TADA3;ATF7IP;SS18;TP53;DNAJC2;KMT2B;MOSPD1;RUNX1;JUNB;GPATCH3;EGF;F2R;IRF8;HOXB4;POU2F1;PLAGL1;MAP2K1;TFAP4;SIN3A;TCF7L2;TCF4;HIVEP1;ATRX;FOXK2;TRIM28;RFX4;CDK8;TAF9;NFATC3;VHL;USP21;TCERG1;SIRT1;SCAF8;XBP1;DDX39B;TMF1;RNF4;RXRB;MLXIP;HCLS1;GLYR1;CAND2;UBA52
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4381363627851582,1.0300831815293705,0.4616216216216216,1.0,1.0,9/48,17.96%,CD19;NPSR1;PRKACA;PDPK1;JPH1;DIAPH1;F2R;PLCG1;SNCA
prerank,T cell activation (GO:0042110),0.4372964737427495,1.030023434923664,0.44895833333333335,1.0,1.0,6/69,5.38%,CD2;PPP3CA;CD74;CD44;PTPN22;RASGRP1
prerank,dendrite morphogenesis (GO:0048813),-0.29280768165968835,-1.0298213423191116,0.40186915887850466,0.7486718312630154,1.0,17/35,27.51%,PAK3;PHACTR1;MINK1;WASL;MAP6;CTNNA2;MEF2A;FARP1;SHANK3;DLG4;CDC42;TMEM106B;CELSR2;KLF7;DVL1;ABITRAM;CHRNA7
prerank,regulation of postsynapse organization (GO:0099175),-0.31250738115015514,-1.0296713617380822,0.4236111111111111,0.7475092969093488,1.0,13/28,20.24%,TANC2;PPFIA2;CDK5R1;ARHGAP44;CDK5;EPHA4;ABI2;SHANK3;ABHD17C;ARHGAP22;CFL1;KIF1A;ZDHHC15
prerank,atrioventricular valve development (GO:0003171),0.5240671139251419,1.0294784263464651,0.4587280108254398,1.0,1.0,6/14,16.23%,ZFPM1;MDM4;NOTCH1;SLIT3;BMPR1A;TGFB2
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3703238298498256,-1.0291540312233145,0.36752136752136755,0.7472786190649888,1.0,7/14,18.44%,CSF1R;CMKLR1;AKIRIN1;PTK2;CSF1;MDK;THBS1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.32124116512239553,-1.0289933181154658,0.4010989010989011,0.7461445810592708,1.0,7/22,22.41%,ANK2;SLC9A1;RYR2;ATP1B1;CALM1;STAC2;GSTO1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.24669757246816143,-1.0289598296539968,0.3333333333333333,0.7447032699053349,1.0,15/69,10.55%,IGF1R;CSF1R;PIK3R5;PLCB2;MYO16;PIK3CD;PIK3R1;IGF1;KCNH1;PI4KA;PIK3C2B;PLCL2;NF1;PLCB4;IRS2
prerank,negative regulation of macrophage activation (GO:0043031),-0.3666530564608559,-1.0288745608605805,0.4125,0.7434442671737332,1.0,6/16,17.87%,LRFN5;GRN;ZC3H12A;CD200;CST7;IL31RA
prerank,endothelial cell development (GO:0001885),0.47786569561154524,1.0287788297700275,0.4578884934756821,1.0,1.0,5/25,11.57%,PECAM1;EZR;PDE2A;MSN;RDX
prerank,innate immune response (GO:0045087),0.4255069387390226,1.028722933029807,0.43843843843843844,1.0,1.0,30/217,12.01%,BLK;TRIM58;RNASE6;PGLYRP1;MEFV;SKP2;TRIM59;FYN;DHX58;CD74;CAMP;PML;KLRD1;ANKHD1;SLPI;SP100;SERINC5;IKBKG;SERINC3;HMGB1;TRIM11;PLCG2;TREML1;TIFA;CARD9;BTK;B2M;MYD88;CLPB;TRIM68
prerank,positive regulation of histone modification (GO:0031058),0.4723119330901594,1.0284497849290517,0.44733861834654587,1.0,1.0,12/33,20.59%,BRCA1;RPS6KA5;SART3;RUVBL2;PAXIP1;ZBTB7B;ING2;NIPBL;TADA2A;GLYR1;BRD7;UBE2N
prerank,glutamate receptor signaling pathway (GO:0007215),-0.2975636380753729,-1.0281142700523318,0.4019607843137255,0.7438118429824383,1.0,9/37,14.61%,APP;DAGLB;GRIA4;GRIN3A;GRM5;CDK5R1;GRIK2;GRM8;DAGLA
prerank,neuron migration (GO:0001764),0.4478965155982802,1.0278635951691129,0.4436008676789588,1.0,1.0,18/48,20.37%,NR4A2;DISC1;MARK2;PAFAH1B1;DNER;RELN;NRP1;MDGA1;FGF13;NRCAM;ADGRL3;SDCCAG8;FGFR1;LRP12;RAC1;SH3RF1;ELP3;MARK1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3963381551557209,-1.0274674437863927,0.40711462450592883,0.7438948224346351,1.0,9/13,32.79%,APP;SQSTM1;LGMN;SHANK3;AKAP5;SHISA7;CHRNA7;ADCY1;EIF2AK4
prerank,organelle disassembly (GO:1903008),0.4605640765691547,1.026882280971878,0.46806167400881055,1.0,1.0,5/33,12.29%,CDK1;STX5;DDRGK1;VRK1;GFM2
prerank,embryonic digestive tract development (GO:0048566),-0.34642031350968655,-1.0268033224783488,0.39690721649484534,0.7440726530937646,1.0,6/18,19.20%,SALL1;PCSK5;GLI3;ID2;PKDCC;SOX11
prerank,positive chemotaxis (GO:0050918),-0.35336874984777444,-1.02676799888894,0.37850467289719625,0.7426853737398921,1.0,5/17,18.84%,PTPRJ;ANGPT1;VEGFA;TSC2;PLXNB3
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5368764727055912,1.0264106345664996,0.4376770538243626,1.0,1.0,5/10,23.23%,ABCD1;DCN;RACK1;LRRK2;SRC
prerank,cGMP-mediated signaling (GO:0019934),0.5124963937671662,1.026392362712169,0.4430379746835443,1.0,1.0,3/13,11.09%,AQP1;PDE2A;KCNC2
prerank,negative regulation of cell activation (GO:0050866),-0.37374805141117096,-1.0263304119668122,0.39849624060150374,0.7423375467597619,1.0,2/14,1.48%,TREM2;APOE
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.4221402041404009,1.026094098018141,0.328,1.0,1.0,388/1668,20.59%,CKAP2;E2F7;CDK1;BRIP1;PAX5;AURKB;E2F8;FOXM1;E2F2;UHRF1;GFI1;FOXA2;NKX6-1;VAX2;MYB;HMGB2;EZH2;CCNB1;RCOR2;SPIB;POU2AF1;PLK1;MYBL1;MEN1;ATAD2;SUV39H1;BRCA1;RAD21;DMRTA1;SMARCC2;NR4A2;TFR2;HMGA1;SOX6;HEY2;DEAF1;LEF1;E2F1;SMARCA5;UXT;RB1;SENP1;TEAD4;ARID1B;IKZF3;PBX4;LIN9;SMARCD2;BATF;RSF1;ELK4;EZR;CBX5;PPM1D;PPP3CA;CCN1;TWIST1;ZFPM1;MCPH1;BCLAF3;DEK;CSRP3;USF1;PBX3;HMGB3;NUCKS1;HDAC10;ERG;UBE2I;BACH2;RPS6KA5;MTA3;LCORL;EPC1;CTCF;RBBP8;RBL1;BRD8;BRD9;FOXP1;ETS2;DACH1;SP100;CAV1;CDKN2A;NR1D1;NKAP;MED30;HOMEZ;TAF1;MBD2;IKBKG;FOXO1;MDM4;FOXJ3;BAZ2B;ATF7;ATM;KDM3B;E2F6;BCL11A;ZBTB26;KANSL3;EBF1;TCF7L1;TCF3;SETX;ARID4A;BCL2L12;ZFP41;IRF9;ARF4;RUNX3;PDE2A;TNRC6C;TFDP1;TNRC6B;TGFA;EBF3;KLF10;BRD4;TAF7;NOTCH1;MED31;PIN1;XRCC6;DDRGK1;HMGB1;CAMTA2;AHR;SAP18;SPEN;MAX;KMT2C;BAZ1B;SMARCA4;IER2;DCN;DMTF1;NEDD4L;PHF2;YEATS4;CIR1;MAPK14;SSBP3;GABPB1;GABPB2;PCGF5;RPS14;ZBTB16;RLF;EFCAB7;E2F5;NCOA7;PLAG1;ETV6;NCOA5;NFE2L1;NRF1;ZBTB7A;EGFR;SIN3B;FLI1;ABCA2;ZNF148;ASXL1;MECP2;PIAS3;SP110;KLF13;EGR1;TFDP2;IFRD1;CPEB3;SMARCC1;HIRA;SALL2;ZBTB32;MYNN;NR2C2;IRF2BPL;RFX2;HIPK2;PSMC3;NR2F2;ID4;KAT6A;ZEB1;TRIM33;CUX1;TSHZ1;DBX2;NFYC;MXI1;RUVBL2;PRDM10;ARID5B;PARK7;ZNF462;NFE2;SUMO1;RTF1;SMAD4;RUVBL1;ATF6;MED8;MLLT10;TAF6;JUN;RPRD1B;PEX2;DHX9;KAT2B;ATF5;PELP1;CRK;PRKCB;MTA2;CCNT1;NPAT;PTEN;ZNF25;FOXP2;CBFB;RNF2;NFATC2IP;PRDM6;HCFC1;BCL9L;APEX1;BMPR1A;RAI1;SATB2;ZBTB33;KMT2A;STAT5B;SP3;SIRT7;NFE2L2;ZBTB7B;HIVEP2;PRKDC;HNRNPU;CC2D1A;PSIP1;SP140;BEX1;HELZ2;NIPBL;DDIT3;CEBPZ;ADCYAP1;BCL6;CREBBP;SKI;MYC;PHF14;CEBPG;NFX1;GABPA;PSEN1;TADA2A;MED14;MYDGF;ZNF112;POU6F1;HTATIP2;CAMTA1;RNF111;PPP1R12A;PBX2;GMEB2;KDM4C;E2F3;CCNK;YEATS2;CNOT1;ELF1;TADA3;SS18;TP53;MOSPD1;RUNX1;JUNB;LRRFIP1;IRF8;HOXB4;PIAS1;POU2F1;PLAGL1;TFAP4;SIN3A;TCF7L2;TCF4;HIVEP1;ZNF23;PURG;DUSP22;ATRX;FOXK2;TRIM28;RFX7;RFX4;CDK8;TAF9;DNAJB1;ZNF445;BAZ1A;NFATC3;PCGF3;VHL;RIF1;TCERG1;SIRT1;SMARCAL1;XBP1;TMF1;RNF4;RXRB;MLXIP;HCLS1;GLYR1;TRIM37;UBA52;ZNF467;HEXIM1;ZBED4;SNCA;POU2F2;HDAC4;RARG;MED1;KDM2B;PHF20;REPIN1;ZBTB34;FOXE1;DPF2;CREB1;ZNF740;PHF20L1;RFX1;SUFU;GMEB1;BRD7;NKX2-8;PROX1;GATAD2B;HDAC1;CDKN1A;SAFB;ZBTB20;ARID3B;ELP3;TBL1XR1;PAX2;TRAF6;SOX9;THRAP3;NPAS2;SREBF2;AGO2;DNMT3B;PRRX1;ZHX3;NCOA6;ZBTB18;HDAC8;ZFX;TAF3;PKD2;PRKD2;MMP12;BRD3;RPL23;SLTM;ACTL6A;RPAP2;MYT1;NCOA2;TPR;MET;KDM2A;ACVR2B;PRDM4;RBPJ;PHF10;FIZ1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5241716949582326,1.0252645944151701,0.45989304812834225,1.0,1.0,7/13,23.45%,DDRGK1;PPP1R15A;ABCA7;RACK1;DNAJB9;PPP1R15B;UFL1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.45833915243583834,1.0251782562512533,0.4682352941176471,1.0,1.0,7/30,14.67%,BRCA1;TNFSF10;TRADD;PARK7;FAS;CFLAR;GSK3B
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4719726947279827,1.0250035708620304,0.45914844649021863,1.0,1.0,6/30,16.14%,CHST3;CSGALNACT2;DCN;CHST12;ARSB;CHSY1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.42810572905135186,1.0243164652532222,0.45417925478348437,1.0,1.0,36/136,20.63%,GFI1;FOXA2;MEN1;CYP1B1;DAP;RB1;FLNA;SP100;CDKN2A;TAF1;TRAF3;LRRC14;PIM1;SUMO1;CDK5RAP3;ARRB2;RNF2;PAXIP1;DDIT3;CEBPG;RBCK1;TCF7L2;NLRC3;COMMD6;NLRP2B;SIRT1;PEX14;TRIM37;USP7;HDAC4;SUFU;PROX1;TAF3;PKD2;KEAP1;AIM2
prerank,motor neuron axon guidance (GO:0008045),0.5028263728988425,1.0239243552306185,0.4445927903871829,1.0,1.0,5/15,16.84%,NTN1;SLIT1;TMEFF1;RAC2;RAC1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.40555294464744523,-1.0238510505144123,0.40977443609022557,0.7468372503525544,1.0,7/11,31.34%,UQCRC2;UQCRQ;UQCRFS1;UQCRB;CYCS;UQCR11;UQCC3
prerank,regulation of phagocytosis (GO:0050764),0.4437829578342952,1.0237638606464405,0.4515086206896552,1.0,1.0,8/53,13.14%,PRTN3;IL2RG;CD47;SNX3;ITGAV;ABCA7;PIP4P2;RACK1
prerank,O-glycan processing (GO:0016266),0.43377661141341034,1.0237227129022441,0.46218487394957986,1.0,1.0,6/54,9.85%,MUC19;GALNT10;GXYLT1;ST3GAL1;ST3GAL2;B3GNT2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.48278024561494365,1.0236367900373704,0.4517766497461929,1.0,1.0,9/21,23.99%,PRTN3;PSEN1;DAG1;SPPL3;ADAM10;ERAP1;ADAM17;MYH9;PRKCQ
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4309478414866736,1.0234725061240963,0.4726166328600406,1.0,1.0,9/98,8.52%,CDK1;UHRF1;CCNB1;DCXR;AGPAT1;RAB1B;MAPK14;GRB2;PICK1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5118842255749066,1.0234153054549033,0.4568245125348189,1.0,1.0,8/12,25.84%,DNMT1;SETDB2;ATF7IP;TASOR;TRIM28;SETDB1;RESF1;TET1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.44420087980654077,1.0232871722110959,0.4597826086956522,1.0,1.0,16/45,23.23%,RPS6KA5;TGFA;GRB2;SOS1;EGFR;PDPK1;DGKD;EGF;PLCG1;PIK3CA;IQGAP1;KIF16B;SOX9;PTPN11;ADAM17;SRC
prerank,lipid droplet organization (GO:0034389),-0.3304657837877814,-1.0230282601505776,0.4022346368715084,0.747364938631089,1.0,4/22,9.70%,CDS1;AUP1;CDS2;ZFYVE1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.48853238222818446,1.023016692189444,0.47176913425345046,1.0,1.0,7/21,19.93%,KCNN4;FOXP1;IKBKG;NFAM1;PRKCB;RPS3;PRKD2
prerank,regulation of neuron death (GO:1901214),0.4325583428572363,1.0228449276370688,0.44969199178644764,1.0,1.0,11/82,10.85%,KIF14;FYN;EIF2S1;IKBKG;INPP5A;MAP3K5;GPR75;NENF;EGR1;PARK7;SIGMAR1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4501735460368721,1.0226165166985042,0.4520396912899669,1.0,1.0,10/38,16.99%,PHLPP2;PHLDA3;BANK1;CIB1;PTEN;ARRB2;RACK1;DDIT3;DAG1;SIRT1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4298751471993746,-1.02234185286602,0.4169611307420495,0.7474664499440354,1.0,4/10,17.44%,RC3H2;ZC3H12A;SMAD7;NFKBID
prerank,regulation of wound healing (GO:0061041),0.4515028876976094,1.0217200811361076,0.477728285077951,1.0,1.0,5/42,11.76%,FOXA2;PRKCE;CAV1;INSL3;CRK
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.2801316127213489,-1.0216681924213158,0.41818181818181815,0.7476645609072575,1.0,7/38,9.20%,CACNB2;CACNA1C;ANK2;BIN1;CTNNA3;SCN1B;JUP
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.5281937793049908,1.0213034029263708,0.4666666666666667,1.0,1.0,5/11,21.51%,TAF7;JAK2;SIRT1;XBP1;CIITA
prerank,skeletal muscle organ development (GO:0060538),0.46772702810279465,1.021144690646613,0.47115384615384615,1.0,1.0,7/26,20.78%,CSRP3;CAV1;FXR1;CFLAR;DISP1;ZBTB18;SVIL
prerank,cell differentiation in spinal cord (GO:0021515),0.5373843960810143,1.0208943923375668,0.4623044096728307,1.0,1.0,2/10,13.02%,SOX6;MDGA1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.5076562016970428,1.0208095103357722,0.472630173564753,1.0,1.0,1/15,0.72%,SLFN14
prerank,positive regulation of protein catabolic process (GO:0045732),0.4201665971472411,1.0207557610946945,0.458546571136131,1.0,1.0,15/84,12.17%,BARD1;NRDC;DTL;EZR;AXIN1;SNX33;FOXO1;FAF1;STX5;NEDD4L;SNX9;MSN;RDX;FZR1;OAZ1
prerank,signal peptide processing (GO:0006465),-0.4033646370331745,-1.020625842244496,0.4155405405405405,0.7488123766792782,1.0,4/11,8.26%,PCSK5;SPCS2;HM13;CLN5
prerank,pharyngeal system development (GO:0060037),-0.3779786115449379,-1.0205467035556945,0.4386792452830189,0.747560723084222,1.0,2/15,3.12%,TGFBR1;BMPR2
prerank,embryonic limb morphogenesis (GO:0030326),0.45572710789033294,1.0204803618186449,0.4742152466367713,1.0,1.0,13/34,23.13%,AFF3;TWIST1;WDPCP;NIPBL;CREBBP;SKI;MAP3K20;TGFB2;RARG;HDAC1;MEGF8;OSR1;INTU
prerank,regulation of endocytosis (GO:0030100),0.4304870797391847,1.020443169090511,0.4653361344537815,1.0,1.0,18/61,18.55%,CD177;TFR2;SNX33;STON1;MTMR2;ARFGAP1;NEDD4L;EPHA3;CBLL1;RIT2;ABCA7;PACSIN2;STON2;FLOT1;RAB5A;MCTP1;SNCA;RUFY1
prerank,lipid oxidation (GO:0034440),-0.39816693975300427,-1.0203900879866283,0.3767605633802817,0.7464571429458104,1.0,2/12,8.79%,PLA2G7;ALOX5
prerank,triglyceride homeostasis (GO:0070328),-0.3045742847585321,-1.0199057543423378,0.39869281045751637,0.7462036299837141,1.0,12/26,39.46%,APOE;LPL;SCARB1;IL18;MTLN;MLXIPL;FITM2;ANGPTL3;DGAT2;C1QTNF3;LIPC;PNPLA8
prerank,negative regulation of protein processing (GO:0010955),-0.39032754308955386,-1.0195177569432905,0.4028268551236749,0.7457473505278295,1.0,4/12,18.44%,SERPINE2;PRNP;SERPINE1;THBS1
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.4241500615320436,-1.0183832368064953,0.46366782006920415,0.7470765769641744,1.0,3/10,14.25%,PRKAR1A;CD274;PRNP
prerank,ear morphogenesis (GO:0042471),0.48280994597394367,1.0183218677595969,0.45098039215686275,1.0,1.0,6/20,23.09%,TWIST1;TIFAB;NIPBL;PAX2;FGFR2;OSR1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.5189396814393654,1.0176208853130242,0.47547683923705725,1.0,1.0,6/12,23.03%,NUP214;PTPN14;SIRT7;AAAS;TPR;NEDD4
prerank,regulation of oxidative phosphorylation (GO:0002082),0.5057518584677179,1.0172593253078652,0.4623376623376623,1.0,1.0,3/16,10.54%,ABCD1;PDE12;ATP7A
prerank,positive regulation of cell cycle (GO:0045787),0.43188128893862854,1.0168569379360846,0.4713983050847458,1.0,1.0,22/62,23.16%,CCNB1;CCNYL1;CHEK1;MAPRE3;CDC25B;PKN2;PRKCA;SMOC2;EGFR;RAD23A;CCDC57;HCFC1;RPS15A;TGFB2;PROX1;PKD2;CCND3;CITED2;MDM2;CDKN1B;FGFR2;ADAM17
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4594477222427398,1.0167912235760586,0.4678362573099415,1.0,1.0,5/33,8.11%,PYCR3;DDAH2;GLS2;PRODH;RIMKLB
prerank,L-serine metabolic process (GO:0006563),0.5281540062171612,1.0166779267027162,0.4564254062038405,1.0,1.0,2/10,5.95%,SERINC5;SERINC3
prerank,rRNA metabolic process (GO:0016072),0.42241566260575525,1.0166722987865868,0.483,1.0,1.0,57/160,23.13%,SLFN14;RPL7;RPL18A;UTP3;RPL36;RPL14;RPS19;DDX49;RPS7;HELQ;EXOSC8;RPL23A;RPL28;EXOSC10;RPL41;RPS14;NOL11;RPLP2;EMG1;RPS27;NIFK;UTP6;RPLP0;FBL;PELP1;RPL27A;WDR74;RPS9;NOL8;RPL12;NOP58;POP4;RPL3;RPL18;UBA52;DKC1;PES1;MPHOSPH6;RPS17;RPS6;RPL5;DIS3L;DDX54;RPL21;XRN1;RPL23;RPL17;MAPT;RPL8;RPL24;RPL27;RPL13A;DIS3;RPL15;RPL10;RPF1;NOP14
prerank,substantia nigra development (GO:0021762),-0.2755235868670277,-1.0160854064348515,0.4036697247706422,0.7511203580461155,1.0,17/37,19.70%,PLP1;MBP;SEC16A;PADI2;BASP1;COX6B1;CNP;SUDS3;GLUD1;ACTB;CKB;NDUFS3;CALM1;HSPA5;TTBK1;CDC42;NDRG2
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.35258699560835527,-1.0157507042076428,0.45023696682464454,0.7505472492334908,1.0,9/17,40.13%,GPLD1;APOC1;SORL1;IL1B;ADRA2A;PDE3B;PRKAA1;MFSD2A;HCAR2
prerank,negative regulation of translation (GO:0017148),0.4193764801470141,1.0156427293936332,0.47100712105798576,1.0,1.0,35/87,24.35%,EIF3E;FTO;EIF4EBP3;EIF4A3;CPEB3;PUM1;TYMS;IGF2BP3;METTL16;FXR1;ROCK2;RACK1;LSM14A;CNOT1;METTL14;SAMD4A;EPRS1;EIF4ENIF1;RPS3;AGO2;DAPK1;CNOT8;TPR;SYNCRIP;CNOT7;ROCK1;GAPDH;CELF1;RPL13A;EIF4E2;YBX1;NCL;MEX3D;DAPK3;EIF2AK2
prerank,regulation of histone methylation (GO:0031060),-0.3907377906239641,-1.015364331376183,0.4087301587301587,0.7500312305009726,1.0,4/13,17.24%,CTR9;MTHFR;CHTOP;PIH1D1
prerank,atrial septum morphogenesis (GO:0060413),0.5387281549815011,1.0153093935359656,0.47639484978540775,1.0,1.0,2/10,3.56%,HEY2;ZFPM1
prerank,negative regulation of cell communication (GO:0010648),-0.3267138144052783,-1.014822215390905,0.4031413612565445,0.7499986135368466,1.0,2/21,0.65%,ACVR1;UBASH3B
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5190870876503715,1.014444095031036,0.47285714285714286,1.0,1.0,4/12,16.99%,BRCA1;PIBF1;WDTC1;SIRT1
prerank,gonad development (GO:0008406),0.4452046048247712,1.0142337806649477,0.4628632938643703,1.0,1.0,8/41,19.46%,SRD5A2;NUP107;CSDE1;NR2F2;FGF9;TGFB2;KITLG;SOX9
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4981981901931925,1.0140039802196852,0.47304582210242585,1.0,1.0,1/13,1.29%,CD177
prerank,canonical Wnt signaling pathway (GO:0060070),0.43114765104869623,1.0139656520436924,0.4728205128205128,1.0,1.0,14/68,18.10%,NR4A2;LEF1;AXIN1;CAV1;TCF7L1;CSNK1A1;PTEN;BCL9L;GSK3B;TCF7L2;RAB5A;LRRK2;PPP1CA;RARG
prerank,peptidyl-asparagine modification (GO:0018196),0.4474342923772435,1.0129298555371355,0.46938775510204084,1.0,1.0,8/31,16.51%,MAGT1;ALG8;STT3A;MGAT2;FUT8;OST4;TUSC3;LMAN1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.5032391465094036,1.0128486204081217,0.4619289340101523,1.0,1.0,8/17,20.17%,NCBP1;CPEB3;CCNT1;ZC3H3;VIRMA;RNF20;NCBP2;CPSF7
prerank,myeloid cell development (GO:0061515),0.48347006365351985,1.0120328722465493,0.47309136420525655,1.0,1.0,3/18,5.07%,ALAS2;ABCB10;FOXP1
prerank,cellular response to decreased oxygen levels (GO:0036294),0.43713221364914345,1.011771272021503,0.4875259875259875,1.0,1.0,15/65,17.86%,SUV39H1;PMAIP1;AQP1;TWIST1;TBL2;MDM4;ZFP36L1;PICK1;UBQLN1;HIPK2;MYC;TP53;SIRT1;PGK1;NDRG1
prerank,L-glutamate transmembrane transport (GO:0015813),0.5266304747140997,1.011532448622489,0.4839609483960948,1.0,1.0,4/10,17.48%,SLC25A12;SLC25A22;SLC25A13;ARL6IP5
prerank,response to glucagon (GO:0033762),-0.341408585925742,-1.0112153388630107,0.4063926940639269,0.7576021323495894,1.0,4/19,4.80%,PRKACB;PRKAR1A;ADCY7;ADCY2
prerank,actin filament bundle assembly (GO:0051017),0.46066184480412875,1.01099361803341,0.48412698412698413,1.0,1.0,8/33,17.49%,EZR;NEDD9;SHROOM2;LIMA1;PAWR;ADD2;CALD1;HSP90B1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4495187419179081,1.010971739091405,0.47761194029850745,1.0,1.0,8/30,16.51%,MAGT1;ALG8;STT3A;MGAT2;FUT8;OST4;TUSC3;LMAN1
prerank,secondary palate development (GO:0062009),0.5132437596323126,1.0109150220009524,0.4553805774278215,1.0,1.0,4/14,20.82%,LEF1;SMAD4;TGFB2;SMAD2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4373834072291729,1.0108388608285526,0.46976241900647947,1.0,1.0,4/47,5.32%,GFI1;BRCA1;FYN;CAV1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5189859771037697,1.0107077807570668,0.49519890260631,1.0,1.0,1/13,1.11%,CHST3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.39245636076350054,-1.0106082977609605,0.40145985401459855,0.7576527451461555,1.0,4/12,25.87%,TLR4;STRAP;NOD2;RBP4
prerank,cellular macromolecule catabolic process (GO:0044265),0.44079581622725744,1.0104101822198703,0.48272138228941686,1.0,1.0,7/49,8.95%,RNASE6;CHEK2;PPP1R8;FBXO44;FBXO17;DNASE1L1;NCBP1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.43168128262016503,1.0100465294304595,0.4737991266375546,1.0,1.0,16/48,21.62%,FLNA;NEDD9;CRKL;CIB1;CUX1;CRK;NRP1;PRKDC;LIMS1;TRIOBP;RAC1;ARHGEF7;FBXW8;S100A10;ILK;CAPRIN2
prerank,positive regulation of cell death (GO:0010942),0.43184595449321495,1.0096976478202417,0.47654584221748403,1.0,1.0,20/59,22.57%,FYN;EIF2S1;FAF1;MAP3K5;PRODH;PRR7;EGR1;HTATIP2;TYROBP;GSK3B;MARK4;FCGR2B;LRRK2;SNCA;RARG;BNIP3;RIPK1;MAPT;CELF1;CDKN1B
prerank,response to exogenous dsRNA (GO:0043330),0.4808943000526348,1.0090840959406782,0.4729559748427673,1.0,1.0,5/18,17.80%,CGAS;CAV1;DHX9;FLOT1;COLEC12
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.29786416392796733,-1.008841819608238,0.3835616438356164,0.7605979722825454,1.0,14/29,32.89%,PTPN2;PTPN6;YTHDF2;MAVS;RNASEL;CDC37;ZBP1;USP18;CACTIN;MUL1;TTLL12;WNT5A;ISG15;PTPN1
prerank,presynapse assembly (GO:0099054),0.5043512000691955,1.0087295620487107,0.4801536491677337,1.0,1.0,4/16,11.97%,CEL;LRP4;BSN;PTEN
prerank,protein oxidation (GO:0018158),0.5112429064656077,1.0086402146909208,0.4685792349726776,1.0,1.0,2/11,13.26%,CHCHD4;SUMF1
prerank,RNA splicing (GO:0008380),0.4236264020876201,1.0080681964706897,0.5,1.0,1.0,34/95,20.41%,PPP1R9B;LSM6;SNRNP25;SCAF11;SNRPF;HNRNPC;U2AF1;TXNL4A;RNPC3;SRSF4;NCBP1;SNRNP35;RNPS1;NONO;CCAR2;YJU2;PPIG;PRPF4;PDCD7;SRSF10;SNRNP40;SRSF7;SRPK1;TCERG1;DDX39B;SNRPG;PRPF8;RSRC1;NCBP2;PPP2CA;SRSF2;SNRNP48;SNRPB;SYNCRIP
prerank,maturation of SSU-rRNA (GO:0030490),0.44702478872881346,1.0079425165719573,0.4807480748074808,1.0,1.0,12/34,19.61%,LSM6;UTP3;RPS19;NOL10;RPS14;NOL11;RIOK3;UTP6;SRFBP1;NAT10;RIOK1;HELB
prerank,ether lipid metabolic process (GO:0046485),-0.378158384671892,-1.007840413793673,0.41596638655462187,0.761455092658267,1.0,7/14,19.48%,PLA2G7;DHRS7B;GNPAT;NCEH1;PLA2G6;TMEM86B;AGMO
prerank,negative regulation of viral release from host cell (GO:1902187),0.4929012255098247,1.0076027144614383,0.4583333333333333,1.0,1.0,5/13,17.04%,PML;TRIM11;TRIM5;TRIM28;CHMP3
prerank,proteoglycan biosynthetic process (GO:0030166),-0.2918944797182562,-1.0068451337581616,0.43902439024390244,0.7622946655456772,1.0,11/31,13.32%,NDST3;BMPR2;CHST8;IGF1;B3GAT3;BMPR1B;EXT2;CHST11;XYLT2;EXTL3;B4GALT7
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.4185044828150558,1.006692683117775,0.49147442326980945,1.0,1.0,51/166,20.02%,ZCCHC4;DDAH2;RBM3;ABCB10;PCNA;EIF3E;NR1D1;ATAD5;SLC25A37;RPS4X;FAF1;SORBS1;EIF4A3;NIBAN1;DNA2;SMOC2;EGFR;EGR1;CPEB3;ATP7A;PARK7;BRPF3;DHX9;CTC1;CNEP1R1;UPF3B;FXR1;PRKDC;MYC;TLR6;IRS1;ELOVL5;PLD1;METTL14;EGF;APPL1;PYM1;SAMD4A;ASS1;EEF2;VIM;LARP4B;SIRT1;NAT10;POLDIP3;SNCA;ELAVL1;RPL5;PKD2;PRKD2;EIF6
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.2303679284449533,-1.0063787265572246,0.4411764705882353,0.7619683343861043,1.0,12/76,11.55%,CMKLR1;C3AR1;GNA15;HTR2C;P2RY12;CX3CR1;GRM5;GNA14;GPR157;C5AR1;TGM2;ADRA1A
prerank,regulation of amyloid-beta formation (GO:1902003),-0.27783852389212466,-1.0060116550765545,0.38461538461538464,0.7614043185456216,1.0,10/34,16.21%,RTN4;APOE;GGA3;RELA;IGF1;BIN1;GSK3A;CASP3;PRNP;EPHA4
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.309475948143807,-1.0055688492044315,0.44516129032258067,0.7610638815749875,1.0,13/26,32.20%,APP;ZFYVE28;ZGPAT;NCF1;FBXW7;SNX6;NCK2;SOCS5;ERRFI1;HBEGF;CHMP6;BTC;ADRA2A
prerank,response to interferon-gamma (GO:0034341),0.4229133472184535,1.005374336716935,0.49111807732497387,1.0,1.0,18/67,21.83%,MEFV;CD47;GBP4;CD74;SP100;PDE12;GBP2;IFITM3;IRF8;CCL25;EPRS1;SNCA;LGALS9;DAPK1;SYNCRIP;GAPDH;CIITA;RPL13A
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.44938950823605783,1.0051034651302928,0.4794215795328142,1.0,1.0,7/39,13.45%,MYO5C;MYO15A;NDE1;FBXW11;PAFAH1B1;HAP1;ACTN4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4763449889037217,1.0049799746452825,0.46335403726708074,1.0,1.0,8/19,23.30%,PML;PHLDA3;HIPK2;TP53;TMEM109;SIRT1;AEN;HIPK1
prerank,regulation of complement activation (GO:0030449),0.44840646388852434,1.0049027864453208,0.4844789356984479,1.0,1.0,1/40,0.38%,CD19
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.47355970175821827,1.0046824818383355,0.4684014869888476,1.0,1.0,2/20,5.93%,PLA2R1;GSN
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.5186503325361225,1.0046134183003914,0.47441217150760717,1.0,1.0,3/11,16.23%,HEY2;BMPR1A;TGFB2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3234929747425619,-1.0044921301355407,0.43523316062176165,0.7621811926858959,1.0,8/22,24.98%,CACNB2;SRI;DMD;GNB5;CACNB4;STAC2;CBARP;CACNB1
prerank,positive regulation of RNA splicing (GO:0033120),0.4594937005754954,1.0042160138816802,0.48924122310305773,1.0,1.0,13/29,24.71%,RBM3;POLR2A;SETX;NCBP1;DYRK1A;NUP98;DAZAP1;HNRNPLL;THRAP3;ZPR1;NCL;CIRBP;RBM22
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4588790401249869,1.0039615524842285,0.4807467911318553,1.0,1.0,1/29,0.38%,CD19
prerank,gene silencing by miRNA (GO:0035195),0.448492965080443,1.00382246135325,0.459613196814562,1.0,1.0,14/32,22.17%,ZC3H7A;TNRC6C;TNRC6B;PUM2;PUM1;CNOT1;LIMD1;TARBP2;CNOT6;AGO2;EIF6;CNOT8;CNOT7;AGO1
prerank,metal ion export (GO:0070839),-0.2985378846183848,-1.0037202823618088,0.43089430894308944,0.7627116661428971,1.0,8/31,25.34%,SLC9A1;ATP1A1;ATP1B2;ATP1B1;KCND3;ATP1A2;ATP1A3;ATP1B3
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5311179598604443,1.0036734681427972,0.4720229555236729,1.0,1.0,2/10,8.38%,PDE2A;RNF157
prerank,positive regulation of phospholipase C activity (GO:0010863),0.44348955735940765,1.0033582788724864,0.48184818481848185,1.0,1.0,3/40,3.43%,NTF4;S1PR4;HTR2A
prerank,phospholipid transport (GO:0015914),-0.25327070925978495,-1.003092163545213,0.4576271186440678,0.7629098603621475,1.0,15/52,13.35%,ATP8A2;APOE;OSBPL2;ABCA1;ATP9A;ATP8B1;PLTP;ABCC1;PRELID2;SCP2;MTTP;SCARB1;PITPNB;SCARB2;NPC2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.48286957458364965,1.0020912936007909,0.468557336621455,1.0,1.0,7/20,18.94%,BRCA1;RPS6KA5;RUVBL2;PAXIP1;TADA2A;GLYR1;BRD7
prerank,regulation of neurogenesis (GO:0050767),0.4325054143955433,1.0016632269260402,0.493576017130621,1.0,1.0,7/55,11.18%,HMGB2;HEY2;LIG4;NOTCH1;SPEN;PCM1;B2M
prerank,oogenesis (GO:0048477),0.500196565676009,1.001094298144293,0.47468354430379744,1.0,1.0,1/15,1.66%,TRIP13
prerank,cellular lipid catabolic process (GO:0044242),0.4658714986054426,1.0010395813423807,0.4846698113207547,1.0,1.0,5/27,11.02%,CYP1B1;CEL;ACBD5;NUDT19;PLBD1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4526103489716624,1.001018863560975,0.49598163030998854,1.0,1.0,5/33,5.75%,UBASH3A;EZR;PTPN22;KCNN4;IKBKG
prerank,NIK/NF-kappaB signaling (GO:0038061),0.42533723943716134,1.000222594698264,0.4963579604578564,1.0,1.0,20/72,19.45%,CARD10;PSMB7;PSMD11;FBXW11;PSMF1;PSMC1;BIRC2;PSMC3;PSMA4;PSMC4;PSMD13;PSME1;TLR6;PSMB1;PSMD8;PSME4;PSMD4;MAP3K7;MALT1;TRAF6
prerank,positive regulation of cyclase activity (GO:0031281),-0.3772405717412358,-0.9997406612217774,0.444015444015444,0.7699483632676789,1.0,6/14,24.33%,CACNA1C;NF1;MAPK8;ORAI1;STIM1;AKAP5
prerank,acyl-CoA biosynthetic process (GO:0071616),-0.35553560054854616,-0.9997178383230511,0.43190661478599224,0.7685545250733223,1.0,9/16,27.36%,ACLY;PPT1;ACACA;PPT2;ACAT1;MLYCD;GCDH;PPCS;SCD
prerank,respiratory tube development (GO:0030323),-0.3004663512001125,-0.9996945437390918,0.42142857142857143,0.7671827590143072,1.0,16/28,38.55%,PCSK5;BAG6;NPHP3;VEGFA;FGF2;LOXL3;CCDC39;RBP4;PDPN;ITGA3;ABCA3;CCDC40;GLI2;WNT7B;FGF7;BMP4
prerank,dendritic spine morphogenesis (GO:0060997),-0.34332532579487063,-0.9992400911650389,0.44814814814814813,0.7668835932139845,1.0,5/15,19.06%,PAK3;WASL;SHANK3;DLG4;CDC42
prerank,positive regulation of organelle organization (GO:0010638),-0.28918801620369106,-0.9989752386787403,0.46218487394957986,0.7660877684162749,1.0,9/32,9.38%,TREM2;SYNJ1;SORBS3;TMED9;AKT2;SHCBP1L;RAB3GAP2;IRGM;HTRA2
prerank,negative regulation of immune effector process (GO:0002698),0.5088738487665622,0.9987769461809213,0.48678720445062584,1.0,1.0,6/13,19.23%,CD47;RPS19;RC3H1;APPL1;SLAMF8;CD55
prerank,rRNA processing (GO:0006364),0.4151346032938845,0.9986240067113678,0.5025025025025025,1.0,1.0,63/172,23.13%,RPL7;RPL18A;LSM6;UTP3;RPL36;RPL14;RPS19;DDX49;RPS7;HELQ;EXOSC8;RPL23A;RPL28;EXOSC10;TFB1M;RPL41;RPS14;NOL11;RPLP2;EMG1;RPS27;RIOK3;UTP6;RPLP0;FBL;PELP1;RPL27A;ERI1;SRFBP1;WDR74;RPS9;PRKDC;NOL8;NSA2;RPL12;NOP58;SART1;POP4;NAT10;RPL3;RPL18;UBA52;DKC1;PES1;RIOK1;MPHOSPH6;RPS17;RPS6;RPL5;DDX54;RPL21;EIF6;RPL23;RPL17;RPL8;RPL24;RPL27;RPL13A;DIS3;RPL15;RPL10;RPF1;NOP14
prerank,negative regulation of type I interferon production (GO:0032480),-0.2754319995611674,-0.9985372537536659,0.4375,0.7657471012431963,1.0,11/40,11.33%,SIRPA;HAVCR2;PTPRS;PYCARD;TNFAIP3;RNF135;IKBKE;UBA7;MAVS;TRIM25;TRAF3IP1
prerank,receptor clustering (GO:0043113),0.45631510507788875,0.9984873167684943,0.49278846153846156,1.0,1.0,13/27,27.54%,ITGB7;LRP4;FLNA;PICK1;NRXN2;NRXN1;DLG3;ITGA4;ITGB1BP1;DNAJA3;PTN;NLGN1;SAV1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.43302791585783934,0.9983464169213395,0.47890295358649787,1.0,1.0,16/55,17.79%,AURKA;PSMB7;PSMD11;PSMF1;PSMC1;PSMC3;PSMA4;ATF5;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4;AVEN
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.2788819534950812,-0.9982329122566569,0.4489795918367347,0.7650622280829281,1.0,9/37,16.76%,TENM2;PTPRD;FAT4;CD164;TENM1;NECTIN4;CADM1;CXADR;ITGAL
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.4558262818911251,0.9982179277629046,0.4936268829663963,1.0,1.0,10/32,18.50%,POLR1B;TAF1;POLR1A;ERCC3;POLR1F;POLR1C;POLR2K;TAF1C;TAF1D;POLR1G
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.3776368733509627,-0.997172698966856,0.46311475409836067,0.7661874912654063,1.0,6/13,29.21%,SEC16A;CD81;INSIG1;BRSK2;SAR1A;SORL1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4808520320710842,0.9965046504340097,0.49226804123711343,1.0,1.0,7/18,21.16%,PLK1;ABCA2;ZDHHC7;APPL1;LDLRAP1;CLN3;VPS4A
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5096307555657027,0.9961933268166099,0.4767616191904048,1.0,1.0,4/11,21.03%,EGFR;TP53;MAP2K1;RIPK1
prerank,"wound healing, spreading of cells (GO:0044319)",0.46825752998947656,0.9961313445450988,0.5024096385542168,1.0,1.0,6/24,14.97%,FLNA;CCN1;CD44;ARHGAP35;TOR1A;PDCD10
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.45226184015847615,0.9958585940827053,0.48009367681498827,1.0,1.0,4/27,9.65%,SLFN14;RNASE6;PDE12;CSTF3
prerank,selective autophagy (GO:0061912),0.4218443684517896,0.9957261570617256,0.5111346765641569,1.0,1.0,17/56,17.62%,ATG13;PCNT;ACBD5;ATM;HDAC6;DDRGK1;DYNC1H1;UBE2V1;UBQLN1;PARK7;BECN1;AMBRA1;ARL13B;DYNLL1;VIM;ATG2B;UBA52
prerank,negative regulation of T cell activation (GO:0050868),0.4486679860239792,0.9954739643875034,0.5038845726970034,1.0,1.0,4/35,4.26%,SPN;GLMN;RIPOR2;PTPN22
prerank,regulation of actin filament depolymerization (GO:0030834),0.5176155498698649,0.9952341957915074,0.5042016806722689,1.0,1.0,4/12,16.81%,MTPN;CFL2;LIMA1;PIK3CA
prerank,regulation of trans-synaptic signaling (GO:0099177),0.4463260135554112,0.9952256481794622,0.5022471910112359,1.0,1.0,13/33,27.45%,NTF4;CEL;RELN;BCR;BTBD9;CACNA1B;GRIK5;GRIK3;PXK;BDNF;ABR;NLGN2;NLGN1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.23443930722683606,-0.9951316342782385,0.40540540540540543,0.769798425783731,1.0,18/72,14.45%,IGF1R;TREM2;PTPN6;PIK3R5;PIK3CD;FLT1;PIK3R1;HGF;IGF1;PDGFD;PDGFC;GAB1;IRS2;NCF1;PIK3CB;PTK2;FGF2;IL18
prerank,regulation of transferase activity (GO:0051338),0.48732344921463855,0.9950428224796019,0.5019157088122606,1.0,1.0,4/17,15.92%,SMG6;ATM;NABP2;SLAMF8
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.36640132225513905,-0.9949402764173323,0.46332046332046334,0.768874353293533,1.0,7/15,31.73%,PTPN2;YTHDF2;USP18;CACTIN;MUL1;TTLL12;ISG15
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.3282924330142192,-0.9946160232060617,0.45263157894736844,0.7681998253367579,1.0,5/20,18.28%,ADRA1A;LMBRD2;ADRA1B;ADRB1;ADRB2
prerank,regulation of T cell activation (GO:0050863),0.43431126298123635,0.9938438717949513,0.5077262693156733,1.0,1.0,5/42,8.59%,CD2;CD47;PTPN22;CCR2;CYRIB
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.48697178808214403,0.9925993781909539,0.5126262626262627,1.0,1.0,5/17,14.90%,S100A11;CCN4;FGF9;NRP1;ADAMTS1
prerank,blood vessel diameter maintenance (GO:0097746),0.44052637251542115,0.9924480279049578,0.5045766590389016,1.0,1.0,1/34,0.98%,KEL
prerank,myeloid dendritic cell activation (GO:0001773),0.5110181042707879,0.9923088924525603,0.4943019943019943,1.0,1.0,2/12,7.33%,BATF;HMGB1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3769798655192269,-0.9922381829583768,0.4357976653696498,0.7724633546437051,1.0,4/13,10.07%,IRAK2;UNC93B1;TLR7;TNIP2
prerank,regulation of humoral immune response (GO:0002920),0.4389853216134047,0.9921893164854201,0.4928806133625411,1.0,1.0,1/44,0.38%,CD19
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.45826488263377846,0.9918423068508484,0.48477466504263095,1.0,1.0,3/22,4.26%,UBASH3A;EZR;PTPN22
prerank,proteasome assembly (GO:0043248),0.517481094853703,0.991809693353521,0.5007112375533428,1.0,1.0,7/11,26.35%,PSMD11;POMP;PSMD13;PSMD4;PSMG1;PSMG2;PSMD9
prerank,osteoclast differentiation (GO:0030316),-0.3116047155739913,-0.9916660633812259,0.4685714285714286,0.7724073996588511,1.0,4/22,2.71%,TREM2;CSF1R;FARP2;SBNO2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.32616320185408776,-0.9914904843078054,0.453551912568306,0.7714193202368371,1.0,6/20,15.12%,NUMB;BCL2L1;LZTFL1;AP2M1;RHOQ;PPFIA1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.35055513953776424,-0.9914756209248907,0.4532710280373832,0.7700368142244701,1.0,7/16,12.43%,GBF1;SEC16A;ANK2;UBAC2;MIA3;RYR2;BCAP31
prerank,regulation of oxidoreductase activity (GO:0051341),0.5004085836491754,0.9913101040783983,0.5059760956175299,1.0,1.0,5/13,21.05%,HDAC6;ATP7A;SZT2;SLAMF8;SIRT4
prerank,positive regulation of cell migration (GO:0030335),0.410592366235347,0.9902599036379416,0.53,1.0,1.0,29/253,8.42%,KIF20B;GTSE1;ARHGEF39;TNFRSF18;LEF1;PECAM1;FBXO5;SYNE2;TIAM1;S100A11;SUN2;PPP3CA;CCN1;PRKCE;CCN4;NEDD9;CAV1;CCR2;CRKL;CLASP1;ATM;TRADD;HDAC6;NOTCH1;DDRGK1;CIB1;PRKCA;INSL3;PLCG2
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4063560759914585,0.9897653728213828,0.549,1.0,1.0,113/532,17.74%,BIRC5;PRTN3;IL12A;TNFRSF18;LMNB1;EDARADD;IL2RG;IL2RA;IL7R;GRAP2;TNFSF13B;FYN;PSMB7;IL18RAP;BATF;TWIST1;PSMD11;PML;CD44;FBXW11;IL16;RPS6KA5;PSMF1;SP100;CCR2;CNN2;IL21R;CRKL;LAMA5;IKBKG;FOXO1;TRADD;COL1A2;IRF9;TRAF3;PSMC1;GBP2;BIRC2;TCP1;GPR75;HNRNPA2B1;SMARCA4;TAB1;UBE2V1;PRKACA;GRB2;JAK2;IL20RA;SOS1;TAB3;XAF1;IL17RA;PIM1;EGR1;PSMC3;ZEB1;SOCS2;IL22;MSN;RHOU;IL1R1;RPLP0;TNFRSF13B;PSMA4;SMAD4;B2M;IL10RA;PLCB1;FLT3;CRK;ADIPOR1;MYD88;TRIM68;PSMC4;CANX;F3;STAT5B;PSMD13;IFITM3;ACTN4;PSME1;BCL6;MYC;IL27;PPIA;IRS1;TRIM5;PSMB1;LIMS1;TP53;JUNB;IRF8;APPL1;TNFRSF11A;POU2F1;GPR35;PSMD8;PAK2;MTAP;PSME4;VIM;TRAF3IP2;CCL25;JAK3;MAOA;PIK3CA;PSMD4;SIRT1;FN1;HSP90B1;UBA52;F13A1;MAP3K7
prerank,negative regulation of gene expression (GO:0010629),0.4089962855644863,0.9896987135653983,0.522,1.0,1.0,93/302,22.40%,SLFN14;EZH2;HEY2;RB1;AURKA;LSM6;PPM1D;HELLS;PPP1R11;PTPN22;SUZ12;RPS6KA5;EPC1;RBL1;FOXP1;CRKL;TAF1;TERF2;RBBP4;LRP3;TNRC6C;TNRC6B;EIF4A3;PHF19;NOTCH1;DDRGK1;H3-3A;DCP2;PHF1;ABCC2;LSM2;ZNF148;MECP2;ASB1;PARP14;CPEB3;DNMT1;PARK7;TYMS;KAT2B;IGF2BP3;LSM5;SETDB2;BMPR1A;METTL16;FXR1;ROCK2;RACK1;DXO;LSM14A;PSEN1;CNOT1;PDCD10;RUNX1;JARID2;MAP2K1;SAMD4A;LGR4;ZFP36L2;TASOR;TGFB2;VHL;SIRT1;CNPY2;APLN;FCGR2B;EPRS1;FLOT2;ADAM10;EIF4ENIF1;PTGER4;SETDB1;HDAC1;RPS3;LGALS9;AGO2;DNMT3B;DAPK1;CNOT8;PNPT1;SYNCRIP;PTBP2;CNOT7;CITED2;MAPT;GAPDH;CELF1;RPL13A;EIF4E2;ATP2B4;AGO1;AEBP2;HDAC9
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.37725532769969716,-0.9894854385347871,0.4090909090909091,0.773580703856877,1.0,4/12,11.45%,TMEFF2;HDAC2;AR;SELENOS
prerank,regulation of developmental growth (GO:0048638),-0.29452481845522227,-0.9891367904488609,0.45185185185185184,0.7730116417749501,1.0,4/29,5.23%,DNM2;APP;APOE;IGF1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.3826391140707769,-0.9887708883712416,0.4354243542435424,0.7725702440012375,1.0,4/12,16.21%,SERPINE2;BIN1;ID2;EPHA4
prerank,positive regulation of transport (GO:0051050),0.41599306847991746,0.9886380318380104,0.5158002038735984,1.0,1.0,20/85,17.96%,SPAG5;TFR2;IL2RG;C2CD5;CD47;MLC1;BOK;DYNC1H1;NEDD4L;CBLL1;ABCA7;KMT2A;CHCHD10;FLOT1;NUMA1;GSK3B;CAPN10;CYBA;FCGR2B;SNCA
prerank,stress granule assembly (GO:0034063),0.46448972027733676,0.9882844696972014,0.5055624227441285,1.0,1.0,11/20,25.27%,EIF2S1;CSDE1;DYNC1H1;LSM14A;PRRC2C;UBAP2L;G3BP1;MAPT;ATXN2L;CIRBP;RPS23
prerank,pyroptosis (GO:0070269),-0.358739757830261,-0.9881275471318812,0.49107142857142855,0.772729995759381,1.0,2/15,2.88%,TREM2;CASP4
prerank,monocarboxylic acid transport (GO:0015718),0.42922284410776246,0.9879966903284912,0.5122470713525027,1.0,1.0,7/51,12.43%,SLC6A12;SLC16A12;SLC16A1;ABCC2;STARD5;ABCC4;SLCO2A1
prerank,regulation of membrane depolarization (GO:0003254),0.47086515168784415,0.9878917827738228,0.48267008985879334,1.0,1.0,3/18,7.98%,ABCD1;GPD1L;NEDD4L
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4804023631467095,0.987720749030158,0.4866666666666667,1.0,1.0,8/16,19.73%,CAV1;PARP14;ADIPOR1;PIBF1;HGS;VHL;INPP5F;PPP2CA
prerank,potassium ion homeostasis (GO:0055075),0.4607757898074106,0.9876664846767053,0.5122249388753056,1.0,1.0,5/23,13.04%,SLC12A3;SLC12A7;SLC12A1;SLC12A6;KCNJ2
prerank,actin filament organization (GO:0007015),0.4116377256573104,0.9876281210674805,0.5315947843530592,1.0,1.0,16/151,10.79%,MYO5C;TMOD4;SPTA1;RFLNB;PPP1R9B;SAMD14;MYO15A;FLNA;GAS2L3;NEDD9;GSN;RND3;SHROOM2;FLII;WHAMM;SHROOM4
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4603645925123105,0.9873716857912945,0.48902439024390243,1.0,1.0,8/21,20.64%,TWIST1;MED30;SETX;JUN;PAXIP1;MED14;MED1;MED13
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3161489895287234,-0.9873618961707844,0.4807692307692308,0.7731992732624396,1.0,4/23,5.23%,APP;ARNT;PRKAA2;IGF1
prerank,positive regulation of ATPase activity (GO:0032781),0.43394197362136716,0.9871651849494737,0.5104972375690607,1.0,1.0,8/41,16.43%,UHRF1;MSH6;DNAJB11;AHSA1;DHX9;HNRNPU;DYNLL1;DNAJB1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.2862563120397994,-0.987122737273357,0.44,0.772309198919086,1.0,8/28,10.52%,ERO1A;CASP4;QRICH1;ERN1;ATF4;TMEM117;SELENOK;BAG6
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.36842388046506425,-0.9869985809926992,0.4716981132075472,0.771197388113475,1.0,5/13,17.60%,CTNNB1;SEMA3E;ENG;VEGFA;TGFBR2
prerank,cellular respiration (GO:0045333),0.43672232075493594,0.9867497931750613,0.5116022099447514,1.0,1.0,12/41,20.39%,SDHAF4;NDUFS8;COQ10B;ME3;COX10;SLC25A13;ATP5F1D;NDUFA5;NDUFS1;MDH2;ETFRF1;UQCRH
prerank,cellular component assembly (GO:0022607),0.40866634054383627,0.9865044187411938,0.538,1.0,1.0,57/253,17.73%,KNTC1;CHAF1A;RAD21;TRIP13;CARD10;FANCA;CFAP206;FLNA;EZR;CD74;PML;HAS1;NEDD9;NAPG;TUBGCP4;IKBKG;GSN;MDM4;TEX11;RBBP4;KPNA3;ARL6IP1;SHROOM2;SNX9;LAMC1;ZW10;BSN;NDUFAF1;NIFK;LIMA1;PAWR;RHOU;CHAF1B;FAS;CDAN1;MAGI1;KMT2A;CHCHD10;RAC2;ADD2;CREBBP;P3H4;VCPIP1;LIMS1;TP53;PARVB;PDCD10;KIFAP3;TFAP4;FANCC;RTN3;DARS1;PARVA;RAC1;CALD1;PEX14;EPRS1
prerank,mitochondrial fusion (GO:0008053),-0.33102982935424713,-0.9864925740704038,0.47465437788018433,0.7710987411390339,1.0,10/18,29.33%,MFN2;MIEF1;MIGA2;MFF;SPG7;STOML2;AFG3L2;USP30;MFN1;MIEF2
prerank,regulation of receptor internalization (GO:0002090),-0.27914581440504216,-0.986442188644033,0.4628099173553719,0.7698310934415586,1.0,7/35,8.47%,MKLN1;AHI1;ATXN2;CD63;ARRB1;TBC1D5;ANGPT1
prerank,sensory perception (GO:0007600),-0.26590333551211043,-0.9860400330795712,0.45161290322580644,0.769422559382706,1.0,27/45,39.99%,WHRN;GNAS;MYO7A;SCN9A;TTC8;C5AR1;KCNA2;PCDH15;CDH23;NIPSNAP1;PENK;P2RX4;PTGES;CHRNA7;GNAL;NTSR2;CHRNA4;CCL2;OPRL1;OPRK1;CLRN1;USH2A;PNOC;ALOXE3;PDYN;KCNK4;CHRNB2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.3250036256345148,-0.9860024472356312,0.45054945054945056,0.7681490318903164,1.0,6/21,15.97%,KDM1A;CTNNB1;CX3CR1;FZD3;VEGFA;MDK
prerank,smooth muscle tissue development (GO:0048745),-0.40318211599842046,-0.9858879160558686,0.4707792207792208,0.7670627284580106,1.0,3/10,9.21%,SMO;NF1;ENG
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4245290828744345,0.9856886202758398,0.510880829015544,1.0,1.0,17/66,19.45%,EZH2;ARHGEF5;RASGRP1;MAP3K5;EGFR;MAP3K11;FLT3;TLR6;PDCD10;EGF;TNFRSF11A;FGFR1;CD24;MAP3K7;LRRK2;RPS3;TRAF6
prerank,positive regulation of reproductive process (GO:2000243),-0.2985646109464365,-0.9856301582790978,0.44881889763779526,0.7663154728482073,1.0,7/31,19.34%,LHFPL2;CFAP69;PRDM9;PGAM4;VEGFA;SMURF2;TACR3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.28515444594970607,-0.9854141225255816,0.45045045045045046,0.7654772154662283,1.0,4/34,3.44%,LACC1;GPI;CD86;STX4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3762546902726466,-0.9845209380909663,0.463768115942029,0.766252961790461,1.0,3/12,9.87%,ABCA1;ABCA5;ITGB3
prerank,membrane protein proteolysis (GO:0033619),0.42840516378962484,0.9842086787139643,0.5118110236220472,1.0,1.0,9/37,19.45%,PRTN3;NAPSA;MBTPS2;PSEN1;DAG1;SPPL3;ADAM10;ERAP1;TRAF6
prerank,central nervous system neuron development (GO:0021954),0.4925043593578328,0.9840268205356154,0.5045161290322581,1.0,1.0,4/15,11.97%,GBA2;ARHGAP35;ATP7A;PTEN
prerank,regulation of T cell mediated immunity (GO:0002709),0.5082132663494598,0.9836062344605484,0.496274217585693,1.0,1.0,4/10,22.90%,CCR2;HMGB1;TRPM4;ZBTB1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.41614450429595207,0.9834562360367785,0.5158002038735984,1.0,1.0,25/80,20.02%,ZCCHC4;RBM3;EIF3E;RPS4X;EIF4A3;NIBAN1;ABCA2;CPEB3;UPF3B;FXR1;ROCK2;RACK1;PRKDC;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;LARP4B;NAT10;POLDIP3;ELAVL1;RPL5;EIF6
prerank,cell-cell junction organization (GO:0045216),0.41471722106419195,0.9833519420815693,0.5353846153846153,1.0,1.0,14/79,16.23%,PRTN3;CD177;SDK1;CTNNA1;TJP3;CDH18;CDH24;NECTIN1;GJA4;LIMS1;F2R;CTNND2;CDH4;TGFB2
prerank,cellular response to mechanical stimulus (GO:0071260),0.42881693521008146,0.9833177742986025,0.504875406283857,1.0,1.0,14/46,20.84%,AQP1;CHEK1;CNN2;CASP2;PDE2A;MAP3K1;FAS;MYD88;TMEM150C;TLR5;PTGER4;CASP8;SOX9;BNIP3
prerank,response to ketone (GO:1901654),0.4629747263169156,0.983092021965339,0.5240384615384616,1.0,1.0,6/24,21.77%,CATSPERB;CAV1;SLIT3;TGFB2;ABHD2;NR1H3
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.46890756828265984,0.9829307519575753,0.5277435265104808,1.0,1.0,5/21,17.89%,AXIN1;CAV1;CSNK1A1;GSK3B;PPP1CA
prerank,cellular response to estradiol stimulus (GO:0071392),0.48046561429990753,0.9826498693215294,0.5134443021766966,1.0,1.0,3/18,10.64%,CRHBP;EGFR;RUVBL2
prerank,gland development (GO:0048732),0.4169524340233577,0.9825631405917744,0.5418875927889714,1.0,1.0,19/59,22.90%,EZR;CAV1;ARHGAP35;PHF2;MSN;ARID5B;CDK5RAP3;CEBPG;PRKCSH;XBP1;FOXE1;NKX2-8;PROX1;SOX9;PKD2;MET;CITED2;FGFR2;ZBTB1
prerank,basement membrane organization (GO:0071711),0.4907098831939436,0.9822929309717008,0.5102880658436214,1.0,1.0,5/14,10.81%,FLRT2;LAMB2;LAMB3;NTNG2;NID1
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4725544309679397,0.9819100796280932,0.49742268041237114,1.0,1.0,4/18,13.71%,CAV1;NEDD4L;SLC43A2;STK39
prerank,positive regulation of dendrite development (GO:1900006),-0.40936256146068095,-0.9812564106628215,0.48,0.7727597688108243,1.0,5/10,20.24%,PACSIN1;LRP8;DAB2IP;VLDLR;ZDHHC15
prerank,histone H2A ubiquitination (GO:0033522),0.4820807277370652,0.9811341746996914,0.5190839694656488,1.0,1.0,7/17,18.15%,UBR2;RNF168;RNF8;RNF2;TRIM37;DDB2;KDM2B
prerank,positive regulation of vasoconstriction (GO:0045907),0.4939618597398324,0.9809676947708055,0.49793672627235214,1.0,1.0,3/13,17.00%,CAV1;F2R;TRPM4
prerank,lung epithelium development (GO:0060428),0.5185906379968662,0.9809246876779391,0.5237410071942447,1.0,1.0,1/10,3.54%,RCN3
prerank,aspartate family amino acid catabolic process (GO:0009068),0.46659605714931457,0.9808644528828675,0.49625,1.0,1.0,1/19,1.71%,SLC25A21
prerank,regulation of cilium assembly (GO:1902017),0.41893083352200167,0.980824380657801,0.5260960334029228,1.0,1.0,20/62,21.72%,CDKL1;TBC1D1;CCDC88A;TCHP;TBC1D22B;EVI5;ARHGAP35;FUZ;TAPT1;BBS4;DYNLT2B;SDCCAG8;MARK4;LIMK2;IFT140;RABEP2;SGSM3;CROCC;TBC1D15;EVI5L
prerank,negative regulation of cellular component movement (GO:0051271),0.4917353685456428,0.9806151979579077,0.4927916120576671,1.0,1.0,3/15,11.76%,SP100;PIN1;CRK
prerank,regulation of intracellular transport (GO:0032386),0.43681406084504726,0.9803856340171225,0.5072463768115942,1.0,1.0,14/38,22.79%,SPAG5;MLC1;NUP214;DYNC1H1;HAP1;RAB11B;NUMA1;DYNLT2B;AAAS;CAPN10;LRRK2;INPP5F;NEFH;ATPSCKMT
prerank,regulation of immune effector process (GO:0002697),0.43455792192587317,0.9801001838012816,0.5104740904079382,1.0,1.0,1/41,0.38%,CD19
prerank,lipid translocation (GO:0034204),0.4674046778330689,0.9800113158176953,0.5011933174224343,1.0,1.0,9/21,20.72%,ATP11C;ATP8B4;ABCA7;RFT1;ATP8A1;ATP11B;TMEM30A;ATP11A;ATP8B2
prerank,negative regulation of nervous system development (GO:0051961),0.47814282417239096,0.979473308356011,0.4966532797858099,1.0,1.0,4/17,11.71%,NOTCH1;PCM1;B2M;SLIT1
prerank,positive regulation of cytokine production (GO:0001819),0.40335534569844783,0.9794517974404379,0.564,1.0,1.0,54/292,15.44%,IL12A;CD2;POU2AF1;CYP1B1;PLA2R1;BRCA1;GLMN;BATF;DHX58;TWIST1;ZFPM1;CD74;SULF2;IL16;PTPN22;FOXP1;CGAS;AGPAT1;CCR2;RASGRP1;PAEP;NFAM1;XRCC6;HMGB1;MAPK14;PLCG2;CYRIB;IL17RA;EGR1;IL1R1;CARD9;PARK7;DHX9;PLCB1;MYD88;F3;ROCK2;ZBTB7B;TLR5;FLOT1;PRKDC;DDIT3;POLR1C;CREBBP;PIBF1;CEBPG;IL27;TLR6;TYROBP;CCBE1;RUNX1;LRRFIP1;F2R;APPL1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.4335957337760986,0.9793482731163915,0.5204419889502763,1.0,1.0,9/44,15.86%,LBR;SRD5A2;OSBPL3;CYP27A1;SLC27A2;PARK7;CYP46A1;PRKAG2;DHCR7
prerank,glucose transmembrane transport (GO:1904659),0.4741554353217794,0.9792578903501341,0.5031055900621118,1.0,1.0,6/18,24.08%,SLC2A4;SLC2A8;SLC2A3;SLC2A1;PPARD;SLC5A3
prerank,negative regulation of cellular process (GO:0048523),0.40416612447650613,0.9791844233822571,0.594,1.0,1.0,94/521,16.99%,E2F7;CDKN3;PRTN3;FOXM1;MYBL1;MEN1;CYP1B1;CDKN2C;JADE1;ANP32B;HMGA1;ITGA1;BLM;PPP1R9B;SPN;RB1;FBXO5;TCHP;ERBB3;GLMN;S100A11;PPM1D;CCN1;PML;CCN4;RIPOR2;SUZ12;ARID2;SNX3;CTCF;STK11;ARHGDIB;CDK6;SP100;CDKN2A;PTHLH;MDM4;RBBP4;GMNN;PDE12;RUNX3;KLF10;NOTCH1;PIM2;FUZ;CIB1;SMARCA4;HPGD;RAD18;PLXNA2;JAK2;STRN;JAM2;CDKN2D;CBLL1;PIP4P2;PARK7;UBR2;SMAD4;PTPN14;TAF6;CCAR2;KAT2B;BECN1;ATF5;SLIT3;PTEN;BAP1;PDS5B;SIRT7;RACK1;ING5;SLURP1;SERTAD2;BCL6;SKI;TMEM115;MYC;ADAMTS1;TP53;TGFBI;F2R;PTPRU;HGS;MAP2K1;TFAP4;TMEM109;TGFB2;NDRG3;ARHGDIA;VHL;NLRP2B;PDE8A;SIRT1
prerank,positive regulation of gene expression (GO:0010628),0.4051162804720097,0.979033168729935,0.586,1.0,1.0,124/442,22.37%,PLA2R1;BRCA1;TFR2;POLR1B;HEY2;MAPK1;LEF1;E2F1;SMARCA5;ZCCHC4;GLMN;BATF;EZR;RBM3;TWIST1;DEK;CD74;POLR2A;PTPN22;CTCF;TFRC;AGPAT1;EIF3E;RPS7;RPS4X;GSN;ATM;TERF2;MYOM1;SETX;EPHX2;PDE2A;LRP3;TNRC6C;TNRC6B;EIF4A3;NOTCH1;NFAM1;DDRGK1;ELAVL4;NIBAN1;BAZ1B;PHF2;MAPK14;PLCG2;EGFR;POLR1A;EGR1;CPEB3;DNMT1;MSN;DYRK1A;CARD9;PARK7;FGF9;KAT2B;RDX;MYD88;POLR1F;HCFC1;F3;UPF3B;FXR1;NFE2L2;ROCK2;ZBTB7B;FLOT1;PRKDC;POLR1C;MYC;GABPA;PSEN1;TLR6;DTNBP1;TYROBP;GSK3B;LIMS1;TADA3;PLD1;TP53;PDCD10;METTL14;EGF;HGS;MAP2K1;PYM1;SAMD4A;EEF2;VIM;POLR2K;LARP4B;NAT10;POLDIP3;FN1;TAF1C;MED1;TAF1D;POLR1G;PTGER4;ELAVL1;HNRNPLL;RPL5;RPS3;LGALS9;SOX9;AGO2;DNMT3B;EIF6;RPL23;RBPJ;RAB27A;CITED2;PRKAG1;ROCK1;RIPK1;GAPDH;CELF1;CALCOCO1;FGR;ACTG1;AGO1;TENT4A;MED23;NTRK3
prerank,peptidyl-methionine modification (GO:0018206),0.5042831638237688,0.978972425946953,0.49382716049382713,1.0,1.0,4/12,15.19%,METAP2;NAA16;NAA25;NAA20
prerank,response to cadmium ion (GO:0046686),0.45717297165644216,0.9787917315229575,0.5053254437869823,1.0,1.0,5/26,11.33%,MAPK1;HAAO;EGFR;SUMO1;JUN
prerank,positive regulation of receptor internalization (GO:0002092),-0.3225070636519082,-0.9786345297872494,0.4624277456647399,0.7778324801280744,1.0,5/22,8.47%,AHI1;CD63;ARRB1;TBC1D5;ANGPT1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.46925764793767494,0.9784702951435743,0.5071335927367056,1.0,1.0,7/17,23.16%,CCNYL1;MAPRE3;EGFR;PROX1;PKD2;CCND3;ADAM17
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.48060427928830945,0.9782800931688443,0.5,1.0,1.0,6/17,17.33%,EMC6;EMC10;EMC3;GET3;EMC1;CAMLG
prerank,negative regulation of cellular protein localization (GO:1903828),0.44506564977528906,0.9780123945123486,0.5128779395296752,1.0,1.0,10/34,16.59%,CTNNA1;RIPOR2;SNX33;NEDD4L;ACTN2;ROCK2;LATS1;GSK3B;SIN3A;ANKRD13A
prerank,protein K48-linked deubiquitination (GO:0071108),0.4636009767221552,0.9779980294284274,0.49938650306748467,1.0,1.0,10/23,22.19%,USP27X;BAP1;VCPIP1;OTUD5;USP50;YOD1;USP25;USP34;OTUD7A;MINDY2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.3137226604972797,-0.9779847039260404,0.5027932960893855,0.7780267461926198,1.0,10/22,27.14%,MVB12B;PLAA;VPS36;TOM1L1;UBAP1L;PTPN23;VPS37C;RNF126;UBAP1;VPS28
prerank,stress-activated MAPK cascade (GO:0051403),0.4181585311042418,0.9777674128920254,0.5251046025104602,1.0,1.0,21/61,20.99%,MAPK1;FBXW11;CRKL;IKBKG;CCM2;ZFP36L1;MAP3K5;MAP4K2;TAB1;UBE2V1;MAPK14;TAB3;MAP3K11;MAP3K20;UBA52;MAP3K7;PTGER4;LGALS9;TRAF6;UBE2N;IKBKB
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.5093841714069461,0.9777256197270083,0.5,1.0,1.0,4/10,16.43%,RUVBL2;RUVBL1;ZNHIT6;TAF9
prerank,detection of mechanical stimulus (GO:0050982),-0.3273633398824933,-0.9768233675869358,0.4492753623188406,0.7794299592797707,1.0,9/19,24.11%,CTNNB1;CDH2;JUP;PKD1;PTK2;PIEZO2;PKD2L1;PKD1L2;PKD2L2
prerank,post-translational protein modification (GO:0043687),0.40308644135525235,0.9763960721073375,0.584,1.0,1.0,73/332,18.92%,CCNF;ESCO2;F5;MEN1;FBXL15;FN3KRP;DSCC1;SKP2;DTL;PSMB7;CCN1;PSMD11;FBXW11;PSMF1;LRRC41;RAB1B;FBXO44;PSMC1;STT3A;ASB7;SPSB3;RAB8A;FBXO17;ZBTB16;LAMC1;LAMB2;KLHL9;ASB1;CUL3;PSMC3;SOCS2;DCAF17;PSMA4;SPSB4;DCAF7;FBXL4;PSMC4;RAB11B;FBXO11;CUL9;PSMD13;SUMF1;PSME1;RAB2A;DCAF11;PSMB1;RBBP5;PRKCSH;CHML;PRSS23;PSMD8;WDTC1;DCAF8;ASB8;PSME4;RAB5A;DCAF5;VHL;KLHL22;SCG3;PSMD4;DCAF4;FN1;HSP90B1;UBE2M;DDB2;SDC2;FEM1C;SUMF2;ADAM10;FBXW8;CKAP4;ICMT
prerank,protein methylation (GO:0006479),0.42216329724452645,0.9760530633247527,0.5283018867924528,1.0,1.0,14/40,23.06%,EZH2;LCMT1;EHMT1;NSD3;GSPT1;PRMT3;RAB6A;ICMT;SNRPB;PRMT7;TRMT112;EEF1AKMT2;ATPSCKMT;NSD1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.48268695438593934,0.975883597403731,0.503448275862069,1.0,1.0,4/13,19.26%,PALM;CCR2;ADGRV1;GRM3
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4875131718461464,0.9753417654492924,0.5254237288135594,1.0,1.0,1/15,1.11%,CHST3
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4866666859073453,0.9747910851265991,0.5020080321285141,1.0,1.0,3/14,13.06%,CAV1;ZEB1;SPRED2
prerank,positive regulation of growth (GO:0045927),0.4142686479980197,0.9740386904237746,0.5222337125129266,1.0,1.0,19/64,23.16%,S100A9;BRAT1;DDX49;S100A8;H3-3A;CIB1;MTPN;NCBP1;EGFR;DERL2;PLCB1;PABIR1;TGFB2;KLHL22;ADAM10;USP47;RPS6KA3;ZPR1;ADAM17
prerank,cellular response to fatty acid (GO:0071398),-0.3784113661211983,-0.9740336190808871,0.4639175257731959,0.7850253094359992,1.0,2/12,6.25%,LPL;ZC3H12A
prerank,cytoplasmic microtubule organization (GO:0031122),0.41494719696949517,0.9739866411639528,0.5392895586652314,1.0,1.0,15/54,16.64%,TUBGCP6;CCDC88A;SLK;EZR;TUBGCP4;CLASP1;CCDC88C;DYNC1H1;CIB1;PCM1;SLAIN2;TUBGCP3;NUMA1;LIMK2;KPNB1
prerank,snRNA metabolic process (GO:0016073),0.47991162442794144,0.9739650267197867,0.5056890012642224,1.0,1.0,8/17,22.93%,INTS4;INTS9;INTS1;RBM7;TUT1;ZCCHC8;INTS12;INTS11
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.5084870582658249,0.9737881102271897,0.5128939828080229,1.0,1.0,4/10,21.42%,MAPK1;FAS;MAP2K1;NBR1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.48422931388134416,0.973751178502755,0.5161725067385444,1.0,1.0,3/14,8.42%,CD74;GPRC5B;PLCG2
prerank,organelle transport along microtubule (GO:0072384),0.43354484753036815,0.973502863493945,0.515358361774744,1.0,1.0,10/31,21.13%,UXT;NDE1;FBXW11;PAFAH1B1;HAP1;PEX14;RAB6A;CLN3;TRAK2;MAPT
prerank,DNA methylation or demethylation (GO:0044728),0.4704465708173665,0.9734808588486614,0.5089058524173028,1.0,1.0,8/19,20.88%,PPM1D;HELLS;DNMT1;EHMT1;ATF7IP;ATRX;DNMT3B;GATAD2A
prerank,DNA alkylation (GO:0006305),0.4704465708173665,0.9734808588486614,0.5089058524173028,1.0,1.0,8/19,20.88%,PPM1D;HELLS;DNMT1;EHMT1;ATF7IP;ATRX;DNMT3B;GATAD2A
prerank,response to histamine (GO:0034776),-0.39710760360971015,-0.9733174205376389,0.4670846394984326,0.7853274311352376,1.0,2/10,3.02%,GABRB3;GABRG2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.49183871543419133,0.9718090780879242,0.523224043715847,1.0,1.0,3/12,7.33%,CD74;FOXP1;HMGB1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.4083541703777008,0.9717684424559421,0.5619335347432024,1.0,1.0,26/124,16.84%,BLK;STMN1;TSGA10IP;PPP1R9B;SAMD14;RB1;BLOC1S4;WDPCP;MNS1;FRY;MAP4;ODF2;HMGB1;FRYL;LIMA1;TOR1A;VAPA;RAB35;ADCYAP1;CDK16;DTNBP1;GSK3B;KIFAP3;MARK4;LRP12;RAC1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4544209967323931,0.9708432205471121,0.5125628140703518,1.0,1.0,4/21,11.99%,CEL;ACBD5;NUDT19;FAH
prerank,Wnt signaling pathway (GO:0016055),0.4067063849725611,0.9707312424658873,0.5430597771023303,1.0,1.0,21/92,20.09%,NR4A2;LEF1;AXIN1;SNX3;NXN;CCDC88C;TCF7L1;CSNK1A1;CSNK1G2;PLCG2;STRN;PTEN;BCL9L;GSK3B;TCF7L2;CD24;UBA52;LRRK2;RARG;USP34;DIXDC1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.33182804099264185,-0.9706062553009469,0.4930875576036866,0.7903437990584634,1.0,5/19,6.25%,NLRP3;IGF1;TNFAIP3;ZC3H12A;CX3CR1
prerank,BMP signaling pathway (GO:0030509),-0.2486032330199292,-0.9702846372270106,0.4473684210526316,0.7897451915179465,1.0,11/62,15.54%,ACVR1;SMAD1;BMPR2;SMAD3;USP9X;SMAD6;BMPR1B;ENG;SMAD7;TGFBR3;ACVRL1
prerank,histone monoubiquitination (GO:0010390),0.4564647876927043,0.9697863916112166,0.5332541567695962,1.0,1.0,7/24,18.15%,UHRF1;RNF168;RNF2;RNF20;TRIM37;DDB2;KDM2B
prerank,regulation of type I interferon production (GO:0032479),0.4062735552623068,0.9696993203251875,0.5502049180327869,1.0,1.0,21/84,17.01%,RNF26;POLA1;DHX58;PTPN22;CGAS;NPLOC4;TRAF3;PIN1;XRCC6;PCBP2;DHX9;MYD88;PRKDC;POLR1C;CREBBP;LRRFIP1;GPATCH3;OTUD5;IRF8;POLR2K;NLRX1
prerank,peptidyl-tyrosine modification (GO:0018212),0.4155531037245012,0.9694384798375795,0.5395987328405492,1.0,1.0,10/56,11.69%,BLK;FYN;TPST1;JAK2;EGFR;EPHA3;DYRK1A;BTK;RELN;FLT3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.49258294087722904,0.9693182879625333,0.5322128851540616,1.0,1.0,5/11,19.34%,RUNX3;HMGB1;CBFB;RUNX1;LGALS9
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.43502916322950935,0.9692488065995722,0.5028571428571429,1.0,1.0,10/33,15.02%,AXIN1;HDAC6;DDRGK1;H3-3A;PARK7;TRIM68;CBFB;LATS1;KDM4C;RUNX1
prerank,organelle organization (GO:0006996),0.40134107389594126,0.9688486460176298,0.618,1.0,1.0,65/388,14.24%,DIAPH3;KIF4A;CDCA8;CEP55;CENPW;CECR2;DES;TSGA10IP;PTCD2;ATP8B4;LIG4;WDPCP;MNS1;STX17;NEDD9;ATL2;TMCC1;ABCD1;CAV1;CNN2;ODF2;CLASP1;AGTPBP1;ANK1;NPLOC4;CSNK1A1;TFB1M;FAF2;GABPB1;TFB2M;PEX11B;ZW10;MAST2;FGD6;BLZF1;NRF1;CAV2;LONP1;IRAG2;RHOU;ATP7A;PARK7;HPS3;DYM;SYNE3;TOR1A;PDZD8;PEX2;FGD3;VAPA;SEC31A;HCFC1;PACSIN2;PLD2;RAB43;PI4K2B;CHCHD10;CHMP1B;NUMA1;PALLD;RAB2A;MYC;GABPA;PPIA;DIAPH1
prerank,negative regulation of endocytosis (GO:0045806),0.4517010804452812,0.9687560493546511,0.5191846522781774,1.0,1.0,9/24,23.08%,SNX33;CAV1;MTMR2;EPHA3;ABCA7;RAC1;MCTP1;NR1H3;LRSAM1
prerank,neurotransmitter uptake (GO:0001504),-0.3833494457508298,-0.9687424165440257,0.48698884758364314,0.7922066802966677,1.0,6/12,32.23%,GLUL;SLC1A3;ATP1A2;SNAP25;SLC38A1;SLC1A6
prerank,endosome organization (GO:0007032),0.42474937306085825,0.9687349767111189,0.5350389321468298,1.0,1.0,13/41,20.53%,RNF26;SNX33;SNX3;TMCC1;WASHC4;RAB22A;DNAJC13;PI4K2B;VPS33B;USP50;CHMP2B;AKTIP;RAB27A
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.42858241962036964,0.9687310702773663,0.5189599133261105,1.0,1.0,7/41,15.54%,FOXA2;CD47;CD44;MAGI1;FLOT1;DENND6A;PTPRU
prerank,regulation of neurotransmitter transport (GO:0051588),0.4704742803456272,0.9687011655425516,0.5161707632600259,1.0,1.0,1/16,0.81%,CHRNB4
prerank,positive regulation of immune response (GO:0050778),0.4121199399326895,0.9681195744095096,0.5451713395638629,1.0,1.0,13/64,20.41%,MYB;CD177;CD74;RIOK3;DHX9;TGFB2;SIRT1;CYBA;XBP1;FCGR2B;IFI35;LGALS9;POLR3B
prerank,positive regulation of interleukin-12 production (GO:0032735),0.43169815890727714,0.9675902418291903,0.5308219178082192,1.0,1.0,5/31,11.66%,IL16;HMGB1;MAPK14;PLCG2;PLCB1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4509182201576144,0.9672502273139107,0.5321782178217822,1.0,1.0,8/22,20.64%,MED30;PSMC3;PSMC4;PAXIP1;MED14;TP53;MED1;MED13
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.44031295367637246,0.9670552929837177,0.5106132075471698,1.0,1.0,8/30,14.20%,ATG13;SAE1;UBL5;ABLIM3;RHOU;BAP1;RAC2;ARIH2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.4775262367498724,0.9670384321149929,0.5092592592592593,1.0,1.0,5/14,12.24%,SEC23B;SEC24B;SEC24A;SEC13;SEC31A
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.4677841376051757,0.9670341149555942,0.5150375939849624,1.0,1.0,6/17,16.99%,TWIST1;CD74;CD44;DYRK1A;YJU2;SIRT1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.41702019538645824,0.9669203150776365,0.5330444203683641,1.0,1.0,13/49,21.42%,CD2;CD74;HMGB1;PARK7;MYD88;F3;TLR5;DDIT3;F2R;LGALS9;PRKD2;RIPK1;SYK
prerank,regulation of mRNA processing (GO:0050684),0.4340289567565972,0.9660212722116558,0.5511811023622047,1.0,1.0,16/32,25.66%,PTCD2;ZFP36L1;SRSF3;IWS1;NCBP1;DHX9;METTL16;SRSF10;SRPK1;SAFB;CDK11B;SLTM;PAPOLA;HNRNPK;YTHDC1;KHDRBS3
prerank,regulation of hydrolase activity (GO:0051336),0.4086493245434318,0.9655498556380002,0.5466804979253111,1.0,1.0,23/71,22.34%,ARHGEF5;ARHGAP15;FBXW11;CAV1;PLXNA2;FGD6;EPHA3;PAFAH1B1;CFAP73;RDX;CRK;FGD3;CDK5RAP3;ARHGAP9;ADAP1;TDG;OCRL;WRN;TBC1D15;SIPA1L1;VAV3;FGD4;PLXNC1
prerank,regulation of filopodium assembly (GO:0051489),-0.2669972615616403,-0.9651810823312442,0.5052631578947369,0.7997017482167156,1.0,12/38,15.98%,TENM2;ARAP1;RALA;PIK3R1;WASL;ARHGAP44;TENM1;GAP43;FXR2;MYO10;RHOQ;AGRN
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2833844895605402,-0.9649439750523411,0.5069444444444444,0.7988671808519622,1.0,7/26,14.95%,GAK;SNAP91;SIGLEC1;CLTB;AP2S1;AP2M1;PIP5K1C
prerank,regulation of pH (GO:0006885),-0.377635229442307,-0.9645921406322217,0.4585987261146497,0.7983101705507168,1.0,2/11,5.73%,LACC1;SLC9A1
prerank,cellular response to hypoxia (GO:0071456),0.40535842803063976,0.9641959006241277,0.5761523046092184,1.0,1.0,31/126,17.86%,SUV39H1;PMAIP1;AQP1;PSMB7;TWIST1;PSMD11;TBL2;PSMF1;MDM4;ZFP36L1;PSMC1;UBQLN1;HIPK2;PSMC3;PSMA4;PSMC4;PSMD13;PSME1;CREBBP;MYC;PSMB1;TP53;LIMD1;PSMD8;PSME4;VHL;PSMD4;SIRT1;UBA52;PGK1;NDRG1
prerank,smooth muscle cell differentiation (GO:0051145),0.4963163591332551,0.9640953000942242,0.5451977401129944,1.0,1.0,2/12,13.56%,HEY2;TMEM204
prerank,proteasomal protein catabolic process (GO:0010498),0.40162531017617153,0.9637506896299869,0.5901803607214429,1.0,1.0,51/201,18.14%,KIF14;PMAIP1;SKP2;PSMB7;RCN3;PSMD11;PML;PRPF19;FBXW11;PSMF1;NR1D1;FAF1;FBXO44;PSMC1;FBXO45;BIRC2;SPSB3;UBE2K;UBE4B;NEDD4L;TNFAIP1;CUL3;PSMC3;PCBP2;RAD23A;PSMA4;SPSB4;TRIM3;ARRB2;PSMC4;PCNP;NFE2L2;PSMD13;SPOP;PSME1;DDIT3;DCAF11;ZFAND2B;PSMB1;RBCK1;ARMC8;PSMD8;PSME4;KLHL22;PSMD4;SIRT1;UBXN1;RNF4;SYVN1;FEM1C;UBE2G1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4763753044682625,0.9630195442621723,0.525,1.0,1.0,3/15,16.23%,BRCA1;FGFR1;TGFB2
prerank,epidermis development (GO:0008544),0.4173074888390584,0.9630181746586426,0.556975505857295,1.0,1.0,4/56,12.95%,NTF4;PTHLH;LAMB3;EMP1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4002535463918956,0.9629433405801682,0.6026026026026026,1.0,1.0,50/199,22.40%,FOXA2;HEY2;BRCA2;RB1;NRDC;LRP4;VASN;MAP2K6;PPP1R11;CRHBP;RPS6KA5;STK11;RPS19;ARHGDIB;ACOT11;NR1D1;PAEP;NOTCH1;LAMA4;SFMBT1;NOVA2;ACOT13;EGFR;ASB1;ADIPOR1;RPS6KA6;PTEN;TIFAB;SPRED2;ROCK2;DDIT3;GSK3B;F2R;SLAMF8;LGR4;CHSY1;ADAMTS5;FCGR2B;TLE3;PTGER4;SOX9;PPP2CA;ACVR2B;RBPJ;PLCL1;ROCK1;NR1H3;ATP2B4;EFNA1;HDAC9
prerank,negative regulation of cyclase activity (GO:0031280),0.4758667663806774,0.9628024203814632,0.5262430939226519,1.0,1.0,4/14,19.26%,PALM;CCR2;ADGRV1;GRM3
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.29170880107836206,-0.9626197977143811,0.49056603773584906,0.8018518336051603,1.0,9/24,16.85%,APOE;PSMD14;CTSC;UBE3A;NUB1;PKD1;PINK1;EPHA4;GPX1
prerank,regulation of viral transcription (GO:0046782),0.42797854725582607,0.9624284555139604,0.5232300884955752,1.0,1.0,13/39,17.80%,RSF1;POLR2I;POLR2A;TRIM11;NELFA;DHX9;CCNT1;IFITM3;NELFB;TARBP2;POLR2K;POLR2J;HEXIM1
prerank,cellular protein modification process (GO:0006464),0.3960247657087768,0.9621488968051483,0.697,1.0,1.0,232/982,18.39%,CCNF;CDK1;BIRC5;AURKB;EPB42;NEK2;F5;PLK1;MEN1;CCNE1;STK26;FBXL15;CHEK2;MAPK1;FN3KRP;CDKL1;SKP2;AURKA;ART3;OXSR1;DTL;DAPK2;CEL;FYN;PSMB7;PIGH;PPM1D;PTPRA;PPP3CA;CCN1;PRKCE;PSMD11;HASPIN;FBXW11;RSKR;PTPN22;ERG;UBE2I;JMJD4;RPS6KA5;MAP4K1;PSMF1;LRRC41;PPP2R5E;STK11;CHEK1;CDK6;GRK6;TLK1;GMFG;PPP1CB;TAF1;SIK2;PPP2R5A;MSRA;RAB1B;ATM;LCMT1;FBXO44;ARF4;RUNX3;CSNK1A1;PSMC1;MPI;STK38L;STT3A;ASB7;NUS1;MAP3K5;CDC25B;UBL5;MTMR2;PIM2;METAP2;PKN2;ST3GAL1;SPSB3;CDK17;AKT3;BIRC6;CSNK1G2;PIM3;MAP3K1;MAP4K2;TAB1;RAB8A;PRKCA;PRKACA;ST3GAL2;SLC35A1;HCST;FBXO17;ZBTB16;STK38;LAMC1;LAMB2;MARK2;PICK1;JAK2;ST8SIA4;LMTK3;KLHL9;MAST2;ENGASE;STK24;SEPHS1;ASB1;CUL3;PIM1;PARP14;PPP2CB;B3GNT2;PDPK1;MAP4K5;ATG4B;CDK19;HIPK2;PSMC3;MAP3K11;TESK2;SOCS2;DCAF17;ABCA7;PIGT;MELK;DYRK1A;PARK7;BTK;VRK1;PSMA4;PTPN7;PTPN14;PPP1CC;SPSB4;DCAF7;PRKCB;MTMR6;CCNT1;PTEN;FBXL4;PHKA2;PSMC4;BAP1;BMPR1A;RAB11B;LMTK2;FBXO11;CUL9;SIRT7;ROCK2;GRK2;PSMD13;SUMF1;CHRM3;PRKDC;PSME1;PRKAG2;LATS1;CDK16;STK39;PGAP1;RAB2A;NRBP1;FAM20A;DCAF11;PIGU;PPP3CC;PSMB1;SGK3;RBBP5;PPP1R12A;GSK3B;PRKCSH;CHML;STK4;MAP3K20;PRSS23;PTPN5;NTAQ1;BCR;MTM1;PPP6C;ST3GAL5;PTPRU;PSMD8;PAK5;MAP2K1;WDTC1;PMM2;PPP2R5D;DCAF8;MARK4;TRIOBP;FGFR1;PAK2;LIMK2;ASB8;TGFB2;CDK8;PSME4;RAB5A;DCAF5;JAK3;VHL;KLHL22;USP25;DUSP12;SRPK1;SCG3;PSMD4;SIRT1;ADPRH;DCAF4;FN1;HSP90B1;UBA52;F13A1;UBE2M;DDB2;PTPN13;SDC2;LRRK2;PPP1CA;FEM1C;FAM20B;TAOK1;MORC3;STK17B;ILKAP;SUMF2;ADAM10;CREB1
prerank,blood vessel morphogenesis (GO:0048514),0.4131382420927393,0.9621312063209808,0.5494155154091392,1.0,1.0,13/54,21.91%,CYP1B1;HEY2;GLMN;CAV1;CCM2;AGGF1;NRP1;CCBE1;COL4A1;PROX1;RBPJ;SYK;EGFL7
prerank,COPII-coated vesicle budding (GO:0090114),0.4096958299000609,0.96212911706455,0.5538140020898642,1.0,1.0,26/68,21.68%,F5;SEC23B;RAB1B;STX5;PEF1;ANKRD28;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;VAPA;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3;SCAP;TMED10;TRAPPC10
prerank,response to estrogen (GO:0043627),0.4313310560451453,0.9617479523689646,0.5234192037470726,1.0,1.0,6/31,16.41%,BRCA1;CRHBP;CAV1;PELP1;RBBP5;CD24
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4323998635534453,0.9616776030280757,0.5337278106508876,1.0,1.0,10/27,19.45%,MAP3K1;TAB1;TAB3;BTK;MYD88;TLR5;TLR6;UBA52;MAP3K7;TRAF6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.3873108057749661,-0.9616661686242757,0.47104247104247104,0.8013759287011224,1.0,4/10,20.10%,NSMAF;SIRT3;PLA2G6;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.3873108057749661,-0.9616661686242757,0.47104247104247104,0.8013759287011224,1.0,4/10,20.10%,NSMAF;SIRT3;PLA2G6;SPHK2
prerank,negative regulation of neuron death (GO:1901215),0.4066027246180396,0.9611780811630163,0.572736520854527,1.0,1.0,6/93,6.27%,KIF14;NTF4;ERBB3;LIG4;IKBKG;INPP5A
prerank,mitochondrion localization (GO:0051646),0.4576676170926883,0.9611702210411835,0.525609756097561,1.0,1.0,8/19,22.55%,BRAT1;MARK2;HAP1;MTM1;LRRK2;TRAK2;MARK1;ATCAY
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.40740455944967524,0.961162734790327,0.5376344086021505,1.0,1.0,6/57,13.81%,IL12A;TNFRSF18;JAK2;PARP14;FLT3;PIBF1
prerank,establishment of protein localization to organelle (GO:0072594),0.4041315227221901,0.9607370936519278,0.5570539419087137,1.0,1.0,28/72,23.75%,NEURL1B;POM121;NUP107;TNPO1;IPO13;NUP50;NUP214;SEC13;IPO7;NUP188;RANBP6;IL10RA;RPAIN;E2F3;APPL1;IPO5;KPNB1;EIF4ENIF1;NUP85;MMP12;TPR;TNPO2;TNPO3;SYK;NUP93;PHB2;LRSAM1;IPO8
prerank,cartilage development (GO:0051216),0.41662568654767107,0.960245117737343,0.5439914163090128,1.0,1.0,7/49,10.54%,SOX6;CD44;SULF2;RUNX3;DDRGK1;ZBTB16;ATP7A
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4123735310890289,0.9601497750510468,0.5187224669603524,1.0,1.0,10/45,15.41%,PML;CD44;SP100;IRF9;GBP2;JAK2;B2M;TRIM68;TRIM5;IRF8
prerank,metal ion homeostasis (GO:0055065),0.42275731200867855,0.959931431551054,0.5394006659267481,1.0,1.0,8/40,14.00%,SLC12A3;CAV1;SLC12A7;SLC12A1;KCNA1;TMTC2;SLC12A6;FAM20A
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.2995572720080876,-0.9596241525586973,0.4838709677419355,0.8051042161848883,1.0,7/25,10.52%,FBXL17;NGLY1;CLPP;RNF185;AUP1;ZER1;BAG6
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4186405816677828,0.9593072327577642,0.5474919957310566,1.0,1.0,16/50,21.48%,AQP1;CD44;DPEP1;BCL2L12;ARL6IP1;CDKN2D;PARK7;XIAP;CAAP1;PAK2;SH3RF1;YWHAE;SNCA;PAX2;USP47;RPS6KA3
prerank,regulation of endopeptidase activity (GO:0052548),-0.24828862697829845,-0.9585283128674716,0.625,0.8062577520981092,1.0,10/59,15.51%,SPOCK1;SERPINE2;TIMP2;VSIR;SPOCK2;TIMP3;SERPINI1;SERPINE1;PSMB8;APH1A
prerank,embryonic organ morphogenesis (GO:0048562),-0.26534611519925605,-0.9583943559118369,0.5542168674698795,0.8052148727570463,1.0,17/42,29.93%,ACVR1;DSCAML1;RYR2;FBN1;DYNC2I1;ID2;EFEMP1;SOX11;HOXC4;HOXD4;HOXA3;RBP4;HOXD3;HOXC9;HOXA9;HOXB9;PDGFRA
prerank,negative regulation of protein modification process (GO:0031400),0.4103287716206916,0.958239858137892,0.5709876543209876,1.0,1.0,28/79,22.84%,MEN1;XRCC1;PTPA;CRTAP;PPP1R8;CRKL;NIBAN1;CIB1;IBTK;PPP1R15A;PARK7;PTEN;CDK5RAP3;PRKDC;PPIA;GSK3B;FKBP8;SIRT1;PTPN13;LRRK2;PRR5L;MAPT;CADM4;PPP1R15B;ATP2B4;PPP1R16B;NTRK3;TARDBP
prerank,regulation of protein import into nucleus (GO:0042306),0.4260085092834488,0.9582037681747865,0.5389830508474577,1.0,1.0,10/36,20.29%,ECT2;FLNA;EFCAB7;BAG3;PSEN1;IPO5;TRIM28;HCLS1;SUFU;TPR
prerank,positive regulation of inflammatory response (GO:0050729),0.4002316162086698,0.9577799250221393,0.5736354273944387,1.0,1.0,13/86,11.50%,CD47;IL16;CCN4;S100A9;RPS19;GPRC5B;CCR2;S100A8;TRADD;PDE2A;IL17RA;NAPEPLD;DHX9
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.435477745800346,0.9577303744167682,0.5244922341696535,1.0,1.0,10/26,21.89%,CDK5RAP2;CLASP1;SLAIN2;NUMA1;RAC1;DRG1;RPS3;MET;MAPT;DCTN1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.43411621813178897,0.9573510773331009,0.565068493150685,1.0,1.0,4/32,7.79%,CARD10;NOTCH1;AKT3;CIB1
prerank,import into cell (GO:0098657),0.4249067165284959,0.9573000500923692,0.5619469026548672,1.0,1.0,8/41,13.99%,NEURL1B;SLC7A1;SLC12A7;LRRC8C;SLC19A1;IL10RA;SLC12A6;SLC29A1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.457178278959187,0.9570297895279339,0.550125313283208,1.0,1.0,5/20,18.66%,TSPO;CYP46A1;STARD3NL;TSPOAP1;FDXR
prerank,protein-containing complex disassembly (GO:0032984),0.41270528034675114,0.9569178392136187,0.5524920466595971,1.0,1.0,18/54,21.16%,STX17;AXIN1;CAV1;CSNK1A1;LIX1;UBQLN1;VPS16;MYC;VPS33B;RUBCNL;GSK3B;PYM1;CHMP3;EPG5;PPP1CA;CLN3;RPL23;VPS4A
prerank,regulation of lipid storage (GO:0010883),-0.3126316991659496,-0.956710621318292,0.5080213903743316,0.8080748325410362,1.0,6/22,9.87%,PTPN2;LPL;ZC3H12A;IKBKE;VSTM2A;ITGB3
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.2690523115782579,-0.9562710795597499,0.5,0.8076850380625542,1.0,13/40,16.85%,BCL2L1;GHITM;HGF;PYCARD;PLAUR;FAM162A;IGF1;DNM1L;MLLT11;PRKN;PINK1;MFF;GPX1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4041840410316468,0.956259365934882,0.575,1.0,1.0,19/73,22.37%,NTF4;CD44;AXIN1;TFRC;CAV1;HDAC6;EGFR;TXN;PARK7;LATS1;STK4;PDCD10;HCLS1;SNCA;PRKD2;ARAF;CAPRIN2;ATP2B4;NTRK3
prerank,sphingolipid catabolic process (GO:0030149),-0.33989364870295175,-0.955606184014051,0.5112781954887218,0.8078682558795075,1.0,7/15,30.82%,ENPP2;PPT1;SMPDL3A;GLA;ACER2;SMPD2;SGPL1
prerank,glucose import (GO:0046323),0.4858144378107213,0.9555671898217506,0.5247933884297521,1.0,1.0,4/13,18.63%,SLC2A4;ZDHHC7;SLC2A3;SLC2A1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4358015226537733,0.955341434079282,0.5324675324675324,1.0,1.0,5/25,10.19%,PML;PSMF1;RPS7;TAF1;HIPK2
prerank,response to chemokine (GO:1990868),0.48096695291342384,0.9548700914314886,0.5455746367239102,1.0,1.0,2/13,4.12%,OXSR1;RIPOR2
prerank,endoplasmic reticulum organization (GO:0007029),-0.2229269505153854,-0.954461739531787,0.6590909090909091,0.8092616285875527,1.0,18/72,14.25%,RTN4;APP;GAK;SEC16A;REEP3;TOR1B;DNM1L;REEP5;SGTA;MIA3;VAMP2;SEC61G;SEC61A1;HMOX1;STX1A;TRAM1;SERP1;PRNP
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.40040341208527036,0.954442457536146,0.5645491803278688,1.0,1.0,17/76,17.67%,GFI1;CYP1B1;DAP;CDKN2A;FAF1;TRAF3;LRRC14;CDK5RAP3;ARRB2;DDIT3;RBCK1;NLRC3;COMMD6;NLRP2B;SIRT1;TRIM37;USP7
prerank,response to interleukin-1 (GO:0070555),0.3926180433935972,0.9544313908239979,0.5557872784150156,1.0,1.0,17/73,19.46%,ADAMTS7;CD47;TANK;NR1D1;GBP2;PRKCA;IL1R1;MYD88;RC3H1;TNFRSF11A;TAF9;CCL25;SNCA;HDAC4;LGALS9;TRAF6;SOX9
prerank,ATP transport (GO:0015867),0.4997048364896081,0.954407009134108,0.5460893854748603,1.0,1.0,1/10,2.56%,CD47
prerank,iron ion transmembrane transport (GO:0034755),-0.3951583821158443,-0.954108460036393,0.49324324324324326,0.8087024311899568,1.0,4/10,16.67%,ABCC5;SLC11A2;SLC39A14;SLC39A8
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5014764074441173,0.9539956505197199,0.5429799426934098,1.0,1.0,4/10,21.65%,PPP3CA;PPP3CC;NFATC3;ADGRB2
prerank,calcineurin-mediated signaling (GO:0097720),0.5014764074441173,0.9539956505197199,0.5429799426934098,1.0,1.0,4/10,21.65%,PPP3CA;PPP3CC;NFATC3;ADGRB2
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.35012249440894677,-0.9539922738475866,0.49537037037037035,0.8075610438409152,1.0,3/15,9.53%,HDAC2;EDA;ROGDI
prerank,regulation of gene expression (GO:0010468),0.3931486529928527,0.9532457054104942,0.724,1.0,1.0,163/903,15.76%,MBNL3;TCF19;TRIM58;TMPRSS4;MYB;EZH2;ERMAP;MYBL1;BRCA1;SPIN4;AFF3;HMGA1;SOX6;CHEK2;MEFV;HEY2;BRCA2;MAPK1;LEF1;E2F1;NSD2;RB1;AURKA;GLMN;AFF1;EZR;TWIST1;CD74;PML;NUP107;POLR2A;CCN4;PTPN22;HDAC10;RPS6KA5;CTCF;RBL1;ACTR5;TFRC;ZC3H7A;FOXP1;CDK6;RPS7;NKAP;CRKL;EDF1;TAF1;PTHLH;NFXL1;HNRNPL;LIN54;GSN;ATF7;ATM;TERF2;MYOM1;TCF7L1;TCF3;ZFP36L1;RUNX3;HDAC6;EPHX2;PDE2A;TRAF3;LRP3;TNRC6C;TNRC6B;PUM2;PHF19;ZUP1;NOTCH1;PIN1;DDRGK1;MLF2;AHR;ZNF326;PSPC1;DMTF1;PHF1;NOVA2;UBE2V1;MAPK14;TRIM11;ERC1;PLCG2;METTL4;SART3;PLAG1;CLK4;ABCC2;NONO;ZNF148;MECP2;PARP14;SRRT;BTN3A3;EGR1;PFDN5;SPTY2D1;NR2C2;DNMT1;PCBP2;RBM38;MSN;TRIM44;NFYC;PRDM10;PARK7;ZNF462;PUM1;ATXN7L3B;UBAP2;CCAR2;FGF9;ATF5;RDX;IGF2BP3;NSD3;MYD88;NPAT;TRIM68;PRDM6;HCFC1;SETDB2;BMPR1A;METTL16;F3;NELL1;SP3;NFE2L2;ROCK2;RACK1;ZBTB7B;ING2;REXO4;DDIT3;BCL6;CREBBP;MYC;NFX1;GABPA;PSEN1;HNRNPAB;TLR6;RNF20;DTNBP1;TRIM5;PCBP3;TYROBP;GSK3B;LIMS1;TADA3;TP53;PDCD10;RUNX1;RC3H1;GON4L;LIMD1;EGF;HGS;SRSF10;AHNAK;MAP2K1
prerank,cation transport (GO:0006812),0.39438565416741117,0.9531766091827351,0.6166166166166166,1.0,1.0,13/167,9.21%,RHAG;SLC38A5;SLC12A3;SLC5A5;AQP1;SLC7A1;ANO10;KCNN4;TAF7;TRPM7;NEDD4L;KCNA1;KCNJ3
prerank,positive regulation of cellular component movement (GO:0051272),0.44062943643783464,0.9529611522840503,0.5362853628536285,1.0,1.0,4/24,4.80%,NTN1;TWIST1;STK11;RPS19
prerank,protein maturation (GO:0051604),0.3965259399916016,0.9525098723817528,0.6004036326942482,1.0,1.0,22/95,19.95%,TMPRSS4;KEL;NAA40;CIAO2A;CPM;CASP2;DNAJB11;METAP2;TSPAN33;PITRM1;NAA16;F3;PSEN1;PCSK1;NDUFAB1;CPD;TSPAN5;ADAM10;GCSH;CLN3;PCSK7;MME
prerank,protein homooligomerization (GO:0051260),0.3961008453768021,0.9522812195146191,0.5774647887323944,1.0,1.0,14/114,11.18%,ECT2;POLQ;TK1;BLM;SLC1A5;ATL2;CBR4;ACOT13;MPP2;TIFA;CARD9;SIGMAR1;KCNC2;B2M
prerank,MAPK cascade (GO:0000165),0.39514135203500117,0.9517988636348745,0.63,1.0,1.0,72/295,19.46%,CDK1;SPTA1;MEN1;MAPK1;IL2RG;IL2RA;ERBB3;FYN;PSMB7;ABHD17A;PTPRA;PSMD11;FBXW11;PSMF1;RASGRP1;GFRA2;PPP1CB;IKBKG;SETX;CCM2;ZFP36L1;PSMC1;TGFA;MAP3K5;GRB2;JAK2;SOS1;ITGAV;LYPLA1;EGFR;CUL3;PDE6D;ACTN2;PSMC3;RIT2;ABHD17B;PSMA4;PTPN7;PPP1CC;FGF9;FLT3;PSMC4;FGF13;PSMD13;PSME1;MYC;GFRA1;IRS1;PSMB1;LAMTOR3;MAP3K20;SPTAN1;EGF;PSMD8;MAP2K1;ZFP36L2;FGFR1;PSME4;JAK3;PIK3CA;PSMD4;YWHAE;KITLG;UBA52;MAP3K7;LRRK2;TAOK1;PTGER4;ICMT;KSR1;LGALS9;SOX9
prerank,P-body assembly (GO:0033962),0.4826105856370101,0.9514002895467755,0.5062586926286509,1.0,1.0,6/12,18.62%,DYNC1H1;EDC3;LSM14A;RC3H1;LIMD1;EIF4ENIF1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.46605478181904764,0.9511998257691002,0.5403645833333334,1.0,1.0,6/16,16.99%,FTO;PIM1;NAPEPLD;ZBTB7B;HNRNPU;SIRT1
prerank,cytoplasmic translational initiation (GO:0002183),-0.3287378990759682,-0.9511499466624028,0.55,0.8129988521651879,1.0,5/17,9.53%,EIF4A2;EIF2B3;MCTS1;EIF3M;RBM4
prerank,ribosome biogenesis (GO:0042254),0.39517284799209085,0.9508291667575179,0.612,1.0,1.0,61/187,23.38%,MRPL36;XPO1;RPL7;RPL18A;EIF2A;UTP3;RPL36;RPL14;RPS19;DDX49;RPS7;HELQ;EXOSC8;RPL23A;MRPL22;RPL28;EXOSC10;URB2;RPL41;RPS14;NOL11;RPLP2;EMG1;RPS27;UTP6;RPLP0;FBL;PELP1;RPL27A;DHX29;WDR74;RPS9;NOL8;RPL12;NOP58;POP4;RPL3;RPL18;UBA52;DKC1;PES1;RIOK1;MPHOSPH6;RPS17;RPS6;RPL5;DDX54;RPL21;EIF6;RPL23;RPL17;RPL8;RPL24;RPL27;RPL13A;DIS3;RPL15;RPL10;RPF1;NOP14;ABCE1
prerank,development of primary male sexual characteristics (GO:0046546),0.4221675209133618,0.9508118987161464,0.5482796892341842,1.0,1.0,6/34,19.46%,SRD5A2;CSDE1;FGF9;TGFB2;KITLG;SOX9
prerank,regulation of proteolysis (GO:0030162),0.4145111861370993,0.9503647082767316,0.5601300108342362,1.0,1.0,7/48,6.75%,PLK1;AURKAIP1;FBXW11;CYFIP2;CAV1;HDAC6;TRAF3
prerank,regulation of cellular component biogenesis (GO:0044087),0.42175189576619865,0.9501182601247774,0.564927857935627,1.0,1.0,9/39,13.62%,HJURP;EZR;NOTCH1;SPTY2D1;MSN;RDX;HCFC1;ROCK2;LATS1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.43361752143114835,0.9497199000719247,0.5473684210526316,1.0,1.0,9/30,18.50%,POLR1B;POLR1A;ERCC3;POLR1F;POLR1C;POLR2K;TAF1C;TAF1D;POLR1G
prerank,snRNA processing (GO:0016180),0.4809513959811953,0.9494794335950099,0.547144754316069,1.0,1.0,7/16,22.93%,INTS4;INTS9;INTS1;INTS14;TUT1;INTS12;INTS11
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.28042346332814505,-0.9490193856328327,0.5028571428571429,0.8167662324402261,1.0,7/27,18.03%,PTPN2;PTPRE;PIP4K2B;GSK3A;GRB10;TSC2;SLC27A4
prerank,regulation of protein transport (GO:0051223),-0.29328849186359707,-0.948684786560129,0.5695364238410596,0.8161776707440607,1.0,14/27,32.89%,NDFIP1;STXBP5L;NDFIP2;PPM1F;STXBP5;DNAJC1;LLGL1;CHP1;RHBDF2;GAPVD1;LLGL2;P3H1;RHBDF1;PTPN1
prerank,regulation of cholesterol transport (GO:0032374),0.4574143207650743,0.9482424338213784,0.5503778337531486,1.0,1.0,4/20,9.30%,ABCA13;NUS1;TSPO;ABCA2
prerank,cellular response to interleukin-1 (GO:0071347),0.3889416051824738,0.9471159130635272,0.6138415245737212,1.0,1.0,32/143,17.74%,ADAMTS7;CD47;PSMB7;PSMD11;FBXW11;TANK;RPS6KA5;PSMF1;NR1D1;IKBKG;PSMC1;GBP2;TAB1;UBE2V1;TAB3;EGR1;PSMC3;IL1R1;PSMA4;PLCB1;MYD88;PSMC4;PSMD13;PSME1;PSMB1;RC3H1;PSMD8;PSME4;CCL25;PSMD4;UBA52;MAP3K7
prerank,regulation of cellular protein catabolic process (GO:1903362),0.45384360410219443,0.9470557596297837,0.5463917525773195,1.0,1.0,6/18,12.88%,EZR;FAF1;MSN;RDX;CDK5RAP3;NELL1
prerank,eye development (GO:0001654),0.4093240603911765,0.9469271811282252,0.5741728922091782,1.0,1.0,11/54,16.23%,PBX4;PBX3;SHROOM2;SALL2;HIPK2;ATF6;SMG9;NIPBL;SKI;PBX2;TGFB2
prerank,positive regulation of behavior (GO:0048520),0.5019998496840192,0.946889848737036,0.5383522727272727,1.0,1.0,1/10,3.13%,AGRP
prerank,embryonic heart tube morphogenesis (GO:0003143),0.41917739425134126,0.9466647181078951,0.5626373626373626,1.0,1.0,1/43,0.26%,STIL
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.481412762906335,0.9466164144519876,0.5291723202170964,1.0,1.0,3/13,13.24%,TPST1;BPNT2;SULT6B1
prerank,intermediate filament organization (GO:0045109),0.4600448756500582,0.9464329793570683,0.5513307984790875,1.0,1.0,3/17,16.48%,DES;MTM1;VIM
prerank,carboxylic acid transmembrane transport (GO:1905039),0.4135381468946724,0.9463159925080206,0.545755237045204,1.0,1.0,4/40,11.20%,SLC38A5;SLC25A21;SLC16A1;SLC19A1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.39541942982111633,0.9457111701264042,0.6050251256281407,1.0,1.0,45/132,21.52%,EIF4B;GEMIN8;PRPF19;SCAF11;RPS19;SNRPF;SNRPC;SETX;CRNKL1;RPL23A;SNRNP200;TXNL4A;RPS14;SART3;NCBP1;RPS27;MRPS7;RPS5;RPLP0;DHX9;DHX29;PRKDC;CLNS1A;LUC7L2;SART1;SRSF10;GEMIN7;TARBP2;SRPK1;DDX39B;RPL3;SNRPG;GCFC2;CLP1;EIF2D;RPL5;SF3A2;EIF6;CPSF7;SNRPB;PRMT7;RSL24D1;RPL24;KHDC4;CELF1
prerank,regulation of feeding behavior (GO:0060259),0.49630789789069796,0.9456896676404152,0.5435393258426966,1.0,1.0,1/11,3.13%,AGRP
prerank,Ras protein signal transduction (GO:0007265),0.3934390699234871,0.9455769524253801,0.6060301507537689,1.0,1.0,41/137,19.82%,CCNA2;GPSM2;PHACTR4;RB1;GRAP2;TIAM1;NTN1;ARHGDIB;RASGRP1;CDKN2A;CRKL;ARHGEF3;COL1A2;MAPK14;DBNL;GRB2;SOS1;DNMT1;RIT2;PARK7;JUN;CDC42EP3;ROCK2;RAC2;BRK1;RIPOR1;PLD1;TP53;USP50;TRIM28;ARHGDIA;KPNB1;RAC1;RASSF1;SETDB1;CDC42EP1;CDKN1A;KSR1;ARHGAP1;SGSM3;G3BP1
prerank,calcium ion import (GO:0070509),0.43043755862594196,0.9455038383948092,0.5516840882694541,1.0,1.0,5/28,14.08%,MS4A1;CACNA1I;MICU3;MICU1;MCU
prerank,secondary alcohol biosynthetic process (GO:1902653),0.42893500678144963,0.9452437136856674,0.5565714285714286,1.0,1.0,6/30,15.86%,LBR;LSS;IDI1;NSDHL;FDPS;DHCR7
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.46945423132791675,0.9448363433814303,0.5341365461847389,1.0,1.0,6/15,16.77%,MEFV;MYD88;TLR6;USP50;NLRC3;NLRP2B
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.4781150208114233,0.944766042385647,0.5432098765432098,1.0,1.0,4/13,14.50%,SNX33;GPD1L;ABCA7;TYROBP
prerank,autophagosome assembly (GO:0000045),0.40757488528554864,0.9444402432877944,0.5735930735930735,1.0,1.0,12/52,16.97%,EMC6;ATG13;STX17;RAB1B;UBQLN1;TMEM41B;BECN1;AMBRA1;RAB43;TP53INP2;ATG101;ATG2B
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.38316087691051526,-0.9444284775059776,0.5331010452961672,0.8249113816257735,1.0,3/11,12.36%,RC3H2;ZC3H12A;SMAD7
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.41544870040093523,0.9444275019213871,0.549889135254989,1.0,1.0,12/38,19.82%,ATG13;SAE1;UBL5;ABLIM3;RHOU;BAP1;RAC2;ARIH2;LMAN1;LRRK2;SREBF2;HPS4
prerank,regulation of phosphatase activity (GO:0010921),0.4394061098745646,0.9443748105022115,0.5574783683559951,1.0,1.0,6/24,17.49%,PTPA;PPP1R35;CDK5RAP3;PPP6R3;PPP1R2;HSP90B1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.39919592125269954,0.9443207379171094,0.5956112852664577,1.0,1.0,16/75,17.80%,PLK1;MEN1;RB1;CDKN2A;STK38;PKIG;HEG1;IPO7;NR2F2;PTEN;CDK5RAP3;LATS1;IPO5;TFAP4;SIRT1;HEXIM1
prerank,cellular protein catabolic process (GO:0044257),0.40502197014531244,0.9440467054595065,0.571127502634352,1.0,1.0,16/59,21.14%,ADAMTS7;PISD;CHEK2;FAP;CLTC;LONP1;AP2B1;CTSO;CTSK;MYLIP;UBE2G1;MALT1;CASP8;BNIP3;RIPK1;MDM2
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2380776202531391,-0.9438227652340212,0.5571428571428572,0.8249739600743659,1.0,20/52,19.82%,SRPRA;ERN1;WIPI1;ZBTB17;ADD1;HDGF;GSK3A;HYOU1;GOSR2;TATDN2;EXTL3;TSPYL2;SRPRB;PARP16;SERP1;EXTL2;LMNA;HSPA5;WFS1;PDIA5
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.4764932955519566,0.9435956752392138,0.5388888888888889,1.0,1.0,7/13,26.67%,JAK2;CANX;IL27;TYK2;IL6ST;JAK1;OAS2
prerank,visual system development (GO:0150063),0.42056428264763807,0.9432882976021885,0.5728699551569507,1.0,1.0,8/37,16.23%,PBX4;PBX3;SALL2;HIPK2;ATF6;SMG9;PBX2;TGFB2
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.4372338747612462,0.9431535788876174,0.5504926108374384,1.0,1.0,5/23,11.30%,CCDC88A;TUBA1C;CCDC88C;TUBA1B;TUBB
prerank,erythrocyte differentiation (GO:0030218),0.40845169273871956,0.9429469910100342,0.5551982851018221,1.0,1.0,12/44,18.12%,ALAS2;ZFPM1;RPS19;ABCB10;RPS14;JAK2;HIPK2;CDK5RAP3;CEBPG;JAK3;HCLS1;MED1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.39014744111768596,0.9429409690173928,0.662,1.0,1.0,60/327,16.28%,MYB;EZH2;MYBL1;SPIN4;HMGA1;SOX6;CHEK2;BRCA2;E2F1;NSD2;RB1;NIF3L1;PML;NUP107;POLR2A;HDAC10;RPS6KA5;ACTR5;EDF1;NFXL1;LIN54;ATF7;TCF7L1;TCF3;RUNX3;PHF19;NOTCH1;MLF2;AHR;PSPC1;DMTF1;PHF1;UBE2V1;ERC1;PLAG1;RALY;NONO;SRRT;PFDN5;SPTY2D1;NR2C2;NFYC;CCAR2;ATF5;NSD3;HCFC1;SP3;ING2;ACTN4;REXO4;DDIT3;CREBBP;NFX1;RNF20;TP53;GON4L;LIMD1;SRSF10;ATRX;FOXK2
prerank,tRNA wobble base modification (GO:0002097),-0.33871563704633445,-0.9427192383187217,0.5137254901960784,0.8262661948383796,1.0,10/14,39.27%,MTO1;ALKBH1;DPH3;GTPBP3;TRMT9B;CTU2;CTU1;MOCS3;ADAT2;KTI12
prerank,regulation of calcium ion transport (GO:0051924),-0.24931103128157614,-0.9426148290042569,0.5660377358490566,0.8250807610137422,1.0,16/54,20.00%,CD84;CACNB2;CTNNB1;ANK2;PLPP4;SRI;SLC8B1;CAMK2G;CCL4;CAMK2B;SARAF;WFS1;CCL3;ORAI1;STIM1;P2RX4
prerank,muscle organ development (GO:0007517),-0.2394936951327794,-0.9423896777268299,0.5892857142857143,0.8242329282805138,1.0,11/54,9.84%,SGCD;CAPN3;SGCE;SPEG;IGF1;LARGE1;FKTN;SRI;VAMP5;DMD;FHL1
prerank,regulation of cellular component movement (GO:0051270),0.4051285969021608,0.9420526516557602,0.554140127388535,1.0,1.0,20/49,24.01%,ERBB3;RPS19;CDK6;SP100;HDAC6;PKN2;ZSWIM4;EGFR;ROCK2;ACTN4;DIAPH1;EGF;MEMO1;INPP5F;ROCK1;CADM4;ARHGAP18;ACTN1;ADAM17;DAPK3
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.30676988177080666,-0.9418205712071639,0.5251396648044693,0.824197832400584,1.0,5/23,6.25%,NLRP3;IGF1;TNFAIP3;ZC3H12A;CX3CR1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.47824131777591766,0.9416780251526511,0.5415472779369628,1.0,1.0,1/11,1.29%,CD177
prerank,heterochromatin organization (GO:0070828),0.46667513685259515,0.941380569465749,0.5317139001349528,1.0,1.0,6/14,23.97%,SMCHD1;SETDB2;SIRT1;SETDB1;SETD7;HMGA2
prerank,cellular response to cytokine stimulus (GO:0071345),0.3858507877712612,0.9409208310192859,0.688,1.0,1.0,81/416,17.77%,BIRC5;PRTN3;IL12A;ADAMTS7;BRCA1;IL2RG;LEF1;CD47;GBP4;IL2RA;GRAP2;OXSR1;FYN;BATF;TWIST1;CRHBP;IL16;RIPOR2;TANK;CCR2;NR1D1;CRKL;LAMA5;FOXO1;TRADD;COL1A2;PDE12;ZFP36L1;PDE2A;GBP2;UBE2K;CIB1;PRKACA;GRB2;JAK2;IL20RA;SOS1;PIM1;EGR1;ZEB1;SOCS2;IL22;RHOU;IL1R1;PTPN7;PTPN14;DHX9;IL10RA;FLT3;CRK;F3;STAT5B;NFE2L2;HNRNPU;STK39;BCL6;MYC;GSK3B;TP53;JUNB;PTPN5;RC3H1;IRF8;POU2F1;ZFP36L2;VIM;CCL25;JAK3;MAOA;PIK3CA;SIRT1;XBP1;LDLRAP1;FN1;HSP90B1;HCLS1;UBA52;F13A1;CXCR4;EPRS1;PTPN13
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.48228868885182824,0.9404321010408114,0.5589403973509933,1.0,1.0,6/14,20.17%,CPSF2;NCBP1;TUT1;CPSF1;NCBP2;CPSF7
prerank,phospholipid dephosphorylation (GO:0046839),0.42244991844311974,0.9401741357081206,0.5647840531561462,1.0,1.0,9/37,15.26%,PLPPR3;MTMR12;EPHX2;MTMR2;PIP4P2;MTMR6;PTEN;PLPPR4;MTM1
prerank,muscle contraction (GO:0006936),0.3927766860989666,0.93985768136743,0.6195761856710393,1.0,1.0,17/126,17.45%,TMOD4;DES;ITGA1;SSPN;MYL1;MYOM1;SORBS1;SNTB1;MYBPC1;GNAO1;ACTN2;EMD;ROCK2;TPM4;VIM;CALD1;UTRN
prerank,cellular response to hormone stimulus (GO:0032870),0.39960931656833365,0.9397399572580408,0.5820433436532507,1.0,1.0,11/69,12.75%,SLC5A5;RAMP1;CRHBP;BRD8;CAV1;ZFP36L1;SOCS2;RDX;SLIT3;PELP1;STAT5B
prerank,positive regulation of hydrolase activity (GO:0051345),0.3891847712211222,0.9395996790853688,0.633901705115346,1.0,1.0,13/137,9.31%,ECT2;PRTN3;HMGB2;EZH2;ARHGAP11A;NET1;RCN3;RASGRP1;EVI5;PIN1;SNX9;LARS1;CAV2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4155718793104047,0.939477833222081,0.5618615209988649,1.0,1.0,14/37,20.10%,PML;RPS7;TAF1;DDRGK1;HIPK2;PARK7;CCAR2;UCHL5;TAF9;UBXN1;CAMLG;USP7;RPL5;RPL23
prerank,ERBB signaling pathway (GO:0038127),0.39568233772270933,0.9392244589778692,0.598343685300207,1.0,1.0,16/64,19.46%,MAPK1;ERBB3;RPS6KA5;TGFA;PRKCA;GRB2;SOS1;EGFR;PDPK1;DGKD;EGF;PLCG1;PIK3CA;IQGAP1;KIF16B;SOX9
prerank,apoptotic mitochondrial changes (GO:0008637),-0.26930742060095925,-0.9391547337534674,0.5391304347826087,0.8292683306521276,1.0,5/32,6.54%,HK2;ERBB4;BCL2L1;HSPD1;DNM1L
prerank,renal filtration (GO:0097205),0.4935135573401146,0.9385534081901271,0.5359116022099447,1.0,1.0,2/10,3.98%,TBC1D8B;SULF2
prerank,cellular response to unfolded protein (GO:0034620),-0.29075646023565327,-0.9384568664513542,0.5238095238095238,0.829574405643166,1.0,8/26,19.85%,HSPD1;OPTN;ERN1;TM7SF3;PRKN;HSPA5;DAB2IP;HSPA13
prerank,electron transport chain (GO:0022900),-0.3449681547129871,-0.9382701159168068,0.5319148936170213,0.8286092503756519,1.0,7/15,26.61%,POR;SDHB;UQCRFS1;SDHA;PDIA5;PPARGC1A;NDOR1
prerank,insulin secretion (GO:0030073),-0.32107879421096297,-0.9381647675653756,0.5097087378640777,0.8275370610227891,1.0,6/19,16.50%,RIMS2;SELENOT;CYB5R4;CAMK2G;PTPRN;RAB11FIP5
prerank,regulation of execution phase of apoptosis (GO:1900117),0.48542727145319,0.9372667780465388,0.5615050651230101,1.0,1.0,3/11,14.93%,FAP;BOK;TP53
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.49608909928223033,0.9371187803218763,0.5482093663911846,1.0,1.0,4/10,20.56%,PCGF5;MECP2;PCGF3;PRMT7
prerank,positive regulation of establishment of protein localization (GO:1904951),0.45551207730940574,0.9367201768895155,0.5630461922596754,1.0,1.0,8/18,19.50%,CEP295;CCT7;CCT2;TCP1;CCT5;DKC1;WRAP53;CCT6A
prerank,neuron projection development (GO:0031175),0.38958863217207024,0.9365550611043303,0.6389167502507522,1.0,1.0,25/168,14.82%,KIF20B;BLK;NTF4;STMN1;PPP1R9B;SAMD14;RB1;BLOC1S4;FRY;MAP4;HMGB1;DBNL;FRYL;MARK2;ATP7A;VASH2;TOR1A;PTEN;VAPA;RAB35;ADCYAP1;CDK16;DTNBP1;GSK3B;ADGRV1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.4680213496290226,0.9364942363410281,0.5529100529100529,1.0,1.0,3/14,16.74%,MEFV;PIBF1;JAK3
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.41799459971930747,0.9357468569282686,0.5671981776765376,1.0,1.0,12/36,22.17%,LEF1;PPP3CA;TNRC6C;TNRC6B;GNAO1;PLCB1;PLCB3;TCF7L2;MAP3K7;AGO2;GNB1;AGO1
prerank,positive regulation of bone resorption (GO:0045780),0.48704961975914673,0.9357310052724321,0.5712187958883994,1.0,1.0,5/11,21.42%,PRKCA;TNFRSF11A;ATP6AP1;PLEKHM1;SYK
prerank,neuronal action potential (GO:0019228),-0.3151332174392403,-0.9357248765398108,0.524390243902439,0.8322002814658641,1.0,6/22,11.03%,ANK3;SCN8A;SCN1A;SCN9A;SCN3A;KCNA2
prerank,protein localization to cell junction (GO:1902414),0.44378259210098625,0.9352038396168456,0.5721331689272503,1.0,1.0,6/22,16.06%,TJP3;ARHGEF18;BSN;HEG1;NECTIN1;PAK2
prerank,positive regulation of insulin secretion (GO:0032024),0.41368856560474476,0.9351782031101473,0.576837416481069,1.0,1.0,7/36,17.26%,BLK;BAIAP3;MCU;TCF7L2;CAPN10;TRPM4;ADCY8
prerank,positive regulation of vasculature development (GO:1904018),0.3905424528313733,0.9350494238182766,0.6030612244897959,1.0,1.0,19/94,17.11%,CYP1B1;BRCA1;AQP1;TWIST1;EMC10;PGF;PRKCA;SMOC2;PDPK1;HIPK2;VASH2;PRKCB;F3;AGGF1;MYDGF;RUNX1;PLCG1;SIRT1;XBP1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.22674980054298705,-0.9349374510941705,0.6176470588235294,0.832716718626475,1.0,29/79,23.51%,GCNT2;ST8SIA1;BMPR2;CHST8;COG7;ST3GAL6;IGF1;LARGE1;FUT10;B4GALT5;BMPR1B;ALG5;B3GALNT2;ST3GAL4;CHST11;MGAT1;GOLGA2;B4GALT7;SERP1;NPC1;ST8SIA5;TMEM106A;ALG1;ST8SIA3;DAD1;GAL3ST4;B3GALT5;DDOST;B3GALT2
prerank,COPII vesicle coating (GO:0048208),0.399954157872743,0.9346393695678135,0.5810526315789474,1.0,1.0,21/61,19.27%,F5;RAB1B;STX5;PEF1;ANKRD28;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3
prerank,vesicle coating (GO:0006901),0.399954157872743,0.9346393695678135,0.5810526315789474,1.0,1.0,21/61,19.27%,F5;RAB1B;STX5;PEF1;ANKRD28;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.399954157872743,0.9346393695678135,0.5810526315789474,1.0,1.0,21/61,19.27%,F5;RAB1B;STX5;PEF1;ANKRD28;TGFA;TRAPPC9;SEC24B;SEC24A;CUL3;SEC13;TRAPPC4;BET1;SEC31A;PPP6R3;PPP6C;CNIH1;LMAN1;GORASP1;SAR1B;TRAPPC3
prerank,response to iron ion (GO:0010039),0.47028903652745035,0.934638838443516,0.5405777166437414,1.0,1.0,3/12,17.96%,TFR2;B2M;SNCA
prerank,membrane assembly (GO:0071709),-0.27295562960080616,-0.9343419030766401,0.6020408163265306,0.8329247279618137,1.0,8/34,7.65%,ANK3;GAK;PTPRD;UBXN2A;STX4;SPAST;STX2;UBXN2B
prerank,regulation of interleukin-13 production (GO:0032656),0.46410899430090646,0.9332533206274977,0.5521390374331551,1.0,1.0,1/13,2.33%,LEF1
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.3516522915989748,-0.9331206311139112,0.5196850393700787,0.8343593186504354,1.0,8/13,25.98%,UBAC2;OS9;EDEM2;BCAP31;ERLEC1;UBE2G2;BRSK2;EDEM1
prerank,C4-dicarboxylate transport (GO:0015740),0.46585559087265216,0.9330551377340933,0.5598958333333334,1.0,1.0,3/14,14.54%,SLC25A12;SLC25A22;SLC25A13
prerank,positive regulation of filopodium assembly (GO:0051491),-0.28989132186146815,-0.9321824345962686,0.5575757575757576,0.8352473558148557,1.0,8/24,15.98%,TENM2;ARAP1;RALA;PIK3R1;WASL;TENM1;RHOQ;AGRN
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3879857546179337,0.9320852563419992,0.6442885771543087,1.0,1.0,43/161,19.87%,JADE1;PSMB7;LRP4;PSMD11;AXIN1;PSMF1;STK11;CAV1;CCDC88C;CSNK1A1;PSMC1;FUZ;TLE4;CUL3;PFDN5;PSMC3;AMFR;RUVBL2;EMD;PSMA4;PSMC4;TMEM131L;PSMD13;PSME1;DDIT3;LATS1;PSMB1;GSK3B;STK4;LIMD1;PTPRU;PSMD8;TCF7L2;PSME4;PSMD4;LMBR1L;TMEM170B;AMER2;TLE3;HDAC1;STK3;SOX9;NPHP4
prerank,transition metal ion transport (GO:0000041),0.427294320323248,0.9320631989096563,0.5863228699551569,1.0,1.0,4/35,5.06%,TFR2;CUTC;HEPH;TFRC
prerank,regulation of protein localization to cell surface (GO:2000008),0.4205545888275909,0.9320615580187165,0.5626423690205011,1.0,1.0,10/33,15.40%,SNX33;GPD1L;NEDD4L;ABCA2;ACTN2;ABCA7;TOR1A;RAB11B;TYROBP;EGF
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.31904056405063463,-0.9318994423746038,0.5252525252525253,0.834470082443786,1.0,8/19,17.85%,PTPRJ;TSC1;FERMT2;PPM1F;VEGFA;MAP4K4;COL16A1;THY1
prerank,positive regulation of protein deacetylation (GO:0090312),0.4742943837675532,0.9317997795008522,0.5708609271523178,1.0,1.0,4/14,13.56%,DYRK1A;ZBTB7B;ING2;NIPBL
prerank,inositol phosphate-mediated signaling (GO:0048016),0.44516201536288086,0.9315354949036332,0.5651644336175395,1.0,1.0,4/19,16.70%,PPP3CA;INPP5A;PPP3CC;NFATC3
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.466121602723757,0.9314658180466471,0.5646437994722955,1.0,1.0,3/15,11.62%,FAP;CLASP1;DPP4
prerank,neuron development (GO:0048666),0.3898761304730677,0.931361376467908,0.6287726358148893,1.0,1.0,30/141,17.20%,BLK;STMN1;PPP1R9B;SAMD14;RB1;PBX4;BLOC1S4;PBX3;FRY;MAP4;RUNX3;GBA2;HMGB1;TDP2;FRYL;ATP7A;TOR1A;VAPA;RAB35;ADCYAP1;CDK16;DTNBP1;PBX2;GSK3B;RUNX1;THOC2;LRP12;TGFB2;XBP1;LGI4
prerank,cellular response to drug (GO:0035690),0.43386378642311246,0.9312238081691248,0.5695600475624257,1.0,1.0,11/25,26.62%,CRHBP;TFRC;DPEP1;MYC;TP53;SLAMF8;AIM2;PPM1E;RBM22;PDE4B;GAS6
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.42041378842133814,0.9310171949623248,0.5810185185185185,1.0,1.0,7/30,16.84%,NET1;LPAR4;ARHGEF3;F2R;LPAR1;GPR35;RAC1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.4243686535931387,0.9303422333116677,0.5531674208144797,1.0,1.0,6/29,10.22%,KRI1;UTP3;RPS19;NOL10;RPS14;UTP6
prerank,cardiolipin metabolic process (GO:0032048),-0.35568194868627506,-0.9303300890181111,0.5355805243445693,0.8371112129141897,1.0,7/13,27.54%,SLC27A1;CRLS1;PLA2G6;PGS1;PLSCR3;TAMM41;PLA2G4A
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3881877166526168,-0.9302825301281623,0.541795665634675,0.8358512050105905,1.0,4/10,9.28%,OPHN1;MYO9A;RAP2A;SH3BP1
prerank,sodium-independent organic anion transport (GO:0043252),0.4868737214155872,0.9299049972501238,0.5667613636363636,1.0,1.0,6/10,25.19%,SLCO4C1;SLCO4A1;SLCO2A1;SLCO3A1;SLCO5A1;SLCO1C1
prerank,regulation of response to biotic stimulus (GO:0002831),0.4225790285344816,0.9290648602187901,0.5845238095238096,1.0,1.0,12/28,19.45%,DHX58;PTPN22;FOXP1;TRAF3;BIRC2;XIAP;TRIM5;APPL1;FCGR2B;ERAP1;CD55;CASP8
prerank,cobalamin metabolic process (GO:0009235),-0.32356018445831375,-0.9290358865770285,0.511520737327189,0.837419730378448,1.0,7/17,28.79%,MMADHC;ABCC1;MMUT;MTRR;TCN2;LMBRD1;CD320
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.26719129546650755,-0.9289298571383522,0.56,0.8362496335130839,1.0,22/35,35.87%,CSF1R;F11R;SEMA3E;BAIAP2;FES;CDK5;MDK;CDC42;ABL2;RAPGEF3;HRAS;PTK2B;HCK;TJP1;TRPM2;PDGFRA;NOTCH2;ABI3;TEK;STAP1;PHPT1;BAIAP2L2
prerank,lymphocyte mediated immunity (GO:0002449),0.474668952425794,0.9288404051516423,0.5524079320113314,1.0,1.0,5/12,27.69%,KLRD1;BTN3A3;CD55;MYO1G;MSH2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4090440284960516,0.9287818948404025,0.588937093275488,1.0,1.0,13/44,21.48%,AQP1;CD44;DPEP1;ARL6IP1;CDKN2D;XIAP;SH3RF1;YWHAE;SNCA;CAST;PAX2;USP47;RPS6KA3
prerank,myeloid cell differentiation (GO:0030099),0.40289268122549426,0.9286659205906467,0.5946236559139785,1.0,1.0,12/47,17.50%,ALAS2;ZFPM1;RPS19;PRKX;RPS14;ZBTB16;JAK2;HIPK2;KAT6A;RUNX1;JAK3;HCLS1
prerank,cellular response to leucine starvation (GO:1990253),-0.37880947579158,-0.9281539236795505,0.5342465753424658,0.8366877867415636,1.0,5/10,21.49%,IMPACT;RRAGD;SESN3;GCN1;SESN2
prerank,regulation of sensory perception of pain (GO:0051930),-0.3721374323662475,-0.9280662995428878,0.5114754098360655,0.8355129076477407,1.0,4/11,21.97%,MGLL;ZFHX2;CCL3;TMEM100
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4311429680434557,0.9280049034202181,0.5732558139534883,1.0,1.0,5/27,13.99%,PISD;CHKB;PCYT2;NAPEPLD;SELENOI
prerank,regulation of chromatin binding (GO:0035561),0.4955642519244584,0.9271744547391997,0.5622317596566524,1.0,1.0,6/10,26.13%,DDX11;GMNN;WAPL;BTAF1;MED25;PARP9
prerank,negative regulation of growth (GO:0045926),0.38659032547277017,0.9267607167814053,0.6346153846153846,1.0,1.0,23/121,16.99%,TMPRSS4;CDKN2C;JADE1;PPP1R9B;RB1;TCHP;PML;STK11;CDKN2A;NOTCH1;SMARCA4;CDKN2D;SMAD4;CCAR2;SLIT3;RACK1;ING5;SERTAD2;BCL6;TP53;TGFB2;NDRG3;SIRT1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.45502112236604764,0.9264148537998377,0.5607476635514018,1.0,1.0,3/15,6.97%,REEP4;ATL2;ARL6IP1
prerank,mitochondrial transcription (GO:0006390),0.49116743084260583,0.9263403664330143,0.5655270655270656,1.0,1.0,3/10,12.36%,TFB1M;TFB2M;TEFM
prerank,activation of protein kinase B activity (GO:0032148),0.42300741487978805,0.9263053465728073,0.5862857142857143,1.0,1.0,6/29,14.16%,CCDC88A;PDPK1;TXN;PARK7;MLST8;PPIA
prerank,negative regulation of cellular metabolic process (GO:0031324),0.40778006818756746,0.9262514379232186,0.5843439911797134,1.0,1.0,5/37,9.30%,BRCA1;RIN3;MTMR2;ITGAV;ABCA2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4422721549460952,0.9261934405425436,0.5786240786240786,1.0,1.0,4/19,13.24%,TPST1;BPNT2;PAPSS2;SULT6B1
prerank,regulation of inclusion body assembly (GO:0090083),-0.365718480912661,-0.9261501825472309,0.5287769784172662,0.8387615917341769,1.0,2/11,4.99%,SNCAIP;DNAJB6
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.32289776035253165,-0.9260648514554647,0.5194805194805194,0.8376092021834272,1.0,7/16,22.73%,GPR137C;RRAGD;FLCN;LAMTOR5;PIH1D1;SIK3;CLEC16A
prerank,cAMP biosynthetic process (GO:0006171),-0.38317877937542205,-0.9260407569143636,0.5438066465256798,0.836311454680051,1.0,2/10,4.80%,ADCY7;ADCY2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.4799463882514503,0.9257120366059066,0.5712230215827339,1.0,1.0,4/11,14.93%,MBTPS2;ATF6;DDIT3;TP53
prerank,regulation of viral release from host cell (GO:1902186),0.4271538924157195,0.925468145166876,0.5603015075376885,1.0,1.0,13/21,29.41%,PML;TRIM11;TRIM5;TRIM28;CHMP3;CHMP2B;VPS4A;TRIM35;TSG101;TRIM62;TRIM21;VPS37B;TRIM13
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.33279748328058767,-0.9253392306571103,0.5515873015873016,0.8366434252175876,1.0,4/15,14.61%,DAGLB;GRM5;GRM8;DAGLA
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.21964627558955138,-0.9252140304995633,0.7222222222222222,0.83558783691384,1.0,20/77,17.24%,ACVR1;TGFBR1;BCL2L1;GHITM;HGF;RELA;PLAUR;MCL1;IGF1;CX3CR1;AR;PRKN;BCL2L2;PINK1;NDUFS3;NOC2L;QARS1;ACAA2;GPX1;PIH1D1
prerank,mitochondrial transport (GO:0006839),0.39826976594706737,0.9246756726923075,0.6126609442060086,1.0,1.0,13/53,14.54%,PMAIP1;ABCB10;TOMM34;TMEM14C;SLC25A16;TSPO;PITRM1;TIMM9;GDAP1;FIS1;TOMM70;TIMM23;SLC25A13
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.33050160087254943,-0.9244992842095041,0.5560165975103735,0.8359515299697712,1.0,3/14,11.98%,ANK2;ATP1B2;ATP1B1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.42330267280709893,0.9239068822542391,0.5875576036866359,1.0,1.0,10/27,21.70%,CCDC88A;ULK4;DISC1;NTNG2;PTEN;PSEN1;GSK3B;FCGR2B;MARK1;BRSK1
prerank,sterol metabolic process (GO:0016125),0.39228401771526494,0.9232832389884331,0.6223628691983122,1.0,1.0,14/60,21.29%,LBR;CYP1B1;OSBPL5;GBA2;CYP27A1;CYP46A1;PRKAG2;NSDHL;DHCR7;LDLRAP1;FDXR;PPARD;OSBPL1A;SCAP
prerank,positive regulation of protein acetylation (GO:1901985),-0.3671867957435908,-0.922688473749214,0.5477031802120141,0.8387792541425741,1.0,3/12,4.48%,DIP2B;CAMK1;PRKAA2
prerank,regulation of glucose metabolic process (GO:0010906),0.4123802546162887,0.9226866384765086,0.5768799102132436,1.0,1.0,9/34,17.67%,PMAIP1;ADIPOR1;SIRT7;SDHAF3;IRS1;RUBCNL;FOXK2;SIRT1;USP7
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.3920984483232294,0.9225441705981122,0.6387755102040816,1.0,1.0,14/95,10.96%,CHST3;FMOD;HSPG2;CSGALNACT2;HAS1;EXT1;ST3GAL1;DCN;SLC35D2;ST3GAL2;SLC10A7;B3GNT2;CHST12;OGN
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3775643798293418,0.9223599848435018,0.7,1.0,1.0,66/234,21.03%,NKX6-1;ARHGEF5;IL18RAP;PIDD1;S100A9;RPS6KA5;TFRC;CAV1;TAF1;MBTPS2;IKBKG;S100A8;TRADD;TCF3;TFDP1;NFAM1;DDRGK1;CIB1;SMARCA4;TAB1;UBE2V1;ERC1;PLCG2;MTPN;TAB3;ZBTB7A;HIPK2;CARD9;ARID5B;PARK7;BTK;RELN;DHX9;PRKCB;MYD88;PTEN;TRIM68;FLOT1;BEX1;DDIT3;CFLAR;CEBPG;PPIA;TLR6;TRIM5;RBCK1;TNFRSF11A;ADCY8;HCLS1;TRIM37;UBA52;MAP3K7;FLOT2;HDAC4;MALT1;RPS3;STK3;LGALS9;TRAF6;PRKD2;ALK;UBE2N;AIM2;SLCO3A1;IKBKB;RIPK1
prerank,positive regulation of viral process (GO:0048524),0.396696594884121,0.9215582735334307,0.6088794926004228,1.0,1.0,20/60,21.16%,RSF1;POLR2I;POLR2A;PDE12;PKN2;RAD23A;NELFA;DHX9;CCNT1;PPIA;STAU1;NELFB;TARBP2;POLR2K;SRPK1;POLR2J;PPIE;PPIH;CNOT7;VPS4A
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3863981482288395,0.9215039761431069,0.655241935483871,1.0,1.0,28/124,17.74%,LEF1;PSMB7;TIAM1;PPP3CA;PSMD11;PSMF1;CCDC88C;TNRC6C;PSMC1;TNRC6B;CLTC;GNAO1;PSMC3;PSMA4;PLCB1;ARRB2;PSMC4;AP2B1;PLCB3;PSMD13;PSME1;PSMB1;PSMD8;TCF7L2;PSME4;RAC1;PSMD4;MAP3K7
prerank,fatty acid elongation (GO:0030497),0.46997055406565214,0.9209336585954538,0.5763411279229711,1.0,1.0,4/13,16.32%,HACD4;ABCD1;ELOVL5;ELOVL4
prerank,regulation of cellular protein localization (GO:1903827),-0.24909012605685396,-0.920750846997619,0.5714285714285714,0.8418160482146969,1.0,12/45,16.50%,KDM1A;CSNK1E;GBF1;HSP90AA1;CTNNB1;PRKAA2;MAP1A;DVL3;GPC3;PPM1F;GPC5;RAB11FIP5
prerank,sterol biosynthetic process (GO:0016126),0.416589811944985,0.9206656477966833,0.5875,1.0,1.0,7/33,15.86%,LBR;LSS;IDI1;PRKAG2;NSDHL;FDPS;DHCR7
prerank,negative regulation of ossification (GO:0030279),0.42639674144699524,0.9203685896950855,0.5697674418604651,1.0,1.0,6/23,20.51%,LRP4;NOTCH1;CHSY1;TRPM4;SOX9;RBPJ
prerank,female gamete generation (GO:0007292),0.424046212076599,0.919065642587842,0.573943661971831,1.0,1.0,2/29,4.59%,TRIP13;MCM9
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4666893372287756,0.9187851096059974,0.5984147952443857,1.0,1.0,3/15,12.56%,IL16;PGF;F3
prerank,regulation of vasculogenesis (GO:2001212),0.4577306915818538,0.9186195891391601,0.5901201602136181,1.0,1.0,1/14,2.11%,HEY2
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.42085486805546657,0.9185084858274455,0.5794392523364486,1.0,1.0,8/26,17.85%,FYN;TXN;PARK7;NFE2L2;PPIA;PDE8A;SIRT1;LRRK2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.39965958488935754,0.9183986583917847,0.5957446808510638,1.0,1.0,8/46,15.91%,IL12A;CCN4;FOXP1;XRCC6;OGN;PRKDC;ELN;TCF7L2
prerank,sodium ion transmembrane transport (GO:0035725),0.3881510403771964,0.9182614586010428,0.628099173553719,1.0,1.0,5/84,3.54%,SLC6A12;SLC12A3;SLC6A2;SLC6A5;HCN3
prerank,negative regulation of cell population proliferation (GO:0008285),0.37760348685485706,0.9181883881135575,0.752,1.0,1.0,60/351,16.76%,E2F7;CDKN3;IL12A;MEN1;CYP1B1;CDKN2C;HMGA1;ITGA1;E2F1;GLMN;FAP;S100A11;PPM1D;PML;ARID2;CTCF;STK11;CDK6;CDKN2A;PTHLH;MDM4;RBBP4;RUNX3;TFDP1;KLF10;NOTCH1;PIM2;FUZ;CIB1;JAK2;STRN;CDKN2D;EMD;OGN;B2M;PTPN14;MTSS1;PEX2;KAT2B;ATF5;PTEN;BAP1;PDS5B;NELL1;ING5;SLURP1;SKI;TMEM115;MYC;E2F3;ADAMTS1;TP53;F2R;PTPRU;HGS;MAP2K1;TFAP4;TGFB2;NLRC3;VHL
prerank,positive regulation of cartilage development (GO:0061036),0.44818569205802966,0.9179064034756624,0.5927770859277709,1.0,1.0,3/17,11.60%,SOX6;ZBTB16;TAPT1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.4713268272031788,0.9177934785254147,0.5760111576011158,1.0,1.0,3/11,11.11%,FOXO1;NOTCH1;SMAD4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.4402902549007486,0.9175583004399026,0.5542635658914729,1.0,1.0,5/18,17.65%,PMAIP1;BOK;DDIT3;XBP1;FCGR2B
prerank,histone deubiquitination (GO:0016578),-0.31263883797094605,-0.9172961562138775,0.5424528301886793,0.8488326908069123,1.0,8/18,23.90%,ENY2;USP3;USP22;KAT2A;USP49;ATXN7;TRRAP;TAF10
prerank,retinoid metabolic process (GO:0001523),0.3881095795990306,0.9172743484877,0.6317948717948718,1.0,1.0,3/71,3.42%,LRAT;CYP1B1;HSPG2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.48396438646941853,0.916860236153809,0.5785714285714286,1.0,1.0,2/10,9.88%,RB1;EGR1
prerank,regulation of dendrite development (GO:0050773),-0.2509956121797481,-0.9166361771964562,0.5728155339805825,0.8490372839773801,1.0,14/37,24.18%,CAMSAP2;TNIK;HECW1;RAP2A;KNDC1;PACSIN1;LRP8;DAB2IP;RTN4IP1;VLDLR;ZDHHC15;LZTS1;DCC;SEMA4D
prerank,regulation of steroid metabolic process (GO:0019218),0.4317486127694208,0.9165560776988817,0.5847255369928401,1.0,1.0,4/23,10.07%,PANK2;EPHX2;ABCA2;FMO5
prerank,protein lipidation (GO:0006497),-0.22975952216619444,-0.9164742374832001,0.6730769230769231,0.8480515536021468,1.0,26/59,28.74%,GLUL;ZDHHC17;ATG10;ZDHHC13;ZDHHC5;PIGB;PIGN;WIPI1;ZDHHC8;SELENOK;PIGP;MPPE1;GPLD1;ZDHHC16;ZDHHC20;PIGC;ZDHHC15;PIGG;PGAP4;WDR45;ZDHHC3;ZDHHC12;DPM3;PIGQ;PIGZ;HHAT
prerank,microvillus organization (GO:0032528),0.47017707315197577,0.916415758476463,0.5799457994579946,1.0,1.0,3/13,7.35%,STK26;EZR;FXYD5
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.3406546747826188,-0.9160973088252522,0.5719844357976653,0.8475701166483224,1.0,4/13,16.35%,ANK3;SRI;CALM1;SLC8A1
prerank,cholesterol biosynthetic process (GO:0006695),0.413664808508117,0.9158835080253316,0.5986394557823129,1.0,1.0,6/31,15.86%,LBR;LSS;IDI1;NSDHL;FDPS;DHCR7
prerank,spliceosomal complex assembly (GO:0000245),0.39541037033145,0.9158326564123016,0.5980392156862745,1.0,1.0,16/46,21.52%,PRPF19;SCAF11;SETX;CRNKL1;SNRNP200;TXNL4A;NCBP1;LUC7L2;SRSF10;SRPK1;DDX39B;SNRPG;GCFC2;SF3A2;KHDC4;CELF1
prerank,aminoglycan metabolic process (GO:0006022),-0.3647722441451144,-0.9158149918972742,0.5673758865248227,0.8468424765201574,1.0,6/10,32.31%,B3GAT3;XYLT2;B4GALT7;CLN6;CHST9;B3GALT6
prerank,dendritic cell migration (GO:0036336),0.45025501216464536,0.9155825460019089,0.5780189959294437,1.0,1.0,5/16,17.70%,CCR2;HMGB1;CCR6;TRPM4;CXCR4
prerank,positive regulation of hemostasis (GO:1900048),-0.3730486440394365,-0.9152319924428682,0.53156146179402,0.845545244251211,1.0,4/10,18.44%,ST3GAL4;SERPINE1;HPSE;THBS1
prerank,positive regulation of coagulation (GO:0050820),-0.3730486440394365,-0.9152319924428682,0.53156146179402,0.845545244251211,1.0,4/10,18.44%,ST3GAL4;SERPINE1;HPSE;THBS1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.3877937599768822,0.9150681157735097,0.6016949152542372,1.0,1.0,18/59,21.03%,TANK;IKBKG;TRADD;BIRC2;TAB1;ERC1;TAB3;TIFA;ROCK2;RBCK1;NLRC3;UBA52;MAP3K7;NKIRAS1;TRAF6;IKBKB;ROCK1;RIPK1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.38678584235816793,-0.9148610999535025,0.5800604229607251,0.8450230224728613,1.0,4/10,18.44%,AKT2;CTTNBP2NL;IRS2;THBS1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.4761126545433712,0.9148541239149575,0.573997233748271,1.0,1.0,3/12,9.92%,IAPP;VBP1;PFDN5
prerank,positive regulation of sodium ion transport (GO:0010765),-0.3633201196147033,-0.9147510777129222,0.5733333333333334,0.843876293895592,1.0,3/12,9.09%,ANK3;CNKSR3;SCN1B
prerank,regulation of neuron apoptotic process (GO:0043523),0.3863023730526448,0.9141704159512083,0.6417004048582996,1.0,1.0,4/96,3.67%,KIF14;NTF4;ERBB3;LIG4
prerank,primary miRNA processing (GO:0031053),-0.36488860793904615,-0.9140333305428079,0.5403508771929825,0.8441983315587395,1.0,3/10,4.40%,SMAD1;PUS10;SMAD3
prerank,regulation of kinase activity (GO:0043549),0.37878995737478677,0.9136942795866274,0.6262729124236253,1.0,1.0,26/89,22.80%,ECT2;RB1;ERBB3;LMO4;CD74;RBL1;SMG8;EGFR;EPHA3;FLT3;LMTK2;HNRNPU;RAD50;SLAMF8;FGFR1;ALK;EPHA7;DSTYK;MET;MAPT;EPHA10;DDR2;FGR;NTRK3;CDKN1B;FGFR2
prerank,negative regulation of cilium assembly (GO:1902018),0.4739417480640782,0.9133254197217742,0.5814285714285714,1.0,1.0,2/12,4.87%,TCHP;MAP4
prerank,response to glucocorticoid (GO:0051384),0.4226756737260028,0.9132702918660306,0.5980975029726516,1.0,1.0,5/26,16.03%,ZFP36L1;SLIT3;HNRNPU;PDCD7;ZFP36L2
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3833511220378685,0.9130569277010484,0.639511201629328,1.0,1.0,15/98,9.94%,PMAIP1;CNPY4;E2F1;C2CD5;FYN;PRKCE;YWHAH;SORBS1;TFDP1;CIB1;EFCAB7;EGFR;EPHA3;PDPK1;TFDP2
prerank,vesicle organization (GO:0016050),0.3946900624485048,0.9130283864478249,0.593952483801296,1.0,1.0,13/46,19.30%,RNF26;SNX33;CAV1;WASHC4;RAB22A;CAV2;DNAJC13;PI4K2B;VPS33B;USP50;CHMP2B;SAR1B;AKTIP
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.38347111367713643,0.9129398273954155,0.6429298067141404,1.0,1.0,25/94,17.74%,PSMB7;PSMD11;FBXW11;RPS6KA5;PSMF1;IKBKG;PSMC1;TAB1;UBE2V1;TAB3;EGR1;PSMC3;IL1R1;PSMA4;PLCB1;MYD88;PSMC4;PSMD13;PSME1;PSMB1;PSMD8;PSME4;PSMD4;UBA52;MAP3K7
prerank,tRNA aminoacylation (GO:0043039),-0.2550891220892811,-0.9128865702371854,0.6129032258064516,0.8455771160914018,1.0,12/37,13.15%,IARS2;CARS1;WARS2;SARS1;NARS1;AIMP1;FARSA;IARS1;HARS2;HARS1;QRSL1;TARS1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.2896636802649877,-0.9124622966119345,0.5714285714285714,0.8452246654084491,1.0,11/24,33.36%,TNFAIP3;KRIT1;ANGPT1;TNIP2;SERPINE1;MAPK7;NDNF;KDR;ICAM1;PAK4;TEK
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.38801114026178146,0.9123091575612844,0.6264428121720882,1.0,1.0,19/67,17.02%,PSMB7;PSMD11;PSMF1;IKBKG;PSMC1;TAP1;ITGAV;PSMC3;PSMA4;B2M;PSMC4;PSMD13;PSME1;PSMB1;CYBB;PSMD8;PSME4;PSMD4;CYBA
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.38538954663021774,0.9121105268366569,0.6324435318275154,1.0,1.0,24/78,21.67%,CDC20;PLK1;CAV1;TAF1;CSNK1A1;DDRGK1;UBQLN1;SUMO1;RAD23A;FZR1;NFE2L2;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;RNF19A;LRRK2;KEAP1;MDM2;CBFA2T3;UBQLN2;HECTD1
prerank,lipid biosynthetic process (GO:0008610),0.38902905463780235,0.9119986196192581,0.6211498973305954,1.0,1.0,14/77,18.66%,HSD17B3;SRD5A2;LSS;AGPAT4;PCYT2;CBR4;AGPAT3;ACSL5;PDSS2;NDUFAB1;ELOVL4;XBP1;AGPS;FDXR
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.2811614071664919,-0.9118798123274203,0.6130952380952381,0.8453292966259958,1.0,11/26,19.06%,FHOD1;ASAP3;PFN1;SLC9A1;LIMK1;TSC1;PRKN;PFN2;SHANK3;PLEK;CDC42
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3922941620245188,0.9115726876790894,0.6191512513601741,1.0,1.0,6/47,10.91%,UHRF1;EIF2A;RBM3;MTPN;PUM3;TCOF1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.4352302733863238,0.9114919132646433,0.58125,1.0,1.0,10/20,23.28%,MBTPS2;EPHX2;SEC14L2;ABCA2;FMO5;KPNB1;LDLRAP1;SREBF2;TTC39B;LPCAT3
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.47734146349148293,0.910775860786658,0.5945165945165946,1.0,1.0,3/10,15.66%,CLTC;AP2B1;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.47734146349148293,0.910775860786658,0.5945165945165946,1.0,1.0,3/10,15.66%,CLTC;AP2B1;MYLIP
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.39893213376117803,0.9104206605049807,0.6004296455424275,1.0,1.0,6/51,10.59%,IL12A;MAPK1;PGF;CCR2;HMGB1;CCR6
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.31701553754684986,-0.910362977543147,0.558252427184466,0.8474608386386491,1.0,7/17,35.92%,ADRA1A;ADRA1B;ADRB1;ADRB2;ADRA2A;DRD2;GPR101
prerank,positive regulation of hormone secretion (GO:0046887),0.4455796202027693,0.9101227210420155,0.5926412614980289,1.0,1.0,1/17,1.86%,TFR2
prerank,defense response to symbiont (GO:0140546),0.37870965214827584,0.9099849519872495,0.6425661914460286,1.0,1.0,8/92,6.58%,RNASE6;PMAIP1;SKP2;FLNA;CGAS;SERINC5;SERINC3;PDE12
prerank,negative regulation by host of viral transcription (GO:0043922),0.46046881923123784,0.9099678261037826,0.5975274725274725,1.0,1.0,6/12,23.97%,PSMC3;JUN;TFAP4;HDAC1;TARDBP;HMGA2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4096125615685928,0.9097936236973513,0.6,1.0,1.0,1/34,0.38%,CD19
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.46872448254235677,0.9096464507506251,0.5898801597869507,1.0,1.0,5/12,22.88%,SORBS1;ZBTB7B;IRS1;SIRT1;PTPN11
prerank,cellular protein metabolic process (GO:0044267),0.37442698923183054,0.9095242720815194,0.789,1.0,1.0,111/396,22.91%,MRPL36;F5;MEN1;NAPSA;CHEK2;RPL7;RPL18A;RPS20;MRPL18;PIGH;CCN1;RPL36;RPL14;L2HGDH;UBE2I;RPS19;RPS7;RPS4X;MSRA;RPS18;MRPL10;LCMT1;RPL23A;UBL5;ST3GAL1;RPL28;SPCS1;MRPL37;SLC35A1;RPL41;RPS14;STK38;LAMC1;LAMB2;ST8SIA4;RPLP2;TMEM208;SEPHS1;RPS27;MRPL51;MRPS7;MRPL43;RPS5;DHPS;RPS29;RPLP0;LTA4H;RPS11;MRPS17;IGF2BP3;RPL27A;PHKA2;BAP1;FBXO11;RPS15A;RPS9;CHRM3;PRKDC;MRPL24;PSEN1;RPL12;PRKCSH;PRSS23;NTAQ1;DARS1;USP25;DUSP12;SCG3;RPL3;ADPRH;RPL18;FN1;HSP90B1;GSPT1;SPPL3;UBA52;UBE2M;SDC2;UBE2G1;ADAM10;CKAP4;FDXR;YARS2;RPS17;ICMT;RPS6;RPL5;RPS3;RPL21;AGO2;SRBD1;RPL23;RPL17;ARAF;SPCS3;RIPK1;DNAJC3;RPL8;RSL24D1;RPL24;PADI4;RPL27;RPL13A;IGFBP7;MRPS12;RPS12;NEDD8;RPS8;RPL15;RPL10;IGFBP2
prerank,microtubule anchoring (GO:0034453),0.45436661696989383,0.9095170903966616,0.5616438356164384,1.0,1.0,4/12,17.46%,CLASP1;PCM1;DAG1;PEX14
prerank,positive regulation of glucose import (GO:0046326),-0.29883074947777893,-0.9094976426015259,0.546448087431694,0.8481155468538579,1.0,6/21,14.42%,PRKCI;PIK3R1;IGF1;AKT2;IRS2;RHOQ
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.37994902454185675,0.9093522901455235,0.6733466933867736,1.0,1.0,39/138,22.44%,E2F2;NR4A2;TEAD4;GTF2E1;POLR2I;POLR2A;HDAC10;NR1D1;TAF1;TAF7;NOTCH1;TAF15;GTF2A1;ERCC3;NR2C2;TAF6;KAT2B;TAF2;CREBBP;NRBP1;E2F3;TAF9;POLR2K;POLR2J;RXRB;RARG;MED1;HDAC1;TBL1XR1;TAF3;GTF2A2;NRBF2;RBPJ;PPARD;TAF11;NR1H3;MED23;HDAC9;POLR2B
prerank,cellular response to amino acid stimulus (GO:0071230),0.4024024660041512,0.9089822198109017,0.6024636058230683,1.0,1.0,11/33,20.74%,FYN;LARS1;CPEB3;UBR2;LAMTOR4;LAMTOR3;IPO5;KLHL22;XBP1;GLRA1;RRAGB
prerank,long-chain fatty acid metabolic process (GO:0001676),0.382841314796374,0.9088384430074833,0.6182572614107884,1.0,1.0,11/64,15.07%,CYP1B1;ABCD1;EPHX2;HPGD;ACOT2;SLC27A2;LTA4H;CPT1A;ACSL5;ELOVL5;CPT2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.4471001185595241,0.9086836126338371,0.5858854860186418,1.0,1.0,5/14,21.42%,PTPN22;CCR2;CD55;LGALS9;SYK
prerank,carnitine metabolic process (GO:0009437),0.4597461416459747,0.9086775952520825,0.5829846582984658,1.0,1.0,4/12,15.07%,ACADM;CPT1B;CPT1A;CPT2
prerank,tetrapyrrole metabolic process (GO:0033013),-0.31384008081477044,-0.9083014733992054,0.5606060606060606,0.8495576129588467,1.0,7/18,28.79%,MMADHC;ABCC1;MMUT;MTRR;TCN2;LMBRD1;CD320
prerank,regulation of heart contraction (GO:0008016),-0.21167966227734522,-0.908290661897215,0.9,0.8482364953185296,1.0,24/90,20.67%,ITPR2;ASPH;ANK2;SLC8A3;ATP2B2;ATP1A1;TRPC1;CELF2;SRI;ATP1B2;RYR2;GSK3A;ATP1B1;SMAD7;ASB3;ADORA3;CALM1;ATP2B3;SLC8A1;ITPR3;ATP1A2;STIM1;P2RX4;AGT
prerank,activation of GTPase activity (GO:0090630),0.38193105014348794,0.9081192047635838,0.6418367346938776,1.0,1.0,9/89,5.59%,ECT2;ARHGEF5;TBC1D1;TIAM1;TBC1D8B;TBC1D22B;RASGRP1;RANGAP1;EVI5
prerank,regulation of primary metabolic process (GO:0080090),0.38062754438960167,0.9079938996433622,0.6629889669007021,1.0,1.0,39/126,20.70%,PSMB7;PSMD11;PSMF1;AZIN1;LSS;NR1D1;EDF1;PSMC1;SIN3B;IDI1;PSMC3;ABCA7;NFYC;PSMA4;FASN;ADIPOR1;PSMC4;OAZ1;ROCK2;PSMD13;BBS4;PSME1;HELZ2;CREBBP;PSMB1;RUBCNL;FDPS;PSMD8;DHCR7;SIN3A;PSME4;PSMD4;MED1;CERS2;TBL1XR1;SREBF2;NCOA6;NCOA2;PPARD
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.2990398950506122,-0.9076532885638936,0.5596330275229358,0.8482813691433729,1.0,5/18,15.51%,APOE;PSEN2;ADAM19;NSG1;APH1A
prerank,embryonic digit morphogenesis (GO:0042733),0.43561699741307813,0.9075855664353096,0.5620347394540943,1.0,1.0,7/18,23.13%,TWIST1;WDPCP;CREBBP;MAP3K20;HDAC1;OSR1;INTU
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4324994699335794,0.9071417984105672,0.5906862745098039,1.0,1.0,4/20,8.34%,CDK6;ZFP36L1;CIB1;ZBTB16
prerank,regulation of adaptive immune response (GO:0002819),-0.30351575617588145,-0.9066321891465136,0.5954545454545455,0.8493470449736955,1.0,4/18,8.16%,ADCY7;PYCARD;TRIM27;IRF1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.382085187426598,0.9061755936860622,0.6308654848800834,1.0,1.0,15/63,17.28%,PML;TNFSF10;SP100;CAV1;TRADD;BCL2L12;BIRC6;ITGAV;PARK7;FAS;CFLAR;TCF7L2;FGFR1;PAK2;SH3RF1
prerank,mammary gland development (GO:0030879),0.4241515098237825,0.9059981601089576,0.5956151035322778,1.0,1.0,5/21,17.21%,CAV1;ARHGAP35;JAK2;ZBTB7B;APLN
prerank,microvillus assembly (GO:0030033),0.4591789177897027,0.9055748158898166,0.5952380952380952,1.0,1.0,3/14,7.35%,STK26;EZR;FXYD5
prerank,regulation of MAPK cascade (GO:0043408),0.3769779586986137,0.9053780739559655,0.6886886886886887,1.0,1.0,34/157,18.02%,FAM83D;ARHGEF5;IAPP;MAPK1;CCN1;CD74;ULK4;CAV1;RASGRP1;HMGB1;PLCG2;EGFR;CAV2;RIT2;ABCA7;FLT3;FAS;ROCK2;MYDGF;TRIM5;DAG1;STK4;EGF;F2R;LPAR1;PAK5;MAP2K1;STYX;FGFR1;PAK2;CD24;FN1;IQGAP1;TAOK1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.23912371129994098,-0.9053573822660717,0.6338028169014085,0.8509730654166954,1.0,13/46,17.66%,SIRPA;PTPN2;CNKSR3;CAMK2N1;TLR4;TIMP3;DUSP3;DUSP10;FLCN;DLG1;SPRED1;DAB2IP;RANBP9
prerank,regulation of keratinocyte differentiation (GO:0045616),0.4193372051726352,0.9050347903348236,0.5898345153664303,1.0,1.0,9/24,23.07%,ZFP36L1;CBFB;CTSK;ROCK2;NUMA1;RUNX1;MED1;ROCK1;NCOA3
prerank,'de novo' posttranslational protein folding (GO:0051084),0.41453449672065595,0.9049534145645711,0.616532721010333,1.0,1.0,15/30,26.63%,CHCHD4;CCT2;DNAJC18;ENTPD5;DNAJC7;BAG1;SDF2;DNAJB1;DNAJB4;DNAJB12;DNAJB14;HSPE1;HSPA9;UGGT1;ST13
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3842529396355033,0.9047803461616772,0.6183524504692388,1.0,1.0,13/61,16.84%,NET1;LPAR4;MMD2;RASGRP1;CRKL;ARHGEF3;NOTCH1;GRB2;JAK2;F2R;LPAR1;GPR35;RAC1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4065247092688632,0.904687861192564,0.6074660633484162,1.0,1.0,5/34,9.47%,E2F1;ZFPM1;FOXO1;LRP3;ASXL1
prerank,leukotriene metabolic process (GO:0006691),0.4317825275025645,0.9046494980697469,0.5985130111524164,1.0,1.0,4/19,13.10%,DPEP2;DPEP1;LTA4H;ABCC10
prerank,protein N-linked glycosylation (GO:0006487),0.38036935010548023,0.9045094846097135,0.6381647549530761,1.0,1.0,15/66,16.51%,MAGT1;KRTCAP2;ALG8;ALG14;STT3A;MGAT2;ST3GAL1;ENTPD5;FUT8;OST4;GFPT2;SRD5A3;PMM2;TUSC3;LMAN1
prerank,ruffle organization (GO:0031529),-0.3144067504394421,-0.9044548202740353,0.5321100917431193,0.8517474330784807,1.0,6/16,22.74%,CSF1R;AIF1;ARFIP2;PLEK;CORO1B;CYFIP1
prerank,regulation of cilium movement (GO:0003352),0.48402104948365243,0.9042228616271836,0.5874822190611664,1.0,1.0,1/10,3.22%,CFAP206
prerank,regulation of regulated secretory pathway (GO:1903305),-0.25734531295888885,-0.9038640249970009,0.6302521008403361,0.8517537525468206,1.0,9/34,16.27%,RIMS1;RIMS2;SYT1;PREPL;SYT4;SYT7;SYT9;SNAPIN;SYT6
prerank,regulation of myoblast differentiation (GO:0045661),0.41171939031537613,0.9038305787464573,0.6044692737430167,1.0,1.0,7/32,19.46%,RIPOR2;ZFP36L1;NOTCH1;MAPK14;PLCB1;FLOT2;SOX9
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.3757922457687651,-0.9034579486947635,0.5686900958466453,0.8513182267823304,1.0,6/10,21.60%,NAGK;GNE;NPL;GNPDA1;GNPDA2;AMDHD2
prerank,maturation of 5.8S rRNA (GO:0000460),0.44382613851366975,0.9034226252853466,0.5930521091811415,1.0,1.0,8/17,23.04%,EXOSC10;URB1;PRKDC;NSA2;PES1;MPHOSPH6;EIF6;RPF1
prerank,pulmonary valve morphogenesis (GO:0003184),0.44279104503164407,0.9029941084930189,0.5957446808510638,1.0,1.0,2/17,7.16%,HEY2;NOTCH1
prerank,regulation of microglial cell activation (GO:1903978),-0.33171323255171264,-0.9025057097226813,0.5813953488372093,0.8521421150276068,1.0,5/15,19.61%,TREM2;GRN;TTBK1;CST7;CCL3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.43531535850078185,0.9015534289975756,0.6048780487804878,1.0,1.0,4/19,12.18%,POLD1;POLD2;TYMS;POLD3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.45061316010230634,0.9012148771265251,0.5938748335552596,1.0,1.0,5/15,15.44%,IL17RA;CARD9;MYD88;TLR6;APPL1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3775921547356714,-0.9011606067078091,0.5933333333333334,0.8540424203706425,1.0,3/10,10.06%,DIP2B;PRKAA2;FLCN
prerank,positive regulation of axon extension (GO:0045773),-0.29116316570248063,-0.9006964931979472,0.6226415094339622,0.8538752753681097,1.0,9/22,20.27%,RUFY3;MACF1;MAP3K13;LIMK1;GOLGA4;VEGFA;L1CAM;TWF2;SEMA7A
prerank,PERK-mediated unfolded protein response (GO:0036499),0.470965226199628,0.9006929203928917,0.5614285714285714,1.0,1.0,3/10,13.59%,EIF2S1;NFE2L2;DDIT3
prerank,cellular response to chemokine (GO:1990869),0.3909858671821518,0.9005485100232874,0.6199782844733985,1.0,1.0,7/46,16.69%,OXSR1;RIPOR2;CCR2;GPR75;STK39;GPR35;CCL25
prerank,regulation of defense response to virus by host (GO:0050691),0.4063494430827882,0.9003786163404343,0.6009280742459396,1.0,1.0,8/30,16.50%,PTPN22;CGAS;TRIM44;DHX9;TOMM70;TARBP2;SIN3A;TRAF3IP2
prerank,negative regulation of cellular component organization (GO:0051129),0.38341115747916354,0.9000045758856762,0.65527950310559,1.0,1.0,17/74,17.61%,IAPP;FAP;SNX33;LCMT1;TERF2;HDAC6;MTMR2;RTEL1;EPHA3;RIOK3;ABCA7;RDX;TFIP11;GSK3B;AIDA;DNAJB1;MCTP1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.46840916869525345,0.8998724021951535,0.591304347826087,1.0,1.0,4/11,16.76%,CAV1;ADIPOR1;HGS;VHL
prerank,sensory perception of sound (GO:0007605),0.3758795854354332,0.8997993182662434,0.6397134083930399,1.0,1.0,11/88,17.35%,BIRC5;RIPOR2;CLIC5;TIMM9;NIPBL;ADGRV1;EYA1;CCDC50;LRTOMT;HOMER2;TSPEAR
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.42822663239016984,0.8994097799777155,0.5942408376963351,1.0,1.0,6/18,21.18%,CCR2;CACNG5;RELN;CACNG8;NRXN1;CACNG4
prerank,clathrin coat assembly (GO:0048268),-0.31996245193946476,-0.8993688977795998,0.5889328063241107,0.855592749316919,1.0,9/15,30.52%,CLTB;AP2S1;NSG1;EPS15;HIP1R;PICALM;NSG2;CALY;SGIP1
prerank,amyloid fibril formation (GO:1990000),0.38443369525420046,0.8991087510727532,0.6034297963558414,1.0,1.0,16/51,21.14%,IAPP;HSPG2;GSN;H3-3A;TSPAN33;B2M;GGA1;TGFBI;UBA52;GGA2;SNCA;TSPAN5;ADAM10;RIPK1;MAPT;MDM2
prerank,phosphate ion transport (GO:0006817),-0.32383085469728773,-0.8990835802491297,0.6495327102803738,0.8548786178558536,1.0,4/16,21.83%,SLC25A3;SLC25A11;SLC37A1;SLC37A2
prerank,negative regulation of T cell proliferation (GO:0042130),0.4168214120679059,0.8989005249274267,0.5983510011778563,1.0,1.0,2/28,3.02%,SPN;GLMN
prerank,regulation of transmembrane transport (GO:0034762),0.40551066041135636,0.8986444402030209,0.6168757126567845,1.0,1.0,8/31,18.72%,NEDD4L;KCNJ3;PIM1;PRKCB;KCNJ2;SNCA;SLC2A1;KCNJ10
prerank,N-glycan processing (GO:0006491),-0.29978237254032614,-0.89855982233582,0.6181818181818182,0.8548244380857272,1.0,4/18,3.28%,ST8SIA1;MAN1C1;MAN2A2;GANAB
prerank,sensory perception of mechanical stimulus (GO:0050954),0.37593101102991666,0.8979740849714263,0.6413155190133607,1.0,1.0,11/85,17.35%,BIRC5;RIPOR2;CLIC5;TIMM9;NIPBL;ADGRV1;EYA1;CCDC50;LRTOMT;HOMER2;TSPEAR
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.43087534312616577,0.8977648268614654,0.5954198473282443,1.0,1.0,8/18,23.16%,HMGB1;AKT3;PDPK1;FGFR1;PLCG1;APLN;ITGA4;ADAM17
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.38361167499780724,0.8968977890446631,0.6187904967602592,1.0,1.0,13/47,20.54%,FLNA;NEDD9;CRKL;CIB1;CRK;NRP1;ACTN4;LIMS1;TRIOBP;RAC1;ARHGEF7;S100A10;ILK
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4049744031137492,0.896754529208046,0.6092089728453365,1.0,1.0,4/27,7.98%,GPD1L;YWHAH;FXYD5;NEDD4L
prerank,negative regulation of translational initiation (GO:0045947),0.4521172798066917,0.8961861539951923,0.5832205683355887,1.0,1.0,5/13,24.36%,EIF3E;EIF4EBP3;AGO2;TPR;EIF2AK1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.41663592434245184,0.896008854446791,0.608433734939759,1.0,1.0,6/24,16.50%,PTPN22;CGAS;TRIM44;TOMM70;SIN3A;TRAF3IP2
prerank,regulation of T cell proliferation (GO:0042129),0.38270584798306023,0.8959385404113056,0.6382754994742377,1.0,1.0,4/61,5.06%,SPN;SLC7A1;GLMN;TFRC
prerank,morphogenesis of an epithelium (GO:0002009),0.4074242552642453,0.8956179693232473,0.6024096385542169,1.0,1.0,9/25,23.01%,TIMELESS;LAMA5;PRKX;DAG1;KDM2B;SOX9;ACTG1;FGFR2;VCL
prerank,positive regulation of interleukin-6 production (GO:0032755),0.3838973198582216,0.8951483071291745,0.6663190823774765,1.0,1.0,16/68,17.98%,POU2AF1;TWIST1;CD74;IL16;HMGB1;PLCG2;IL17RA;CARD9;DHX9;MYD88;TLR6;TYROBP;F2R;CYBA;XBP1;POU2F2
prerank,negative regulation of cell junction assembly (GO:1901889),-0.27169961128936804,-0.8950356840059416,0.58,0.8615203476743925,1.0,8/25,20.27%,ARHGAP6;APOD;CLASP2;CORO1C;RCC2;ACVRL1;THBS1;PHLDB2
prerank,entry into host (GO:0044409),0.45150842433892857,0.8948647932682898,0.5986666666666667,1.0,1.0,8/13,25.96%,GRB2;ITGAV;CBLL1;PPIA;CXCR4;MET;SRC;CBL
prerank,cellular response to metal ion (GO:0071248),0.37288232197109017,0.8941950923403765,0.6955645161290323,1.0,1.0,15/123,11.40%,ECT2;SLFN14;TFR2;AQP1;MAPK1;CRHBP;SYT8;DPEP1;PLCG2;KCNA1;EGFR;SUMO1;B2M;JUN;SYT3
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4057747478042689,0.8939822826253901,0.6201641266119577,1.0,1.0,10/28,20.59%,MAP2K6;IKBKG;TAB1;UBE2V1;TAB3;UBA52;MAP3K7;TRAF6;CASP8;UBE2N
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.26449168949005236,-0.8932651455312504,0.6457142857142857,0.8642797974378634,1.0,6/24,14.87%,SEMA3D;SEMA3E;SEMA4C;SEMA4G;VEGFA;SEMA3A
prerank,ncRNA processing (GO:0034470),0.37091562692229857,0.8931508064727683,0.7397397397397397,1.0,1.0,67/200,23.13%,RPL7;RPL18A;UTP3;RPL36;RPL14;INTS4;RPS19;DDX49;RPS7;INTS9;HELQ;EXOSC8;RPL23A;RPL28;EXOSC10;HNRNPA2B1;RPL41;RPS14;NOL11;RPLP2;EMG1;RPS27;SRRT;UTP6;INTS1;RPLP0;TUT4;FBL;PELP1;RPL27A;WDR74;RPS9;NOL8;RPL12;NOP58;TARBP2;POP4;TUT1;RPL3;RPL18;UBA52;DKC1;PES1;MPHOSPH6;RPS17;RPS6;RPL5;DDX54;RPL21;AGO2;ZCCHC8;RPL23;RPL17;INTS12;SMAD2;RPL8;RPL24;RPL27;RPL13A;AGO1;DIS3;RPP30;RPL15;RPL10;INTS11;RPF1;NOP14
prerank,ovarian follicle development (GO:0001541),-0.33947843697279795,-0.893073183332108,0.5734265734265734,0.863369954203485,1.0,4/13,21.71%,VEGFA;EIF2B4;ANG;EIF2B2
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3760693831732072,0.892980104401713,0.6477272727272727,1.0,1.0,27/72,24.91%,CD74;AGPAT1;IKBKG;TRADD;BIRC2;JAK2;TRIM44;SUMO1;CBFB;SPATA2;RACK1;CFLAR;RBCK1;ELF1;RUNX1;PIAS1;CD24;CASP8;IKBKB;RIPK1;SYK;PTPN11;HIPK1;ABCE1;VRK2;MADD;IFNGR1
prerank,regulation of insulin secretion (GO:0050796),0.36912372956896505,0.8927640861966698,0.6940222897669707,1.0,1.0,14/101,16.78%,BLK;FOXA2;ITPR1;NR1D1;PRKCA;PICK1;KCNC2;EIPR1;DPP4;CDK16;MCU;IRS1;TCF7L2;CAPN10
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.41294663835352935,0.8927448201009272,0.6055488540410132,1.0,1.0,4/23,16.22%,EPHX2;HPGD;LTA4H;GSTM1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3671974000112195,0.8924410350102532,0.7313131313131314,1.0,1.0,45/149,21.03%,IL18RAP;PIDD1;S100A9;RPS6KA5;TFRC;CAV1;IKBKG;S100A8;TRADD;DDRGK1;CIB1;TAB1;UBE2V1;ERC1;MTPN;TAB3;ZBTB7A;CARD9;BTK;DHX9;PRKCB;MYD88;TRIM68;FLOT1;CFLAR;PPIA;TLR6;TRIM5;RBCK1;TNFRSF11A;TRIM37;UBA52;MAP3K7;FLOT2;MALT1;RPS3;LGALS9;TRAF6;PRKD2;ALK;UBE2N;AIM2;SLCO3A1;IKBKB;RIPK1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3765015418710516,0.8921455202373658,0.6788247213779128,1.0,1.0,19/95,14.60%,MEN1;VASN;STK11;CAV1;PMEPA1;PIN1;ZBTB7A;PDPK1;HIPK2;TRIM33;SMAD4;SNX25;BCL9L;SPRED2;ING2;LATS1;CREBBP;SKI;RNF111
prerank,catecholamine metabolic process (GO:0006584),-0.3339030862517631,-0.8919429802797094,0.583969465648855,0.8647324225236548,1.0,3/14,12.01%,SNCAIP;RNF180;PRKN
prerank,cell-cell junction assembly (GO:0007043),-0.22123295074287785,-0.8915054156433921,0.72,0.8644750700145953,1.0,17/63,15.95%,CDH11;CDH8;PATJ;CTNNB1;CTNND1;CDH2;CLDN11;CDH12;JUP;FLCN;EPB41L3;ACTB;SMAD7;GJA1;PIP5K1C;TLN2;TRPV4
prerank,cellular response to growth factor stimulus (GO:0071363),0.3715083998668503,0.8913626297322359,0.724172517552658,1.0,1.0,42/151,23.72%,KNSTRN;ADAMTS7;SOX6;CD44;HAS1;CRKL;KIDINS220;SETX;ZFP36L1;PDE2A;NOTCH1;CIB1;MAPK14;EGFR;PDPK1;EMD;SMAD4;BMPR1A;STAT5B;NRP1;RACK1;RAB35;LIMS1;APPL1;ZFP36L2;DUSP22;PLCG1;PDE8A;IQGAP1;MED1;SOX9;PRKD2;DSTYK;ACVR2B;MAPT;SEMA6A;ACVR1B;NTRK3;PTPN11;ZPR1;EHD1;ITGB1BP1
prerank,alpha-amino acid catabolic process (GO:1901606),0.40803819643816086,0.8913152364563977,0.6137184115523465,1.0,1.0,4/29,11.99%,HAAO;KMO;PRODH;FAH
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.30027367806359867,-0.891173858614508,0.5772727272727273,0.8639087256967615,1.0,11/19,28.90%,ITGAM;TLR4;NMI;LY96;TIRAP;ITGB2;TICAM2;PIK3AP1;SCIMP;CD14;TNIP3
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.44548006424916514,0.8910389519224893,0.6212319790301442,1.0,1.0,5/15,22.80%,TWIST1;EIF4A3;NIPBL;MTHFD1L;FGFR2
prerank,potassium ion import across plasma membrane (GO:1990573),0.39337632120738697,0.8902415151518165,0.6441048034934498,1.0,1.0,6/41,13.04%,SLC12A3;SLC12A7;SLC12A1;KCNJ3;SLC12A6;KCNJ2
prerank,autophagosome organization (GO:1905037),0.38316297399638594,0.8901870376929716,0.6472491909385113,1.0,1.0,11/50,16.97%,EMC6;ATG13;RAB1B;UBQLN1;TMEM41B;BECN1;AMBRA1;RAB43;TP53INP2;ATG101;ATG2B
prerank,endoderm development (GO:0007492),0.4461011629480741,0.8900965640805198,0.5892617449664429,1.0,1.0,2/13,18.31%,LAMC1;KIF16B
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.2897286097813593,-0.8899317789574978,0.5789473684210527,0.8655138461511459,1.0,6/22,15.97%,PTPRK;PRKD1;SRSF6;EPB41L4B;ZFP36;MDK
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3720719264933369,0.8896813164963122,0.7134207870837538,1.0,1.0,26/113,19.28%,ERCC4;RPA2;CHD1L;TFRC;FAF1;ATM;TERF1;RPA1;ERCC3;PSMC3;PARK7;SUMO1;MYD88;PSMC4;RACK1;TLR6;RPA3;BRK1;GSK3B;TP53;USP50;DDB2;SNCA;GNL3L;SLF1;RPS3
prerank,heart morphogenesis (GO:0003007),0.387911869139219,0.8891005179341219,0.6418703506907545,1.0,1.0,8/50,16.23%,HEY2;ZFPM1;FLRT2;MDM4;NOTCH1;BMPR1A;NIPBL;TGFB2
prerank,maturation of LSU-rRNA (GO:0000470),0.4069365593671879,0.8886862603151484,0.6216530849825378,1.0,1.0,8/26,20.02%,RPL7;DDX18;URB1;NIFK;ZNHIT6;NSA2;PES1;EIF6
prerank,histone H3 deacetylation (GO:0070932),0.43745365904263184,0.8884259781340957,0.6171875,1.0,1.0,8/15,22.40%,ELK4;SIRT7;SIRT1;HDAC4;HDAC1;HDAC8;SMARCAD1;HDAC9
prerank,regulation of interleukin-8 production (GO:0032677),0.37179973318225046,0.8882496366332596,0.6494845360824743,1.0,1.0,11/69,15.41%,CD2;CD74;PTPN22;HMGB1;PARK7;MYD88;F3;TLR5;DDIT3;TLR6;F2R
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.46062303490776735,0.8877468176620322,0.5745554035567716,1.0,1.0,4/10,15.41%,PRKD3;PICK1;DGKD;F2R
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3711183053318509,0.887525417811875,0.6718426501035196,1.0,1.0,22/75,22.20%,HMGB2;EMC10;PGF;HMGB1;AKT3;PRKCA;PDPK1;VASH2;F3;AGGF1;NRP1;MYDGF;EGF;FGFR1;PLCG1;SIRT1;APLN;PROX1;PRKD2;EGFL7;PPP1R16B;ITGA4
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.2223802443166032,-0.887436672902243,0.8125,0.8696350575895487,1.0,15/63,13.00%,TREM2;TBC1D14;TIMP2;KDM4A;HGF;MCL1;ATRAID;TIMP3;FOXK1;EIF4G3;GSK3A;GOLGA2;WASHC1;STAT3;ZKSCAN3
prerank,glycogen metabolic process (GO:0005977),0.4136793938959553,0.8873675171947981,0.6301703163017032,1.0,1.0,6/27,15.27%,PGM2;NR1D1;PHKA2;PRKAG2;GSK3B;GBE1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4157228505601989,0.887354409497635,0.6126582278481013,1.0,1.0,7/20,23.16%,CCNYL1;MAPRE3;EGFR;PROX1;PKD2;CCND3;ADAM17
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.2800203458426763,-0.8871316668183121,0.6402439024390244,0.8690428718789757,1.0,7/21,18.44%,CSF1R;CMKLR1;AKIRIN1;PTK2;CSF1;MDK;THBS1
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4417257774417707,0.8866896614639088,0.6073697585768743,1.0,1.0,3/16,11.66%,RIPOR2;MAPK14;PLCB1
prerank,protein modification process (GO:0036211),0.3741413304783328,0.886450617291729,0.668724279835391,1.0,1.0,22/76,18.92%,PIGH;UBE2I;MSRA;LCMT1;UBL5;ST3GAL1;SLC35A1;STK38;ST8SIA4;SEPHS1;PHKA2;BAP1;FBXO11;CHRM3;PRKDC;NTAQ1;USP25;DUSP12;ADPRH;UBA52;UBE2M;ICMT
prerank,protein localization to cell-cell junction (GO:0150105),0.4382885065185991,0.8860148498161332,0.6025974025974026,1.0,1.0,2/15,4.48%,TJP3;ARHGEF18
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.45212834150291625,0.88585729790136,0.6161202185792349,1.0,1.0,4/12,18.66%,TSPO;STARD3NL;TSPOAP1;FDXR
prerank,cardiac conduction system development (GO:0003161),0.40811974948811713,0.8855961264823563,0.6206088992974239,1.0,1.0,3/24,12.44%,HEY2;SMAD4;BMPR1A
prerank,negative regulation of macroautophagy (GO:0016242),-0.26526724270503477,-0.8854159062813595,0.6474358974358975,0.8714789591202975,1.0,11/26,27.78%,FEZ2;FEZ1;TSC1;PINK1;TSC2;CHMP4B;CHMP4A;LZTS1;CLEC16A;SEC22B;RUBCN
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.31728180873433953,-0.8853863972440249,0.6130434782608696,0.8702527044785441,1.0,1/15,0.14%,ACVR1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.4004449896343013,0.8853747676969194,0.6342857142857142,1.0,1.0,12/30,22.03%,FOXP1;HDAC6;H3-3A;SMARCA4;ZBTB7A;PARK7;TRIM68;KDM4C;SIRT1;HDAC1;NCOA2;RNF6
prerank,activation of adenylate cyclase activity (GO:0007190),-0.25810119525359965,-0.8850776756348777,0.6610169491525424,0.8696168049955517,1.0,9/35,20.94%,ADCY7;ADCY2;CAP2;LGR5;ADORA3;ADRB1;ADRB2;ADCY5;EDNRA
prerank,organelle fission (GO:0048285),-0.29677142476557006,-0.8850216533864044,0.611764705882353,0.868431152163782,1.0,9/24,16.69%,DNM2;DNM3;CORO1C;DNM1L;PEX19;MIEF1;PRKN;MFF;MTFR1L
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.29728896306728786,-0.8848569974067344,0.6571428571428571,0.8675052475748282,1.0,7/20,19.35%,NUMB;BCL2L1;AP2M1;RHOQ;PPFIA1;PKDCC;CSK
prerank,camera-type eye development (GO:0043010),0.4066131540077199,0.8846098175540811,0.6196172248803827,1.0,1.0,3/25,13.79%,CYP1B1;SHROOM2;SKI
prerank,regulation of microtubule-based process (GO:0032886),0.39642573406649834,0.8843862407491322,0.6071428571428571,1.0,1.0,15/36,22.29%,AURKA;CLASP1;HDAC6;MARK2;EPHA3;ATF5;DIAPH1;GSK3B;MARK4;TAOK1;MEMO1;ROCK1;MAPT;KLHL42;PHLDB1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3698527064109659,0.8843766476746603,0.6883248730964467,1.0,1.0,21/102,17.73%,NR4A2;C2CD5;SLC2A4;USF1;CRHBP;CAV1;FOXO1;DENND4C;SORBS1;ZFP36L1;RAB8A;PRKACA;PDPK1;KAT2B;RAB8B;PRKDC;IRS1;CAPN10;XBP1;ADCY8;EPRS1
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.3940502128500356,0.8842422635730213,0.6240179573512907,1.0,1.0,4/35,10.32%,IL12A;CAV1;CAV2;NR2F2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.4404721342945511,0.8840833604734898,0.6365979381443299,1.0,1.0,3/16,6.72%,PIGH;PIGF;PIGA
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4389311567769867,0.8835906837125727,0.6019021739130435,1.0,1.0,3/14,10.76%,RASGRP1;PAEP;CARD9
prerank,mitochondrial genome maintenance (GO:0000002),0.4648196667270018,0.8833269889236115,0.596931659693166,1.0,1.0,4/11,14.72%,AKT3;LONP1;TOP3A;MPV17
prerank,cellular component maintenance (GO:0043954),0.4539398654125531,0.882987738087343,0.6122159090909091,1.0,1.0,3/12,8.52%,FYN;MTMR2;PICK1
prerank,defense response to tumor cell (GO:0002357),-0.37064442200313286,-0.8829606534872618,0.6052631578947368,0.8706766931996736,1.0,6/10,33.85%,SPI1;PRDX2;KLF4;RBMS3;ABI3;DLEC1
prerank,acute-phase response (GO:0006953),0.4528276484395643,0.8825102258066994,0.6167582417582418,1.0,1.0,1/12,10.43%,IL22
prerank,endothelial cell migration (GO:0043542),0.3802832972275908,0.8824355350075589,0.6294642857142857,1.0,1.0,5/37,12.89%,CYP1B1;FAP;PRKX;DPP4;NRP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.36553684829400734,0.882388006386705,0.7108433734939759,1.0,1.0,16/121,13.81%,IL12A;TNFRSF18;PECAM1;ERBB3;CD74;CD44;NEDD9;GPRC5B;BANK1;PLCG2;JAK2;PARP14;RELN;FLT3;NRP1;PIBF1
prerank,protein stabilization (GO:0050821),0.36439033223619965,0.8823245238659929,0.7537537537537538,1.0,1.0,46/168,20.43%,GTSE1;USP27X;CHEK2;TSPAN1;FLNA;FKBPL;CRTAP;NAPG;CCT7;RPS7;TAF1;MDM4;CCT2;TCP1;PIN1;PIM2;TRIM44;PARK7;SUMO1;CCT5;PTEN;NAA16;HCFC1;FLOT1;BAG3;BAG1;TYROBP;ATF7IP;STK4;PDCD10;TAF9;VHL;PARVA;CAMLG;USP7;SYVN1;FLOT2;MORC3;CREB1;RPL5;CDKN1A;STK3;CCT6A;HPS4;RPL23;NCLN
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.3161002160070232,-0.8822187650246504,0.6098654708520179,0.870968340871858,1.0,3/16,7.88%,PADI2;PPARGC1B;AR
prerank,carboxylic acid catabolic process (GO:0046395),-0.3392191330669057,-0.88217624384652,0.6031746031746031,0.869758466928971,1.0,7/12,29.32%,NAGK;NPL;GNPDA1;GNPDA2;AMDHD2;IL4I1;RENBP
prerank,Golgi to endosome transport (GO:0006895),-0.31744326524497735,-0.8819125266182166,0.6064814814814815,0.8690231571885767,1.0,4/16,8.39%,RAB14;GBF1;VPS13C;WIPI1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.22470886076819968,-0.8814395046336807,0.7454545454545455,0.8688052671091518,1.0,17/57,19.83%,APP;DLGAP4;GRIA1;GRIA4;DLG2;SHISA6;MINK1;CACNG2;CACNG7;DLGAP2;LRRC7;CAMK2B;DLG1;DLGAP3;DLG4;GSG1L;PRRT1
prerank,cellular response to gamma radiation (GO:0071480),0.44351854881186686,0.8810727420523483,0.6323155216284987,1.0,1.0,8/17,24.28%,ATM;XRCC6;TP53;MAP3K20;TMEM109;WRN;MDM2;TLK2
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4040521896958069,0.8798382431752583,0.6183115338882283,1.0,1.0,4/27,8.59%,CD47;CD44;CCR2;CYRIB
prerank,cellular response to glucose stimulus (GO:0071333),-0.2565742752124358,-0.8793907670188199,0.688,0.872189073674783,1.0,8/30,16.50%,IGF1R;SELENOT;PRKAA2;ERN1;SLC39A14;PTPRN;SOX4;RAB11FIP5
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.36405523762477987,-0.8791400209119824,0.5860805860805861,0.8714781008719412,1.0,3/10,12.96%,IMPACT;ENG;MVP
prerank,positive regulation of peptidase activity (GO:0010952),0.4160712707832676,0.8787515645847747,0.6226415094339622,1.0,1.0,4/20,13.51%,RCN3;TANK;DDRGK1;PSME1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.4473384666240977,0.8787022266025728,0.6040816326530613,1.0,1.0,2/13,7.20%,GLS2;PRODH
prerank,membrane depolarization during action potential (GO:0086010),-0.2750626553712816,-0.8782033902947542,0.6026490066225165,0.8722183513712076,1.0,10/26,18.55%,SCN8A;CACNA1C;SCN1A;SCN9A;SCN3A;SCN1B;HCN2;SLC8A1;ATP1A2;CACNA1G
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.36650936748962293,0.8781171959508377,0.7008196721311475,1.0,1.0,24/93,23.06%,NTF4;CD44;AXIN1;TFRC;CAV1;GPD1L;HDAC6;EGFR;TXN;PARK7;PTEN;RACK1;LATS1;STK4;PDCD10;NLRP2B;HCLS1;SNCA;PRKD2;ARAF;CAPRIN2;ATP2B4;NTRK3;NSD1
prerank,proteolysis (GO:0006508),0.36207924229698807,0.8778896772146011,0.7927927927927928,1.0,1.0,53/252,21.14%,PRTN3;TMPRSS4;TMPRSS3;ADAMTS7;KEL;NAPSA;SENP1;FAP;FBXO3;CPA6;CPM;CASP2;DESI2;DESI1;CTSE;METAP2;SPCS1;PITRM1;CAPN1;LONP1;ATG4B;VASH2;FAM111A;DPP4;PSMC4;CTSO;CTSK;F3;MMP19;PSEN1;PCSK1;ADGRV1;CPD;VHL;CAPN10;USP25;NAALAD2;SPPL3;MALT1;SENP6;ADAM10;ERAP1;RNPEP;SUFU;CLN3;PCSK7;CASP8;MMP12;MME;SPCS3;PRCP;CAPN15;MDM2
prerank,postsynaptic membrane organization (GO:0001941),0.4225750243949314,0.877564000703792,0.617157490396927,1.0,1.0,5/17,18.97%,CEL;LRP4;NRXN2;GPHN;NRXN1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.24488490275134078,-0.8773942405452285,0.6759259259259259,0.8726522431351046,1.0,9/40,14.30%,AHI1;PPT1;CD63;ARRB1;WASL;TBC1D5;ANGPT1;VEGFA;SERPINE1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2607789899483108,-0.8772005933061071,0.6792452830188679,0.8717785184378116,1.0,13/26,31.73%,BCL2L1;MCL1;HTRA2;PPP2R1B;IL1A;UNC5B;EYA2;MAPK7;BCL2;PF4;RET;INHBA;IL1B
prerank,membrane lipid metabolic process (GO:0006643),0.41217496024617817,0.8771886327891532,0.6302211302211302,1.0,1.0,1/22,1.41%,CYP1B1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4566766733296654,0.8767479094132484,0.6137339055793991,1.0,1.0,5/10,20.81%,JUN;BAG3;DNAJB1;VHL;CITED2
prerank,positive regulation of B cell activation (GO:0050871),0.3849288003938185,0.8765506894670843,0.6710239651416122,1.0,1.0,10/50,17.11%,TNFSF13B;CD38;CD74;TFRC;PPP2R3C;BTK;KMT5C;PAXIP1;RIF1;XBP1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.45923272627074235,0.8764947015584662,0.6072992700729927,1.0,1.0,5/11,22.68%,ABCA2;ABCA7;AGO2;NECAB1;SOAT1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.4482599887230959,0.8762841460054067,0.611764705882353,1.0,1.0,5/13,22.88%,SORBS1;ZBTB7B;IRS1;SIRT1;PTPN11
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.37095098562140505,0.8757259113956851,0.6863354037267081,1.0,1.0,22/73,23.23%,BLK;MAPK1;FYN;PRKCE;CYFIP2;GRB2;PLCG2;CRK;PLD2;BRK1;ELMO2;PLCG1;PIK3CA;RAC1;FCGR2B;VAV3;SYK;FGR;ACTG1;NCKIPSD;PRKCD;SRC
prerank,regulation of p38MAPK cascade (GO:1900744),0.3910474657102386,0.8756555929972066,0.6579247434435576,1.0,1.0,5/35,5.38%,EZR;ULK4;EMC10;PTPN22;RASGRP1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.2198872679805042,-0.875612889242615,0.7758620689655172,0.8740401263294094,1.0,19/59,24.37%,OSBPL2;ACLY;LPL;ACACA;OSBPL9;OSBPL7;ALOX5;SCP2;OSBPL6;OSBP;CH25H;HOGA1;LIPH;PER2;CYP39A1;MLYCD;AMACR;OXSM;MCAT
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.441940189271451,0.875553945110339,0.6216216216216216,1.0,1.0,4/13,13.39%,PIM1;NAPEPLD;ZBTB7B;HNRNPU
prerank,phospholipid translocation (GO:0045332),0.40548549886057633,0.8754932148475523,0.6169965075669382,1.0,1.0,9/28,20.72%,ATP11C;ATP8B4;ABCA7;ATP8A1;ATP11B;TMEM30A;ANO6;ATP11A;ATP8B2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.45872021151814574,0.8754861445344778,0.6348314606741573,1.0,1.0,6/11,27.39%,BIRC2;CASP8;RIPK1;SLC25A4;ARHGEF2;NUPR1
prerank,polyamine metabolic process (GO:0006595),0.44844948136349616,0.8749813808154898,0.6303191489361702,1.0,1.0,4/13,12.62%,HDAC10;HDAC6;DHPS;SMS
prerank,response to cytokine (GO:0034097),0.36085158905766906,0.8748372415102288,0.7244488977955912,1.0,1.0,32/141,19.95%,FOXA2;AFF3;MEFV;LEF1;CD74;PML;MAPKAPK3;SP100;PRKCA;JAK2;XAF1;IL1R1;PTPN7;PTPN14;FLT3;MYD88;IFITM3;PTPN5;TNFRSF11A;TAF9;JAK3;LDLRAP1;HCLS1;CXCR4;PTPN13;SNCA;HDAC4;ADAM10;LGALS9;TRAF6;CASP8;MME
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.37041583502703324,0.8744578344744598,0.6840458811261731,1.0,1.0,19/70,17.02%,PSMB7;PSMD11;PSMF1;IKBKG;PSMC1;TAP1;ITGAV;PSMC3;PSMA4;B2M;PSMC4;PSMD13;PSME1;PSMB1;CYBB;PSMD8;PSME4;PSMD4;CYBA
prerank,calcium ion transport into cytosol (GO:0060402),0.41384275043548785,0.874355163999485,0.6167076167076168,1.0,1.0,1/21,1.23%,MS4A1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.37554939216371486,0.8742934246976661,0.6405228758169934,1.0,1.0,14/48,23.16%,NUS1;HMGB1;AKT3;CIB1;PRKCA;MAPK14;PDPK1;FGFR1;PLCG1;SIRT1;ATP5F1B;PRKD2;HDAC9;ADAM17
prerank,response to zinc ion (GO:0010043),-0.2680126639660635,-0.8737426795122489,0.6586826347305389,0.876873862534471,1.0,12/25,20.00%,GLRA2;SLC30A4;MT1E;MT1F;MT1G;MT1B;MT1M;MT1A;MT1H;MT1X;MT2A;P2RX4
prerank,external encapsulating structure organization (GO:0045229),0.36025572857979776,0.8735638417587637,0.761,1.0,1.0,35/205,17.47%,ADAMTS7;ICAM4;ITGA1;ECM2;ITGB7;CD47;PECAM1;HSPG2;CD44;LAMA5;COL1A2;LAMA4;DCN;COL4A4;LAMC1;LAMB2;LAMB3;ITGAV;SMOC2;JAM2;ATP7A;NID1;BSG;ITGA8;COL23A1;MMP19;DAG1;ADAMTS1;TGFBI;ELN;ST7;ADAMTSL3;ADAMTS5;COL4A1;FN1
prerank,regulation of ion transmembrane transport (GO:0034765),0.393630472688457,0.8732328585146901,0.6399548532731377,1.0,1.0,9/33,23.69%,NEDD4L;KCNJ3;KCNJ2;CHRM3;YWHAE;ANO6;KCNJ10;NEDD4;WNK3
prerank,fatty acid transport (GO:0015908),-0.311467068029666,-0.8731249655510622,0.6434426229508197,0.8769025507717385,1.0,3/17,5.48%,APOE;SLC27A1;GOT2
prerank,regulation of isotype switching (GO:0045191),0.43764495567359757,0.8731012307874283,0.6089918256130791,1.0,1.0,4/14,16.90%,TFRC;KMT5C;PAXIP1;RIF1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.39184708565428167,0.8728290405867823,0.6274738067520372,1.0,1.0,8/30,18.82%,HACD4;ABCD1;ACOT2;SLC27A2;PEX2;ELOVL5;ELOVL4;ABCD4
prerank,regulation of endocytic recycling (GO:2001135),0.4550556062264482,0.8723146905577088,0.6348074179743224,1.0,1.0,6/11,23.47%,ACTN2;EIPR1;RAB11B;ARHGAP1;INPP5F;EHD1
prerank,protein trimerization (GO:0070206),0.43234724682133024,0.8715562867490048,0.635752688172043,1.0,1.0,4/14,20.25%,SLC1A5;SIGMAR1;DISP1;PNPT1
prerank,protein homotrimerization (GO:0070207),0.43234724682133024,0.8715562867490048,0.635752688172043,1.0,1.0,4/14,20.25%,SLC1A5;SIGMAR1;DISP1;PNPT1
prerank,homotypic cell-cell adhesion (GO:0034109),-0.23709560577130415,-0.8709060912439546,0.7127659574468085,0.8805205307148222,1.0,17/39,25.94%,UBASH3B;FERMT3;P2RY12;GNAS;RAP2B;TJP2;ITGB3;ACTB;PIK3CB;METAP1;MEGF11;PLEK;PLPP3;STXBP1;MEGF10;MYL12A;TYRO3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4360933331923321,0.8707981511924527,0.6011004126547456,1.0,1.0,2/13,5.07%,ALG8;ALG14
prerank,sulfur compound catabolic process (GO:0044273),0.38512351506333514,0.8707227056283133,0.6487093153759821,1.0,1.0,6/38,13.67%,FMOD;GALNS;DPEP1;DCN;OGN;ARSB
prerank,positive regulation of protein modification process (GO:0031401),0.36250749696746676,0.8706844359642143,0.7827827827827828,1.0,1.0,60/203,23.59%,CDCA2;PECAM1;RAMP1;PTPA;CCN1;CD74;ANKLE2;AXIN1;BRAT1;PGF;CEP295;TFRC;RASGRP1;CRKL;PPP2R5A;PIN1;NIBAN1;CIB1;EGFR;P2RY1;TXN;DYRK1A;WDFY2;FGF9;FAS;CNEP1R1;FXR1;ROCK2;RACK1;FLOT1;FAM20A;MYDGF;PPIA;CAMTA1;STK4;LIMK2;RAC1;PDE8A;SIRT1;SPPL3;LRRK2;TAOK1;FAM161A;AKTIP;SOX9;SVIP;CCND3;ILK;UBE2N;SLCO3A1;RIPK1;CALM3;PPP1R16B;EFNA1;NTRK3;ASPSCR1;ADAM17;PRKCD;C3;SMPD1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4053581955843759,0.8706308851657231,0.6457073760580411,1.0,1.0,6/26,18.88%,RNF26;DHX58;PCBP2;NLRC3;TRAFD1;PPM1B
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4308795207352039,0.8705429191054299,0.6163849154746424,1.0,1.0,5/15,16.99%,CD74;CD44;ING2;TAF9;SIRT1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.4179757161514613,0.8704484534547051,0.625,1.0,1.0,5/18,11.57%,EZR;FAF1;ABCA2;MSN;RDX
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.45258856925603136,0.8701432708932483,0.6199158485273493,1.0,1.0,3/11,14.73%,ATL2;ARL6IP1;VCPIP1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.26210687341549643,-0.8699399908073595,0.6625,0.8813505326924574,1.0,7/26,16.08%,KCNAB1;ANK2;ATP1B2;FHL1;VAMP2;ATP1B1;DLG1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3896422502988886,0.8699162200534845,0.643507972665148,1.0,1.0,9/31,19.96%,PEX26;CHCHD4;DNAJC15;PEX2;TOMM70;TIMM23;GRPEL2;PEX14;TOMM40L
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.39697523745093816,0.869568110718283,0.649643705463183,1.0,1.0,9/29,21.03%,TANK;IKBKG;TRAF3;BIRC2;TLR6;UBA52;CASP8;IKBKB;RIPK1
prerank,early endosome to late endosome transport (GO:0045022),-0.29587402586685474,-0.8695300405385683,0.6347826086956522,0.8809254033009293,1.0,7/20,20.51%,WDR91;EEA1;ANKRD27;SNX16;HOOK2;HOOK3;PTPN23
prerank,membrane lipid biosynthetic process (GO:0046467),0.37305978762504144,0.8695024448998266,0.6733193277310925,1.0,1.0,16/58,20.19%,SGMS2;HACD4;PRKD3;CSNK1G2;ST3GAL2;VAPA;CERS4;SGMS1;ELOVL5;CERS6;ELOVL4;ACER3;GBGT1;CERS2;PRKD2;ST8SIA6
prerank,icosanoid metabolic process (GO:0006690),0.3794376412747206,0.8693810321557793,0.6511111111111111,1.0,1.0,7/40,13.12%,CYP1B1;DPEP2;DPEP1;HPGD;LTA4H;ABCC10;PON3
prerank,protein O-linked mannosylation (GO:0035269),-0.28725757340411767,-0.869324816490363,0.6105769230769231,0.8800971110149501,1.0,3/18,6.89%,CRPPA;LARGE1;FKTN
prerank,negative regulation of lyase activity (GO:0051350),0.4222186352297377,0.8691833258467828,0.6246648793565683,1.0,1.0,4/16,19.26%,PALM;CCR2;ADGRV1;GRM3
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.36087168190050967,0.8691055588808682,0.7665330661322646,1.0,1.0,47/186,19.87%,JADE1;PSMB7;LRP4;PSMD11;AXIN1;PSMF1;STK11;NXN;CAV1;CCDC88C;CSNK1A1;PSMC1;FUZ;TLE4;CUL3;HMGXB4;PFDN5;PSMC3;AMFR;RUVBL2;EMD;PSMA4;PSMC4;TMEM131L;RACK1;PSMD13;PSME1;DDIT3;LATS1;PSMB1;GSK3B;STK4;LIMD1;PTPRU;PSMD8;TCF7L2;PSME4;PSMD4;LMBR1L;TMEM170B;AMER2;TLE3;RNF43;HDAC1;STK3;SOX9;NPHP4
prerank,response to retinoic acid (GO:0032526),0.37177406160238147,0.8689141140107524,0.6799163179916318,1.0,1.0,12/59,19.46%,AQP1;ATM;SETX;EPHA3;CDKN2D;ASXL1;PTK7;RXRB;RARG;CREB1;PAX2;SOX9
prerank,protein targeting (GO:0006605),-0.1975272120177863,-0.8683759779908112,0.9090909090909091,0.8807453238999063,1.0,48/118,27.15%,SRPRA;RAB3IP;TOMM40;PRKCI;DNAJC19;SPCS2;AP4S1;ZFAND2A;GOLGA7;LAMP2;MFN2;MYO1C;FUT10;RABGEF1;TIMM17A;PEX19;SEC61G;GIPC1;SEC61A1;BCAP31;NCF1;SRPRB;LONP2;CDC37;RTP4;ARL6;MFF;ZDHHC24;AIP;PEX1;SRP14;ZDHHC20;TIMM22;TIMM10B;ZDHHC15;FBXO7;MICALL1;PARD3;VPS37C;TIMM13;ZDHHC3;TOMM7;KIF13B;TOMM22;EDEM1;ZDHHC12;TIMM8B;PEX16
prerank,neutrophil degranulation (GO:0043312),0.36243159285816645,0.8681106677660094,0.87,1.0,1.0,94/425,18.64%,PRTN3;RAB44;MS4A3;CHRNB4;CD177;P2RX1;PGLYRP1;PGM2;ABCA13;MAPK1;CD47;PECAM1;CLEC12A;MAGT1;ATP8B4;PSMB7;S100A11;PSMD11;CAMP;CD44;APAF1;GALNS;PA2G4;S100A9;TUBB4B;SLPI;FRMPD3;CNN2;GMFG;S100A8;GSN;CCT2;NFAM1;XRCC6;HMGB1;SLCO4C1;DYNC1H1;ILF2;MAPK14;DBNL;FAF2;DNASE1L1;ITGAV;KCMF1;CAPN1;IMPDH2;IRAG2;SLC27A2;PSMC3;LTA4H;ORMDL3;B2M;TUBB;ATP8A1;VAPA;CRACR2A;DNAJC13;ARHGAP9;PSMD13;ARHGAP45;ARSB;PSEN1;ATP11B;PPIA;DIAPH1;COMMD9;PSMB1;TYROBP;SCAMP1;LAMTOR3;PLD1;DYNLL1;SPTAN1;ARMC8;GCA;CYBB;PDXK;HVCN1;NBEAL2;EEF2;SLC2A3;KPNB1;RAC1;GLIPR1;CYBA;CANT1;TMEM30A;ANO6;IQGAP1;ADAM10;RAB6A;FUCA1;PPIE;CKAP4
prerank,regulation of biosynthetic process (GO:0009889),-0.34078919687717885,-0.8679821855842245,0.6319218241042345,0.8803141504472117,1.0,5/11,33.90%,ALOX5;SPHK2;MID1IP1;THRSP;SLC25A33
prerank,peptidyl-lysine dimethylation (GO:0018027),0.41972344550560103,0.8676308967447134,0.6301020408163265,1.0,1.0,7/18,22.64%,SUV39H1;EHMT1;KMT2A;KMT2B;ASH1L;SETD7;EEF1AKMT2
prerank,regulation of lipid metabolic process (GO:0019216),0.36665089213747193,0.8675648435913085,0.7036659877800407,1.0,1.0,26/88,20.70%,PANK2;LSS;CAV1;NR1D1;EDF1;SIN3B;IDI1;ABCA7;NFYC;FASN;ADIPOR1;BBS4;HELZ2;PRKAG2;CREBBP;RUBCNL;FDPS;DHCR7;SIN3A;MED1;CERS2;TBL1XR1;SREBF2;NCOA6;NCOA2;PPARD
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.3194844612628364,-0.8670929834494769,0.6334661354581673,0.8809623378372011,1.0,6/15,16.15%,ABHD12;GOT2;ABHD16A;GGT5;HOGA1;CHAC2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.3700394043698219,0.8669439608719601,0.6854166666666667,1.0,1.0,11/69,14.50%,CD2;SPN;TWIST1;CCR2;RASGRP1;HMGB1;PLCG2;JAK2;DHX9;PSEN1;TYROBP
prerank,negative regulation of response to wounding (GO:1903035),-0.29251817119589335,-0.8667325197484211,0.6359447004608295,0.8804200671350304,1.0,6/19,16.21%,PTPRS;ALOX5;FGF2;SERPINE1;MDK;EPHA4
prerank,neutrophil activation involved in immune response (GO:0002283),0.3614049868717969,0.8663217153005391,0.872,1.0,1.0,94/428,18.64%,PRTN3;RAB44;MS4A3;CHRNB4;CD177;P2RX1;PGLYRP1;PGM2;ABCA13;MAPK1;CD47;PECAM1;CLEC12A;MAGT1;ATP8B4;PSMB7;S100A11;PSMD11;CAMP;CD44;APAF1;GALNS;PA2G4;S100A9;TUBB4B;SLPI;FRMPD3;CNN2;GMFG;S100A8;GSN;CCT2;NFAM1;XRCC6;HMGB1;SLCO4C1;DYNC1H1;ILF2;MAPK14;DBNL;FAF2;DNASE1L1;ITGAV;KCMF1;CAPN1;IMPDH2;IRAG2;SLC27A2;PSMC3;LTA4H;ORMDL3;B2M;TUBB;ATP8A1;VAPA;CRACR2A;DNAJC13;ARHGAP9;PSMD13;ARHGAP45;ARSB;PSEN1;ATP11B;PPIA;DIAPH1;COMMD9;PSMB1;TYROBP;SCAMP1;LAMTOR3;PLD1;DYNLL1;SPTAN1;ARMC8;GCA;CYBB;PDXK;HVCN1;NBEAL2;EEF2;SLC2A3;KPNB1;RAC1;GLIPR1;CYBA;CANT1;TMEM30A;ANO6;IQGAP1;ADAM10;RAB6A;FUCA1;PPIE;CKAP4
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.3676522586004398,0.8663155288262463,0.6892307692307692,1.0,1.0,13/76,12.23%,BRCA1;SAE1;AXIN1;TANK;CAV1;UBA2;BIRC2;UBQLN1;CUL3;PIAS3;XIAP;CDK5RAP3;PAXIP1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.2612460679063537,-0.8656117830391807,0.6811594202898551,0.8815554017271429,1.0,14/28,32.79%,APP;SQSTM1;APOE;LGMN;NSG1;EPHA4;SHANK3;CALB1;AKAP5;SHISA7;CHRNA7;ADCY1;CALB2;EIF2AK4
prerank,AMP metabolic process (GO:0046033),0.43824408230571155,0.8655261938358754,0.6353741496598639,1.0,1.0,3/13,16.93%,AK9;ADSL;AK3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.4336904996222201,0.8655178564340846,0.625,1.0,1.0,4/13,16.64%,KPNA3;RANBP2;IPO5;KPNB1
prerank,phospholipid homeostasis (GO:0055091),0.4508906376069238,0.8652430815149311,0.6129476584022039,1.0,1.0,1/11,3.54%,RCN3
prerank,neutrophil mediated immunity (GO:0002446),0.3609288498025893,0.8651854576607093,0.876,1.0,1.0,95/432,18.64%,PRTN3;RAB44;MS4A3;CHRNB4;CD177;P2RX1;PGLYRP1;PGM2;ABCA13;MAPK1;CD47;PECAM1;CLEC12A;MAGT1;ATP8B4;PSMB7;S100A11;PSMD11;CAMP;CD44;APAF1;GALNS;PA2G4;S100A9;TUBB4B;SLPI;FRMPD3;CNN2;GMFG;S100A8;GSN;CCT2;NFAM1;XRCC6;HMGB1;SLCO4C1;DYNC1H1;ILF2;MAPK14;DBNL;FAF2;DNASE1L1;ITGAV;KCMF1;CAPN1;IMPDH2;IRAG2;SLC27A2;PSMC3;CARD9;LTA4H;ORMDL3;B2M;TUBB;ATP8A1;VAPA;CRACR2A;DNAJC13;ARHGAP9;PSMD13;ARHGAP45;ARSB;PSEN1;ATP11B;PPIA;DIAPH1;COMMD9;PSMB1;TYROBP;SCAMP1;LAMTOR3;PLD1;DYNLL1;SPTAN1;ARMC8;GCA;CYBB;PDXK;HVCN1;NBEAL2;EEF2;SLC2A3;KPNB1;RAC1;GLIPR1;CYBA;CANT1;TMEM30A;ANO6;IQGAP1;ADAM10;RAB6A;FUCA1;PPIE;CKAP4
prerank,mitochondrion distribution (GO:0048311),0.4405346537852488,0.8650442074784456,0.6463245492371706,1.0,1.0,7/12,25.75%,HAP1;MTM1;LRRK2;TRAK2;MAPT;ATCAY;TRAK1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2699907637041419,-0.8650069275311512,0.6621621621621622,0.8815702439798722,1.0,3/27,1.91%,C3AR1;GNA15;HTR2C
prerank,cytosolic calcium ion transport (GO:0060401),-0.2578269111415641,-0.8649279508083534,0.6971830985915493,0.8804629463656515,1.0,11/28,22.11%,CACNA1C;MCUR1;RYR2;ADRA1A;ATP2B3;JPH4;SLC8A1;ITPR3;MAIP1;AFG3L2;SMDT1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.356064032126581,-0.864609100994587,0.6446540880503144,0.8798765204000298,1.0,2/10,5.89%,TSNAX;TSN
prerank,defense response to virus (GO:0051607),0.3592937819832456,0.8634128123447397,0.7157360406091371,1.0,1.0,13/100,14.44%,RNASE6;PMAIP1;SKP2;FLNA;CGAS;SERINC5;SERINC3;PDE12;MYD88;CLPB;NT5C3A;IFITM3;TRIM5
prerank,regulation of macrophage differentiation (GO:0045649),-0.30488743209845154,-0.8632987071502464,0.680161943319838,0.8813789689909702,1.0,4/15,14.40%,PTPN2;C1QC;CSF1;ID2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.374746155113325,0.8630333988371431,0.6414253897550112,1.0,1.0,12/39,23.69%,GPD1L;YWHAH;FXYD5;NEDD4L;CHRM3;STK39;UTRN;YWHAE;RIPK1;PHB2;NEDD4;WNK3
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.463093720443902,0.8625624974003226,0.635116598079561,1.0,1.0,4/10,23.39%,NCBP1;CPEB3;NCBP2;LEO1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.2654499117033312,-0.8625390727391288,0.6505376344086021,0.8816901584877885,1.0,9/23,28.97%,UBASH3B;PSEN2;ANK2;PRNP;ATP1A2;CBARP;CACNB1;PTK2B;CAMK2D
prerank,positive regulation of defense response (GO:0031349),0.3628634926215273,0.8623198416696726,0.711340206185567,1.0,1.0,13/89,11.50%,CD47;IL16;CCN4;S100A9;GPRC5B;CCR2;S100A8;TRADD;PDE2A;IL17RA;RIOK3;NAPEPLD;DHX9
prerank,neutrophil activation (GO:0042119),-0.3348302918522878,-0.8619822492628079,0.6494464944649446,0.8815807444910496,1.0,2/12,6.67%,KMT2E;FCER1G
prerank,axonal transport of mitochondrion (GO:0019896),-0.3521708547992992,-0.8618678890629515,0.6418439716312057,0.8805379248620293,1.0,3/11,8.52%,ACTR10;SPAST;SYBU
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4001331091981255,0.8613076019071697,0.6352657004830918,1.0,1.0,7/25,16.84%,RIN3;MTMR2;ITGAV;ABCA2;PSEN1;ANKRD13A;RAC1
prerank,positive regulation of TOR signaling (GO:0032008),-0.2321331069159819,-0.861197513745731,0.7317073170731707,0.8806885258913233,1.0,12/40,18.86%,TREM2;GPR137C;RRAGD;HDAC3;WDR59;FLCN;FNIP1;LAMTOR5;NCKAP1L;RRAGC;PIH1D1;SIK3
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.2571567049456457,-0.8610830389959194,0.6714285714285714,0.8796738325614779,1.0,5/30,7.28%,CD274;CD34;HSPD1;PYCARD;TLR4
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.30551521538185544,-0.8610775901895179,0.6431718061674009,0.8784134377790531,1.0,5/15,17.82%,SLC27A1;SCARB1;CTDNEP1;FBXW7;GPLD1
prerank,anterior/posterior axis specification (GO:0009948),0.42614498946469115,0.8610498019143551,0.6286472148541115,1.0,1.0,3/15,16.10%,DDIT3;SKI;TASOR
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4009154053707097,0.860490230594439,0.6578947368421053,1.0,1.0,8/23,19.72%,MTMR12;MTMR2;PIP4P2;MTMR6;PTEN;MTM1;OCRL;INPP5F
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.31131860536861733,-0.8602438081048445,0.6417322834645669,0.8788924487741911,1.0,3/15,7.06%,WHRN;SCN1A;COL11A1
prerank,neuron differentiation (GO:0030182),0.3593510662965754,0.8601432275512864,0.7807807807807807,1.0,1.0,13/165,9.43%,FOXA2;VAX2;NR4A2;PBX4;NIF3L1;PBX3;RUNX3;PIN1;TDP2;IER2;MYEF2;MTPN;ERCC3
prerank,positive regulation of protein ubiquitination (GO:0031398),0.36488031057194587,0.8601167234267661,0.7119509703779366,1.0,1.0,13/80,12.23%,PLK1;BRCA1;AXIN1;CAV1;PEF1;BIRC2;PIN1;UBQLN1;CUL3;XIAP;SPSB4;CDK5RAP3;PAXIP1
prerank,heart contraction (GO:0060047),-0.2372524559983319,-0.8598241087904654,0.7524752475247525,0.8785444060441658,1.0,9/41,18.50%,SGCD;SGCZ;DMD;SCN1B;RYR2;ATP1B1;SLC8A1;GPX1;ATP1A2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.39455743359705797,0.8596453700350754,0.6601382488479263,1.0,1.0,7/30,17.01%,BATF;TNFRSF13B;FLT3;PRRC2C;TP53;HOXB4;LMBR1L
prerank,T cell activation involved in immune response (GO:0002286),0.43472128997290443,0.8591017607757468,0.6225071225071225,1.0,1.0,1/12,3.69%,CD74
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4102217214421305,0.8590706039914723,0.6317780580075663,1.0,1.0,7/20,19.45%,IL1R1;B2M;DENND1B;MAP3K7;MALT1;CD55;TRAF6
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.3999008178987689,0.8588033044434701,0.6560587515299877,1.0,1.0,9/26,25.72%,BRCA1;ADIPOR1;PRKAG2;ELOVL5;WDTC1;EIF6;NR1H3;PRKAB2;NR1H2
prerank,T cell receptor signaling pathway (GO:0050852),0.3548962260669518,0.858631484890385,0.7555110220440882,1.0,1.0,38/138,20.99%,ERMAP;GRAP2;FYN;PSMB7;PSMD11;FBXW11;PTPN22;PSMF1;IKBKG;PSMC1;PLCG2;BTN3A3;PDPK1;PSMC3;PSMA4;PSMC4;PRAM1;DENND1B;PSMD13;PSME1;THEMIS;PSMB1;RBCK1;RC3H1;PSMD8;PAK2;PSME4;PLCG1;PIK3CA;PSMD4;SPPL3;MAP3K7;MALT1;TRAF6;PRKD2;UBE2N;EIF2B5;IKBKB
prerank,negative regulation of receptor internalization (GO:0002091),0.4400724073519472,0.8585981220385897,0.642754662840746,1.0,1.0,4/12,21.65%,RIN3;MTMR2;ANKRD13A;UBQLN2
prerank,extracellular structure organization (GO:0043062),0.3544103937556409,0.8585429765534155,0.796,1.0,1.0,35/204,17.47%,ADAMTS7;ICAM4;ITGA1;ECM2;ITGB7;CD47;PECAM1;HSPG2;CD44;LAMA5;COL1A2;LAMA4;DCN;COL4A4;LAMC1;LAMB2;LAMB3;ITGAV;SMOC2;JAM2;ATP7A;NID1;BSG;ITGA8;COL23A1;MMP19;DAG1;ADAMTS1;TGFBI;ELN;ST7;ADAMTSL3;ADAMTS5;COL4A1;FN1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.4529922354325795,0.8583004974145513,0.6476608187134503,1.0,1.0,3/10,19.10%,PTPN22;AIDA;HIPK3
prerank,protein localization to cell surface (GO:0034394),0.39570063678431183,0.8582064166093993,0.6391875746714456,1.0,1.0,6/26,17.85%,CD177;FLNA;GGA1;PIGU;PTPRU;GGA2
prerank,UV protection (GO:0009650),0.4623550137504129,0.8581276607717886,0.6526772793053546,1.0,1.0,1/10,4.84%,FEN1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.3821984708991989,0.8581092648628676,0.6550169109357384,1.0,1.0,4/33,12.54%,IL12A;OGN;PTEN;EFEMP2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.2898994513305604,-0.8575786696294582,0.6492146596858639,0.8821023682216617,1.0,6/19,14.97%,TGFBR1;ERBB4;ZFPM2;FGF2;TGFBR3;VGLL4
prerank,regulation of RNA metabolic process (GO:0051252),0.36887520681947294,0.85757306929199,0.7085953878406709,1.0,1.0,17/59,21.52%,MBNL3;HNRNPL;ZNF326;NOVA2;METTL4;CLK4;PCBP2;RBM38;IGF2BP3;PCBP3;RC3H1;AHNAK;MED1;HNRNPLL;AFF2;PTBP2;CELF1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3626017826254123,0.8574040792442909,0.7182095625635809,1.0,1.0,18/85,16.98%,PSMB7;TIAM1;PSMD11;PSMF1;PSMC1;CLTC;PSMC3;PSMA4;ARRB2;PSMC4;AP2B1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;RAC1;PSMD4
prerank,regulation of RNA splicing (GO:0043484),0.36655440542560896,0.85721820307923,0.7251282051282051,1.0,1.0,27/69,25.81%,MBNL3;POLR2A;HNRNPL;SETX;SRSF3;ZNF326;METTL4;CLK4;RBM38;DYRK1A;METTL16;SRSF10;AHNAK;SRPK1;HNRNPLL;AFF2;PTBP2;CELF1;ZPR1;HNRNPK;CLK2;PTBP1;RBM22;HNRNPH1;YTHDC1;KHDRBS3;HNRNPH3
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4385483943833728,0.8563473761488233,0.6605890603085554,1.0,1.0,4/12,16.03%,NOTCH1;HNRNPU;NELFB;ZFP36L2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.285660273836843,-0.8556205874700056,0.7163461538461539,0.8848762467364287,1.0,10/19,29.71%,PTPRJ;GRM5;RYR2;BCAP31;PRNP;FKBP1B;KDR;ADGRL1;VCAM1;TRPM2
prerank,cardiac muscle cell contraction (GO:0086003),-0.29184507813937477,-0.8555906436984271,0.6666666666666666,0.8836689461386967,1.0,7/19,21.85%,CACNA1C;SCN1A;ATP1A1;SCN1B;FGF12;CACNA1G;SCN3B
prerank,positive regulation of blood coagulation (GO:0030194),0.421644539334566,0.8555100972262524,0.6368286445012787,1.0,1.0,6/17,23.72%,USF1;F3;F2R;ANO6;APOH;ENPP4
prerank,cellular response to ATP (GO:0071318),0.41669759274544793,0.8554205446810247,0.6351706036745407,1.0,1.0,3/14,17.49%,TAF1;P2RY1;HSP90B1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.3821767925232123,0.8553759420524673,0.6505073280721533,1.0,1.0,6/35,9.72%,STMN1;RIPOR2;ARHGAP35;TNFAIP1;CUL3;HEG1
prerank,regulation of activated T cell proliferation (GO:0046006),-0.2579878337046896,-0.8550437996518495,0.7209302325581395,0.8835239695263717,1.0,6/30,14.45%,PRKAR1A;CD274;PYCARD;IGF1;PRNP;IL18
prerank,regulation of response to external stimulus (GO:0032101),0.3512080248428547,0.8550285672725048,0.7640562248995983,1.0,1.0,28/121,19.45%,FOXA2;DHX58;PTPN22;FOXP1;CAV1;CCR2;TRAF3;BIRC2;BRD4;METAP2;JAK2;CYRIB;STK24;IL1R1;PARK7;XIAP;MYD88;USP14;SPATA2;BCL6;TRIM5;F2R;APPL1;FCGR2B;CXCR4;ERAP1;CD55;CASP8
prerank,acute inflammatory response (GO:0002526),0.3993618094034307,0.854975053079661,0.6690647482014388,1.0,1.0,3/23,17.56%,IL22;F3;ANO6
prerank,respiratory chain complex IV assembly (GO:0008535),0.4075574952806727,0.8547757211751619,0.6588089330024814,1.0,1.0,3/21,9.90%,PET100;COA6;COX10
prerank,regulation of establishment of planar polarity (GO:0090175),0.3601399676959943,0.8543801887788177,0.72579001019368,1.0,1.0,18/88,16.98%,PSMB7;TIAM1;PSMD11;PSMF1;PSMC1;CLTC;PSMC3;PSMA4;ARRB2;PSMC4;AP2B1;PSMD13;PSME1;PSMB1;PSMD8;PSME4;RAC1;PSMD4
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3566828523385258,0.8543266066932437,0.7363636363636363,1.0,1.0,5/110,5.66%,ADGRD1;S1PR4;IAPP;RAMP1;PTHLH
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.35691057537180537,0.8541424287327041,0.7111574556830031,1.0,1.0,15/76,20.09%,SPAG5;GPSM2;PRKCE;SYNPO2;DYNC1H1;SNX9;CFL2;CDC42EP3;NRP1;NUMA1;KATNBL1;HCLS1;CDC42EP1;PROX1;PLK4
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2848312657706307,-0.8541055224881142,0.639344262295082,0.8842676672094533,1.0,5/18,8.46%,HEATR1;PHF8;WDR75;DHX33;ATF4
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.35390679639001804,0.85408952158865,0.7685370741482966,1.0,1.0,17/152,16.02%,ADGRD1;S1PR4;VIPR2;IAPP;RAMP1;AKAP12;PTHLH;PDE2A;GNAI1;INSL3;GNAO1;CALCRL;S1PR2;ADCYAP1;ADGRL3;LPAR1;LGR4
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.25077007033192333,-0.8536462876817131,0.6538461538461539,0.8838764569404274,1.0,5/29,7.82%,ACLY;PPT1;ACACA;ELOVL7;PPT2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4083611320249537,0.8535877124168679,0.6444159178433889,1.0,1.0,3/17,12.44%,HEY2;NOTCH1;BMPR1A
prerank,histone ubiquitination (GO:0016574),0.4045449827839538,0.8532093603730979,0.6724137931034483,1.0,1.0,4/21,14.26%,UHRF1;UBR2;RNF8;RNF20
prerank,regulation of GTPase activity (GO:0043087),0.35504152026195424,0.8530358971659805,0.7837837837837838,1.0,1.0,27/177,14.77%,ECT2;PRTN3;EZH2;ARHGEF5;ARHGAP15;ARHGAP11A;NET1;RASGRP1;EVI5;PIN1;SNX9;PLXNA2;FGD6;LARS1;EPHA3;CAV2;GMIP;RDX;CRK;FGD3;ARHGAP9;RACK1;RSU1;ADAP1;ADCYAP1;GSK3B;LIMS1
prerank,substrate-dependent cell migration (GO:0006929),0.4328789033984584,0.852759321273562,0.6508152173913043,1.0,1.0,3/14,12.89%,NTN1;ANKS1A;NRP1
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.29626728708405436,-0.8526542403009831,0.6339285714285714,0.8847221095733401,1.0,11/17,36.63%,DGKQ;SMAD7;CALM1;SPRED1;SPRED3;PARD3;CALM2;DDIT4;SPRY2;SIRT2;PPEF2
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.30057944954405813,-0.8517075086265323,0.6772727272727272,0.8854310849859908,1.0,4/18,7.83%,SBNO2;PYCARD;FCER1G;NMI
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4123399598170321,0.8511284235985686,0.6649550706033376,1.0,1.0,2/18,9.75%,PMAIP1;ALKBH7
prerank,intracellular protein transmembrane transport (GO:0065002),0.372306888075189,0.8508340512978512,0.6684901531728665,1.0,1.0,11/42,17.46%,PEX26;C2CD5;CHCHD4;DNAJC15;PEX2;TOMM70;TIMM23;GRPEL2;ZFAND2B;SEC63;PEX14
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4008524259538592,0.8508133331459586,0.6861313868613139,1.0,1.0,7/23,22.13%,MAPK1;PRKACA;GABPA;LRRK2;SNCA;GNB1;ATP2B4
prerank,regulation of metal ion transport (GO:0010959),0.4169751343985702,0.8505760807036269,0.6619537275064268,1.0,1.0,2/16,4.45%,IL16;EPB41
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.392098428185674,0.8503534968161728,0.6606929510155317,1.0,1.0,11/26,26.95%,CIB1;PLCG2;CAMTA1;GSK3B;STIMATE;HOMER2;SPPL3;ATP2B4;PTBP1;DYRK2;AKAP6
prerank,cardiac muscle tissue development (GO:0048738),0.36955219156004493,0.8503053747265619,0.6853220696937699,1.0,1.0,6/50,12.44%,HEY2;ZFPM1;CSRP3;NOTCH1;SMAD4;BMPR1A
prerank,positive regulation of isotype switching (GO:0045830),0.4168295730727791,0.8502703026207766,0.6311688311688312,1.0,1.0,4/15,16.90%,TFRC;KMT5C;PAXIP1;RIF1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3859567460317934,0.8499619646555332,0.6807511737089202,1.0,1.0,9/30,21.03%,TANK;IKBKG;TRAF3;BIRC2;TLR6;UBA52;CASP8;IKBKB;RIPK1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.3794059917984971,0.849731322707348,0.6821192052980133,1.0,1.0,12/37,22.57%,DNMT1;JUN;FGF9;PTEN;BMPR1A;EFEMP2;ADAMTS1;APLN;LDLRAP1;CDKN1A;MEF2D;CDKN1B
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3193796269467466,-0.8496956889135666,0.6139705882352942,0.8884003260846539,1.0,5/13,19.63%,ENTPD7;GNAI3;RHOQ;RAN;GTPBP1
prerank,regulation of T cell migration (GO:2000404),0.41264683985920103,0.8495930659100228,0.655819774718398,1.0,1.0,3/18,10.59%,SPN;RIPOR2;CCR6
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.35538314495688156,0.8494776472603175,0.7733199598796389,1.0,1.0,42/152,21.62%,DEPDC1B;PSMB7;PSMD11;AXIN1;SULF2;PSMF1;GPRC5B;CAV1;DISC1;PSMC1;PIN1;CSNK1G2;SMARCA4;EGFR;PSMC3;PSMA4;RUVBL1;XIAP;CCAR2;PSMC4;LRRK1;PSMD13;PSME1;SKI;PSMB1;EGF;PSMD8;LGR4;PSME4;PSMD4;TRPM4;PTK7;LRRK2;PPM1B;TBL1XR1;USP34;RSPO2;ILK;SPIN1;USP47;ZEB2;CAPRIN2
prerank,hippo signaling (GO:0035329),0.39155112103795686,0.8490149093079394,0.6600467289719626,1.0,1.0,10/26,19.87%,TEAD4;AMOTL2;LATS1;MOB1A;STK4;YWHAE;AMOTL1;MOB1B;STK3;NPHP4
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.3694327839614392,0.8488342022745778,0.6803455723542117,1.0,1.0,11/48,18.91%,NPPC;PANK2;GUCY1A1;SLC25A16;IMPDH2;PAPSS2;DCAKD;ADSL;AK5;ADCY8;PANK1
prerank,chemical homeostasis (GO:0048878),0.3622509933094302,0.8487072972398917,0.7183544303797469,1.0,1.0,3/61,7.98%,SLC4A1;USF1;NEDD4L
prerank,regulation of phospholipase activity (GO:0010517),0.43711968679099983,0.8486328618181047,0.6601398601398601,1.0,1.0,5/10,22.80%,RASGRP1;PDPK1;FGFR1;SNCA;FGFR2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.21767775930226868,-0.8478922946265335,0.8333333333333334,0.8908447124418288,1.0,11/46,13.86%,OPHN1;SYT1;CDH2;GRM5;DGKI;CACNG2;CACNG7;DGKZ;CDK5;UNC13A;GRM8
prerank,glycolipid metabolic process (GO:0006664),-0.21930324482817032,-0.847752094475328,0.7966101694915254,0.8898866951503674,1.0,12/47,18.91%,HEXB;CTSA;PSAP;ST3GAL6;ST6GALNAC4;ST6GALNAC6;ST3GAL4;B4GALNT1;GALC;CERK;GLA;ST6GALNAC3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.41559792326998524,0.8476719834424138,0.6470588235294118,1.0,1.0,4/16,16.03%,ZFP36L1;CPEB3;RC3H1;ZFP36L2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.42212922642071216,0.8472313713919032,0.6381842456608812,1.0,1.0,3/14,19.45%,TYROBP;ATP6AP1;TRAF6
prerank,Rho protein signal transduction (GO:0007266),0.3619921407041937,0.8471906376444869,0.6926315789473684,1.0,1.0,12/53,19.43%,PHACTR4;NTN1;ARHGDIB;ARHGEF3;COL1A2;RHOU;CDC42EP3;ROCK2;RIPOR1;ARHGDIA;CDC42EP1;ARHGAP1
prerank,megakaryocyte differentiation (GO:0030219),0.43482412828097966,0.8466898969782961,0.672752808988764,1.0,1.0,1/11,3.56%,ZFPM1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.39124163689773284,0.8464535481833262,0.6931155192532089,1.0,1.0,8/28,19.01%,SMCHD1;MRNIP;KMT5C;SIRT7;PRKDC;TFIP11;RIF1;WRAP53
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.43998285188215247,0.8464060474551034,0.636231884057971,1.0,1.0,4/11,18.91%,PANK2;SLC25A16;DCAKD;PANK1
prerank,coenzyme A biosynthetic process (GO:0015937),0.43998285188215247,0.8464060474551034,0.636231884057971,1.0,1.0,4/11,18.91%,PANK2;SLC25A16;DCAKD;PANK1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.43998285188215247,0.8464060474551034,0.636231884057971,1.0,1.0,4/11,18.91%,PANK2;SLC25A16;DCAKD;PANK1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.23799809172112205,-0.8462724069772708,0.7452830188679245,0.891821929245195,1.0,8/35,11.72%,NRP2;FARP2;PLXNA4;SEMA3D;SEMA3E;SEMA4C;SH3BP1;SEMA4G
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3950332474886213,0.8461896952086293,0.6780905752753978,1.0,1.0,7/22,26.06%,CHD1L;ERCC3;UBA52;DDB2;XPA;PARP1;RBX1
prerank,lamellipodium assembly (GO:0030032),0.38855535483692544,0.8461740517043835,0.6607981220657277,1.0,1.0,12/26,25.91%,CCDC88A;ABLIM3;WHAMM;PARVB;RAC1;ARHGEF7;ABLIM2;GOLPH3;VCL;SRGAP2;ABLIM1;ARHGEF6
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.4137345616661701,0.8461566293174216,0.6755725190839694,1.0,1.0,4/18,15.02%,RB1;CLASP1;EFEMP2;RUNX1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.29805568738172117,-0.8461200471634527,0.6939655172413793,0.8909033308123261,1.0,2/16,3.67%,VSIR;CD274
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.38649049385904677,0.8460249255615493,0.6566626650660264,1.0,1.0,4/24,8.42%,ITPR1;HTR2A;IBTK;PLCG2
prerank,skeletal muscle contraction (GO:0003009),0.41090548919985753,0.8456513593950374,0.6606683804627249,1.0,1.0,1/19,4.10%,CCDC78
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4217043619195394,0.8450546418415836,0.633377135348226,1.0,1.0,5/14,16.68%,SAP18;SRSF4;RNPS1;SRSF10;SRSF7
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4273006279735011,0.8447488287679247,0.6590909090909091,1.0,1.0,1/13,2.29%,CACNA1I
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.2771046596399921,-0.8444264024460164,0.7128205128205128,0.8930450929964849,1.0,9/20,24.50%,MBTPS1;PSEN2;RELA;HM13;ADAM9;APH1A;SPPL2B;APH1B;SPPL2A
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.34665066342039536,0.8441851386304375,0.7857142857142857,1.0,1.0,22/140,19.23%,S1PR4;CXCR5;IAPP;LPAR4;CAV1;CCR2;HMGB1;P2RY1;CCR6;FIS1;ADCYAP1;JPH1;F2R;LPAR1;GPR35;CD24;TRPM4;ADCY8;SPPL3;CXCR4;PTGER4;CD55
prerank,cellular response to retinoic acid (GO:0071300),0.369901541486732,0.8439698387430606,0.6840934371523916,1.0,1.0,8/42,19.46%,AQP1;ATM;SETX;EPHA3;PTK7;CREB1;PAX2;SOX9
prerank,pinocytosis (GO:0006907),0.4355418616741656,0.8439410455305074,0.6413793103448275,1.0,1.0,2/10,4.97%,SNX33;MAPKAPK3
prerank,positive regulation of catabolic process (GO:0009896),0.354809233881643,0.843528358251003,0.7165437302423604,1.0,1.0,8/65,12.17%,BARD1;DTL;AXIN1;FOXO1;STX5;NEDD4L;FZR1;OAZ1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.35553460765369327,0.8434704767011416,0.7132429614181439,1.0,1.0,12/67,16.74%,BLK;FYN;JAK2;EGFR;EPHA3;DYRK1A;BTK;RELN;FLT3;PIBF1;FGFR1;JAK3
prerank,ganglioside metabolic process (GO:0001573),-0.27417410755726396,-0.8432002476895316,0.6613756613756614,0.8943093027880014,1.0,7/20,20.58%,HEXB;ST6GALNAC4;ST6GALNAC6;B4GALNT1;ST6GALNAC3;CLN6;ST8SIA3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.3643363919030186,0.8430546771931733,0.6723356009070295,1.0,1.0,12/39,23.69%,PRKCE;GPD1L;YWHAH;FXYD5;NEDD4L;FGF13;STK39;UTRN;HECW2;NEDD4;OSR1;WNK3
prerank,histone H3-K36 demethylation (GO:0070544),-0.35206910790297896,-0.842847747753141,0.6713286713286714,0.8937556320647587,1.0,4/10,6.91%,KDM7A;KDM4A;PHF8;KDM4B
prerank,inorganic anion transmembrane transport (GO:0098661),0.3608352815780541,0.8427983296878885,0.7171398527865405,1.0,1.0,8/63,12.57%,SLC12A3;SLC5A5;SLC12A7;SLC12A1;GABRA4;GABRA5;ANO3;SLC12A6
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.44082567079568735,0.8424174347491779,0.6656976744186046,1.0,1.0,5/10,24.60%,ACADM;IVD;ETFDH;ETFB;ETFA
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.2732623339824404,-0.8422295854243842,0.7043010752688172,0.893786398712118,1.0,6/22,13.90%,MAN1C1;EDEM3;RNF185;OS9;EDEM2;RNF139
prerank,regulation of peptide hormone secretion (GO:0090276),0.3491427209201004,0.8417457157465238,0.7009443861490031,1.0,1.0,8/67,11.62%,TFR2;ITPR1;CRHBP;PRKCA;PICK1;KCNC2;EIPR1;DPP4
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3439850370750083,0.8416504867870567,0.756811301715439,1.0,1.0,26/116,23.63%,VIPR2;IAPP;RAMP1;FYN;PTHLH;DPEP1;NPSR1;PRKACA;MAPK14;INSL3;PLCG2;CALCRL;ADCYAP1;PLCG1;ADCY8;FCGR2B;CREB1;PTGER4;PRKAR2A;SYK;ADCY9;FGR;GNB1;ADAM17;SRC;MYH9
prerank,positive regulation of neurogenesis (GO:0050769),-0.2174265170331507,-0.8413617802545346,0.8478260869565217,0.8943045815218978,1.0,21/68,20.43%,NUMB;KDM1A;PTPRD;PLXNA4;CTNNB1;CX3CR1;ROBO1;MAP6;FZD3;TGM2;TIAM2;CUX2;VEGFA;PLXNA1;SHANK3;CAPRIN1;PLXNB3;SOX11;CDKL3;SOX8;TRIM32
prerank,detection of visible light (GO:0009584),0.4094307425374578,0.8413480543529254,0.6688144329896907,1.0,1.0,1/16,7.90%,CEP250
prerank,mesonephros development (GO:0001823),0.44312058945299493,0.8411672511960816,0.6666666666666666,1.0,1.0,3/11,23.09%,ZBTB16;PAX2;OSR1
prerank,cellular response to glucose starvation (GO:0042149),0.3689844670032552,0.8409366974446932,0.6889375684556407,1.0,1.0,14/41,22.69%,PMAIP1;TBL2;SIK2;PICK1;SZT2;BECN1;PRKAG2;TP53;XBP1;HNRNPA1;NIM1K;PRKAG1;BRSK1;MYBBP1A
prerank,JNK cascade (GO:0007254),0.3687453576257051,0.8405610484541778,0.6893523600439078,1.0,1.0,13/40,20.59%,CRKL;IKBKG;MAP3K5;MAP4K2;TAB1;UBE2V1;TAB3;MAP3K11;UBA52;MAP3K7;PTGER4;TRAF6;UBE2N
prerank,ventricular septum development (GO:0003281),0.3760706058929336,0.8403823970644904,0.6835016835016835,1.0,1.0,8/37,12.44%,HEY2;ZFPM1;MDM4;PDE2A;NOTCH1;SMAD4;SLIT3;BMPR1A
prerank,regulation of ossification (GO:0030278),0.38158200642927115,0.840167306650869,0.7063403781979978,1.0,1.0,12/36,22.88%,LRP4;SGMS2;TWIST1;NOTCH1;ZBTB16;CHSY1;TGFB2;SOX9;RBPJ;NBR1;DDR2;PTPN11
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.42519701240583313,0.8399750669474778,0.6545698924731183,1.0,1.0,4/14,16.90%,TFRC;KMT5C;PAXIP1;RIF1
prerank,negative regulation of immune response (GO:0050777),0.3419550062180758,0.839222238120317,0.7889447236180904,1.0,1.0,27/154,19.41%,RNF26;VIPR2;IAPP;RAMP1;FYN;DHX58;CCR2;PTHLH;DPEP1;NPSR1;PRKACA;MAPK14;INSL3;PLCG2;PCBP2;CALCRL;ADCYAP1;RC3H1;NLRC3;PLCG1;ADCY8;TRAFD1;FCGR2B;CREB1;PTGER4;PPM1B;PRKAR2A
prerank,nucleotide metabolic process (GO:0009117),-0.2641676670010015,-0.8390666401694074,0.6948051948051948,0.8977191419826424,1.0,15/23,35.33%,CMPK1;ME1;NMNAT3;DCK;NMNAT1;FHIT;DCTD;AK1;NMNAT2;AK7;GUK1;ENPP3;AK4;AK8;NME2
prerank,myelin assembly (GO:0032288),0.44068624122864875,0.8389472238419782,0.6459537572254336,1.0,1.0,2/10,9.66%,ABCA2;PMP22
prerank,ketone body metabolic process (GO:1902224),0.4436943181577523,0.838862024698547,0.6656934306569343,1.0,1.0,2/10,9.69%,ACSS3;BDH1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3489431260469514,-0.8387609494430294,0.6283783783783784,0.897056931040684,1.0,6/10,40.94%,IL18;RARA;SPHK2;IRF4;PRKCZ;GATA3
prerank,focal adhesion assembly (GO:0048041),0.39915190620903535,0.8387069891201333,0.6735187424425635,1.0,1.0,8/21,23.23%,SORBS1;WHAMM;ACTN2;TESK2;BCR;ARHGEF7;ACTN1;SRC
prerank,response to lipopolysaccharide (GO:0032496),0.3455539057181527,0.8386304564398734,0.7623363544813696,1.0,1.0,13/138,8.57%,GFI1;IL12A;HMGB2;PTPN22;S100A9;MAPKAPK3;SLPI;FOXP1;NR1D1;S100A8;HMGB1;MAPK14;JAK2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.32393261548932983,-0.8382576761487986,0.6807017543859649,0.8967543878144087,1.0,4/11,17.82%,SLC27A1;SCARB1;CTDNEP1;GPLD1
prerank,positive regulation of biosynthetic process (GO:0009891),0.36973321306518125,0.8382547289978415,0.7099236641221374,1.0,1.0,12/40,21.05%,SORBS1;PLCG2;MTPN;TLR6;RUNX1;F2R;VIM;CYBA;CREB1;ZBTB20;RAB27A;SIRT4
prerank,positive regulation of catalytic activity (GO:0043085),0.37695317781622867,0.8379367057727902,0.6882681564245811,1.0,1.0,7/37,14.04%,PHACTR4;MSH6;CAV1;CIB1;MAPK14;ATP7A;PSEN1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.3925827278263899,0.8378444181055954,0.6902985074626866,1.0,1.0,3/22,8.00%,NRDC;SNX33;SNX9
prerank,receptor catabolic process (GO:0032801),0.3820404566112612,0.8377020761113623,0.6513317191283293,1.0,1.0,7/24,18.66%,CLTC;BECN1;SNX25;AP2B1;MYLIP;KIF16B;RNF43
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.35700749919637664,0.8373292191264545,0.7115789473684211,1.0,1.0,11/53,13.51%,XPO1;GLMN;PSMF1;DESI1;DDRGK1;PRKACA;PSMC3;RAD23A;UCHL5;USP14;PSME1
prerank,positive regulation of cell motility (GO:2000147),0.34722557036898494,0.8368930187027619,0.8378378378378378,1.0,1.0,31/205,15.56%,GTSE1;ARHGEF39;LEF1;PECAM1;SYNE2;TIAM1;NTN1;SUN2;PPP3CA;CCN1;TWIST1;NEDD9;CAV1;ATM;TRADD;NOTCH1;DDRGK1;CIB1;PRKCA;EGFR;CBLL1;RDX;F3;ROCK2;RACK1;ACTN4;RIPOR1;PDCD10;EGF;F2R;SPAG9
prerank,cranial nerve development (GO:0021545),0.43268096653360427,0.8366321690244639,0.6708333333333333,1.0,1.0,3/11,19.42%,ERBB3;TIFAB;PAX2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4228809953387936,0.8364825479798677,0.6649214659685864,1.0,1.0,5/15,17.81%,NPLOC4;FAF2;DERL2;HSP90B1;SYVN1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.30936817913382786,-0.8364436900860207,0.6678832116788321,0.8991022582510038,1.0,5/13,18.84%,NRP2;PLXNA4;PLXNA1;SEMA3A;PLXNB3
prerank,response to estradiol (GO:0032355),0.3776669704404661,0.8363171590917224,0.6979405034324943,1.0,1.0,5/31,12.75%,CRHBP;EGFR;SOCS2;RUVBL2;STAT5B
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.43432156988992593,0.8361497653331329,0.6610878661087866,1.0,1.0,2/12,10.16%,DCN;CHST12
prerank,toxin transport (GO:1901998),0.43775795376498505,0.8360623190085631,0.6545961002785515,1.0,1.0,2/10,18.29%,ANTXR2;ADAM10
prerank,cellular response to starvation (GO:0009267),0.34941163037305983,0.8359667745021225,0.8058058058058059,1.0,1.0,38/147,20.89%,STK26;PMAIP1;DAP;MAPK1;EIF2S1;TBL2;SIK2;FOXO1;KLF10;MAP3K5;PICK1;LARS1;STK24;SEC13;SZT2;MLST8;BECN1;FAS;RNF152;ATP6V0E1;PRKAG2;LAMTOR4;RIPOR1;LAMTOR3;TP53;NPRL3;SIRT1;XBP1;ATP6V0D1;LRRK2;HNRNPA1;NIM1K;CDKN1A;SREBF2;WDR45B;RRAGB;WRN;PRKAG1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.23073735100535017,-0.835807446941186,0.8076923076923077,0.8991607835602179,1.0,12/33,28.32%,TNFAIP3;KRIT1;ANGPT1;TNIP2;SERPINE1;MDK;WFS1;MAPK7;NDNF;YAP1;KDR;ICAM1
prerank,cell projection assembly (GO:0030031),0.39277623620369706,0.8355864597988292,0.6698679471788715,1.0,1.0,6/22,16.84%,GSN;RHOU;RAC2;PARVB;PARVA;RAC1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.28315390807761615,-0.8354353237132175,0.7606382978723404,0.8986690372711755,1.0,8/19,27.51%,APP;TMEM106A;MAPK8;WFS1;KLF2;MAPK7;KLF4;CHRNA7
prerank,presynapse organization (GO:0099172),-0.3391232730738145,-0.8350912778508078,0.6688741721854304,0.8981203951421965,1.0,5/10,37.59%,C5AR1;DVL1;LRRTM3;WNT5A;WNT7A
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.308523781519624,-0.8348423416468618,0.7118055555555556,0.8974236641566582,1.0,1/13,0.15%,HEXB
prerank,regulation of sodium ion transport (GO:0002028),-0.24044537156420862,-0.8346299211572205,0.7109375,0.8966251121319162,1.0,9/34,16.08%,NKAIN2;ANK3;CNKSR3;ATP1A1;SNTA1;SCN1B;FGF12;PER1;DLG1
prerank,renal absorption (GO:0070293),0.43983860592780505,0.8343793746915753,0.6710526315789473,1.0,1.0,1/10,5.93%,GSN
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.40962988578264115,0.8341821783021575,0.6884353741496598,1.0,1.0,1/16,1.54%,BRCA1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.40264069784684664,0.8339695029138595,0.6856780735107731,1.0,1.0,2/20,4.26%,PRKCE;PTPN22
prerank,acidic amino acid transport (GO:0015800),0.40580907472345795,0.8339295829736167,0.6595744680851063,1.0,1.0,4/17,17.48%,SLC25A12;SLC25A22;SLC25A13;ARL6IP5
prerank,negative regulation by host of viral process (GO:0044793),0.4401473545219824,0.8338386781043516,0.6722689075630253,1.0,1.0,3/10,14.78%,PSMC3;VAPA;CCNK
prerank,dermatan sulfate metabolic process (GO:0030205),0.4267974559990225,0.8335495059267329,0.6611796982167353,1.0,1.0,2/13,10.16%,DCN;CHST12
prerank,cholesterol metabolic process (GO:0008203),0.3551489829773342,0.8335243855241011,0.7412008281573499,1.0,1.0,12/68,17.38%,LBR;CEL;LSS;OSBPL5;GBA2;IDI1;CYP27A1;CYP46A1;NSDHL;FDPS;DHCR7;LDLRAP1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.34178524732296767,0.8334264871580017,0.7737373737373737,1.0,1.0,11/117,8.42%,VIPR2;IAPP;RAMP1;FYN;PTHLH;DPEP1;NPSR1;PRKACA;MAPK14;INSL3;PLCG2
prerank,negative regulation of protein polymerization (GO:0032272),0.38237673592206994,0.8331605086386727,0.6737089201877934,1.0,1.0,9/27,23.18%,STMN1;CYRIB;DYRK1A;SNCA;TBCD;EML2;SSH2;TWF1;PRKCD
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.39688498234285163,0.8330649832685307,0.6590621039290241,1.0,1.0,7/19,21.01%,PRKACA;CBFB;ROCK2;RUNX1;NPHP4;IKBKB;ROCK1
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.3733109824675831,0.8326044896873782,0.6989010989010989,1.0,1.0,12/38,22.49%,DHX58;PUM2;PRKCA;RIOK3;PUM1;DHX9;USP15;CYBA;IFI35;POLR3B;SASH1;AKIRIN2
prerank,establishment of protein localization to membrane (GO:0090150),-0.22202610838948167,-0.8325340848526689,0.7962962962962963,0.8996271153331946,1.0,21/66,24.41%,RAB3IP;PRKCI;GOLGA7;AFDN;MYO1C;RAB3GAP2;RABGEF1;NCF1;RAB11A;RTP4;NPC1;ARL6;ZDHHC24;ZDHHC20;COX18;ZDHHC15;MICALL1;PARD3;VPS37C;REEP1;ZDHHC3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.2566921473758864,-0.8324046545824296,0.7160493827160493,0.8986352765736985,1.0,9/24,24.51%,EPN2;ARNT;ITGA5;ITGB3;GRB10;DAB2IP;HIF1A;MT3;VTN
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.3987303364367142,0.8323034164432895,0.6856060606060606,1.0,1.0,5/18,19.03%,SOX6;NOTCH1;XBP1;HDAC4;HDAC1
prerank,negative regulation of cholesterol transport (GO:0032375),0.43616821026080643,0.8319439842853187,0.6623931623931624,1.0,1.0,2/10,19.59%,ABCA2;SREBF2
prerank,cellular response to interferon-gamma (GO:0071346),0.34432604204411216,0.8319411948212847,0.7304526748971193,1.0,1.0,21/88,21.83%,CD47;GBP4;PML;CD44;SP100;IRF9;PDE12;GBP2;JAK2;B2M;TRIM68;TRIM5;IRF8;CCL25;EPRS1;LGALS9;DAPK1;SYNCRIP;GAPDH;CIITA;RPL13A
prerank,response to insulin (GO:0032868),0.351617061446029,0.8318462240381019,0.7471967380224261,1.0,1.0,18/80,17.73%,C2CD5;SLC2A4;USF1;FOXO1;DENND4C;SORBS1;ZFP36L1;RAB8A;PDPK1;KAT2B;RAB8B;ZBTB7B;PRKDC;IRS1;CAPN10;SIRT1;XBP1;EPRS1
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.19242250658509102,-0.8317909925967548,0.9354838709677419,0.8985512941887223,1.0,10/70,13.66%,PLA2G15;LPIN1;PLA2G7;ENPP2;SLC27A1;MBOAT1;CHPT1;ABHD3;PLA2G6;LPCAT1
prerank,bile acid biosynthetic process (GO:0006699),-0.2657764308633444,-0.831671404098882,0.7103825136612022,0.8975471664218684,1.0,7/24,12.39%,OSBPL2;OSBPL9;OSBPL7;SCP2;OSBPL6;OSBP;CH25H
prerank,adipose tissue development (GO:0060612),0.4369022895212987,0.8315457968028391,0.6676136363636364,1.0,1.0,3/11,17.11%,PGRMC2;ARID5B;XBP1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.41041488577062835,0.8313323385522278,0.6653439153439153,1.0,1.0,6/14,23.16%,ABCA7;DYRK1A;PSEN1;ADAM10;CLN3;ADAM17
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.2360294000514656,-0.8313210961638197,0.859375,0.8970342104726393,1.0,14/42,16.48%,IARS2;CARS1;WARS2;SARS1;NARS1;AIMP1;FARSA;IARS1;HARS2;HARS1;NARS2;TARS1;QARS1;TARS3
prerank,transcription preinitiation complex assembly (GO:0070897),0.4234637319793402,0.8312288452456497,0.6761517615176151,1.0,1.0,4/12,21.66%,TAF1;TAF7;GTF2A2;TAF11
prerank,protein tetramerization (GO:0051262),0.35464663514682965,0.8312035208772568,0.7307692307692307,1.0,1.0,12/67,20.17%,MS4A1;TK1;CUTC;CBR4;ACOT13;B2M;KCNJ2;TRPM4;SNCA;PKD2;KCNC1;CPSF7
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.3414279322193575,-0.8311807649807671,0.6875,0.8960637431459452,1.0,7/10,33.65%,NEXMIF;PPM1F;VEGFA;BMP6;RGCC;NOTCH4;MAD2L2
prerank,regulation of tissue remodeling (GO:0034103),-0.2834423149788772,-0.8310157161502149,0.7180616740088106,0.8951226585208648,1.0,5/18,22.21%,SYT7;IL18;MDK;LEPR;CEACAM1
prerank,glucan catabolic process (GO:0009251),0.41149495910724776,0.8309779752405513,0.6715425531914894,1.0,1.0,2/15,12.09%,PGM2;PHKA2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.23704288037751503,-0.8309619872649558,0.7623762376237624,0.8940035531142667,1.0,4/35,6.98%,CDH11;CDH8;CDH13;CDH12
prerank,regulation of microtubule-based movement (GO:0060632),0.4403640298827564,0.8303966752480031,0.6852861035422343,1.0,1.0,4/11,21.47%,HDAC6;HAP1;DYNLT2B;NEFH
prerank,cardiac cell development (GO:0055006),-0.32416272443165367,-0.8300736037321077,0.68561872909699,0.8946644226781584,1.0,4/11,16.65%,VEGFA;SLC8A1;JAG1;CXADR
prerank,dendritic spine organization (GO:0097061),-0.25086787033618785,-0.8297411569562352,0.7225433526011561,0.8940913781911367,1.0,3/26,0.60%,IGF1R;PAK3;TREM2
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.37160897410486127,0.829680526441671,0.703579418344519,1.0,1.0,4/33,9.48%,CARD10;NOTCH1;HMGB1;MECP2
prerank,protein processing (GO:0016485),0.34498707782463633,0.8295336925404149,0.7681307456588355,1.0,1.0,21/102,20.48%,TMPRSS4;KEL;MYRFL;PIDD1;CPM;CASP2;METAP2;SPCS1;PITRM1;TMEM208;FAM111A;F3;PSEN1;PCSK1;CPD;SPPL3;ADAM10;CLN3;PCSK7;MME;SPCS3
prerank,extracellular matrix organization (GO:0030198),0.34168791889058203,0.829518149020918,0.871,1.0,1.0,47/276,17.47%,ADAMTS7;ICAM4;CYP1B1;ITGA1;ECM2;ITGB7;CD47;PECAM1;HSPG2;CD44;HAS1;PLOD3;FLRT2;CRTAP;LAMA5;GSN;COL1A2;LAMA4;DCN;COL4A4;LAMC1;LAMB2;LAMB3;ITGAV;SMOC2;JAM2;CAPN1;ATP7A;NID1;TLL2;BSG;CTSK;ITGA8;FLOT1;COL23A1;MMP19;DAG1;P3H4;ADAMTS1;TGFBI;ELN;ST7;TGFB2;ADAMTSL3;ADAMTS5;COL4A1;FN1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.35171495686079157,0.8294793989559089,0.7238883143743536,1.0,1.0,10/71,12.41%,ADAMTS7;PMAIP1;FAP;PRPF19;NR1D1;FBXO44;HDAC6;LONP1;CTSO;CTSK
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.27491475484832356,-0.8293822359567387,0.7010309278350515,0.8935137677247432,1.0,4/20,7.82%,ACLY;PPT1;ACACA;PPT2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.35139662568164837,0.829147551170875,0.7239958805355304,1.0,1.0,11/73,14.50%,CD2;SPN;TWIST1;CCR2;RASGRP1;HMGB1;PLCG2;JAK2;DHX9;PSEN1;TYROBP
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.31150491941482555,-0.8284792129184794,0.7087719298245614,0.8940623811235083,1.0,4/13,10.55%,IGF1;AKT2;PHKG2;IRS2
prerank,monosaccharide transmembrane transport (GO:0015749),0.4082907889421322,0.828405816839463,0.6808785529715762,1.0,1.0,2/16,11.00%,SLC2A8;SLC2A12
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.37098509216734465,0.8283084587867341,0.7007963594994312,1.0,1.0,5/35,8.86%,AQP1;PDE7B;PDE2A;AHR;NUDT4
prerank,positive regulation of GTPase activity (GO:0043547),0.34360821164336347,0.8278389006128134,0.847,1.0,1.0,19/188,9.58%,ECT2;PRTN3;EZH2;ARHGEF5;ARHGAP11A;TBC1D1;TIAM1;NET1;TBC1D8B;TBC1D22B;RASGRP1;RANGAP1;EVI5;PIN1;SNX9;RAP1GAP2;LARS1;CAV2;GMIP
prerank,phosphate ion transmembrane transport (GO:0035435),-0.32388564356346466,-0.8273744331682871,0.6728624535315985,0.8949947425921333,1.0,4/12,21.83%,SLC25A3;SLC25A11;SLC37A1;SLC37A2
prerank,positive regulation of glucose metabolic process (GO:0010907),0.41806488598855995,0.8269324767072613,0.6767955801104972,1.0,1.0,3/14,16.99%,PMAIP1;IRS1;SIRT1
prerank,smooth muscle contraction (GO:0006939),-0.2981353600290624,-0.8268915418116897,0.704119850187266,0.8947358063195584,1.0,4/14,20.94%,TPCN2;ADRA1A;SLC8A1;EDNRA
prerank,regulation of vesicle-mediated transport (GO:0060627),0.34677429158498496,0.8265017269978102,0.775950668036999,1.0,1.0,23/91,18.55%,RAB33B;CD177;MAPK1;STON1;ARFGAP1;RAB8A;LGI3;ITGAV;RIT2;RAB8B;DNAJC13;PACSIN2;HAP1;RAB11B;NRP1;STON2;PLD1;MAP2K1;RAB5A;CHMP3;USP7;LRRK2;RUFY1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.3950323070198264,0.8263566057932586,0.6917385943279901,1.0,1.0,4/20,16.39%,TMPRSS3;NEDD4L;KCNJ2;ATP6AP1
prerank,carnitine shuttle (GO:0006853),0.43684461448284506,0.8261303542949684,0.6766381766381766,1.0,1.0,4/11,15.07%,CPT1B;CPT1A;PRKAG2;CPT2
prerank,positive regulation of developmental process (GO:0051094),0.34217682205851657,0.8260545000468751,0.8208208208208209,1.0,1.0,45/164,23.23%,FOXA2;CDC20;SOX6;AURKA;FBXO5;PA2G4;TFRC;CLASP1;DCN;ZBTB16;LLPH;RBM19;CPEB3;NR2C2;RELN;KMT5C;TAPT1;PLCB1;FIS1;PAXIP1;BMPR1A;NUMA1;PSEN1;MCU;DAG1;FGFR1;VHL;RIF1;SIRT1;TRPM4;XBP1;ARHGEF7;NRXN1;PAX2;SOX9;AGO2;ALK;BNIP3;RPS6KA3;ZDHHC6;PHLDB1;ACVR1B;NIBAN2;NCOA3;SRC
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.34146636263023605,0.8259044332789536,0.8046324269889225,1.0,1.0,25/142,19.23%,S1PR4;CXCR5;IAPP;CAV1;CCR2;HMGB1;PRKACA;CAV2;P2RY1;CCR6;SLC35G1;FIS1;ADCYAP1;F2R;LPAR1;GPR35;CD24;TRPM4;ADCY8;YWHAE;SPPL3;CXCR4;PTGER4;CLN3;CD55
prerank,ncRNA 3'-end processing (GO:0043628),0.41380477497914103,0.8256637599824008,0.668010752688172,1.0,1.0,5/14,20.45%,INTS14;ERI1;TRNT1;PTCD1;INTS12
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.3595615256109185,0.8256456451371352,0.7217962760131434,1.0,1.0,13/42,21.01%,PLEKHA2;CDK6;CIB1;GFUS;EFEMP2;NRP1;GSK3B;LIMS1;CCL25;RAC1;UTRN;S100A10;ROCK1
prerank,camera-type eye morphogenesis (GO:0048593),0.4389682531345078,0.8253638150761238,0.6803977272727273,1.0,1.0,3/10,18.15%,SHROOM2;SKI;KDM2B
prerank,positive regulation of lymphocyte migration (GO:2000403),0.4275854185252421,0.8253345081133368,0.6829268292682927,1.0,1.0,2/12,9.17%,SPN;JAM2
prerank,positive regulation of response to external stimulus (GO:0032103),0.3447721496669284,0.8252132898519767,0.7937310414560161,1.0,1.0,18/128,11.50%,CD47;DHX58;USF1;IL16;CCN4;S100A9;GPRC5B;CCR2;S100A8;TRADD;PDE2A;PUM2;PRKCA;IL17RA;RIOK3;NAPEPLD;PUM1;DHX9
prerank,cellular response to sterol (GO:0036315),-0.31641224150466396,-0.824800651591988,0.66015625,0.8975674045335874,1.0,5/13,19.48%,SMO;OSBPL7;GRAMD1B;GPLD1;INSIG1
prerank,negative regulation of MAPK cascade (GO:0043409),0.34772191103493294,0.8247540229337765,0.757948717948718,1.0,1.0,15/87,14.46%,FOXM1;EZR;CAV1;FOXO1;PIN1;STK38;ABCA7;SMAD4;RPS6KA6;PTEN;CDK5RAP3;SPRED2;MYC;PPIA;DAG1
prerank,negative regulation of protein secretion (GO:0050709),0.3601826640525768,0.824690278090498,0.7108433734939759,1.0,1.0,1/38,0.73%,IL12A
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3474248338679947,0.8246609169443737,0.7479508196721312,1.0,1.0,19/74,17.62%,PSMB7;PSMD11;PSMF1;PSMC1;NOTCH1;PSMC3;PSMA4;PSMC4;NFE2L2;PSMD13;PSME1;CREBBP;PSMB1;LIMD1;PSMD8;PSME4;VHL;PSMD4;UBA52
prerank,amide biosynthetic process (GO:0043604),0.36095845281020866,0.8245682011496532,0.7176724137931034,1.0,1.0,9/47,16.25%,RHD;SGMS2;NMRAL1;CERS4;SGMS1;PCSK1;ASL;ASS1;CERS6
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.40909144080813953,0.8245228848892614,0.6762402088772846,1.0,1.0,3/15,16.03%,ZFP36L1;HNRNPU;ZFP36L2
prerank,regulation of calcium ion import (GO:0090279),-0.2564461892040521,-0.8243782865429787,0.7368421052631579,0.8970884675117008,1.0,8/21,22.56%,CTNNB1;PSEN2;PLPP4;TRIM27;PRNP;CCL3;SPHK2;SLC30A1
prerank,negative regulation of cell adhesion (GO:0007162),0.35168717598079186,0.8242682253529381,0.7505175983436853,1.0,1.0,8/72,9.84%,CYP1B1;SPN;ERBB3;RIPOR2;ARHGDIB;NOTCH1;PLXNA2;CBLL1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.38820074534183624,0.8240041486652203,0.6825,1.0,1.0,2/21,4.03%,PGM2;H6PD
prerank,inner mitochondrial membrane organization (GO:0007007),-0.22037028865392883,-0.8236667107359293,0.8767123287671232,0.8972271198881379,1.0,25/47,32.63%,MICOS10;GHITM;APOO;AGK;MTX2;LETM1;ATP5F1C;MTX3;SPG7;ATP5MC3;MAIP1;TIMM22;TIMM10B;AFG3L2;ATP5MC1;MTX1;TIMM13;CHCHD6;TIMM8B;TMEM11;ROMO1;TIMM29;UQCC3;IMMT;ATP5MG
prerank,response to calcium ion (GO:0051592),0.34152481672211454,0.8235318567938344,0.7874493927125507,1.0,1.0,14/102,14.82%,ECT2;SLC25A12;PPP3CA;CRHBP;SYT8;CAV1;DPEP1;PEF1;PLCG2;SYT3;SEC31A;SLC25A13;ANXA11;ADGRV1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3620242849796162,0.823247931569126,0.7049180327868853,1.0,1.0,6/41,11.01%,ERBB3;FYN;NEDD9;GPRC5B;TGFA;RELN
prerank,negative regulation of chemokine production (GO:0032682),0.4151432307560602,0.823199585560094,0.6945205479452055,1.0,1.0,1/14,2.08%,MEFV
prerank,epidermal cell differentiation (GO:0009913),-0.2271924944059294,-0.8230106696784882,0.8235294117647058,0.8972925138948274,1.0,7/41,16.41%,CTNNB1;HDAC2;ST14;CASP3;ADAM9;ERCC2;JAG1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3384508470955366,-0.8228801403942412,0.6557377049180327,0.8963043757373284,1.0,6/10,27.46%,DLGAP4;DLGAP2;DLGAP3;NPTX1;DLGAP1;BEGAIN
prerank,dicarboxylic acid transport (GO:0006835),0.37986171365558,0.8228369461020054,0.6968641114982579,1.0,1.0,6/28,17.48%,SLC25A12;ABCC2;SLC19A1;SLC25A22;SLC25A13;ARL6IP5
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.42952416316585745,0.8227810548498287,0.6713681241184767,1.0,1.0,7/12,22.81%,ABCA2;ABCA7;ROCK2;FLOT2;ROCK1;TMED10;FKBP1A
prerank,positive regulation of angiogenesis (GO:0045766),0.3433319952721215,0.8226118376234709,0.7925101214574899,1.0,1.0,19/108,17.11%,CYP1B1;BRCA1;AQP1;TWIST1;EMC10;PGF;PRKCA;SMOC2;PDPK1;HIPK2;VASH2;PRKCB;F3;AGGF1;MYDGF;RUNX1;PLCG1;SIRT1;XBP1
prerank,receptor metabolic process (GO:0043112),0.34878345017846446,0.8224517691256258,0.7179215270413574,1.0,1.0,15/53,18.31%,RAMP1;TFRC;CAV1;CLTC;GRB2;CALCRL;BECN1;SNX25;ARRB2;RAB11B;LMTK2;GRK2;LDLRAP1;SNCA;KIF16B
prerank,limb morphogenesis (GO:0035108),-0.2613508950760729,-0.8219517729161158,0.7089201877934272,0.8968634908514032,1.0,4/20,12.83%,PCSK5;IQCE;BMPR1B;GLI3
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.4189142798279645,0.8209285500630491,0.691358024691358,1.0,1.0,8/13,26.30%,CNOT1;RC3H1;CNOT8;PNPT1;PRR5L;CNOT7;ZC3HAV1;KHSRP
prerank,programmed necrotic cell death (GO:0097300),-0.2779143274165588,-0.8198930931610502,0.7205240174672489,0.8996410957034887,1.0,9/18,27.37%,ITPK1;DNM1L;TLR4;LY96;TICAM1;IPMK;TICAM2;MLKL;CD14
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.29032425446548255,-0.8197374472481814,0.701195219123506,0.8987202362502695,1.0,3/14,8.91%,ACOX3;ECI2;SCP2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.25884353753223277,-0.8191481967279183,0.7365591397849462,0.898566003942622,1.0,2/22,0.92%,MBP;GCNT2
prerank,protein targeting to lysosome (GO:0006622),-0.27321097189406296,-0.8190456105012136,0.7272727272727273,0.8975647141651457,1.0,5/20,14.07%,GGA3;LAMP2;SNX16;SCARB2;NAGPA
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.30897979045252155,-0.8183765976175874,0.6583333333333333,0.8976170088098083,1.0,2/13,1.27%,TGFBR1;RBPMS
prerank,response to reactive oxygen species (GO:0000302),0.3512005420646652,0.8183093634395721,0.7352320675105485,1.0,1.0,14/54,21.13%,STK26;MAPK1;FYN;STK24;EGFR;JUN;APTX;MPV17;PDCD10;ERCC6L2;SIRT1;RPS3;PKD2;MAPT
prerank,regulation of muscle contraction (GO:0006937),0.3787439758773294,0.8180793890936114,0.7023529411764706,1.0,1.0,3/26,8.88%,CAV1;PPP1R12B;KCNA1
prerank,long-term synaptic potentiation (GO:0060291),-0.2638657300105568,-0.8177577460243778,0.7313432835820896,0.8975770323620651,1.0,4/21,9.94%,STX4;SLC8A3;SHANK2;VAMP2
prerank,regulation of protein phosphorylation (GO:0001932),0.34048471808333086,0.8175923518312149,0.887,1.0,1.0,68/256,23.16%,ECT2;MEN1;PECAM1;CCDC88A;FYN;CCN1;CD74;PML;AXIN1;BRAT1;PGF;PPP2R5E;TFRC;RASGRP1;CRKL;PPP2R5A;CCDC88C;SMG8;BRD4;PIN1;NIBAN1;CIB1;IBTK;EGFR;P2RY1;PARK7;WDFY2;FGF9;FAS;PTEN;CDK5RAP3;FXR1;ROCK2;RACK1;FLOT1;PRKDC;FAM20A;MYDGF;PPIA;STK4;FKBP8;PPP2R5D;LIMK2;RAC1;PDE8A;SIRT1;FN1;PTPN13;LRRK2;MOB1B;AKTIP;SOX9;PPP2CA;EPHA7;CCND3;PRR5L;ILK;SLCO3A1;RIPK1;CADM4;FGR;PPP1R15B;EFNA1;NTRK3;TARDBP;TWF1;NSD1;ADAM17
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2511903490494171,-0.8174491227193613,0.7584269662921348,0.8969691139670907,1.0,14/25,32.59%,EVL;CDK10;TBC1D30;ARHGAP44;CEP97;ARHGAP24;PFN2;PLXNB3;CAPZB;YAP1;ODF2L;TBC1D7;KANK1;ABI3
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.40261207522485065,0.8173721112848759,0.6885456885456885,1.0,1.0,5/17,22.57%,PTEN;EFEMP2;APLN;CDKN1A;CDKN1B
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.34635657312875306,0.817272230923535,0.739406779661017,1.0,1.0,16/56,17.74%,S100A9;MAPKAPK3;S100A8;TRAF3;HMGB1;TAB1;PLCG2;TAB3;TIFA;MYD88;CTSK;TLR5;TLR6;HSP90B1;UBA52;MAP3K7
prerank,regulation of neurotransmitter secretion (GO:0046928),0.37270179955407573,0.817184910326778,0.7183580387685291,1.0,1.0,10/32,21.68%,CHRNB4;BAIAP3;DTNBP1;GSK3B;RAB5A;MCTP1;LRRK2;HCRT;RIMS3;MCTP2
prerank,homocysteine metabolic process (GO:0050667),-0.33432809593032775,-0.8167003007403119,0.6622073578595318,0.8971158769183306,1.0,4/11,14.39%,MTHFR;MMUT;MTRR;NOX4
prerank,lamellipodium organization (GO:0097581),0.3705753644966891,0.8166124813541022,0.6933797909407665,1.0,1.0,16/29,29.22%,CCDC88A;ABLIM3;WHAMM;PARVB;RAC1;ARHGEF7;ABLIM2;GOLPH3;VCL;ABLIM1;ARHGEF6;WASF1;SNX1;ARHGEF4;CARMIL1;KIT
prerank,glycogen catabolic process (GO:0005980),0.40136309224587313,0.8164625505144195,0.6884154460719041,1.0,1.0,2/15,12.09%,PGM2;PHKA2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.2549598827859953,-0.8164244759352762,0.782608695652174,0.8964204267955171,1.0,14/27,33.65%,CACNB2;ANK2;DMD;CACNB4;CALM1;JPH4;SELENON;CACNB1;FKBP1B;CAMK2D;CALM2;ADRA2A;NOS1;JPH3
prerank,negative regulation of leukocyte migration (GO:0002686),-0.3383962250612561,-0.8160912413559536,0.7119741100323624,0.895872258017379,1.0,3/10,12.93%,CD300A;CD200;HMOX1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.4046625364718577,0.81585694830805,0.6758530183727034,1.0,1.0,8/15,27.45%,HAP1;CNTNAP4;BAIAP3;CLN3;USP46;SYN3;NLGN2;NLGN1
prerank,regulation of translation (GO:0006417),0.3375777690371129,0.8154400812286623,0.8378378378378378,1.0,1.0,60/173,24.35%,ZCCHC4;EIF4B;EIF2A;RBM3;EIF3E;RPS4X;CSDE1;EIF4A3;NIBAN1;MTG2;MTPN;NCBP1;CPEB3;PUM3;TCOF1;TYMS;DHX9;IGF2BP3;UPF3B;FXR1;RACK1;PRKDC;LSM14A;NSUN3;PAIP1;CNOT1;PLD1;METTL14;PYM1;SAMD4A;EEF2;VIM;LARP4B;NAT10;POLDIP3;GSPT1;EPRS1;EIF4ENIF1;ELAVL1;RPL5;NCBP2;RPS3;DAPK1;EIF6;CNOT8;RBM4B;SYNCRIP;CNOT7;GLE1;GAPDH;RPS6KA3;RPL13A;EIF4E2;RPL10;YBX1;NCL;NPM1;CIRBP;DAPK3;EIF2AK2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.42492040733366776,0.8153544383554431,0.6885245901639344,1.0,1.0,3/10,22.32%,TUT4;UBA52;NEDD8
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.31115395716285754,-0.8153248908610562,0.69921875,0.8960039778011963,1.0,7/14,31.61%,PRKCI;ECSCR;THBS1;PDCD4;CD40;RGCC;CCL2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.3167480397967819,-0.8153036132035941,0.7013422818791947,0.8948478426203456,1.0,3/11,6.29%,RREB1;ENPP2;CORO1C
prerank,protein acylation (GO:0043543),-0.22118241234666344,-0.8151208166756431,0.8272727272727273,0.8940380503074529,1.0,16/38,26.25%,GLUL;ZDHHC17;ZDHHC13;ZDHHC5;ZDHHC8;SELENOK;KAT2A;NAT9;ZDHHC16;ING4;ZDHHC20;ZDHHC15;GTF2B;ZDHHC3;NAA10;ZDHHC12
prerank,linoleic acid metabolic process (GO:0043651),0.3926941206412068,0.814523577300818,0.6784313725490196,1.0,1.0,2/17,14.51%,ABCD1;ELOVL5
prerank,protein transport (GO:0015031),0.3376248941296535,0.814391540409189,0.916,1.0,1.0,66/332,17.85%,CENPF;NEURL1B;TFR2;TBC1D1;NDC1;RAMP1;TBC1D8B;RCN3;CD74;STX17;SNX33;TBC1D22B;ARL5C;NAPG;TFRC;TLK1;EVI5;SYS1;ARL11;RAB1B;RAB22A;YWHAH;STX5;ARF4;HDAC6;ARFGAP3;SNX9;RAB8A;CLTC;SLC10A7;PICK1;BLZF1;SEC13;MIA2;STX11;CALCRL;GGA1;KIF13A;RAB8B;IL10RA;PRKCB;ARF3;SEC31A;CANX;RAB43;RAB11B;LMTK2;CHMP1B;ATP6V0E1;COPZ1;VPS33B;SCAMP1;TBC1D25;ARL4C;STEAP3;ATP6AP1;RAB5A;CHMP3;NAPB;ATP6V0D1;CHMP2B;ADPRH;ARL6IP5;HSP90B1;EIF2D;GGA2
prerank,regulation of cytoskeleton organization (GO:0051493),0.34287297264230143,0.8143411349924198,0.8006072874493927,1.0,1.0,23/108,18.76%,ARHGEF5;MAPK1;CCDC88A;EZR;S100A9;S100A8;CLASP1;RND3;ARHGAP35;MARK2;EPHA3;MLST8;CRK;ROCK2;RAC2;DIAPH1;GSK3B;PAK2;RAC1;KATNBL1;IQGAP1;TAOK1;CLN3
prerank,cellular response to organic substance (GO:0071310),0.34074458360356563,0.8142961272504607,0.8076923076923077,1.0,1.0,27/116,20.46%,CYP1B1;LEF1;RAMP1;DCPS;HDAC6;CIB1;SOCS2;PARK7;EMD;PTPN7;PTPN14;FLT3;SLIT3;BMPR1A;STAT5B;RACK1;PTPN5;LDLRAP1;ARL6IP5;HCLS1;CXCR4;PTPN13;LRRK2;TRAF6;MME;NCOA2;ACVR2B
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3596197954220852,0.8142051464219383,0.7101123595505618,1.0,1.0,6/36,9.21%,DDAH2;CAV1;TERF2;NUS1;LYPLA1;EGFR
prerank,ether lipid biosynthetic process (GO:0008611),-0.3410893485503958,-0.813973293917815,0.6885245901639344,0.8950356656260283,1.0,7/10,35.91%,DHRS7B;GNPAT;CHPT1;PEDS1;PLA2G4A;PLA2G4C;PEX7
prerank,protein localization to organelle (GO:0033365),0.33933441331320013,0.813423224254582,0.82744702320888,1.0,1.0,30/133,18.30%,RAB33B;RPA2;CNTLN;CSRP3;SYS1;STX5;GBP2;DDRGK1;CEP250;ZBTB7A;RPA1;PPP1R15A;ABCA7;EMD;TOR1A;DHX9;VAPA;DCP1A;PACSIN2;CNEP1R1;BBS4;RAB35;RIPOR1;SCG3;IFT140;BBS9;TMEM30A;YWHAE;LRRK2;RAB6A
prerank,endodermal cell differentiation (GO:0035987),-0.23621442023037909,-0.8128154861817731,0.7596899224806202,0.8960148097017004,1.0,5/31,7.87%,ITGB5;CTR9;ITGA5;COL11A1;MMP14
prerank,regulation of protein kinase B signaling (GO:0051896),0.3370776927458522,0.8128079853393506,0.8678678678678678,1.0,1.0,35/193,17.58%,CD19;IAPP;PHLPP2;ERBB3;FYN;RCN3;PHLDA3;BANK1;TGFA;CIB1;GRB2;STRN;EGFR;PDPK1;TXN;PARK7;FGF9;FLT3;PTEN;ARRB2;F3;RACK1;RAC2;DDIT3;MYDGF;IRS1;DAG1;EGF;TCF7L2;FGFR1;PIK3CA;RAC1;SIRT1;HCLS1;KITLG
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.27234464624888793,-0.8123894951122783,0.7399103139013453,0.8955565063933458,1.0,8/18,25.36%,ENY2;SARNP;DDX19A;DDX19B;NUP133;PABPN1;MCM3AP;ZC3H11A
prerank,glycoprotein catabolic process (GO:0006516),-0.2756361372233483,-0.8118528670795533,0.7222222222222222,0.8953678470158364,1.0,3/17,3.69%,MANBA;NGLY1;STT3B
prerank,7-methylguanosine mRNA capping (GO:0006370),0.3696713839257132,0.811545628306976,0.7164009111617312,1.0,1.0,10/31,22.44%,POLR2I;POLR2A;CMTR2;NCBP1;ERCC3;POLR2K;POLR2J;NCBP2;RNMT;POLR2B
prerank,7-methylguanosine RNA capping (GO:0009452),0.3696713839257132,0.811545628306976,0.7164009111617312,1.0,1.0,10/31,22.44%,POLR2I;POLR2A;CMTR2;NCBP1;ERCC3;POLR2K;POLR2J;NCBP2;RNMT;POLR2B
prerank,positive regulation of cellular catabolic process (GO:0031331),0.33788682968590694,0.8110120259421671,0.8160804020100503,1.0,1.0,39/132,21.01%,MEFV;NRDC;EZR;TWIST1;SNX33;STK11;ABCD1;ZC3H18;FOXO1;FAF1;HMGB1;PIM2;DCN;SNX9;ENTPD5;MSN;ORMDL3;ATF6;RDX;TRIM68;RNF152;DXO;PSEN1;IRS1;TRIM5;GSK3B;CNOT1;RC3H1;LRRK2;SNCA;ZBTB20;DAPK1;SVIP;CNOT8;PNPT1;PRR5L;CNOT7;BNIP3;ROCK1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.4262584115895282,0.8106279058606196,0.6863572433192686,1.0,1.0,6/10,29.56%,ACTN4;RXRB;RARG;RXRG;RXRA;SNW1
prerank,embryonic hemopoiesis (GO:0035162),0.4152405308927068,0.8105515555815727,0.6601398601398601,1.0,1.0,4/12,17.58%,ZFPM1;KMT2A;THOC5;KITLG
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.3796836466686999,0.8103702176590349,0.6835138387484958,1.0,1.0,7/21,21.24%,DNMT1;JUN;FGF9;BMPR1A;ADAMTS1;LDLRAP1;MEF2D
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.2651087223476377,-0.8099999044884536,0.7542857142857143,0.897560874986724,1.0,2/21,1.27%,TGFBR1;RBPMS
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.34832042447816947,0.8098662991569522,0.7439153439153439,1.0,1.0,10/59,17.12%,SDK1;PECAM1;HMCN1;IGSF21;BSG;PALLD;NECTIN1;KIRREL3;CDH4;EMB
prerank,mesenchyme morphogenesis (GO:0072132),0.3962308982241181,0.8095488377764503,0.6939820742637645,1.0,1.0,6/17,20.82%,MDM4;NOTCH1;BMPR1A;TGFB2;SOX9;SMAD2
prerank,organophosphate biosynthetic process (GO:0090407),-0.23240692551786105,-0.8094868160053046,0.8035714285714286,0.8972519593364219,1.0,9/37,14.19%,AGPAT5;ITPKB;MBOAT1;IP6K1;GNPAT;TPI1;MOCS2;LPCAT1;FGF2
prerank,actin filament depolymerization (GO:0030042),0.42098943549674395,0.8088623502363986,0.6911357340720221,1.0,1.0,2/11,8.98%,GSN;CFL2
prerank,response to organophosphorus (GO:0046683),-0.28232494779711237,-0.8088009241310128,0.7058823529411765,0.8973173962091158,1.0,6/16,28.13%,DGKQ;TRPC3;P2RX4;VGF;NDUFS4;ABCC9
prerank,negative regulation of synaptic transmission (GO:0050805),0.37728019087400155,0.808753888000648,0.6816524908869988,1.0,1.0,7/23,21.26%,MTMR2;PICK1;PTEN;SLC24A2;LRRK2;ATAD1;GRIK3
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3422809589361377,0.8085540021068102,0.7905544147843943,1.0,1.0,18/80,20.54%,ANLN;CCDC88A;PALM;RIPOR2;ARHGAP35;FUZ;TAPT1;CDC42EP3;NRP1;RAC2;BBS4;BRK1;MARK4;PIK3CA;RAC1;CDC42EP1;PLEKHM1;CROCC
prerank,regulation of ruffle assembly (GO:1900027),-0.2583512984352801,-0.8084844444475514,0.7613636363636364,0.8966660117933934,1.0,7/23,20.00%,EVL;PFN1;P2RY12;EPS8;ARHGAP24;PFN2;P2RX4
prerank,muscle cell migration (GO:0014812),-0.3401253120627464,-0.808450431845412,0.6977491961414791,0.8955516133341186,1.0,4/10,23.49%,ITGB3;AAMP;MEGF10;PLAT
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3827547944428709,0.8079444727830283,0.7113772455089821,1.0,1.0,4/24,12.06%,C2CD5;FYN;CIB1;FIS1
prerank,myotube cell development (GO:0014904),0.4150110725979326,0.8074870776006359,0.6933139534883721,1.0,1.0,2/10,13.79%,CAV2;SKI
prerank,epithelial tube morphogenesis (GO:0060562),-0.2424275967190532,-0.8073456702499786,0.7685185185185185,0.8962750438254906,1.0,5/32,10.17%,ACVR1;CSF1R;CTNNB1;RYR2;PKD1
prerank,odontogenesis (GO:0042476),0.36423126646621207,0.8073131517082905,0.7239467849223947,1.0,1.0,7/35,23.09%,AQP1;COL1A2;ANKRD11;TGFB2;HDAC1;FGFR2;OSR1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.3379855013962816,0.8072875748025974,0.7852760736196319,1.0,1.0,23/86,17.62%,PSMB7;PSMD11;PSMF1;CHEK1;PSMC1;PSMC3;PSMA4;PSMC4;NFE2L2;PSMD13;PSME1;DDIT3;CREBBP;BAG3;PSMB1;TP53;LIMD1;PSMD8;PSME4;DNAJB1;VHL;PSMD4;UBA52
prerank,cellular iron ion homeostasis (GO:0006879),0.35280035444869573,0.8072720878745989,0.7736842105263158,1.0,1.0,5/55,5.06%,TFR2;HEPH;ALAS2;CYBRD1;TFRC
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.28318735587962773,-0.8067908667734609,0.7251908396946565,0.8960597913466272,1.0,4/15,20.67%,SMO;VEGFA;SOX8;AGT
prerank,positive regulation of transporter activity (GO:0032411),0.4054816279485294,0.8062856670930342,0.6946666666666667,1.0,1.0,5/13,27.29%,KMT2A;STK39;NR1H3;WNK3;RXRA
prerank,cellular polysaccharide catabolic process (GO:0044247),0.3958071395561055,0.8060767107097204,0.6906005221932114,1.0,1.0,1/16,1.77%,PGM2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.33599457976283226,0.8057467018488025,0.893,1.0,1.0,67/248,21.62%,JADE1;PSMB7;LRP4;PSMD11;AXIN1;PSMF1;STK11;GPRC5B;CAV1;CCDC88C;CSNK1A1;PSMC1;PIN1;CSNK1G2;FUZ;TLE4;EGFR;CUL3;PFDN5;PSMC3;AMFR;RUVBL2;EMD;PSMA4;RUVBL1;XIAP;CCAR2;PSMC4;TMEM131L;LRRK1;PSMD13;PSME1;DDIT3;LATS1;PSEN1;PSMB1;GSK3B;STK4;LIMD1;EGF;PTPRU;PSMD8;TCF7L2;CTNND2;LGR4;PSME4;PSMD4;TRPM4;LMBR1L;PTK7;TMEM170B;LRRK2;PPP1CA;AMER2;TLE3;PPM1B;HDAC1;STK3;TBL1XR1;SOX9;USP34;NPHP4;ILK;KREMEN1;USP47;ZEB2;CAPRIN2
prerank,negative regulation of receptor binding (GO:1900121),-0.33019743004497404,-0.8057391248245851,0.6907894736842105,0.8968373115130932,1.0,1/10,2.10%,ADAM15
prerank,toll-like receptor signaling pathway (GO:0002224),0.33519567824629737,0.8038855109982127,0.7829218106995884,1.0,1.0,27/84,21.48%,S100A9;MAPKAPK3;IKBKG;S100A8;TRAF3;BIRC2;HMGB1;MAP3K1;TAB1;PLCG2;TAB3;BTK;MYD88;CTSK;TLR5;TLR6;HSP90B1;EPG5;UBA52;MAP3K7;COLEC12;LGALS9;TRAF6;CASP8;IKBKB;RIPK1;RPS6KA3
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3333705061725948,0.8038406659308012,0.8058645096056622,1.0,1.0,32/100,23.45%,PLK1;XPO1;GLMN;TAF1;CSNK1A1;DESI1;DDRGK1;PARK7;SUMO1;RAD23A;CCAR2;UCHL5;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;TAF9;UBXN1;CAMLG;RNF19A;USP7;LRRK2;KEAP1;ARAF;MDM2;CBFA2T3;HECTD1;DDA1;BBS7;UFL1
prerank,phosphate ion homeostasis (GO:0055062),0.4172106452422797,0.8038234115638113,0.7015781922525107,1.0,1.0,10/10,58.31%,XPR1;SFRP4;ENPP1;SLC34A1;GCM2;SLC34A2;SLC34A3;FGF23;FGFR4;TFAP2B
prerank,melanosome localization (GO:0032400),0.38191245631406306,0.8034958508392381,0.69559902200489,1.0,1.0,9/21,24.71%,SHROOM2;RAB11B;BBS4;VPS33B;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,aorta morphogenesis (GO:0035909),0.3902166988948795,0.8034078311275724,0.7088607594936709,1.0,1.0,5/17,20.51%,HEY2;BMPR1A;EFEMP2;PROX1;RBPJ
prerank,mitochondrial membrane organization (GO:0007006),-0.2335069153404703,-0.8032271288689139,0.7857142857142857,0.9003651347423577,1.0,17/32,28.83%,BCL2L1;MICOS10;GHITM;MFN2;APOO;MTX2;MTX3;SPG7;MAIP1;BAD;MTX1;SLC25A5;CHCHD6;BCL2;TMEM11;MFN1;TIMM50
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.40406934579686704,0.8031122922136401,0.702457956015524,1.0,1.0,2/14,7.73%,SULF2;FUZ
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.3055880127754575,-0.8026958897478502,0.7639344262295082,0.9002291650725869,1.0,4/12,20.67%,SMO;VEGFA;SOX8;AGT
prerank,intracellular protein transport (GO:0006886),0.3348795781679042,0.8026193175801424,0.931,1.0,1.0,83/304,21.96%,ANKLE1;XPO1;POM121;TBC1D1;C2CD5;TBC1D8B;CD74;STX17;NUP107;CCHCR1;TBC1D22B;ARL5C;NAPG;TNPO1;TLK1;EVI5;NUP42;IPO13;ARL11;RAB1B;RAB22A;YWHAH;NUP50;STX5;AP4B1;ARF4;AP1S3;HDAC6;DESI1;NUP214;ARFGAP3;SNX9;CLTC;PICK1;SEC13;IPO7;AP4E1;NUP188;STX11;RANBP6;GGA1;KIF13A;ARF3;SEC31A;HAP1;RAB43;RPAIN;BAG3;COPZ1;VPS33B;E2F3;TBC1D25;APPL1;ARL4C;IPO5;RAB5A;LMAN1;XPO4;KPNB1;NAPB;ADPRH;EIF2D;GGA2;RAB6A;STAM;EIF4ENIF1;SAR1B;NUP85;TRAK2;SGSM3;HPS4;MMP12;TPR;TNPO2;TBC1D15;ARL5B;SNX13;TNPO3;SYK;TMED10;EVI5L;AP3B1;NUP93
prerank,negative regulation of cell growth (GO:0030308),0.3350935535756394,0.8023504864291461,0.8272727272727273,1.0,1.0,21/121,16.99%,CDKN2C;JADE1;PPP1R9B;RB1;TCHP;PML;STK11;CDKN2A;SMARCA4;CDKN2D;SMAD4;CCAR2;SLIT3;FGF13;RACK1;SERTAD2;BCL6;TP53;TGFB2;NDRG3;SIRT1
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.276712395736104,-0.8023004176042576,0.7400881057268722,0.8996947111001752,1.0,6/17,26.49%,ATP1A1;AR;TFPI;ATP1A2;ATP1A3;URI1
prerank,ceramide transport (GO:0035627),0.41558785101719886,0.8018721418192668,0.698744769874477,1.0,1.0,2/12,9.30%,ABCA13;ABCA2
prerank,dephosphorylation (GO:0016311),0.33575690269497005,0.8011215077031625,0.8485456369107321,1.0,1.0,32/147,18.13%,PLPPR3;ALPL;PPM1D;PTPRA;PPP3CA;FBXW11;PTPN22;PPP2R5E;STK11;PPP1CB;PPP2R5A;EPHX2;MTMR2;TAB1;PPP2CB;PTPN7;PTPN14;PPP1CC;MTMR6;PTEN;PPP3CC;PPP1R12A;PLPPR4;PTPN5;MTM1;PPP6C;PTPRU;PPP2R5D;DUSP12;PTPN13;PPP1CA;ILKAP
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.332319878970363,0.8005470806613403,0.874,1.0,1.0,50/182,22.84%,HEY2;RB1;AURKA;PTPN22;RBL1;FOXP1;RIN3;CRKL;TAF1;TERF2;LRP3;TNRC6C;TNRC6B;NOTCH1;MTMR2;DDRGK1;ABCC2;ZNF148;MECP2;PARP14;DNMT1;PARK7;SETDB2;BMPR1A;ROCK2;RACK1;PSEN1;PDCD10;RUNX1;MAP2K1;TGFB2;ANKRD13A;VHL;SIRT1;CNPY2;APLN;FLOT2;ADAM10;SETDB1;HDAC1;LGALS9;AGO2;CNOT7;CITED2;MAPT;CELF1;ATP2B4;AGO1;LDLR;TARDBP
prerank,regulation of interleukin-4 production (GO:0032673),0.3730726562095601,0.8003246574167082,0.7167701863354037,1.0,1.0,2/21,3.56%,LEF1;ZFPM1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.3013145707518765,-0.8002906742233613,0.7325102880658436,0.901887708255616,1.0,6/13,26.50%,FEZ2;FEZ1;PINK1;CHMP4B;CHMP4A;SEC22B
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.3612933639949505,0.7999253652796878,0.6972909305064782,1.0,1.0,4/26,8.42%,ITPR1;HTR2A;IBTK;PLCG2
prerank,cell differentiation in hindbrain (GO:0021533),-0.3220993648371651,-0.7997591231237607,0.7183098591549296,0.9016338626040189,1.0,3/11,8.41%,OPHN1;KNDC1;FAIM2
prerank,receptor internalization (GO:0031623),0.3428441343118811,0.7993840583820123,0.7381465517241379,1.0,1.0,11/44,17.96%,RAMP1;TFRC;CAV1;CLTC;GRB2;CALCRL;ARRB2;GRK2;RAB5A;LDLRAP1;SNCA
prerank,excitatory postsynaptic potential (GO:0060079),0.3843146283213775,0.7987734830927816,0.6915167095115681,1.0,1.0,5/19,21.61%,MPP2;ARRB2;GSK3B;LRRK2;GRIN2D
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.3759017428327346,0.798589622650032,0.706700379266751,1.0,1.0,7/18,18.07%,EMD;PEX2;SKI;MYC;TP53;NLRC3;MORC3
prerank,sulfur compound biosynthetic process (GO:0044272),0.3365659010972189,0.7985533908081114,0.8166160081053698,1.0,1.0,16/104,16.22%,CHST3;FMOD;CSGALNACT2;ST3GAL1;DCN;SLC35D2;ST3GAL2;SLC10A7;B3GNT2;CHST12;OGN;METTL16;PAPSS2;TPK1;CHSY1;GSTM1
prerank,cytoplasmic sequestering of protein (GO:0051220),0.3996505649503243,0.7982683036697175,0.7098515519568152,1.0,1.0,5/13,20.22%,FLNA;LATS1;SUFU;PKD2;KEAP1
prerank,melanosome organization (GO:0032438),0.3647978881907193,0.7981947353502313,0.7149587750294464,1.0,1.0,6/26,21.82%,BLOC1S4;SHROOM2;KIF13A;DTNBP1;HPS4;AP3B1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.33508426868126323,0.798005334002553,0.8247213779128673,1.0,1.0,26/110,20.43%,HJURP;IAPP;RB1;TFRC;FAF1;GSN;LCMT1;HDAC6;RIOK3;PARK7;SUMO1;HCFC1;RACK1;TFIP11;LATS1;BRK1;GSK3B;ATF7IP;AIDA;NAPB;GNL3L;SAR1B;SLF1;RPS3;SVIP;NCLN
prerank,peptidyl-amino acid modification (GO:0018193),0.41501400697242796,0.7978657995810438,0.7040673211781207,1.0,1.0,2/10,10.54%,METAP2;ATP7A
prerank,cellular amide metabolic process (GO:0043603),0.33067026288909607,0.7975893823955997,0.8085106382978723,1.0,1.0,24/102,23.59%,DNPEP;PANK2;ACOT11;CPM;ST3GAL1;MTHFD2L;ACOT13;ACOT2;ABCA2;NAPEPLD;ORMDL3;SLC19A1;MCCC1;CPD;ALDH1L1;MTHFD1L;PPP2CA;MME;NAAA;HLCS;ACOT8;ACSL6;PLPP1;SMPD1
prerank,regulation of protein polymerization (GO:0032271),-0.22932380229457056,-0.7973994620166921,0.8225806451612904,0.9044562654223129,1.0,10/35,19.53%,PAK3;CAMSAP2;HSP90AA1;PFN1;COTL1;PFN2;TTBK1;ARL2;RASA1;CTTN
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.387942083095345,0.7972182383162555,0.7190721649484536,1.0,1.0,6/16,24.70%,ATP5F1E;ATP5F1D;ATP5MC2;ATP5F1B;ATP5MF;ATP5ME
prerank,regulation of actin filament-based process (GO:0032970),0.3418940758433904,0.7970554775195495,0.8,1.0,1.0,11/70,13.20%,ARHGEF5;CCDC88A;EZR;CNN2;RND3;ARHGAP35;EPHA3;MLST8;CRK;ROCK2;RAC2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3358126566370501,0.796308351810424,0.8341759352881699,1.0,1.0,40/129,24.12%,PSMB7;PSMD11;AXIN1;PSMF1;GPRC5B;CAV1;PSMC1;PIN1;CSNK1G2;EGFR;PSMC3;PSMA4;RUVBL1;XIAP;CCAR2;PSMC4;LRRK1;PSMD13;PSME1;PSMB1;EGF;PSMD8;LGR4;PSME4;PSMD4;TRPM4;PTK7;LRRK2;PPM1B;TBL1XR1;USP34;ILK;USP47;ZEB2;CAPRIN2;PSME2;FGFR2;DAAM2;DAPK3;PSME3
prerank,regulation of fibroblast migration (GO:0010762),0.3827203474428446,0.7958786890481225,0.7176616915422885,1.0,1.0,9/20,23.72%,PRKCE;HAS1;APPL1;RAC1;ARHGEF7;CLN3;PRR5L;DDR2;ITGB1BP1
prerank,peptidyl-proline modification (GO:0018208),0.3662718378638396,0.7958105433988101,0.725748502994012,1.0,1.0,11/25,23.77%,PPIL3;PIN1;PPWD1;PPIG;PPIA;PPIE;PPIH;PPIL1;FKBP1A;CWC27;NKTR
prerank,maintenance of protein localization in organelle (GO:0072595),0.3807130947670471,0.7953095273667284,0.7002551020408163,1.0,1.0,7/19,19.92%,PML;TAPT1;CHCHD10;BBS4;HNRNPU;MORC3;TAF3
prerank,response to laminar fluid shear stress (GO:0034616),-0.3296624013167009,-0.7950130826571423,0.7133757961783439,0.9073700754258913,1.0,6/10,25.23%,ABCA1;SMAD6;SMAD7;KLF2;MAPK7;KLF4
prerank,protein mannosylation (GO:0035268),-0.249040166985365,-0.79495091872504,0.7803468208092486,0.9062596181139605,1.0,3/22,6.89%,CRPPA;LARGE1;FKTN
prerank,regulation of response to cytokine stimulus (GO:0060759),0.38435981615828296,0.794840949750442,0.7026022304832714,1.0,1.0,6/19,16.43%,DHX9;CBFB;ELF1;RUNX1;CD24;TAF9
prerank,regulation of cell migration (GO:0030334),0.3294908913226372,0.7940731358298823,0.948,1.0,1.0,58/382,15.56%,KIF14;GTSE1;ARHGEF39;CYP1B1;STK26;LEF1;PECAM1;SYNE2;TIAM1;FLNA;SLK;SUN2;PPP3CA;CCN1;LMO4;CD74;ULK4;NEDD9;ARID2;DACH1;AMOTL2;CAV1;ATM;TRADD;DPEP1;NOTCH1;DDRGK1;FUZ;CIB1;PRKX;PRKCA;PLXNA2;CYRIB;STK24;EGFR;NTNG2;CBLL1;KIF2A;ZMYND8;FGF9;RDX;PTEN;F3;ROCK2;RACK1;ACTN4;SLURP1;ARSB;RNF20;DAG1;SGK3;RIPOR1;PDCD10;EGF;F2R;APPL1;PTPRU;SPAG9
prerank,NAD biosynthetic process (GO:0009435),0.3761486434760116,0.7939916431541401,0.71875,1.0,1.0,1/20,2.64%,HAAO
prerank,protein localization to Golgi apparatus (GO:0034067),0.37130180115118966,0.7931541291343175,0.7488262910798122,1.0,1.0,9/27,21.43%,RAB33B;ARL5C;SYS1;RIPOR1;VPS13A;RAB6A;GOLPH3;ARL5B;TMED10
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.38481958615305345,0.7931299444499247,0.7049180327868853,1.0,1.0,6/18,18.70%,CTNNA1;POLR1A;LATS1;GSK3B;SIN3A;SUFU
prerank,regulation of smooth muscle cell migration (GO:0014910),0.378920754245617,0.7927397122397053,0.730958230958231,1.0,1.0,4/20,12.89%,S100A11;CCN4;BMPR1A;NRP1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.40520003641236135,0.7918517847376982,0.6892265193370166,1.0,1.0,3/12,21.93%,ABCD1;ELOVL5;ACOT8
prerank,regulation of vasculature development (GO:1901342),-0.23932431575147228,-0.7916467215863526,0.8109756097560976,0.9106983200968479,1.0,8/26,22.00%,EGLN1;CTNNB1;NF1;HMOX1;FGF2;VASH1;BMPER;TSPAN12
prerank,dicarboxylic acid metabolic process (GO:0043648),0.336569544508817,0.7916341700318391,0.7790697674418605,1.0,1.0,15/52,22.49%,HAAO;L2HGDH;MTHFD2L;ME3;SLC19A1;PHYH;SDHAF3;IDH2;ASS1;ALDH1L1;MDH2;MTHFD1L;GCLM;ACOT8;GCLC
prerank,protein prenylation (GO:0018342),-0.3256415653970049,-0.7907526913872771,0.731629392971246,0.9110073724065431,1.0,1/10,0.93%,PGGT1B
prerank,platelet degranulation (GO:0002576),0.3278393764643806,0.7902600916281589,0.8338368580060423,1.0,1.0,25/118,23.01%,BLK;F5;PECAM1;FLNA;PHACTR2;CYRIB;ACTN2;APOOL;BRPF3;ABCC4;OLA1;ACTN4;EGF;TGFB2;SCG3;FN1;F13A1;NHLRC2;TAGLN2;ENDOD1;STXBP2;RAB27B;ACTN1;APOH;VCL
prerank,pseudouridine synthesis (GO:0001522),0.4015142099930295,0.7901555078366909,0.7127371273712737,1.0,1.0,4/13,18.03%,NOP10;PUS3;TRUB2;DKC1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.28145134020952134,-0.7901554525266118,0.7755905511811023,0.9107803348033742,1.0,9/14,35.33%,CMPK1;SMPDL3A;ITPA;AK1;AK7;ENPP3;AK4;AK8;NME2
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.4097767473156778,0.789617595209789,0.7168508287292817,1.0,1.0,2/12,4.94%,TWIST1;ABCD1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.30631690321045,-0.7893283879834878,0.7209302325581395,0.9109481049679132,1.0,3/12,11.84%,APOD;PTPRJ;NDRG4
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3876966140280708,0.7890501855884287,0.7133243606998654,1.0,1.0,2/17,7.98%,GPD1L;NEDD4L
prerank,regulation of lamellipodium assembly (GO:0010591),-0.2305257615072076,-0.7889162949387235,0.8165137614678899,0.9104931778092907,1.0,19/34,41.00%,AKIRIN1;PIK3R1;ARPC2;ABI2;TWF2;PLXNB3;CDC42;CAPZB;CYFIP1;FER;PLCE1;ABI3;CLRN1;ACTR3;WAS;OCLN;EPHA2;CARMIL2;SLIT2
prerank,positive regulation of cell differentiation (GO:0045597),0.33203252708606923,0.7885557322081924,0.911,1.0,1.0,38/237,17.11%,ECT2;EZH2;SOX6;LEF1;FBXO5;CTNNA1;TIAM1;CCN1;TWIST1;CCN4;RIPOR2;PA2G4;GPRC5B;MMD2;TCF3;ZFP36L1;LRP3;MMD;MAPK14;ZBTB16;ZEB1;SMAD4;WDFY2;PLCB1;BCL9L;BMPR1A;NELL1;NRCAM;HOXB4;SPAG9;SIN3A;TCF4;FGFR1;TGFB2;ATP6AP1;VHL;TRPM4;XBP1
prerank,chondrocyte differentiation (GO:0002062),0.3596110775957496,0.7884603009331401,0.7622298065984073,1.0,1.0,3/32,6.66%,SOX6;SULF2;RUNX3
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3687414566556465,0.7884341232505031,0.7337349397590361,1.0,1.0,3/23,12.11%,PMAIP1;TIMM9;TOMM70
prerank,RNA polyadenylation (GO:0043631),0.36618707131627604,0.7883488449512072,0.7393364928909952,1.0,1.0,12/26,23.39%,CPSF2;CSTF3;TUT1;SCAF8;PCF11;CPSF1;CLP1;TENT2;PNPT1;WDR33;PAPOLA;LEO1
prerank,mRNA polyadenylation (GO:0006378),0.36618707131627604,0.7883488449512072,0.7393364928909952,1.0,1.0,12/26,23.39%,CPSF2;CSTF3;TUT1;SCAF8;PCF11;CPSF1;CLP1;TENT2;PNPT1;WDR33;PAPOLA;LEO1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.39101201345179437,0.7879914815806739,0.7324675324675325,1.0,1.0,5/15,21.82%,BLOC1S4;AP3M2;DTNBP1;AP3M1;AP3B1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.39101201345179437,0.7879914815806739,0.7324675324675325,1.0,1.0,5/15,21.82%,BLOC1S4;AP3M2;DTNBP1;AP3M1;AP3B1
prerank,positive regulation of cellular component organization (GO:0051130),0.3283206417232993,0.7878507330728942,0.8181818181818182,1.0,1.0,25/107,19.28%,CDC20;TFR2;RB1;LRP4;TFRC;FAF1;NEDD4L;CBLL1;PPP1R15A;PARK7;SUMO1;RELN;RACK1;FLOT1;BRK1;GSK3B;RUNX1;TGFB2;LMAN1;TMEM30A;SNCA;GNL3L;NRXN1;SLF1;RPS3
prerank,iron ion homeostasis (GO:0055072),0.34212295847252283,0.787797138683041,0.8,1.0,1.0,10/58,17.14%,TFR2;HEPH;ALAS2;CYBRD1;TFRC;SMAD4;B2M;MYC;ATP6AP1;ATP6V0D1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.32869417775059645,0.7865968780898449,0.8270980788675429,1.0,1.0,27/108,21.27%,DEPDC1B;TIAM1;AXIN1;SULF2;SNX3;NXN;DISC1;TCF7L1;SMARCA4;TMEM237;HMGXB4;EMD;CBFB;RACK1;SKI;PSEN1;RUNX1;CTNND2;PTK7;LRRK2;PPP1CA;AMER2;RNF43;PPP2CA;RSPO2;SPIN1;KREMEN1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3930629673064633,0.786410166493058,0.7141009055627425,1.0,1.0,3/14,15.15%,RFK;IMPDH2;ADSL
prerank,cellular response to fluid shear stress (GO:0071498),0.40537031160007353,0.7864038260711932,0.7215909090909091,1.0,1.0,5/12,19.93%,MTSS1;NFE2L2;ASS1;SREBF2;PKD2
prerank,bone development (GO:0060348),0.3465683230160165,0.7863335015164772,0.7614269788182831,1.0,1.0,6/39,14.93%,SULF2;MBTPS2;SLC10A7;DYM;SKI;TP53
prerank,purine nucleotide catabolic process (GO:0006195),0.3999803930157405,0.7862860913447467,0.7106666666666667,1.0,1.0,3/13,19.55%,GDA;NT5C2;PNP
prerank,cellular defense response (GO:0006968),0.3453215144123354,0.7861692684567907,0.75,1.0,1.0,6/40,14.50%,SPN;LSP1;ZNF148;CCR6;BECN1;TYROBP
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.39426949076870194,0.7860791596372575,0.7148488830486203,1.0,1.0,2/14,4.94%,TWIST1;ABCD1
prerank,ncRNA metabolic process (GO:0034660),0.34389861613275285,0.7859411560440955,0.7569988801791714,1.0,1.0,8/37,23.32%,NIFK;TUT4;DTD2;TARBP2;AGO2;ZCCHC8;MAPT;DTD1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.39908358825263485,0.785766959093207,0.7165562913907285,1.0,1.0,6/14,26.14%,DDRGK1;DNAJB9;UFL1;TMEM33;BCL2L11;BAK1
prerank,cellular response to cadmium ion (GO:0071276),0.36779800079339664,0.7856036259521656,0.7464622641509434,1.0,1.0,4/24,11.33%,MAPK1;EGFR;SUMO1;JUN
prerank,bone morphogenesis (GO:0060349),-0.2793610460105128,-0.7855061913133338,0.7341772151898734,0.9151454355908716,1.0,2/14,8.86%,BMPR2;BMPR1B
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.34350182834124743,0.7853399529710225,0.7683982683982684,1.0,1.0,11/46,14.07%,CHCHD4;TOMM34;TSPO;PITRM1;TIMM9;DNAJC15;GDAP1;FIS1;TOMM70;TIMM23;GRPEL2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.37000713979505534,0.7852158972469053,0.7478787878787879,1.0,1.0,5/22,13.07%,NOTCH1;PRKCA;MTPN;SMAD4;ROCK2
prerank,dopamine metabolic process (GO:0042417),0.3783852284451785,0.7851027903537159,0.7329910141206675,1.0,1.0,5/18,17.96%,ATP7A;LRTOMT;TGFB2;MAOA;SNCA
prerank,regulation of neutrophil migration (GO:1902622),-0.3148633798972008,-0.7849577251823141,0.7165109034267912,0.9149315032948102,1.0,4/10,14.48%,MPP1;RHOG;NCKAP1L;RHOH
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.39490185792545396,0.7849339250370622,0.7374517374517374,1.0,1.0,3/14,10.90%,ENTPD3;ENTPD5;NUDT9
prerank,neuromuscular process controlling balance (GO:0050885),0.4015896126670046,0.7849215883465974,0.7346938775510204,1.0,1.0,4/12,18.97%,PAFAH1B1;TIFAB;CLN3;NRXN1
prerank,maintenance of blood-brain barrier (GO:0035633),0.34932745874353355,0.7848781126830824,0.7371565113500598,1.0,1.0,4/30,9.17%,PECAM1;TJP3;LAMC1;JAM2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.3254978918708875,0.7845034762669492,0.8323232323232324,1.0,1.0,11/112,8.57%,CD2;SPN;CD47;TWIST1;PTPN22;FOXP1;CCR2;RASGRP1;HMGB1;PLCG2;JAK2
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3774510283688214,0.7838807172387386,0.7340686274509803,1.0,1.0,2/20,7.16%,HEY2;NOTCH1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3231687531161927,0.7835871160690561,0.933,1.0,1.0,40/308,13.68%,FOXA2;NKX6-1;EZH2;PLA2R1;SOX6;LEF1;FBXO5;GLMN;TIAM1;BATF;TWIST1;RPS19;TFRC;AGPAT1;CAV1;CCR2;NFAM1;ALMS1;DYNC1H1;ZBTB16;JAK2;UCP2;RBM19;NR2C2;ABCA7;EHMT1;CARD9;SMAD4;KMT5C;TAPT1;PLCB1;ADIPOR1;PAXIP1;BCL9L;HAP1;BMPR1A;ZBTB7B;FLOT1;NUMA1;ADCYAP1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4058790690309725,0.7835643013707858,0.7126917712691772,1.0,1.0,3/11,18.03%,EXOSC10;FBL;DKC1
prerank,steroid catabolic process (GO:0006706),0.4212665770666558,0.7830885410868743,0.7448979591836735,1.0,1.0,1/10,6.12%,YWHAH
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.270807776556916,-0.7829453528083804,0.8045454545454546,0.9170464922275124,1.0,3/18,9.31%,RGS10;GNA15;CDK5R1
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3224253867696714,0.7824589830478235,0.94,1.0,1.0,82/348,22.37%,BRCA1;HEY2;MAPK1;LEF1;E2F1;EZR;TWIST1;CD74;PTPN22;CTCF;TFRC;RPS7;GSN;ATM;TERF2;MYOM1;EPHX2;PDE2A;LRP3;TNRC6C;TNRC6B;NOTCH1;DDRGK1;MAPK14;PLCG2;PICK1;MTPN;EGR1;DNMT1;MSN;PARK7;FGF9;RDX;MYD88;ARRB2;HCFC1;SETDB2;F3;NFE2L2;ROCK2;ZBTB7B;MYC;GABPA;PSEN1;TLR6;DTNBP1;TYROBP;GSK3B;LIMS1;TADA3;ATF7IP;TP53;PDCD10;EGF;HGS;MAP2K1;TASOR;TRIM28;FN1;SNCA;MED1;ATAD1;SETDB1;RPL5;RPS3;LGALS9;SOX9;AGO2;DNMT3B;INPP5F;RPL23;RBPJ;RAB27A;CITED2;PRKAG1;ROCK1;CELF1;CALCOCO1;ACTG1;AGO1;MED23;NTRK3
prerank,GPI anchor metabolic process (GO:0006505),0.3590688633568531,0.7824386858007868,0.7289719626168224,1.0,1.0,8/26,22.47%,PIGH;PIGF;PIGA;PGAP1;PIGU;PIGM;PGAP2;DPM2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.33854118293198504,0.7820804247426384,0.7556512378902045,1.0,1.0,3/44,2.78%,ARHGEF5;CD47;CCDC88A
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3531310957051325,0.7819402550027511,0.759860788863109,1.0,1.0,10/29,22.17%,ZC3H7A;PUM2;HNRNPA2B1;SRRT;TUT4;PUM1;TARBP2;AGO2;SMAD2;AGO1
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4098415332561459,0.7818821986928335,0.7279305354558611,1.0,1.0,3/10,21.77%,PTPN22;IFI35;NR1H3
prerank,response to peptide hormone (GO:0043434),0.3434290412061588,0.7815945715556983,0.7733188720173536,1.0,1.0,13/43,21.01%,CAV1;ZFP36L1;GNAI1;STAT5B;ROCK2;ZBTB7B;IRS1;SIRT1;XBP1;CREB1;EIF6;EIF2B5;ROCK1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.36712611666397643,0.7812212292450469,0.7488207547169812,1.0,1.0,2/25,4.43%,PMAIP1;TNFSF10
prerank,regulation of cytoplasmic translation (GO:2000765),0.39503022915401187,0.7808585729251487,0.7368421052631579,1.0,1.0,2/14,11.50%,CPEB3;DHX9
prerank,regulation of interleukin-6 production (GO:0032675),0.325317367794754,0.7806995215325643,0.8319838056680162,1.0,1.0,19/96,17.98%,POU2AF1;CD47;TWIST1;CD74;IL16;PTPN22;HMGB1;PLCG2;IL17RA;CARD9;DHX9;MYD88;TLR6;TYROBP;F2R;NLRC3;CYBA;XBP1;POU2F2
prerank,secretory granule organization (GO:0033363),0.4145564081698857,0.7805615434257156,0.7225433526011561,1.0,1.0,3/10,15.41%,VPS33B;DTNBP1;F2R
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3413355239095927,0.7798452308653862,0.76431718061674,1.0,1.0,8/38,16.84%,CD47;DDAH2;CAV1;JAK2;ROCK2;TLR6;ASS1;RAC1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3516032103908026,0.7792789738470942,0.7172897196261683,1.0,1.0,6/26,14.90%,TFDP1;MTBP;EGFR;RDX;PLCB1;ADAMTS1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.34837609284802307,0.7785373556313535,0.7614269788182831,1.0,1.0,6/36,10.32%,SP100;NOTCH1;HMGB1;DCN;MECP2;NR2F2
prerank,T cell migration (GO:0072678),-0.2944818660479196,-0.7782798526937151,0.7184115523465704,0.9235145327759905,1.0,3/13,9.70%,SLC12A2;PIK3CD;S1PR1
prerank,regulation of monooxygenase activity (GO:0032768),0.363378348082919,0.7778133572384492,0.7359413202933985,1.0,1.0,7/23,18.45%,DDAH2;CAV1;LYPLA1;EGFR;NOSIP;SNCA;NOSTRIN
prerank,type I interferon signaling pathway (GO:0060337),0.34053444728384785,0.7777646335582621,0.7538461538461538,1.0,1.0,8/41,15.41%,SP100;IRF9;GBP2;XAF1;EGR1;MYD88;IFITM3;IRF8
prerank,cellular response to type I interferon (GO:0071357),0.34053444728384785,0.7777646335582621,0.7538461538461538,1.0,1.0,8/41,15.41%,SP100;IRF9;GBP2;XAF1;EGR1;MYD88;IFITM3;IRF8
prerank,pulmonary valve development (GO:0003177),0.3734083830238826,0.7776550798415583,0.7109677419354838,1.0,1.0,2/18,7.16%,HEY2;NOTCH1
prerank,negative regulation of heart contraction (GO:0045822),-0.3113693011170505,-0.7770840156102382,0.7346938775510204,0.9243021577131078,1.0,5/11,32.99%,ZC3H12A;SRI;ATP1A2;FKBP1B;SPTBN4
prerank,ventricular septum morphogenesis (GO:0060412),0.359006957653593,0.7770797764691282,0.7302709069493521,1.0,1.0,6/27,12.44%,HEY2;ZFPM1;NOTCH1;SMAD4;SLIT3;BMPR1A
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3344117736138213,0.7761599608261961,0.7753396029258098,1.0,1.0,11/57,14.93%,PMAIP1;AURKA;TNFSF10;BOK;DCN;PARK7;FIS1;CHCHD10;MCU;GSK3B;TP53
prerank,sodium ion import across plasma membrane (GO:0098719),-0.26041630308449176,-0.7761075449711714,0.7918552036199095,0.9246475139085845,1.0,4/17,16.35%,SLC12A2;SLC9A1;HCN2;SLC8A1
prerank,negative regulation of signal transduction (GO:0009968),0.3203541867372143,0.7753858510976993,0.923,1.0,1.0,38/249,18.70%,IL12A;EZH2;NR4A2;PHACTR4;CD47;RB1;ERBB3;PALM;NTN1;SULF2;CRHBP;NXN;MTMR2;DCN;RNF157;LRRC14;ZBTB7A;EGFR;ASXL1;KCTD21;HMGXB4;PRKCB;PTEN;HHIP;RACK1;IRS1;CNOT1;EGF;APPL1;HGS;LGR4;NLRP2B;PIP4K2A;APLN;LRRK2;SNCA;RNF43;SUFU
prerank,cellular response to leucine (GO:0071233),0.4076344805301222,0.7752882018770694,0.7376093294460642,1.0,1.0,3/10,16.80%,LARS1;UBR2;KLHL22
prerank,response to leucine (GO:0043201),0.4076344805301222,0.7752882018770694,0.7376093294460642,1.0,1.0,3/10,16.80%,LARS1;UBR2;KLHL22
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3687183576114763,0.7752027259163446,0.7625,1.0,1.0,5/22,16.37%,PSMB7;PSMA4;NFE2L2;PSMB1;PSME4
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.32530406767701553,0.7746952263669123,0.8240081383519837,1.0,1.0,16/87,17.72%,SDHAF4;PET100;NDUFS8;CHCHD4;NDUFAF8;NDUFB7;NDUFAF1;NDUFAF7;NDUFA1;NDUFAF5;FOXRED1;SDHAF3;UQCC1;NDUFAB1;NDUFA5;NDUFS1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.25395259857309227,-0.7745729069928359,0.7712765957446809,0.9260065416620665,1.0,10/20,23.06%,SMAD1;RELA;CARF;ATF4;VEGFA;SESN2;SMAD9;CREB3;HIF1A;MT3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.22431161041806758,-0.7745208110416215,0.8290598290598291,0.9249116585479641,1.0,9/30,19.20%,SMAD3;PCSK6;FSTL1;ENG;LATS2;SMAD7;TGFBR3;SMURF2;SOX11
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.31900524627874216,0.7744920549026566,0.9099099099099099,1.0,1.0,51/208,21.21%,ECT2;TRIM59;FLNA;CD74;PIDD1;TANK;TNFSF10;GPRC5B;TFRC;NR1D1;IKBKG;TRADD;TRAF3;BIRC2;BRD4;PIM2;UBE2V1;PLCG2;TAB3;PDPK1;RIOK3;TIFA;CARD9;PRKCB;MYD88;TRIM68;VAPA;CC2D1A;CFLAR;TLR6;TRIM5;RBCK1;F2R;LPAR1;TRAF3IP2;NLRC3;SIRT1;NLRX1;CANT1;MAP3K7;MALT1;PPM1B;LGALS9;TRAF6;CASP8;UBE2N;SLC44A2;IKBKB;RIPK1;OTUD7A;GAPDH
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.3653703546813916,0.7744380860104917,0.7416563658838071,1.0,1.0,5/18,16.99%,NONO;PARK7;NFE2L2;PPIA;SIRT1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.2145671215122408,-0.7741987309157464,0.8909090909090909,0.9242505456927994,1.0,7/39,14.19%,SALL1;CTNNB1;SEMA3E;ENG;PKD1;VEGFA;FGF2
prerank,sphingoid metabolic process (GO:0046519),-0.30638667226242133,-0.7741846395592731,0.7584905660377359,0.9230923991207846,1.0,4/12,23.87%,SGPP1;SPHK2;PLPP3;DEGS2
prerank,2-oxoglutarate metabolic process (GO:0006103),0.3881087968882367,0.7741189772264202,0.721763085399449,1.0,1.0,3/13,14.99%,L2HGDH;PHYH;IDH2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.25488964515800955,-0.7737604488476167,0.7947368421052632,0.9226341153678155,1.0,6/20,18.60%,RAP1GDS1;SELENOK;TGM2;BCAP31;THADA;WFS1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.36271249503109826,0.7737168461939498,0.758873929008568,1.0,1.0,5/21,16.77%,CAV1;GPD1L;PTEN;RACK1;NLRP2B
prerank,positive regulation of protein secretion (GO:0050714),0.3274367593406997,0.7733088923297325,0.8181818181818182,1.0,1.0,9/69,16.78%,BLK;EZR;MYOM1;MYH10;MCU;PPIA;TCF7L2;TGFB2;CAPN10
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3624868719930078,0.7732360912361541,0.7520958083832335,1.0,1.0,7/25,17.60%,SCAF11;TXNL4A;SRSF4;PRPF4;SRSF10;SNRNP40;PRPF8
prerank,GPI anchor biosynthetic process (GO:0006506),0.35370537898688326,0.7731477563449173,0.7517321016166282,1.0,1.0,9/30,22.47%,PIGH;PIGF;PIGA;PIGT;PGAP1;PIGU;PIGM;PGAP2;DPM2
prerank,myoblast differentiation (GO:0045445),0.3830675870391373,0.7731266166931153,0.7418136020151134,1.0,1.0,1/14,2.67%,RB1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.322132327642721,0.772398075983231,0.891,1.0,1.0,35/173,15.35%,SPTA1;F5;STX17;ATL2;RAB1B;ANK1;STX5;PEF1;ARF4;TGFA;DYNC1H1;ARFGAP3;ARFGAP1;SEC24B;SEC24A;ZW10;CUL3;SEC13;ERGIC2;WHAMM;TRAPPC4;MIA2;BET1;COG6;VAPA;SEC31A;KDELR2;TMEM115;PGAP1;RAB2A;COPZ1;NRBP1;DYNLL1;SPTAN1;CNIH1
prerank,eye morphogenesis (GO:0048592),0.36930932117020154,0.7721030317435469,0.743073047858942,1.0,1.0,5/19,18.10%,AGTPBP1;SHROOM2;NIPBL;SKI;RARG
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3620681770402141,0.7720493085037043,0.7382716049382716,1.0,1.0,2/21,6.63%,OSBPL5;MBOAT2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.34668953054296614,0.7716410425224162,0.7594339622641509,1.0,1.0,8/29,20.23%,CCR2;JAK2;SOCS2;STAT5B;PIAS1;JAK3;PKD2;SOCS6
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.2646819707138496,-0.7715504961847537,0.7748917748917749,0.9248136569882786,1.0,8/18,43.90%,SLC8B1;MDK;LYN;PTK2B;MTUS1;F7;SLIT2;IL6
prerank,fatty acid metabolic process (GO:0006631),0.32169721458503564,0.7710454381374889,0.8436548223350254,1.0,1.0,21/115,17.11%,CEL;ACADM;ACOT11;ACBD5;CPT1B;CBR4;NUDT19;HPGD;ACOT2;ALKBH7;SLC27A2;PEX2;FASN;ADIPOR1;PON3;CPT1A;ACSL5;CPT2;NDUFAB1;ELOVL4;XBP1
prerank,protein insertion into ER membrane (GO:0045048),0.3443186532725828,0.7710279093268355,0.7647058823529411,1.0,1.0,9/37,17.33%,EMC6;EMC10;STX5;EMC3;GET3;EMD;VAPA;EMC1;CAMLG
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3185785364056234,0.7707275020412738,0.8905622489959839,1.0,1.0,38/158,21.21%,ECT2;FLNA;CD74;TNFSF10;GPRC5B;TFRC;IKBKG;TRADD;BIRC2;BRD4;PIM2;UBE2V1;TAB3;TIFA;CARD9;PRKCB;MYD88;TRIM68;VAPA;CC2D1A;CFLAR;TLR6;TRIM5;RBCK1;F2R;LPAR1;TRAF3IP2;CANT1;MAP3K7;MALT1;LGALS9;TRAF6;CASP8;UBE2N;SLC44A2;IKBKB;RIPK1;GAPDH
prerank,regulation of mitochondrion organization (GO:0010821),0.33855602817609515,0.7706314524855933,0.7694770544290288,1.0,1.0,12/47,21.13%,PISD;IAPP;HDAC6;PDE2A;CYRIB;FIS1;SIRT7;GSK3B;LRRK2;SREBF2;GOLPH3;MAPT
prerank,regulation of TOR signaling (GO:0032006),0.32916464802147605,0.7705535191089281,0.8133472367049009,1.0,1.0,15/67,20.74%,FAM83D;TTI1;GPAT3;LARS1;SEC13;UBR2;MLST8;LAMTOR4;LAMTOR3;NPRL3;PIK3CA;SIRT1;GOLPH3;ARAF;RRAGB
prerank,regulation of fat cell differentiation (GO:0045598),0.3262889184689969,0.7704571197596654,0.8119218910585817,1.0,1.0,16/74,18.56%,E2F1;ZFPM1;NR1D1;FOXO1;FTO;ZFP36L1;LRP3;ZBTB16;ASXL1;WDFY2;ZFP36L2;SIRT1;TRPM4;XBP1;CREB1;AAMDC
prerank,regulation of RNA export from nucleus (GO:0046831),0.40883960949900516,0.7703920460701664,0.7367706919945726,1.0,1.0,6/11,27.12%,IWS1;DHX9;NCBP2;TPR;SETD2;CPSF6
prerank,female gonad development (GO:0008585),0.3663276487198516,0.7702113625791224,0.7419354838709677,1.0,1.0,2/19,10.32%,NUP107;NR2F2
prerank,regulation of smooth muscle contraction (GO:0006940),0.3653060262411733,0.770000163029533,0.730817610062893,1.0,1.0,4/20,15.41%,CAV1;CHRM3;NMU;F2R
prerank,stem cell development (GO:0048864),0.37300236764396555,0.7699250281284623,0.7105263157894737,1.0,1.0,3/16,11.60%,PEF1;TCOF1;TAPT1
prerank,response to steroid hormone (GO:0048545),0.3549556165297212,0.7697929651748097,0.7675736961451247,1.0,1.0,3/31,9.30%,CATSPERB;CAV1;ABCA2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.34023530885159625,0.7695985880342474,0.7547380156075808,1.0,1.0,10/37,19.41%,IFT80;TNPO1;SSX2IP;PCM1;IFT57;DYNLL1;KIFAP3;IFT172;IFT140;DYNLRB1
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.401852548153428,0.7695226272820469,0.7422096317280453,1.0,1.0,2/11,5.86%,TJP3;RAB1B
prerank,autophagosome maturation (GO:0097352),0.34500899474565444,0.7691796386678795,0.7531428571428571,1.0,1.0,16/32,27.15%,STX17;LIX1;UBQLN1;VPS16;VPS33B;RUBCNL;CHMP3;EPG5;CLN3;VMP1;TSG101;VCP;VIPAS39;ATG14;GABARAP;ATP2A2
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.23922538537340146,-0.7689877510927354,0.8012820512820513,0.927758427643654,1.0,7/23,19.20%,SMAD3;ENG;LATS2;SMAD7;TGFBR3;SMURF2;SOX11
prerank,negative regulation of kinase activity (GO:0033673),0.32545321258448284,0.7688566071076307,0.8190376569037657,1.0,1.0,19/62,23.72%,RB1;PPP2R5A;TAF7;CEP85;TAB1;PDPK1;PARK7;HNRNPU;PRKAG2;PPIA;DTNBP1;TARBP2;PAK2;SNCA;MAPT;YWHAG;CDKN1B;PPM1E;ITGB1BP1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3565029767481387,0.7684434047978232,0.7606132075471698,1.0,1.0,8/25,17.80%,BRD4;RNF168;NELFA;RNF8;HNRNPU;NELFB;TCERG1;HEXIM1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.3607028204061853,0.7677292583467491,0.7453183520599251,1.0,1.0,8/24,21.79%,MBTPS2;NOTCH1;ATF6;NFE2L2;DDIT3;TP53;RBPJ;CHD6
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.35459836385419513,0.7672975469302586,0.7453874538745388,1.0,1.0,9/24,19.05%,SEC24B;TAP1;SEC24A;SEC13;B2M;SEC31A;CANX;ERAP1;SAR1B
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3663257477720321,0.766906034624566,0.7359198998748435,1.0,1.0,4/20,18.25%,BRCA1;ABCA2;WDTC1;PRMT3
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.36211498732853487,0.7665080709210159,0.7535121328224776,1.0,1.0,1/21,3.27%,FLNA
prerank,regulation of amyloid fibril formation (GO:1905906),0.3828500978150403,0.7662134638752335,0.7398692810457517,1.0,1.0,4/15,14.04%,IAPP;VBP1;PFDN5;PSEN1
prerank,negative regulation of JNK cascade (GO:0046329),0.3428428260663635,0.7654503523781376,0.7424593967517401,1.0,1.0,2/31,4.26%,MEN1;PTPN22
prerank,negative regulation of GTPase activity (GO:0034260),-0.24131067365344885,-0.765180386459322,0.8390804597701149,0.9327258273770909,1.0,7/22,21.03%,F11R;RASA4;RCC2;DAB2IP;ARL2;PLXNB3;TMED2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.2678796240319138,-0.7649406678526673,0.8112244897959183,0.9318883981534766,1.0,3/18,9.07%,PAG1;DUSP3;MIA3
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.33873991344986365,0.7648545028778412,0.7737306843267108,1.0,1.0,6/33,15.40%,CCDC88A;SHKBP1;TGFA;HAP1;DGKD;EGF
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3293583042265842,0.764760534991948,0.7876857749469215,1.0,1.0,9/52,13.14%,CNPY4;PRKCE;SORBS1;CIB1;EGFR;EPHA3;PDPK1;CNST;RACK1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.3769923778563762,0.7646061387753399,0.7248908296943232,1.0,1.0,2/12,10.86%,PAFAH1B1;SZT2
prerank,muscle tissue development (GO:0060537),0.38301438102483676,0.7635810031225496,0.7320954907161804,1.0,1.0,2/13,9.13%,CSRP3;CSRP1
prerank,cAMP-mediated signaling (GO:0019933),0.35249583277908364,0.763489470306235,0.7425860023724793,1.0,1.0,7/24,20.52%,PDE7B;PDE2A;AHR;ADCYAP1;KSR1;SOX9;PDE7A
prerank,retrograde axonal transport (GO:0008090),0.36729104331369866,0.7634093560725056,0.7386804657179818,1.0,1.0,4/16,12.39%,FBXW11;DYNC1H1;PAFAH1B1;HAP1
prerank,calcium ion transport (GO:0006816),0.3168585570325988,0.7633925220397223,0.8561368209255533,1.0,1.0,20/113,17.56%,MS4A1;CACNA1I;RAMP1;ITPR1;FYN;KCNN4;CAV1;ORAI2;TRPM7;ITGAV;CALCRL;CRACR2A;MICU1;PSEN1;TPT1;SLC24A4;SLC24A2;TRPM4;CACNA1B;ANO6
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.27884411209904064,-0.7629325180011615,0.8017241379310345,0.9337668083453509,1.0,10/14,35.33%,CMPK1;ME1;NMNAT3;NMNAT1;AK1;NMNAT2;AK7;AK4;AK8;NME2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3733435678220127,0.7629164856794617,0.7549148099606815,1.0,1.0,5/16,19.01%,SMCHD1;KMT5C;PRKDC;RIF1;WRAP53
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3207363229865675,0.7625686141017642,0.8483316481294236,1.0,1.0,26/101,23.97%,EZH2;INCENP;CCNYL1;RASGRP1;MAPRE3;CIB1;EGFR;FLT3;PDCD10;EGF;MAP2K1;FGFR1;CD24;SIRT1;LRRK2;SNCA;PROX1;PPP2CA;PKD2;CCND3;CALM3;ATP2B4;ADAM17;SRC;TELO2;HMGA2
prerank,regulation of protein neddylation (GO:2000434),0.38821252566625736,0.7625620641937929,0.738944365192582,1.0,1.0,1/10,4.64%,COPS9
prerank,regulation of interleukin-2 production (GO:0032663),0.32579244000471386,0.7624976800488255,0.760485651214128,1.0,1.0,12/43,19.93%,GLMN;EZR;CCR2;PLCG2;RUNX1;HOMER2;MAP3K7;MALT1;RPS3;TRAF6;PNP;PRKD2
prerank,spinal cord development (GO:0021510),-0.298144789078857,-0.7624973120573312,0.7462121212121212,0.9332778937863782,1.0,5/12,19.20%,NF1;PKD1;SOX4;LOXL3;SOX11
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.32275770329847214,0.7623414270119011,0.8229273285568065,1.0,1.0,23/76,23.24%,PLK1;AXIN1;TAF1;CSNK1A1;DDRGK1;SUMO1;RAD23A;PTEN;CDK5RAP3;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;RNF19A;LRRK2;KEAP1;MDM2;CBFA2T3;HECTD1;DDA1;BBS7
prerank,autophagy of peroxisome (GO:0030242),0.39054502410978087,0.7609336981318012,0.7598371777476255,1.0,1.0,2/12,6.00%,ACBD5;ATM
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3346936818543034,0.7606255887367299,0.7830802603036876,1.0,1.0,16/45,23.11%,POLR2A;ZC3H18;SETX;EGFR;DYRK1A;SIRT7;DXO;TP53;DIMT1;MAP2K1;RIOK1;HNRNPLL;PNPT1;RIPK1;TRMT112;ZPR1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.3592048801156146,0.7604808502320298,0.7419354838709677,1.0,1.0,7/23,17.81%,NPLOC4;FAF2;SEC13;DERL2;LMAN1;HSP90B1;SYVN1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3587514905963466,0.7604445149014564,0.741421568627451,1.0,1.0,4/20,13.37%,LY6H;PLCB1;GRK2;CHRM3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.40104236459462383,0.7598525006888411,0.7503448275862069,1.0,1.0,3/10,20.60%,CSGALNACT2;B3GAT2;B3GAT1
prerank,myotube differentiation (GO:0014902),0.36644347742384636,0.7598059609057403,0.7522697795071336,1.0,1.0,4/17,16.96%,MYEF2;JAM2;SKI;ADAMTS5
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3510815052820354,0.7595826151768567,0.7428571428571429,1.0,1.0,3/22,13.16%,CARD9;MYD88;ZBTB7B
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.3848642490483063,0.7594170345302373,0.7271505376344086,1.0,1.0,2/14,5.75%,KCNN4;IKBKG
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3456848694463912,0.7593302235613016,0.7661574618096357,1.0,1.0,7/29,19.27%,RAB33B;NAPG;COG6;COPZ1;VTI1A;RAB6A;TRAPPC3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.32870053887314243,0.7592051412525805,0.7903743315508022,1.0,1.0,14/50,19.83%,FBXO5;NXN;CAV1;TAF1;PRR7;PARK7;ARRB2;SIRT7;UBXN1;CAMLG;PRMT3;GNL3L;RPS3;HDAC8
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.36993841425139906,0.7590376045740415,0.7335092348284961,1.0,1.0,3/15,22.38%,TGFB2;JAK3;CUEDC2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.2419114191730307,-0.7589690959365162,0.8,0.9376521548449445,1.0,9/22,27.51%,RELA;GSK3A;CASP3;EPHA4;RANBP9;LYN;PICALM;LRRTM3;CHRNA7
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.32768425851392674,0.7587650738689014,0.7895310796074155,1.0,1.0,9/45,12.50%,EIF2A;RBM3;ZC3H7A;PUM2;MTPN;PUM3;TCOF1;PUM1;METTL16
prerank,membrane depolarization (GO:0051899),0.33691665053690617,0.7587343139710174,0.7710011507479861,1.0,1.0,3/32,6.12%,CACNA1I;CAV1;YWHAH
prerank,negative regulation of stress fiber assembly (GO:0051497),0.35107502331602186,0.7585746700830728,0.7573170731707317,1.0,1.0,3/24,5.95%,STMN1;ARHGEF18;CLASP1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.3092401255540587,-0.7585410294333776,0.7885906040268457,0.937137098605673,1.0,3/11,10.52%,RNF185;AUP1;BAG6
prerank,sensory perception of smell (GO:0007608),0.39898983935759125,0.7584377456457625,0.7485795454545454,1.0,1.0,2/11,15.72%,BBS4;SLC24A4
prerank,regulation of signal transduction (GO:0009966),0.31128126463184885,0.7583884395940225,0.9138276553106213,1.0,1.0,53/190,23.72%,CD177;RGS12;ERBB3;FYN;AXIN1;NUCKS1;SNX3;SP100;GRK6;SIK2;TCF7L1;GIT2;FUZ;TMEM237;MFNG;SOCS2;AMFR;PLCB1;CRK;CBFB;HHIP;GRK2;ZDHHC7;TMEM204;ADCYAP1;CREBBP;PPIA;ZFAND2B;DTNBP1;TRIM5;ELF1;RUNX1;CD24;SIRT1;TSPEAR;LRRK2;CD55;SREBF2;PPP2CA;NCLN;ILK;POFUT1;GRK3;CDC42SE2;IGFBP7;YWHAG;PXN;FGFR2;IGFBP2;INTU;SRC;GDNF;ITGB1BP1
prerank,positive regulation of endocytosis (GO:0045807),0.32961293433515926,0.7583546508727415,0.7871878393051032,1.0,1.0,11/45,18.76%,TFR2;ABCA13;NEDD4L;CBLL1;TOR1A;B2M;FLOT1;LDLRAP1;ANO6;SNCA;CLN3
prerank,body fluid secretion (GO:0007589),-0.2764624581545001,-0.7582831824111923,0.8165938864628821,0.9363087513820751,1.0,3/15,14.06%,ERBB4;PRLR;VEGFA
prerank,protein targeting to mitochondrion (GO:0006626),0.32668897178701817,0.7582737890915854,0.7957219251336899,1.0,1.0,11/52,14.07%,CHCHD4;TOMM34;TSPO;PITRM1;TIMM9;DNAJC15;GDAP1;FIS1;TOMM70;TIMM23;GRPEL2
prerank,lipoprotein catabolic process (GO:0042159),0.4016982258966886,0.7581826185715892,0.7454545454545455,1.0,1.0,3/11,10.68%,ABHD17A;LYPLA1;ABHD17B
prerank,regulation of protein targeting to membrane (GO:0090313),0.3507096639159363,0.7581642251942393,0.7608440797186401,1.0,1.0,4/28,12.06%,C2CD5;FYN;CIB1;FIS1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.34480181495119877,0.7578118857651462,0.762936221419976,1.0,1.0,8/26,21.77%,PTPN22;CAV1;HMGB1;TLR5;FLOT1;CYBA;IFI35;NR1H3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.37869988923437115,0.7576149661574579,0.7464788732394366,1.0,1.0,4/12,18.78%,GFUS;FUT8;GFPT2;GMDS
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.3437044499676192,0.7573680564075842,0.7415599534342259,1.0,1.0,2/29,7.16%,ZFPM1;NOTCH1
prerank,positive regulation of neuron death (GO:1901216),0.33050057955345563,0.7567095376093499,0.8015184381778742,1.0,1.0,13/46,21.13%,FYN;EIF2S1;MAP3K5;EGR1;DDIT3;TLR6;TYROBP;GSK3B;TGFB2;FCGR2B;SNCA;EPHA7;MAPT
prerank,chloride transmembrane transport (GO:1902476),0.3297698703965204,0.7565751452860664,0.7890792291220556,1.0,1.0,7/48,12.57%,SLC12A3;SLC12A7;SLC12A1;GABRA4;GABRA5;ANO3;SLC12A6
prerank,ESCRT complex disassembly (GO:1904896),0.3965177341168731,0.7565340935918416,0.7503486750348675,1.0,1.0,6/10,27.64%,CHMP1B;CHMP2B;VTA1;VPS4A;CHMP5;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),0.3965177341168731,0.7565340935918416,0.7503486750348675,1.0,1.0,6/10,27.64%,CHMP1B;CHMP2B;VTA1;VPS4A;CHMP5;VPS4B
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.3300730279236504,0.7559796809311543,0.7802786709539121,1.0,1.0,8/46,14.87%,AGPAT1;AGPAT4;GPD1L;GPAT3;AGPAT3;PLD2;DGKD;PLD1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3646451021785274,0.7557809195331119,0.7792041078305519,1.0,1.0,1/17,2.29%,CACNA1I
prerank,embryonic appendage morphogenesis (GO:0035113),0.38258803845488126,0.7557617335250505,0.7482710926694329,1.0,1.0,4/12,27.86%,SKI;TGFB2;MEGF8;MBNL1
prerank,retina homeostasis (GO:0001895),0.35387947666114294,0.7556654401366677,0.7542168674698795,1.0,1.0,3/23,13.22%,POC1B;B2M;BBS4
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.3121412587418564,0.7554735928725144,0.987,1.0,1.0,91/390,22.48%,SHCBP1;BLK;NTF4;STMN1;MAPK1;ERBB3;FYN;TIAM1;POLR2I;SULF2;POLR2A;NEDD9;FLRT2;PGF;MAPKAPK3;CYFIP2;GFRA2;HNRNPM;FOXO1;SETX;SORBS1;NUS1;MAPK14;GRB2;JAK2;SOS1;ITGAV;NCBP1;EGFR;EPHA3;CAV2;ANKS1A;SOCS2;MTSS1;FGF9;PLCB1;FLT3;CRK;ARHGEF28;AP2B1;HAP1;LMTK2;NRP1;SPRED2;ROCK2;ATP6V0E1;PSEN1;IRS1;BRK1;GSK3B;CEP57;APPL1;CYBB;ELMO2;ANKS1B;FGFR1;PAK2;FIBP;ATP6AP1;POLR2K;PIK3CA;RAC1;CYBA;ATP6V0D1;POLR2J;SDC2;ARHGEF7;KIF16B;POLR1G;HNRNPA1;NCBP2;NCF4;GRB14;PRKD2;ALK;EPHA7;MET;SIPA1L1;ROCK1;VAV3;SH2D2A;EPHA10;SYK;DDR2;FGR;RBFOX2;ACTG1;EFNA1;NTRK3;POLR2B;PXN
prerank,carbohydrate derivative transport (GO:1901264),-0.2548260551119682,-0.7552836512256961,0.8177083333333334,0.9397296101599995,1.0,5/18,18.20%,SLC15A3;PLTP;SCARB1;NPC2;VLDLR
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.17311605966181448,-0.7551094370383246,0.9565217391304348,0.9388067033254855,1.0,21/79,22.73%,EPN2;VWC2L;SMAD1;BMPR2;SPART;SMAD6;BMPR1B;UBE2D1;SKIL;SULF1;LEMD2;SMAD7;FGF2;HTRA3;DAB2IP;SMURF2;THBS1;BMPER;AGT;SMAD9;ADAMTS12
prerank,heterocycle biosynthetic process (GO:0018130),0.3752836754185091,0.7548892234432832,0.7661623108665749,1.0,1.0,1/14,2.57%,PYCR3
prerank,ATP synthesis coupled proton transport (GO:0015986),0.36361887287613676,0.7544734450365468,0.7625160462130937,1.0,1.0,6/17,24.70%,ATP5F1E;ATP5F1D;ATP5MC2;ATP5F1B;ATP5MF;ATP5ME
prerank,regulation of secretion (GO:0051046),0.3726531856041056,0.7543997273434696,0.7352537722908093,1.0,1.0,1/13,2.99%,ERBB3
prerank,genitalia development (GO:0048806),-0.28813520734412773,-0.7541133984971996,0.788235294117647,0.9390744196176853,1.0,3/12,18.99%,DNAJC19;PKD1;CHD7
prerank,positive regulation of monooxygenase activity (GO:0032770),0.34742657962362533,0.7529886169112301,0.7747318235995232,1.0,1.0,4/26,10.78%,TERF2;NUS1;ATP7A;PARK7
prerank,regulation of protein modification process (GO:0031399),0.3291595920081253,0.7526633598706688,0.8032085561497326,1.0,1.0,15/50,22.56%,CCDC88A;PML;CCDC88C;PIN1;ABCA2;PUM3;CCAR2;KAT2B;SPRED2;FN1;PPP1R16A;PPP2CA;CADM4;PPP1R16B;ASPSCR1
prerank,cell-substrate junction assembly (GO:0007044),0.33804559619494784,0.7518398451782902,0.7760180995475113,1.0,1.0,9/33,18.29%,SORBS1;LAMC1;LAMB3;WHAMM;ACTN2;TESK2;BCR;FN1;ARHGEF7
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.2356967639269491,-0.7509657726017779,0.8532608695652174,0.9425479913651561,1.0,5/24,11.45%,IGF1;AKT2;IRS2;GSK3A;SELENOS
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.30971876985654606,0.7509594471253709,0.987,1.0,1.0,115/509,21.21%,CD19;ECT2;PMAIP1;IAPP;RPS20;ERBB3;FYN;FLNA;DHX58;CD74;S100A9;TNFSF10;GPRC5B;TFRC;CGAS;CAV1;IKBKG;S100A8;TRADD;TGFA;BIRC2;PUM2;BRD4;HMGB1;PIM2;BOK;DCN;UBE2V1;HCST;GRB2;PLCG2;JAK2;ITGAV;TAB3;STRN;LARS1;EGFR;CAV2;PDPK1;SEC13;TXN;RIT2;TIFA;TRIM44;CARD9;PARK7;RELN;PUM1;MLST8;FGF9;BECN1;FLT3;PRKCB;MYD88;TRIM68;VAPA;FIS1;CDK5RAP3;F3;ROCK2;RACK1;RAC2;CC2D1A;ACTN4;DDIT3;LAMTOR4;CFLAR;MYDGF;TLR6;USP15;IRS1;TRIM5;RBCK1;LIMS1;LAMTOR3;ADGRV1;TP53;EGF;F2R;LPAR1;TCF7L2;FGFR1;TGFB2;TRAF3IP2;PIK3CA;RAC1;SIRT1;CANT1;FN1;HCLS1;KITLG;MAP3K7;HEXIM1;IQGAP1;MALT1;KSR1;RPS3;IFI35;LGALS9;TRAF6;CASP8;SOX9;GOLPH3;PRKD2;RPL23;MET;ILK;UBE2N;SLC44A2;RRAGB;IKBKB;ROCK1;RIPK1;SASH1;GAPDH
prerank,glial cell differentiation (GO:0010001),-0.2261251089487302,-0.7503790869237674,0.9,0.9422260794125917,1.0,12/28,23.79%,PTPRZ1;SLC8A3;CDH2;GPR157;STAT3;CDK5;SOX4;ADGRG6;SOX11;SOX8;SOX10;NFIB
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.28261711879801205,-0.7502928799300598,0.8223938223938224,0.9411875689193538,1.0,1/13,0.52%,EPN2
prerank,embryonic skeletal system development (GO:0048706),0.3344523873849905,0.7489723736851284,0.79841449603624,1.0,1.0,3/35,7.73%,DEAF1;SULF2;FUZ
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.20288718256780536,-0.7489170217870105,0.9090909090909091,0.9419744620619411,1.0,9/44,13.28%,APOE;PTPRJ;CD300A;NF1;DUSP10;SH2B3;PIK3CB;DUSP7;PAQR3
prerank,endoderm formation (GO:0001706),-0.20871681589619023,-0.7487701141306676,0.918918918918919,0.9410074328542699,1.0,4/35,7.87%,ITGB5;ITGA5;COL11A1;MMP14
prerank,membrane raft organization (GO:0031579),0.3659717020983413,0.7480458943861488,0.722875816993464,1.0,1.0,5/15,19.18%,ABCA7;FLOT1;FLOT2;CLN3;S100A10
prerank,snRNA 3'-end processing (GO:0034472),0.36291242989715355,0.7479517307007891,0.7579617834394905,1.0,1.0,5/19,20.45%,EXOSC8;INTS1;INTS14;TUT1;INTS12
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3062679749923027,-0.7474394620790527,0.7718120805369127,0.9418092659812662,1.0,5/10,32.20%,BIN1;ATP1A2;CBARP;FKBP1B;ADRA2A
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.34440318779322976,0.7472698555250051,0.7617328519855595,1.0,1.0,6/25,21.61%,MPP2;ARRB2;GSK3B;LRRK2;GLRA1;GRIN2D
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.35845590105895003,0.7471750725359533,0.7751256281407035,1.0,1.0,5/21,13.07%,SLK;PTPRA;CLASP1;EPHA3;ROCK2
prerank,sterol homeostasis (GO:0055092),0.31871012363542217,0.747003903792785,0.8350730688935282,1.0,1.0,17/65,23.47%,ABCD1;CAV1;NR1D1;EPHX2;RALY;ABCA2;LIMA1;CD24;SIRT1;XBP1;LDLRAP1;NR1H3;HDAC9;LDLR;SOAT1;TTC39B;EHD1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.362111340116652,0.7467281695464436,0.7420178799489144,1.0,1.0,7/17,23.28%,MBTPS2;SEC14L2;ABCA2;KPNB1;SREBF2;SCAP;LPCAT3
prerank,cellular response to oxygen levels (GO:0071453),0.39246935596279664,0.7465748743150464,0.7695652173913043,1.0,1.0,3/10,17.14%,PICK1;ATP6AP1;ATP6V0D1
prerank,positive regulation of bone mineralization (GO:0030501),-0.21193621194219675,-0.746507485853581,0.8775510204081632,0.9420857492107921,1.0,8/35,17.71%,ACVR1;BMPR2;ATRAID;ALOX5;BMPR1B;SLC8A1;PKDCC;BMP6
prerank,regulation of synapse organization (GO:0050807),0.34288680967195956,0.7461947756954019,0.7858823529411765,1.0,1.0,8/26,23.03%,ABHD17A;ABHD17B;MDGA1;PDLIM5;CLN3;SLITRK2;SETD5;NEDD4
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.3504561245200263,0.7460692624966889,0.7521367521367521,1.0,1.0,8/21,20.79%,PNLDC1;TUT4;CNOT4;CNOT1;CNOT6;SAMD4A;CNOT8;CNOT7
prerank,rRNA pseudouridine synthesis (GO:0031118),0.39800781311013694,0.7460094944304123,0.7553956834532374,1.0,1.0,1/10,3.55%,NOP10
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2282971350394324,-0.7457773529066328,0.8444444444444444,0.9418979345992473,1.0,6/28,14.77%,ARRDC1;ARRB1;YTHDF2;MMP14;TSPAN15;FBXW7
prerank,ERBB2 signaling pathway (GO:0038128),0.3365673559990055,0.74568989662453,0.791860465116279,1.0,1.0,7/31,16.81%,ERBB3;PRKCA;GRB2;SOS1;EGFR;EGF;PIK3CA
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3133758026836066,0.745542744240202,0.8050847457627118,1.0,1.0,16/54,23.30%,IKBKG;TRADD;TRAIP;BIRC2;UBE2K;SPATA2;RACK1;CFLAR;RBCK1;NLRP2B;CASP8;IKBKB;RIPK1;SYK;ADAM17;HIPK1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.2983609095217965,-0.745371136538472,0.7807308970099668,0.9413360898007752,1.0,6/11,35.43%,STMN2;TRPV4;PLEK;NES;KATNB1;PDXP
prerank,Golgi organization (GO:0007030),0.31262587951043835,0.7452758548794297,0.8733535967578521,1.0,1.0,31/112,21.43%,CDK1;ATP8B4;STX17;ATL2;CLASP1;STX5;NPLOC4;CSNK1A1;ZW10;BLZF1;DYM;BET1;VRK1;RAB43;PI4K2B;RAB2A;VCPIP1;PDCD10;FAM174B;LMAN1;SYNE1;GORASP1;LRRK2;VTI1A;ARHGEF7;FBXW8;GOLPH3;GORASP2;ATP8B2;VAMP4;TMED10
prerank,regulation of angiogenesis (GO:0045765),0.30755349261105647,0.7450439823534188,0.9229229229229229,1.0,1.0,32/192,17.63%,CYP1B1;BRCA1;AQP1;HSPG2;TWIST1;EMC10;PML;PGF;SP100;CCR2;DCN;PRKCA;SMOC2;MECP2;PDPK1;HIPK2;CEMIP2;VASH2;PRKCB;F3;AGGF1;ROCK2;MYDGF;HTATIP2;ADAMTS1;RUNX1;HGS;TGFB2;PLCG1;SIRT1;XBP1;PGK1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.36144730416545146,0.7449529647230255,0.7636594663278272,1.0,1.0,5/17,23.09%,CAV1;PRKX;CD24;SOX9;OSR1
prerank,I-kappaB phosphorylation (GO:0007252),-0.31325235570289334,-0.7445162173649653,0.7840531561461794,0.9413799763797782,1.0,4/10,16.94%,TLR7;TLR4;CHUK;DAB2IP
prerank,negative regulation of defense response (GO:0031348),0.31177891773481253,0.7443417884514402,0.8360655737704918,1.0,1.0,5/77,5.39%,RNF26;MEFV;RB1;DHX58;NR1D1
prerank,negative regulation of myotube differentiation (GO:0010832),0.37647635055015755,0.7442464619211139,0.7736625514403292,1.0,1.0,6/12,26.74%,NOTCH1;XBP1;HDAC4;HDAC1;BDNF;TMEM119
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.30855525704169956,0.7438470498808755,0.9319319319319319,1.0,1.0,32/190,17.01%,CIT;PHLPP2;TRIM59;ITPR1;TWIST1;TANK;PHLDA3;BANK1;CAV1;NR1D1;GPD1L;PDE2A;CIB1;MAPK14;RNF157;CYRIB;RIOK3;ABCA7;UBR2;ADIPOR1;PTEN;ARRB2;RACK1;DGKD;UACA;DDIT3;DAG1;LIMD1;NPRL3;NLRC3;SIRT1;NLRX1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3875648131685038,0.7437258971373991,0.7746666666666666,1.0,1.0,3/11,13.14%,NONO;PARK7;RACK1
prerank,cellular response to calcium ion (GO:0071277),0.31346196411228633,0.743593211663045,0.8321167883211679,1.0,1.0,5/67,8.42%,ECT2;CRHBP;SYT8;DPEP1;PLCG2
prerank,negative regulation of RNA splicing (GO:0033119),0.3589652490884524,0.7435899192885682,0.7646341463414634,1.0,1.0,10/19,28.01%,SAP18;SRSF4;RNPS1;SRSF10;SRSF7;PTBP2;PTBP1;SFSWAP;RPS13;PTBP3
prerank,proton transmembrane transport (GO:1902600),-0.20592689315260004,-0.7434988875430736,0.9252336448598131,0.9417531609300842,1.0,13/36,29.39%,SLC9A1;ATP1A1;ATP6V1A;ATP6V1H;ATP6V1F;ATP1A2;NNT;ATP6V0C;SLC36A1;ATP1A3;SLC25A27;ATP6V0E2;SLC46A1
prerank,modified amino acid transport (GO:0072337),0.3687884539451386,0.7432431544612064,0.7601078167115903,1.0,1.0,2/15,11.20%,SLC16A12;SLC19A1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.3164868946257441,0.7430058089609295,0.8141499472016895,1.0,1.0,13/51,23.72%,ARHGEF5;CD47;CCDC88A;SYNPO2;NRP1;ROCK2;LPAR1;RAC1;S100A10;ARHGEF10L;PXN;PPM1E;ITGB1BP1
prerank,DNA catabolic process (GO:0006308),0.3820006578975889,0.7429386087681524,0.7560627674750356,1.0,1.0,2/11,13.53%,DNASE1L1;REXO4
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.33825702462915574,0.742887393401081,0.786046511627907,1.0,1.0,3/29,8.72%,ACOT11;ACOT13;ACOT2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.33825702462915574,0.742887393401081,0.786046511627907,1.0,1.0,3/29,8.72%,ACOT11;ACOT13;ACOT2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.2896853711689934,-0.7423359536604281,0.822463768115942,0.9422393843079491,1.0,3/12,16.41%,BASP1;PTPRO;JAG1
prerank,negative regulation of cytokine production (GO:0001818),0.30504219014465267,0.7418446816571912,0.9128256513026052,1.0,1.0,29/163,17.65%,IL12A;MEFV;LEF1;EZR;DHX58;ZFPM1;PPP1R11;PTPN22;RPS6KA5;ABCD1;NPLOC4;PIN1;HMGB1;ASB1;PCBP2;DDIT3;PIBF1;TLR6;TYROBP;GPATCH3;OTUD5;LGR4;HOMER2;NLRC3;JAK3;RAC1;NLRX1;FN1;FCGR2B
prerank,negative regulation of protein phosphorylation (GO:0001933),0.30763011211344404,0.7417071119355569,0.9116465863453815,1.0,1.0,31/150,17.96%,MEN1;RB1;TWIST1;CAV1;CRKL;GPD1L;PMEPA1;TAF7;NIBAN1;CEP85;CIB1;TAB1;IBTK;PDPK1;PARK7;SNX25;PTEN;CDK5RAP3;SPRED2;RACK1;PRKDC;PRKAG2;PPIA;DTNBP1;FKBP8;TARBP2;PAK2;NLRP2B;PTPN13;LRRK2;SNCA
prerank,regulation of NMDA receptor activity (GO:2000310),0.32949944964258937,0.7413022551748153,0.8127167630057803,1.0,1.0,6/32,11.54%,CRHBP;CCR2;CAPN1;ACTN2;RELN;GRIA3
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.23803771539429752,-0.7411768681065928,0.8113207547169812,0.9426858639460898,1.0,7/24,22.74%,AKIRIN1;PIK3R1;ARPC2;ABI2;TWF2;CDC42;CYFIP1
prerank,receptor recycling (GO:0001881),-0.3037323492506893,-0.7410832847504698,0.793918918918919,0.9416479550833897,1.0,1/10,0.16%,ARFGEF2
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.3826176181385156,0.7405892372014568,0.7548476454293629,1.0,1.0,5/12,24.08%,PLCG2;TLR6;CYBA;RAB27A;SLC5A3
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3845180003150529,0.7405847713744046,0.7542613636363636,1.0,1.0,6/11,25.29%,IMPA1;INPP5A;PTEN;OCRL;IMPA2;INPP5B
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3845180003150529,0.7405847713744046,0.7542613636363636,1.0,1.0,6/11,25.29%,IMPA1;INPP5A;PTEN;OCRL;IMPA2;INPP5B
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.27158113526607985,-0.7405477381131579,0.8373983739837398,0.94118942973907,1.0,6/15,24.13%,CDH13;MVB12B;LGMN;CEACAM1;RHBDF2;FER
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.34396842140953476,0.740292353004375,0.7590966122961104,1.0,1.0,6/20,22.17%,ZC3H7A;PUM2;PUM1;TARBP2;AGO2;AGO1
prerank,water-soluble vitamin metabolic process (GO:0006767),0.3119118476610488,0.7400130812109235,0.8424870466321244,1.0,1.0,15/68,19.16%,PANK2;MTHFD2L;RFK;SLC52A1;SLC19A1;MTR;MCCC1;TPK1;PDXK;SLC2A3;MMAA;ALDH1L1;SLC2A1;ABCD4;MTHFD1L
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.23613687081712637,-0.7397258121231892,0.8491620111731844,0.941200251556878,1.0,3/23,7.87%,MAML1;IGF1;MMP14
prerank,cellular response to copper ion (GO:0071280),0.36657615662410925,0.7389575688654957,0.7712418300653595,1.0,1.0,1/16,1.86%,AQP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.3838626555500339,0.7389029087154227,0.7725988700564972,1.0,1.0,4/12,17.56%,CIB1;CAMTA1;STIMATE;SPPL3
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.3838626555500339,0.7389029087154227,0.7725988700564972,1.0,1.0,4/12,17.56%,CIB1;CAMTA1;STIMATE;SPPL3
prerank,positive regulation of cell growth (GO:0030307),0.3089711064873301,0.7381856982357825,0.8607467204843592,1.0,1.0,15/96,11.40%,NTN1;S100A9;BRAT1;DDX49;S100A8;H3-3A;CIB1;NEDD4L;DBNL;RNF157;MTPN;NCBP1;EGFR;DERL2;SYT3
prerank,early endosome to Golgi transport (GO:0034498),0.3870394396451547,0.7380079771829362,0.7763713080168776,1.0,1.0,4/11,21.68%,STX5;LMAN1;RAB6A;TRAPPC10
prerank,protein ADP-ribosylation (GO:0006471),0.33831907649672693,0.7375882546172265,0.7928994082840237,1.0,1.0,9/28,26.13%,ART3;ARF4;PARP14;SIRT1;SIRT4;PARP11;ZC3HAV1;PARP1;PARP9
prerank,sensory perception of chemical stimulus (GO:0007606),-0.2717520105867714,-0.7375677874895517,0.8376383763837638,0.943056089574131,1.0,7/15,33.05%,GNAS;C5AR1;CD36;UBR3;GNAL;MKKS;DRD2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.26319058333450457,-0.7372667299832107,0.8431372549019608,0.9423019478936348,1.0,4/15,16.46%,KCNN2;ATP1A1;ATP1B1;KCND3
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3564232063407994,0.7364059671776589,0.7831021437578815,1.0,1.0,7/19,22.90%,XRCC6;PPP2R3C;BTK;PRKDC;XBP1;SYK;ZBTB1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.23891470920738603,-0.7357102437562704,0.8725490196078431,0.9432516946648589,1.0,20/20,76.14%,GSK3A;CRY1;WNT4;EP300;C1QTNF3;CDA;UGT1A8;C1QTNF12;MST1;SLC22A13;DKKL1;ACMSD;ERFE;ADIPOQ;NCOR1;SIK1;GCK;BCKDK;CLK2;PGP
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.3498125382706367,0.7354326024309236,0.7914183551847438,1.0,1.0,3/22,8.45%,DDX11;SMARCA4;NOL11
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.36567465693255485,0.7352962067892284,0.7794871794871795,1.0,1.0,5/17,17.81%,NPLOC4;FAF2;DERL2;HSP90B1;SYVN1
prerank,establishment of melanosome localization (GO:0032401),0.352885058543571,0.7351927154430832,0.7669543773119606,1.0,1.0,8/19,24.71%,SHROOM2;RAB11B;BBS4;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.35469155739494906,0.7346932466033883,0.7613488975356679,1.0,1.0,3/17,14.61%,GMFG;PICK1;BRK1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.2882417574964059,-0.7344225089044985,0.8047138047138047,0.9426628357730557,1.0,5/11,31.02%,SRI;CALM1;GSTO1;FKBP1B;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.2882417574964059,-0.7344225089044985,0.8047138047138047,0.9426628357730557,1.0,5/11,31.02%,SRI;CALM1;GSTO1;FKBP1B;CALM2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.37951267042534487,0.7342301891792377,0.7632311977715878,1.0,1.0,3/10,16.74%,JAK2;STAT5B;JAK3
prerank,protein dephosphorylation (GO:0006470),0.30836114980540663,0.7341855662281898,0.9074446680080482,1.0,1.0,37/135,20.44%,PPM1D;PTPRA;PPP3CA;FBXW11;PTPN22;PPP2R5E;STK11;PPP1CB;PPP2R5A;MTMR2;EYA3;TAB1;PPP2CB;PPP1R15A;PTPN7;PTPN14;PPP1CC;RPRD1B;MTMR6;PTEN;PPP3CC;PPP1R12A;EYA1;PTPN5;MTM1;PPP6C;PTPRU;PPP2R5D;DUSP22;DUSP12;PTPN13;PPP1CA;ILKAP;PPM1B;PPP2CA;RPAP2;DUSP16
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3136141197311808,0.7337913015242787,0.8424870466321244,1.0,1.0,21/67,21.28%,FYN;PGF;MAPKAPK3;CYFIP2;MAPK14;ITGAV;CRK;NRP1;ROCK2;BRK1;CYBB;ELMO2;PAK2;PIK3CA;RAC1;CYBA;NCF4;PRKD2;ROCK1;VAV3;SH2D2A
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.2854584040422749,-0.7334363353114127,0.8256227758007118,0.9428224929536211,1.0,3/13,11.49%,ASPH;TBC1D10A;LGMN
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.31235544225199197,0.7334299189529885,0.8471933471933472,1.0,1.0,15/67,19.58%,CDKL1;TBC1D1;TBC1D22B;CAV1;EVI5;RDX;FXR1;PLD1;DYNLT2B;SDCCAG8;RAB5A;RAC1;IFT140;RABEP2;SGSM3
prerank,regulation of small molecule metabolic process (GO:0062012),0.3338766307830088,0.7334052789496089,0.7829099307159353,1.0,1.0,6/28,16.99%,PANK2;EPHX2;FMO5;ADIPOR1;FOXK2;SIRT1
prerank,fatty acid transmembrane transport (GO:1902001),0.3566178011213738,0.7333291262964691,0.7681528662420383,1.0,1.0,7/19,18.82%,ABCD1;CPT1B;CPT1A;PRKAG2;CPT2;SLC2A1;ABCD4
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3424897763390461,0.7332470816889138,0.7980884109916367,1.0,1.0,6/25,17.96%,CAV1;TRPM7;KCNA1;TMTC2;FAM20A;SNCA
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3667263184932611,0.7330045221828526,0.7688243064729194,1.0,1.0,4/15,14.50%,RIPOR2;MAPK14;FLOT1;TYROBP
prerank,regulation of epidermal cell differentiation (GO:0045604),0.3524278858544724,0.7325659229819884,0.78375,1.0,1.0,5/21,15.02%,ZFP36L1;CBFB;CTSK;ROCK2;RUNX1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.38297821490264905,0.7325492469463094,0.78328611898017,1.0,1.0,3/10,23.07%,NUMA1;MED1;NCOA3
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3519543255624939,0.7325004780700942,0.7690355329949239,1.0,1.0,7/17,23.43%,S1PR2;ROCK2;PPP1R12A;IKBKB;ROCK1;VCL;ZDHHC21
prerank,eye photoreceptor cell development (GO:0042462),-0.25770153318531225,-0.7320277107771729,0.8305084745762712,0.9435113019451694,1.0,3/15,17.85%,MYO7A;VEGFA;THY1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3441095923050538,0.7318434062787339,0.7808219178082192,1.0,1.0,2/21,6.32%,NPPC;GUCY1A1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.3897983255711845,0.731823094095116,0.7719054242002782,1.0,1.0,2/10,17.96%,HDAC6;SNCA
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.38149091881435787,0.7313736724911084,0.7650513950073421,1.0,1.0,3/10,18.44%,CAV1;SUMO1;KCNRG
prerank,purine nucleotide metabolic process (GO:0006163),-0.221642581990951,-0.7310495118566452,0.9183673469387755,0.9436858469914604,1.0,10/24,24.99%,HPRT1;PRPS2;PPAT;GPX1;FHIT;ITPA;NT5C;GART;PRPSAP2;NT5E
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.3682188293456349,0.7308010726937192,0.7735099337748345,1.0,1.0,4/14,16.81%,PGF;NUS1;NRP1;PIK3CA
prerank,metanephric mesenchyme development (GO:0072075),-0.2968442091928108,-0.7302818628404368,0.8108108108108109,0.9435759406663174,1.0,1/10,2.30%,BASP1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3064408397349097,0.7300767285148568,0.8834853090172239,1.0,1.0,24/100,17.77%,MAPK1;ERBB3;TWIST1;PIP5K1B;DCN;HCST;ENTPD5;JAK2;EGFR;BECN1;FLT3;PTEN;MYDGF;EGF;F2R;FGFR1;TGFB2;NLRC3;PIK3CA;SIRT1;PIP4K2A;FN1;HCLS1;PTPN13
prerank,negative regulation of viral transcription (GO:0032897),-0.27379663650702823,-0.7300327089103245,0.7963636363636364,0.9427634084687457,1.0,6/13,20.43%,MID2;TRIM27;ZFP36;LARP7;UBP1;TRIM32
prerank,positive regulation of cation channel activity (GO:2001259),-0.20465278835712486,-0.7299342522587329,0.9247311827956989,0.9417831910765659,1.0,3/40,4.87%,CTSS;ANK3;ANK2
prerank,actin cytoskeleton reorganization (GO:0031532),0.3108761788339035,0.7296700799581652,0.8276955602536998,1.0,1.0,14/63,17.38%,FLNA;EZR;NEDD9;GSN;GRB2;WHAMM;S1PR2;NRP1;MCU;DTNBP1;PARVB;CAPN10;PARVA;PTK7
prerank,regulation of receptor binding (GO:1900120),-0.29964357172387124,-0.7295607699072483,0.8200692041522492,0.9411514280587638,1.0,2/10,12.54%,ADAM15;GREM2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3076677559925929,0.7293228469341653,0.8659160696008188,1.0,1.0,10/75,13.68%,PPP1R9B;RGS12;GRK6;GIT2;METAP2;RNF157;PLCB1;ROCK2;ZDHHC7;ADCYAP1
prerank,receptor signaling pathway via STAT (GO:0097696),0.3360002782386037,0.7292583506074368,0.7967980295566502,1.0,1.0,7/25,20.23%,CCR2;JAK2;SOCS2;STAT5B;PIAS1;PKD2;SOCS6
prerank,positive regulation of histone deacetylation (GO:0031065),-0.28730775820324717,-0.7290269659311751,0.8228346456692913,0.9407192290298381,1.0,3/12,6.19%,PRKD1;AKAP8L;SAP30BP
prerank,receptor-mediated endocytosis (GO:0006898),0.3011393996671298,0.7288388645230504,0.9206030150753769,1.0,1.0,27/132,18.76%,TFR2;RAMP1;HSPG2;AP1G2;TFRC;CAV1;LRP3;SNX9;CLTC;GRB2;PDLIM7;CAV2;M6PR;AP4E1;CALCRL;ARRB2;DNAJC13;AP2B1;CANX;GRK2;LMBR1L;LDLRAP1;HSP90B1;FCGR2B;COLEC12;SNCA;CLN3
prerank,regulation of cellular catabolic process (GO:0031329),0.31374551281813423,0.7284731308466096,0.839831401475237,1.0,1.0,15/62,21.13%,DAPK2;ITPR1;ABCD1;ATM;HDAC6;BOK;RAB8A;DDIT3;PIP4K2A;LRRK2;DAPK1;KEAP1;RRAGB;ROCK1;MAPT
prerank,calcium import into the mitochondrion (GO:0036444),0.3894937072577184,0.7283235820082871,0.7794117647058824,1.0,1.0,3/10,14.08%,MICU3;MICU1;MCU
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.3011611692553264,0.7282576752204578,0.8993963782696177,1.0,1.0,13/138,12.69%,BLK;NTF4;ERBB3;FYN;NPPC;NEDD9;GFRA2;JAK2;EGFR;EPHA3;MTSS1;FLT3;LMTK2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.22552614048063965,-0.7281709495638168,0.8633093525179856,0.9407088551165921,1.0,9/25,22.22%,TMEM50B;UBXN6;LEPROTL1;TMEM50A;SORT1;CHMP7;LEPROT;CHMP4B;CHMP4A
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.3013302519580411,-0.7279386783678743,0.7987012987012987,0.9398920694330231,1.0,5/10,27.88%,SMOX;ALDH7A1;SARDH;CHDH;HNMT
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.23632363145141172,-0.7277309273957985,0.8481675392670157,0.939043158003048,1.0,9/18,29.14%,PTPRZ1;TNFRSF1B;NF1;MDK;TNFRSF21;TMEM98;TENM4;SLC45A3;IL34
prerank,autonomic nervous system development (GO:0048483),0.35082507488287973,0.726995505966752,0.7942643391521197,1.0,1.0,3/17,17.47%,PHACTR4;NRP1;FN1
prerank,ganglioside biosynthetic process (GO:0001574),0.363950243968109,0.726511150903644,0.7979139504563233,1.0,1.0,5/15,20.19%,ST3GAL1;ST3GAL2;ST8SIA4;ST3GAL5;ST8SIA6
prerank,positive regulation of endothelial cell migration (GO:0010595),0.30459579189624514,0.7258338992702249,0.8621041879468846,1.0,1.0,22/84,21.16%,EMC10;FOXP1;NUS1;HMGB1;AKT3;PRKCA;MAPK14;GFUS;SMOC2;PDPK1;NRP1;ROCK2;EGF;FGFR1;PLCG1;RAC1;SIRT1;ATP5F1B;PROX1;PRKD2;MET;SASH1
prerank,positive regulation of tissue remodeling (GO:0034105),0.37620752285390113,0.7258279601954519,0.7847919655667145,1.0,1.0,2/10,21.01%,ROCK2;ROCK1
prerank,regulation of BMP signaling pathway (GO:0030510),0.31074329793098604,0.7255411449652135,0.8701030927835052,1.0,1.0,11/73,13.79%,FBXL15;CCN1;UBE2O;NOTCH1;HIPK2;TRIM33;SMAD4;XIAP;BMPR1A;NUMA1;SKI
prerank,artery morphogenesis (GO:0048844),0.3292715259479333,0.7252520110992161,0.7986111111111112,1.0,1.0,6/30,16.23%,HEY2;NOTCH1;HPGD;BMPR1A;NRP1;TGFB2
prerank,cellular response to amino acid starvation (GO:0034198),0.31016164862670076,0.7251676482702553,0.8633540372670807,1.0,1.0,15/71,17.14%,DAP;MAPK1;EIF2S1;MAP3K5;LARS1;SEC13;SZT2;MLST8;FAS;RNF152;ATP6V0E1;LAMTOR4;LAMTOR3;NPRL3;ATP6V0D1
prerank,regulation of blood circulation (GO:1903522),0.3277026545088095,0.7249334805922507,0.8035914702581369,1.0,1.0,1/34,1.72%,DES
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.29365662486468136,-0.7247026271504057,0.7647058823529411,0.9417636955727196,1.0,8/11,29.32%,NAGK;PGM3;GNPDA1;GNPDA2;AMDHD2;GNPNAT1;GFPT1;RENBP
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3103021487589073,0.7240482515195384,0.8720083246618107,1.0,1.0,11/62,17.85%,DDIAS;CDKN2D;PARK7;CCAR2;NFE2L2;PPIA;TPT1;SIRT1;XBP1;SYVN1;LRRK2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.3732168842371216,0.7237922992493133,0.7550432276657061,1.0,1.0,3/11,23.99%,CARD9;MALT1;PRKCQ
prerank,neural crest cell migration (GO:0001755),-0.19128542851792957,-0.7236482669592799,0.9166666666666666,0.9419758253762222,1.0,12/36,24.18%,ERBB4;SEMA3D;SEMA3E;SEMA4C;CORO1C;SEMA4G;SEMA3A;SOX8;SEMA7A;SOX10;ANXA6;SEMA4D
prerank,negative regulation of cell death (GO:0060548),0.3086141613580458,0.7231600694545735,0.8785714285714286,1.0,1.0,18/88,19.54%,FYN;CCN1;CCN4;DCPS;IKBKG;INPP5A;PDE12;RAD18;NENF;PARK7;BECN1;GSK3B;TMEM109;PDE8A;LRRK2;SNCA;PAX2;NPAS2
prerank,tetrahydrofolate metabolic process (GO:0046653),0.38358045693738996,0.7229997901888884,0.7802359882005899,1.0,1.0,3/10,19.16%,MTHFD2L;TYMS;MTHFD1L
prerank,positive regulation of calcium ion transport (GO:0051928),-0.20067199878023922,-0.7227777583641842,0.9385964912280702,0.9419157499102306,1.0,9/36,20.10%,CACNB2;ANK2;CCL4;TRPC3;WFS1;CCL3;ORAI1;P2RX4;SPHK2
prerank,response to muscle stretch (GO:0035994),0.36080962573058994,0.7227245981308242,0.7751633986928105,1.0,1.0,2/15,5.93%,CSRP3;GSN
prerank,mesonephric tubule development (GO:0072164),-0.26180593289439985,-0.7226884380898316,0.844,0.9408827986094564,1.0,2/15,10.17%,SALL1;PKD1
prerank,cellular response to oxidative stress (GO:0034599),0.30121940573192607,0.7226876831478399,0.9021190716448032,1.0,1.0,28/118,20.32%,PLA2R1;MAPK1;EIF2S1;MSRA;FOXO1;SETX;EGFR;LONP1;PARK7;JUN;NFE2L2;PPIA;RAD52;MPV17;TP53;CYBB;ERCC6L2;FANCC;CYBA;LRRK2;SNCA;RPS3;NCF4;PKD2;DAPK1;KEAP1;PNPT1;PRR5L
prerank,protein catabolic process (GO:0030163),0.306652507932632,0.7220265534641902,0.8350730688935282,1.0,1.0,6/59,8.18%,PMAIP1;CHEK2;PRPF19;NR1D1;FBXO44;FBXO17
prerank,positive regulation of endopeptidase activity (GO:0010950),0.33147811952999723,0.721946070291933,0.7878787878787878,1.0,1.0,9/26,24.12%,MEFV;FYN;ROCK2;PSME1;USP50;AIM2;PSME2;EFNA1;PSME3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3689574599314279,0.7218009107101914,0.7724137931034483,1.0,1.0,6/12,26.14%,BOK;ATF6;XBP1;TMEM33;BCL2L11;BAK1
prerank,B cell homeostasis (GO:0001782),0.38187397796148614,0.7215715654628096,0.7688022284122563,1.0,1.0,4/10,23.20%,PPP2R3C;TNFRSF13B;CAMLG;DOCK10
prerank,negative regulation of ATP metabolic process (GO:1903579),0.3591562477021897,0.7212061875579231,0.7848761408083442,1.0,1.0,7/17,27.39%,PDE12;FIS1;HDAC4;CBFA2T3;PARP1;PID1;NUPR1
prerank,response to amino acid starvation (GO:1990928),0.30816969974828223,0.7210746732162088,0.8734439834024896,1.0,1.0,15/72,17.14%,DAP;MAPK1;EIF2S1;MAP3K5;LARS1;SEC13;SZT2;MLST8;FAS;RNF152;ATP6V0E1;LAMTOR4;LAMTOR3;NPRL3;ATP6V0D1
prerank,negative regulation of inflammatory response (GO:0050728),0.2942696294261235,0.7206954444979344,0.9288577154308617,1.0,1.0,15/182,8.42%,VIPR2;IAPP;MEFV;RB1;RAMP1;FYN;RPS19;NR1D1;PTHLH;DPEP1;NPSR1;PRKACA;MAPK14;INSL3;PLCG2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.36815755472552275,0.720302533927575,0.7851239669421488,1.0,1.0,1/13,2.21%,XPO1
prerank,diterpenoid metabolic process (GO:0016101),0.31172234524446546,0.7197862641718262,0.8333333333333334,1.0,1.0,2/55,3.42%,LRAT;HSPG2
prerank,endocardial cushion morphogenesis (GO:0003203),0.3502800235612444,0.7197317755610839,0.7853470437017995,1.0,1.0,5/18,19.46%,MDM4;NOTCH1;BMPR1A;TGFB2;SOX9
prerank,amino sugar metabolic process (GO:0006040),0.37563016115964953,0.7196151551256044,0.7670623145400594,1.0,1.0,2/10,13.52%,ST3GAL1;GFPT2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.30158752971895003,0.7195707395522485,0.8815653964984552,1.0,1.0,14/88,15.40%,HMGB2;EMC10;PGF;CAV1;AKT3;PRKCA;CAV2;NR2F2;VASH2;F3;AGGF1;NRP1;MYDGF;EGF
prerank,phagosome-lysosome fusion (GO:0090385),-0.2991845641670212,-0.7193069447984584,0.8220064724919094,0.9438895387377632,1.0,2/10,10.76%,RAB20;SYT7
prerank,copper ion homeostasis (GO:0055070),0.3564747205524412,0.7190240142002369,0.8010139416983524,1.0,1.0,4/17,17.18%,CUTC;ATP7A;XIAP;ATOX1
prerank,positive regulation of dendritic spine development (GO:0060999),0.33827534508627066,0.7181184353007849,0.778343949044586,1.0,1.0,5/20,14.04%,DBNL;LLPH;CPEB3;RELN;PSEN1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.31477052163937097,0.7180594897591184,0.8266522210184182,1.0,1.0,8/41,22.81%,HEY2;NOTCH1;BMPR1A;TGFB2;PROX1;RBPJ;FGFR2;FKBP1A
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3018568619685347,0.7179259024521667,0.866869918699187,1.0,1.0,20/88,15.55%,EXOC2;STXBP6;BLOC1S4;EXOC4;AP1G2;SYS1;OSBPL5;AP4B1;AP1S3;RP2;CLTC;AP4E1;PUM1;STEAP2;EXOC5;AP1S2;DTNBP1;SCAMP1;VPS13A;HGS
prerank,phosphatidic acid metabolic process (GO:0046473),0.31321691734523743,0.7174529836905423,0.8187633262260128,1.0,1.0,8/48,14.87%,AGPAT1;AGPAT4;GPD1L;GPAT3;AGPAT3;PLD2;DGKD;PLD1
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.3267906885099174,0.7172198508623341,0.8014268727705113,1.0,1.0,3/27,5.95%,STMN1;ARHGEF18;CLASP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3251277314418732,0.7169380653101988,0.7947494033412887,1.0,1.0,9/26,24.08%,ABCD1;PLCG2;PARK7;TLR6;CYBA;SNCA;RAB27A;ABCB7;SLC5A3
prerank,regulation of stress fiber assembly (GO:0051492),0.2996326905975148,0.7163958969297844,0.850669412976313,1.0,1.0,7/74,7.60%,ARHGEF5;STMN1;CD47;CCDC88A;ARHGEF18;CLASP1;ALMS1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.30551226101885837,0.7162519193590446,0.8682572614107884,1.0,1.0,18/66,23.81%,BRCA2;CDK6;CAV1;RUNX3;CAV2;NR2F2;B2M;MTSS1;PEX2;TGFB2;NLRC3;MED1;SOX9;CASK;FGFR2;KLF9;APOH;WDR77
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.36319351179824844,0.7158881233929721,0.7951153324287653,1.0,1.0,3/13,16.32%,HACD4;ELOVL5;ELOVL4
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.2018574245323877,-0.7158397047960808,0.9010989010989011,0.9470191406629139,1.0,8/39,17.71%,MBP;NEXMIF;MIA3;PPM1F;PTK2;VEGFA;JAG1;BMP6
prerank,positive regulation of lipid catabolic process (GO:0050996),0.34510124404903275,0.7156292700834984,0.7812895069532237,1.0,1.0,2/19,4.94%,TWIST1;ABCD1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2941672271591092,0.715330153395632,0.982,1.0,1.0,49/291,19.97%,GFI1;HMGB2;SLC5A5;AQP1;MAPK1;EZR;HCN3;CRHBP;NR1D1;TAF1;FOXO1;ATM;DPEP1;SETX;ZFP36L1;PDE2A;HMGB1;AHR;MAPK14;LARS1;EGFR;EPHA3;P2RY1;EGR1;CPEB3;RUVBL2;KCNC2;JUN;MYD88;ROCK2;LAMTOR4;MTR;IRS1;MPV17;LAMTOR3;IPO5;ERCC6L2;VIM;XBP1;PTK7;HSP90B1;CREB1;RPS3;GLRA1;PAX2;TRAF6;SOX9;PKD2;DAPK1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.35313382713169345,0.7147754552751745,0.7873485868102288,1.0,1.0,5/14,22.37%,PKIG;SIRT1;PRKAR2A;ATP2B4;PKIA
prerank,cellular response to heat (GO:0034605),0.3234686348527028,0.7145579128666878,0.8446490218642118,1.0,1.0,8/35,21.13%,HSBP1L1;PRKACA;SUMO1;CLPB;BAG3;YWHAE;TPR;MAPT
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3287420358596168,0.7138864323234178,0.7627737226277372,1.0,1.0,5/22,21.05%,SORBS1;CREB1;ZBTB20;PPARD;SIRT4
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.2553990064536292,-0.7138357932086964,0.8726415094339622,0.9483285115863357,1.0,10/16,39.98%,GSK3A;SLC39A14;PRMT5;PDE6H;MRAP2;CHGA;ACP3;GRP;PDE6G;NECAB2
prerank,TOR signaling (GO:0031929),0.32986779540108013,0.7135731050243573,0.8039673278879813,1.0,1.0,6/26,20.32%,CCDC88A;MLST8;NPRL3;RPS6;MAPKAP1;PRR5L
prerank,modulation by host of viral genome replication (GO:0044827),0.3627446572725111,0.7128336763860088,0.7932379713914174,1.0,1.0,3/13,14.78%,NUCKS1;VAPA;CCNK
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3427943400551403,0.7127811659087497,0.8082191780821918,1.0,1.0,5/21,17.65%,PTPN22;BANK1;PIBF1;JAK3;FCGR2B
prerank,mRNA splice site selection (GO:0006376),0.32410719327397347,0.7125692936983687,0.8097447795823666,1.0,1.0,11/30,26.11%,SNRPC;SETX;PSIP1;LUC7L2;SRSF10;SF3A2;KHDC4;CELF1;SFSWAP;YTHDC1;PRPF39
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.294214526703328,0.7124822659745923,0.964,1.0,1.0,32/214,16.86%,FAM83D;ARHGEF5;EZR;HTR2A;CCN1;CD74;CD44;PTPN22;RASGRP1;CRKL;NOTCH1;PIN1;HMGB1;CIB1;PRKCA;EGFR;P2RY1;ABCA7;CARD9;SMAD4;RPS6KA6;PTEN;ARRB2;NRP1;SPRED2;ADCYAP1;F2R;MAP2K1;STYX;ATP6AP1;CCL25;PDE8A
prerank,endothelial tube morphogenesis (GO:0061154),0.37436315649125906,0.7122582757057948,0.8104956268221575,1.0,1.0,3/10,20.51%,CCM2;PRKD2;RBPJ
prerank,regulation of programmed necrotic cell death (GO:0062098),0.33872626424029384,0.7112724321583015,0.825,1.0,1.0,7/20,21.03%,BIRC2;SPATA2;FLOT1;CFLAR;FLOT2;CASP8;RIPK1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.2862144084713319,-0.7106388727409989,0.8231292517006803,0.9510669334951358,1.0,4/11,26.56%,PRDX2;GPX1;PRDX3;PRDX4
prerank,triglyceride biosynthetic process (GO:0019432),0.34276740036880227,0.7106243506329617,0.7856257744733581,1.0,1.0,2/18,7.38%,GPAT3;MOGAT2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.3687026201085445,0.7102403035985471,0.8074792243767313,1.0,1.0,2/12,13.30%,CD44;FLOT1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.3568436964871752,0.710158236109686,0.7997159090909091,1.0,1.0,1/12,5.32%,CAV1
prerank,negative regulation of neuron differentiation (GO:0045665),0.3326421270167223,0.7101258586433075,0.7995198079231692,1.0,1.0,5/22,22.58%,B2M;GSK3B;MED1;SOX9;CNTN4
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3165165020561003,0.7097696398808918,0.8539576365663322,1.0,1.0,7/40,17.85%,PMAIP1;ABCD1;PPA2;PARK7;ARL6IP5;NDUFS1;LRRK2
prerank,metal ion transport (GO:0030001),0.29671342955745617,0.709397530365704,0.8844580777096115,1.0,1.0,18/86,19.93%,RAMP1;MAGT1;ITPR1;FYN;KCNN4;CAV1;TRPM7;CALCRL;PSEN1;TPT1;TUSC3;NIPAL4;CACNA1B;SLC30A5;CACNG8;NIPA2;NIPAL3;PKD2
prerank,regulation of mitochondrial fission (GO:0090140),0.3382752792035742,0.7093010816149409,0.8107784431137725,1.0,1.0,8/24,21.13%,AURKA;DCN;CYRIB;FIS1;MCU;LRRK2;BNIP3;MAPT
prerank,peptidyl-lysine methylation (GO:0018022),0.32040999828793,0.7091478773528697,0.7952380952380952,1.0,1.0,1/26,1.48%,SUV39H1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.29521249725118026,0.7090225306066201,0.9467871485943775,1.0,1.0,41/172,21.36%,PISD;MTMR12;CHKB;PLEKHA2;AGPAT1;AGPAT4;PCYT2;IMPA1;GPD1L;GPAT3;PIP5K1B;MTMR2;PLCG2;AGPAT3;CDIPT;MTMR14;MTMR6;PTEN;ARF3;INPP4A;SLC44A1;PLD2;PI4K2B;DGKD;SELENOI;PLD1;MTM1;RAB5A;PIK3CA;PIP4K2A;FAR1;PTPN13;RUFY1;CLN3;OCRL;INPP5F;GPD1;SLC44A2;CHKA;PTDSS1;DGKE
prerank,endothelial cell differentiation (GO:0045446),-0.27833581948414565,-0.7087642384565452,0.8131868131868132,0.9522068925092695,1.0,7/12,27.58%,BMPR2;FSTL1;ACVRL1;JAG1;KDM6B;SCUBE1;KDR
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2938735719885431,0.7087621610077349,0.8862704918032787,1.0,1.0,29/84,24.35%,EIF4A3;PIN1;CPEB3;ABCA7;ORMDL3;TYMS;IGF2BP3;HAP1;FXR1;RACK1;LSM14A;CNOT1;RTN3;SAMD4A;EPRS1;EIF4ENIF1;RPS3;DAPK1;CNOT8;SYNCRIP;CNOT7;ROCK1;GAPDH;RPL13A;EIF4E2;YBX1;NCL;DAPK3;EIF2AK2
prerank,negative regulation of TOR signaling (GO:0032007),0.31288692908538007,0.7086045166547004,0.831638418079096,1.0,1.0,7/36,16.99%,STK11;ATM;SZT2;UBR2;RNF152;NPRL3;SIRT1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3136574165525051,0.7084836964000157,0.8307692307692308,1.0,1.0,9/39,18.37%,ITGA1;TGFA;GRB2;EGFR;EGF;HGS;RNF115;ARHGEF7;STAM
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3401991487280471,0.7083400287921401,0.8182926829268292,1.0,1.0,7/22,17.16%,BRD4;CCNT1;THOC5;CCNK;TCERG1;SCAF8;DDX39B
prerank,actin filament capping (GO:0051693),0.3465863147641163,0.7081715330186168,0.779746835443038,1.0,1.0,6/18,23.05%,GSN;FLII;ADD2;TRIOBP;SVIL;TWF1
prerank,barbed-end actin filament capping (GO:0051016),0.3465863147641163,0.7081715330186168,0.779746835443038,1.0,1.0,6/18,23.05%,GSN;FLII;ADD2;TRIOBP;SVIL;TWF1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.294516021078856,0.707494822162612,0.885480572597137,1.0,1.0,20/86,21.89%,CDK5RAP2;RB1;PRKCE;CLASP1;SYNPO2;SNX9;CFL2;SLAIN2;CDC42EP3;EFEMP2;NUMA1;PSEN1;RAC1;DRG1;CDC42EP1;PROX1;RPS3;MET;MAPT;DCTN1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.29064781910919235,-0.7070041799931557,0.8311688311688312,0.9530463426051762,1.0,5/10,21.55%,UBAC2;OS9;ERLEC1;INSIG1;UBE2G2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.29906202524810327,0.7067323498663718,0.848421052631579,1.0,1.0,8/57,17.26%,FLNA;AKAP12;PDE2A;GNAI1;INSL3;CHRM3;LPAR1;ADCY8
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.3423923744983779,0.7045356003103549,0.80306905370844,1.0,1.0,2/16,7.04%,TERF2;NUS1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.327354419694582,0.7045022870368303,0.8250591016548463,1.0,1.0,5/26,16.78%,C2CD5;SORBS1;IRS1;APPL1;CAPN10
prerank,dorsal/ventral pattern formation (GO:0009953),0.34301227074878393,0.704015508638987,0.8132678132678133,1.0,1.0,3/20,15.68%,FBXL15;BMPR1A;AIDA
prerank,metanephros development (GO:0001656),-0.21693207596268768,-0.7039459976316798,0.9415204678362573,0.9553693110631656,1.0,3/26,10.17%,BASP1;NF1;PKD1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.24841872589266226,-0.703505179359855,0.8669527896995708,0.954767038036106,1.0,8/17,26.12%,CD180;CARD16;LY96;CD36;BMP6;TRIB1;CACTIN;SCIMP
prerank,autophagy of nucleus (GO:0044804),0.34248427509173984,0.7032889446765399,0.8125836680053548,1.0,1.0,1/16,2.51%,ATG13
prerank,regulation of inflammatory response (GO:0050727),0.2899623336303852,0.7032869285229707,0.9538152610441767,1.0,1.0,23/190,11.93%,MEFV;CD47;RB1;IL16;CCN4;S100A9;GPRC5B;FOXP1;CCR2;NR1D1;S100A8;TRADD;PDE2A;BIRC2;BRD4;JAK2;IL17RA;NAPEPLD;IL1R1;PARK7;XIAP;DHX9;MYD88
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2922880739107477,0.7024251934520795,0.9467336683417086,1.0,1.0,24/150,17.58%,CD19;IAPP;ERBB3;FYN;TGFA;GRB2;STRN;EGFR;PDPK1;TXN;PARK7;FGF9;FLT3;F3;RAC2;MYDGF;IRS1;EGF;TCF7L2;FGFR1;PIK3CA;RAC1;HCLS1;KITLG
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2703199896948059,-0.7022802952032894,0.8527131782945736,0.9550794085096855,1.0,3/12,16.77%,MIA3;MDK;SKAP1
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.32574769678237325,0.7018185263457302,0.8203309692671394,1.0,1.0,11/25,25.43%,GLMN;EGFR;NRP1;PSEN1;EGF;SNCA;ILK;SRC;DSCAM;MIF;ITGA6
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.35302924190390045,0.7017750365227242,0.7983651226158038,1.0,1.0,5/14,22.11%,PPP3CA;PPP2CB;PPP1CA;PPP2CA;PPP1R15B
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.30272391535567844,0.7017274826226243,0.8603411513859275,1.0,1.0,15/54,19.83%,COPS9;NXN;CAV1;PIAS3;PRR7;PARK7;ARRB2;SIRT7;UBXN1;CAMLG;PRMT3;GNL3L;RPL5;RPS3;HDAC8
prerank,arachidonic acid metabolic process (GO:0019369),0.3081186557014103,0.7016590237353356,0.8278595696489242,1.0,1.0,3/35,6.72%,CYP1B1;CYP2A6;EPHX2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.2945686643757175,0.7012313217525669,0.9069767441860465,1.0,1.0,28/109,19.72%,MTMR12;PLEKHA2;IMPA1;PIP5K1B;MTMR2;PLCG2;PIP4P2;CDIPT;PLBD1;MTMR14;PLCB1;MTMR6;PTEN;ARF3;INPP4A;PLCB3;PI4K2B;PGAP1;PLCD1;MTM1;RAB5A;PLCG1;PIK3CA;PIP4K2A;PTPN13;RUFY1;OCRL;INPP5F
prerank,neuron projection fasciculation (GO:0106030),-0.2885233601343287,-0.7012214240768505,0.8378378378378378,0.9551528614062766,1.0,3/10,16.21%,RTN4;CDK5R1;EPHA4
prerank,regulation of AMPA receptor activity (GO:2000311),-0.22491821511665444,-0.7008024473221643,0.9066666666666666,0.9544860069669653,1.0,8/25,19.83%,SHISA6;MINK1;CACNG2;CACNG7;SHANK3;ADRB2;GSG1L;PRRT1
prerank,protein hydroxylation (GO:0018126),0.3444761747610797,0.7005004983219763,0.8155216284987278,1.0,1.0,4/15,14.67%,PLOD3;JMJD4;VPS33B;P3H4
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.24556257775720539,-0.7004912850539095,0.8578947368421053,0.953669348583126,1.0,2/17,4.70%,VSIR;HDAC2
prerank,transferrin transport (GO:0033572),0.3189489764969044,0.7002844671281723,0.835632183908046,1.0,1.0,9/33,17.14%,TFR2;TFRC;CLTC;RAB11B;LMTK2;ATP6V0E1;STEAP3;ATP6AP1;ATP6V0D1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.29183030352997225,0.7000528484098574,0.9006085192697769,1.0,1.0,7/101,8.09%,GFI1;HMGB2;PRKCE;PTPN22;NR1D1;HMGB1;MAPK14
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.28374827024149085,-0.6998351986028802,0.8473520249221184,0.9532220488354056,1.0,4/10,25.82%,BAG6;BTLA;CD40;LYN
prerank,anterior/posterior pattern specification (GO:0009952),-0.18466861149723107,-0.699547498187779,0.9571428571428572,0.9523578664430946,1.0,5/53,3.98%,TGFBR1;BASP1;BMPR2;WLS;PCSK5
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.294365971210965,0.6993026327770068,0.9217479674796748,1.0,1.0,24/113,19.94%,HMGB2;EMC10;PGF;TGFA;AKT3;PRKCA;LAMC1;EGFR;VASH2;FGF9;F3;AGGF1;NRP1;MYC;MYDGF;EGF;TCF7L2;SIRT1;XBP1;PROX1;PAX2;SOX9;PRKD2;MMP12
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.31487415614590747,0.6991420358194833,0.8460648148148148,1.0,1.0,11/30,20.13%,DDRGK1;PARK7;CCAR2;UCHL5;USP14;STYX;TAF9;UBXN1;CAMLG;USP7;SVIP
prerank,negative regulation of myoblast differentiation (GO:0045662),0.3555667996933314,0.6990537973676942,0.8079019073569482,1.0,1.0,2/13,19.46%,NOTCH1;SOX9
prerank,muscle cell differentiation (GO:0042692),0.315022703485691,0.6989508903166419,0.8344519015659956,1.0,1.0,2/32,3.02%,HEY2;GLMN
prerank,amino sugar biosynthetic process (GO:0046349),-0.2757923554273852,-0.6989332598896438,0.8290909090909091,0.9518850895835802,1.0,8/12,29.32%,NAGK;PGM3;GNPDA1;GNPDA2;AMDHD2;GNPNAT1;GFPT1;RENBP
prerank,regulation of viral genome replication (GO:0045069),0.2969715318870415,0.6987963792633877,0.8681434599156118,1.0,1.0,13/56,18.96%,SLPI;PDE12;PKN2;RAD23A;FAM111A;IFITM3;PPIA;STAU1;TARBP2;SRPK1;PPIE;PPIH;PROX1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.2560265163932086,-0.6984700425438416,0.8211678832116789,0.9512820269007215,1.0,4/12,17.82%,STX4;PLA2G6;C2CD2L;GPLD1
prerank,purine-containing compound catabolic process (GO:0072523),0.3572318224177069,0.6983666011694096,0.816711590296496,1.0,1.0,2/13,9.67%,GDA;NT5C2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.2903467998089109,0.6983252331753377,0.8981670061099797,1.0,1.0,23/93,21.73%,EMC10;AXIN1;RASGRP1;TRAF3;MAP3K5;HMGB1;MAP4K2;HIPK2;MAP3K11;CARD9;PLCB1;PDCD10;TGFB2;DUSP22;RELL1;SH3RF1;ARL6IP5;FCGR2B;TAOK1;TRAF6;RIPK1;SASH1;MTURN
prerank,regulation of aerobic respiration (GO:1903715),0.34773128588393093,0.6982421759193215,0.8255208333333334,1.0,1.0,2/15,10.54%,ABCD1;ATP7A
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.2935224000617474,0.6981781351790275,0.8747412008281573,1.0,1.0,13/74,17.28%,BRCA1;TNFSF10;TRADD;BIRC6;EYA3;ITGAV;PARK7;FAS;CFLAR;GSK3B;EYA1;TCF7L2;SH3RF1
prerank,glycolipid biosynthetic process (GO:0009247),0.3120474438981864,0.6980860118212854,0.8355555555555556,1.0,1.0,11/38,22.47%,PIGH;PIGF;PIGA;ST3GAL2;PIGU;ST3GAL5;GBGT1;PIGM;ST8SIA6;PGAP2;DPM2
prerank,sterol transport (GO:0015918),0.3343419267351856,0.6974828239036318,0.8160919540229885,1.0,1.0,2/19,6.22%,CAV1;OSBPL5
prerank,negative regulation of cell projection organization (GO:0031345),0.29912660696309945,0.6970254370670446,0.8568376068376068,1.0,1.0,8/48,17.16%,GFI1;FYN;YWHAH;CIB1;PTEN;LPAR1;MYLIP;GORASP1
prerank,positive regulation of ERAD pathway (GO:1904294),0.35339071877576467,0.6967825823589658,0.791023842917251,1.0,1.0,3/13,13.03%,CAV1;UBQLN1;NFE2L2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.31644890255076913,0.6962893739534021,0.8416289592760181,1.0,1.0,3/33,10.30%,E2F2;PDPK1;CEMIP2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.35697854973833876,0.6962819223032006,0.7985611510791367,1.0,1.0,3/11,17.55%,KCNJ3;KCNJ2;YWHAE
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3043018224722567,0.6960410602031295,0.8329646017699115,1.0,1.0,11/38,21.12%,TRIM59;TANK;NR1D1;RIOK3;NLRC3;SIRT1;NLRX1;PPM1B;CASP8;RIPK1;OTUD7A
prerank,regulation of cell death (GO:0010941),0.2919607601295474,0.6960089876816536,0.893037336024218,1.0,1.0,16/94,17.96%,CCN1;NOA1;CCN4;FAF1;PDE12;GPR75;PRODH;RAD18;PRR7;PARK7;BECN1;TMEM109;ACER3;PDE8A;LRRK2;SNCA
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.29767768893136176,0.6951351041843983,0.8621794871794872,1.0,1.0,15/54,23.16%,NUS1;HMGB1;AKT3;PRKCA;MAPK14;MECP2;PDPK1;FGFR1;PLCG1;SIRT1;ATP5F1B;PRKD2;PRCP;ATP2B4;ADAM17
prerank,cellular response to misfolded protein (GO:0071218),0.3346253102525178,0.6950691164318301,0.8153266331658291,1.0,1.0,12/20,27.83%,DNAJC18;CUL3;TOR1A;KLHL15;DNAJB12;DNAJB14;DERL1;POMT2;UBE2W;VCP;UGGT1;UGGT2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.22052828221737983,-0.6950203461345619,0.9106145251396648,0.952733309979447,1.0,9/21,31.73%,BCL2L1;MCL1;IL1A;UNC5B;EYA2;MAPK7;BCL2;PF4;IL1B
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.22052828221737983,-0.6950203461345619,0.9106145251396648,0.952733309979447,1.0,9/21,31.73%,BCL2L1;MCL1;IL1A;UNC5B;EYA2;MAPK7;BCL2;PF4;IL1B
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3139530444267258,0.6945039755442696,0.8366666666666667,1.0,1.0,9/32,24.19%,SORBS1;ADIPOR1;PRKAG2;CREB1;ZBTB20;EIF6;SIRT4;C3;PRKAB2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.31945076797998845,0.6937093865499725,0.8425287356321839,1.0,1.0,5/28,12.13%,AXIN1;DDRGK1;PSMC3;PTEN;CDK5RAP3
prerank,nucleoside phosphate catabolic process (GO:1901292),0.3516194758153044,0.6932387048563367,0.8202396804260985,1.0,1.0,2/13,8.34%,ENTPD3;ENTPD5
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.20740557632764262,-0.6931308543967063,0.924812030075188,0.9536152768166309,1.0,10/30,24.62%,PTPN2;PTPN6;CD300A;SH2B3;MVP;THY1;PPP2R1A;SH3BP5L;SEMA4D;SAMSN1
prerank,"phototransduction, visible light (GO:0007603)",-0.26086239794724764,-0.6928670256809633,0.8106995884773662,0.9527688855277533,1.0,8/14,49.94%,GNAQ;SAG;PDE6G;PDE6B;ABCA4;RP1;PDE6A;CNGB1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.3417893610329442,0.6928202843926756,0.8170426065162907,1.0,1.0,4/18,14.08%,AURKA;DCN;FIS1;MCU
prerank,aerobic respiration (GO:0009060),0.3312343175589624,0.6927369837038861,0.8284993694829761,1.0,1.0,5/20,20.39%,NDUFS8;ME3;ATP5F1D;MDH2;UQCRH
prerank,central nervous system neuron differentiation (GO:0021953),0.31396901890471485,0.6917054374031363,0.8526434195725534,1.0,1.0,6/33,15.87%,NR4A2;AGTPBP1;GBA2;ATP7A;MDGA1;SIN3A
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.3540328392974287,0.6916021688926175,0.8171589310829818,1.0,1.0,3/12,13.19%,LAMA5;FUZ;ZDHHC7
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.3181189854736513,0.6915080971241662,0.8114086146682189,1.0,1.0,3/24,8.09%,CTNNA1;TCF3;MAPK14
prerank,catecholamine biosynthetic process (GO:0042423),0.35868239933999574,0.6913231444222191,0.8117977528089888,1.0,1.0,2/11,17.96%,TGFB2;SNCA
prerank,cellular protein localization (GO:0034613),0.28785268260807345,0.6910852281272731,0.981,1.0,1.0,65/285,20.94%,CD177;CNTLN;HEY2;TBC1D1;ATG13;TBC1D8B;FLNA;ABHD17A;CSRP3;CD74;STX17;PRPF19;TBC1D22B;ARL5C;NAPG;TLK1;EVI5;ARL11;RAB1B;RAB22A;YWHAH;STX5;ARF4;HDAC6;ARFGAP3;CEP250;SNX9;CLTC;PICK1;EGFR;SEC13;STX11;GGA1;KIF13A;ARF3;SEC31A;RAB43;BBS4;NIPBL;COPZ1;VPS33B;PIGU;LAMTOR3;TBC1D25;ARL4C;PTPRU;HGS;RAB5A;NAPB;SEPTIN9;ADPRH;EIF2D;LRRK2;GGA2;RAB6A;SAR1B;TM9SF1;SGSM3;CROCC;WDR45B;FBLN5;RRAGB;TBC1D15;ARL5B;SNX13
prerank,positive regulation of interleukin-1 production (GO:0032732),0.29968348265588163,0.6909029166701691,0.8650371944739639,1.0,1.0,13/51,21.43%,IL16;HMGB1;JAK2;EGR1;MYD88;TLR6;TYROBP;USP50;MALT1;LGALS9;CASP8;AIM2;TMED10
prerank,oxoacid metabolic process (GO:0043436),0.3162618935200963,0.6907759914466665,0.8339181286549707,1.0,1.0,4/27,13.24%,TPST1;PPA2;BPNT2;SULT6B1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.2940232107472156,0.6907537318094181,0.8844169246646026,1.0,1.0,14/62,17.21%,POLR2I;POLR2A;IWS1;NCBP1;ERCC3;RTF1;NELFA;CCNT1;CCNK;ELOF1;NELFB;MLLT1;POLR2K;POLR2J
prerank,regulation of cellular amide metabolic process (GO:0034248),0.30866698840335294,0.6907519059735444,0.8514285714285714,1.0,1.0,5/32,10.91%,EIF2A;RBM3;MTPN;PUM3;TCOF1
prerank,negative regulation of neurogenesis (GO:0050768),0.30844849270306257,0.6903613944582991,0.8312570781426953,1.0,1.0,8/34,17.16%,LRP4;YWHAH;NOTCH1;PCM1;B2M;PTEN;ARHGDIA;GORASP1
prerank,extracellular matrix disassembly (GO:0022617),0.29282704672000237,0.69024227065044,0.8569903948772679,1.0,1.0,12/53,19.94%,CD44;GSN;LAMC1;CAPN1;TLL2;BSG;CTSK;FLOT1;MMP19;ADAMTS5;ADAM10;MMP12
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.2678645657936124,-0.6899732854520796,0.8607594936708861,0.9548052527113872,1.0,4/11,26.12%,UNC93B1;TNIP2;TICAM1;SCIMP
prerank,coenzyme A metabolic process (GO:0015936),0.3402521837601987,0.6896303534410146,0.8049113233287858,1.0,1.0,4/14,18.91%,PANK2;SLC25A16;DCAKD;PANK1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.3522465000171706,0.688306701514043,0.8324022346368715,1.0,1.0,2/12,6.36%,JMJD4;SETX
prerank,ameboidal-type cell migration (GO:0001667),0.29716767808315225,0.68797652379485,0.8491561181434599,1.0,1.0,4/51,7.43%,PHACTR4;ITGB7;AMOTL2;PKN2
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.23795373302115802,-0.6875990663062683,0.8878504672897196,0.956123613533965,1.0,8/17,31.02%,BCL2L1;DNM1L;MFF;BAD;SOD2;BCL2;TIMM50;BBC3
prerank,cellular component disassembly (GO:0022411),0.2911469682452675,0.687032951190572,0.8575982996811902,1.0,1.0,12/53,19.94%,CD44;GSN;LAMC1;CAPN1;TLL2;BSG;CTSK;FLOT1;MMP19;ADAMTS5;ADAM10;MMP12
prerank,positive regulation of signal transduction (GO:0009967),0.2826882030392683,0.6868616248220794,0.977977977977978,1.0,1.0,57/238,21.77%,DEPDC1B;FGFBP3;IL7R;SLC2A4;FLNA;CD74;TEDC2;SULF2;AGPAT1;DISC1;SORBS1;NOTCH1;SMARCA4;PRKCA;JAK2;ITGAV;SMOC2;CAV2;ASXL1;TRIM44;RELN;KAT2B;PRKCB;FAS;PTEN;HAP1;UCHL5;F3;NRP1;ZBTB7B;ING5;CREBBP;SKI;IRS1;LIMS1;CCBE1;TUBD1;PDCD10;TGFB2;SIRT1;XBP1;LRRK2;TSPAN5;TXNDC15;NRXN1;RPS3;RSPO2;PKD2;PRKD2;DSTYK;RBPJ;ILK;SPIN1;CITED2;SASH1;RAB34;ADAMTS3
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.34789435726341394,0.6864538013021745,0.8340306834030683,1.0,1.0,4/12,26.57%,GSK3B;HOMER2;ATP2B4;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.34789435726341394,0.6864538013021745,0.8340306834030683,1.0,1.0,4/12,26.57%,GSK3B;HOMER2;ATP2B4;DYRK2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.292444967013964,0.6864115873036223,0.8746081504702194,1.0,1.0,21/70,23.23%,MAPK1;FYN;PRKCE;CYFIP2;GRB2;PLCG2;CRK;PLD2;BRK1;ELMO2;PLCG1;PIK3CA;RAC1;FCGR2B;VAV3;SYK;FGR;ACTG1;NCKIPSD;PRKCD;SRC
prerank,nervous system development (GO:0007399),0.282222625673773,0.6863216266220522,0.994,1.0,1.0,54/429,16.00%,STIL;ECT2;VAX2;NTF4;SDK1;CDK5RAP2;WDR62;SOX6;ERBB3;LIG4;ANKLE2;WDPCP;APAF1;LRCH4;LY6H;HAPLN2;GFRA2;GSN;GBA2;GDA;NRSN2;DBNL;ZBTB16;ST8SIA4;PMP22;NR2C2;IRF2BPL;RBFOX3;DYRK1A;SZT2;DNER;RELN;TRIM3;IGF2BP3;RPS6KA6;PTEN;CYP46A1;HAP1;NELL1;FGF13;CHRM3;NRCAM;ADGRL3;MTR;GFRA1;KIRREL3;ADGRV1;NRXN2;ARHGAP26;LPAR1;JARID2;MYLIP;PPP2R5D;MARK4
prerank,protein O-linked glycosylation (GO:0006493),0.28527909777374694,0.6863077174870332,0.9203629032258065,1.0,1.0,8/96,11.03%,MUC19;GALNT10;PLOD3;GXYLT1;ST3GAL1;ST3GAL2;B3GNT2;TMTC2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.30025129917133864,0.6856877512897656,0.8617363344051447,1.0,1.0,8/43,17.38%,CCN4;FOXP1;DNMT1;JUN;FGF9;BMPR1A;ADAMTS1;LDLRAP1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3034565372901565,0.6853506341589021,0.8517279821627648,1.0,1.0,4/38,5.32%,ERBB3;NEDD9;GPRC5B;CAV1
prerank,membrane organization (GO:0061024),0.28354081485686655,0.6852964104371986,0.968,1.0,1.0,38/227,17.62%,CEP55;KIF20A;NEMP1;IL7R;CCDC88A;REEP4;SUN2;SNX3;TMCC1;NAPG;TFRC;SLC2A8;TGFA;SNX9;CLTC;GRB2;PICK1;EGFR;M6PR;STX11;EMD;TOR1A;VAPA;ARRB2;PACSIN2;AP2B1;STON2;CHMP1B;VPS33B;REPS1;EGF;GCA;HGS;RAB5A;CHMP3;CHMP2B;LDLRAP1;UBA52
prerank,cellular response to peptide (GO:1901653),0.294183037853583,0.6845720313806923,0.894962486602358,1.0,1.0,13/56,17.65%,DDX11;FYN;TIMELESS;PTPN22;CAV1;ZFP36L1;PSEN1;TLR6;GSK3B;TP53;VIM;XBP1;FCGR2B
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.2991927639255439,0.684402639123332,0.8547854785478548,1.0,1.0,2/41,4.94%,CYP1B1;ABCD1
prerank,regulation of cholesterol esterification (GO:0010872),-0.2873252513267696,-0.6840825297169227,0.8811188811188811,0.958474559651196,1.0,5/10,33.58%,APOE;APOC1;AGT;LAMTOR1;STARD4
prerank,protein localization to membrane (GO:0072657),0.28284806687847247,0.6840312774067483,0.971,1.0,1.0,30/187,15.75%,ITGB7;C2CD5;NDC1;RAMP1;FLNA;ABHD17A;EZR;ARL5C;CAV1;ANK1;DENND4C;RAB8A;PICK1;TSPAN33;P2RY1;ACTN2;SYNE3;BSG;RDX;RAB8B;CYP46A1;PRAM1;RAB11B;ROCK2;FGF13;FLOT1;TTC7A;NRXN2;HGS;PACS1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3375462691135007,0.6837512679814988,0.8082706766917294,1.0,1.0,3/16,17.78%,HNRNPM;DHX9;RSRC1
prerank,protein neddylation (GO:0045116),-0.2601677527560856,-0.683025155724948,0.89453125,0.9584179142268189,1.0,6/13,31.94%,UBE2F;DCUN1D2;RNF7;DCUN1D1;NAE1;UBA3
prerank,fat cell differentiation (GO:0045444),0.29071526152615645,0.6830118369743189,0.8697033898305084,1.0,1.0,10/57,18.38%,NR4A2;FOXO1;ZBTB7A;ATF5;BBS4;TCF7L2;SIRT1;BBS9;MED1;ERAP1
prerank,myelin maintenance (GO:0043217),0.3595407171895155,0.682655786241326,0.8256484149855908,1.0,1.0,3/10,17.70%,ABCD1;PTEN;CXCR4
prerank,calcium ion import across plasma membrane (GO:0098703),-0.2567048491753645,-0.6826252941247816,0.8478260869565217,0.9577095526123478,1.0,5/14,30.16%,SLC8A3;TRPV4;SLC8A1;TRPM2;SLC8A2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3492320306036132,0.6817786953692648,0.8355978260869565,1.0,1.0,3/12,16.79%,ATP7A;SMS;MAOA
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.29014331411717853,0.6816921442296513,0.8963730569948186,1.0,1.0,14/64,17.21%,POLR2I;POLR2A;IWS1;NCBP1;ERCC3;RTF1;NELFA;CCNT1;CCNK;ELOF1;NELFB;MLLT1;POLR2K;POLR2J
prerank,iron ion transport (GO:0006826),0.2994052650171356,0.6813732560656524,0.868763557483731,1.0,1.0,10/47,17.14%,TFR2;HEPH;TFRC;CLTC;RAB11B;LMTK2;ATP6V0E1;STEAP3;ATP6AP1;ATP6V0D1
prerank,protein deneddylation (GO:0000338),0.3580827816010863,0.6807423541845404,0.836940836940837,1.0,1.0,4/10,21.94%,TOR1A;COPS3;COPS2;COPS4
prerank,protein targeting to membrane (GO:0006612),0.28722697352484033,0.6805596002978214,0.9075025693730729,1.0,1.0,25/83,24.26%,PEX26;ABCD1;ACBD5;ARL6IP1;PEX11B;PXMP4;GET3;GDAP1;PEX2;RAB8B;FIS1;ZDHHC7;SSR1;SEC63;PEX14;ATAD1;ICMT;SEC62;ZDHHC6;NACA;SSR2;CHM;ZDHHC21;PEX3;YIF1B
prerank,establishment of epithelial cell polarity (GO:0090162),0.3237198638962614,0.6805100808122577,0.8179487179487179,1.0,1.0,5/19,19.67%,EZR;CLASP1;MSN;CYTH1;GOLPH3
prerank,myelination in peripheral nervous system (GO:0022011),-0.2583222996944933,-0.6803488969770886,0.8614232209737828,0.9587742885746493,1.0,9/13,38.63%,NF1;ADGRG6;ARHGEF10;PARD3;CNTNAP1;NCMAP;SIRT2;MYOC;PRX
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.35946155714714545,0.6797846077761694,0.8219373219373219,1.0,1.0,4/10,23.99%,ZBTB7B;CD55;LGALS9;PRKCQ
prerank,Golgi to plasma membrane transport (GO:0006893),0.29688888540280833,0.6795124554109379,0.8796498905908097,1.0,1.0,10/47,14.26%,EXOC2;STXBP6;EXOC4;SYS1;OSBPL5;BLZF1;GGA1;KIF13A;STEAP2;EXOC5
prerank,cell-matrix adhesion (GO:0007160),0.2833134665162501,0.679286641813864,0.9,1.0,1.0,25/95,24.22%,ITGA1;ECM2;ITGB7;TIAM1;CD44;SORBS1;ITGAV;WHAMM;ACTN2;TESK2;ITGA8;BCR;RAC1;FN1;ARHGEF7;ZYX;ILK;FBLN5;ITGA4;ACTN1;VCL;SRC;ITGB1BP1;NPNT;ADAMTS9
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.28379144830173386,0.6792497827195432,0.9114954221770092,1.0,1.0,20/88,22.45%,SLX4;TFRC;FAF1;SYNPO2;PRKCA;PARK7;SUMO1;RACK1;FLOT1;BRK1;GSK3B;HGS;STAM;GNL3L;SLF1;RPS3;TPR;VPS4A;SYK;SPIDR
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.3256867607174377,0.6789855346859377,0.8233082706766918,1.0,1.0,3/18,10.78%,RFK;ATP7A;PARK7
prerank,amino acid import (GO:0043090),0.3255641250512341,0.6779186182065028,0.8452970297029703,1.0,1.0,3/21,18.23%,SLC7A1;SFXN1;SLC22A4
prerank,blood circulation (GO:0008015),0.29210329374231697,0.6777244295729385,0.8788853161843515,1.0,1.0,9/49,23.72%,F5;GUCY1A1;ROCK2;ELN;SGCG;ROCK1;GCLM;GCLC;ITGB1BP1
prerank,contractile actin filament bundle assembly (GO:0030038),0.3367256934384291,0.677684655287166,0.8252933507170795,1.0,1.0,5/15,14.97%,SORBS1;TNFAIP1;CUL3;FAM171A1;PDCD10
prerank,stress fiber assembly (GO:0043149),0.3367256934384291,0.677684655287166,0.8252933507170795,1.0,1.0,5/15,14.97%,SORBS1;TNFAIP1;CUL3;FAM171A1;PDCD10
prerank,serine family amino acid catabolic process (GO:0009071),-0.2739010991373506,-0.677619153221077,0.8647798742138365,0.9602949142636907,1.0,8/10,47.42%,AMT;SHMT2;SHMT1;CBS;THNSL2;DAO;GLDC;SDS
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.29610982974494987,0.6776116922261759,0.865934065934066,1.0,1.0,12/43,23.99%,NUCKS1;SIK2;SORBS1;PRKCB;ZBTB7B;IRS1;SIRT1;PIP4K2A;GRB14;PTPN11;PRKCD;PRKCQ
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3213533811308068,0.6775166788696797,0.8452970297029703,1.0,1.0,5/21,21.60%,TEDC2;UCHL5;TUBD1;TXNDC15;RAB34
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.24293897476471277,-0.6774916541450821,0.9020618556701031,0.959313873390673,1.0,7/15,30.25%,NSMAF;SIRT3;PLA2G6;SPHK2;ORMDL2;ORMDL1;SMPD2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.28703095076216034,0.67741089390068,0.8903966597077244,1.0,1.0,16/69,17.81%,NPLOC4;FBXO44;UBE4B;DNAJC18;FBXO17;FAF2;UBQLN1;DERL2;AMFR;RHBDD2;YOD1;DNAJB9;RNF103-CHMP3;HSP90B1;FAM8A1;SYVN1
prerank,positive regulation of T cell differentiation (GO:0045582),0.30732958043798164,0.676828414738167,0.8621076233183856,1.0,1.0,6/36,19.55%,LEF1;NKAP;BCL6;SART1;XBP1;PNP
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.27797347514530346,-0.6766213896934328,0.8710801393728222,0.9590011920688586,1.0,7/10,42.31%,DNAJB6;SACS;SORL1;DNAJA4;HSPA1A;HSPA2;HSPA1B
prerank,regulation of protein localization (GO:0032880),0.28766640340458194,0.6765262464884183,0.887592788971368,1.0,1.0,10/58,14.44%,BORA;WDPCP;MMD2;MMD;SUMO1;TRIM68;RACK1;ZDHHC7;ADCYAP1;TRIM5
prerank,circulatory system development (GO:0072359),0.28264375242816686,0.6761444163143673,0.9350912778904665,1.0,1.0,31/118,23.42%,HEY2;ERBB3;HSPG2;ZFPM1;STK11;NXN;NOTCH1;PDLIM7;HEG1;SMYD4;KAT2B;PTEN;SMG9;POU6F1;TGFB2;CRIP1;PIK3CA;FN1;PDLIM5;CDKN1A;CASP8;SOX9;NCOA6;PKD2;CITED2;NTRK3;HDAC9;CDKN1B;PTPN11;OSR1;KDM6A
prerank,negative regulation of immune system process (GO:0002683),-0.2360756139789511,-0.6760807731906374,0.8921161825726142,0.9584013815792021,1.0,12/16,47.96%,CD200;HMOX1;PDCD1;HOXA7;LYN;COL3A1;IL17D;ADTRP;FOXP3;FADD;FCRLB;SPINK5
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.2868372587548389,0.6760260964374601,0.9126016260162602,1.0,1.0,16/87,18.02%,ARHGEF5;CCDC88A;EZR;ARHGDIB;RND3;ARHGAP35;EPHA3;MLST8;CRK;ROCK2;RAC2;ARHGDIA;PIK3CA;RAC1;IQGAP1;TAOK1
prerank,positive regulation of JNK cascade (GO:0046330),0.2860838900165738,0.6759222900526436,0.8935281837160751,1.0,1.0,17/70,21.73%,AXIN1;RASGRP1;TRAF3;MAP3K5;HMGB1;MAP4K2;HIPK2;MAP3K11;CARD9;PLCB1;DUSP22;SH3RF1;FCGR2B;TAOK1;TRAF6;RIPK1;MTURN
prerank,sensory perception of pain (GO:0019233),-0.22522649553679314,-0.6758830168577135,0.9264705882352942,0.9574844431556025,1.0,12/21,39.99%,SCN9A;KCNA2;NIPSNAP1;P2RX4;PTGES;CHRNA4;CCL2;OPRL1;OPRK1;ALOXE3;KCNK4;CHRNB2
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3110756149082194,0.6757245730019965,0.8514007308160779,1.0,1.0,6/25,19.45%,PLCG2;B2M;MAP3K7;MALT1;CD55;TRAF6
prerank,ERAD pathway (GO:0036503),0.28389770175753076,0.675142354461477,0.90216271884655,1.0,1.0,18/83,17.81%,RCN3;NPLOC4;FBXO44;UBE4B;DNAJC18;FBXO17;FAF2;UBQLN1;DERL2;AMFR;TOR1A;RHBDD2;YOD1;DNAJB9;RNF103-CHMP3;HSP90B1;FAM8A1;SYVN1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.31784653452874295,0.6744380243086218,0.8509316770186336,1.0,1.0,5/20,17.56%,MEFV;ENTPD5;TXN;PSTPIP1;ANO6
prerank,membrane repolarization during action potential (GO:0086011),-0.25427594643507184,-0.6742846610784055,0.9077490774907749,0.9578662574445278,1.0,3/13,16.46%,ATP1A1;ATP1B1;KCND3
prerank,energy reserve metabolic process (GO:0006112),0.3268053434306743,0.6736220146863554,0.840153452685422,1.0,1.0,5/19,15.27%,GFPT2;PRKAG2;MYC;GSK3B;GBE1
prerank,lipid catabolic process (GO:0016042),0.32296617616372864,0.673087769017528,0.820480404551201,1.0,1.0,1/18,3.01%,CEL
prerank,cellular response to chemical stress (GO:0062197),0.281827957889237,0.6729244525206122,0.926530612244898,1.0,1.0,23/96,20.32%,EIF2S1;CAV1;MSRA;FOXO1;ATM;SETX;LONP1;PARK7;FAS;NFE2L2;PPIA;RAD52;CYBB;FANCC;PIK3CA;CYBA;LRRK2;SNCA;NCF4;PKD2;KEAP1;PNPT1;PRR5L
prerank,positive regulation of MAPK cascade (GO:0043410),0.27839222753158543,0.6723348128006658,0.984,1.0,1.0,41/245,18.02%,EZH2;IAPP;HTR2A;CD74;CD44;PTPN22;RASGRP1;CRKL;NOTCH1;HMGB1;CIB1;PRKCA;PLCG2;EGFR;CAV2;P2RY1;RIT2;ABCA7;CARD9;FLT3;ARRB2;NRP1;ROCK2;ADCYAP1;MYDGF;TRIM5;PDCD10;EGF;F2R;LPAR1;MAP2K1;FGFR1;TGFB2;ATP6AP1;CD24;CCL25;PDE8A;ARL6IP5;LRRK2;IQGAP1;TAOK1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.26046149585365586,-0.672199886575722,0.8604651162790697,0.9586508577245375,1.0,8/13,29.32%,NAGK;PGM3;GNPDA1;GNPDA2;AMDHD2;GNPNAT1;GFPT1;RENBP
prerank,glucose homeostasis (GO:0042593),0.28312777821544116,0.6721875789492754,0.9096446700507614,1.0,1.0,14/83,17.26%,SLC2A4;USF1;NUCKS1;STK11;NR1D1;FOXO1;PARK7;ADIPOR1;MCU;IRS1;TCF7L2;FOXK2;SIRT1;ADCY8
prerank,inositol phosphate catabolic process (GO:0071545),0.3458557113057653,0.6720713877644162,0.8321678321678322,1.0,1.0,3/12,11.97%,IMPA1;INPP5A;PTEN
prerank,striated muscle tissue development (GO:0014706),0.30347949034989835,0.6718374613660492,0.8446490218642118,1.0,1.0,6/29,20.78%,CSRP3;CAV1;CFLAR;SGCG;ZBTB18;SVIL
prerank,cholesterol homeostasis (GO:0042632),0.287085299903245,0.6717885120674036,0.891213389121339,1.0,1.0,16/64,23.47%,CAV1;NR1D1;EPHX2;RALY;ABCA2;LIMA1;CD24;SIRT1;XBP1;LDLRAP1;NR1H3;HDAC9;LDLR;SOAT1;TTC39B;EHD1
prerank,heart process (GO:0003015),0.33753077506984136,0.6711266941448487,0.8486932599724897,1.0,1.0,1/14,3.03%,FYN
prerank,lipid modification (GO:0030258),0.2979203237749,0.6707896740931354,0.8770764119601329,1.0,1.0,3/37,6.72%,PLPPR3;MBOAT2;EPHX2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.2985993532775152,0.6688223717958985,0.8498871331828443,1.0,1.0,8/33,23.72%,CYP1B1;CIB1;DPP4;TGFB2;SYK;EFNA1;PTPN11;ITGB1BP1
prerank,axon guidance (GO:0007411),0.27709849845209206,0.6687681164069804,0.975,1.0,1.0,50/201,23.65%,SPTA1;MAPK1;FYN;NTN1;EZR;PTPRA;RPS6KA5;GFRA2;LAMA5;NOTCH1;ARHGAP35;PRKCA;GRB2;PLXNA2;SOS1;PDLIM7;EPHA3;DOK2;RELN;BSG;SLIT3;SLIT1;TMEFF1;NRP1;RAC2;PALLD;GFRA1;DAG1;SPTAN1;PLCG1;PIK3CA;RAC1;EMB;CXCR4;NRXN1;SEMA4A;TUBB3;EPHA7;EPHA10;SEMA6A;ALCAM;EFNA1;PLXNC1;CNTN4;NIBAN2;PTPN11;SRC;DSCAM;SPTB;GDNF
prerank,positive regulation of response to wounding (GO:1903036),0.3137115503156348,0.6686127815457787,0.8426829268292683,1.0,1.0,2/24,8.41%,PRKCE;INSL3
prerank,regulation of cell killing (GO:0031341),0.3322866142979933,0.6683937290538479,0.833756345177665,1.0,1.0,5/16,19.23%,CR1L;TGFB2;RAC1;CYBA;CD55
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.28356065970548494,0.6683115235631863,0.8887733887733887,1.0,1.0,21/71,23.23%,MAPK1;FYN;PRKCE;CYFIP2;GRB2;PLCG2;CRK;PLD2;BRK1;ELMO2;PLCG1;PIK3CA;RAC1;FCGR2B;VAV3;SYK;FGR;ACTG1;NCKIPSD;PRKCD;SRC
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3015625455784919,0.6680912671052825,0.8537735849056604,1.0,1.0,7/28,26.92%,TRADD;DELE1;BAG3;CASP8;CRADD;CASP8AP2;GABARAP
prerank,hematopoietic stem cell proliferation (GO:0071425),0.3513320868747827,0.667771990172492,0.8417366946778712,1.0,1.0,3/11,15.02%,ETV6;ARIH2;RUNX1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.30805089675884206,0.6676652281593,0.8549346016646849,1.0,1.0,9/24,23.28%,PARK7;RACK1;USP25;UBXN1;XBP1;SYVN1;LRRK2;NR1H3;LPCAT3
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.28506206630729475,0.6669668190219099,0.899063475546306,1.0,1.0,13/65,18.37%,ITGA1;CCDC88A;SHKBP1;TGFA;GRB2;EGFR;HAP1;DGKD;EGF;HGS;RNF115;ARHGEF7;STAM
prerank,fatty acid biosynthetic process (GO:0006633),0.28464578078182123,0.666362893793095,0.896049896049896,1.0,1.0,10/63,17.11%,HACD4;ABCD1;EPHX2;CBR4;HPGD;LTA4H;ELOVL5;NDUFAB1;ELOVL4;XBP1
prerank,transcription by RNA polymerase III (GO:0006383),0.30494736835460895,0.6663004747116663,0.859122401847575,1.0,1.0,3/27,9.11%,GTF3C5;BRF1;SNAPC3
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.310720467076312,0.6659143142275443,0.8659549228944247,1.0,1.0,10/25,24.58%,DNAJC18;DNAJC7;BAG1;SDF2;DNAJB1;DNAJB4;DNAJB12;DNAJB14;HSPE1;HSPA9
prerank,SNARE complex assembly (GO:0035493),0.350954269609064,0.6656621769992497,0.8356589147286821,1.0,1.0,1/10,2.92%,STXBP6
prerank,sulfur amino acid metabolic process (GO:0000096),0.3077612053366019,0.6651065434213662,0.8495684340320592,1.0,1.0,4/24,14.34%,MSRA;DPEP1;SMS;MTR
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.34822162765107134,0.6650643965369751,0.8545454545454545,1.0,1.0,3/10,22.80%,MYC;SOX9;FGFR2
prerank,cellular glucose homeostasis (GO:0001678),0.2942204421188044,0.6649495235473148,0.8632938643702907,1.0,1.0,12/41,21.31%,NUCKS1;NR1D1;FOXO1;PRKACA;RACK1;FOXK2;SIRT1;XBP1;ADCY8;ZBTB20;PAX2;PCK2
prerank,cell projection organization (GO:0030030),0.3046122201721613,0.664801391340692,0.8731082654249127,1.0,1.0,7/30,16.84%,GSN;RHOU;PACSIN2;RAC2;PARVB;PARVA;RAC1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.35497330516899633,0.6646036249718611,0.8236994219653179,1.0,1.0,2/10,8.97%,SNX3;TERF1
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.32983277115777637,0.6645930373852632,0.8567708333333334,1.0,1.0,6/15,25.13%,PRKCA;MTPN;ROCK2;ROCK1;IL6ST;PARP1
prerank,positive regulation of type I interferon production (GO:0032481),0.2805687408234587,0.6640927243076455,0.9014373716632443,1.0,1.0,14/73,16.50%,DHX58;PTPN22;CGAS;XRCC6;RIOK3;DHX9;MYD88;TOMM70;FLOT1;PRKDC;POLR1C;CREBBP;LRRFIP1;POLR2K
prerank,dendrite self-avoidance (GO:0070593),0.32229606329005694,0.6637291841923951,0.8396349413298566,1.0,1.0,6/16,26.87%,BSG;PALLD;EMB;CNTN4;DSCAM;NPTN
prerank,response to amino acid (GO:0043200),0.2970902908045411,0.6633983583482976,0.8581005586592179,1.0,1.0,8/31,20.74%,LARS1;CPEB3;LAMTOR4;LAMTOR3;IPO5;XBP1;GLRA1;RRAGB
prerank,glutamate metabolic process (GO:0006536),0.31776851324271993,0.6633426589416579,0.8423772609819121,1.0,1.0,2/19,7.20%,GLS2;PRODH
prerank,cellular amino acid catabolic process (GO:0009063),0.27656768843327506,0.662877684095649,0.9163265306122449,1.0,1.0,9/87,15.01%,SLC25A21;HAAO;KMO;GLS2;PRODH;AUH;FAH;IVD;MCCC1
prerank,peptidyl-lysine acetylation (GO:0018394),0.3461877026007791,0.6621848809524152,0.847041847041847,1.0,1.0,3/10,16.99%,KAT2B;CREBBP;SIRT1
prerank,regulation of lamellipodium organization (GO:1902743),0.33369918571644563,0.662038834808182,0.8382352941176471,1.0,1.0,1/14,3.88%,CD44
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.27764457921210217,0.6620229501111312,0.9402228976697061,1.0,1.0,34/119,22.47%,PIGH;MTMR12;PIGF;PLEKHA2;IMPA1;PIGA;PIP5K1B;MTMR2;PLCG2;SOCS2;CDIPT;MTMR14;MTMR6;PTEN;ARF3;INPP4A;PI4K2B;TTC7A;PIGU;MTM1;RAB5A;PIK3CA;PIP4K2A;PTPN13;RUFY1;PIGM;OCRL;INPP5F;SOCS6;SOCS4;PGAP2;PLEKHA1;EFR3A;DPM2
prerank,presynaptic endocytosis (GO:0140238),0.312734043054335,0.6620150976138279,0.8694610778443114,1.0,1.0,5/24,13.20%,CEL;SYT8;STON1;CANX;STON2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.31726162049233664,0.6618907488886641,0.8417721518987342,1.0,1.0,7/17,24.35%,CARD9;PDCD10;TGFB2;ARL6IP5;TAOK1;STK25;EIF2AK2
prerank,tRNA wobble uridine modification (GO:0002098),-0.2425721644710911,-0.661070053797101,0.8976377952755905,0.967307206924666,1.0,9/14,39.27%,MTO1;DPH3;GTPBP3;TRMT9B;CTU2;TRMU;CTU1;MOCS3;KTI12
prerank,fatty acid catabolic process (GO:0009062),0.28178770944401393,0.6606193244849917,0.8955067920585162,1.0,1.0,18/67,21.93%,CEL;ACADM;ABCD1;ACBD5;NUDT19;AUH;SLC27A2;PEX2;PHYH;CPT2;HADHA;MMAA;HADHB;ABCD4;DECR1;PPARD;ABHD2;ACOT8
prerank,mitochondrion transport along microtubule (GO:0047497),0.3323529879316611,0.6605804848445255,0.8599439775910365,1.0,1.0,1/13,2.47%,UXT
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2998412734136082,0.660201204851748,0.8720657276995305,1.0,1.0,8/28,20.02%,CD47;JAK2;ADIPOR1;PRKAG2;RAC1;SIRT1;MED1;EIF6
prerank,protein heterooligomerization (GO:0051291),0.3179787426572283,0.660134414959837,0.8467635402906208,1.0,1.0,5/17,21.84%,CBR4;KCNC2;PKD2;CPSF7;MAT2A
prerank,reticulophagy (GO:0061709),-0.2547652183373005,-0.6600552527078487,0.9142857142857143,0.9670783487088169,1.0,5/12,20.62%,ULK1;UFC1;TEX264;ULK2;UBA5
prerank,polyol metabolic process (GO:0019751),0.2885893541840228,0.6598329168951939,0.8907103825136612,1.0,1.0,10/46,16.60%,IMPA1;INPP5A;PLCG2;NUDT4;PLCB1;PTEN;INPP4A;PLCB3;PLCD1;PLCG1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.27965297943592493,0.6598111455603757,0.9125514403292181,1.0,1.0,12/75,19.15%,SLC12A3;SLC12A7;SLC12A1;KCNJ3;SLC12A6;KCNJ2;SLC24A2;SLC9A9;TRPM4;KCNJ10;SLC9A6;SLC9A7
prerank,inflammatory response (GO:0006954),0.27317173972703324,0.6590245519193171,0.9769769769769769,1.0,1.0,29/195,18.01%,MEFV;LY75;IL2RA;HSPG2;CD44;CRHBP;S100A9;CCR2;IKBKG;S100A8;NFAM1;HMGB1;TPST1;IL22;HNRNPA0;TLR5;NFX1;TLR6;F2R;CYBB;TRAF3IP2;CCL25;NFATC3;RAC1;CYBA;ADCY8;FCGR2B;CXCR4;HDAC4
prerank,negative regulation of anoikis (GO:2000811),0.3239437351896167,0.6589346087359246,0.8462549277266754,1.0,1.0,2/14,7.16%,CAV1;NOTCH1
prerank,positive regulation of rRNA processing (GO:2000234),-0.2691979448835277,-0.658236099735386,0.8613861386138614,0.9676460094025021,1.0,5/10,23.07%,HEATR1;WDR75;BUD23;RIOK2;WDR43
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.3439727952179055,0.658019862780736,0.8446866485013624,1.0,1.0,3/10,17.67%,SIRT7;SDHAF3;USP7
prerank,regulation of JNK cascade (GO:0046328),0.2736038663952448,0.657874308356727,0.9300202839756593,1.0,1.0,13/101,11.66%,MEN1;ULK4;AXIN1;RASGRP1;TRAF3;MAP3K5;HMGB1;MAP4K2;EGFR;HIPK2;MAP3K11;CARD9;PLCB1
prerank,regulation of phospholipase C activity (GO:1900274),0.3197016058042354,0.6576311444582437,0.8288973384030418,1.0,1.0,4/15,22.37%,RASGRP1;FGFR1;PLCG1;NTRK3
prerank,regulation of myotube differentiation (GO:0010830),0.3023384888572817,0.6575912905922522,0.8532863849765259,1.0,1.0,10/24,26.74%,NOTCH1;MAPK14;XBP1;HDAC4;HDAC1;ATP11A;HDAC9;PIEZO1;BDNF;TMEM119
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.2845387565991382,0.6571433777150328,0.8904555314533622,1.0,1.0,9/41,22.13%,ITPR1;HTR2A;IBTK;PLCG2;F2R;SLC24A2;PKD2;GRIN2D;ATP2B4
prerank,peptide metabolic process (GO:0006518),0.2812334020795984,0.6571367323336911,0.9117341640706127,1.0,1.0,15/75,21.67%,DNPEP;RHD;CPM;DPEP1;SPCS1;LTA4H;PSEN1;PCSK1;GSTM1;CPD;SPPL3;ERAP1;MME;SPCS3;ETHE1
prerank,regulation of necroptotic process (GO:0060544),0.30545603341375666,0.6571140595296456,0.863030303030303,1.0,1.0,7/23,21.03%,BIRC2;SPATA2;FLOT1;CFLAR;FLOT2;CASP8;RIPK1
prerank,autophagy of mitochondrion (GO:0000422),0.2890024483100918,0.6570617243643254,0.8680709534368071,1.0,1.0,6/38,12.41%,ATG13;MARK2;BECN1;AMBRA1;FIS1;CTSK
prerank,cholesterol transport (GO:0030301),0.2950074257549034,0.657032588535728,0.8825466520307355,1.0,1.0,6/45,11.35%,CEL;CAV1;OSBPL5;LIMA1;ABCA7;STARD5
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.2917395069768686,0.6567899143467671,0.8707182320441988,1.0,1.0,9/37,16.53%,MEFV;ABCD1;MAPK14;IL17RA;CARD9;MYD88;TLR6;APPL1;NLRC3
prerank,negative regulation of viral process (GO:0048525),0.27882495410726194,0.6567146652095815,0.9031914893617021,1.0,1.0,12/57,18.96%,PML;SLPI;TRIM11;FAM111A;IFITM3;PPIA;TRIM5;TRIM28;SRPK1;CHMP3;HEXIM1;PROX1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3325318651884331,0.6565228846357422,0.8479452054794521,1.0,1.0,2/13,12.11%,CIAO2A;ISCA2
prerank,regulation of defense response (GO:0031347),0.27487623921953447,0.6559971093012372,0.913491246138002,1.0,1.0,14/76,13.77%,DHX58;PTPN22;FOXP1;CCR2;TRAF3;BIRC2;BRD4;JAK2;IL1R1;PARK7;XIAP;MYD88;SPATA2;BCL6
prerank,positive regulation of phosphorylation (GO:0042327),0.27234030925019326,0.65595604632054,0.985,1.0,1.0,61/240,23.46%,PECAM1;ERBB3;GLMN;CCN1;LMO4;CD74;AXIN1;BRAT1;PGF;TFRC;RASGRP1;CRKL;PIN1;NIBAN1;CIB1;ENTPD5;EGFR;EPHA3;P2RY1;WDFY2;FGF9;FLT3;FAS;LMTK2;FXR1;NRP1;ROCK2;RACK1;FLOT1;FAM20A;PSEN1;MYDGF;PPIA;RAD50;STK4;EGF;FGFR1;LIMK2;RAC1;PDE8A;SIRT1;LRRK2;ZBTB20;AKTIP;SOX9;ALK;EPHA7;DSTYK;CCND3;MET;ILK;SLCO3A1;RIPK1;EPHA10;DDR2;EFNA1;NTRK3;FGFR2;ADAM17;DSCAM;C3
prerank,hemopoiesis (GO:0030097),0.27718123936968053,0.6555982283012101,0.930161943319838,1.0,1.0,18/87,17.58%,ZFPM1;RUNX3;PRKX;ZBTB16;ETV6;KAT6A;MELK;TNFRSF13B;FLT3;KMT2A;PRRC2C;ARIH2;KIRREL3;TP53;RUNX1;ZFP36L2;TGFB2;KITLG
prerank,cell part morphogenesis (GO:0032990),0.32940999432053586,0.6552959715573397,0.8404401650618982,1.0,1.0,6/13,26.63%,FIS1;PACSIN2;MTM1;PNPT1;PID1;WASF1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.3493171709279899,0.655180455589167,0.8363636363636363,1.0,1.0,3/11,21.03%,PRKCA;CASP8;RIPK1
prerank,alanine transport (GO:0032328),-0.27094921773332903,-0.6550003737819886,0.9017543859649123,0.9693152331151199,1.0,9/10,54.15%,SLC36A4;SLC36A1;SLC7A10;SLC6A17;SLC36A2;SLC36A3;SLC6A6;SLC6A14;SLC38A3
prerank,synaptic vesicle recycling (GO:0036465),0.2995741789575072,0.6548858131555411,0.8681192660550459,1.0,1.0,8/31,17.96%,CEL;SYT8;STON1;PLD2;CANX;STON2;RAB5A;SNCA
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.1839840865421409,-0.6544591228133823,0.9666666666666667,0.9685981122170881,1.0,5/32,13.66%,LPIN1;SLC27A1;CHPT1;ABHD3;LPCAT1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.312882115756546,0.6536955796975343,0.8580562659846548,1.0,1.0,2/18,7.79%,AKT3;CIB1
prerank,inositol phosphate metabolic process (GO:0043647),0.2853520367469344,0.6531350779609905,0.8876772082878953,1.0,1.0,10/46,16.60%,IMPA1;INPP5A;PLCG2;NUDT4;PLCB1;PTEN;INPP4A;PLCB3;PLCD1;PLCG1
prerank,purine ribonucleotide catabolic process (GO:0009154),0.31184441924777856,0.6530098475693048,0.8731527093596059,1.0,1.0,3/21,9.67%,PDE2A;NUDT4;NT5C2
prerank,response to ATP (GO:0033198),0.3082214043362036,0.6529615962935473,0.8560794044665012,1.0,1.0,3/18,17.49%,TAF1;P2RY1;HSP90B1
prerank,response to copper ion (GO:0046688),0.31355164816494646,0.6529523990317441,0.8735919899874843,1.0,1.0,1/20,1.86%,AQP1
prerank,cellular response to acid chemical (GO:0071229),0.2945078317582579,0.6520890328311353,0.8710045662100456,1.0,1.0,8/27,20.74%,LARS1;CPEB3;LAMTOR4;LAMTOR3;IPO5;XBP1;GLRA1;RRAGB
prerank,endocardial cushion development (GO:0003197),0.30686407641661745,0.6519915183951336,0.8590522478736331,1.0,1.0,5/21,19.46%,MDM4;NOTCH1;BMPR1A;TGFB2;SOX9
prerank,growth hormone receptor signaling pathway (GO:0060396),0.32460422276885353,0.65198170448339,0.8388814913448736,1.0,1.0,4/14,16.74%,JAK2;SOCS2;STAT5B;JAK3
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.3302384397526704,0.6516822826641913,0.8401048492791612,1.0,1.0,5/13,22.80%,NOTCH1;PIM1;BMPR1A;RBPJ;FGFR2
prerank,cellular response to insulin stimulus (GO:0032869),0.2711313667942413,0.651602474914424,0.9515640766902119,1.0,1.0,25/124,17.73%,C2CD5;SLC2A4;USF1;FOXO1;DENND4C;SORBS1;ZFP36L1;RAB8A;GRB2;SOS1;CAV2;PDPK1;KAT2B;RAB8B;ZDHHC7;ATP6V0E1;PRKDC;IRS1;GSK3B;APPL1;ATP6AP1;CAPN10;XBP1;ATP6V0D1;EPRS1
prerank,regulation of cellular respiration (GO:0043457),0.3103315145652472,0.6510168416685846,0.8580814717477004,1.0,1.0,5/17,26.53%,NOA1;PNPT1;CBFA2T3;VCP;TRAP1
prerank,positive regulation of autophagy (GO:0010508),0.27450456921647454,0.6505616920015849,0.9079627714581179,1.0,1.0,21/81,21.01%,MEFV;STK11;IKBKG;FOXO1;HMGB1;PIM2;DCN;PARK7;ORMDL3;ATF6;TRIM68;RNF152;TRIM5;GSK3B;SIRT1;MAP3K7;LRRK2;DAPK1;SVIP;BNIP3;ROCK1
prerank,mitochondrion organization (GO:0007005),0.27219747764165947,0.6495434580772097,0.968937875751503,1.0,1.0,28/165,15.26%,PISD;PTCD2;CHCHD4;TOMM34;AGTPBP1;TSPO;AKT3;TFB1M;GABPB1;TFB2M;PITRM1;NRF1;CAV2;LONP1;TIMM9;ATP7A;PARK7;GDAP1;FIS1;TOMM70;HCFC1;HAP1;CHCHD10;TIMM23;GABPA;MPV17;ATP5F1D;MTM1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.267982827366886,0.6492874006137589,0.9729187562688064,1.0,1.0,23/151,16.86%,HTR2A;CD74;CD44;PTPN22;RASGRP1;CRKL;NOTCH1;HMGB1;CIB1;PRKCA;EGFR;P2RY1;ABCA7;CARD9;ARRB2;NRP1;ADCYAP1;F2R;TNFRSF11A;MAP2K1;ATP6AP1;CCL25;PDE8A
prerank,positive regulation of innate immune response (GO:0045089),0.29615597127287163,0.6492053759834282,0.8784722222222222,1.0,1.0,4/30,11.50%,RPS19;UBE2K;RIOK3;DHX9
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.31580947808574816,0.6491017030358169,0.8651102464332037,1.0,1.0,5/14,23.32%,FAF1;SUFU;PKD2;KEAP1;G3BP2
prerank,positive regulation of T cell activation (GO:0050870),0.27741539003764665,0.6490287879356967,0.9191176470588235,1.0,1.0,5/62,8.59%,CD47;SLC7A1;TFRC;CCR2;CYRIB
prerank,cardiac muscle contraction (GO:0060048),0.29056576376036036,0.6485757088918888,0.8675115207373272,1.0,1.0,4/34,16.81%,CSRP3;GSN;GRK2;PIK3CA
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.1974385096526524,-0.6480737233112721,0.9349112426035503,0.9726985572819067,1.0,11/24,33.65%,SRI;DMD;CALM1;JPH4;SELENON;GSTO1;FKBP1B;CAMK2D;CALM2;NOS1;JPH3
prerank,regulation of vacuole organization (GO:0044088),0.3088608171283622,0.6475969322237356,0.861850443599493,1.0,1.0,6/20,17.30%,RAB1B;ENO4;MTM1;NPRL3;RAB5A;ADPRH
prerank,regulation of adenylate cyclase activity (GO:0045761),0.30349156126875376,0.64748517501895,0.8679950186799502,1.0,1.0,2/22,5.33%,PALM;CCR2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3138703881762737,0.6474473095065593,0.8552631578947368,1.0,1.0,4/18,21.03%,EGFR;TP53;MAP2K1;RIPK1
prerank,RNA interference (GO:0016246),0.31065721402618657,0.6473622953395011,0.873202614379085,1.0,1.0,6/17,22.17%,DHX9;TARBP2;CLP1;AGO2;CELF1;AGO1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3440993957139026,0.6472661089699334,0.8615160349854227,1.0,1.0,3/10,23.16%,TGFA;EGF;ADAM17
prerank,protein glycosylation (GO:0006486),0.26959247690748006,0.6467548596225804,0.9517587939698492,1.0,1.0,20/125,16.29%,MAGT1;GALNT10;KRTCAP2;PLOD3;ALG8;MPI;STT3A;NUS1;MGAT2;ST3GAL1;ST3GAL2;ENTPD5;ST8SIA4;B3GNT2;FUT8;GFPT2;ST3GAL5;PMM2;TUSC3;POMT1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.31416923814735653,0.6465366845882143,0.8677792041078306,1.0,1.0,3/18,14.67%,BOK;CHCHD10;GSK3B
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3103106609945621,0.646415938302457,0.8717948717948718,1.0,1.0,7/22,23.10%,PPM1D;PPP2CB;PPP1CA;PPM1B;PPP2CA;DUSP16;PPM1E
prerank,regulation of interleukin-10 production (GO:0032653),0.2786801302255612,0.6463578001630682,0.8944504896626768,1.0,1.0,9/44,21.42%,CD47;HMGB1;PLCG2;PIBF1;TYROBP;JAK3;FCGR2B;LGALS9;SYK
prerank,regulation of smoothened signaling pathway (GO:0008589),0.2806744341340568,0.6461306116645388,0.8996763754045307,1.0,1.0,15/50,23.13%,TEDC2;FUZ;KCTD21;UCHL5;HHIP;RACK1;CREBBP;TUBD1;TXNDC15;SUFU;RAB34;MEGF8;FGFR2;BTRC;INTU
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.33536985864526986,0.6459483046246299,0.8602739726027397,1.0,1.0,2/12,14.90%,FGF9;ADAMTS1
prerank,stabilization of membrane potential (GO:0030322),0.31551244038790854,0.6457769819170482,0.852589641434263,1.0,1.0,4/16,16.52%,KCNN4;CHCHD10;KCNK12;KCNK2
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.2176240979860022,-0.6455670660257077,0.9292452830188679,0.9735554339869592,1.0,7/18,27.51%,RELA;GSK3A;CASP3;EPHA4;PICALM;LRRTM3;CHRNA7
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3265733349120024,0.6455341154355454,0.8569424964936886,1.0,1.0,1/13,3.12%,KRI1
prerank,intracellular lipid transport (GO:0032365),0.3109523236138034,0.6453722274638107,0.8549810844892812,1.0,1.0,6/21,18.82%,ABCD1;CPT1B;CPT1A;PRKAG2;CPT2;ABCD4
prerank,regulation of autophagy (GO:0010506),0.2700928672985407,0.6453438531248876,0.981,1.0,1.0,50/216,21.21%,DAP;MEFV;ATG13;DAPK2;ITPR1;PTPN22;STK11;EXOC4;FOXO1;ATM;HDAC6;HMGB1;PIM2;BOK;DCN;RAB8A;PRKACA;UBQLN1;TAB3;CAPN1;ORMDL3;ATF6;MLST8;IL10RA;TRIM68;RNF152;ATP6V0E1;PRKAG2;DDIT3;LAMTOR4;TRIM5;GSK3B;LAMTOR3;ATG101;FOXK2;KLHL22;PIP4K2A;ATP6V0D1;LRRK2;SREBF2;DAPK1;SVIP;KEAP1;MET;RRAGB;BNIP3;PRKAG1;ROCK1;MAPT;GAPDH
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.31312583578868325,0.6450419787198408,0.879950495049505,1.0,1.0,5/18,26.51%,CRHBP;IRS1;SIRT4;PSMD9;KCNB1
prerank,regulation of supramolecular fiber organization (GO:1902903),0.3038532847618844,0.6449266116412289,0.8817073170731707,1.0,1.0,8/22,24.16%,GBA2;MAPRE3;PARK7;EFEMP2;PIK3CA;MAPT;CAMSAP1;AKAP13
prerank,axonal fasciculation (GO:0007413),0.3277701181639568,0.6448246232067673,0.8497191011235955,1.0,1.0,5/12,22.58%,ARHGAP35;EPHA3;NRCAM;MEGF8;CNTN4
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.27336148334140514,-0.6448234862030987,0.8859934853420195,0.9730061447434162,1.0,5/10,22.48%,ATRAID;EPHA4;DAB2IP;ANXA2;RGP1
prerank,glial cell development (GO:0021782),0.2929293838427926,0.6445181217951512,0.8495260663507109,1.0,1.0,3/25,8.52%,S100A9;CDK6;PICK1
prerank,vitamin transport (GO:0051180),0.2988821012272157,0.6444408380306691,0.8903301886792453,1.0,1.0,3/29,11.20%,SLC2A8;SLC52A1;SLC19A1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.31008019831817585,0.6442960465731745,0.8840764331210191,1.0,1.0,5/19,17.73%,MPI;UAP1;GFPT2;PMM2;UAP1L1
prerank,response to peptide (GO:1901652),0.2847484235759096,0.6437873648969585,0.8840413318025259,1.0,1.0,7/33,20.91%,FYN;GNAI1;STAT5B;IRS1;CACNA1B;MMP12;EIF2B5
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.27659389964479997,0.6434972731270638,0.9243697478991597,1.0,1.0,12/65,17.62%,VASN;CAV1;PMEPA1;PIN1;ZBTB7A;PDPK1;SNX25;BCL9L;SPRED2;SKI;SIRT1;UBA52
prerank,Rac protein signal transduction (GO:0016601),0.30994915490777103,0.6433612979651047,0.8608247422680413,1.0,1.0,5/18,16.84%,TIAM1;DBNL;RAC2;BRK1;RAC1
prerank,acyl-CoA metabolic process (GO:0006637),0.28601556067975215,0.6424301054316771,0.8725824800910125,1.0,1.0,3/35,8.72%,ACOT11;ACOT13;ACOT2
prerank,sulfation (GO:0051923),-0.2509225420781681,-0.6421484563625376,0.8844765342960289,0.974039239817475,1.0,4/11,31.33%,UST;HS3ST5;SULT1A1;SULT4A1
prerank,polarized epithelial cell differentiation (GO:0030859),0.32787473590245503,0.6414651171324443,0.8704735376044568,1.0,1.0,3/13,13.19%,EZR;MSN;ZDHHC7
prerank,regulation of ion transport (GO:0043269),0.2706706208989045,0.6408563516118014,0.9252049180327869,1.0,1.0,12/76,14.41%,NKAIN4;SYT8;YWHAH;NEDD4L;KCNJ3;TOR1A;B2M;SYT3;RAB11B;NKAIN3;KCNJ2;DTNBP1
prerank,phospholipid metabolic process (GO:0006644),0.2751127775915303,0.6406706182236995,0.9357512953367876,1.0,1.0,9/71,15.08%,PLPPR3;AGPAT1;AGPAT4;PCYT2;ABCA2;AGPAT3;PLBD1;PLCD1;PLPPR4
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.29901830938548923,0.6405958238746348,0.8626716604244694,1.0,1.0,9/23,26.35%,JAK2;PARP14;SUMO1;PIAS1;NR1H3;IFNGR1;NR1H2;PARP9;JAK1
prerank,regulation of axon regeneration (GO:0048679),-0.25129670468888504,-0.6405308049256131,0.9157894736842105,0.9741682367191368,1.0,2/12,4.61%,GRN;PTPRS
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.28110174496381635,0.6403378455924317,0.8807649043869517,1.0,1.0,10/36,17.67%,PSMF1;DDRGK1;PARK7;CCAR2;UCHL5;TAF9;USP25;UBXN1;CAMLG;USP7
prerank,positive regulation of exocytosis (GO:0045921),0.2875372170164449,0.6401551273451742,0.8792325056433409,1.0,1.0,11/35,24.50%,CLASP1;HGS;ATP6AP1;RAB5A;SNCA;STAM;RAB27A;VPS4A;RAB27B;RAB9A;TSG101
prerank,regulation of actomyosin structure organization (GO:0110020),0.32237488707324763,0.6396087710501464,0.868,1.0,1.0,7/13,24.16%,ALMS1;ROCK2;RAC1;PTGER4;ROCK1;ACTG1;AKAP13
prerank,positive regulation of heart contraction (GO:0045823),-0.21093428482690646,-0.6393404862452454,0.949438202247191,0.9738949201538311,1.0,5/19,21.85%,RYR2;GSK3A;ADRA1A;ATP1A2;SCN3B
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2716433270058415,0.6384015983385155,0.9117647058823529,1.0,1.0,16/54,23.79%,RPL7;RPL14;RPL23A;RPLP0;WDR74;NSA2;RPL3;PES1;RPL5;EIF6;RSL24D1;RPL24;RPL10;RPF1;NPM1;MRPL20
prerank,regulation of protein secretion (GO:0050708),0.2621201469346678,0.637869063282243,0.9574036511156186,1.0,1.0,10/119,11.62%,IL12A;ITPR1;EZR;MYOM1;PRKCA;PICK1;MYH10;KCNC2;EIPR1;DPP4
prerank,protein localization to plasma membrane (GO:0072659),0.2659818100288705,0.6377901472085149,0.966933867735471,1.0,1.0,19/129,13.74%,C2CD5;RAMP1;CCDC88A;FLNA;EZR;ANK1;DENND4C;RAB8A;TSPAN33;P2RY1;ACTN2;BSG;RDX;RAB8B;PRAM1;ROCK2;FGF13;FLOT1;TTC7A
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.28432241733835484,0.6375892948647864,0.8862343572241184,1.0,1.0,3/31,7.73%,TWIST1;EIF4A3;FUZ
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3339662303044979,0.637541264014597,0.8502906976744186,1.0,1.0,4/10,19.73%,PARP14;PIBF1;INPP5F;PPP2CA
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.31981442523278164,0.6371807343599181,0.8887434554973822,1.0,1.0,4/15,20.36%,NOTCH1;SMOC2;PRKD2;MET
prerank,positive regulation of T cell proliferation (GO:0042102),0.2694813035183986,0.636755769993426,0.9103375527426161,1.0,1.0,4/55,7.33%,SLC7A1;TFRC;CCR2;HMGB1
prerank,negative regulation of cell motility (GO:2000146),0.2673951632428322,0.6362773189132171,0.9545454545454546,1.0,1.0,17/108,16.26%,CYP1B1;STK26;CD74;ARID2;DACH1;DPEP1;PIN1;FUZ;STK24;ZMYND8;CRK;PTEN;SLURP1;RNF20;DAG1;PTPRU;DUSP22
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3272079635253729,0.6362452964505187,0.8631284916201117,1.0,1.0,4/11,22.17%,TNRC6C;AGO2;EIF6;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3272079635253729,0.6362452964505187,0.8631284916201117,1.0,1.0,4/11,22.17%,TNRC6C;AGO2;EIF6;AGO1
prerank,regulation of histone deacetylation (GO:0031063),0.3251239480831456,0.6361657063712673,0.8709239130434783,1.0,1.0,3/13,13.56%,ZBTB7B;ING2;NIPBL
prerank,neuron projection morphogenesis (GO:0048812),0.26253933119881956,0.6361291357661342,0.9618856569709128,1.0,1.0,29/137,23.20%,KIF20B;NTF4;LRP4;RAB8A;DBNL;NTNG2;ATP7A;PTEN;LMTK2;NRCAM;DTNBP1;PLPPR4;CTNND2;SDC2;LRRK2;IQGAP1;TAOK1;SLC9A6;PAX2;SLITRK2;ROCK1;NEFH;BRSK1;ALCAM;CNTN4;S100A6;FGFR2;RAB10;DOCK10
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.28049937824224663,0.6354544162422449,0.9005464480874317,1.0,1.0,10/43,20.24%,ITGA1;TGFA;GRB2;EGFR;EGF;HGS;RNF115;ARHGEF7;STAM;SOCS4
prerank,cellular metal ion homeostasis (GO:0006875),0.266718166270276,0.6354118294586485,0.9585439838220424,1.0,1.0,7/102,8.25%,TMPRSS3;HTR2A;CSRP3;CAV1;CCR2;NEDD4L;SLC10A7
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.29914703148766436,0.6346926219016634,0.8709677419354839,1.0,1.0,10/18,29.22%,JAK2;SMAD4;PTPN11;SRC;IL6ST;CBL;JAK1;ST18;CEBPA;IL6R
prerank,oligodendrocyte differentiation (GO:0048709),0.2988170889287754,0.634376891362601,0.8564102564102564,1.0,1.0,1/19,1.98%,SOX6
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.2634841412377253,0.6343638883318723,0.9385245901639344,1.0,1.0,29/88,25.57%,HDAC6;EIF4A3;CPEB3;TYMS;IGF2BP3;CDK5RAP3;FXR1;NELL1;RACK1;LSM14A;CNOT1;SAMD4A;EPRS1;EIF4ENIF1;CLN3;RPS3;DAPK1;CNOT8;SYNCRIP;CNOT7;GAPDH;RPL13A;EIF4E2;YBX1;NCL;DAPK3;EIF2AK2;GIGYF2;CST3
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.19770013284846416,-0.6339915235254518,0.9523809523809523,0.9765839812432993,1.0,7/23,26.87%,CALM1;METAP1;CAMKMT;NMT1;FNTB;SAG;GUCA1B
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2913934603843495,0.6336694781985629,0.882282996432818,1.0,1.0,4/25,13.27%,CCDC88A;SHKBP1;HAP1;DGKD
prerank,ureteric bud development (GO:0001657),-0.22351315152316886,-0.6327763204858724,0.9380530973451328,0.9763170125645663,1.0,2/17,10.63%,SALL1;GPC3
prerank,integrin-mediated signaling pathway (GO:0007229),0.26723916797086456,0.6327292636158925,0.9302083333333333,1.0,1.0,20/73,23.72%,ITGB7;CD47;PTPRA;NEDD9;LAMA5;CCM2;ITGAV;CUL3;PRAM1;NRP1;ADAMTS1;FN1;ADAM10;ZYX;ILK;SYK;FGR;SRC;MYH9;ITGB1BP1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.28135961156573047,0.6323329548944356,0.8945005611672279,1.0,1.0,6/33,16.81%,ERBB3;HTR2A;ZFP36L1;PTEN;IRS1;PIK3CA
prerank,response to interferon-alpha (GO:0035455),-0.22489402853273616,-0.6320431039658561,0.943127962085308,0.9756905620104537,1.0,5/16,18.05%,ADAR;BST2;AXL;RO60;IFNAR1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.2802093967731273,0.6318486332211909,0.9091954022988505,1.0,1.0,5/35,11.83%,ACSS3;CBR4;HPGD;BDH1;FASN
prerank,regulation of osteoblast proliferation (GO:0033688),0.3087307047476551,0.631408356444882,0.876117496807152,1.0,1.0,2/17,12.88%,CCN1;NELL1
prerank,cellular response to superoxide (GO:0071451),-0.2640667213084926,-0.6310538788030859,0.8980263157894737,0.9753137545815601,1.0,4/10,26.35%,ADPRS;PRDX2;MT3;SOD2
prerank,regulation of cell junction assembly (GO:1901888),0.28949369769947614,0.6306469056468685,0.884125144843569,1.0,1.0,8/27,22.68%,PRKACA;CBFB;ROCK2;FLOT1;RUNX1;PDLIM5;ROCK1;SETD5
prerank,integrated stress response signaling (GO:0140467),0.31827832131360373,0.6306298272842682,0.8560105680317041,1.0,1.0,3/14,13.59%,EIF2S1;NFE2L2;DDIT3
prerank,regulation of transforming growth factor beta production (GO:0071634),0.30511727879187234,0.6304574558318597,0.8808618504435995,1.0,1.0,5/18,19.34%,ITGAV;SMAD4;TGFB2;FN1;LGALS9
prerank,cellular response to estrogen stimulus (GO:0071391),0.3137360461646476,0.6300596990436399,0.8600823045267489,1.0,1.0,2/14,11.74%,CRHBP;PELP1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2797850077223528,0.6300321097636368,0.891832229580574,1.0,1.0,9/38,19.11%,NDUFS8;NDUFB7;NDUFAF1;NDUFA1;NDUFA4;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.21527809610307191,-0.6297451849073868,0.9521739130434783,0.9750221332249266,1.0,9/16,43.32%,IGF1;IGFBP4;IGFBP6;IGFBP3;BMP5;PHIP;BMP2;IGFBP5;CDH3
prerank,bile acid metabolic process (GO:0008206),0.2927358227147134,0.6296011901177663,0.8791866028708134,1.0,1.0,5/27,12.06%,GBA2;OSBPL3;CYP27A1;SLC27A2;CYP46A1
prerank,response to UV-A (GO:0070141),0.3093010089333811,0.629512482068267,0.8677248677248677,1.0,1.0,2/14,19.95%,EGFR;MME
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.2872947673438269,0.6287105194855762,0.8877314814814815,1.0,1.0,3/31,11.40%,CACNA1I;SYT8;SYT3
prerank,protein localization to cell periphery (GO:1990778),0.26144895175026955,0.62843249418856,0.9749247743229689,1.0,1.0,19/133,13.74%,C2CD5;RAMP1;FLNA;EZR;CAV1;ANK1;DENND4C;RAB8A;TSPAN33;P2RY1;ACTN2;BSG;RDX;RAB8B;PRAM1;ROCK2;FGF13;FLOT1;TTC7A
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2626686654407109,0.6277995647282837,0.9358841778697001,1.0,1.0,19/76,22.66%,EZR;PTPN22;TRADD;EGFR;TRIM44;ADIPOR1;ACTN4;UACA;LIMS1;NLRC3;PPM1B;RPS3;IFI35;LGALS9;TRAF6;ILK;SASH1;RTKN2;PHB2
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.2798754776874814,0.6276754016641897,0.9071274298056156,1.0,1.0,6/43,12.88%,FBXO5;CCN1;CCN4;LRP3;BMPR1A;NELL1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.30909734985156784,0.6275500617407525,0.865047233468286,1.0,1.0,1/14,10.78%,PARK7
prerank,histone H4 deacetylation (GO:0070933),0.3294891954715417,0.6274308077638705,0.868421052631579,1.0,1.0,5/10,22.40%,HDAC4;HDAC1;HDAC8;SMARCAD1;HDAC9
prerank,negative regulation of angiogenesis (GO:0016525),0.2637398079021998,0.6273933903537255,0.9547790339157246,1.0,1.0,17/84,22.88%,E2F2;HSPG2;PML;CCR2;DCN;MECP2;ROCK2;ADAMTS1;HGS;TGFB2;PGK1;ROCK1;SEMA6A;ATP2B4;AGO1;NIBAN2;APOH
prerank,central nervous system development (GO:0007417),0.2583840634797922,0.6270050817859228,0.989,1.0,1.0,44/250,20.38%,VAX2;CDK5RAP2;NR4A2;SOX6;PBX4;HSPG2;UTP3;LIG4;ANKLE2;PBX3;HAPLN2;GSN;GBA2;SHROOM2;ZBTB16;SHROOM4;SZT2;DNER;RELN;RPS6KA6;PTEN;CDK5RAP3;HAP1;SMG9;MDGA1;NRCAM;NIPBL;POU6F1;ADGRL3;PBX2;JARID2;COL4A1;PHGDH;CXCR4;SLC2A1;PROX1;ELP3;SOX9;NPAS2;NCOA6;AFF2;PKD2;EPHA7;NHEJ1
prerank,positive regulation of potassium ion transport (GO:0043268),0.2766090646853642,0.6269908297890484,0.9089900110987791,1.0,1.0,5/38,13.04%,FLNA;KCNN4;KCNJ3;ACTN2;KCNJ2
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2758466607997951,0.6266895421289492,0.9081746920492721,1.0,1.0,10/39,20.66%,RCN3;ARFGAP3;RAB8A;MIA2;RAB8B;CANX;STEAP3;PPY;GOLPH3;TVP23A
prerank,positive regulation of biomineral tissue development (GO:0070169),0.2805972697245474,0.6264390090852676,0.9087875417130145,1.0,1.0,6/40,17.56%,FBXO5;CCN1;BMPR1A;NELL1;ADGRV1;ANO6
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.30503558256961416,0.6254205667891009,0.8772845953002611,1.0,1.0,2/17,9.80%,BACH2;BTN3A3
prerank,fatty acid oxidation (GO:0019395),0.2664331910807934,0.6253026021468026,0.9183457051961824,1.0,1.0,13/57,20.70%,ACADM;ABCD1;AUH;SLC27A2;PEX2;ADIPOR1;PHYH;CPT2;HADHA;HADHB;ABCD4;DECR1;PPARD
prerank,monocarboxylic acid metabolic process (GO:0032787),0.257492331029437,0.6251636874066101,0.9563894523326572,1.0,1.0,15/117,15.01%,PANK2;ACOT11;PDHA1;CPT1B;GBA2;SLC16A1;ACOT2;ME3;DLAT;ALKBH7;BSG;FASN;CPT1A;GLO1;MCCC1
prerank,regulation of mitochondrial translation (GO:0070129),0.29449908836992134,0.6242986985021641,0.8892988929889298,1.0,1.0,4/21,16.62%,MPV17L2;MTG2;NSUN3;TRUB2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2645898610374773,0.6242720070841321,0.9460020768431984,1.0,1.0,14/69,20.39%,SDHD;NDUFS8;COA6;NDUFB7;NDUFAF1;COX10;COX4I1;NDUFA1;NDUFA4;NDUFAB1;NDUFA5;NDUFS1;NDUFS5;UQCRH
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2585180763615894,0.622603893006727,0.9708835341365462,1.0,1.0,29/151,21.10%,RHD;SGMS2;ALAS2;HACD4;CHKB;PRKD3;CSNK1G2;ST3GAL2;NMRAL1;VAPA;SLC44A1;CERS4;SGMS1;ELOVL5;PCSK1;ASL;GPHN;ASS1;GSTM1;CERS6;ELOVL4;ACER3;CERS2;GOLPH3;PRKD2;SLC44A2;GCNT1;CHKA;MGST3
prerank,sphingolipid biosynthetic process (GO:0030148),0.26391538982939455,0.6225615148646124,0.9267285861713106,1.0,1.0,12/71,16.54%,SGMS2;HACD4;PRKD3;CSNK1G2;VAPA;CERS4;SGMS1;ELOVL5;ST3GAL5;CERS6;ELOVL4;ACER3
prerank,cardiac myofibril assembly (GO:0055003),0.30595327384643295,0.6221913149395569,0.8727506426735219,1.0,1.0,1/15,3.66%,CSRP3
prerank,lipid homeostasis (GO:0055088),0.2673340930909829,0.6218868411142158,0.9227513227513228,1.0,1.0,6/57,10.96%,RCN3;USF1;POLD1;ABCD1;ABCA2;ORMDL3
prerank,regulation of protein localization to membrane (GO:1905475),0.2849307932684949,0.6212894013736383,0.8980070339976554,1.0,1.0,7/28,21.16%,FYN;GSN;ZDHHC7;APPL1;LDLRAP1;CLN3;VPS4A
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2165330272733586,-0.6212042740031227,0.9514563106796117,0.9795615749424202,1.0,10/16,39.68%,PPAT;LHPP;AMPD2;GART;NUDT2;AMPD3;ADSS1;ADSS2;IMPDH1;ATIC
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.2951927473088814,0.6207335113883724,0.8787878787878788,1.0,1.0,3/20,9.58%,CCT2;NDUFAF1;LONP1
prerank,cellular response to lipid (GO:0071396),0.25679642572059996,0.6205345890813272,0.986986986986987,1.0,1.0,16/191,10.64%,GFI1;HMGB2;AQP1;CRHBP;MAP4K1;NR1D1;ATM;SETX;HMGB1;AHR;GNAI1;MAPK14;EGFR;EPHA3;MSN;RUVBL2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.30304042290512084,0.6204072275910055,0.889920424403183,1.0,1.0,1/15,3.12%,TIAM1
prerank,relaxation of muscle (GO:0090075),0.3145388827225376,0.6195077273579874,0.886058981233244,1.0,1.0,3/13,16.81%,GSN;KCNJ2;PIK3CA
prerank,positive regulation of protein polymerization (GO:0032273),0.2595125007293842,0.6191571066580114,0.927536231884058,1.0,1.0,14/65,21.89%,CDK5RAP2;PRKCE;CLASP1;SNX9;SLAIN2;CDC42EP3;NUMA1;RAC1;DRG1;CDC42EP1;RPS3;MET;MAPT;DCTN1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2577751049023432,0.6189908045090388,0.961577350859454,1.0,1.0,21/112,17.74%,SOX6;ARHGEF18;CRKL;COL1A2;ZFP36L1;PDE2A;HPGD;SMAD4;JUN;ARRB2;BMPR1A;SKI;USP15;LIMS1;APPL1;ZFP36L2;TGFB2;DUSP22;SIRT1;UBA52;MAP3K7
prerank,protein kinase B signaling (GO:0043491),0.28949032831675947,0.6174430885784482,0.8897058823529411,1.0,1.0,3/23,11.97%,SETX;ZFP36L1;PTEN
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.25819101235425934,0.6171272197995658,0.9482758620689655,1.0,1.0,6/95,8.59%,GFI1;HMGB2;NR1D1;HMGB1;MAPK14;CYRIB
prerank,peptidyl-lysine trimethylation (GO:0018023),0.2814536569674987,0.6170422857190501,0.8939759036144578,1.0,1.0,3/26,12.75%,SUV39H1;KMT5C;KMT2A
prerank,regulated exocytosis (GO:0045055),0.25585460129608356,0.6170410443917074,0.984,1.0,1.0,38/173,23.98%,BLK;F5;PECAM1;FLNA;CRHBP;SYT8;PHACTR2;CYRIB;ACTN2;APOOL;SYT3;BRPF3;ABCC4;OLA1;RAB11B;STEAP2;ACTN4;EGF;TGFB2;SCG3;FN1;F13A1;SNCA;NHLRC2;TAGLN2;ENDOD1;SYT2;RIMS3;TMED10;STXBP2;RAB27B;ACTN1;APOH;VCL;RAB10;DNAJC5;MYH9;ARHGAP17
prerank,regulation of axon guidance (GO:1902667),0.3282284706303338,0.6166661235977657,0.8907801418439716,1.0,1.0,2/10,12.89%,ZSWIM4;NRP1
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.23877973761847968,-0.6165382708484354,0.9342560553633218,0.9813476212248734,1.0,11/11,76.14%,CRY1;EP300;C1QTNF3;C1QTNF12;MST1;ERFE;ADIPOQ;SIK1;GCK;CLK2;PGP
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.2938242840747611,0.6164266961589372,0.8824273072060683,1.0,1.0,4/18,19.93%,RPS6KA5;RELN;ADCY8;PRKD2
prerank,regulation of cell communication (GO:0010646),0.27165767577806516,0.6149917550765328,0.9240362811791383,1.0,1.0,9/35,22.36%,GRK6;SOCS2;CRK;GRK2;NCLN;GRK3;CDC42SE2;IGFBP7;YWHAG
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.1857797783588811,-0.6143544837155838,0.9739130434782609,0.9815393868651208,1.0,8/31,19.85%,OPTN;ERN1;TM7SF3;PRKN;ATXN3;HSPA5;DAB2IP;HSPA13
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.28090197046378873,0.613911087702528,0.8953068592057761,1.0,1.0,8/23,26.06%,UBA52;DDB2;COPS3;COPS2;COPS4;XPA;PARP1;RBX1
prerank,mesoderm formation (GO:0001707),-0.21342443267214445,-0.6136473746093484,0.9619047619047619,0.9808155816504182,1.0,7/17,37.40%,BMPR2;ITGB3;KDM6B;ITGB4;ITGA3;ITGB1;SCX
prerank,lung development (GO:0030324),-0.17836708078003463,-0.6135444991486853,0.9652173913043478,0.9797814263081694,1.0,19/33,38.55%,PKD1;BAG6;NPHP3;VEGFA;FGF2;LOXL3;SOX11;CCDC39;RBP4;PDPN;ERRFI1;ITGA3;ABCA3;CCDC40;GLI2;FOXJ1;WNT7B;FGF7;BMP4
prerank,synapse assembly (GO:0007416),0.26070818153089753,0.6132692645018845,0.9360824742268041,1.0,1.0,9/67,14.92%,SDK1;DBNL;DNER;PTEN;FGF13;NRCAM;ADGRL3;KIRREL3;NRXN2
prerank,urogenital system development (GO:0001655),0.3144622831114125,0.6131070061948837,0.9070735090152566,1.0,1.0,4/11,25.16%,PAX2;SOX9;OSR1;AMH
prerank,ethanol metabolic process (GO:0006067),-0.24005021971123666,-0.6128416607740594,0.935251798561151,0.9790813155105814,1.0,12/12,76.02%,ALDH1A1;SULT1A1;ALDH1B1;SULT2A1;SULT1C4;ADH7;ADH1A;ADH4;ACSS2;ACSS1;ALDH2;ADH5
prerank,positive regulation of type 2 immune response (GO:0002830),0.3051254778975792,0.6128219723415103,0.8802153432032301,1.0,1.0,2/14,12.51%,CD74;DENND1B
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.1898360449776996,-0.6122769083446307,0.9702380952380952,0.9783175036002757,1.0,23/23,81.05%,SMAD7;ID2;TGFBR3;DSG2;PKP2;MYL2;MYBPC3;ISL1;TNNC1;TNNI3;TNNT2;MYH6;MYL3;IRX3;MYH7;TBX5;TPM1;TGFB1;ADAMTS9;FKBP1A;FGFR2;HOPX;PROX1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.27821686450061905,0.6122273135007711,0.8912280701754386,1.0,1.0,6/28,17.50%,GBA2;ARHGAP35;DBNL;LATS1;BRK1;HCLS1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.27328087903796894,0.6119889252243141,0.9098173515981736,1.0,1.0,8/29,23.18%,CLASP1;CYRIB;LIMA1;SMAD4;PIK3CA;SSH2;TWF1;PRKCD
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.19817089034183671,-0.6119669921048918,0.975609756097561,0.9774216663646537,1.0,8/23,35.62%,GSK3A;TIGAR;PLEK;CRY1;GIT1;PFKFB1;EP300;C1QTNF3
prerank,histone lysine demethylation (GO:0070076),0.28759363574884755,0.6118084668068734,0.882147024504084,1.0,1.0,3/25,7.99%,RIOX1;KDM3B;PHF2
prerank,cellular response to interferon-beta (GO:0035458),-0.229123346951747,-0.6113829846369627,0.9310344827586207,0.9766964771932831,1.0,3/14,9.38%,IRF1;IRGM;HTRA2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.26128636988625104,0.6113004742079211,0.9396825396825397,1.0,1.0,8/64,9.25%,SLK;PTPRA;PLEKHA2;CDK6;CDKN2A;CLASP1;CIB1;EPHA3
prerank,response to glucose (GO:0009749),0.26737053536578836,0.6112056432925782,0.9286486486486486,1.0,1.0,10/46,21.31%,NKX6-1;PRKACA;RACK1;TCF7L2;XBP1;ADCY8;ZBTB20;PAX2;EIF2B5;PCK2
prerank,positive regulation of cell killing (GO:0031343),-0.22226073035174654,-0.6109776943253576,0.9473684210526315,0.9758327992525315,1.0,6/13,31.62%,NOX1;MAPK8;DVL2;NOXO1;FZD7;WNT5A
prerank,visual perception (GO:0007601),0.26019057526488515,0.6105152859635884,0.9633774160732451,1.0,1.0,8/84,14.82%,CRYBG3;CRYBA1;EYA3;RP2;CEP250;ATF6;RDH10;ADGRV1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.2809667929935281,0.6104491336647427,0.9014251781472684,1.0,1.0,2/26,5.10%,ZFPM1;CDK6
prerank,aminoglycan biosynthetic process (GO:0006023),0.2663437324849158,0.6096552992960937,0.9253246753246753,1.0,1.0,5/49,9.85%,HSPG2;HAS1;EXT1;SLC35D2;B3GNT2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.31998039541169343,0.6092567029184879,0.8866279069767442,1.0,1.0,4/10,25.72%,ABCD1;ELOVL5;NR1H3;NR1H2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.3110587191692493,0.6091964079113146,0.8908045977011494,1.0,1.0,2/12,11.97%,ARHGAP35;PTEN
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.26252332988940597,0.6091441425783718,0.9164021164021164,1.0,1.0,12/56,19.11%,NDUFS8;NDUFAF8;NDUFB7;NDUFAF1;NDUFAF7;NDUFA1;NDUFAF5;FOXRED1;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.26252332988940597,0.6091441425783718,0.9164021164021164,1.0,1.0,12/56,19.11%,NDUFS8;NDUFAF8;NDUFB7;NDUFAF1;NDUFAF7;NDUFA1;NDUFAF5;FOXRED1;NDUFAB1;NDUFA5;NDUFS1;NDUFS5
prerank,respiratory system development (GO:0060541),0.2725756222422286,0.6081713819283852,0.9158134243458476,1.0,1.0,3/32,11.49%,SMCHD1;SPEF2;FGF9
prerank,regulation of innate immune response (GO:0045088),0.25916242775152554,0.6073501203780697,0.9294736842105263,1.0,1.0,19/57,24.37%,DHX58;PTPN22;BIRC2;RIOK3;XIAP;DHX9;APPL1;NLRC3;TRAFD1;FCGR2B;ERAP1;IFI35;CASP8;POLR3B;FGR;AKIRIN2;PTPN11;ABCE1;SAMHD1
prerank,negative regulation of blood pressure (GO:0045776),-0.23316524727173285,-0.6067356909942643,0.9602888086642599,0.97709861308201,1.0,1/13,3.12%,BMPR2
prerank,inorganic cation transmembrane transport (GO:0098662),0.25282848411210324,0.6065903119661229,0.992,1.0,1.0,36/268,20.02%,RHAG;SLC6A12;SLC12A3;RHD;SLC6A2;SLC6A5;HCN3;KCNN4;SLC12A1;TRPM7;ITGAV;KCNA1;UCP2;KCNC2;KCNH7;KCNJ2;ATP6V0E1;KCNK12;SLC9A8;HVCN1;SLC24A4;SLC24A2;SLC9A9;KCNK2;TRPM4;ATP6V0D1;ANO6;SLC30A5;KCNQ5;ATP5F1B;KCNJ10;SLC9A6;SLC9A7;SLC30A6;PKD2;KCNC1
prerank,ribosomal large subunit assembly (GO:0000027),0.28206006626125824,0.606475889869428,0.9082007343941249,1.0,1.0,9/24,23.84%,RPL23A;RPLP0;RPL3;RPL5;RSL24D1;RPL24;RPL10;MRPL20;DDX28
prerank,peptidyl-glutamic acid modification (GO:0018200),0.2814863063435642,0.6063474059071288,0.896551724137931,1.0,1.0,8/24,25.13%,AGTPBP1;TTLL1;TTLL9;TTLL5;TTLL10;TTLL11;TTLL4;PARP1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.31887895371674635,0.6062494017251896,0.894356005788712,1.0,1.0,4/10,27.47%,FTO;ALKBH5;ASCC3;MGMT
prerank,DNA dealkylation (GO:0035510),0.31887895371674635,0.6062494017251896,0.894356005788712,1.0,1.0,4/10,27.47%,FTO;ALKBH5;ASCC3;MGMT
prerank,epithelial cell morphogenesis (GO:0003382),0.29309080411185817,0.6061846674464612,0.8918918918918919,1.0,1.0,1/17,6.11%,CCDC88C
prerank,superoxide anion generation (GO:0042554),0.30890576223620625,0.6057089980725664,0.8660220994475138,1.0,1.0,3/13,19.32%,CYBB;CYBA;NCF4
prerank,positive regulation of secretion by cell (GO:1903532),0.2598856720567421,0.6057015891291017,0.9447340980187695,1.0,1.0,17/70,22.91%,EZR;CLASP1;MYOM1;MYH10;GRK2;BAIAP3;PPIA;DTNBP1;TGFB2;ATP6AP1;RAB5A;SNCA;GOLPH3;RAB27A;TMED10;RAB27B;RAB9A
prerank,macroautophagy (GO:0016236),0.25301614779725173,0.6048736566691176,0.969758064516129,1.0,1.0,30/118,21.42%,ATG13;STX17;HDAC10;ACBD5;LIX1;UBQLN1;ATG4B;VPS16;BECN1;MTMR14;AMBRA1;TOMM70;PRKAG2;VPS33B;RUBCNL;DYNLL1;HGS;ATG101;YOD1;CHMP3;PIP4K2A;CHMP2B;EPG5;VTA1;STAM;CLN3;PLEKHM1;PRKAG1;VPS4A;NBR1
prerank,lipoxygenase pathway (GO:0019372),0.29705896372819895,0.6045143078032141,0.8726541554959786,1.0,1.0,3/14,20.58%,HPGD;PON3;PON2
prerank,phosphatidylserine metabolic process (GO:0006658),0.27232584522421965,0.6041894537614616,0.9157043879907621,1.0,1.0,3/32,6.63%,SERINC5;OSBPL5;MBOAT2
prerank,neuron cell-cell adhesion (GO:0007158),0.2948281577371555,0.6041743881876233,0.904635761589404,1.0,1.0,6/14,27.45%,CEL;NRXN2;NRXN1;CNTN4;NLGN2;NLGN1
prerank,regulation of TORC1 signaling (GO:1903432),0.26799232569244386,0.603823269315673,0.9141242937853107,1.0,1.0,5/33,12.63%,STK11;ATM;LARS1;SZT2;RNF152
prerank,hemidesmosome assembly (GO:0031581),0.31309460117039317,0.6024031168328626,0.9125925925925926,1.0,1.0,2/11,8.65%,LAMC1;LAMB3
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.29117485450815145,0.6019628634060813,0.908974358974359,1.0,1.0,4/17,16.99%,UBQLN1;NFE2L2;PPIA;SIRT1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.28077156099466727,0.6015006635086322,0.9130434782608695,1.0,1.0,7/25,17.16%,ZNF326;CCAR2;CCNT1;THOC5;CCNK;SCAF8;DDX39B
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.22720669170719576,-0.6008942070010669,0.924901185770751,0.979163762138922,1.0,1/12,6.25%,ZC3H12A
prerank,long-chain fatty acid transport (GO:0015909),0.27429732349195024,0.6004502956829331,0.9320843091334895,1.0,1.0,6/30,15.07%,ABCD1;CPT1B;SLC27A2;CPT1A;PRKAG2;CPT2
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.21911779719447966,-0.5999014093523982,0.9529914529914529,0.9785462517374339,1.0,5/15,26.18%,ERN1;TSEN15;RTRAF;FAM98B;DDX1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.3134929584970725,0.5996569441113038,0.8851540616246498,1.0,1.0,2/11,15.92%,RIN3;SLAMF8
prerank,relaxation of cardiac muscle (GO:0055119),0.30363148115337263,0.5994698937216565,0.9018817204301075,1.0,1.0,3/13,16.81%,GSN;KCNJ2;PIK3CA
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.29691718465498834,0.5984247244691916,0.9057104913678619,1.0,1.0,15/15,70.34%,NUMA1;MED1;NCOA3;PRKCH;SFRP4;CYP27B1;VDR;KDF1;SULT2B1;TRIM16;SFN;BMP4;NME2;FOXC1;ETV4
prerank,regulation of trophoblast cell migration (GO:1901163),0.2979192794818273,0.5979137767188721,0.8778523489932886,1.0,1.0,1/14,4.82%,ARHGDIB
prerank,regulation of anoikis (GO:2000209),0.2830060355660017,0.597774129596477,0.8970223325062034,1.0,1.0,2/19,7.16%,CAV1;NOTCH1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.26658223891830396,0.595618461311479,0.9285714285714286,1.0,1.0,6/33,17.21%,SMARCA4;EGR1;JUN;TP53;TGFB2;APLN
prerank,hexose metabolic process (GO:0019318),0.26055796339838444,0.59526329753223,0.9347116430903155,1.0,1.0,8/39,22.18%,BRAT1;DCXR;SLC35A2;GALM;PMM2;FUCA1;PPARD;GDPGP1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.2495398275596917,0.5946943882346539,0.9737903225806451,1.0,1.0,22/107,21.68%,CHRNB4;NTF4;CEL;CACNG5;RELN;PTEN;CNTNAP4;BAIAP3;NMU;BCR;BTBD9;CACNA1B;MCTP1;LRRK2;CLN3;GRM3;HCRT;RIMS3;GRIK5;USP46;GRIK3;MCTP2
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.2911699248426377,0.5946902017451133,0.8923076923076924,1.0,1.0,7/16,26.95%,PRKCA;MTPN;ROCK2;ROCK1;IL6ST;PARP1;AKAP6
prerank,glycosaminoglycan metabolic process (GO:0030203),0.26048845180983443,0.5946651911947907,0.9537136706135629,1.0,1.0,5/54,7.97%,HSPG2;HAS1;HPSE2;EXT1;SLC35D2
prerank,endomembrane system organization (GO:0010256),0.24656551387161732,0.5938553503072522,0.9829488465396189,1.0,1.0,34/178,18.52%,RNF26;ATP8B4;REEP4;SUN2;STX17;SNX33;ATL2;TMCC1;WASHC4;RAB22A;CLASP1;NPLOC4;CSNK1A1;ZW10;BLZF1;CAV2;DYM;TOR1A;VAPA;DNAJC13;SEC31A;RAB43;PI4K2B;RAB2A;VPS33B;FAM174B;USP50;LMAN1;SYNE1;GORASP1;CHMP2B;LRRK2;ARHGEF7;FBXW8
prerank,regulation of lipid catabolic process (GO:0050994),0.28439558414512256,0.5935249452836455,0.9003690036900369,1.0,1.0,1/19,4.94%,ABCD1
prerank,regulation of muscle cell differentiation (GO:0051147),0.27004399038638954,0.5931142338919541,0.9306818181818182,1.0,1.0,3/31,8.09%,CTNNA1;TCF3;MAPK14
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3083339572499502,0.5930281837309213,0.889958734525447,1.0,1.0,2/11,16.99%,EGR1;SIRT1
prerank,organic hydroxy compound transport (GO:0015850),0.2637274535235771,0.5921606675034838,0.9085841694537347,1.0,1.0,4/36,11.74%,SLC16A1;ABCC2;STARD5;ABCC4
prerank,regulation of protein ubiquitination (GO:0031396),0.24758401590719803,0.5916270889043289,0.9647887323943662,1.0,1.0,25/108,21.16%,BRCA1;AXIN1;NXN;CAV1;BIRC2;UBQLN1;CUL3;PRR7;PARK7;XIAP;CDK5RAP3;ARRB2;PAXIP1;SIRT7;UBXN1;CAMLG;LRRK2;MALT1;PRMT3;GNL3L;RPS3;TRAF6;HDAC8;UBE2N;SASH1
prerank,regulation of bone mineralization (GO:0030500),0.25596215594569877,0.5907315453989516,0.9334038054968288,1.0,1.0,12/55,23.09%,SGMS2;CCN1;TWIST1;BMPR1A;NELL1;ADGRV1;TRPM4;ANO6;ACVR2B;NBR1;DDR2;OSR1
prerank,T cell differentiation (GO:0030217),0.2592793352801764,0.5898480781475576,0.9246119733924612,1.0,1.0,3/40,6.60%,LIG4;PTPN22;ZFP36L1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.24695793927552495,-0.5884128192295739,0.9302325581395349,0.9832587211112774,1.0,3/10,18.03%,SLC27A1;CD36;SLC27A4
prerank,renal water homeostasis (GO:0003091),0.27387442274030893,0.5883364620696288,0.9226993865030675,1.0,1.0,2/23,8.09%,AQP1;PRKACA
prerank,keratinocyte differentiation (GO:0030216),-0.17155417520299887,-0.5882295956296889,1.0,0.9822648372300394,1.0,4/29,16.41%,ST14;CASP3;ADAM9;JAG1
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2513647860188557,0.5881685623202126,0.9610115911485775,1.0,1.0,14/66,20.63%,MEFV;FOXP1;JAK2;EGR1;MYD88;TLR6;TYROBP;F2R;USP50;NLRP2B;MALT1;LGALS9;CASP8;AIM2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.24839440985443767,0.5881659385412397,0.9777777777777777,1.0,1.0,15/104,13.79%,VASN;CAV1;PMEPA1;NOTCH1;PIN1;ZBTB7A;PDPK1;HIPK2;TRIM33;SMAD4;SNX25;BCL9L;BMPR1A;SPRED2;SKI
prerank,carboxylic acid metabolic process (GO:0019752),-0.1729492373386412,-0.5878827294220194,0.9829059829059829,0.9813460557045609,1.0,7/33,22.41%,TBXAS1;LIAS;GLUD1;GNE;CYB5R3;AGXT;GSTO1
prerank,GTP metabolic process (GO:0046039),-0.2128503390045437,-0.5877842153503036,0.9426229508196722,0.9803084911851058,1.0,5/15,19.63%,ENTPD7;GNAI3;RHOQ;RAN;GTPBP1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.2676010892716784,0.5875718293384559,0.9334098737083811,1.0,1.0,6/31,17.11%,TFRC;KMT5C;PAXIP1;DNAJB9;RIF1;XBP1
prerank,fatty acid beta-oxidation (GO:0006635),0.25326021073613814,0.5875242099960678,0.942578548212351,1.0,1.0,17/51,24.60%,ACADM;ABCD1;AUH;SLC27A2;PEX2;IVD;CPT2;HADHA;HADHB;ABCD4;DECR1;PPARD;ACOT8;DECR2;ETFDH;ETFB;ETFA
prerank,cellular glucan metabolic process (GO:0006073),0.3068000665072602,0.5873774299834391,0.882689556509299,1.0,1.0,4/11,22.51%,PRKAG2;GSK3B;GBE1;PHKB
prerank,protein homotetramerization (GO:0051289),0.25409596570935206,0.5872698506556089,0.9351753453772582,1.0,1.0,5/49,13.04%,TK1;CBR4;ACOT13;B2M;KCNJ2
prerank,polyol biosynthetic process (GO:0046173),-0.20998460279861914,-0.5867415630530851,0.9585062240663901,0.9796815552837151,1.0,5/16,23.13%,ITPKB;IP6K1;FGF2;IPPK;IPMK
prerank,regulation of exocytosis (GO:0017157),0.2532231523076851,0.5860690716887272,0.9308855291576674,1.0,1.0,14/46,23.06%,STXBP6;CLASP1;RAB8A;LGI3;RAB8B;HAP1;ATP6AP1;RAB5A;CHMP3;SNCA;RAB27A;RAB27B;RAB9A;RAB10
prerank,proteoglycan metabolic process (GO:0006029),0.2754591441705929,0.5857125808030014,0.9318448883666275,1.0,1.0,5/26,18.00%,CSGALNACT2;SULF2;CHST12;CANT1;FAM20B
prerank,protein import into mitochondrial matrix (GO:0030150),0.2819293736204642,0.5856240255786171,0.899749373433584,1.0,1.0,4/18,14.07%,DNAJC15;TOMM70;TIMM23;GRPEL2
prerank,sphingosine metabolic process (GO:0006670),-0.20305175961143834,-0.5855487899792081,0.9592760180995475,0.9791171035224104,1.0,2/17,5.36%,SPTLC1;SGPP1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.2756616605862892,0.5853519425451736,0.915129151291513,1.0,1.0,7/22,24.58%,CIAO2A;ISCA2;CIAO3;MMS19;ABCB7;FXN;HSPA9
prerank,aminoglycan catabolic process (GO:0006026),0.2692320918747738,0.5849568953337078,0.9375,1.0,1.0,2/28,4.76%,HSPG2;HPSE2
prerank,peroxisome organization (GO:0007031),0.26894547276401753,0.5843116011498231,0.9111644657863145,1.0,1.0,8/25,23.67%,ABCD1;PEX11B;PEX2;FIS1;PEX14;ABCD4;ACOT8;PEX3
prerank,response to fatty acid (GO:0070542),0.2805226803917036,0.5841180881171145,0.9038208168642952,1.0,1.0,6/17,28.76%,FOXO1;IRS1;SOX9;FOXO3;PID1;PPP5C
prerank,platelet aggregation (GO:0070527),0.2649543399343724,0.5839653572829497,0.9328018223234624,1.0,1.0,11/33,23.63%,FLNA;CSRP1;CLIC1;PPIA;FIBP;FN1;ILK;ACTG1;ACTN1;VCL;MYH9
prerank,positive regulation of cellular respiration (GO:1901857),-0.2324996284392927,-0.5837361055947432,0.9446254071661238,0.9788920511785182,1.0,4/11,26.72%,PINK1;ISCU;IFNAR1;PRELID1
prerank,protein polyglutamylation (GO:0018095),0.30446361895327306,0.5837323276204126,0.9020979020979021,1.0,1.0,5/11,24.05%,TTLL1;TTLL9;TTLL5;TTLL11;TTLL4
prerank,potassium ion transmembrane transport (GO:0071805),0.24386913463163568,0.5836381081899807,0.9798994974874372,1.0,1.0,23/135,20.02%,SLC12A3;HCN3;KCNN4;SLC12A7;SLC12A1;KCNA1;KCNJ3;KCNC2;KCNH7;SLC12A6;KCNJ2;KCNK12;SLC9A8;SLC24A4;SLC24A2;SLC9A9;KCNK2;KCNQ5;KCNJ10;SLC9A6;SLC9A7;PKD2;KCNC1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.24868383223023144,0.5835317889334484,0.9586864406779662,1.0,1.0,13/54,23.03%,FLNA;KCNN4;CAV1;NEDD4L;KCNJ3;KCNJ2;STK39;YWHAE;KCNJ10;GNB1;KCNN3;KCNIP1;NEDD4
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.2869245811114261,0.583340313635005,0.9082446808510638,1.0,1.0,6/16,21.02%,HDAC6;TBC1D25;GSPT1;CLN3;BNIP3;GLE1
prerank,negative regulation of locomotion (GO:0040013),0.2963034712133321,0.5832067070425965,0.9236111111111112,1.0,1.0,2/12,11.76%,PIN1;CRK
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24897331508384354,0.5825817268140706,0.9586776859504132,1.0,1.0,10/68,17.85%,ACOT11;PTHLH;ACOT13;TPST1;ACOT2;NT5C2;BPNT2;SULT6B1;AK3;LRRK2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.2543770141757484,0.5819168185417979,0.9440258342303552,1.0,1.0,9/43,20.70%,SMARCA4;EGR1;JUN;TP53;TGFB2;NFATC3;APLN;SOX9;PPARD
prerank,negative regulation of biosynthetic process (GO:0009890),0.27884503195841165,0.5807526832969128,0.920844327176781,1.0,1.0,2/16,10.78%,ABCD1;PARK7
prerank,regulation of response to interferon-gamma (GO:0060330),0.28795012497787953,0.5799925282357622,0.9224489795918367,1.0,1.0,7/14,28.56%,JAK2;SUMO1;PIAS1;IFNGR1;PARP9;JAK1;HSP90AB1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.26353540129616004,0.5796645491882203,0.9156908665105387,1.0,1.0,8/29,22.61%,SORBS1;CNEP1R1;ELOVL5;CREB1;ZBTB20;SIRT4;NR1H3;LDLR
prerank,cellular response to BMP stimulus (GO:0071773),0.24939214416633496,0.5785441550095656,0.9729448491155047,1.0,1.0,10/66,20.82%,ADAMTS7;SMAD4;BMPR1A;SLC33A1;USP15;HIVEP1;TGFB2;SOX9;ACVR2B;SMAD2
prerank,regulation of calcium-mediated signaling (GO:0050848),0.2684267555382283,0.5776353562717911,0.9300947867298578,1.0,1.0,3/25,10.25%,ITPR1;PLCG2;RIT2
prerank,positive regulation of fat cell differentiation (GO:0045600),0.25148552859651246,0.5774328542659947,0.9409871244635193,1.0,1.0,11/47,18.56%,ZFP36L1;ZBTB16;PIM1;NAPEPLD;WDFY2;ZBTB7B;HNRNPU;TRPM4;XBP1;CREB1;AAMDC
prerank,amyloid-beta metabolic process (GO:0050435),0.28065151193499877,0.5773375985951588,0.9281210592686002,1.0,1.0,4/16,19.95%,ABCA7;DYRK1A;PSEN1;MME
prerank,negative chemotaxis (GO:0050919),0.2589153781360516,0.5772551004261817,0.9308390022675737,1.0,1.0,4/33,11.71%,NTN1;ITGAV;SLIT3;SLIT1
prerank,macrophage migration (GO:1905517),0.29321997872249206,0.5771993294248434,0.9255172413793104,1.0,1.0,1/13,5.33%,CCR2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.28143796823541434,0.577181604998194,0.9140625,1.0,1.0,2/17,7.33%,CCR2;HMGB1
prerank,positive regulation of phospholipase activity (GO:0010518),0.2674812469843596,0.5769785282914885,0.9200477326968973,1.0,1.0,6/22,22.80%,ARF4;PDPK1;FGFR1;PLCG1;NTRK3;FGFR2
prerank,negative regulation of response to external stimulus (GO:0032102),0.23947599951264983,0.5769063386028067,0.9675456389452333,1.0,1.0,5/105,5.39%,RNF26;MEFV;RB1;DHX58;NR1D1
prerank,neural crest cell differentiation (GO:0014033),0.2752703878961158,0.5765906321974812,0.9260204081632653,1.0,1.0,3/18,11.60%,PEF1;TCOF1;TAPT1
prerank,negative regulation of ion transport (GO:0043271),0.2678100263852243,0.5765265945723033,0.9299516908212561,1.0,1.0,24/24,73.26%,ACTN2;SNCA;NEDD4;PXK;WNK3;CD33;WNK1;INPP5K;LILRB1;CAV3;WNK4;GPM6B;CASQ2;HRH3;VIP;STC1;PLN;HTR1B;NOS1;ADRA2A;PACSIN3;SYT11;PTK2B;WNK2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2405194185479226,0.5760786164836642,0.9745934959349594,1.0,1.0,20/86,23.23%,PECAM1;FYN;CD74;CD44;BANK1;PLCG2;JAK2;EGFR;RELN;NRP1;TP53;PAK2;HCLS1;EPHA7;CNOT7;CADM4;EFNA1;PTPN11;PRKCD;SRC
prerank,aorta development (GO:0035904),0.2920306950489486,0.574955811848872,0.919205298013245,1.0,1.0,5/14,24.22%,PDE2A;EFEMP2;PKD2;HECTD1;ADAMTS9
prerank,positive regulation of wound healing (GO:0090303),0.2589698348103691,0.5740995068346878,0.9279176201372997,1.0,1.0,8/36,23.72%,PRKCE;INSL3;SMOC2;F2R;XBP1;ACTG1;APOH;ENPP4
prerank,response to endoplasmic reticulum stress (GO:0034976),0.23982870695334452,0.5734568331822097,0.9726166328600405,1.0,1.0,20/107,17.81%,ITPR1;EIF2S1;RCN3;MBTPS2;MAP3K5;DDRGK1;NIBAN1;UBQLN1;PPP1R15A;ATF6;JUN;CDK5RAP3;FLOT1;TMX1;DDIT3;GSK3B;TP53;DNAJB9;HSP90B1;SYVN1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.23707663101714357,0.5729048034349788,0.995,1.0,1.0,21/224,13.37%,CHRNB4;MAPK1;CEL;PDE7B;SLC6A2;SLC6A5;HTR2A;EXOC4;SLC12A7;GABRA4;PRKACA;KCNA1;BSN;PMP22;RIT2;GABRA5;PAFAH1B1;GRIA3;HAP1;SLC12A6;CHRM3
prerank,myoblast fusion (GO:0007520),0.28939587462041005,0.5725355932895636,0.9026315789473685,1.0,1.0,2/12,16.96%,JAM2;ADAMTS5
prerank,regulation of cell-substrate adhesion (GO:0010810),0.25455832445256876,0.5719883811947856,0.9433551198257081,1.0,1.0,8/42,18.33%,ECM2;NOTCH1;JAK2;RSU1;RAC2;LIMS1;RAC1;TBCD
prerank,androgen receptor signaling pathway (GO:0030521),0.29927180285900673,0.5718843157755907,0.9145658263305322,1.0,1.0,3/11,23.36%,PMEPA1;TMF1;PLPP1
prerank,response to growth factor (GO:0070848),0.2509403867678578,0.5716331683123541,0.9588299024918743,1.0,1.0,7/41,13.91%,HDAC6;CIB1;EMD;BMPR1A;STAT5B;RACK1;MYC
prerank,carbohydrate homeostasis (GO:0033500),0.2425185997793412,0.5714994220026866,0.9628099173553719,1.0,1.0,10/67,18.98%,SLC2A4;USF1;STK11;PARK7;ADIPOR1;MCU;IRS1;TCF7L2;ADCY8;RPS6
prerank,folic acid metabolic process (GO:0046655),0.2736658001492431,0.5713129168795634,0.9305912596401028,1.0,1.0,4/18,19.16%,MTHFD2L;SLC19A1;ALDH1L1;MTHFD1L
prerank,melanosome transport (GO:0032402),0.2770634139198563,0.5712372273475635,0.9328358208955224,1.0,1.0,7/18,24.71%,RAB11B;BBS4;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,pigment granule transport (GO:0051904),0.2770634139198563,0.5712372273475635,0.9328358208955224,1.0,1.0,7/18,24.71%,RAB11B;BBS4;MREG;RAB27A;RAB27B;BBS7;BBS2
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.29212707685260164,0.5710168026223567,0.9119669876203577,1.0,1.0,2/11,12.11%,TIMM9;TOMM70
prerank,multivesicular body organization (GO:0036257),0.2631113725656077,0.5707154779987667,0.9284890426758939,1.0,1.0,14/31,28.79%,CHMP1B;HGS;CHMP3;CHMP2B;VTA1;STAM;RAB27A;VPS4A;CHMP5;TSG101;VPS37A;STAM2;VPS4B;VPS37B
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.28587240883316023,0.5701761833425912,0.9205729166666666,1.0,1.0,4/14,17.85%,PARK7;XBP1;SYVN1;LRRK2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.235270969892418,0.5690342719138142,0.991,1.0,1.0,37/198,20.44%,PLPPR3;ALPL;PPP3CA;PANK2;AGPAT1;IMPA1;INPP5A;EPHX2;PPA2;PLCG2;NUDT4;PLBD1;PLCB1;PTEN;INPP4A;PLCB3;GFPT2;PLCD1;GPD2;PLPPR4;LIMD1;PAK2;LIMK2;PLCG1;PIK3CA;DUSP12;PIP4K2A;PGK1;LRRK2;PPP1CA;TAOK1;ACYP1;OCRL;NADK;ALK;EPHA7;DUSP16
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.2835826619559484,0.5685092437696276,0.9216467463479415,1.0,1.0,4/15,18.99%,ENTPD3;ENTPD5;AK5;CMPK2
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.24847506085653093,0.5684122587242587,0.9539473684210527,1.0,1.0,10/44,23.69%,FLNA;KCNN4;KCNJ3;ACTN2;KCNJ2;ANO6;KCNJ10;GNB1;KCNN3;WNK3
prerank,positive regulation of axonogenesis (GO:0050772),0.2484792373190331,0.5682997435388814,0.9508196721311475,1.0,1.0,4/43,8.44%,TIAM1;NTN1;DBNL;PLXNA2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.20439380323492112,-0.5681687936694338,0.9675925925925926,0.9843208175748787,1.0,9/17,35.87%,BAIAP2;FES;CDK5;CDC42;HRAS;HCK;TEK;STAP1;BAIAP2L2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.2780119791098501,0.5681403078424433,0.9322250639386189,1.0,1.0,1/18,3.58%,PET100
prerank,positive regulation of neuron projection development (GO:0010976),0.23787306666606253,0.5680561162266672,0.9762886597938144,1.0,1.0,10/85,11.01%,S100A9;SNX3;KIDINS220;SETX;ARHGAP35;DBNL;MARK2;EPHA3;RIT2;RELN
prerank,regulation of response to oxidative stress (GO:1902882),0.29050913038073073,0.567886799501792,0.9226519337016574,1.0,1.0,1/11,4.94%,ABCD1
prerank,ephrin receptor signaling pathway (GO:0048013),0.2370595480382539,0.567877054447226,0.9791449426485923,1.0,1.0,22/82,23.23%,FYN;TIAM1;EPHA3;ANKS1A;CRK;ARHGEF28;AP2B1;ROCK2;PSEN1;ANKS1B;RAC1;SDC2;ARHGEF7;EPHA7;SIPA1L1;ROCK1;VAV3;EPHA10;ACTG1;EFNA1;PTPN11;SRC
prerank,negative regulation of viral genome replication (GO:0045071),0.244206380413875,0.5666828184428305,0.9477693144722524,1.0,1.0,11/40,24.44%,SLPI;FAM111A;IFITM3;TASOR;SRPK1;SETDB1;PROX1;ZC3HAV1;HMGA2;EIF2AK2;RESF1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.26753919867261433,0.5660340718587032,0.935687263556116,1.0,1.0,4/19,19.16%,MTHFD2L;SLC19A1;ALDH1L1;MTHFD1L
prerank,positive regulation of exosomal secretion (GO:1903543),0.28125255750337397,0.5653691400260561,0.929144385026738,1.0,1.0,6/15,29.02%,HGS;STAM;VPS4A;TSG101;VPS4B;SMPD3
prerank,cellular calcium ion homeostasis (GO:0006874),0.2344554232264914,0.5652125642372855,0.9859437751004017,1.0,1.0,19/133,17.55%,HTR2A;CSRP3;PML;CAV1;CCR2;PRKACA;SLC10A7;CAV2;SLC35G1;PDZD8;MICU3;MICU1;PSEN1;MCU;TPT1;SLC24A4;SLC24A2;ADCY8;YWHAE
prerank,bile acid and bile salt transport (GO:0015721),0.26365217598145696,0.5651761255946609,0.9284862932061978,1.0,1.0,3/24,11.74%,ABCC2;STARD5;ABCC4
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.29459838880524486,0.5650718685853874,0.9092240117130308,1.0,1.0,1/10,8.57%,JAK2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.26385613126997237,0.5649724758879627,0.9375,1.0,1.0,7/23,22.96%,KCTD21;HHIP;RACK1;RFX4;SUFU;MEGF8;BTRC
prerank,epithelial cell development (GO:0002064),0.2694722526290864,0.5642884561780236,0.9351285189718482,1.0,1.0,19/20,62.48%,LRTOMT;SLC4A7;RAB25;CLDN3;EXPH5;ROS1;POF1B;RILPL2;PDZD7;TMEM79;GRHL2;ACTA2;PKHD1;DACT2;RILPL1;BFSP1;SIPA1L3;WNT7A;WNT7B
prerank,purine ribonucleotide transport (GO:0015868),0.27941471422657954,0.56408920645557,0.9276485788113695,1.0,1.0,3/16,11.74%,LRRC8C;SLC19A1;ABCC4
prerank,regulation of exosomal secretion (GO:1903541),-0.18978494038965138,-0.5638314762861473,0.9666666666666667,0.9848262557545192,1.0,3/19,12.01%,ATP9A;PDCD6IP;PRKN
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.23603346689525423,0.5631434695992725,0.9745934959349594,1.0,1.0,21/85,23.24%,PLK1;TAF1;CSNK1A1;DDRGK1;PSMC3;SUMO1;RAD23A;RACK1;SUMO2;ARIH2;PABIR1;GSK3B;PIAS1;RNF19A;LRRK2;KEAP1;MDM2;CBFA2T3;HECTD1;DDA1;BBS7
prerank,positive regulation of actin filament polymerization (GO:0030838),0.24715254147212748,0.562775021776061,0.9508733624454149,1.0,1.0,5/44,11.96%,PRKCE;GSN;SNX9;WHAMM;CDC42EP3
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.2534998709789849,0.562285759250068,0.9306029579067122,1.0,1.0,8/31,22.81%,NOTCH1;SMAD4;BMPR1A;TGFB2;PROX1;RBPJ;FGFR2;FKBP1A
prerank,negative regulation of innate immune response (GO:0045824),0.248255859755746,0.5618976321898783,0.9428571428571428,1.0,1.0,6/34,17.54%,DHX58;RPS19;USP15;SLAMF8;NLRC3;TRAFD1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.26831414969990613,0.5618005840047885,0.9339045287637698,1.0,1.0,4/20,16.93%,IMPDH2;NT5C2;ADSL;AK3
prerank,positive regulation of translational initiation (GO:0045948),0.270931231585015,0.5613683522177445,0.9261576971214017,1.0,1.0,10/18,30.49%,BOLL;EIF2B5;CDC123;YTHDF1;YTHDF3;HABP4;RPS6KB1;KHDRBS1;MTOR;POLR2G
prerank,neuromuscular junction development (GO:0007528),0.2628939221969314,0.5608158968793231,0.933253873659118,1.0,1.0,8/24,24.26%,LRP4;F2R;GPHN;PPFIBP1;LRRK2;DCTN1;NEDD4;DNAJA3
prerank,positive regulation of ossification (GO:0045778),0.2510559543402737,0.5603508399079495,0.9543478260869566,1.0,1.0,10/39,23.09%,CCN1;ZBTB16;BMPR1A;NELL1;ADGRV1;TGFB2;ANO6;ACVR2B;PTPN11;OSR1
prerank,T cell mediated immunity (GO:0002456),0.2805058266666893,0.5602169296336278,0.921161825726141,1.0,1.0,4/13,25.96%,BTN3A3;CD55;MYO1G;CTSH
prerank,organic cation transport (GO:0015695),0.2677759839915623,0.5600621986045351,0.9354838709677419,1.0,1.0,4/20,20.66%,SLC44A1;SLC22A4;SEC14L1;SLC44A2
prerank,regulation of macroautophagy (GO:0016241),0.23620483200175915,0.5599230883844022,0.9858012170385395,1.0,1.0,36/105,26.77%,ATG13;EXOC4;IKBKG;HDAC6;DCN;PRKACA;UBQLN1;CAPN1;MLST8;ATP6V0E1;PRKAG2;LAMTOR4;LAMTOR3;TBC1D25;ATG101;PIK3CA;SIRT1;ATP6V0D1;MAP3K7;LRRK2;CLN3;RRAGB;BNIP3;PRKAG1;GAPDH;UBQLN2;NEDD4;SMG1;PRKAB2;USP36;QSOX1;SESN1;UCHL1;BNIP3L;SMCR8;ATP6V1G1
prerank,axonogenesis (GO:0007409),0.23172796463327053,0.5597807181534566,0.999,1.0,1.0,56/237,23.34%,SPTA1;MAPK1;FYN;EZR;PTPRA;RPS6KA5;GFRA2;LAMA5;NOTCH1;ARHGAP35;RAB8A;PRKCA;GRB2;SOS1;PDLIM7;NTNG2;EPHA3;DOK2;RELN;BSG;SLIT3;SLIT1;PTEN;LMTK2;NRP1;NRCAM;PALLD;GFRA1;DAG1;PLPPR4;SPTAN1;PLCG1;PIK3CA;EMB;CXCR4;NRXN1;SLC9A6;SEMA4A;PAX2;SLITRK2;TUBB3;EPHA7;EPHA10;NEFH;BRSK1;SEMA6A;EFNA1;CNTN4;NIBAN2;S100A6;FGFR2;PTPN11;RAB10;SRC;DSCAM;SPTB
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.25084256426516444,0.5589673619145012,0.9417142857142857,1.0,1.0,8/34,21.61%,GABRA4;MPP2;GABRA5;ARRB2;GSK3B;LRRK2;GLRA1;GRIN2D
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.2566761607875636,0.558947655136445,0.9460726846424384,1.0,1.0,8/27,24.49%,PML;PPP1CB;PPP1CC;TP53;PPP1CA;RBM4B;BHLHE40;FBXL12
prerank,cellular response to purine-containing compound (GO:0071415),0.30058444158002035,0.5588919657767485,0.9358974358974359,1.0,1.0,1/10,9.52%,P2RY1
prerank,regulation of pseudopodium assembly (GO:0031272),0.28903801257386497,0.558853141388737,0.9129213483146067,1.0,1.0,3/10,23.95%,CDC42EP3;CDC42EP1;CDC42EP4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.28903801257386497,0.558853141388737,0.9129213483146067,1.0,1.0,3/10,23.95%,CDC42EP3;CDC42EP1;CDC42EP4
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2573012520290712,0.5587996062139982,0.9329268292682927,1.0,1.0,3/22,17.00%,CCR2;BTK;TRPM4
prerank,lipid transport (GO:0006869),0.23412961999520637,0.5577112319466792,0.9694501018329938,1.0,1.0,12/97,12.43%,ABCA13;ABCD1;OSBPL5;ABCC2;ABCA2;NME4;PRELID3B;ABCA7;STARD5;ATP8A1;ABCC4;SLCO2A1
prerank,positive regulation of protein processing (GO:0010954),0.2632358006703986,0.5577022183927722,0.9325153374233128,1.0,1.0,5/19,25.64%,GSN;CCBE1;LPCAT3;MYH9;NLRC4
prerank,regulation of axonogenesis (GO:0050770),0.23819797089455677,0.5575779367963365,0.9553666312433581,1.0,1.0,9/51,16.45%,TIAM1;LRP4;ARHGAP35;PLXNA2;MARK2;PTEN;GSK3B;PAK2;ARHGDIA
prerank,cellular response to nutrient levels (GO:0031669),0.23867417354004863,0.5572893533308169,0.9587628865979382,1.0,1.0,12/62,20.76%,STK26;FOXO1;KLF10;STK24;RIPOR1;SIRT1;XBP1;LRRK2;SREBF2;WDR45B;RRAGB;WRN
prerank,response to muramyl dipeptide (GO:0032495),0.2818734512621886,0.55637843932286,0.9432918395573997,1.0,1.0,1/12,4.26%,PTPN22
prerank,collagen fibril organization (GO:0030199),0.23135136373848741,0.5559725613919108,0.9775051124744376,1.0,1.0,12/88,17.17%,CYP1B1;PLOD3;CRTAP;COL1A2;COL4A4;LAMB3;ATP7A;TLL2;COL23A1;P3H4;TGFB2;COL4A1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.2618253000065015,0.5551723638911714,0.9383313180169287,1.0,1.0,6/22,21.77%,PTPN22;NR1D1;FLOT1;APPL1;IFI35;NR1H3
prerank,aerobic electron transport chain (GO:0019646),0.2351563465192991,0.5551076654178815,0.972972972972973,1.0,1.0,13/68,20.39%,SDHD;NDUFS8;NDUFB7;NDUFAF1;COX10;COX4I1;NDUFA1;NDUFA4;NDUFAB1;NDUFA5;NDUFS1;NDUFS5;UQCRH
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.2711300084191838,0.5548997064200193,0.9529262086513995,1.0,1.0,5/18,22.05%,DERL2;AMFR;UBA52;SYVN1;RNF103
prerank,photoperiodism (GO:0009648),0.25381227902622633,0.5546225403181285,0.9450292397660819,1.0,1.0,8/28,24.49%,PML;PPP1CB;PPP1CC;TP53;PPP1CA;RBM4B;BHLHE40;FBXL12
prerank,cell junction assembly (GO:0034329),0.23237297959665984,0.5544175728810236,0.9837728194726166,1.0,1.0,28/100,25.48%,SDK1;FLNA;DBNL;CDH18;CDH24;DNER;PTEN;NRCAM;ADGRL3;KIRREL3;GJA4;LIMS1;NRXN2;CTNND2;FN1;NRXN1;CDH19;CDH20;CDH7;ILK;ACTG1;ARVCF;DSCAM;VMP1;PKP4;DCHS1;ITGA6;BDNF
prerank,cristae formation (GO:0042407),0.25231809176660663,0.5536863192540596,0.9441805225653207,1.0,1.0,6/27,20.55%,ATP5F1E;APOOL;ATP5F1D;ATP5MC2;ATP5F1B;ATP5MF
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.26089058007624194,0.553632734516561,0.9501187648456056,1.0,1.0,2/23,11.02%,MBOAT2;PLBD1
prerank,neuron projection organization (GO:0106027),0.27235893472377415,0.553241031342391,0.9453333333333334,1.0,1.0,4/15,14.67%,ABCD1;PICK1;PSEN1;GSK3B
prerank,negative regulation of mitochondrion organization (GO:0010823),0.2529101393035744,0.5529708950055482,0.949943117178612,1.0,1.0,2/33,5.06%,IAPP;TFRC
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.2852487545283402,0.5527155941106802,0.9312320916905444,1.0,1.0,3/11,21.48%,ARRB2;GRK2;GRK3
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.22965739909448665,-0.5524851950361167,0.9591194968553459,0.9878181024318115,1.0,5/10,35.11%,GNB5;CALM1;CBARP;DRD2;CRHR1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.2918892483481676,0.5524403947252308,0.9258202567760342,1.0,1.0,2/11,15.13%,NT5C3A;TPK1
prerank,regulation of MAP kinase activity (GO:0043405),0.2355724867025076,0.550973473820948,0.9714576962283384,1.0,1.0,12/92,17.85%,EZH2;RASGRP1;STK38;EGFR;FLT3;CDK5RAP3;PDCD10;EGF;HGS;FGFR1;CD24;LRRK2
prerank,regulation of leukocyte activation (GO:0002694),0.2773828845672017,0.5507662734074767,0.9375,1.0,1.0,1/14,3.69%,CD74
prerank,limb development (GO:0060173),0.2548370056132507,0.5507196976151081,0.9488966318234611,1.0,1.0,7/28,23.13%,LRP4;KAT2B;MAP3K20;RSPO2;KREMEN1;MEGF8;INTU
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.24975604862028294,0.55050497304233,0.9565701559020044,1.0,1.0,5/34,12.89%,PGF;NUS1;NOTCH1;MAPK14;NRP1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.24629488806153954,0.5504079647445428,0.956221198156682,1.0,1.0,10/32,23.03%,YWHAH;NEDD4L;CUX1;GSK3B;GORASP1;SDC2;FBXW8;CAPRIN2;HECW2;NEDD4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.27194325253202667,0.5490366484659215,0.9411764705882353,1.0,1.0,3/16,12.44%,NOTCH1;PIM1;BMPR1A
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.22774274632558825,0.5472342920194796,0.9949849548645938,1.0,1.0,16/159,16.23%,CD177;SDK1;CLDN18;PECAM1;MILR1;HMCN1;CDH18;CDH24;IGSF21;BSG;PALLD;ADGRL3;NECTIN1;KIRREL3;CDH4;TGFB2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.26386754500218557,0.5470412504869401,0.9489528795811518,1.0,1.0,3/17,13.49%,COX10;COX4I1;NDUFA4
prerank,triglyceride metabolic process (GO:0006641),0.23860075610097464,0.5460984686167306,0.9673202614379085,1.0,1.0,3/48,7.38%,CAV1;GPAT3;MOGAT2
prerank,protein heterotetramerization (GO:0051290),0.27708887314835373,0.5454532018750069,0.9241379310344827,1.0,1.0,3/13,20.17%,CBR4;PKD2;CPSF7
prerank,tRNA methylation (GO:0030488),0.24368498114781909,0.5450626295256793,0.9546485260770975,1.0,1.0,9/34,23.23%,TRMO;TRDMT1;TRMT5;TYW3;PRORP;THUMPD3;TRMT112;TRMT10C;DALRD3
prerank,ceramide biosynthetic process (GO:0046513),0.2438079434662327,0.5450096568613921,0.9572836801752465,1.0,1.0,8/40,20.19%,SGMS2;ST8SIA4;CERS4;SGMS1;ST3GAL5;CERS6;CERS2;ST8SIA6
prerank,regulation of translational initiation (GO:0006446),0.2346005783522569,0.5447683610335328,0.9706806282722513,1.0,1.0,14/63,22.11%,EIF4B;EIF3E;BOLL;CSDE1;EIF4EBP3;NCBP1;PAIP1;NCBP2;AGO2;TPR;EIF2B5;GLE1;DNAJC3;PPP1R15B
prerank,skin development (GO:0043588),0.2320843566801936,0.544670616561679,0.9769392033542977,1.0,1.0,3/65,10.54%,STMN1;COL1A2;ATP7A
prerank,Golgi localization (GO:0051645),0.28120258117706426,0.5446259810868215,0.9429763560500696,1.0,1.0,6/11,28.44%,RIPOR1;PDCD10;STK25;TBCCD1;YWHAZ;COPG1
prerank,regulation of glycogen metabolic process (GO:0070873),0.27915881983678603,0.5429414452717601,0.9398907103825137,1.0,1.0,12/12,72.11%,RUBCNL;INPP5K;PPP1R3B;GCGR;PPP1R3G;AKT1;PPP1R3A;PPP1R3E;PPP1R3C;PPP1R3D;KHK;PPP1R3F
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.2565835414200287,0.5428258549492316,0.9449423815620999,1.0,1.0,5/19,21.62%,DBNL;CUX1;RELN;FBXW8;CAPRIN2
prerank,icosanoid secretion (GO:0032309),0.27325800376647813,0.5426754253639651,0.9406896551724138,1.0,1.0,12/12,72.69%,ABCC4;PLA2G1B;DRD4;NOS2;ACE;DRD3;PLA2G5;BDKRB2;NMUR2;PNPLA8;DRD2;ANXA1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.2667828992906312,0.5425023521164525,0.94375,1.0,1.0,3/16,16.48%,RUNX1;F2R;VIM
prerank,nucleotide catabolic process (GO:0009166),0.2682162535746982,0.542233826241665,0.9501278772378516,1.0,1.0,2/16,9.67%,GDA;NT5C2
prerank,negative regulation of cation channel activity (GO:2001258),-0.16024629432209647,-0.5408992321525823,0.994413407821229,0.9905126950367299,1.0,11/26,36.06%,KCNAB1;SRI;GNB5;CALM1;CBARP;GSTO1;FKBP1B;CALM2;DRD2;CRHR1;EPHB2
prerank,ubiquinone biosynthetic process (GO:0006744),0.2650810419870153,0.5402264844944027,0.9503267973856209,1.0,1.0,4/15,18.66%,COQ10B;PDSS2;COQ5;FDXR
prerank,response to interferon-beta (GO:0035456),0.24689636447635152,0.5392139709510365,0.9466666666666667,1.0,1.0,5/22,20.63%,UBE2K;XAF1;IFITM3;PNPT1;AIM2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.22745487473017817,0.5388216081007391,0.9824016563146998,1.0,1.0,16/75,22.88%,HSPG2;PML;CCR2;DCN;MECP2;ROCK2;ADAMTS1;HGS;TGFB2;PGK1;ROCK1;SEMA6A;ATP2B4;AGO1;NIBAN2;APOH
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.27986481479037795,0.5388212199391414,0.9448924731182796,1.0,1.0,2/12,15.15%,IMPDH2;ADSL
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.22913474262179886,0.5373651948183585,0.9584664536741214,1.0,1.0,13/50,22.66%,TRADD;EGFR;TRIM44;ACTN4;LIMS1;RPS3;IFI35;LGALS9;TRAF6;ILK;SASH1;RTKN2;PHB2
prerank,leukotriene biosynthetic process (GO:0019370),-0.19970228952278862,-0.5370299805878213,0.987012987012987,0.9905339385966626,1.0,5/14,30.86%,ALOX5;GGT5;ALOX5AP;PLA2G4A;LTC4S
prerank,regulation of vasoconstriction (GO:0019229),0.24614861454510545,0.5367963398437442,0.9476190476190476,1.0,1.0,4/27,17.00%,CAV1;CHRM3;F2R;TRPM4
prerank,neutrophil chemotaxis (GO:0030593),0.23075781448453073,0.5366674196463167,0.9719525350593312,1.0,1.0,6/53,16.69%,S100A9;S100A8;BSG;PPIA;TGFB2;CCL25
prerank,quinone biosynthetic process (GO:1901663),0.2688884434838067,0.5362529461233198,0.9479305740987984,1.0,1.0,4/14,18.66%,COQ10B;PDSS2;COQ5;FDXR
prerank,striated muscle cell differentiation (GO:0051146),0.26629149084935283,0.5361673787125417,0.9407979407979408,1.0,1.0,2/16,13.79%,MYEF2;SKI
prerank,adenine nucleotide transport (GO:0051503),0.26305285388850386,0.5352091695070547,0.9374201787994891,1.0,1.0,3/17,11.74%,LRRC8C;SLC19A1;ABCC4
prerank,vasculature development (GO:0001944),0.26473602886012176,0.5350578038885803,0.9534883720930233,1.0,1.0,3/16,20.46%,STK11;PIK3CA;ACVR2B
prerank,negative regulation of actin filament polymerization (GO:0030837),0.24868998330455885,0.534928943750238,0.945041816009558,1.0,1.0,2/22,8.59%,GSN;CYRIB
prerank,vitamin D metabolic process (GO:0042359),-0.19640142929158438,-0.5345358568966377,0.979253112033195,0.990129074895313,1.0,2/13,21.09%,LGMN;PIAS4
prerank,neuron projection regeneration (GO:0031102),-0.22082459256557604,-0.5340294764389029,0.9731543624161074,0.9891996514990654,1.0,4/10,26.54%,GAP43;MAPK8IP3;OMG;DHFR
prerank,central nervous system myelination (GO:0022010),0.27870211304330683,0.533637912305542,0.9338959212376934,1.0,1.0,2/11,11.97%,ABCA2;PTEN
prerank,multivesicular body assembly (GO:0036258),0.24427381600982226,0.5304800460034391,0.9481566820276498,1.0,1.0,13/30,28.79%,CHMP1B;HGS;CHMP3;CHMP2B;VTA1;STAM;VPS4A;CHMP5;TSG101;VPS37A;STAM2;VPS4B;VPS37B
prerank,positive regulation of cell projection organization (GO:0031346),0.21901234883213944,0.528708704719129,0.9888324873096447,1.0,1.0,12/115,11.01%,TIAM1;S100A9;SNX3;KIDINS220;SETX;ARHGAP35;PLXNA2;MARK2;EPHA3;RIT2;CUX1;RELN
prerank,acylglycerol biosynthetic process (GO:0046463),0.246541390467925,0.526432291455001,0.959378733572282,1.0,1.0,2/23,7.38%,GPAT3;MOGAT2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.24289238019789688,0.5256964112856501,0.9572953736654805,1.0,1.0,4/25,19.93%,DDAH2;TLR6;ASS1;PKD2
prerank,negative regulation of interleukin-8 production (GO:0032717),0.255746287822974,0.5249837639266568,0.96248382923674,1.0,1.0,2/17,14.21%,PTPN22;TLR6
prerank,regulation of secretion by cell (GO:1903530),0.22581136180905184,0.5245555096355132,0.9830148619957537,1.0,1.0,5/54,12.39%,CHRNB4;RAB8A;LGI3;RAB8B;HAP1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.2793616147379745,0.523374272581438,0.959479015918958,1.0,1.0,4/10,25.94%,EHMT1;SETD7;EEF1AKMT2;SETD2
prerank,cortical cytoskeleton organization (GO:0030865),0.22936095839698323,0.5233358768197963,0.9696312364425163,1.0,1.0,9/41,21.01%,EZR;RND3;PPP2R3C;ROCK2;RAC2;FMNL1;RAC1;IKBKB;ROCK1
prerank,inner ear morphogenesis (GO:0042472),0.24578174346260484,0.5224205965136342,0.9656862745098039,1.0,1.0,4/22,22.80%,TIFAB;PAX2;SOX9;FGFR2
prerank,sphingoid biosynthetic process (GO:0046520),0.27353948084297,0.5221170365185479,0.9549929676511955,1.0,1.0,2/11,16.54%,ABCA2;ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.27353948084297,0.5221170365185479,0.9549929676511955,1.0,1.0,2/11,16.54%,ABCA2;ACER3
prerank,negative regulation of insulin secretion (GO:0046676),0.2575544582666016,0.521845335492593,0.9675,1.0,1.0,5/17,26.51%,PIM3;IRS1;SIRT4;PSMD9;KCNB1
prerank,cognition (GO:0050890),0.23112185705841615,0.5212090274797486,0.9672489082969432,1.0,1.0,8/42,17.26%,MAGT1;JAKMIP1;SHROOM4;BBS4;NIPBL;SOBP;TUSC3;CHMP2B
prerank,regulation of stem cell population maintenance (GO:2000036),0.24694061609291645,0.5210496971080877,0.9650872817955112,1.0,1.0,6/18,25.76%,MYC;CNOT1;ELAVL1;NCOA3;HMGA2;PTN
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.1952507216795111,-0.5203437790441932,0.9922779922779923,0.9915931746423007,1.0,3/13,24.73%,RELA;MDK;ITGB2
prerank,granulocyte chemotaxis (GO:0071621),0.2228001254016218,0.5200502304852994,0.9796137339055794,1.0,1.0,6/55,16.69%,S100A9;S100A8;BSG;PPIA;TGFB2;CCL25
prerank,iron-sulfur cluster assembly (GO:0016226),0.24325874004896686,0.519940336349014,0.9543269230769231,1.0,1.0,7/24,24.58%,CIAO2A;ISCA2;CIAO3;MMS19;ABCB7;FXN;HSPA9
prerank,regulation of cell-cell adhesion (GO:0022407),0.23102502639214662,0.5189746267837858,0.9649122807017544,1.0,1.0,9/39,23.69%,CD47;DPP4;MAGI1;MDGA1;FLOT2;EPHA7;CITED2;SRC;FUT9
prerank,regulation of mitochondrial fusion (GO:0010635),0.26845239397287163,0.5178524371933294,0.9641873278236914,1.0,1.0,1/11,5.06%,TFRC
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.2641916978919465,0.5174718682764224,0.9462068965517242,1.0,1.0,2/12,14.41%,SORBS1;IRS1
prerank,glucose metabolic process (GO:0006006),0.22429587822248215,0.5171534993831819,0.9789695057833859,1.0,1.0,11/58,22.18%,SLC25A12;BRAT1;DCXR;GALM;SLC25A13;PGK1;MDH2;PPARD;GAPDH;PCK2;GDPGP1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.25484761103719755,0.5153661809567497,0.9597855227882037,1.0,1.0,7/13,29.00%,MBTPS2;FCGR2B;NR1H3;LPCAT3;NR1H2;NUPR1;CLU
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.2426514366954824,0.5150779903149174,0.9579617834394905,1.0,1.0,5/18,25.47%,HMGB1;CD24;RPS3;IGFBP2;ICOSLG
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.21193871801683214,-0.5138162853592568,0.9862068965517241,0.9920100446235927,1.0,1/10,3.26%,FERMT3
prerank,neuropeptide signaling pathway (GO:0007218),0.22129362696265767,0.5131613088411399,0.9769392033542977,1.0,1.0,6/58,19.55%,AGRP;SORCS2;NMU;ADCYAP1;GLRA1;PPY
prerank,positive regulation of mitochondrial translation (GO:0070131),0.2615853695298564,0.512907006267106,0.9582210242587601,1.0,1.0,4/14,26.09%,MPV17L2;TRUB2;TRMT10C;FASTKD2
prerank,gastrulation (GO:0007369),-0.18347054903076115,-0.5128038100108905,1.0,0.9911762403775031,1.0,7/15,38.58%,GPC3;NPHP3;UGDH;LMBRD1;MKKS;LRP5;LHX1
prerank,mitochondrion morphogenesis (GO:0070584),0.26638259813507204,0.5098406687705334,0.9601139601139601,1.0,1.0,5/11,26.63%,FIS1;MTM1;PNPT1;PID1;WASF1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.2683004116718227,0.5094440920115252,0.9471428571428572,1.0,1.0,1/10,7.28%,MTMR2
prerank,secondary alcohol metabolic process (GO:1902652),0.2253227992406083,0.5082873496375405,0.9698660714285714,1.0,1.0,10/42,22.68%,OSBPL5;GBA2;CYP27A1;NSDHL;IDH2;LDLRAP1;PPARD;OSBPL1A;SCAP;SOAT1
prerank,regulation of viral life cycle (GO:1903900),0.23592396062348467,0.5062366825817186,0.9597069597069597,1.0,1.0,7/21,28.20%,TRIM68;PPIA;TRIM5;VPS4A;TSG101;TRIM62;TRIM21
prerank,positive regulation of phospholipid transport (GO:2001140),0.2692796565317165,0.5054104989520349,0.9676966292134831,1.0,1.0,2/10,17.31%,ABCA7;TMEM30A
prerank,ubiquinone metabolic process (GO:0006743),0.25094338805272376,0.5047755851105226,0.9658344283837057,1.0,1.0,4/15,18.66%,COQ10B;PDSS2;COQ5;FDXR
prerank,regulation of fatty acid oxidation (GO:0046320),0.24882665560064327,0.5035642659358438,0.9756722151088348,1.0,1.0,4/16,21.05%,ABCD1;PRKAG2;SOX9;SIRT4
prerank,endodermal cell fate commitment (GO:0001711),0.265423853523564,0.5025048642574322,0.9628571428571429,1.0,1.0,2/10,23.39%,RTF1;LEO1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.23163069746254988,0.502278936894669,0.9786476868327402,1.0,1.0,6/25,27.30%,CRHBP;CNRIP1;SOCS4;TSG101;CBL;SLC6A9
prerank,cellular response to UV-A (GO:0071492),0.2600590044567198,0.502161412141255,0.9703389830508474,1.0,1.0,11/11,74.01%,MME;MMP1;OPN1SW;MMP3;PPID;OPN5;MMP9;TIMP1;OPN3;MMP2;CERS1
prerank,striated muscle contraction (GO:0006941),0.2170403680976762,0.5020865383452714,0.984994640943194,1.0,1.0,2/53,4.10%,CSRP3;CCDC78
prerank,axoneme assembly (GO:0035082),0.22645598344055023,0.5016144202320744,0.9703872437357631,1.0,1.0,1/30,3.22%,CFAP206
prerank,regulation of actin filament polymerization (GO:0030833),0.21263218440618437,0.5007800867425896,0.9905759162303664,1.0,1.0,8/69,13.62%,PRKCE;GBA2;SNX9;DBNL;CYRIB;MTPN;CDC42EP3;LATS1
prerank,potassium ion transport (GO:0006813),0.21020652147947327,0.5004207569071731,0.9989878542510121,1.0,1.0,20/120,20.02%,AQP1;HCN3;KCNN4;KCNA1;KCNJ3;KCNC2;KCNH7;KCNJ2;KCNK12;SLC9A8;SLC24A4;SLC24A2;SLC9A9;KCNK2;KCNQ5;KCNJ10;SLC9A6;SLC9A7;PKD2;KCNC1
prerank,ureteric bud morphogenesis (GO:0060675),0.24094538989477501,0.5003620141454945,0.9662775616083009,1.0,1.0,5/16,24.17%,MYC;PAX2;PKD2;GDNF;NPNT
prerank,cAMP metabolic process (GO:0046058),0.2529594898352413,0.4990550017276943,0.967605633802817,1.0,1.0,3/13,21.50%,PTHLH;ADCY8;ADCY9
prerank,cellular response to hexose stimulus (GO:0071331),0.23676347414745413,0.49904560951355387,0.9678571428571429,1.0,1.0,7/23,21.31%,PRKACA;RACK1;XBP1;ADCY8;ZBTB20;PAX2;PCK2
prerank,tyrosine metabolic process (GO:0006570),0.25798332529959384,0.4981915622383105,0.9789915966386554,1.0,1.0,1/11,11.99%,FAH
prerank,inner dynein arm assembly (GO:0036159),0.2581414067591268,0.49746660416562577,0.9560283687943263,1.0,1.0,1/10,10.61%,CFAP73
prerank,regulation of monocyte chemotaxis (GO:0090025),0.23314945230556766,0.4961845674826653,0.9692874692874693,1.0,1.0,4/24,17.56%,CCR2;HMGB1;SLAMF8;ANO6
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.16183296231491887,-0.4953716485763775,0.9949494949494949,0.9935027464617255,1.0,6/19,26.89%,NOX1;PRDX2;GPX1;PRDX3;PRDX4;MAOB
prerank,pre-miRNA processing (GO:0031054),0.24615439964664204,0.494819954667752,0.9633152173913043,1.0,1.0,4/14,22.17%,TUT4;TARBP2;AGO2;AGO1
prerank,oligosaccharide biosynthetic process (GO:0009312),0.23477203953155004,0.4938724532712457,0.9657794676806084,1.0,1.0,2/20,11.67%,ST3GAL2;FUT8
prerank,eye photoreceptor cell differentiation (GO:0001754),0.24829817587597927,0.49378178815766127,0.9696132596685083,1.0,1.0,1/12,6.07%,AGTPBP1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.21502920976816156,0.492644845986677,0.9859762675296656,1.0,1.0,10/45,20.63%,JAK2;EGR1;MYD88;TLR6;TYROBP;USP50;MALT1;LGALS9;CASP8;AIM2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.22534142125889517,0.492386997589006,0.9801401869158879,1.0,1.0,4/26,19.93%,DDAH2;TLR6;ASS1;PKD2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.25640220938990693,0.49164661184692376,0.9578488372093024,1.0,1.0,10/10,74.38%,GNB1;GRK1;GNAT1;CNGA1;RHO;CNGB1;PDE6A;PDE6B;PDE6G;SAG
prerank,calcium ion homeostasis (GO:0055074),0.20400098896395052,0.48931570542064484,0.9919436052366566,1.0,1.0,10/95,15.73%,HTR2A;CSRP3;CAV1;CCR2;SLC10A7;TMTC2;FAM20A;TPT1;SLC24A4;SLC24A2
prerank,cardiocyte differentiation (GO:0035051),0.2583762757003261,0.48899360482559584,0.9680998613037448,1.0,1.0,5/10,30.81%,TGFB2;AKAP13;CBY1;NRG1;SIK1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.25950541737352095,0.48564616024439644,0.9654676258992806,1.0,1.0,3/10,21.40%,ATP7A;APPL1;ZEB2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.23616524032867753,0.48409539304023697,0.9712793733681462,1.0,1.0,3/16,16.99%,ADIPOR1;FOXK2;SIRT1
prerank,regulation of autophagosome maturation (GO:1901096),0.24159435953032193,0.4840489195399826,0.9668965517241379,1.0,1.0,5/13,26.73%,TBC1D25;FYCO1;CLN3;PHF23;SMCR8
prerank,aromatic amino acid family metabolic process (GO:0009072),0.2531748142823145,0.48391965697180545,0.9608938547486033,1.0,1.0,3/10,26.75%,ATP7A;QDPR;ASRGL1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.23718779649738658,0.48303858700344443,0.9655629139072848,1.0,1.0,5/16,24.17%,MYC;PAX2;PKD2;GDNF;NPNT
prerank,negative regulation of protein kinase activity (GO:0006469),0.20327951071614536,0.4823762803007265,0.9949031600407747,1.0,1.0,13/88,16.06%,RB1;CAV1;TAF7;CEP85;TAB1;PDPK1;PARK7;CDK5RAP3;PRKAG2;PPIA;DTNBP1;TARBP2;PAK2
prerank,sensory perception of light stimulus (GO:0050953),0.2058774968454408,0.48187313522241887,0.9948979591836735,1.0,1.0,7/87,14.82%,CRYBG3;CRYBA1;EYA3;RP2;ATF6;RDH10;ADGRV1
prerank,regulation of collagen biosynthetic process (GO:0032965),0.230729707485465,0.48177728154570665,0.9789864029666254,1.0,1.0,4/19,21.51%,RUNX1;F2R;VIM;CIITA
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.23656383310234275,0.48138237512026766,0.968421052631579,1.0,1.0,4/15,20.36%,SMOC2;FGFR1;PRKD2;MET
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.21490477069103006,0.4795144338330628,0.9854260089686099,1.0,1.0,11/35,23.36%,PMEPA1;TADA3;TMF1;MED1;SAFB;DDX54;CALCOCO1;RBFOX2;NEDD4;SRC;PLPP1
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.2399597310230061,0.4758884412421568,0.9743935309973046,1.0,1.0,1/13,9.85%,B3GNT2
prerank,neural crest cell development (GO:0014032),0.20669321863436915,0.47540961500286444,0.9824945295404814,1.0,1.0,4/44,11.60%,PHACTR4;PEF1;TCOF1;TAPT1
prerank,negative regulation of complement activation (GO:0045916),0.2507324100686953,0.4752082083316792,0.9697406340057637,1.0,1.0,2/10,19.23%,CR1L;CD55
prerank,mitochondrion disassembly (GO:0061726),0.21124854572062085,0.4751234654762208,0.9829738933030647,1.0,1.0,8/34,20.84%,MARK2;BECN1;AMBRA1;FIS1;CTSK;ATG2B;WDR45B;BNIP3
prerank,regulation of protein processing (GO:0070613),0.224732100495135,0.4734345074189612,0.9780487804878049,1.0,1.0,6/21,25.64%,CCBE1;RUNX1;LRRK2;CLN3;TMEM59;NLRC4
prerank,tRNA metabolic process (GO:0006399),0.22740082269328077,0.4731874789149536,0.9794608472400513,1.0,1.0,5/17,23.52%,DTD2;YARS2;RPP30;DTD1;KARS1
prerank,ceramide metabolic process (GO:0006672),0.20481702779922004,0.4720226753446688,0.9936034115138592,1.0,1.0,9/49,19.73%,SGMS2;ABCA2;ORMDL3;CERS4;SGMS1;CERS6;ACER3;CERS2;PPP2CA
prerank,chemical synaptic transmission (GO:0007268),0.19532705368497238,0.4715810280514617,1.0,1.0,1.0,45/284,21.70%,CHRNB4;MAPK1;CEL;PDE7B;SLC6A2;SLC6A5;HTR2A;CRHBP;EXOC4;SLC12A7;GABRA4;PRKACA;ERC1;KCNA1;BSN;PMP22;RIT2;GABRA5;PAFAH1B1;GRIA3;PTEN;HAP1;SLC12A6;CHRM3;NRXN2;GRIA2;NAPB;CACNA1B;SNCA;TSPOAP1;ERC2;NRXN1;GRM3;GLRA1;PRKAR2A;GABRB2;HCRT;APBA1;NAAA;GRIK5;GRIK3;SLC1A4;RPS6KA3;GRIN2D;BRSK1
prerank,sphingolipid metabolic process (GO:0006665),0.19566752642517982,0.47097275651529247,0.9989888776541962,1.0,1.0,27/108,25.07%,SGMS2;HACD4;PRKD3;GBA2;CSNK1G2;ABCA2;ORMDL3;VAPA;CERS4;SUMF1;SGMS1;ELOVL5;CERS6;ELOVL4;ACER3;SUMF2;CERS2;PPP2CA;PRKD2;GLTP;NEU1;PLPP1;SMPD1;PPM1L;ESYT2;PDXDC1;B3GALNT1
prerank,negative regulation of hydrolase activity (GO:0051346),0.2069737877118327,0.47024679835982536,0.9935828877005347,1.0,1.0,5/49,11.57%,TERF2;NEIL1;GMIP;PPP1R35;RDX
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.23996591429933628,0.4694140031440757,0.9764216366158114,1.0,1.0,1/12,9.85%,B3GNT2
prerank,carbohydrate biosynthetic process (GO:0016051),0.22166541817297278,0.46802068723716306,0.9837702871410736,1.0,1.0,7/21,29.71%,ST3GAL2;FUT8;ST8SIA6;FUT9;B3GALT1;MPDU1;ST3GAL3
prerank,digestive tract morphogenesis (GO:0048546),0.23795259663574025,0.46563945557367364,0.9813581890812251,1.0,1.0,3/14,23.24%,NIPBL;FGFR2;BBS7
prerank,protein alkylation (GO:0008213),0.21689738971390135,0.46483350972091203,0.9901477832512315,1.0,1.0,5/22,22.64%,LCMT1;GSPT1;PRMT3;SNRPB;EEF1AKMT2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2413813708179749,0.46378105866861136,0.9762258543833581,1.0,1.0,2/10,16.42%,ATP5F1D;ATP5MC2
prerank,regulation of rRNA processing (GO:2000232),0.23049885557718344,0.460518377427389,0.97265625,1.0,1.0,6/16,24.80%,KAT2B;SIRT7;DIMT1;RIOK1;TRMT112;USP36
prerank,protein localization to synapse (GO:0035418),0.23275951347442295,0.4593015763032796,0.978523489932886,1.0,1.0,6/12,28.18%,BSN;NRXN2;NRXN1;NLGN2;NLGN1;SHANK1
prerank,regulation of catecholamine secretion (GO:0050433),0.20867918263949842,0.45808733387093414,0.9896313364055299,1.0,1.0,6/29,20.96%,SYT8;SYT3;GRK2;DTNBP1;SNCA;SYT2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.194028873021085,0.4513062899781431,0.9967672413793104,1.0,1.0,3/53,13.37%,HTR2A;CALCRL;CHRM3
prerank,monocyte chemotaxis (GO:0002548),0.20008497356529703,0.4506510133654977,0.9907940161104718,1.0,1.0,3/32,16.69%,RPS19;TNFRSF11A;CCL25
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.22364538205562862,0.4503175637167309,0.9802631578947368,1.0,1.0,15/15,77.66%,ELOVL5;PPARD;NR1H3;NR1H2;LPGAT1;APOA1;ADIPOQ;NR4A3;PPARA;PPARG;MLXIPL;SLC45A3;MID1IP1;PPARGC1A;MLYCD
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.2346515022188589,0.4493908665912698,0.9873949579831933,1.0,1.0,3/11,22.80%,MYC;SOX9;FGFR2
prerank,peptide hormone secretion (GO:0030072),0.2020457117270547,0.4488399738426656,0.9869668246445498,1.0,1.0,3/26,13.71%,PARK7;ADCYAP1;CDK16
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.2277703184537344,0.448159603691645,0.9815059445178336,1.0,1.0,3/14,18.87%,CPSF1;CLP1;RTCB
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.23239478638488326,0.4461913479082353,0.972027972027972,1.0,1.0,2/12,13.72%,TAPT1;KDELR2
prerank,protein mono-ADP-ribosylation (GO:0140289),0.22734065875475715,0.4456184097337363,0.9768451519536903,1.0,1.0,5/11,29.40%,PARP14;PARP11;PARP9;TIPARP;PARP8
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.2195290423861851,0.4454162501759464,0.9871794871794872,1.0,1.0,17/17,78.07%,PLBD1;LCLAT1;PLAAT3;LPGAT1;PLA2G2E;PLA2G2F;PLA2G1B;PLA2G4D;PLA2G10;PLA2G2D;PLA2G4F;PLA2G5;PLA2G4C;MBOAT7;PLA2G4A;PLA2G12A;PLA2G4E
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.22245862137500033,0.44421125376117226,0.9889042995839112,1.0,1.0,1/13,8.57%,JAK2
prerank,heart trabecula morphogenesis (GO:0061384),0.2141855520494586,0.44273551741102546,0.9838709677419355,1.0,1.0,5/18,22.81%,NOTCH1;BMPR1A;TGFB2;RBPJ;FKBP1A
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.20109612642018765,0.43996138261088147,0.9874285714285714,1.0,1.0,2/29,11.02%,MBOAT2;PLBD1
prerank,regulation of dopamine secretion (GO:0014059),0.20090271687490924,0.43905713649320643,0.988399071925754,1.0,1.0,7/25,25.40%,SYT8;SYT3;DTNBP1;SNCA;SYT2;GDNF;SYT10
prerank,negative regulation of lipid metabolic process (GO:0045833),0.206932068626079,0.43646675238653254,0.9938875305623472,1.0,1.0,1/22,5.73%,PPP2R5A
prerank,superoxide metabolic process (GO:0006801),0.20142413015431324,0.43352544116825165,0.9964285714285714,1.0,1.0,6/29,22.32%,ATP7A;CYBB;CYBA;NCF4;SH3PXD2A;NRROS
prerank,lysosome localization (GO:0032418),0.19069590662727728,0.4324605999935884,0.9954802259887006,1.0,1.0,8/37,24.81%,MILR1;HDAC6;VPS33B;SPAG9;PLEKHM1;RAB34;MYH9;BORCS5
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.19498625248566895,0.43225983270020935,0.9928909952606635,1.0,1.0,6/26,22.81%,UBQLN1;GPR35;YWHAE;PKD2;CALM3;FKBP1A
prerank,tRNA 5'-end processing (GO:0099116),0.2113965660686081,0.430956409424243,0.993573264781491,1.0,1.0,4/15,22.78%,PRORP;POP4;TRMT10C;RPP30
prerank,icosanoid biosynthetic process (GO:0046456),0.2267861760890784,0.4291360162194127,0.9898550724637681,1.0,1.0,2/10,21.10%,LTA4H;MGST3
prerank,lymphocyte migration (GO:0072676),0.19079534416660673,0.42902509401557093,0.9965075669383003,0.9997598537368448,1.0,3/32,16.69%,MSN;CCR6;CCL25
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.22050678713641841,0.4274180987286446,0.9836065573770492,0.999643772711675,1.0,2/12,15.92%,PLCB1;SLAMF8
prerank,response to prostaglandin E (GO:0034695),0.21984924582924367,0.4244362242849856,0.9883551673944687,0.999701691076359,1.0,2/10,22.04%,PTGER4;GNB1
prerank,negative regulation of ATPase activity (GO:0032780),-0.1493783749843024,-0.41075845139736245,1.0,0.9994822971679376,1.0,16/16,85.08%,TSC1;THADA;PAM16;IFIT1;PPIF;TLR9;PLN;LTF;VCPKMT;TNNI3;TNNT2;OXA1L;ATP5IF1;PXK;SIRT1;TP53
prerank,miRNA metabolic process (GO:0010586),0.19226718654024985,0.4098836656619723,0.9900744416873449,1.0,1.0,3/20,19.61%,TUT4;TARBP2;AGO2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.19970440258013822,0.4096138689692128,0.9922077922077922,1.0,1.0,4/17,23.58%,CIB1;TGFB2;SYK;PIEZO1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.21097231812190076,0.4072876389194984,0.993103448275862,1.0,1.0,11/11,78.92%,TGFB2;TGFB1;GATA4;TBX5;WNT3A;MYOCD;GPER1;GREM1;DHX36;MEF2C;EFNB2
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.20652186169687237,0.4067922078172649,0.9946949602122016,1.0,1.0,4/13,23.36%,MED1;ABHD2;CALCOCO1;PLPP1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.18870983629324983,0.40203049048302897,0.9963811821471653,1.0,1.0,6/23,25.96%,CAV1;DUSP22;SOCS4;TSG101;SH3BP5;CBL
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.1983326990864638,0.39996029185819404,0.9960264900662251,1.0,1.0,3/13,20.70%,NFATC3;SOX9;PPARD
prerank,regulation of gluconeogenesis (GO:0006111),0.17892791844489345,0.3956547688847233,0.9942062572421785,1.0,1.0,6/27,23.88%,SIRT7;SDHAF3;SIRT1;USP7;PGP;CLK2
prerank,diol biosynthetic process (GO:0034312),0.19086850434347244,0.38566454329473315,0.9973753280839895,1.0,1.0,2/15,16.54%,ABCA2;ACER3
prerank,negative regulation of glycolytic process (GO:0045820),0.20602185728396136,0.382414265892469,0.9956268221574344,1.0,1.0,3/10,27.39%,HDAC4;CBFA2T3;NUPR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.20602185728396136,0.382414265892469,0.9956268221574344,1.0,1.0,3/10,27.39%,HDAC4;CBFA2T3;NUPR1
prerank,phasic smooth muscle contraction (GO:0014821),0.19490114513134493,0.3750870740137802,1.0,1.0,1.0,2/10,23.65%,TIFAB;GDNF
prerank,negative regulation of RNA metabolic process (GO:0051253),0.18372737401032727,0.37207065289542623,0.9974968710888611,1.0,1.0,6/18,28.01%,KAT2B;PTBP2;PTBP1;NCOR2;RPS13;PTBP3
prerank,tRNA 5'-leader removal (GO:0001682),0.1846545196298467,0.36864453767045696,0.9986928104575163,0.9999859722961455,1.0,3/13,22.78%,PRORP;POP4;RPP30
prerank,embryonic eye morphogenesis (GO:0048048),0.1891688171836303,0.3679617560976523,0.9973226238286479,0.9996674617000272,1.0,2/11,18.15%,RARG;KDM2B
prerank,response to organonitrogen compound (GO:0010243),0.16007802685841246,0.3633292893303259,1.0,0.9995011852343445,1.0,8/38,25.82%,RCN3;SYVN1;GLRA1;CCDC47;HLCS;DNAJB12;DERL1;VCP
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.15801023393419883,0.34013582229777184,0.998769987699877,0.9998659192478669,1.0,6/23,28.00%,ACSL5;ELOVL5;FAR1;ACSL6;ACSL4;ACOT7
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.15409208321957368,0.32199639021520926,1.0,0.9997877173513735,1.0,2/18,14.51%,ACSL5;ELOVL5
